data_2k54_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k54 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.454 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 50.7 p -65.98 -43.62 87.28 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.407 -1.269 . . . . 0.0 111.749 -172.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.21 -6.82 31.46 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.622 0.769 . . . . 0.0 112.722 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.438 ' HB ' HD13 ' A' ' 71' ' ' ILE . 14.4 mm -95.78 -29.64 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.649 0.78 . . . . 0.0 109.016 174.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -77.73 -33.01 53.15 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.701 0.801 . . . . 0.0 111.492 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 3' ' ' SER . 93.0 mt -58.91 -49.54 92.81 Favored Pre-proline 0 N--CA 1.489 1.492 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.384 -176.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.599 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 11.9 Cg_endo -56.29 -60.92 0.39 Allowed 'Trans proline' 0 C--N 1.392 2.816 0 C-N-CA 122.245 1.964 . . . . 0.0 112.303 175.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.447 HG22 HG11 ' A' ' 76' ' ' VAL . 22.6 m -64.27 -29.54 47.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.848 -167.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -68.72 -55.18 12.19 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.564 0.745 . . . . 0.0 109.88 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -62.97 -35.08 78.96 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.892 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -74.79 -42.52 57.97 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.6 0.76 . . . . 0.0 111.438 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 66' ' ' LEU . 22.9 tp -60.76 -46.79 89.11 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.851 0.46 . . . . 0.0 110.401 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.22 -49.94 74.43 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.94 173.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.85 -25.91 68.38 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.267 1.027 . . . . 0.0 112.3 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -63.75 -44.1 94.51 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.595 0.758 . . . . 0.0 110.71 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -91.25 -28.24 17.92 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.814 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.85 -10.23 59.74 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.831 0.852 . . . . 0.0 112.111 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 69.11 44.68 0.97 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.876 1.27 . . . . 0.0 112.095 173.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -115.77 93.81 4.42 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.261 0.624 . . . . 0.0 109.566 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.524 HG13 HG12 ' A' ' 54' ' ' ILE . 12.8 mm -71.62 -29.63 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 122.864 0.466 . . . . 0.0 111.35 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.78 -45.12 93.27 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.458 0.303 . . . . 0.0 111.4 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.43 -32.36 42.79 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.991 0.516 . . . . 0.0 110.94 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.488 ' HB3' ' HA ' ' A' ' 21' ' ' ILE . 50.8 t80 -70.05 -10.33 58.34 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.888 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.661 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -111.53 -29.74 7.64 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.453 0.701 . . . . 0.0 111.24 174.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.04 -54.25 32.31 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.808 0.843 . . . . 0.0 112.241 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.599 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 95.5 m95 -78.39 4.64 12.49 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.467 -1.242 . . . . 0.0 113.452 -169.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.482 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 28.3 m95 -93.29 162.37 14.03 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.54 0.736 . . . . 0.0 109.521 174.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -79.67 152.16 30.11 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.793 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.41 -27.24 66.91 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 120.782 0.325 . . . . 0.0 111.3 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.32 18.86 21.39 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.633 0.773 . . . . 0.0 110.791 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.482 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 53.2 t -60.72 133.8 56.45 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.069 0.548 . . . . 0.0 112.12 -174.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -88.08 148.96 24.23 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 43' ' ' ALA . 56.6 t80 -140.53 112.85 7.87 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.436 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 27.0 m-85 -108.25 154.88 21.14 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.037 0.935 . . . . 0.0 110.83 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.451 ' HB1' HD13 ' A' ' 42' ' ' LEU . . . -113.39 155.31 25.46 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.872 1.269 . . . . 0.0 109.341 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.703 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 69.3 t80 -53.54 125.49 44.96 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.398 1.079 . . . . 0.0 111.971 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -76.85 -58.4 0.14 OUTLIER 'Cis proline' 0 C--N 1.383 2.362 0 CA-C-N 120.344 1.159 . . . . 0.0 113.986 -4.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -145.3 78.85 1.56 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.473 0.709 . . . . 0.0 109.819 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 94.5 m -125.95 106.05 9.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.473 0.709 . . . . 0.0 109.709 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.5 tp -66.12 102.41 0.82 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.549 0.74 . . . . 0.0 110.937 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.451 HD13 ' HB1' ' A' ' 36' ' ' ALA . 41.2 mt -79.79 -35.86 37.92 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.384 0.673 . . . . 0.0 110.553 175.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 34' ' ' TYR . . . -142.49 121.32 12.71 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.436 -171.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.91 35.38 4.9 Favored Glycine 0 C--N 1.347 1.176 0 C-N-CA 123.239 0.447 . . . . 0.0 112.754 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 p30 168.45 161.31 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.65 1.58 . . . . 0.0 109.79 -172.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -64.96 -36.93 85.96 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.407 1.083 . . . . 0.0 112.918 -173.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.28 82.86 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.124 0.569 . . . . 0.0 111.84 -173.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.413 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 27.4 mt-10 -77.02 -33.29 57.44 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.988 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.8 mt -61.64 -50.44 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.676 0.79 . . . . 0.0 110.756 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.661 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 21.3 ptt180 -61.91 -49.93 74.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 118.841 -0.599 . . . . 0.0 110.525 -177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.5 t -59.29 -42.82 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.531 0.732 . . . . 0.0 110.668 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HA ' ' HE ' ' A' ' 52' ' ' ARG . 2.1 tpm_? -55.17 -43.72 74.54 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.024 0.827 . . . . 0.0 110.704 176.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -78.24 -29.78 48.34 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.387 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.524 HG12 HG13 ' A' ' 21' ' ' ILE . 95.7 mt -61.42 -38.47 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 118.414 0.552 . . . . 0.0 109.673 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -58.88 -40.17 83.59 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.653 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -70.47 -32.95 70.69 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.074 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -74.66 -8.66 57.08 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.811 0.844 . . . . 0.0 111.832 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.457 ' HE2' HG23 ' A' ' 54' ' ' ILE . 72.6 mmtt -71.12 -27.27 63.46 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.775 0.43 . . . . 0.0 111.542 174.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.44 117.05 43.25 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.97 -22.08 42.51 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.302 2.002 . . . . 0.0 110.885 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -85.84 -5.54 59.23 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.618 1.567 . . . . 0.0 112.603 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.79 120.9 12.17 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.418 0.287 . . . . 0.0 110.314 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -150.93 117.67 5.8 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.3 102.64 2.95 Favored Glycine 0 C--N 1.344 1.002 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -95.3 103.07 14.92 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.4 ' HB2' HD21 ' A' ' 13' ' ' LEU . 8.7 tp -68.02 139.88 56.32 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.134 0.492 . . . . 0.0 110.81 -177.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mt -107.39 -53.01 2.68 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.463 1.105 . . . . 0.0 108.392 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.8 m -148.11 144.69 27.99 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 113.613 -1.631 . . . . 0.0 109.739 -172.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 25.2 ptt180 -140.7 128.55 21.81 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.115 0.966 . . . . 0.0 108.739 173.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.475 HG21 ' HB ' ' A' ' 77' ' ' ILE . 33.1 m -123.83 152.08 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.438 HD13 ' HB ' ' A' ' 5' ' ' ILE . 11.2 tt -133.35 118.72 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.25 0.548 . . . . 0.0 110.401 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.6 t -112.18 95.27 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.368 1.067 . . . . 0.0 108.429 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.92 -111.1 3.8 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 116.027 -0.533 . . . . 0.0 113.433 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -93.44 12.43 25.0 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.769 0.828 . . . . 0.0 111.615 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.1 t -125.72 134.25 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.74 0.816 . . . . 0.0 109.52 -171.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.447 HG11 HG22 ' A' ' 9' ' ' VAL . 24.5 t -125.69 135.17 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 122.807 0.443 . . . . 0.0 110.355 175.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.559 HD11 ' HB ' ' A' ' 98' ' ' ILE . 9.0 mm -99.81 105.06 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.092 1.357 . . . . 0.0 108.006 169.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.01 105.87 17.86 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 167.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.451 ' HE1' ' HB3' ' A' ' 94' ' ' ASP . 1.8 t60 -100.21 106.78 18.49 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.95 169.18 12.95 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.942 1.297 . . . . 0.0 110.18 -176.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.6 m -116.71 110.16 18.09 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.2 t -81.29 103.41 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.362 0.665 . . . . 0.0 110.123 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 88.0 m -66.24 118.81 10.48 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -123.98 -169.29 1.93 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.572 1.149 . . . . 0.0 108.031 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.1 109.37 16.33 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.39 0.676 . . . . 0.0 109.424 169.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -103.81 147.02 33.62 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 123.655 0.782 . . . . 0.0 110.015 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.02 -9.86 27.54 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.876 2.384 . . . . 0.0 114.216 -175.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -92.35 -15.14 27.7 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.419 0.287 . . . . 0.0 111.66 173.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.05 -121.66 1.03 Allowed Glycine 0 C--N 1.355 1.626 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.956 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -53.79 -84.57 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.503 1.121 . . . . 0.0 111.994 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.58 28.54 2.72 Favored Glycine 0 C--N 1.349 1.276 0 C-N-CA 121.686 -0.292 . . . . 0.0 113.575 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -89.77 119.57 30.27 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -173.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 116' ' ' PRO . 33.4 m -116.49 123.16 71.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 CA-C-O 121.114 0.483 . . . . 0.0 110.045 -175.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.451 ' HB3' ' HE1' ' A' ' 79' ' ' HIS . 2.8 m-20 -84.19 108.0 16.83 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.46 HG22 HG12 ' A' ' 113' ' ' ILE . 24.0 t -113.14 149.42 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.788 1.235 . . . . 0.0 109.432 -174.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -112.84 103.19 11.18 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 167.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 76.7 m -93.76 109.05 20.74 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.559 ' HB ' HD11 ' A' ' 77' ' ' ILE . 4.9 tt -99.3 134.6 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.244 1.018 . . . . 0.0 109.739 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -123.22 155.6 36.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.773 0.829 . . . . 0.0 109.866 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -129.07 119.42 24.17 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.892 1.277 . . . . 0.0 107.645 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.479 HG21 HG12 ' A' ' 106' ' ' ILE . 97.1 t -107.46 117.62 53.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.226 1.01 . . . . 0.0 109.695 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.519 ' HG2' ' ND2' ' A' ' 103' ' ' ASN . 43.0 tt0 -126.95 133.26 50.66 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.92 0.888 . . . . 0.0 109.23 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.519 ' ND2' ' HG2' ' A' ' 102' ' ' GLU . 48.1 m-80 61.54 28.62 17.84 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.027 1.331 . . . . 0.0 111.798 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.05 -7.56 80.0 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -121.27 149.29 43.1 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.479 HG12 HG21 ' A' ' 101' ' ' VAL . 47.7 mt -66.41 109.77 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 102' ' ' GLU . . . -75.78 -38.41 58.31 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.865 0.866 . . . . 0.0 110.608 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -149.12 146.7 27.82 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.191 0.996 . . . . 0.0 109.059 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -145.84 139.68 26.52 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.154 0.582 . . . . 0.0 109.504 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.436 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 2.0 m-90 -131.78 155.8 47.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -142.24 145.02 33.62 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 171.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.703 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 59.9 pttt -129.06 124.27 34.42 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.627 0.771 . . . . 0.0 109.066 175.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.46 HG12 HG22 ' A' ' 95' ' ' VAL . 96.5 mt -88.63 123.94 41.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.9 -66.84 2.24 Favored Glycine 0 C--O 1.242 0.607 0 O-C-N 124.39 1.056 . . . . 0.0 112.876 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -158.55 163.77 23.27 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.084 0.554 . . . . 0.0 109.653 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.662 ' HA ' HG12 ' A' ' 93' ' ' VAL . 88.7 Cg_endo -82.23 137.29 9.39 Favored 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.561 2.174 . . . . 0.0 112.475 163.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -132.82 158.74 41.73 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.74 0.781 . . . . 0.0 111.934 175.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.3 mm -138.54 139.63 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.235 1.414 . . . . 0.0 108.375 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.493 1.709 0 C-N-CA 124.001 0.921 . . . . 0.0 111.827 -179.384 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.49 ' HB2' HD11 ' A' ' 71' ' ' ILE . 11.1 m120 . . . . . 0 N--CA 1.474 0.752 0 CA-C-O 121.617 0.722 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.467 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 45.7 m -67.42 -33.22 74.71 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.547 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.29 -11.27 30.16 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.618 0.767 . . . . 0.0 112.408 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.504 HG13 ' HA ' ' A' ' 74' ' ' ASN . 16.3 mm -98.06 -32.55 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.742 0.817 . . . . 0.0 109.824 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -69.18 -33.81 73.94 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.66 0.784 . . . . 0.0 112.099 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.9 mt -66.83 -50.33 44.33 Favored Pre-proline 0 N--CA 1.486 1.331 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.182 -173.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.568 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 12.2 Cg_endo -54.83 -52.23 8.5 Favored 'Trans proline' 0 C--N 1.398 3.132 0 C-N-CA 122.136 1.891 . . . . 0.0 111.525 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.439 HG13 HG12 ' A' ' 76' ' ' VAL . 72.4 t -58.08 -43.64 85.66 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 C-N-CA 124.774 1.23 . . . . 0.0 112.496 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.402 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 24.4 tp60 -66.13 -55.87 14.25 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.409 0.684 . . . . 0.0 111.472 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 27' ' ' TRP . 73.4 mmtt -65.33 -38.34 89.85 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.325 0.65 . . . . 0.0 110.817 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -62.89 -39.49 94.65 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.523 1.129 . . . . 0.0 111.343 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.81 -52.81 63.88 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 20.5 mm-40 -61.57 -32.03 72.09 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.806 -174.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.57 -27.64 55.93 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.588 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -63.66 -47.36 81.6 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.218 1.007 . . . . 0.0 110.812 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -84.76 -23.49 29.2 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.17 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.64 -6.8 58.76 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.153 0.581 . . . . 0.0 112.337 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 71.8 12.59 6.22 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.268 1.427 . . . . 0.0 113.042 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -76.28 94.46 3.57 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.457 HG13 HG12 ' A' ' 54' ' ' ILE . 12.5 mm -66.95 -28.54 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.728 0.811 . . . . 0.0 110.883 173.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -58.62 -46.63 86.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.851 0.46 . . . . 0.0 111.1 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.6 -30.88 41.64 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.365 0.666 . . . . 0.0 110.972 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -72.87 -7.66 51.94 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.49 0.716 . . . . 0.0 110.514 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.729 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -116.35 -25.31 7.56 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.409 0.684 . . . . 0.0 112.034 175.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.6 -40.53 79.28 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.835 0.854 . . . . 0.0 113.123 -171.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 90.5 m95 -89.69 1.7 55.71 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.404 -173.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 14.2 m95 -99.05 138.6 35.92 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.576 0.75 . . . . 0.0 109.141 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -71.46 160.66 32.35 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.443 0.697 . . . . 0.0 111.174 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -61.25 -39.82 91.74 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.398 0.679 . . . . 0.0 111.546 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -99.12 19.98 14.25 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.463 1.105 . . . . 0.0 110.856 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 50.1 t -58.03 115.12 2.68 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.224 0.609 . . . . 0.0 111.714 -176.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -75.68 153.2 37.3 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 59.8 t80 -142.07 118.67 11.0 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -115.82 153.1 32.08 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.476 1.11 . . . . 0.0 109.673 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.39 161.23 23.84 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.232 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -57.99 128.97 81.96 Favored Pre-proline 0 CA--C 1.562 1.404 0 O-C-N 124.327 1.017 . . . . 0.0 110.77 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -75.9 -51.16 0.16 OUTLIER 'Cis proline' 0 C--N 1.384 2.44 0 CA-C-N 120.185 1.102 . . . . 0.0 114.03 -0.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.0 86.4 0.62 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.2 m -141.88 117.7 10.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.38 0.672 . . . . 0.0 109.977 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 tt -68.84 106.76 2.81 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.258 1.023 . . . . 0.0 109.899 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.3 mt -82.29 -42.52 18.72 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.397 0.679 . . . . 0.0 111.345 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . . . -141.47 117.22 10.39 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.872 0.469 . . . . 0.0 111.113 -170.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.27 42.72 1.9 Allowed Glycine 0 N--CA 1.478 1.441 0 O-C-N 123.117 0.26 . . . . 0.0 113.014 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 p30 167.69 156.51 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.649 1.579 . . . . 0.0 108.934 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -63.61 -32.88 74.48 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.782 0.833 . . . . 0.0 112.776 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.79 90.99 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.156 0.582 . . . . 0.0 112.221 -173.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 30.2 mt-10 -74.16 -34.86 63.96 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.617 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.8 mt -58.59 -45.41 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.049 0.94 . . . . 0.0 110.432 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.729 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 21.6 ttt180 -54.33 -56.71 15.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.43 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.7 t -54.77 -49.47 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 124.708 1.255 . . . . 0.0 111.568 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -62.18 -36.97 83.51 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.345 -174.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -77.55 -34.57 53.75 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 118.894 -0.574 . . . . 0.0 111.842 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 50' ' ' ARG . 77.5 mt -56.42 -40.32 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.053 0.454 . . . . 0.0 109.867 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -57.26 -43.0 82.62 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.506 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -76.25 -22.33 55.28 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 120.801 0.334 . . . . 0.0 111.282 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.457 ' HA ' HD23 ' A' ' 62' ' ' LEU . 3.5 m-30 -79.76 -0.5 34.62 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.527 0.731 . . . . 0.0 112.032 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -73.55 -30.63 63.19 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.097 0.559 . . . . 0.0 111.28 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -63.08 121.04 66.65 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.278 0.631 . . . . 0.0 110.883 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.75 -23.67 26.01 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.263 1.976 . . . . 0.0 110.773 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.34 -10.53 59.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.015 1.326 . . . . 0.0 111.477 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 57' ' ' PHE . 42.7 tp -59.29 112.63 1.81 Allowed 'General case' 0 C--N 1.36 1.024 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -148.76 130.37 14.95 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.259 1.023 . . . . 0.0 108.332 -175.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.16 127.15 8.24 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -122.56 102.99 8.4 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.512 HD11 ' HG2' ' A' ' 80' ' ' GLU . 6.3 tp -69.72 138.11 52.6 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.403 0.62 . . . . 0.0 111.208 -175.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.467 HD11 ' HG1' ' A' ' 81' ' ' THR . 7.7 mt -105.88 -50.85 3.09 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.822 1.249 . . . . 0.0 108.253 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.7 m -150.11 141.44 23.25 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 113.24 -1.8 . . . . 0.0 109.844 -173.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -131.38 130.43 42.6 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 165.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.59 127.6 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.884 1.274 . . . . 0.0 110.273 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.49 HD11 ' HB2' ' A' ' 2' ' ' ASN . 15.7 tt -102.89 120.67 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.145 0.578 . . . . 0.0 109.7 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.43 94.54 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 124.194 0.998 . . . . 0.0 108.486 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.37 -118.02 11.91 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 123.323 0.389 . . . . 0.0 112.669 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.504 ' HA ' HG13 ' A' ' 5' ' ' ILE . 2.5 p-10 -95.04 7.99 44.36 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.325 0.65 . . . . 0.0 111.689 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.6 t -116.31 141.54 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.59 1.156 . . . . 0.0 108.581 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.454 HG21 HG21 ' A' ' 5' ' ' ILE . 70.0 t -126.29 133.5 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.004 0.522 . . . . 0.0 109.615 170.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.48 HG12 ' HB ' ' A' ' 98' ' ' ILE . 5.2 mt -100.65 114.84 40.79 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 164.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -96.65 150.84 20.22 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 166.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -138.09 106.34 5.77 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.512 ' HG2' HD11 ' A' ' 66' ' ' LEU . 6.6 mt-10 -115.75 158.98 22.02 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.344 0.658 . . . . 0.0 109.558 176.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.467 ' HG1' HD11 ' A' ' 67' ' ' LEU . 56.9 m -97.05 103.14 15.04 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 163.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.53 125.2 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.452 0.644 . . . . 0.0 111.319 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.9 m -76.28 122.92 25.11 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.121 0.969 . . . . 0.0 111.708 -175.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.2 mmt-85 -119.97 -168.29 1.58 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.623 1.169 . . . . 0.0 109.189 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.81 104.99 9.29 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.275 1.03 . . . . 0.0 109.539 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.408 ' HE2' ' HB3' ' A' ' 116' ' ' PRO . 12.6 m-30 -112.4 149.46 41.09 Favored Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 123.558 0.743 . . . . 0.0 111.054 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.61 -18.84 64.05 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.952 2.435 . . . . 0.0 113.608 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -87.0 -4.38 59.17 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.44 -122.68 1.48 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.931 -0.372 . . . . 0.0 112.466 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -60.43 -82.14 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.983 0.913 . . . . 0.0 111.5 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.41 26.92 3.27 Favored Glycine 0 C--N 1.343 0.952 0 O-C-N 122.953 0.158 . . . . 0.0 113.205 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.453 ' HB2' HG23 ' A' ' 81' ' ' THR . 16.9 pt-20 -89.21 104.7 17.22 Favored 'General case' 0 C--O 1.207 -1.138 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -174.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.691 HG13 ' HA ' ' A' ' 116' ' ' PRO . 20.3 m -105.16 131.12 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 121.33 -0.856 . . . . 0.0 109.973 -171.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -78.33 127.91 32.91 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.503 HG23 HG12 ' A' ' 113' ' ' ILE . 43.1 t -131.57 126.25 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.09 99.41 12.43 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 172.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.6 m -94.81 108.51 20.53 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.152 0.981 . . . . 0.0 108.843 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.586 HG21 ' HB2' ' A' ' 110' ' ' TRP . 11.1 tt -105.86 107.23 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 C-N-CA 124.403 1.081 . . . . 0.0 110.735 -172.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -104.14 131.17 51.7 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.35 1.06 . . . . 0.0 110.024 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -97.82 112.03 24.09 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 168.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 106' ' ' ILE . 75.2 t -99.62 125.1 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.077 0.951 . . . . 0.0 109.15 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.523 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 11.4 tp10 -125.81 127.94 46.9 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.476 0.71 . . . . 0.0 109.981 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.523 ' ND2' ' HG3' ' A' ' 102' ' ' GLU . 43.5 m-80 61.48 30.43 18.82 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.45 1.5 . . . . 0.0 112.116 -176.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.54 1.95 90.56 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 113.781 0.272 . . . . 0.0 113.781 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -124.79 136.0 53.46 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.047 0.939 . . . . 0.0 109.007 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.491 HG12 HG22 ' A' ' 101' ' ' VAL . 68.8 mt -62.43 102.86 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.252 1.021 . . . . 0.0 109.811 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -78.47 -29.89 47.09 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.291 0.636 . . . . 0.0 110.765 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -148.57 143.26 26.49 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -137.05 131.03 32.22 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.586 ' HB2' HG21 ' A' ' 98' ' ' ILE . 0.9 OUTLIER -135.37 152.86 51.84 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -176.319 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -143.0 144.85 32.46 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -130.82 123.7 29.69 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.503 HG12 HG23 ' A' ' 95' ' ' VAL . 96.7 mt -88.22 127.48 41.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.93 -78.82 0.16 Allowed Glycine 0 N--CA 1.468 0.826 0 O-C-N 124.331 1.019 . . . . 0.0 112.667 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -158.83 164.58 20.65 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.691 ' HA ' HG13 ' A' ' 93' ' ' VAL . 72.3 Cg_endo -72.2 117.69 5.26 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.433 2.089 . . . . 0.0 112.581 169.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.403 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 15.6 mmt180 -102.11 144.11 31.09 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 49.4 mm -122.83 152.37 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 173.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 N--CA 1.493 1.715 0 C-N-CA 122.646 0.378 . . . . 0.0 111.402 -178.741 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 119.747 -0.168 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.43 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 78.7 p -63.78 -37.79 88.69 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.461 ' HG3' HG12 ' A' ' 5' ' ' ILE . 9.5 pt-20 -55.8 -28.28 55.41 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.72 1.208 . . . . 0.0 112.716 174.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.575 HG13 ' HA ' ' A' ' 74' ' ' ASN . 32.8 mm -89.83 -27.88 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.492 1.117 . . . . 0.0 109.826 -177.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.39 -24.04 60.25 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.117 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 3' ' ' SER . 79.5 mt -63.6 -50.65 71.34 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.725 -175.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.466 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 11.6 Cg_endo -55.96 -60.4 0.52 Allowed 'Trans proline' 0 C--N 1.394 2.932 0 C-N-CA 121.866 1.711 . . . . 0.0 111.984 172.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.3 t -51.07 -48.95 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 C-N-CA 124.509 1.123 . . . . 0.0 113.347 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.417 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -63.09 -52.21 63.56 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.173 0.989 . . . . 0.0 110.937 -176.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -63.54 -37.17 86.29 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.029 0.532 . . . . 0.0 111.282 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -68.26 -38.1 81.42 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.116 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 66' ' ' LEU . 50.8 tp -62.53 -50.86 69.69 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.524 0.73 . . . . 0.0 110.872 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 4.0 mm-40 -55.42 -47.23 76.27 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.31 1.007 . . . . 0.0 109.477 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 20' ' ' ASP . . . -66.22 -28.79 69.01 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.229 -1.35 . . . . 0.0 112.329 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -67.45 -48.26 67.76 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.176 0.59 . . . . 0.0 110.488 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -83.71 -14.67 51.11 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.251 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.96 0.4 55.95 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.425 0.69 . . . . 0.0 111.992 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 62.71 26.0 15.4 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.463 1.105 . . . . 0.0 111.851 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 13.1 t70 -96.48 110.57 22.92 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.793 1.237 . . . . 0.0 109.31 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.4 mm -76.84 -32.89 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.1 0.56 . . . . 0.0 110.999 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 24.8 t70 -58.19 -49.06 78.38 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.745 0.653 . . . . 0.0 112.161 -168.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.81 -35.63 22.2 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.177 0.991 . . . . 0.0 111.392 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -63.01 -14.18 44.67 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.293 0.371 . . . . 0.0 112.0 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 68.2 mmm -120.66 -14.4 8.6 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -60.79 -36.51 79.19 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.552 0.691 . . . . 0.0 112.304 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 91.8 m95 -93.57 14.03 20.13 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.718 -170.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.429 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 19.3 m95 -99.12 152.45 19.85 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.778 0.831 . . . . 0.0 109.267 174.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -78.92 154.54 29.58 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.262 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.44 -32.04 72.84 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.118 0.567 . . . . 0.0 111.184 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -99.42 17.9 19.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.889 0.875 . . . . 0.0 111.337 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.429 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 46.9 t -64.54 117.92 8.06 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 123.209 0.318 . . . . 0.0 111.549 -174.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.411 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 33.2 mm-40 -77.68 154.09 32.47 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -139.39 110.44 6.87 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.468 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 96.4 m-85 -113.37 138.33 50.22 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.818 0.847 . . . . 0.0 110.572 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.508 ' HB1' HD22 ' A' ' 42' ' ' LEU . . . -92.21 154.95 18.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.459 166.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -50.04 130.03 22.73 Favored Pre-proline 0 CA--C 1.567 1.617 0 C-N-CA 124.268 1.027 . . . . 0.0 112.508 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.43 -36.34 2.15 Favored 'Cis proline' 0 C--N 1.383 2.371 0 CA-C-N 119.967 1.024 . . . . 0.0 112.134 -4.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.62 94.57 1.16 Allowed 'General case' 0 C--N 1.345 0.41 0 C-N-CA 124.821 1.248 . . . . 0.0 107.748 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 7.2 m -130.18 102.4 6.21 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.5 tp -73.1 100.89 3.15 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 117.961 0.346 . . . . 0.0 110.447 -175.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.508 HD22 ' HB1' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -83.36 -34.31 25.63 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.044 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -146.37 116.91 7.54 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.81 -173.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -107.53 46.66 1.14 Allowed Glycine 0 C--N 1.347 1.147 0 C-N-CA 123.032 0.349 . . . . 0.0 113.034 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.43 ' O ' HG13 ' A' ' 49' ' ' ILE . 9.6 p30 162.08 154.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 126.149 1.78 . . . . 0.0 109.227 -171.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -63.5 -26.28 68.64 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -175.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.22 -51.4 67.93 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.803 0.441 . . . . 0.0 110.98 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.429 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.0 mt-10 -68.41 -33.43 74.21 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.108 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 45' ' ' ASN . 54.2 mt -69.2 -43.14 81.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 122.962 0.505 . . . . 0.0 110.264 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.484 ' O ' HG13 ' A' ' 54' ' ' ILE . 32.0 ptt180 -69.87 -45.18 68.28 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.605 -173.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.8 m -68.95 -35.03 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 122.859 0.463 . . . . 0.0 111.894 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -71.41 -40.1 70.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.297 0.639 . . . . 0.0 110.357 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -64.61 -33.33 75.68 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.57 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 50' ' ' ARG . 97.0 mt -58.16 -47.07 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 122.557 0.343 . . . . 0.0 110.184 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.21 -33.3 75.09 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.455 0.702 . . . . 0.0 111.498 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -66.79 -35.04 79.15 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.174 0.59 . . . . 0.0 110.956 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -78.75 -2.45 39.47 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.21 0.604 . . . . 0.0 112.02 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -84.58 -19.71 32.63 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.948 0.499 . . . . 0.0 110.756 171.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.11 113.55 8.17 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 123.694 0.798 . . . . 0.0 109.813 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -61.35 -32.23 89.37 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 123.107 2.538 . . . . 0.0 113.547 -169.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.22 -0.6 56.79 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.723 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.6 tp -62.82 118.9 8.37 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.202 0.455 . . . . 0.0 111.359 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.476 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 76.3 t80 -151.02 127.56 10.77 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.84 104.2 2.53 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -97.83 100.89 12.27 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.168 0.587 . . . . 0.0 109.51 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.424 ' HB2' HD12 ' A' ' 13' ' ' LEU . 7.7 tt -79.53 129.7 34.71 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.442 HD11 ' CD2' ' A' ' 79' ' ' HIS . 1.7 pp -115.9 -29.8 6.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.468 -175.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.5 m -150.69 143.79 24.77 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.957 0.903 . . . . 0.0 109.559 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -143.61 136.92 27.93 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.56 0.744 . . . . 0.0 109.326 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.78 130.88 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.493 HD13 ' HB ' ' A' ' 5' ' ' ILE . 9.5 tt -121.98 136.51 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.031 0.532 . . . . 0.0 110.258 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 p -143.35 110.05 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 124.678 1.191 . . . . 0.0 109.186 -176.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.78 -119.71 9.26 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.202 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.575 ' HA ' HG13 ' A' ' 5' ' ' ILE . 27.0 p-10 -108.63 19.86 19.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.275 0.63 . . . . 0.0 111.077 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -127.48 133.63 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.09 0.956 . . . . 0.0 109.251 -175.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 15.1 t -122.57 138.97 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.175 0.59 . . . . 0.0 110.255 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.516 HD13 ' HB ' ' A' ' 98' ' ' ILE . 6.7 mm -104.96 111.9 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.061 1.344 . . . . 0.0 107.708 167.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -106.35 116.06 31.28 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.443 ' HE1' ' HB3' ' A' ' 94' ' ' ASP . 1.5 t60 -99.83 109.01 21.43 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.36 140.05 52.06 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.947 1.299 . . . . 0.0 110.624 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.1 m -86.1 106.5 17.28 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.82 0.848 . . . . 0.0 109.131 169.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.4 t -82.79 104.08 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.754 0.822 . . . . 0.0 110.441 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 63' ' ' TYR . 25.3 m -68.06 127.99 34.89 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.089 0.556 . . . . 0.0 110.425 170.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -139.07 -170.24 2.83 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.801 0.84 . . . . 0.0 109.097 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -119.3 100.55 7.38 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.877 0.471 . . . . 0.0 110.648 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -100.22 142.6 24.92 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 123.714 0.806 . . . . 0.0 109.65 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.04 -23.03 66.79 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.983 2.455 . . . . 0.0 114.026 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -86.54 -4.91 59.24 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.22 -134.24 3.41 Favored Glycine 0 N--CA 1.474 1.174 0 CA-C-O 119.566 -0.574 . . . . 0.0 111.83 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.404 ' CG ' ' HG3' ' A' ' 92' ' ' GLU . 3.0 tppp? -53.15 -87.24 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.659 0.784 . . . . 0.0 112.804 172.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 124.37 26.69 1.44 Allowed Glycine 0 C--N 1.347 1.155 0 N-CA-C 113.761 0.265 . . . . 0.0 113.761 -174.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.454 ' HG2' ' HA ' ' A' ' 83' ' ' THR . 46.8 mt-10 -89.61 115.51 27.06 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 117.099 0.45 . . . . 0.0 109.943 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 116' ' ' PRO . 17.2 m -108.96 130.12 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.432 0.693 . . . . 0.0 109.613 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.443 ' HB3' ' HE1' ' A' ' 79' ' ' HIS . 1.3 m-20 -85.45 108.81 18.06 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.408 HG21 HG12 ' A' ' 113' ' ' ILE . 34.6 t -113.18 162.55 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.108 1.363 . . . . 0.0 108.995 -171.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.18 102.71 6.35 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.573 1.149 . . . . 0.0 108.029 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 80.6 m -93.1 107.92 19.62 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.685 HG22 ' HB2' ' A' ' 110' ' ' TRP . 5.7 tt -102.59 111.05 31.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.148 -176.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -100.46 153.85 19.02 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.618 0.767 . . . . 0.0 110.601 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -126.66 117.45 22.77 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.263 1.425 . . . . 0.0 107.47 171.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.454 ' HB ' HG21 ' A' ' 5' ' ' ILE . 86.2 t -109.02 124.31 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.266 1.026 . . . . 0.0 110.254 -173.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.515 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 10.6 tp10 -131.57 135.5 47.05 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.032 0.933 . . . . 0.0 109.406 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.515 ' ND2' ' HG3' ' A' ' 102' ' ' GLU . 54.1 m-80 62.5 30.02 17.13 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.726 1.211 . . . . 0.0 112.488 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.47 7.82 79.43 Favored Glycine 0 N--CA 1.478 1.499 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.843 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -127.26 148.12 50.22 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.994 1.318 . . . . 0.0 108.149 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.454 HG12 HG22 ' A' ' 101' ' ' VAL . 53.0 mt -69.29 113.72 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 102' ' ' GLU . . . -78.03 -36.66 48.33 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.703 0.801 . . . . 0.0 111.105 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.532 ' HE2' ' HE1' ' A' ' 110' ' ' TRP . 61.4 mtpt -150.59 132.49 15.12 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.055 0.942 . . . . 0.0 108.66 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -124.69 132.58 53.38 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.685 ' HB2' HG22 ' A' ' 98' ' ' ILE . 1.6 m-90 -130.77 152.45 50.1 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -176.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -144.25 147.02 33.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.797 0.332 . . . . 0.0 110.201 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -128.95 117.92 21.77 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.965 0.906 . . . . 0.0 109.064 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.408 HG12 HG21 ' A' ' 95' ' ' VAL . 94.5 mt -86.79 132.72 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.74 -83.12 0.09 OUTLIER Glycine 0 CA--C 1.526 0.778 0 O-C-N 123.708 0.63 . . . . 0.0 112.05 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.15 166.29 16.84 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.498 0.719 . . . . 0.0 109.463 175.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.547 ' HA ' HG12 ' A' ' 93' ' ' VAL . 51.5 Cg_endo -65.85 110.42 1.69 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.532 2.155 . . . . 0.0 113.111 168.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -109.6 149.83 29.09 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.83 0.852 . . . . 0.0 110.232 173.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.4 mm -124.68 154.93 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.4 t . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.516 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.1 m120 . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 121.299 0.571 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 m -66.31 -39.05 89.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.711 0.804 . . . . 0.0 111.345 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.18 -12.37 60.82 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.112 0.565 . . . . 0.0 111.808 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.9 mm -98.02 -39.15 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.927 0.891 . . . . 0.0 109.391 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -58.91 -44.58 91.28 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.54 1.136 . . . . 0.0 112.338 177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.53 -57.11 24.2 Favored Pre-proline 0 CA--C 1.561 1.391 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.883 -171.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.572 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 21.1 Cg_endo -58.27 -48.76 14.47 Favored 'Trans proline' 0 C--N 1.395 3.022 0 C-N-CA 122.401 2.067 . . . . 0.0 112.28 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.2 t -59.27 -44.06 91.26 Favored 'Isoleucine or valine' 0 C--O 1.247 0.956 0 C-N-CA 124.91 1.284 . . . . 0.0 112.605 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -46.07 67.06 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -63.35 -27.74 69.52 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.786 0.834 . . . . 0.0 111.919 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -63.2 -46.18 88.24 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.684 0.615 . . . . 0.0 110.221 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.16 -53.76 52.95 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.153 0.908 . . . . 0.0 109.218 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -52.17 -36.37 51.5 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 124.653 1.221 . . . . 0.0 111.089 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -81.75 -27.96 33.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.651 1.18 . . . . 0.0 112.195 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -69.66 -48.41 59.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.721 0.409 . . . . 0.0 110.267 -172.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -76.07 -28.97 57.8 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.932 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.46 1.16 56.92 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.55 0.74 . . . . 0.0 112.051 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 67.64 18.79 9.87 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.577 1.151 . . . . 0.0 112.797 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.476 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 67.9 m-20 -88.59 95.3 10.19 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.964 0.506 . . . . 0.0 110.467 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.9 mm -67.77 -26.87 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 123.024 0.53 . . . . 0.0 110.648 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -52.44 -48.38 65.84 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.485 0.714 . . . . 0.0 111.59 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.37 -35.0 31.34 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.883 0.473 . . . . 0.0 110.952 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -71.07 -5.84 34.52 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.617 0.767 . . . . 0.0 111.279 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.583 ' SD ' ' HB2' ' A' ' 46' ' ' ALA . 19.6 tpp -121.03 -25.62 5.3 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.173 0.589 . . . . 0.0 112.456 172.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.13 -44.22 74.84 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.572 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.1 m95 -82.71 -3.79 56.94 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -172.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -91.36 149.16 21.85 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.387 0.675 . . . . 0.0 109.8 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.419 ' O ' ' HB1' ' A' ' 46' ' ' ALA . . . -74.05 152.26 40.01 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.349 0.66 . . . . 0.0 110.033 176.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.94 -23.93 65.13 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.112 0.482 . . . . 0.0 110.929 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -102.26 18.61 20.52 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.68 1.192 . . . . 0.0 111.114 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 42.1 t -64.57 122.98 18.07 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.931 0.396 . . . . 0.0 111.916 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -83.11 154.38 24.38 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.493 0.717 . . . . 0.0 109.481 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 33.9 t80 -145.68 120.69 10.05 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.415 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 43.3 m-85 -121.18 153.92 36.92 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.279 1.032 . . . . 0.0 110.484 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.499 ' HB3' HD12 ' A' ' 42' ' ' LEU . . . -120.44 159.83 24.34 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.385 1.074 . . . . 0.0 110.702 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.633 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 82.9 t80 -62.37 130.71 93.44 Favored Pre-proline 0 CA--C 1.56 1.36 0 O-C-N 124.18 0.925 . . . . 0.0 110.383 174.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.67 -47.43 0.31 Allowed 'Cis proline' 0 C--N 1.386 2.506 0 CA-C-N 120.697 1.285 . . . . 0.0 113.447 -1.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.68 93.35 0.82 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 98.3 m -141.33 115.79 9.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.155 0.582 . . . . 0.0 109.6 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 tt -70.8 101.71 2.17 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.499 HD12 ' HB3' ' A' ' 36' ' ' ALA . 94.7 mt -80.64 -37.84 30.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.554 0.741 . . . . 0.0 110.868 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 34' ' ' TYR . . . -148.23 121.24 8.82 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.421 0.451 . . . . 0.0 111.185 -171.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.4 39.55 2.81 Favored Glycine 0 C--N 1.35 1.327 0 C-N-CA 123.116 0.389 . . . . 0.0 113.26 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 166.06 165.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 125.847 1.659 . . . . 0.0 109.155 -171.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.583 ' HB2' ' SD ' ' A' ' 25' ' ' MET . . . -66.54 -36.81 83.59 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.749 0.82 . . . . 0.0 112.748 -175.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.11 -46.87 84.82 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.15 0.58 . . . . 0.0 111.743 -174.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 31.1 mt-10 -72.85 -29.99 63.65 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.487 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.1 mt -67.43 -44.41 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.007 0.523 . . . . 0.0 109.704 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.429 ' O ' HG13 ' A' ' 54' ' ' ILE . 76.6 ttt180 -59.83 -56.1 26.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.552 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.5 m -61.58 -41.59 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 124.429 1.081 . . . . 0.0 112.563 -173.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -72.17 -29.15 63.73 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.145 0.578 . . . . 0.0 110.96 -176.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -77.94 -30.83 50.63 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 118.929 -0.558 . . . . 0.0 111.2 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 50' ' ' ARG . 99.0 mt -59.69 -41.28 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.9 -38.36 88.08 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.919 0.888 . . . . 0.0 111.414 175.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -78.84 -23.33 45.09 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.141 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -84.12 0.62 47.76 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.295 0.638 . . . . 0.0 110.931 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -79.76 -20.36 46.49 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.064 0.545 . . . . 0.0 111.673 170.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.631 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 7.3 mm-40 -64.45 112.86 8.67 Favored Pre-proline 0 CA--C 1.547 0.846 0 O-C-N 123.805 0.691 . . . . 0.0 109.802 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -65.63 -18.34 58.71 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.333 2.022 . . . . 0.0 112.24 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.02 2.85 46.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.377 1.071 . . . . 0.0 111.714 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.631 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 19.4 tp -66.28 116.14 7.0 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.627 0.371 . . . . 0.0 110.15 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -145.02 117.87 8.74 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.437 ' HA2' HG12 ' A' ' 82' ' ' VAL . . . -93.45 103.48 3.04 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 175.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.44 98.14 10.01 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.5 tt -86.72 126.47 34.59 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.427 HD13 ' CD2' ' A' ' 79' ' ' HIS . 2.3 pp -114.32 -30.17 6.68 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.276 1.03 . . . . 0.0 110.438 -171.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.8 m -155.17 132.85 11.29 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.429 1.092 . . . . 0.0 109.055 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 0.8 OUTLIER -132.45 134.71 45.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.59 0.756 . . . . 0.0 109.288 167.181 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -118.88 119.8 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.561 0.745 . . . . 0.0 109.807 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.444 HG13 HG21 ' A' ' 76' ' ' VAL . 17.3 tt -95.29 129.4 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-O 121.321 0.581 . . . . 0.0 109.504 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 p -141.01 96.41 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.515 1.126 . . . . 0.0 108.65 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.76 -128.08 31.67 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.337 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -83.43 3.47 31.83 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.698 0.799 . . . . 0.0 112.578 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.1 t -126.45 134.97 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.811 0.844 . . . . 0.0 109.765 -171.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.444 HG21 HG13 ' A' ' 71' ' ' ILE . 21.6 t -124.18 140.6 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 122.988 0.515 . . . . 0.0 109.627 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.488 HD13 ' HB ' ' A' ' 98' ' ' ILE . 16.2 mm -99.27 103.26 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 172.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -90.35 104.65 17.2 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.427 ' CD2' HD13 ' A' ' 67' ' ' LEU . 2.0 t60 -98.07 108.36 21.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -117.41 152.29 35.28 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.288 -1.324 . . . . 0.0 109.611 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.5 m -103.19 101.87 11.83 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 159.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.437 HG12 ' HA2' ' A' ' 64' ' ' GLY . 32.8 m -91.97 127.81 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.065 0.459 . . . . 0.0 110.367 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.3 m -75.71 120.49 21.17 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.149 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.554 HH21 HG11 ' A' ' 93' ' ' VAL . 61.3 mtm180 -125.05 -163.51 1.19 Allowed 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -127.8 109.24 11.43 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 118.284 0.493 . . . . 0.0 111.074 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.409 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 19.2 m-30 -108.34 144.6 29.81 Favored Pre-proline 0 N--CA 1.481 1.095 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.57 -7.52 20.98 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.791 2.328 . . . . 0.0 112.807 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -84.17 -20.72 31.92 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.065 0.946 . . . . 0.0 111.804 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.07 -125.15 1.09 Allowed Glycine 0 C--N 1.349 1.256 0 CA-C-O 119.549 -0.584 . . . . 0.0 111.962 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -59.61 -80.54 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.188 0.995 . . . . 0.0 111.931 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.409 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 118.52 24.12 3.24 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 116.308 -0.405 . . . . 0.0 113.048 -177.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.539 ' HG3' ' HB2' ' A' ' 117' ' ' ARG . 7.1 pt-20 -87.54 147.68 25.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.566 HG13 ' HA ' ' A' ' 116' ' ' PRO . 7.5 m -138.59 134.96 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 121.975 -0.453 . . . . 0.0 111.388 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.67 111.08 13.07 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.329 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.458 HG21 HG12 ' A' ' 113' ' ' ILE . 48.9 t -124.64 144.93 32.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 124.169 0.988 . . . . 0.0 108.95 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -106.5 107.3 18.24 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 170.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 56.5 m -93.12 104.34 16.55 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.584 HG22 ' HB2' ' A' ' 110' ' ' TRP . 5.5 tt -105.99 109.82 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.217 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -104.13 151.47 23.27 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.528 0.731 . . . . 0.0 110.549 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -121.43 114.33 21.12 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.144 0.978 . . . . 0.0 108.628 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.51 HG22 HG12 ' A' ' 106' ' ' ILE . 45.1 t -101.74 115.21 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.077 0.951 . . . . 0.0 109.2 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 41.7 tt0 -116.75 128.77 55.62 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.151 0.981 . . . . 0.0 109.006 176.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 62.25 32.37 17.18 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.951 0.901 . . . . 0.0 111.462 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.42 11.67 84.13 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 114.595 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -133.02 136.73 46.18 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.485 1.114 . . . . 0.0 108.679 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.51 HG12 HG22 ' A' ' 101' ' ' VAL . 60.0 mt -66.63 100.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . . . -78.05 -28.07 48.86 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.227 0.611 . . . . 0.0 110.967 -175.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -149.58 153.77 37.64 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.076 0.951 . . . . 0.0 108.592 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -148.67 134.54 18.99 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.584 ' HB2' HG22 ' A' ' 98' ' ' ILE . 1.7 m-90 -135.53 154.8 51.27 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -143.03 146.37 33.78 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 169.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.633 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 17.1 ptpt -129.34 124.52 34.49 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.916 0.886 . . . . 0.0 109.182 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 95' ' ' VAL . 92.1 mt -88.19 119.19 35.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.26 -63.41 3.27 Favored Glycine 0 N--CA 1.465 0.624 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.684 -177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -157.16 166.4 16.72 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 122.768 0.427 . . . . 0.0 110.35 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.566 ' HA ' HG13 ' A' ' 93' ' ' VAL . 97.2 Cg_endo -75.67 132.69 14.81 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.653 2.235 . . . . 0.0 112.069 163.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.539 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 15.6 mmt180 -115.84 140.84 48.84 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.381 1.072 . . . . 0.0 108.567 175.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.2 mm -132.04 149.8 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.732 0.301 . . . . 0.0 110.466 179.253 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.497 ' HB2' HD11 ' A' ' 71' ' ' ILE . 3.3 p-10 . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.414 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 81.8 p -62.26 -43.98 97.58 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.977 0.511 . . . . 0.0 110.084 -177.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -64.37 -14.68 57.82 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.676 1.19 . . . . 0.0 112.679 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.534 HG13 ' HA ' ' A' ' 74' ' ' ASN . 44.0 mm -89.85 -34.21 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.864 0.866 . . . . 0.0 109.992 174.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -84.97 -10.09 57.4 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.256 0.622 . . . . 0.0 111.709 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 3' ' ' SER . 65.3 mt -65.93 -54.46 27.78 Favored Pre-proline 0 N--CA 1.481 1.123 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.092 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.502 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 13.0 Cg_endo -56.32 -46.73 28.4 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 121.752 1.635 . . . . 0.0 112.572 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.589 ' HA ' HE21 ' A' ' 12' ' ' GLN . 54.8 t -64.48 -45.89 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 124.048 0.939 . . . . 0.0 113.215 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -41.33 65.78 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -176.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -66.6 -26.39 67.07 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.907 0.483 . . . . 0.0 111.329 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.589 HE21 ' HA ' ' A' ' 9' ' ' VAL . 39.6 mt-30 -60.89 -46.53 90.25 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.168 0.292 . . . . 0.0 110.232 171.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.93 -51.97 67.41 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 123.516 0.51 . . . . 0.0 109.702 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -55.19 -34.39 63.84 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 124.684 1.24 . . . . 0.0 110.145 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -82.45 -27.65 31.77 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.776 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -71.01 -44.07 66.64 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.871 0.469 . . . . 0.0 110.298 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -79.39 -28.55 41.85 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.004 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.2 5.02 52.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.578 0.751 . . . . 0.0 112.24 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 64.79 13.26 8.33 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.035 1.334 . . . . 0.0 113.992 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.511 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 18.6 m-20 -76.91 95.13 4.04 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.297 0.57 . . . . 0.0 111.583 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.406 HG13 HG12 ' A' ' 54' ' ' ILE . 29.5 mm -64.33 -25.49 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.144 0.578 . . . . 0.0 110.365 167.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -50.44 -50.55 51.84 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.99 0.916 . . . . 0.0 111.194 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -82.68 -37.72 24.41 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.181 0.592 . . . . 0.0 110.762 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -66.83 -6.63 16.96 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.215 0.606 . . . . 0.0 111.565 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.761 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -120.56 -30.63 4.48 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 171.325 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.44 -34.92 73.11 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.166 0.507 . . . . 0.0 112.303 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.502 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 99.4 m95 -88.54 4.0 48.33 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.867 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -102.97 157.31 17.07 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.64 0.776 . . . . 0.0 109.9 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -81.8 148.84 28.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.825 0.85 . . . . 0.0 109.404 171.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -66.45 -24.1 66.38 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.336 0.589 . . . . 0.0 111.031 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -86.51 -2.26 58.32 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.143 1.377 . . . . 0.0 111.724 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 42.3 t -59.89 132.89 55.33 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -167.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -88.12 154.7 20.25 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.453 0.701 . . . . 0.0 109.957 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -145.19 110.08 5.11 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.424 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 36.7 m-85 -111.1 155.19 23.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.951 0.9 . . . . 0.0 110.644 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.407 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -114.32 159.52 20.12 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.278 173.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.543 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 90.5 t80 -52.06 127.32 36.79 Favored Pre-proline 0 N--CA 1.486 1.342 0 C-N-CA 123.95 0.9 . . . . 0.0 111.149 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.8 -47.56 0.31 Allowed 'Cis proline' 0 C--N 1.387 2.556 0 CA-C-N 120.614 1.255 . . . . 0.0 113.681 -1.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.44 79.26 0.44 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.0 m -123.33 106.96 11.13 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.703 0.801 . . . . 0.0 109.282 -176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.2 tp -67.0 102.34 0.97 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.032 0.533 . . . . 0.0 110.198 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.407 HD12 ' HB1' ' A' ' 36' ' ' ALA . 65.6 mt -81.85 -36.67 28.0 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.973 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -145.57 116.56 7.81 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.372 -174.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.46 41.07 2.22 Favored Glycine 0 N--CA 1.474 1.181 0 C-N-CA 122.986 0.327 . . . . 0.0 113.398 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.5 p30 164.82 152.18 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 126.226 1.81 . . . . 0.0 108.852 -173.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -61.98 -26.78 68.42 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.965 0.906 . . . . 0.0 113.149 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.32 90.66 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.44 0.296 . . . . 0.0 111.547 -177.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.497 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 27.2 mt-10 -77.77 -31.22 51.83 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.997 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.7 mt -68.62 -41.36 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.759 0.824 . . . . 0.0 111.265 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.761 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 5.7 ptp180 -62.8 -45.9 90.47 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.069 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.411 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 96.5 t -54.8 -55.29 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.686 0.795 . . . . 0.0 110.29 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -52.07 -44.1 64.16 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.926 1.29 . . . . 0.0 111.963 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -78.35 -34.64 48.28 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.025 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 50' ' ' ARG . 97.0 mt -60.77 -45.3 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-N 118.982 0.81 . . . . 0.0 109.472 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 51' ' ' VAL . 43.4 mt-10 -63.77 -32.84 74.47 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.355 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -88.22 -15.98 34.47 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -85.97 -4.53 59.19 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.107 0.563 . . . . 0.0 110.556 173.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.71 -20.21 63.54 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.265 0.626 . . . . 0.0 111.533 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 20.3 mm-40 -65.97 120.21 67.49 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.431 0.692 . . . . 0.0 110.314 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.14 -18.75 18.18 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.222 1.948 . . . . 0.0 112.249 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -81.62 -22.9 37.36 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.24 0.616 . . . . 0.0 110.775 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 30.8 tp -56.29 129.97 42.56 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.808 0.843 . . . . 0.0 112.024 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.437 ' CE2' ' HB2' ' A' ' 65' ' ' GLU . 46.2 t80 -151.24 144.35 24.65 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.595 0.758 . . . . 0.0 109.617 175.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.58 118.78 5.08 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.844 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 63' ' ' TYR . 35.6 tt0 -126.32 99.77 6.0 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.8 tt -80.43 140.31 36.04 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.185 0.517 . . . . 0.0 110.169 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.533 HD12 ' HG1' ' A' ' 81' ' ' THR . 6.3 mt -109.46 -51.84 2.83 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.285 -173.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.0 m -147.99 139.5 23.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.909 -172.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 14.1 ptt180 -131.6 119.65 21.76 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.321 0.648 . . . . 0.0 109.693 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -115.84 127.16 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.034 0.934 . . . . 0.0 109.044 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.497 HD11 ' HB2' ' A' ' 2' ' ' ASN . 13.8 tt -114.96 132.98 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-O 121.386 0.613 . . . . 0.0 111.534 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.9 t -117.75 103.33 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 125.42 1.488 . . . . 0.0 107.851 172.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.6 -102.81 0.42 Allowed Glycine 0 N--CA 1.476 1.345 0 N-CA-C 113.994 0.357 . . . . 0.0 113.994 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.534 ' HA ' HG13 ' A' ' 5' ' ' ILE . 23.4 p-10 -111.67 21.19 16.36 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.121 0.568 . . . . 0.0 112.284 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.0 p -135.6 135.04 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.025 0.53 . . . . 0.0 110.012 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -117.75 137.43 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.265 0.626 . . . . 0.0 109.663 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.571 HD13 ' HB ' ' A' ' 98' ' ' ILE . 7.7 mm -98.95 102.68 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 165.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -102.54 105.69 16.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -98.4 107.02 19.38 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.205 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -103.87 172.77 6.62 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.547 1.139 . . . . 0.0 110.955 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.533 ' HG1' HD12 ' A' ' 67' ' ' LEU . 97.2 m -116.14 102.69 9.83 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 160.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.7 m -88.5 133.38 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.661 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.0 m -88.12 128.37 35.43 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -155.27 146.98 23.2 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -77.94 103.74 8.07 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -166.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -92.37 127.6 48.13 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 165.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -62.41 -15.97 48.71 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.465 2.777 . . . . 0.0 114.224 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -83.59 -32.12 25.95 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.405 0.282 . . . . 0.0 111.636 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.84 -136.35 2.1 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-O 119.456 -0.636 . . . . 0.0 111.65 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -72.54 -79.41 0.08 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 117.318 0.559 . . . . 0.0 110.468 171.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.1 30.43 2.3 Favored Glycine 0 C--N 1.346 1.091 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.713 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -88.82 98.48 11.74 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 122.456 1.122 . . . . 0.0 108.227 -174.495 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.444 HG13 ' H ' ' A' ' 117' ' ' ARG . 20.7 m -104.59 145.61 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.374 -0.829 . . . . 0.0 111.14 -165.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -78.11 132.4 37.68 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 176.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.562 HG23 HG12 ' A' ' 113' ' ' ILE . 46.8 t -136.27 124.39 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.01 100.53 11.12 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.6 m -94.08 122.79 36.96 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.631 HG23 ' HB2' ' A' ' 110' ' ' TRP . 6.2 tt -123.87 115.38 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.925 0.89 . . . . 0.0 109.814 -173.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -116.86 127.22 54.07 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.849 0.859 . . . . 0.0 110.41 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -98.57 111.1 23.57 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.532 ' HB ' HG22 ' A' ' 5' ' ' ILE . 99.5 t -98.39 130.45 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.691 1.196 . . . . 0.0 109.977 -174.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.468 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 10.8 tp10 -129.42 124.65 34.68 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.229 1.012 . . . . 0.0 109.298 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.468 ' ND2' ' HG3' ' A' ' 102' ' ' GLU . 52.9 m-80 62.65 37.25 13.0 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.876 1.271 . . . . 0.0 112.45 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.11 5.25 65.29 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 113.884 0.314 . . . . 0.0 113.884 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.8 mmt85 -122.79 135.13 54.45 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.614 1.166 . . . . 0.0 108.285 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.423 HG12 HG23 ' A' ' 101' ' ' VAL . 77.8 mt -65.56 105.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -86.4 -23.35 26.14 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.764 0.426 . . . . 0.0 111.2 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -147.1 149.26 32.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.813 0.845 . . . . 0.0 109.711 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.92 137.4 24.9 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.744 0.818 . . . . 0.0 109.088 -176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.631 ' HB2' HG23 ' A' ' 98' ' ' ILE . 4.5 m-90 -139.0 152.71 47.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -142.3 137.1 30.35 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 169.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 51.6 mtmt -126.15 129.65 49.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.562 HG12 HG23 ' A' ' 95' ' ' VAL . 90.8 mt -88.35 131.94 34.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.93 -75.24 0.28 Allowed Glycine 0 CA--C 1.527 0.783 0 O-C-N 124.12 0.888 . . . . 0.0 112.354 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.91 166.44 16.43 Favored Pre-proline 0 CA--C 1.554 1.096 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.35 137.6 51.97 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.307 2.005 . . . . 0.0 112.289 173.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 19.8 mmt180 -135.35 138.89 43.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.258 1.023 . . . . 0.0 109.078 -174.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.9 mm -126.62 143.53 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.7 t . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.281 0.562 . . . . 0.0 110.679 176.718 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 121.598 0.713 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.2 m -63.31 -42.39 99.03 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.005 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -13.68 62.49 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.411 0.684 . . . . 0.0 112.374 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.521 HG23 ' HB ' ' A' ' 101' ' ' VAL . 26.9 mm -85.09 -32.05 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 122.94 0.496 . . . . 0.0 110.006 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HG3' HD12 ' A' ' 71' ' ' ILE . 58.1 mt-10 -87.74 -10.02 52.32 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.2 mt -61.37 -50.24 84.11 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.256 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.465 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 18.4 Cg_endo -59.18 -50.95 7.46 Favored 'Trans proline' 0 C--N 1.389 2.697 0 CA-C-N 120.907 1.36 . . . . 0.0 111.285 172.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.467 HG23 HG21 ' A' ' 76' ' ' VAL . 63.4 t -50.55 -53.22 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 124.654 1.181 . . . . 0.0 113.029 -173.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 25.8 tp60 -61.77 -47.26 85.96 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.066 -177.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -71.18 -29.62 65.41 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.227 0.611 . . . . 0.0 111.824 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' HG2' ' HE1' ' A' ' 28' ' ' TRP . 44.8 mt-30 -62.4 -49.5 75.25 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.568 0.747 . . . . 0.0 109.775 176.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.485 HD23 HD11 ' A' ' 66' ' ' LEU . 31.9 tp -57.61 -52.06 66.97 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.47 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 13.4 mm-40 -58.38 -41.87 85.76 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.369 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 20' ' ' ASP . . . -71.22 -28.28 64.09 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.25 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -68.43 -41.45 80.34 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.979 0.911 . . . . 0.0 110.54 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -83.61 -29.59 27.61 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.682 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.02 2.53 53.88 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.118 0.567 . . . . 0.0 112.462 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.414 HH21 ' HA ' ' A' ' 60' ' ' PRO . 37.7 mmt-85 69.77 8.11 6.56 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.118 1.367 . . . . 0.0 113.362 176.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.516 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 20.7 m-20 -77.27 94.57 4.17 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.219 0.533 . . . . 0.0 110.391 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.433 HG13 HG12 ' A' ' 54' ' ' ILE . 15.6 mm -67.81 -23.71 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 123.197 0.599 . . . . 0.0 109.705 167.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -54.56 -50.6 67.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.066 0.946 . . . . 0.0 112.196 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.5 -37.02 25.89 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.108 0.48 . . . . 0.0 110.496 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -65.92 -7.69 18.11 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.562 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.688 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -118.01 -30.88 5.23 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.957 -0.464 . . . . 0.0 112.22 172.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -30.96 69.48 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.05 0.54 . . . . 0.0 112.347 -175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 97.5 m95 -92.78 9.5 34.87 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.593 0.757 . . . . 0.0 112.693 -176.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.47 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 10.0 m95 -110.51 164.6 12.55 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.228 1.011 . . . . 0.0 108.906 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -82.78 153.78 25.07 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.836 0.454 . . . . 0.0 110.138 175.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.99 -27.67 68.99 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.976 0.511 . . . . 0.0 111.407 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -105.79 20.48 18.85 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.886 0.875 . . . . 0.0 110.697 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.47 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 44.0 t -57.7 113.1 1.68 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.867 0.365 . . . . 0.0 111.598 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -74.2 151.35 40.0 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -145.45 115.76 7.53 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -174.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.46 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 14.0 m-85 -115.06 156.38 25.27 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.949 1.3 . . . . 0.0 110.712 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.505 ' HB2' HD13 ' A' ' 42' ' ' LEU . . . -119.82 155.11 33.23 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.536 173.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.463 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 70.1 t80 -64.25 132.13 95.23 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.698 0.799 . . . . 0.0 111.477 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.81 -56.65 0.14 OUTLIER 'Cis proline' 0 C--N 1.386 2.505 0 CA-C-N 120.599 1.25 . . . . 0.0 113.958 -1.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.35 92.84 1.54 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.963 0.505 . . . . 0.0 109.665 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.0 m -135.72 109.16 7.88 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.595 0.758 . . . . 0.0 109.5 174.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.5 tt -69.11 103.11 1.8 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' A' ' 36' ' ' ALA . 52.0 mt -78.58 -45.86 20.75 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.999 0.92 . . . . 0.0 109.951 178.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.1 124.96 25.51 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.475 -171.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.41 36.15 4.59 Favored Glycine 0 N--CA 1.475 1.297 0 O-C-N 123.076 0.235 . . . . 0.0 113.271 -174.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 167.93 158.63 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.503 1.521 . . . . 0.0 108.727 -171.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.465 ' HB3' ' SD ' ' A' ' 25' ' ' MET . . . -57.95 -43.54 86.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.804 0.841 . . . . 0.0 112.532 -176.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.11 76.18 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.933 0.493 . . . . 0.0 112.091 -171.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -76.65 -31.46 57.35 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.831 0.452 . . . . 0.0 111.559 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.405 ' HB ' ' HE1' ' A' ' 25' ' ' MET . 74.4 mt -65.1 -51.88 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.083 0.553 . . . . 0.0 110.271 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.688 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 21.2 ptt180 -64.63 -43.45 93.65 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.736 -172.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.503 ' HA ' HD12 ' A' ' 54' ' ' ILE . 30.2 m -66.29 -33.21 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 123.336 0.397 . . . . 0.0 111.696 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -71.75 -35.75 70.2 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.273 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -75.64 -29.37 59.13 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.439 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 51' ' ' VAL . 74.4 mt -55.32 -42.87 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 118.55 0.614 . . . . 0.0 109.973 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.98 -40.03 87.72 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.965 0.906 . . . . 0.0 111.328 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.0 tpp85 -73.44 -28.62 62.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.718 0.807 . . . . 0.0 111.095 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -82.1 -9.05 59.66 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.829 0.852 . . . . 0.0 110.991 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -76.85 -34.24 57.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.477 0.311 . . . . 0.0 111.382 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -83.99 118.25 70.82 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HA ' HH21 ' A' ' 19' ' ' ARG . 89.7 Cg_endo -74.13 -9.15 21.78 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.433 2.755 . . . . 0.0 114.193 -166.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -77.87 -13.54 59.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.737 0.815 . . . . 0.0 111.097 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.3 tp -58.71 111.51 1.29 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.218 0.607 . . . . 0.0 110.603 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 91.3 t80 -149.91 115.4 5.51 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.09 101.96 2.06 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -84.49 101.51 12.12 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 78' ' ' ASP . 6.7 tt -84.79 128.31 34.55 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -176.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.84 -32.86 4.97 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.853 -167.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 99.0 m -147.9 138.56 23.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.087 0.955 . . . . 0.0 109.556 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -133.31 129.49 37.61 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 167.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.8 m -107.29 129.45 61.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 123.716 0.806 . . . . 0.0 109.593 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.449 HD12 ' HG3' ' A' ' 6' ' ' GLU . 10.5 tt -113.19 122.85 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.136 0.493 . . . . 0.0 110.145 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.28 94.13 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 56.66 -112.03 3.14 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 123.23 0.331 . . . . 0.0 113.664 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -99.15 15.82 24.76 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.452 0.701 . . . . 0.0 112.297 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.8 p -134.97 133.74 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.381 0.672 . . . . 0.0 109.19 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.467 HG21 HG23 ' A' ' 9' ' ' VAL . 64.4 t -123.01 136.03 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.98 0.512 . . . . 0.0 110.789 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.562 HG12 ' HB ' ' A' ' 98' ' ' ILE . 6.4 mt -103.11 119.9 52.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 163.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.519 ' HB2' HD13 ' A' ' 66' ' ' LEU . 6.9 p-10 -97.4 155.09 17.06 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 168.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -137.53 108.45 6.7 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.45 168.72 11.76 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.083 1.353 . . . . 0.0 109.715 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.2 m -115.65 105.58 12.92 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.107 168.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 63' ' ' TYR . 4.0 m -86.38 125.25 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.179 0.514 . . . . 0.0 110.944 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 62.8 m -72.35 117.63 14.24 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 170.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -125.46 120.92 32.31 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.39 89.29 2.1 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.194 0.521 . . . . 0.0 110.95 -172.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -82.66 144.95 49.71 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.515 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.84 -20.21 58.26 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 123.158 2.572 . . . . 0.0 113.88 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -82.25 -27.44 32.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.114 0.565 . . . . 0.0 112.521 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.52 -134.62 2.96 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.823 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -55.74 -71.23 0.09 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.165 0.986 . . . . 0.0 111.28 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.418 ' H ' HD11 ' A' ' 118' ' ' ILE . . . 94.21 32.34 7.49 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.397 0.436 . . . . 0.0 113.066 175.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -86.89 107.89 18.54 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.745 0.783 . . . . 0.0 108.996 -173.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.686 HG13 ' HA ' ' A' ' 116' ' ' PRO . 5.3 m -105.77 143.85 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.413 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -91.54 142.12 27.99 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.0 t -130.44 149.52 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.78 101.74 8.56 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.7 m -98.14 108.03 20.64 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.627 HG21 ' HB2' ' A' ' 110' ' ' TRP . 12.1 tt -98.82 112.46 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.066 0.946 . . . . 0.0 109.04 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.45 138.54 52.36 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.166 0.508 . . . . 0.0 110.938 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -98.7 113.3 25.32 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.342 1.057 . . . . 0.0 109.445 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.521 ' HB ' HG23 ' A' ' 5' ' ' ILE . 92.2 t -88.82 116.1 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.017 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -124.44 128.61 49.28 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.153 0.981 . . . . 0.0 109.497 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 59.18 31.04 20.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.784 1.234 . . . . 0.0 111.856 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.04 -20.1 30.93 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 115.568 -0.742 . . . . 0.0 113.738 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -107.07 140.46 39.85 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.319 1.048 . . . . 0.0 108.834 -172.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.1 mt -67.36 106.21 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.93 -34.07 44.87 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.281 0.633 . . . . 0.0 111.241 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -144.31 146.75 32.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.082 0.953 . . . . 0.0 108.685 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.9 137.9 35.21 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.674 0.789 . . . . 0.0 109.516 -177.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.627 ' HB2' HG21 ' A' ' 98' ' ' ILE . 2.5 m-90 -140.33 148.41 41.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -144.45 147.17 32.98 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.077 0.853 . . . . 0.0 111.097 174.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 21.5 ptmt -127.25 127.9 45.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.36 0.664 . . . . 0.0 109.494 172.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 80.0 mt -89.42 121.75 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.35 -94.72 0.02 OUTLIER Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.564 1.165 . . . . 0.0 114.497 -174.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -134.56 155.11 79.88 Favored Pre-proline 0 CA--C 1.547 0.827 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.686 ' HA ' HG13 ' A' ' 93' ' ' VAL . 41.4 Cg_endo -90.0 114.72 0.55 Allowed 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.908 2.405 . . . . 0.0 113.394 174.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -111.79 153.4 26.61 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.415 0.626 . . . . 0.0 111.114 -175.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.418 HD11 ' H ' ' A' ' 91' ' ' GLY . 35.2 mm -131.11 156.06 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 124.572 1.149 . . . . 0.0 108.181 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.7 t . . . . . 0 N--CA 1.486 1.354 0 C-N-CA 122.654 0.381 . . . . 0.0 110.573 173.702 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.2 m120 . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.482 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 13.1 m -61.7 -48.87 78.82 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.962 0.905 . . . . 0.0 110.719 -175.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -7.59 25.92 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.899 0.88 . . . . 0.0 113.026 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.4 mm -94.39 -31.34 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.639 0.775 . . . . 0.0 109.705 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.29 -32.85 32.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.274 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.2 mt -58.44 -47.64 98.41 Favored Pre-proline 0 CA--C 1.563 1.46 0 CA-C-O 118.405 -0.807 . . . . 0.0 112.185 -177.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.529 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 10.1 Cg_endo -56.2 -63.07 0.19 Allowed 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 121.885 1.723 . . . . 0.0 112.379 172.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.41 -27.08 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -168.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.24 -55.39 6.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.449 0.7 . . . . 0.0 109.728 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -68.8 -29.82 68.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.983 0.513 . . . . 0.0 111.583 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -74.8 -36.85 62.48 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.827 0.851 . . . . 0.0 111.527 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.56 -48.77 80.31 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -57.87 -45.31 86.51 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 124.561 1.163 . . . . 0.0 109.315 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.78 -24.81 66.24 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.033 -1.44 . . . . 0.0 112.722 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -67.68 -40.61 84.39 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.579 0.352 . . . . 0.0 110.32 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -91.73 -25.73 18.93 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.429 0.692 . . . . 0.0 110.936 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.04 -6.38 59.47 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.493 0.717 . . . . 0.0 111.846 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 69.39 14.87 8.45 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.081 1.352 . . . . 0.0 112.929 171.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -83.81 95.3 8.41 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.471 HG13 HG12 ' A' ' 54' ' ' ILE . 20.7 mm -64.8 -29.77 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.427 0.691 . . . . 0.0 110.43 173.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -55.96 -47.04 78.34 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.902 0.481 . . . . 0.0 111.384 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.43 -32.89 28.78 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.306 0.642 . . . . 0.0 111.42 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -72.94 -8.82 57.39 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.104 0.562 . . . . 0.0 110.828 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.708 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 27.7 tpp -120.96 -15.76 8.21 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.909 0.484 . . . . 0.0 112.287 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.06 -50.46 61.46 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.492 0.717 . . . . 0.0 112.548 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 85.3 m95 -87.18 6.92 30.54 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.989 -168.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.436 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 12.9 m95 -93.96 149.81 20.9 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.415 0.686 . . . . 0.0 109.482 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -75.64 152.11 37.66 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.153 0.581 . . . . 0.0 109.976 171.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -64.16 -29.79 70.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.884 0.474 . . . . 0.0 111.249 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -96.91 20.36 11.23 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.816 0.846 . . . . 0.0 111.385 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.436 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 48.6 t -61.85 115.63 4.18 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -71.57 148.58 46.51 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.649 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 42.8 t80 -141.67 118.1 10.85 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.416 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 11.8 m-85 -117.51 148.82 41.5 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.692 0.797 . . . . 0.0 110.081 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.497 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -103.12 153.48 20.27 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.601 171.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.515 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 90.4 t80 -56.59 128.94 75.77 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.87 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.46 -60.46 0.08 OUTLIER 'Cis proline' 0 C--N 1.384 2.43 0 CA-C-N 120.583 1.244 . . . . 0.0 113.488 0.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.35 74.06 0.68 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.652 0.781 . . . . 0.0 108.991 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 55.3 m -105.54 111.69 24.49 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.167 0.987 . . . . 0.0 109.016 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 tt -66.35 103.06 0.94 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.497 HD12 ' HB1' ' A' ' 36' ' ' ALA . 78.7 mt -82.67 -43.47 16.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.656 0.783 . . . . 0.0 110.649 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . . . -139.73 116.58 10.93 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.787 0.435 . . . . 0.0 111.083 -171.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.07 32.61 5.31 Favored Glycine 0 N--CA 1.482 1.708 0 C-N-CA 122.811 0.243 . . . . 0.0 113.064 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.487 HD22 ' HG3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER 169.5 153.4 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.035 1.334 . . . . 0.0 109.645 -165.322 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.708 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -67.98 -24.61 65.16 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.079 0.952 . . . . 0.0 112.911 -176.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.52 -47.61 78.99 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.504 0.721 . . . . 0.0 112.141 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.487 ' HG3' HD22 ' A' ' 45' ' ' ASN . 35.2 mt-10 -74.21 -31.33 62.59 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.494 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.9 mt -64.81 -49.24 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.13 0.572 . . . . 0.0 111.188 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.483 ' O ' HG13 ' A' ' 54' ' ' ILE . 6.9 ptm180 -62.78 -49.21 75.86 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 123.498 0.499 . . . . 0.0 110.724 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.402 ' HA ' HD11 ' A' ' 54' ' ' ILE . 76.3 t -63.47 -42.53 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.779 0.832 . . . . 0.0 111.399 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -68.36 -31.62 71.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.577 0.751 . . . . 0.0 110.879 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -77.91 -28.94 49.91 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.721 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 50' ' ' ARG . 98.1 mt -57.88 -38.92 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 118.711 0.687 . . . . 0.0 109.729 174.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.38 -34.52 78.35 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.314 1.046 . . . . 0.0 111.38 175.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -78.66 -24.48 45.14 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.163 0.585 . . . . 0.0 110.916 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -83.53 -5.16 59.09 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.37 0.668 . . . . 0.0 110.631 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 70.4 mmtt -78.02 -9.99 59.39 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.096 0.558 . . . . 0.0 111.89 169.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.606 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 8.5 mm-40 -71.94 111.02 9.08 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 170.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.95 -28.14 74.97 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.297 1.998 . . . . 0.0 112.232 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -92.19 4.84 52.39 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.803 0.841 . . . . 0.0 112.048 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.606 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 28.4 tp -64.75 111.82 2.95 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-O 120.757 0.313 . . . . 0.0 110.213 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -148.07 116.15 6.47 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.98 101.14 2.71 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 174.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -81.51 99.95 9.07 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.2 tp -76.25 126.62 31.32 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.73 -33.99 5.94 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.956 0.902 . . . . 0.0 109.638 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 96.8 m -152.93 139.75 19.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.341 1.056 . . . . 0.0 108.99 -176.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -142.3 125.64 16.57 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 163.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.8 m -106.72 119.08 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.939 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.03 143.42 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 121.338 0.59 . . . . 0.0 110.033 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 p -148.32 97.49 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.263 1.425 . . . . 0.0 107.832 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.53 -116.2 7.27 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.673 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -101.89 18.7 19.91 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.072 0.549 . . . . 0.0 111.688 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.0 t -131.92 136.01 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.137 0.975 . . . . 0.0 109.5 -174.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -125.29 137.05 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 123.254 0.622 . . . . 0.0 110.012 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.541 HD12 ' HB ' ' A' ' 98' ' ' ILE . 2.5 mm -98.17 103.96 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 169.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.93 108.18 19.42 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -98.31 107.45 19.92 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 133.76 49.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.489 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.0 m -80.1 103.98 10.35 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 172.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -80.91 116.24 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.469 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.4 m -71.12 118.29 13.72 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.353 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 43.3 mmm-85 -119.02 -171.21 2.06 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -122.53 112.74 18.38 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.957 0.503 . . . . 0.0 109.763 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -113.44 137.35 22.08 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.032 0.933 . . . . 0.0 108.658 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -59.98 -18.94 53.05 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 123.218 2.612 . . . . 0.0 114.306 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -79.2 -25.94 42.65 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.044 0.538 . . . . 0.0 112.299 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.34 -117.39 0.58 Allowed Glycine 0 C--N 1.348 1.245 0 CA-C-O 119.683 -0.51 . . . . 0.0 112.914 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -68.83 -84.03 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.469 0.707 . . . . 0.0 111.88 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 116.93 26.69 2.95 Favored Glycine 0 C--N 1.343 0.947 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 -173.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.66 104.15 16.59 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.978 0.894 . . . . 0.0 108.591 -172.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.595 HG11 ' HA ' ' A' ' 116' ' ' PRO . 21.7 m -103.7 136.59 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.509 -172.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -75.64 133.18 40.93 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.667 HG22 HG12 ' A' ' 113' ' ' ILE . 18.6 t -132.86 147.28 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.99 103.06 9.56 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 166.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 83.9 m -93.7 108.41 20.16 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.541 ' HB ' HD12 ' A' ' 77' ' ' ILE . 4.8 tt -102.11 111.94 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.631 1.172 . . . . 0.0 110.416 -173.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -103.43 129.95 50.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.902 0.881 . . . . 0.0 109.877 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 30.8 tt0 -100.22 111.92 24.22 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 168.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.552 HG22 HG12 ' A' ' 106' ' ' ILE . 48.7 t -94.59 113.79 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.488 1.115 . . . . 0.0 109.4 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -121.06 133.31 55.23 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.963 0.905 . . . . 0.0 109.185 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 62.63 30.42 16.95 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.244 1.017 . . . . 0.0 111.574 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.12 -7.09 79.56 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.268 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -130.75 147.5 52.42 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.943 0.897 . . . . 0.0 109.292 -173.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.552 HG12 HG22 ' A' ' 101' ' ' VAL . 45.7 mt -68.08 102.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 122.876 0.47 . . . . 0.0 110.677 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.16 -22.47 38.94 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.205 0.602 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 81.3 mttt -149.28 143.01 25.58 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.192 0.997 . . . . 0.0 108.781 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -146.67 134.23 20.94 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.495 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.1 m-90 -132.76 149.51 52.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -133.57 146.47 51.03 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 19.9 pttp -144.83 129.58 18.19 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.667 HG12 HG22 ' A' ' 95' ' ' VAL . 91.7 mt -89.84 120.53 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.03 -68.67 1.57 Allowed Glycine 0 C--N 1.344 1.024 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.354 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.96 163.61 23.57 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.595 ' HA ' HG11 ' A' ' 93' ' ' VAL . 83.5 Cg_endo -80.18 144.99 16.93 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 121.938 1.759 . . . . 0.0 111.9 165.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 47.4 mtm105 -132.81 142.81 49.17 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.495 0.664 . . . . 0.0 110.652 169.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.2 mm -128.28 124.84 63.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.678 1.191 . . . . 0.0 108.094 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.484 1.238 0 O-C-N 123.51 0.506 . . . . 0.0 109.909 179.377 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 39.5 p30 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 p -63.04 -43.57 98.31 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.132 0.973 . . . . 0.0 111.557 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.35 -2.31 18.75 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.599 0.76 . . . . 0.0 112.506 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.592 HG22 HG22 ' A' ' 76' ' ' VAL . 26.3 mm -94.81 -32.72 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.871 0.868 . . . . 0.0 109.264 174.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.95 -32.14 39.97 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.053 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 72.1 mt -57.97 -49.33 94.27 Favored Pre-proline 0 CA--C 1.564 1.484 0 CA-C-O 118.051 -0.976 . . . . 0.0 112.592 -177.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.55 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 9.3 Cg_endo -54.2 -61.79 0.38 Allowed 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 122.205 1.936 . . . . 0.0 111.648 175.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.493 HG12 ' HB ' ' A' ' 76' ' ' VAL . 16.7 m -64.12 -22.54 31.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.669 -171.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.519 ' HG2' HH22 ' A' ' 69' ' ' ARG . 0.9 OUTLIER -72.76 -55.62 6.46 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.552 0.741 . . . . 0.0 109.587 178.482 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 72.2 mmtt -70.28 -37.26 74.81 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.148 0.579 . . . . 0.0 110.972 -173.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -65.44 -39.31 91.91 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.052 0.941 . . . . 0.0 111.061 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.409 HD12 ' HB2' ' A' ' 66' ' ' LEU . 22.9 tp -57.89 -50.85 71.94 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.003 0.815 . . . . 0.0 110.09 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.44 -52.37 64.92 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.525 1.141 . . . . 0.0 109.444 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -60.92 -27.86 68.5 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.786 1.234 . . . . 0.0 112.182 -176.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -70.93 -39.73 72.51 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.757 0.823 . . . . 0.0 110.806 -177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -94.06 -17.71 22.57 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.987 0.515 . . . . 0.0 111.179 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.74 -3.58 54.55 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.349 0.66 . . . . 0.0 111.884 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 70.93 28.42 3.24 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.816 1.247 . . . . 0.0 112.39 174.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.419 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 17.6 m-20 -101.0 112.8 25.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.529 0.732 . . . . 0.0 110.067 174.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.0 mm -77.45 -31.46 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 122.719 0.408 . . . . 0.0 110.335 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -55.44 -48.38 74.54 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.848 0.459 . . . . 0.0 111.888 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.56 -29.64 33.37 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.638 0.375 . . . . 0.0 111.287 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -73.06 -8.17 54.53 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.136 0.574 . . . . 0.0 111.08 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.515 ' SD ' ' HB2' ' A' ' 46' ' ' ALA . 25.4 tpp -121.99 -15.55 7.77 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 173.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.46 -32.71 68.98 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -174.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.55 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 90.2 m95 -104.0 9.75 36.43 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.46 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 24.1 m95 -95.55 153.19 17.83 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.869 0.468 . . . . 0.0 110.102 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.434 ' O ' ' HB1' ' A' ' 46' ' ' ALA . . . -80.0 151.18 30.13 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.341 0.656 . . . . 0.0 109.954 173.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -61.71 -31.11 71.24 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.449 0.699 . . . . 0.0 112.454 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -102.66 19.68 18.67 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.456 0.702 . . . . 0.0 111.303 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.46 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 46.1 t -60.49 119.25 7.67 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 121.074 0.464 . . . . 0.0 112.238 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.565 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 77.9 mm-40 -81.21 144.07 31.87 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.182 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -134.83 113.6 11.76 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.482 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 31.6 m-85 -115.88 155.11 28.53 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.922 0.889 . . . . 0.0 111.602 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.9 159.99 22.18 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.682 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.445 ' HB3' ' HA ' ' A' ' 112' ' ' LYS . 18.3 p90 -55.27 136.41 68.71 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 123.993 0.917 . . . . 0.0 111.925 176.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -77.71 -40.27 1.16 Allowed 'Cis proline' 0 C--N 1.379 2.159 0 CA-C-N 119.854 0.984 . . . . 0.0 112.691 -7.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.71 66.66 0.21 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.832 0.853 . . . . 0.0 109.36 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 25.1 m -107.52 119.27 38.95 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.138 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tt -82.67 102.69 11.65 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.4 -45.18 16.47 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.836 0.454 . . . . 0.0 110.259 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . . . -142.01 120.1 12.12 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -171.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.86 28.1 15.15 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.268 0.355 . . . . 0.0 113.898 -174.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.6 p30 176.18 157.77 0.26 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.254 1.422 . . . . 0.0 109.835 -174.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.515 ' HB2' ' SD ' ' A' ' 25' ' ' MET . . . -60.48 -32.12 71.11 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.48 1.112 . . . . 0.0 113.378 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.449 ' O ' HG21 ' A' ' 51' ' ' VAL . . . -60.55 -51.77 68.03 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.97 0.508 . . . . 0.0 111.124 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 33.9 mt-10 -69.27 -29.07 66.89 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.806 -175.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.1 mt -63.9 -52.11 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.329 0.652 . . . . 0.0 110.4 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.488 ' O ' HG13 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -67.19 -38.79 85.94 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.64 -175.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.472 ' HA ' HD11 ' A' ' 54' ' ' ILE . 70.9 t -59.54 -49.37 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.481 0.712 . . . . 0.0 111.605 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -69.01 -29.41 67.59 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.765 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -77.87 -29.8 50.54 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 118.537 -0.745 . . . . 0.0 111.483 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 50' ' ' ARG . 76.2 mt -55.44 -46.78 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-N 118.645 0.657 . . . . 0.0 109.597 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -56.44 -42.44 78.11 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 124.413 1.071 . . . . 0.0 111.425 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.428 ' HG3' HD21 ' A' ' 62' ' ' LEU . 14.8 tpp180 -70.5 -31.5 68.62 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.414 0.686 . . . . 0.0 110.873 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -75.65 -14.31 60.36 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.534 0.734 . . . . 0.0 110.846 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 69.2 mmtt -91.6 -5.03 54.62 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.332 0.653 . . . . 0.0 111.565 170.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -105.49 122.1 43.91 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 122.985 0.514 . . . . 0.0 109.951 -175.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.54 -19.05 48.96 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.665 2.91 . . . . 0.0 115.165 -164.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -72.24 -24.42 61.37 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.629 0.372 . . . . 0.0 111.304 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.428 HD21 ' HG3' ' A' ' 56' ' ' ARG . 55.3 tp -56.19 120.66 7.9 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.661 0.784 . . . . 0.0 112.364 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -151.96 144.27 24.03 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.26 105.09 0.67 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -101.24 107.18 18.5 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.652 0.781 . . . . 0.0 109.525 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.409 ' HB2' HD12 ' A' ' 13' ' ' LEU . 14.3 tp -78.59 131.74 36.85 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 pp -111.98 -28.68 7.92 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.452 0.701 . . . . 0.0 110.206 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.9 m -157.47 143.69 17.76 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.288 1.035 . . . . 0.0 109.287 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.519 HH22 ' HG2' ' A' ' 10' ' ' GLN . 12.1 ptt180 -142.14 139.59 32.19 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.236 0.541 . . . . 0.0 110.315 162.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.11 143.7 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.843 1.257 . . . . 0.0 109.56 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.1 tt -115.85 134.07 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-O 121.309 0.576 . . . . 0.0 110.709 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -126.56 95.59 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 125.31 1.444 . . . . 0.0 107.81 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.2 -103.24 0.51 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 123.561 0.538 . . . . 0.0 113.369 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -106.46 18.18 22.31 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.529 0.732 . . . . 0.0 111.38 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.5 t -133.3 140.61 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.976 0.91 . . . . 0.0 109.071 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.592 HG22 HG22 ' A' ' 5' ' ' ILE . 57.1 t -125.86 137.82 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 118.516 0.598 . . . . 0.0 109.928 172.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.493 HG12 ' HB ' ' A' ' 98' ' ' ILE . 1.6 mt -99.86 110.0 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 167.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.435 ' HB2' ' SG ' ' A' ' 97' ' ' CYS . 1.3 m-20 -88.67 108.03 19.24 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 167.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.416 ' HE1' ' HB3' ' A' ' 94' ' ' ASP . 0.9 OUTLIER -98.5 108.71 21.46 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.318 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.99 163.67 21.82 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.516 1.127 . . . . 0.0 110.632 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.8 m -108.18 106.17 16.23 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.406 1.082 . . . . 0.0 108.582 165.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 m -90.52 134.05 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 122.481 0.313 . . . . 0.0 111.114 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 49.0 m -76.59 127.89 33.68 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.706 0.402 . . . . 0.0 109.994 175.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.4 mtm105 -126.72 161.48 28.04 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -90.17 99.31 12.35 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.825 0.345 . . . . 0.0 111.402 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -103.37 125.13 35.89 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.07 -16.17 53.42 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.087 2.525 . . . . 0.0 113.877 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -85.3 -9.03 58.18 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.912 0.485 . . . . 0.0 111.756 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.83 -127.14 1.18 Allowed Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.529 -0.595 . . . . 0.0 111.7 172.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -75.97 -83.34 0.07 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 117.282 0.541 . . . . 0.0 111.27 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.97 29.12 1.56 Allowed Glycine 0 C--N 1.354 1.542 0 N-CA-C 114.388 0.515 . . . . 0.0 114.388 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -89.82 99.28 12.32 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 122.136 0.969 . . . . 0.0 110.027 -172.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.9 m -102.75 137.5 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 121.616 -0.678 . . . . 0.0 111.444 -165.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB3' ' HE1' ' A' ' 79' ' ' HIS . 13.1 m-20 -79.31 115.01 18.7 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.686 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.5 HG21 HG12 ' A' ' 113' ' ' ILE . 35.2 t -119.17 156.17 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 125.12 1.368 . . . . 0.0 109.156 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.03 106.11 10.12 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 78' ' ' ASP . 20.5 p -97.23 109.06 21.89 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.527 HG23 ' HB2' ' A' ' 110' ' ' TRP . 7.1 tt -100.4 114.76 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.353 1.061 . . . . 0.0 109.622 -177.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -107.91 132.54 53.36 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.757 0.823 . . . . 0.0 109.71 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -98.4 112.83 24.71 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.497 HG23 HG12 ' A' ' 106' ' ' ILE . 42.1 t -95.08 113.85 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.192 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 41.7 tt0 -119.61 128.05 53.51 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.865 0.866 . . . . 0.0 109.511 175.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 64.37 31.35 12.81 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.391 1.077 . . . . 0.0 111.903 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.81 6.52 89.04 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.726 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -134.1 139.43 45.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.537 1.135 . . . . 0.0 108.957 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.497 HG12 HG23 ' A' ' 101' ' ' VAL . 45.9 mt -68.28 104.86 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 122.429 0.291 . . . . 0.0 110.316 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.492 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . . . -78.33 -30.25 48.08 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.68 0.792 . . . . 0.0 111.175 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.565 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 97.9 mttt -149.48 152.18 35.19 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.877 0.871 . . . . 0.0 109.091 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -146.17 137.42 24.6 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.963 0.905 . . . . 0.0 108.824 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.527 ' HB2' HG23 ' A' ' 98' ' ' ILE . 4.0 m-90 -135.56 150.95 49.86 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -142.43 146.41 34.8 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 171.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 20.5 ptmt -131.19 125.36 32.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.537 176.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.5 HG12 HG21 ' A' ' 95' ' ' VAL . 87.2 mt -87.44 123.92 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.26 -65.94 2.97 Favored Glycine 0 CA--C 1.526 0.754 0 O-C-N 124.451 1.094 . . . . 0.0 113.187 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -159.5 167.63 13.81 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.19 138.31 33.08 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.558 2.172 . . . . 0.0 112.334 165.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 30.1 mmt180 -135.52 146.38 48.01 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.81 0.844 . . . . 0.0 111.213 -175.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.5 mm -136.83 132.65 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.855 1.262 . . . . 0.0 108.445 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.9 t . . . . . 0 N--CA 1.503 2.18 0 C-N-CA 123.734 0.813 . . . . 0.0 111.944 -178.709 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 121.822 0.82 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.5 m -75.78 -49.17 18.89 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.637 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -12.86 58.41 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.173 0.989 . . . . 0.0 113.387 -175.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.518 HG23 HG23 ' A' ' 76' ' ' VAL . 33.2 mm -87.1 -34.26 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.472 ' HG3' HD13 ' A' ' 71' ' ' ILE . 44.3 mt-10 -84.55 -22.33 30.15 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.5 -53.91 61.41 Favored Pre-proline 0 CA--C 1.568 1.639 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.662 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.53 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 33.6 Cg_endo -62.27 -49.56 5.97 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 122.156 1.904 . . . . 0.0 113.052 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.639 ' HA ' HE21 ' A' ' 12' ' ' GLN . 15.6 m -66.95 -37.87 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -169.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -43.67 62.85 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.423 0.689 . . . . 0.0 109.977 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -68.68 -29.72 68.24 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.326 0.651 . . . . 0.0 112.065 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.639 HE21 ' HA ' ' A' ' 9' ' ' VAL . 44.9 mt-30 -59.47 -48.03 83.23 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.904 0.752 . . . . 0.0 110.308 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.55 -51.75 68.51 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 124.012 0.82 . . . . 0.0 110.092 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.62 -27.1 66.02 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 124.029 0.831 . . . . 0.0 110.896 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.493 ' HB1' ' HB1' ' A' ' 23' ' ' ALA . . . -83.08 -32.31 26.85 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.389 1.076 . . . . 0.0 112.285 175.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -72.02 -39.66 68.99 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.256 0.622 . . . . 0.0 110.534 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.67 1.07 54.73 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.887 0.875 . . . . 0.0 111.834 177.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.56 3.17 10.72 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.999 0.92 . . . . 0.0 111.171 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 70.28 9.53 7.02 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.127 1.371 . . . . 0.0 113.695 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 8.9 m-20 -81.13 116.86 21.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.14 0.495 . . . . 0.0 110.916 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.505 HG13 HG12 ' A' ' 54' ' ' ILE . 22.8 mm -82.58 -25.6 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.093 0.957 . . . . 0.0 110.073 171.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -54.74 -48.82 72.11 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.038 0.935 . . . . 0.0 112.097 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.493 ' HB1' ' HB1' ' A' ' 15' ' ' ALA . . . -79.4 -35.18 41.07 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.94 0.496 . . . . 0.0 110.623 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -69.93 -8.26 47.37 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.178 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.649 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 16.6 tpp -119.87 -28.64 5.15 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.447 0.699 . . . . 0.0 112.401 173.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.4 -47.42 75.9 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.036 0.534 . . . . 0.0 112.087 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 98.4 m95 -79.43 1.62 24.81 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -170.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -95.05 168.34 10.83 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.373 0.669 . . . . 0.0 110.045 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -87.1 148.35 25.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.54 0.736 . . . . 0.0 109.353 171.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.16 -25.79 67.96 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.316 0.646 . . . . 0.0 111.706 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -109.19 18.97 19.98 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.976 1.311 . . . . 0.0 111.381 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.7 t -60.84 133.93 56.58 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -173.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.555 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 36.6 mm-40 -95.44 105.46 17.43 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.567 0.747 . . . . 0.0 109.967 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.425 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 48.4 t80 -94.6 111.44 23.2 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.635 0.774 . . . . 0.0 110.246 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -105.16 139.89 39.14 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.287 1.035 . . . . 0.0 110.029 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.6 161.48 14.82 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.24 1.016 . . . . 0.0 110.345 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.437 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 71.3 t80 -50.26 127.58 22.74 Favored Pre-proline 0 CA--C 1.566 1.593 0 O-C-N 124.285 0.99 . . . . 0.0 112.039 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.23 -50.29 0.19 OUTLIER 'Cis proline' 0 C--N 1.386 2.519 0 CA-C-N 119.77 0.953 . . . . 0.0 113.513 -5.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.33 78.83 0.81 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.8 m -117.48 114.03 22.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.033 0.933 . . . . 0.0 109.237 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.74 101.48 0.81 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.8 mt -79.63 -36.36 38.02 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.275 0.63 . . . . 0.0 109.93 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.446 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . . . -142.45 116.3 9.29 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.612 -170.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.0 33.21 4.77 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 123.374 0.421 . . . . 0.0 112.771 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.434 ' O ' HG13 ' A' ' 49' ' ' ILE . 8.9 p30 167.05 158.29 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.204 1.402 . . . . 0.0 109.816 -167.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.649 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -70.65 -25.2 62.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.245 1.018 . . . . 0.0 113.148 -175.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.4 98.27 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.861 0.465 . . . . 0.0 111.259 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 26.6 mt-10 -75.39 -32.36 60.75 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.611 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.448 HD11 ' HA ' ' A' ' 46' ' ' ALA . 72.4 mt -65.44 -46.29 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.197 0.599 . . . . 0.0 110.945 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 54' ' ' ILE . 14.0 ptm180 -64.67 -51.43 62.56 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.686 0.616 . . . . 0.0 110.641 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.412 ' HA ' HD13 ' A' ' 54' ' ' ILE . 20.6 m -65.61 -35.23 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 122.97 0.508 . . . . 0.0 111.825 -175.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -71.41 -34.92 70.77 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.855 0.862 . . . . 0.0 110.476 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -75.08 -32.61 61.52 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.642 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.514 HG22 ' HE2' ' A' ' 58' ' ' LYS . 97.7 mt -58.15 -37.76 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.672 0.389 . . . . 0.0 110.026 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.12 -34.56 78.34 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.654 0.782 . . . . 0.0 111.6 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -75.2 -25.98 58.63 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.867 0.467 . . . . 0.0 110.157 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.509 ' HA ' HD23 ' A' ' 62' ' ' LEU . 2.8 m-85 -83.9 -4.42 58.68 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.59 0.756 . . . . 0.0 111.347 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.514 ' HE2' HG22 ' A' ' 54' ' ' ILE . 74.5 mmtt -73.07 -25.84 61.05 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.717 0.407 . . . . 0.0 111.109 169.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 50.4 mm-40 -57.42 116.7 14.7 Favored Pre-proline 0 N--CA 1.481 1.113 0 C-N-CA 123.583 0.753 . . . . 0.0 110.748 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.23 -26.61 41.91 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.321 2.014 . . . . 0.0 112.609 -175.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.42 2.25 55.77 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.053 0.941 . . . . 0.0 111.484 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 57' ' ' PHE . 17.6 tp -62.23 114.02 3.21 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.932 0.493 . . . . 0.0 111.276 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -151.65 115.62 4.95 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.535 0.734 . . . . 0.0 109.084 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.12 104.59 3.11 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -91.68 101.82 14.45 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.7 tt -79.26 124.88 28.8 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.52 -32.79 5.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.736 -172.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.7 m -148.69 134.86 19.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.367 1.067 . . . . 0.0 108.558 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.403 HH12 ' HG2' ' A' ' 6' ' ' GLU . 52.3 ptt85 -137.76 133.31 33.94 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 166.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -121.56 128.09 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.511 1.124 . . . . 0.0 109.43 -172.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.472 HD13 ' HG3' ' A' ' 6' ' ' GLU . 11.9 tt -108.7 128.77 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 121.253 0.549 . . . . 0.0 110.657 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.1 p -123.89 94.46 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 173.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.27 -110.83 3.15 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.823 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -87.99 -1.1 57.78 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.609 1.163 . . . . 0.0 111.8 -172.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.3 t -128.77 140.18 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.074 0.95 . . . . 0.0 109.786 -172.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.518 HG23 HG23 ' A' ' 5' ' ' ILE . 33.2 t -125.29 134.65 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.349 0.66 . . . . 0.0 109.512 172.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.457 HG12 ' HB ' ' A' ' 98' ' ' ILE . 2.4 mt -99.58 107.04 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 165.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.75 109.32 20.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -98.74 109.69 22.41 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.25 159.24 36.73 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.467 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.2 m -107.43 110.05 21.91 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.121 172.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.0 t -81.77 103.25 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 123.293 0.637 . . . . 0.0 110.258 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.3 m -66.75 129.56 40.27 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.854 0.862 . . . . 0.0 110.205 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 91' ' ' GLY . 80.7 mtp180 -133.56 -162.53 1.25 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -130.21 83.5 2.13 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.917 0.389 . . . . 0.0 110.357 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -90.18 137.83 27.64 Favored Pre-proline 0 N--CA 1.475 0.8 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.3 8.15 1.56 Allowed 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.839 2.359 . . . . 0.0 113.046 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.91 -32.68 57.56 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.082 0.953 . . . . 0.0 109.314 169.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.09 -98.03 0.13 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.355 175.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -76.91 -82.41 0.08 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.786 0.834 . . . . 0.0 110.281 175.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 84' ' ' ARG . . . 117.43 28.59 2.31 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 121.312 -0.47 . . . . 0.0 113.877 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -88.1 140.95 28.97 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -174.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.588 HG13 ' HA ' ' A' ' 116' ' ' PRO . 29.1 m -127.43 129.27 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 122.04 -0.413 . . . . 0.0 110.817 -176.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -77.34 110.43 12.07 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.039 0.536 . . . . 0.0 109.703 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.447 HG21 HG12 ' A' ' 113' ' ' ILE . 33.8 t -114.15 156.55 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.607 1.163 . . . . 0.0 108.859 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.88 103.32 6.73 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 71.6 m -96.35 111.84 23.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.235 1.014 . . . . 0.0 109.959 -174.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.457 ' HB ' HG12 ' A' ' 77' ' ' ILE . 8.6 tt -103.42 110.96 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 124.602 1.161 . . . . 0.0 110.155 -175.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -105.69 133.64 50.1 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.167 0.587 . . . . 0.0 110.905 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -100.45 119.68 38.84 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.195 0.998 . . . . 0.0 108.474 169.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.5 t -110.28 115.25 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.014 0.926 . . . . 0.0 110.536 -173.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 11.4 tp10 -118.68 126.39 51.82 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.145 0.578 . . . . 0.0 109.806 177.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.411 HD21 ' HG3' ' A' ' 102' ' ' GLU . 54.9 m-80 61.55 30.25 18.62 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.892 1.277 . . . . 0.0 112.174 -177.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.45 0.03 86.03 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 116.379 -0.373 . . . . 0.0 113.774 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -117.38 138.41 51.82 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 67.1 mt -68.56 105.91 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . . . -78.11 -32.13 50.36 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.056 0.542 . . . . 0.0 110.705 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.555 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 62.4 mtpt -150.2 134.23 16.98 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -130.4 132.28 45.68 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.401 ' HB2' HG22 ' A' ' 98' ' ' ILE . 0.7 OUTLIER -132.42 148.64 52.41 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -177.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -142.62 146.69 34.78 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.284 0.493 . . . . 0.0 110.03 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 25.1 pttm -121.19 127.68 51.73 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.447 HG12 HG21 ' A' ' 95' ' ' VAL . 88.3 mt -89.69 124.99 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.21 -73.88 0.52 Allowed Glycine 0 CA--C 1.526 0.765 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.914 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -160.69 170.3 8.71 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.134 0.574 . . . . 0.0 109.676 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.588 ' HA ' HG13 ' A' ' 93' ' ' VAL . 72.4 Cg_endo -73.84 123.74 8.68 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.215 1.943 . . . . 0.0 112.225 165.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.8 mmt85 -110.01 147.58 33.25 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.212 1.005 . . . . 0.0 109.243 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.9 mm -139.05 127.79 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.489 1.481 0 C-N-CA 123.711 0.805 . . . . 0.0 111.74 -175.877 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.6 m120 . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 121.552 0.691 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.408 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 33.8 p -67.74 -33.02 74.05 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.702 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.65 -20.32 63.27 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.49 1.116 . . . . 0.0 112.578 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 74' ' ' ASN . 30.0 mm -91.79 -28.98 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.946 0.898 . . . . 0.0 109.409 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -75.0 -27.39 60.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.965 174.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 3' ' ' SER . 83.7 mt -59.92 -55.21 47.83 Favored Pre-proline 0 CA--C 1.564 1.484 0 CA-C-O 117.884 -1.055 . . . . 0.0 112.032 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 19.3 Cg_endo -56.91 -55.59 2.55 Favored 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 122.111 1.874 . . . . 0.0 112.613 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.5 m -62.98 -35.36 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.489 -171.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -73.66 -52.2 14.12 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.163 0.585 . . . . 0.0 110.394 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -62.86 -28.29 69.93 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -75.42 -43.56 49.27 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.853 0.861 . . . . 0.0 111.422 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.14 -52.05 65.38 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.003 0.521 . . . . 0.0 110.331 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.71 -25.81 68.37 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.021 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . . . -80.76 -27.64 36.68 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.372 1.069 . . . . 0.0 112.177 172.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.532 ' HH ' HD12 ' A' ' 62' ' ' LEU . 70.6 t80 -66.91 -47.52 71.52 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.252 0.548 . . . . 0.0 109.885 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.62 -14.57 59.6 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.847 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.43 -2.77 41.45 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.449 0.699 . . . . 0.0 112.118 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 67.55 25.48 8.35 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.791 1.237 . . . . 0.0 112.835 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.521 ' HB2' ' HB2' ' A' ' 15' ' ' ALA . 11.0 m-20 -92.8 100.04 12.6 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.311 0.644 . . . . 0.0 110.011 173.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.403 HG13 HG12 ' A' ' 54' ' ' ILE . 12.6 mm -70.39 -31.17 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.001 0.52 . . . . 0.0 110.787 170.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -61.36 -45.11 95.77 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.014 0.525 . . . . 0.0 111.691 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.03 -30.82 44.39 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.134 0.574 . . . . 0.0 110.977 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -72.94 -5.94 41.93 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.855 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.748 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -112.75 -30.52 7.04 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.217 0.607 . . . . 0.0 112.215 172.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.75 -32.7 67.72 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -169.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.484 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.9 m95 -97.97 7.83 45.7 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -173.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.473 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 46.8 m95 -94.25 157.51 16.01 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.01 0.524 . . . . 0.0 110.288 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.402 ' O ' ' HB1' ' A' ' 46' ' ' ALA . . . -76.76 148.49 36.66 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.322 169.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -67.83 -24.29 65.26 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.158 0.583 . . . . 0.0 111.32 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -106.18 18.33 22.18 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.312 1.045 . . . . 0.0 111.236 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.473 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 51.5 t -64.93 138.99 58.71 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -174.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -98.21 136.61 38.17 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.763 0.825 . . . . 0.0 108.847 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.458 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 56.4 t80 -130.92 110.98 11.66 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -109.64 151.81 26.38 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.602 0.761 . . . . 0.0 110.512 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.25 158.47 19.67 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.634 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.633 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 87.2 t80 -61.29 130.82 91.97 Favored Pre-proline 0 CA--C 1.558 1.276 0 O-C-N 123.899 0.749 . . . . 0.0 110.335 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.38 -57.25 0.14 OUTLIER 'Cis proline' 0 C--N 1.383 2.39 0 CA-C-N 120.138 1.085 . . . . 0.0 113.6 -1.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.26 81.53 1.42 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.7 m -129.19 108.21 10.17 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.497 0.719 . . . . 0.0 109.915 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.5 tp -65.78 102.57 0.77 Allowed 'General case' 0 CA--C 1.535 0.377 0 O-C-N 123.572 0.545 . . . . 0.0 109.824 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.9 mt -78.68 -25.74 44.87 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.531 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -157.3 117.05 3.41 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.85 35.34 4.59 Favored Glycine 0 C--N 1.346 1.119 0 C-N-CA 123.28 0.467 . . . . 0.0 112.926 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 p30 163.96 160.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 126.306 1.843 . . . . 0.0 108.426 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 29' ' ' ALA . . . -69.55 -26.14 64.35 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -171.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.69 -41.65 99.22 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.331 0.586 . . . . 0.0 110.884 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -76.28 -29.19 57.31 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.922 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.449 ' HB ' ' HE1' ' A' ' 25' ' ' MET . 69.0 mt -64.24 -50.96 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 122.916 0.486 . . . . 0.0 110.639 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.748 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 30.8 ptt180 -60.68 -51.59 68.75 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.904 0.752 . . . . 0.0 110.671 -176.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.44 ' HA ' HD12 ' A' ' 54' ' ' ILE . 35.5 m -63.97 -38.22 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -174.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -61.87 -38.08 86.96 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 123.815 0.697 . . . . 0.0 110.376 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -78.22 -34.32 49.37 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.121 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 50' ' ' ARG . 98.0 mt -56.46 -39.99 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.089 0.556 . . . . 0.0 110.182 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.87 -41.01 95.11 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.139 0.976 . . . . 0.0 111.576 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -73.9 -29.27 61.97 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.409 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -73.49 -4.66 35.15 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.002 0.521 . . . . 0.0 111.62 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -74.46 -36.22 63.33 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.962 0.505 . . . . 0.0 111.011 172.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.53 115.78 12.8 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 123.493 0.717 . . . . 0.0 110.919 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.89 -25.07 28.4 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.482 2.121 . . . . 0.0 112.49 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.78 -7.79 58.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.821 0.848 . . . . 0.0 111.69 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.532 HD12 ' HH ' ' A' ' 16' ' ' TYR . 56.1 tp -64.55 120.56 12.56 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 122.477 0.311 . . . . 0.0 110.547 176.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -151.2 115.55 5.08 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 169.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.91 102.97 2.75 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -100.87 109.77 21.76 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 80' ' ' GLU . 13.8 tp -66.7 140.33 57.88 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.164 0.507 . . . . 0.0 110.089 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.553 HD11 ' HG1' ' A' ' 81' ' ' THR . 5.7 mt -107.0 -51.1 2.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.457 1.122 . . . . 0.0 107.989 -177.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.9 m -154.54 141.07 18.85 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 113.024 -1.898 . . . . 0.0 109.032 -172.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -135.14 121.83 20.83 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 168.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.468 HG21 ' HB ' ' A' ' 77' ' ' ILE . 19.3 m -107.96 136.07 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.5 tt -120.71 129.83 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.274 0.559 . . . . 0.0 110.775 -175.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.95 99.35 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 C-N-CA 124.859 1.264 . . . . 0.0 108.393 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.79 -125.66 22.92 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.583 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.446 ' HA ' HG13 ' A' ' 5' ' ' ILE . 26.3 p-10 -91.48 17.98 7.9 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.307 0.643 . . . . 0.0 111.88 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.6 t -127.45 135.76 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.162 0.985 . . . . 0.0 109.8 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.2 t -125.37 139.66 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.006 0.522 . . . . 0.0 109.788 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.468 ' HB ' HG21 ' A' ' 70' ' ' VAL . 10.0 mm -98.81 104.33 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 167.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -94.87 105.16 17.07 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -100.19 105.81 17.44 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -121.28 171.16 8.93 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.156 1.382 . . . . 0.0 109.918 -178.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.553 ' HG1' HD11 ' A' ' 67' ' ' LEU . 98.4 m -118.09 106.23 12.66 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.924 0.89 . . . . 0.0 108.935 172.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.0 m -82.47 124.16 39.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-O 121.613 0.721 . . . . 0.0 109.194 170.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.9 m -83.09 119.42 24.48 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.681 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.628 HH21 ' HZ ' ' A' ' 86' ' ' PHE . 61.9 mtm180 -119.06 -160.89 0.82 Allowed 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -139.59 111.47 7.36 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.773 0.715 . . . . 0.0 110.32 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.628 ' HZ ' HH21 ' A' ' 84' ' ' ARG . 17.3 m-30 -109.28 151.49 42.09 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.745 0.818 . . . . 0.0 110.127 -178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.37 -28.82 88.58 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.649 2.232 . . . . 0.0 113.736 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -88.53 2.74 52.35 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.06 -146.56 16.09 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-O 119.479 -0.623 . . . . 0.0 113.235 173.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -39.07 -72.92 0.05 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.316 1.446 . . . . 0.0 113.059 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 103.62 25.7 7.17 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 113.897 0.319 . . . . 0.0 113.897 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -92.84 129.25 38.82 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.584 HG11 ' HA ' ' A' ' 116' ' ' PRO . 20.7 m -123.05 143.88 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.511 ' HB3' HH21 ' A' ' 117' ' ' ARG . 9.8 p-10 -85.89 122.95 30.67 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 174.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.432 HG21 HG12 ' A' ' 113' ' ' ILE . 44.2 t -113.68 142.33 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -106.12 97.65 7.43 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 94.1 m -93.49 108.28 19.99 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.357 0.663 . . . . 0.0 109.214 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.78 115.75 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.897 0.879 . . . . 0.0 108.979 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -107.39 133.91 51.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.684 0.794 . . . . 0.0 109.711 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -103.31 113.37 26.81 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 168.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.584 HG23 HG12 ' A' ' 106' ' ' ILE . 96.9 t -100.0 135.29 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.204 1.001 . . . . 0.0 110.035 -176.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -133.27 119.2 19.49 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.959 0.904 . . . . 0.0 109.866 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 61.12 30.54 19.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.927 1.291 . . . . 0.0 112.375 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.67 -6.64 83.13 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.009 -0.542 . . . . 0.0 113.858 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -113.86 133.51 55.38 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.584 HG12 HG23 ' A' ' 101' ' ' VAL . 57.5 mt -67.68 107.59 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.53 -32.1 47.84 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.495 0.718 . . . . 0.0 110.997 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -150.09 152.32 34.6 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.068 0.947 . . . . 0.0 108.821 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.66 135.49 12.73 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -136.75 151.79 49.61 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -139.57 144.79 37.96 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.249 0.547 . . . . 0.0 110.31 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.633 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 16.8 ttpt -117.03 125.6 51.59 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 172.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.432 HG12 HG21 ' A' ' 95' ' ' VAL . 62.0 mt -86.44 125.56 40.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.86 -132.21 1.47 Allowed Glycine 0 CA--C 1.52 0.4 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.938 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -83.5 134.26 45.5 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.591 0.756 . . . . 0.0 111.325 -169.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.584 ' HA ' HG11 ' A' ' 93' ' ' VAL . 77.5 Cg_endo -74.07 93.37 0.88 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 123.346 2.697 . . . . 0.0 111.435 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.511 HH21 ' HB3' ' A' ' 94' ' ' ASP . 49.5 mtm105 -100.45 141.48 33.24 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.532 0.682 . . . . 0.0 111.216 -169.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.3 mm -127.8 124.72 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.732 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 N--CA 1.481 1.107 0 C-N-CA 123.834 0.853 . . . . 0.0 110.258 177.199 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.412 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 13.8 m -65.68 -42.59 91.1 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.465 1.106 . . . . 0.0 111.348 -169.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.77 -19.17 64.78 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.038 0.935 . . . . 0.0 112.72 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 mm -96.1 -29.69 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.177 0.991 . . . . 0.0 109.617 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -71.53 -36.94 71.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.247 1.019 . . . . 0.0 111.212 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.456 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 91.4 mt -58.15 -52.76 72.18 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.061 -175.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.418 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 16.9 Cg_endo -57.19 -59.77 0.55 Allowed 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 121.6 1.533 . . . . 0.0 112.271 176.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.5 m -62.42 -29.81 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -169.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 26.2 tp60 -73.44 -55.61 6.13 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 122.852 0.461 . . . . 0.0 110.399 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.2 mmtt -63.68 -36.33 83.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 123.752 0.658 . . . . 0.0 111.002 -175.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.38 -46.0 90.59 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.136 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.44 -48.78 80.33 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 55.7 mm-40 -58.44 -33.72 70.02 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.508 1.13 . . . . 0.0 110.488 -176.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.71 -26.06 32.35 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.574 1.15 . . . . 0.0 112.417 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -69.7 -44.36 70.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.977 0.511 . . . . 0.0 109.945 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.87 -22.79 52.94 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.272 175.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.79 -0.78 57.81 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.28 0.632 . . . . 0.0 112.19 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 mmt85 68.96 7.72 6.39 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.009 1.324 . . . . 0.0 113.323 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.95 98.69 6.51 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.231 0.612 . . . . 0.0 110.228 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.415 HG13 HG12 ' A' ' 54' ' ' ILE . 12.5 mm -63.06 -36.02 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.02 0.528 . . . . 0.0 110.77 172.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -57.52 -49.17 77.21 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.505 0.722 . . . . 0.0 111.405 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.0 -30.79 27.87 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.136 0.575 . . . . 0.0 111.963 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -65.93 -20.68 66.3 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.11 0.256 . . . . 0.0 110.646 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 67.7 mmm -120.16 6.19 10.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.701 0.8 . . . . 0.0 112.107 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.84 -47.57 58.63 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.295 0.569 . . . . 0.0 110.426 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 92.0 m95 -86.95 9.3 19.85 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.349 -169.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.438 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 30.1 m95 -89.29 156.74 18.55 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 173.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -76.72 149.96 36.33 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 173.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.71 -27.4 68.3 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.74 0.416 . . . . 0.0 110.645 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.97 19.37 19.58 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.596 1.158 . . . . 0.0 111.017 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.438 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 52.1 t -63.5 123.57 19.11 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.058 0.456 . . . . 0.0 111.815 -174.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -85.73 140.44 30.5 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.411 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 63.0 t80 -132.87 110.08 10.06 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -172.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.404 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 24.2 m-85 -111.03 155.91 22.06 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.364 1.065 . . . . 0.0 110.955 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.26 160.29 29.6 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.67 170.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -50.93 132.5 29.53 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 124.674 1.19 . . . . 0.0 112.156 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.85 -41.49 0.9 Allowed 'Cis proline' 0 C--N 1.379 2.145 0 CA-C-N 119.961 1.022 . . . . 0.0 113.801 -2.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.06 56.89 0.12 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.215 0.606 . . . . 0.0 110.894 -177.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 75.5 m -109.33 114.22 27.71 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.67 0.788 . . . . 0.0 110.218 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.4 tt -76.5 109.48 10.27 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.17 -44.54 14.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.224 0.61 . . . . 0.0 109.664 174.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . . . -132.13 122.34 25.2 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.742 -171.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.21 46.74 1.13 Allowed Glycine 0 N--CA 1.478 1.448 0 C-N-CA 122.612 0.148 . . . . 0.0 112.793 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.438 ' O ' HG13 ' A' ' 49' ' ' ILE . 9.5 p30 162.34 152.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 126.341 1.856 . . . . 0.0 108.319 -171.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -63.44 -25.38 68.24 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.765 0.826 . . . . 0.0 113.194 -174.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.422 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -64.07 -44.27 92.92 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.942 0.497 . . . . 0.0 111.331 -177.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 33.0 mt-10 -75.68 -33.53 60.39 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 45' ' ' ASN . 53.2 mt -65.77 -42.81 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.098 0.559 . . . . 0.0 110.598 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.458 ' O ' HG13 ' A' ' 54' ' ' ILE . 14.0 ptm180 -66.44 -42.8 87.11 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.952 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 47' ' ' ALA . 97.8 t -61.04 -44.56 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 123.787 0.68 . . . . 0.0 110.572 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -63.59 -34.7 78.4 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.19 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -77.2 -35.55 55.64 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.038 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.477 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 78.9 mt -55.5 -44.22 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 123.195 0.598 . . . . 0.0 110.124 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -54.98 -43.15 73.26 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 124.377 1.048 . . . . 0.0 111.203 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.3 tpp85 -72.68 -30.7 64.47 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.619 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -78.22 -6.63 55.47 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.71 0.404 . . . . 0.0 111.596 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 69.4 mmtt -87.11 -12.63 46.52 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.229 0.612 . . . . 0.0 111.645 171.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.71 114.73 18.96 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.733 0.813 . . . . 0.0 108.886 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.62 -27.21 38.92 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.632 2.221 . . . . 0.0 113.157 -170.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -89.16 -6.54 56.87 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.625 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.4 tp -56.99 121.95 11.17 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.48 0.488 . . . . 0.0 111.571 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -149.31 119.47 7.24 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.498 ' HA2' HG13 ' A' ' 82' ' ' VAL . . . -88.8 104.93 3.13 Favored Glycine 0 C--N 1.34 0.778 0 O-C-N 123.524 0.515 . . . . 0.0 112.197 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -102.43 101.93 12.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 tt -83.74 131.24 34.93 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.65 -30.73 6.07 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.175 0.99 . . . . 0.0 111.136 -173.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.6 m -149.35 130.68 14.67 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.4 0.68 . . . . 0.0 109.344 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -137.82 117.58 13.16 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.43 115.69 47.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.778 0.831 . . . . 0.0 109.573 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.5 tt -106.51 123.9 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 122.935 0.494 . . . . 0.0 109.983 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 t -118.75 95.73 3.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.1 -95.33 0.2 Allowed Glycine 0 CA--C 1.531 1.077 0 O-C-N 123.661 0.601 . . . . 0.0 113.78 176.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -108.39 4.23 24.17 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.456 1.102 . . . . 0.0 111.495 -171.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.93 138.53 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.511 1.124 . . . . 0.0 109.631 -173.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.01 127.62 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.497 0.719 . . . . 0.0 109.388 173.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.484 HG12 ' HB ' ' A' ' 98' ' ' ILE . 4.0 mt -99.03 106.54 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 163.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -89.99 132.5 35.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 172.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -128.58 110.54 12.35 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.24 171.08 8.55 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.366 1.466 . . . . 0.0 109.282 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.416 HG22 ' HB2' ' A' ' 92' ' ' GLU . 97.1 m -125.9 102.64 7.37 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 164.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.498 HG13 ' HA2' ' A' ' 64' ' ' GLY . 15.0 m -84.22 124.37 39.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.843 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.439 HG22 ' HD2' ' A' ' 90' ' ' LYS . 88.2 m -66.4 123.9 21.26 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.958 170.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -129.81 -170.61 2.34 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -126.06 97.29 5.04 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 118.974 0.806 . . . . 0.0 111.018 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -100.92 140.32 21.23 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.093 0.957 . . . . 0.0 108.952 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -64.69 -17.74 60.47 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.687 2.258 . . . . 0.0 113.637 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -83.59 -9.24 59.05 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.925 0.49 . . . . 0.0 112.093 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.66 -120.49 0.94 Allowed Glycine 0 C--N 1.349 1.295 0 CA-C-O 120.041 -0.31 . . . . 0.0 112.495 172.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.439 ' HD2' HG22 ' A' ' 83' ' ' THR . 16.0 tppt? -66.76 -83.28 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.841 0.856 . . . . 0.0 111.317 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 119.44 27.06 2.26 Favored Glycine 0 C--N 1.346 1.086 0 O-C-N 123.094 0.246 . . . . 0.0 112.558 -174.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.416 ' HB2' HG22 ' A' ' 81' ' ' THR . 9.7 pt-20 -89.45 108.62 19.75 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.566 0.698 . . . . 0.0 109.441 -172.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.625 HG12 ' HA ' ' A' ' 116' ' ' PRO . 4.8 m -112.64 142.32 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 122.858 0.463 . . . . 0.0 109.849 -175.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -96.77 144.37 26.82 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.537 HG22 HG12 ' A' ' 113' ' ' ILE . 15.3 t -136.82 136.63 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.608 0.763 . . . . 0.0 109.17 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.32 98.83 9.44 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 170.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 63.1 m -98.22 112.69 24.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.598 0.759 . . . . 0.0 109.641 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.526 HG23 ' HB2' ' A' ' 110' ' ' TRP . 6.3 tt -97.56 110.8 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 123.58 0.752 . . . . 0.0 109.989 177.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -98.32 154.83 17.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.456 0.702 . . . . 0.0 109.843 174.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -132.88 119.41 20.17 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.18 0.992 . . . . 0.0 108.452 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 56.6 t -94.54 140.03 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.909 0.883 . . . . 0.0 110.254 -174.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 24.3 tt0 -138.98 123.03 17.91 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.82 31.1 16.6 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.537 0.735 . . . . 0.0 110.934 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.49 -5.73 83.91 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.929 -0.578 . . . . 0.0 114.161 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -125.39 134.6 52.09 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.779 0.831 . . . . 0.0 109.748 -175.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 64.2 mt -63.66 103.61 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 122.854 0.462 . . . . 0.0 110.397 -178.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . . . -81.28 -24.84 36.98 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.168 0.587 . . . . 0.0 111.559 -176.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -149.25 139.81 22.54 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.572 0.749 . . . . 0.0 109.405 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.88 138.25 33.79 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.08 0.952 . . . . 0.0 108.786 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.526 ' HB2' HG23 ' A' ' 98' ' ' ILE . 3.2 m-90 -136.84 142.8 42.86 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -142.64 147.1 35.2 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 119.181 0.901 . . . . 0.0 111.233 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -131.91 130.35 41.47 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.852 0.861 . . . . 0.0 108.839 173.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.537 HG12 HG22 ' A' ' 95' ' ' VAL . 95.9 mt -87.85 127.17 41.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.86 -80.22 0.12 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 114.923 -1.035 . . . . 0.0 113.355 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -158.55 163.67 23.58 Favored Pre-proline 0 C--O 1.243 0.745 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.625 ' HA ' HG12 ' A' ' 93' ' ' VAL . 97.8 Cg_endo -81.35 141.5 12.73 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.061 1.841 . . . . 0.0 112.495 166.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -132.67 157.63 44.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.893 0.877 . . . . 0.0 110.335 174.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.417 HG23 ' H ' ' A' ' 90' ' ' LYS . 45.9 mm -133.43 144.47 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.891 1.276 . . . . 0.0 107.825 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.0 t . . . . . 0 N--CA 1.491 1.619 0 C-N-CA 122.948 0.499 . . . . 0.0 110.915 179.149 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.9 m -52.4 -53.17 48.46 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.254 1.422 . . . . 0.0 113.89 -163.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.96 -11.88 59.66 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.421 ' HB ' HD11 ' A' ' 71' ' ' ILE . 13.3 mm -98.38 -30.51 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.978 0.911 . . . . 0.0 109.984 175.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.12 -35.9 71.92 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.137 0.975 . . . . 0.0 110.632 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -65.71 -46.71 67.13 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.219 1.407 . . . . 0.0 112.579 -168.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.525 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 11.6 Cg_endo -55.13 -57.81 1.49 Allowed 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 121.561 1.507 . . . . 0.0 111.425 171.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.404 HG13 HG11 ' A' ' 76' ' ' VAL . 73.6 t -59.63 -33.37 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.506 1.122 . . . . 0.0 112.407 -173.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.547 ' HA ' HH12 ' A' ' 69' ' ' ARG . 0.9 OUTLIER -69.43 -56.07 8.49 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.532 0.733 . . . . 0.0 110.306 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -66.34 -35.4 80.25 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.414 0.686 . . . . 0.0 111.423 -174.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.04 -39.29 93.13 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.615 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.656 ' HB2' HH22 ' A' ' 69' ' ' ARG . 58.1 tp -59.02 -52.55 65.28 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.671 0.607 . . . . 0.0 110.666 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -54.97 -46.92 75.11 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.969 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.54 -30.69 71.47 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.336 1.054 . . . . 0.0 112.307 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -68.74 -48.54 63.51 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.154 0.582 . . . . 0.0 110.467 -175.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -82.21 -19.79 39.04 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.098 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.01 -3.56 58.89 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.408 0.683 . . . . 0.0 112.124 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 68.2 21.24 8.62 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.773 1.229 . . . . 0.0 112.171 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -90.05 123.21 33.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.934 0.894 . . . . 0.0 110.506 174.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.5 mm -87.15 -28.32 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.47 0.708 . . . . 0.0 110.736 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.44 -47.29 86.04 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.325 0.65 . . . . 0.0 111.981 -170.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.64 -32.24 41.62 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.072 0.549 . . . . 0.0 110.66 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -73.27 -7.18 50.44 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.088 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.729 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 1.1 tpt -116.94 -33.95 4.58 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.303 0.641 . . . . 0.0 111.864 176.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.09 -48.53 78.36 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.338 0.655 . . . . 0.0 112.066 -172.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 99.1 m95 -76.43 -0.67 23.71 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.236 -173.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.456 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 14.8 m95 -91.99 149.4 21.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 173.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 107' ' ' ALA . . . -75.42 155.15 36.64 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.975 0.51 . . . . 0.0 110.651 176.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.75 -24.55 66.98 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.451 0.701 . . . . 0.0 111.384 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -104.56 19.19 20.81 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 124.366 1.066 . . . . 0.0 110.465 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.456 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 49.0 t -60.52 114.86 3.19 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -173.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -92.49 102.87 15.32 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.887 0.875 . . . . 0.0 110.099 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.459 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 78.4 t80 -97.08 111.28 23.58 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 125.265 1.426 . . . . 0.0 110.242 -173.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.488 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 45.5 m-85 -111.08 155.59 22.58 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.53 1.132 . . . . 0.0 110.55 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.69 157.05 23.67 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.242 170.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -55.81 134.3 72.71 Favored Pre-proline 0 CA--C 1.564 1.497 0 C-N-CA 124.374 1.07 . . . . 0.0 112.251 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.33 -40.83 1.11 Allowed 'Cis proline' 0 C--N 1.381 2.289 0 CA-C-N 120.146 1.088 . . . . 0.0 113.011 -8.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.16 92.62 0.75 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.983 0.913 . . . . 0.0 108.945 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 90.5 m -139.0 117.38 11.98 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.729 0.812 . . . . 0.0 108.863 176.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 tt -81.93 103.14 11.37 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -176.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.403 HD21 ' O ' ' A' ' 40' ' ' THR . 2.4 mm? -89.73 -29.42 18.73 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.509 0.323 . . . . 0.0 110.785 177.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -146.83 116.34 7.09 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -175.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.96 36.26 4.22 Favored Glycine 0 N--CA 1.478 1.478 0 C-N-CA 123.19 0.424 . . . . 0.0 113.396 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 p30 168.94 163.28 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.473 1.509 . . . . 0.0 109.438 -172.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -64.0 -35.42 80.66 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.945 0.898 . . . . 0.0 112.602 -177.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.86 -45.61 91.89 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.164 0.586 . . . . 0.0 111.717 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -71.67 -31.82 67.22 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.709 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.3 mt -66.04 -38.73 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.55 0.74 . . . . 0.0 110.097 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.729 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 75.3 ttt180 -62.27 -57.05 12.82 Favored 'General case' 0 C--N 1.348 0.53 0 O-C-N 123.994 0.809 . . . . 0.0 110.091 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.2 t -55.34 -48.41 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 125.043 1.464 . . . . 0.0 110.843 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.1 ttt-85 -61.33 -37.74 84.38 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.325 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -78.75 -28.37 44.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 118.889 -0.577 . . . . 0.0 112.136 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 50' ' ' ARG . 97.2 mt -61.64 -44.43 98.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 118.879 0.763 . . . . 0.0 109.06 174.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -65.33 -34.33 78.08 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.978 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -71.16 -30.33 66.32 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.2 0.6 . . . . 0.0 110.961 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -79.55 -5.7 55.47 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.127 0.571 . . . . 0.0 111.304 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -82.53 -8.57 59.61 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.875 0.47 . . . . 0.0 111.577 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 24.0 mm-40 -70.1 118.64 65.62 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.81 -22.25 27.52 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.32 2.013 . . . . 0.0 112.76 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.07 -6.97 49.99 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.727 0.811 . . . . 0.0 111.731 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 21.7 tp -58.43 111.89 1.39 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.222 0.464 . . . . 0.0 111.282 -175.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -148.23 117.01 6.68 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.99 126.71 8.19 Favored Glycine 0 C--O 1.24 0.482 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 171.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -119.46 100.9 7.58 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.8 tt -91.29 117.87 30.01 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.45 -47.01 5.56 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.378 1.071 . . . . 0.0 109.559 175.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.3 m -121.69 139.42 53.59 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.601 0.76 . . . . 0.0 111.672 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.656 HH22 ' HB2' ' A' ' 13' ' ' LEU . 2.2 ptp180 -144.07 125.17 14.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.455 0.702 . . . . 0.0 109.322 159.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' A' ' 77' ' ' ILE . 20.4 m -110.71 152.4 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.999 0.919 . . . . 0.0 108.88 175.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.423 HG13 HG22 ' A' ' 76' ' ' VAL . 19.7 tt -138.53 144.97 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 122.604 0.361 . . . . 0.0 110.812 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.444 HG11 HG12 ' A' ' 75' ' ' VAL . 2.1 p -149.46 101.67 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 124.431 1.093 . . . . 0.0 109.075 -177.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.2 -123.35 20.78 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.488 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -98.76 19.32 15.05 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.831 0.453 . . . . 0.0 111.749 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.444 HG12 HG11 ' A' ' 72' ' ' VAL . 3.0 p -135.28 139.32 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.102 0.561 . . . . 0.0 110.785 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.423 HG22 HG13 ' A' ' 71' ' ' ILE . 15.8 t -124.86 141.86 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.047 0.939 . . . . 0.0 110.165 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.473 HD11 ' HB ' ' A' ' 98' ' ' ILE . 8.4 mm -107.28 104.4 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 165.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -100.95 114.17 27.81 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -106.11 112.07 24.96 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.875 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -108.42 166.69 10.58 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.22 171.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.5 m -99.98 100.87 11.82 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 152.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.0 m -86.82 138.59 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 37.6 m -95.99 120.11 35.68 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.055 0.455 . . . . 0.0 110.664 -173.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -111.46 -162.8 0.81 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 175.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 3.4 t-20 -132.57 110.1 10.22 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.226 -0.296 . . . . 0.0 110.474 172.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -104.96 143.3 26.42 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 124.425 1.09 . . . . 0.0 108.741 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.05 -9.9 26.49 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.663 2.242 . . . . 0.0 113.706 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -85.48 -13.09 50.21 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.782 0.433 . . . . 0.0 112.085 175.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.68 -129.86 1.56 Allowed Glycine 0 C--N 1.349 1.262 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.981 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 15.8 tppt? -75.25 -72.32 0.31 Allowed 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.196 0.598 . . . . 0.0 110.428 174.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.92 26.94 3.13 Favored Glycine 0 C--N 1.341 0.836 0 O-C-N 123.277 0.361 . . . . 0.0 113.723 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 117' ' ' ARG . 4.8 pm0 -90.29 122.37 33.14 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -174.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.563 HG13 ' HA ' ' A' ' 116' ' ' PRO . 34.1 m -123.57 143.63 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.448 0.699 . . . . 0.0 110.619 -169.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -79.34 108.4 12.83 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.139 0.575 . . . . 0.0 109.657 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.466 HG22 HG12 ' A' ' 113' ' ' ILE . 59.8 t -123.41 138.81 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.84 0.856 . . . . 0.0 110.078 -176.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.34 117.91 30.81 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.528 0.731 . . . . 0.0 109.399 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 64.2 m -94.27 123.29 37.58 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.602 HG21 ' HB2' ' A' ' 110' ' ' TRP . 10.3 tt -104.78 105.23 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.369 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -99.53 127.88 45.62 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.613 0.765 . . . . 0.0 109.996 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -100.42 113.26 25.88 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 168.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.505 HG22 HG12 ' A' ' 106' ' ' ILE . 60.8 t -97.28 126.05 50.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 125.123 1.369 . . . . 0.0 110.508 -175.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.457 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 8.5 tp10 -133.15 139.28 46.99 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.108 0.963 . . . . 0.0 109.635 174.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.457 ' ND2' ' HG3' ' A' ' 102' ' ' GLU . 37.0 m-80 63.21 29.46 15.97 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.736 1.214 . . . . 0.0 111.644 -173.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.51 8.42 62.87 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.893 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -128.46 145.24 51.16 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.759 1.224 . . . . 0.0 108.4 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.505 HG12 HG22 ' A' ' 101' ' ' VAL . 57.5 mt -69.78 100.53 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 118.435 0.562 . . . . 0.0 109.832 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.459 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . . . -87.61 -15.31 37.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.723 0.409 . . . . 0.0 111.626 -177.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -148.33 129.73 14.79 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.4 132.93 48.51 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.602 ' HB2' HG21 ' A' ' 98' ' ' ILE . 1.6 m-90 -133.98 152.59 51.91 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -143.72 148.55 35.87 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 118.805 0.73 . . . . 0.0 111.251 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.6 ' HZ1' ' HB3' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -123.7 129.72 51.53 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.422 1.089 . . . . 0.0 109.546 176.115 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.466 HG12 HG22 ' A' ' 95' ' ' VAL . 75.2 mt -90.23 127.76 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 171.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.53 -74.11 0.93 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.24 -176.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.96 167.41 13.23 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.099 0.56 . . . . 0.0 109.49 -175.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.563 ' HA ' HG13 ' A' ' 93' ' ' VAL . 56.8 Cg_endo -84.21 137.79 7.39 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.428 2.086 . . . . 0.0 113.001 168.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 29.3 mmt180 -131.22 149.64 52.49 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.974 0.91 . . . . 0.0 109.126 173.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.6 mm -131.58 131.55 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.033 0.933 . . . . 0.0 108.608 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.4 t . . . . . 0 N--CA 1.49 1.567 0 C-N-CA 123.218 0.607 . . . . 0.0 111.64 -177.456 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 . . . . . 0 N--CA 1.5 2.03 0 CA-C-O 121.054 0.454 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.454 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 14.4 m -75.75 -20.31 58.39 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.235 1.014 . . . . 0.0 112.483 -167.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -72.76 -19.77 61.31 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.527 0.331 . . . . 0.0 111.358 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.471 ' HB ' HD13 ' A' ' 71' ' ' ILE . 37.5 mm -88.88 -27.41 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 173.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.633 ' HG2' HH12 ' A' ' 69' ' ' ARG . 40.2 mt-10 -78.45 -19.79 52.4 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.663 173.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 3' ' ' SER . 77.6 mt -61.5 -50.75 81.38 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-O 118.736 -0.649 . . . . 0.0 111.729 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 19.6 Cg_endo -59.09 -55.33 1.98 Allowed 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 121.745 1.63 . . . . 0.0 111.709 173.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.1 t -54.4 -47.97 69.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 125.681 1.592 . . . . 0.0 113.576 -172.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -62.22 -47.4 84.59 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.859 0.864 . . . . 0.0 110.212 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -68.63 -35.18 76.95 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.632 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.29 -51.79 67.41 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.475 0.71 . . . . 0.0 111.033 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.66 -49.37 78.0 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.963 0.789 . . . . 0.0 109.494 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.42 ' HA ' HD22 ' A' ' 17' ' ' ASN . 22.3 mm-40 -60.11 -35.0 74.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 123.972 0.795 . . . . 0.0 111.03 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -74.17 -28.0 61.09 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.058 0.943 . . . . 0.0 111.395 175.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -70.36 -42.59 71.63 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.369 0.668 . . . . 0.0 110.238 -174.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.42 HD22 ' HA ' ' A' ' 14' ' ' GLU . 9.2 p30 -82.04 -28.33 32.54 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.433 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.92 11.38 27.48 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 63.74 20.69 12.35 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.351 1.06 . . . . 0.0 112.412 172.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.457 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 4.5 t70 -91.38 100.62 13.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.54 0.736 . . . . 0.0 109.406 -178.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.467 HG13 HG12 ' A' ' 54' ' ' ILE . 10.4 mm -74.47 -28.8 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.255 0.222 . . . . 0.0 110.974 173.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -62.72 -45.42 92.84 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.501 0.721 . . . . 0.0 110.891 -172.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.89 -36.05 31.76 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.787 0.835 . . . . 0.0 110.569 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -64.94 -8.8 17.17 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.25 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.743 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -112.27 -31.48 6.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.538 0.735 . . . . 0.0 111.855 174.033 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.07 -28.77 66.79 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -170.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 96.7 m95 -96.82 13.85 27.22 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.81 0.844 . . . . 0.0 112.782 -175.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.408 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 13.3 m95 -112.83 147.54 36.74 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.834 0.853 . . . . 0.0 109.011 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.412 ' O ' ' HB1' ' A' ' 46' ' ' ALA . . . -72.48 152.86 41.67 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.402 0.681 . . . . 0.0 110.517 175.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.67 -27.72 69.43 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.264 0.625 . . . . 0.0 111.642 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -101.45 12.26 37.65 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.153 0.981 . . . . 0.0 111.345 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.408 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 53.4 t -59.69 125.89 25.42 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -169.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -81.08 150.41 28.8 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.593 0.757 . . . . 0.0 109.562 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.404 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 59.6 t80 -146.73 112.88 5.83 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.344 0.658 . . . . 0.0 109.309 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.413 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 34.1 m-85 -114.26 150.77 33.88 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.003 0.921 . . . . 0.0 111.331 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.513 ' HB1' HD11 ' A' ' 42' ' ' LEU . . . -99.03 159.44 14.97 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 113.942 -1.481 . . . . 0.0 108.294 165.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -58.65 136.83 86.44 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-O 119.116 -0.468 . . . . 0.0 110.269 173.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.83 -55.97 0.14 OUTLIER 'Cis proline' 0 C--N 1.381 2.263 0 CA-C-N 120.406 1.181 . . . . 0.0 112.556 -7.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -148.2 58.92 1.1 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.708 0.766 . . . . 0.0 109.865 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.4 m -95.65 104.0 15.9 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.407 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.64 104.29 1.58 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.513 HD11 ' HB1' ' A' ' 36' ' ' ALA . 56.9 mt -82.1 -45.68 14.88 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.153 177.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . . . -143.46 117.1 9.21 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.992 -172.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.77 37.05 3.89 Favored Glycine 0 N--CA 1.478 1.465 0 C-N-CA 122.874 0.273 . . . . 0.0 113.536 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.3 p30 168.74 156.26 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.786 1.634 . . . . 0.0 109.013 -171.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 29' ' ' ALA . . . -58.97 -36.11 74.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.806 0.842 . . . . 0.0 112.82 -174.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.17 94.68 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.073 0.549 . . . . 0.0 112.082 -173.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 29.1 mt-10 -76.24 -32.54 58.95 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.969 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.417 ' HB ' ' HE3' ' A' ' 25' ' ' MET . 78.5 mt -63.54 -42.83 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.396 0.679 . . . . 0.0 109.97 176.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.743 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 74.6 ttt180 -56.03 -58.51 7.61 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.913 1.285 . . . . 0.0 110.861 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.32 -35.55 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.876 -168.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -72.0 -34.11 68.61 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.857 0.463 . . . . 0.0 110.334 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -74.57 -27.07 60.34 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.742 -0.646 . . . . 0.0 111.548 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 50' ' ' ARG . 85.1 mt -56.99 -42.72 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 118.453 0.57 . . . . 0.0 109.837 173.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -61.09 -37.24 82.02 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.009 0.818 . . . . 0.0 111.151 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -64.97 -39.15 93.05 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.571 0.749 . . . . 0.0 110.064 174.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -81.3 1.85 30.71 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.1 0.96 . . . . 0.0 112.17 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 9.8 mmpt? -95.97 -16.04 21.95 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.805 0.442 . . . . 0.0 111.177 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -70.54 122.64 87.19 Favored Pre-proline 0 N--CA 1.482 1.138 0 CA-C-O 119.023 -0.513 . . . . 0.0 109.965 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.22 -26.02 72.3 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.59 2.194 . . . . 0.0 112.374 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -86.12 -5.82 59.13 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.871 0.868 . . . . 0.0 112.137 -177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.4 tp -57.87 114.39 2.29 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 120.969 0.414 . . . . 0.0 110.575 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -147.5 117.03 7.02 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 169.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.96 102.29 1.74 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -97.07 102.86 14.73 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 69' ' ' ARG . 8.2 tt -74.59 115.61 14.34 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 171.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.41 ' H ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -101.45 -29.86 11.76 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.52 0.728 . . . . 0.0 110.695 -177.087 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.2 m -150.19 133.15 16.1 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.865 0.866 . . . . 0.0 110.008 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.633 HH12 ' HG2' ' A' ' 6' ' ' GLU . 52.5 ptt85 -139.56 139.69 36.91 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.139 0.576 . . . . 0.0 109.637 170.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.9 m -121.95 125.64 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.951 0.901 . . . . 0.0 109.455 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.471 HD13 ' HB ' ' A' ' 5' ' ' ILE . 14.0 tt -108.21 135.87 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 121.005 0.431 . . . . 0.0 110.713 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 p -142.68 96.24 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 124.778 1.231 . . . . 0.0 108.557 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.44 -124.69 22.41 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.616 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -88.25 7.51 31.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.17 0.588 . . . . 0.0 112.559 -175.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.16 142.86 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 122.989 0.516 . . . . 0.0 110.952 -175.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.13 141.88 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.796 0.839 . . . . 0.0 109.745 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.514 HD11 ' HB ' ' A' ' 98' ' ' ILE . 5.2 mm -99.25 105.88 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 168.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -99.34 105.43 17.41 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.498 0.719 . . . . 0.0 109.668 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -98.83 104.47 16.52 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -102.09 164.1 11.88 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.421 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.6 m -105.68 101.88 11.37 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 158.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.0 t -85.87 103.43 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.883 1.273 . . . . 0.0 110.028 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 48.3 m -71.12 127.16 31.64 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.624 0.77 . . . . 0.0 111.276 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -117.25 -161.37 0.81 Allowed 'General case' 0 C--O 1.247 0.931 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -131.65 103.82 6.59 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 172.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -108.37 134.96 20.03 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 123.861 0.864 . . . . 0.0 109.528 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.74 -10.98 24.41 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.426 2.751 . . . . 0.0 114.359 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -79.61 -28.31 40.98 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.94 0.496 . . . . 0.0 111.337 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.28 -115.63 0.49 Allowed Glycine 0 C--N 1.35 1.328 0 C-N-CA 121.497 -0.383 . . . . 0.0 112.873 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -70.02 -80.81 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.12 0.968 . . . . 0.0 111.437 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 116.15 26.45 3.22 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 116.437 -0.347 . . . . 0.0 113.221 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 9.3 pt-20 -89.0 114.54 25.73 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.416 0.627 . . . . 0.0 109.872 -172.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.667 HG13 ' HA ' ' A' ' 116' ' ' PRO . 33.6 m -111.0 126.15 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.183 0.593 . . . . 0.0 109.637 -173.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.19 109.28 13.37 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.1 t -113.06 131.8 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.321 0.648 . . . . 0.0 110.248 -172.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.1 99.87 12.38 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.756 0.822 . . . . 0.0 109.323 173.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 56.9 m -94.47 108.2 20.14 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.433 1.093 . . . . 0.0 108.436 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.514 ' HB ' HD11 ' A' ' 77' ' ' ILE . 5.1 tt -106.37 115.21 47.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.937 0.895 . . . . 0.0 110.205 -174.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -112.47 133.79 54.35 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.33 0.652 . . . . 0.0 110.025 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -106.96 112.88 26.04 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.766 0.826 . . . . 0.0 108.803 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 50.1 t -85.18 140.12 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.137 1.375 . . . . 0.0 110.332 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.403 ' HG3' HD21 ' A' ' 103' ' ' ASN . 9.7 tp10 -141.31 105.64 4.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.287 1.035 . . . . 0.0 108.866 -173.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.403 HD21 ' HG3' ' A' ' 102' ' ' GLU . 33.4 m-80 62.4 31.67 17.13 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.651 1.18 . . . . 0.0 112.11 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.86 -7.58 67.69 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.78 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -131.72 133.37 44.75 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.725 0.81 . . . . 0.0 109.653 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 67.1 mt -67.57 112.11 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.507 0.723 . . . . 0.0 110.191 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.25 -10.98 26.67 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -150.28 131.13 14.18 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.58 139.78 31.48 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.629 0.772 . . . . 0.0 109.232 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.424 ' HB2' HG23 ' A' ' 98' ' ' ILE . 3.1 m-90 -138.29 156.99 47.12 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -143.5 147.09 33.98 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.028 0.442 . . . . 0.0 110.149 171.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -129.02 122.51 30.19 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.245 1.018 . . . . 0.0 108.363 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.7 mt -87.69 130.38 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.35 -129.87 0.56 Allowed Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.469 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -90.18 161.11 38.59 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.667 ' HA ' HG13 ' A' ' 93' ' ' VAL . 76.2 Cg_endo -83.96 114.79 1.98 Allowed 'Trans proline' 0 CA--C 1.551 1.357 0 C-N-CA 122.234 1.956 . . . . 0.0 112.136 167.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.416 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 34.6 mtm180 -107.0 148.42 28.71 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 121.852 0.834 . . . . 0.0 110.759 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.3 mm -128.65 147.09 33.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.486 1.34 0 C-N-CA 123.553 0.741 . . . . 0.0 112.488 -177.227 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.434 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 22.2 t -68.73 -45.78 70.61 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 123.963 0.905 . . . . 0.0 110.902 -175.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -60.63 -17.33 46.41 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.886 0.875 . . . . 0.0 112.909 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.42 HG21 ' HB ' ' A' ' 101' ' ' VAL . 28.1 mm -87.29 -34.6 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.239 0.616 . . . . 0.0 109.574 178.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.91 -17.78 32.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 118.652 -0.69 . . . . 0.0 112.053 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.2 mt -62.7 -50.36 78.32 Favored Pre-proline 0 N--CA 1.488 1.465 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.635 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.634 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 14.1 Cg_endo -57.25 -51.92 7.59 Favored 'Trans proline' 0 C--N 1.388 2.642 0 C-N-CA 122.089 1.86 . . . . 0.0 112.047 172.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.402 ' HA ' ' OE1' ' A' ' 12' ' ' GLN . 85.5 t -63.96 -31.31 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 C-N-CA 124.55 1.14 . . . . 0.0 112.733 -172.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.61 -47.86 44.42 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.82 0.848 . . . . 0.0 109.519 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.1 mmtt -70.62 -25.56 63.09 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.947 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 9' ' ' VAL . 45.7 mt-30 -61.1 -46.77 89.26 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.654 0.597 . . . . 0.0 110.39 175.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.39 -50.45 71.56 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.144 0.903 . . . . 0.0 109.54 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -57.57 -45.78 84.77 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 124.656 1.222 . . . . 0.0 109.524 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 20' ' ' ASP . . . -68.82 -26.62 65.26 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.932 -1.485 . . . . 0.0 112.161 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -73.39 -38.71 65.54 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.022 0.529 . . . . 0.0 109.667 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -91.08 -29.9 17.06 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.563 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.69 0.29 57.45 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.361 0.664 . . . . 0.0 111.989 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.9 mmt-85 65.96 24.26 11.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.523 1.129 . . . . 0.0 113.121 172.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 48.1 m-20 -87.97 95.26 10.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.954 0.406 . . . . 0.0 110.724 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.498 HG13 HG12 ' A' ' 54' ' ' ILE . 8.3 mm -64.05 -30.44 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.568 0.747 . . . . 0.0 111.314 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.87 -45.63 92.93 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.313 0.383 . . . . 0.0 111.116 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.82 -35.99 62.43 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.259 0.624 . . . . 0.0 110.711 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -71.73 -4.4 27.36 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.845 0.858 . . . . 0.0 111.052 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.75 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -120.95 -23.2 5.94 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 172.198 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.74 -35.79 75.28 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.672 0.789 . . . . 0.0 112.82 -173.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.634 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 97.2 m95 -89.89 -7.69 53.6 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.41 ' CZ3' HG23 ' A' ' 49' ' ' ILE . 14.6 m95 -91.91 143.75 26.17 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.288 0.635 . . . . 0.0 110.049 -173.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.72 152.31 45.5 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.216 0.607 . . . . 0.0 110.066 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -68.82 -24.2 64.36 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 120.932 0.396 . . . . 0.0 110.689 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.59 19.32 16.01 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.727 1.211 . . . . 0.0 110.69 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.7 t -65.04 122.49 17.15 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 122.073 -0.392 . . . . 0.0 111.628 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -87.39 154.61 20.53 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.745 0.818 . . . . 0.0 109.331 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 48.2 t80 -145.06 114.28 7.03 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.413 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 17.3 m-85 -109.23 153.91 23.16 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.51 0.724 . . . . 0.0 110.288 176.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.408 ' HB2' HD12 ' A' ' 42' ' ' LEU . . . -112.84 151.28 30.58 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.066 173.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.635 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 84.7 t80 -57.64 128.84 80.47 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 123.656 0.782 . . . . 0.0 111.581 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.92 -50.32 0.19 OUTLIER 'Cis proline' 0 C--N 1.389 2.666 0 CA-C-N 120.464 1.201 . . . . 0.0 114.046 0.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.41 91.63 0.93 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.958 0.903 . . . . 0.0 108.757 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.3 m -136.7 107.84 6.78 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.5 103.97 1.8 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.271 0.628 . . . . 0.0 109.695 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 36' ' ' ALA . 49.5 mt -80.63 -36.55 32.45 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.948 0.899 . . . . 0.0 110.71 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 34' ' ' TYR . . . -140.09 121.18 14.72 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.154 0.582 . . . . 0.0 111.436 -171.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -107.62 40.01 2.68 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 123.401 0.524 . . . . 0.0 113.042 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.9 p30 165.64 164.67 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 126.023 1.729 . . . . 0.0 108.963 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.15 -37.86 88.73 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.777 0.831 . . . . 0.0 112.556 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.46 -43.26 99.18 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.294 0.638 . . . . 0.0 112.337 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -73.08 -30.0 63.35 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.711 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.41 HG23 ' CZ3' ' A' ' 28' ' ' TRP . 85.9 mt -66.58 -46.15 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.517 0.727 . . . . 0.0 109.871 173.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.75 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 36.8 ttt180 -56.28 -56.4 21.46 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.837 -176.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.438 ' HA ' HD12 ' A' ' 54' ' ' ILE . 29.4 m -63.48 -37.31 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 124.543 1.152 . . . . 0.0 113.147 -172.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -71.37 -34.51 70.5 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.028 0.442 . . . . 0.0 110.753 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -76.5 -26.96 55.84 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 118.965 -0.541 . . . . 0.0 111.2 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.498 HG12 HG13 ' A' ' 21' ' ' ILE . 85.6 mt -59.66 -47.82 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 172.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.03 -42.25 89.76 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.998 0.919 . . . . 0.0 111.179 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -66.44 -32.71 74.26 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.104 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -82.04 -13.31 57.53 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.259 0.624 . . . . 0.0 111.356 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 67.4 mmtt -73.13 -28.82 62.47 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.737 0.415 . . . . 0.0 110.486 170.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.53 115.38 21.56 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.987 0.915 . . . . 0.0 109.991 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.1 -22.76 18.96 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.578 2.185 . . . . 0.0 112.693 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.85 -12.09 59.48 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.786 0.834 . . . . 0.0 111.508 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.7 tp -60.02 117.17 4.77 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 123.515 0.509 . . . . 0.0 109.975 175.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -149.87 117.11 6.03 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.7 103.08 2.91 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -94.47 102.06 13.99 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 tt -82.83 125.39 31.27 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -29.98 5.97 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.01 0.924 . . . . 0.0 111.077 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 92.2 m -144.96 133.59 22.12 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.428 0.691 . . . . 0.0 109.991 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.495 ' NH2' HG13 ' A' ' 76' ' ' VAL . 7.4 ptm180 -142.87 138.35 30.2 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.929 0.492 . . . . 0.0 110.429 171.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.439 HG21 ' HB ' ' A' ' 77' ' ' ILE . 15.0 m -128.67 158.35 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 124.517 1.127 . . . . 0.0 108.761 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -129.75 142.53 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-O 121.025 0.44 . . . . 0.0 110.085 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.462 HG11 HG13 ' A' ' 75' ' ' VAL . 2.2 p -137.1 95.85 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 124.509 1.124 . . . . 0.0 108.945 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.71 -120.14 8.73 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.024 -0.535 . . . . 0.0 113.154 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -97.47 15.0 24.46 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.108 0.563 . . . . 0.0 112.063 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.462 HG13 HG11 ' A' ' 72' ' ' VAL . 4.4 p -135.88 135.5 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.526 0.73 . . . . 0.0 110.255 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.495 HG13 ' NH2' ' A' ' 69' ' ' ARG . 5.1 t -114.05 141.92 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.354 0.662 . . . . 0.0 110.245 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.452 HD13 ' HB ' ' A' ' 98' ' ' ILE . 17.7 mm -99.67 114.73 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.929 1.292 . . . . 0.0 107.896 168.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -112.21 106.03 14.51 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.468 ' HE2' ' HB3' ' A' ' 94' ' ' ASP . 51.9 t-80 -97.62 107.17 19.61 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -112.78 144.58 42.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.168 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.1 m -91.55 102.08 14.73 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 162.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.8 m -92.83 133.36 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.104 0.478 . . . . 0.0 110.791 -176.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 73.0 m -81.31 120.73 25.3 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.771 -177.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.581 HH21 HG12 ' A' ' 93' ' ' VAL . 72.9 mtm180 -118.84 -162.86 0.92 Allowed 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.693 1.197 . . . . 0.0 107.911 170.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -125.09 108.54 11.9 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 118.477 0.58 . . . . 0.0 110.994 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -109.95 145.03 31.21 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 123.794 0.838 . . . . 0.0 109.824 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.94 -19.03 67.94 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 123.369 2.713 . . . . 0.0 114.164 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -79.57 -20.04 47.97 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.29 -111.36 0.46 Allowed Glycine 0 C--N 1.348 1.242 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.726 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -62.37 -82.32 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.957 0.903 . . . . 0.0 111.693 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 117.14 26.1 3.06 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.994 -176.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -87.22 138.83 31.15 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.607 HG11 ' HA ' ' A' ' 116' ' ' PRO . 13.9 m -137.12 140.95 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 121.988 -0.445 . . . . 0.0 111.316 -173.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.468 ' HB3' ' HE2' ' A' ' 79' ' ' HIS . 72.9 m-20 -75.6 112.79 12.31 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 174.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.24 133.6 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.079 0.952 . . . . 0.0 108.499 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.77 111.13 23.47 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.4 m -94.08 107.49 19.41 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.617 HG23 ' HB2' ' A' ' 110' ' ' TRP . 5.4 tt -112.87 107.94 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 124.35 1.06 . . . . 0.0 109.82 -169.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -109.93 127.91 55.05 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.815 0.846 . . . . 0.0 110.408 -174.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 33.6 tt0 -99.26 112.81 24.89 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 173.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.433 HG22 HG12 ' A' ' 106' ' ' ILE . 60.7 t -96.98 113.14 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.322 1.049 . . . . 0.0 109.492 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 35.0 tt0 -113.54 126.88 55.79 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.835 0.854 . . . . 0.0 108.94 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 63.09 33.67 14.39 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.262 1.025 . . . . 0.0 112.096 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.86 7.2 88.7 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.807 -0.633 . . . . 0.0 114.336 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -133.84 143.76 48.53 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.161 0.984 . . . . 0.0 108.852 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' A' ' 8' ' ' PRO . 55.2 mt -67.95 102.7 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.42 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -84.06 -23.02 31.03 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.165 0.586 . . . . 0.0 111.02 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 79.5 mttt -149.28 146.47 27.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.01 0.924 . . . . 0.0 109.061 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -142.81 133.07 24.66 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.617 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.0 m-90 -135.68 159.49 41.48 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -142.78 145.6 33.42 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 169.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.635 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 14.4 ptmm? -126.86 123.52 37.48 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 95.1 mt -89.33 116.16 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.4 -71.8 1.03 Allowed Glycine 0 CA--C 1.523 0.561 0 CA-C-N 114.24 -1.345 . . . . 0.0 113.592 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -157.01 162.86 26.84 Favored Pre-proline 0 CA--C 1.548 0.904 0 CA-C-N 116.825 0.313 . . . . 0.0 110.723 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.607 ' HA ' HG11 ' A' ' 93' ' ' VAL . 92.7 Cg_endo -77.37 137.01 16.36 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.598 2.199 . . . . 0.0 113.596 171.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -129.26 153.56 47.67 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.438 1.095 . . . . 0.0 109.98 176.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.4 mm -138.98 151.51 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.487 1.388 0 C-N-CA 122.999 0.52 . . . . 0.0 111.259 178.456 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 . . . . . 0 CA--C 1.553 1.077 0 CA-C-O 121.021 0.439 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.4 m -71.8 -35.07 69.85 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.405 0.682 . . . . 0.0 112.693 -169.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -14.36 62.02 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.649 0.38 . . . . 0.0 111.718 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.491 HG13 ' HA ' ' A' ' 74' ' ' ASN . 27.2 mm -90.68 -28.45 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.866 0.867 . . . . 0.0 110.111 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.28 -32.08 71.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.676 0.79 . . . . 0.0 111.615 173.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.6 mt -61.94 -52.1 70.46 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-O 118.675 -0.678 . . . . 0.0 112.358 -175.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 23.0 Cg_endo -60.35 -51.1 5.8 Favored 'Trans proline' 0 C--N 1.396 3.063 0 C-N-CA 122.493 2.129 . . . . 0.0 113.739 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.5 m -67.81 -32.72 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 122.699 0.4 . . . . 0.0 112.025 -170.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -73.38 -50.68 20.61 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.255 0.622 . . . . 0.0 111.076 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -70.96 -30.64 66.98 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.5 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -69.6 -39.6 77.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.142 0.577 . . . . 0.0 109.477 177.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -58.87 -52.28 66.41 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.219 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.44 -29.57 64.28 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.824 0.702 . . . . 0.0 111.202 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 20' ' ' ASP . . . -79.47 -31.57 42.44 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.997 0.919 . . . . 0.0 111.881 176.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -62.94 -51.29 67.48 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.173 0.589 . . . . 0.0 111.271 -173.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -75.96 -20.94 57.52 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.691 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.9 1.23 54.57 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.515 0.726 . . . . 0.0 112.401 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 62.86 22.79 13.63 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.656 1.182 . . . . 0.0 111.936 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 5.8 t70 -89.86 131.74 35.63 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.433 ' HA ' ' HB3' ' A' ' 24' ' ' PHE . 14.9 mm -104.12 -27.46 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.292 0.637 . . . . 0.0 110.816 174.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.27 -48.36 81.78 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.85 0.46 . . . . 0.0 111.58 -176.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.46 -33.76 36.44 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.749 0.82 . . . . 0.0 110.637 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.433 ' HB3' ' HA ' ' A' ' 21' ' ' ILE . 49.8 t80 -59.87 -24.7 64.46 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.39 175.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 79.6 mmm -120.44 0.6 10.57 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.09 -41.16 77.86 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.367 0.603 . . . . 0.0 111.608 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 89.9 m95 -83.42 -0.02 48.15 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.654 -173.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.5 ' HE1' ' HG3' ' A' ' 12' ' ' GLN . 21.7 m95 -91.24 143.17 26.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.225 0.61 . . . . 0.0 110.352 -175.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -70.5 148.55 48.12 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.9 173.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.56 -28.64 70.01 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 120.84 0.353 . . . . 0.0 111.588 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -97.4 19.08 13.85 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.205 1.002 . . . . 0.0 110.973 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 48.6 t -62.62 123.52 18.58 Favored 'General case' 0 C--N 1.357 0.909 0 O-C-N 121.913 -0.492 . . . . 0.0 111.987 -174.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -89.72 151.4 21.86 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.294 1.038 . . . . 0.0 109.31 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -139.34 119.25 13.36 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.462 ' HH ' HD13 ' A' ' 41' ' ' LEU . 61.9 m-85 -122.34 154.8 37.16 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.13 0.972 . . . . 0.0 111.197 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.46 ' HB3' HD21 ' A' ' 42' ' ' LEU . . . -128.75 160.12 33.53 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.769 1.228 . . . . 0.0 109.625 177.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -63.18 139.71 97.58 Favored Pre-proline 0 CA--C 1.561 1.385 0 C-N-CA 124.114 0.966 . . . . 0.0 111.538 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.89 -44.59 0.51 Allowed 'Cis proline' 0 C--N 1.381 2.287 0 CA-C-N 120.152 1.09 . . . . 0.0 113.183 -9.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.53 79.58 0.5 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.132 0.573 . . . . 0.0 110.382 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.9 m -123.44 125.22 44.55 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.688 0.795 . . . . 0.0 109.588 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.462 HD13 ' HH ' ' A' ' 35' ' ' TYR . 3.8 tt -84.33 110.95 18.99 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 173.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.46 HD21 ' HB3' ' A' ' 36' ' ' ALA . 1.4 mm? -85.55 -51.1 6.72 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.27 0.628 . . . . 0.0 109.363 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . . . -140.13 120.73 14.23 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.219 -168.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.28 37.42 3.83 Favored Glycine 0 N--CA 1.477 1.372 0 O-C-N 123.135 0.272 . . . . 0.0 113.539 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.5 p30 175.45 155.22 0.17 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.02 1.728 . . . . 0.0 108.722 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -64.12 -25.89 68.3 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.806 0.843 . . . . 0.0 113.162 -172.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.93 -47.25 81.26 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.928 0.491 . . . . 0.0 110.78 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 31.7 mt-10 -70.83 -37.97 73.22 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.771 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.5 mt -61.68 -43.25 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.262 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.482 ' O ' HG13 ' A' ' 54' ' ' ILE . 69.4 ttt-85 -60.17 -56.25 23.94 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.272 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.8 t -53.8 -49.06 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 124.546 1.154 . . . . 0.0 111.98 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -61.14 -36.26 79.29 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.183 0.593 . . . . 0.0 111.383 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -75.97 -32.7 59.62 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.748 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 50' ' ' ARG . 64.4 mt -64.64 -42.67 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -62.98 -31.25 72.32 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.096 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -85.33 -11.18 55.23 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.324 0.65 . . . . 0.0 111.525 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.451 ' HA ' HD21 ' A' ' 62' ' ' LEU . 3.3 m-85 -89.99 -0.7 57.73 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.471 0.709 . . . . 0.0 110.876 172.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.446 ' HE2' HG22 ' A' ' 54' ' ' ILE . 72.6 mmtt -82.56 -4.13 57.12 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.28 0.632 . . . . 0.0 112.091 173.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.716 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 22.5 mm-40 -67.66 120.13 71.13 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -65.62 -24.33 55.74 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.058 1.838 . . . . 0.0 112.693 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -111.54 21.76 15.81 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.596 0.758 . . . . 0.0 111.611 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.716 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 39.4 tp -67.2 111.62 4.04 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 120.795 0.331 . . . . 0.0 110.235 175.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -138.11 136.41 36.7 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.514 0.726 . . . . 0.0 109.301 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.32 128.06 8.93 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.329 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -127.74 99.91 5.74 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 tt -81.35 134.75 35.62 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-O 121.452 0.644 . . . . 0.0 110.354 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.446 HD22 ' HG1' ' A' ' 81' ' ' THR . 7.8 mt -107.05 -50.7 3.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.161 -171.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.2 m -152.48 125.89 8.76 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.243 -1.799 . . . . 0.0 109.136 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -118.18 132.92 56.29 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 167.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.3 m -118.8 122.52 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.006 0.923 . . . . 0.0 109.285 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.472 HD13 ' HB ' ' A' ' 5' ' ' ILE . 17.4 tt -105.74 136.77 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 122.782 0.433 . . . . 0.0 110.796 -175.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.411 HG12 HG12 ' A' ' 75' ' ' VAL . 2.1 p -146.38 112.87 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.419 1.087 . . . . 0.0 109.488 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.83 -104.73 1.06 Allowed Glycine 0 C--N 1.346 1.098 0 CA-C-N 116.384 -0.371 . . . . 0.0 112.743 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.491 ' HA ' HG13 ' A' ' 5' ' ' ILE . 4.0 p-10 -122.55 15.61 10.34 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.096 0.559 . . . . 0.0 111.074 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.411 HG12 HG12 ' A' ' 72' ' ' VAL . 3.0 p -135.37 132.64 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.766 0.826 . . . . 0.0 110.173 -173.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.03 141.22 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.65 0.78 . . . . 0.0 110.239 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.561 HG12 ' HB ' ' A' ' 98' ' ' ILE . 3.1 mt -100.58 103.93 15.49 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 165.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -93.38 106.22 18.21 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -100.09 109.35 21.64 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.691 -176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.15 171.14 7.61 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.103 0.961 . . . . 0.0 111.057 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.446 ' HG1' HD22 ' A' ' 67' ' ' LEU . 18.0 m -109.13 102.23 11.21 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 161.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -81.98 108.91 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.659 1.184 . . . . 0.0 110.029 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 75.7 m -68.59 119.02 12.36 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 122.952 0.501 . . . . 0.0 110.502 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -117.06 -169.13 1.59 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.396 1.078 . . . . 0.0 109.787 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -118.34 102.91 9.31 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.63 0.772 . . . . 0.0 110.448 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -112.07 134.07 21.52 Favored Pre-proline 0 N--CA 1.474 0.728 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 171.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.74 -12.4 32.84 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.827 2.351 . . . . 0.0 113.409 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -83.1 -10.86 58.45 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.657 0.383 . . . . 0.0 111.902 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.86 -125.75 1.09 Allowed Glycine 0 C--N 1.349 1.269 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.691 172.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -71.01 -80.1 0.06 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.84 0.856 . . . . 0.0 110.704 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.33 27.15 2.06 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 113.455 0.142 . . . . 0.0 113.455 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 1.5 pm0 -88.95 112.28 23.14 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.762 0.791 . . . . 0.0 109.501 -171.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 116' ' ' PRO . 30.2 m -106.43 141.12 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.594 0.757 . . . . 0.0 110.313 -172.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -83.62 124.1 30.47 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.0 127.65 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.051 0.541 . . . . 0.0 109.649 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.47 102.59 14.41 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.627 0.771 . . . . 0.0 109.235 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.4 m -98.31 118.28 34.6 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.561 ' HB ' HG12 ' A' ' 77' ' ' ILE . 11.3 tt -111.75 105.77 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 C-N-CA 123.94 0.896 . . . . 0.0 110.81 -177.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -99.29 129.07 45.48 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.098 0.959 . . . . 0.0 110.457 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 34.8 tt0 -97.72 114.44 26.44 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.237 0.541 . . . . 0.0 109.68 170.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 61.7 t -99.86 111.65 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 124.562 1.145 . . . . 0.0 110.133 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 34.5 tt0 -112.18 132.97 54.59 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.253 1.021 . . . . 0.0 109.942 174.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 63.46 30.34 15.33 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.604 1.161 . . . . 0.0 111.46 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.99 14.0 75.98 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.051 -0.522 . . . . 0.0 113.458 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -129.79 134.66 47.71 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.803 1.241 . . . . 0.0 108.96 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 70.6 mt -63.95 99.39 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -82.7 -24.31 33.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.423 0.689 . . . . 0.0 110.912 -177.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 74.2 mttt -147.88 148.47 30.88 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.378 1.071 . . . . 0.0 108.216 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.78 132.19 20.79 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 172.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.539 ' HB2' HG23 ' A' ' 98' ' ' ILE . 1.5 m-90 -128.62 146.76 50.76 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -177.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -142.47 146.88 35.23 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.381 0.991 . . . . 0.0 110.97 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -129.91 122.14 28.02 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.073 0.949 . . . . 0.0 108.663 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.35 128.96 41.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.47 -121.24 0.55 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.099 -0.955 . . . . 0.0 113.448 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -97.91 141.09 22.42 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.22 1.008 . . . . 0.0 110.459 -172.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.565 ' HA ' HG11 ' A' ' 93' ' ' VAL . 55.9 Cg_endo -71.51 115.86 4.46 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.006 2.471 . . . . 0.0 110.492 170.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -121.22 153.87 37.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.273 0.629 . . . . 0.0 111.377 -174.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.5 mm -129.77 132.84 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.806 1.242 . . . . 0.0 108.966 174.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.6 t . . . . . 0 N--CA 1.492 1.629 0 C-N-CA 123.999 0.92 . . . . 0.0 112.197 179.439 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.474 ' HB2' HD12 ' A' ' 71' ' ' ILE . 16.3 m120 . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 121.326 0.584 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 66.6 m -69.36 -41.02 77.13 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.8 0.84 . . . . 0.0 111.736 -176.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -11.73 58.23 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.04 0.536 . . . . 0.0 112.208 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.443 HG22 HG23 ' A' ' 76' ' ' VAL . 37.8 mm -91.09 -33.11 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.57 0.748 . . . . 0.0 109.918 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -79.9 -17.59 52.72 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 119.099 -0.477 . . . . 0.0 112.225 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 3' ' ' SER . 93.5 mt -62.74 -52.1 67.0 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.963 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.573 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 24.4 Cg_endo -60.76 -47.37 13.48 Favored 'Trans proline' 0 C--N 1.395 2.988 0 C-N-CA 121.797 1.664 . . . . 0.0 111.887 173.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.431 ' HA ' HE21 ' A' ' 12' ' ' GLN . 73.5 t -59.02 -43.73 89.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 124.226 1.011 . . . . 0.0 112.285 -173.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.665 ' HG2' HH12 ' A' ' 69' ' ' ARG . 6.7 mm100 -68.47 -49.36 60.33 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.082 0.553 . . . . 0.0 111.767 175.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -63.81 -27.71 69.37 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -175.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.431 HE21 ' HA ' ' A' ' 9' ' ' VAL . 46.7 mt-30 -69.0 -47.32 65.82 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 123.489 0.493 . . . . 0.0 109.768 174.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.502 HD12 ' HB2' ' A' ' 66' ' ' LEU . 2.7 tt -57.1 -54.16 49.92 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.782 1.301 . . . . 0.0 109.442 -177.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.44 ' HA ' HD22 ' A' ' 17' ' ' ASN . 16.0 mm-40 -61.17 -37.8 84.19 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.859 -176.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -71.07 -27.4 63.6 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.55 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.406 ' CZ ' HD11 ' A' ' 62' ' ' LEU . 84.8 t80 -73.08 -38.57 66.37 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.006 0.922 . . . . 0.0 110.522 -175.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.44 HD22 ' HA ' ' A' ' 14' ' ' GLU . 10.0 p30 -88.42 -28.3 21.0 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.983 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.84 0.84 57.47 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.366 0.666 . . . . 0.0 112.265 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 64.7 mmt-85 71.33 12.6 6.68 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.058 1.343 . . . . 0.0 113.619 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.527 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 10.2 m-20 -74.37 95.12 2.64 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.824 0.449 . . . . 0.0 110.917 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.2 mm -66.22 -26.19 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 122.942 0.497 . . . . 0.0 110.574 169.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -60.14 -48.78 80.27 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.164 0.586 . . . . 0.0 111.142 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.62 -30.31 36.76 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.18 0.592 . . . . 0.0 110.767 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -72.56 -6.78 46.39 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.224 0.61 . . . . 0.0 110.967 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.739 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -119.26 -27.25 5.68 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 173.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.94 -30.09 70.01 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -172.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.573 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.3 m95 -95.37 -0.12 52.95 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.355 0.662 . . . . 0.0 112.575 -175.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -97.55 148.66 23.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.435 0.694 . . . . 0.0 109.219 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.68 154.74 29.88 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.42 0.688 . . . . 0.0 109.402 172.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -69.84 -23.66 63.33 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.81 0.444 . . . . 0.0 111.468 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -95.59 17.99 13.73 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.079 0.952 . . . . 0.0 111.073 177.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 45.4 t -64.21 123.24 18.58 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.006 0.431 . . . . 0.0 111.95 -174.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.406 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . 35.4 mm-40 -96.17 103.74 15.66 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.06 0.944 . . . . 0.0 109.743 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 55.2 t80 -96.37 111.86 23.8 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.001 0.92 . . . . 0.0 110.276 -177.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.406 ' HE1' ' HB3' ' A' ' 33' ' ' GLN . 80.5 m-85 -116.05 155.16 28.62 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.719 0.808 . . . . 0.0 110.498 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.91 160.67 17.19 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.691 1.196 . . . . 0.0 108.332 167.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -52.04 133.19 40.14 Favored Pre-proline 0 CA--C 1.568 1.635 0 C-N-CA 123.599 0.759 . . . . 0.0 112.431 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.48 -40.95 1.02 Allowed 'Cis proline' 0 C--N 1.384 2.398 0 C-N-CA 124.759 -0.934 . . . . 0.0 112.963 -7.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.83 56.86 0.2 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.631 0.772 . . . . 0.0 109.861 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.2 m -92.9 114.4 26.95 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.134 0.973 . . . . 0.0 109.484 176.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.7 tp -78.16 103.82 8.34 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.447 0.567 . . . . 0.0 109.595 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.04 -37.89 33.06 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 34' ' ' TYR . . . -146.38 117.17 7.65 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.14 -172.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.24 45.23 1.39 Allowed Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.989 -0.339 . . . . 0.0 112.322 -176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 161.35 161.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 126.233 1.813 . . . . 0.0 109.066 -171.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 49' ' ' ILE . . . -64.75 -35.52 81.34 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.857 0.863 . . . . 0.0 113.049 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.65 -46.91 87.61 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.041 0.536 . . . . 0.0 112.092 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.6 mt-10 -72.45 -29.41 63.65 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.823 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 46' ' ' ALA . 94.6 mt -63.97 -49.19 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.788 0.835 . . . . 0.0 110.264 175.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.739 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 77.4 ttt180 -55.76 -56.63 18.21 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.152 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.454 ' HA ' HD12 ' A' ' 54' ' ' ILE . 26.8 m -65.21 -35.99 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 124.433 1.083 . . . . 0.0 112.698 -173.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -69.06 -34.95 75.98 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.195 0.598 . . . . 0.0 110.423 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -78.42 -28.49 46.79 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 118.455 -0.784 . . . . 0.0 111.785 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 51' ' ' VAL . 94.2 mt -57.34 -41.19 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-N 118.593 0.633 . . . . 0.0 109.514 173.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.16 -37.72 86.29 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.349 1.06 . . . . 0.0 111.735 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -79.43 -25.98 41.92 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.387 0.675 . . . . 0.0 111.014 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -79.8 -15.97 56.41 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.818 0.447 . . . . 0.0 110.649 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -62.61 -28.47 69.91 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.941 0.497 . . . . 0.0 110.823 168.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -66.26 118.61 54.75 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.617 0.767 . . . . 0.0 110.581 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.29 -29.2 17.41 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.541 2.161 . . . . 0.0 111.704 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.14 -18.02 63.21 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.322 1.049 . . . . 0.0 111.504 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.406 HD11 ' CZ ' ' A' ' 16' ' ' TYR . 46.1 tp -59.17 123.57 17.11 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.595 0.758 . . . . 0.0 111.511 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.496 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 69.9 t80 -152.21 125.49 8.72 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.49 109.22 3.39 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -118.4 110.93 18.05 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.316 0.647 . . . . 0.0 109.731 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.502 ' HB2' HD12 ' A' ' 13' ' ' LEU . 17.4 tp -76.91 146.53 37.55 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.428 0.455 . . . . 0.0 111.155 -177.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mt -112.69 -51.45 2.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.815 0.846 . . . . 0.0 109.346 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.7 m -157.45 153.11 26.61 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.758 -1.564 . . . . 0.0 108.922 -170.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.665 HH12 ' HG2' ' A' ' 10' ' ' GLN . 4.3 ptp180 -142.27 139.2 31.84 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.921 0.488 . . . . 0.0 109.901 169.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.479 HG22 ' HB ' ' A' ' 77' ' ' ILE . 17.8 m -112.42 111.28 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 122.159 0.98 . . . . 0.0 108.592 173.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 2' ' ' ASN . 11.7 tt -99.93 139.13 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.038 -177.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.453 HG11 HG11 ' A' ' 75' ' ' VAL . 2.5 p -145.9 99.45 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.801 1.24 . . . . 0.0 108.666 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.12 -120.82 21.2 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.986 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -86.44 2.44 47.72 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.496 0.718 . . . . 0.0 112.777 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.453 HG11 HG11 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -129.19 132.46 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.309 0.643 . . . . 0.0 110.716 -173.055 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.443 HG23 HG22 ' A' ' 5' ' ' ILE . 59.2 t -116.0 138.85 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.925 0.89 . . . . 0.0 109.074 174.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.563 HD12 ' HB ' ' A' ' 98' ' ' ILE . 9.6 mm -97.11 103.15 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 164.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -95.68 104.19 16.1 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -177.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -99.92 107.96 20.08 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.581 0.705 . . . . 0.0 109.846 -173.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.32 168.5 12.41 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.132 -177.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 m -117.47 104.27 10.92 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 168.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.0 m -91.22 125.17 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.274 0.559 . . . . 0.0 111.463 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 63' ' ' TYR . 34.9 m -76.86 133.66 39.25 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.073 176.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -133.12 -160.72 1.07 Allowed 'General case' 0 C--O 1.247 0.944 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -128.89 105.52 8.28 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.446 0.566 . . . . 0.0 110.193 174.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -106.32 135.03 19.53 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.88 -21.12 71.63 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.921 2.414 . . . . 0.0 113.446 -174.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -74.64 -25.81 59.46 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.01 0.524 . . . . 0.0 111.693 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.14 -120.08 0.6 Allowed Glycine 0 C--N 1.352 1.463 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.709 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -72.53 -81.0 0.06 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.605 0.762 . . . . 0.0 111.3 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.19 27.24 2.07 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 113.722 0.249 . . . . 0.0 113.722 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -90.7 133.39 35.18 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.574 HG13 ' HA ' ' A' ' 116' ' ' PRO . 35.9 m -130.66 134.62 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 122.464 0.306 . . . . 0.0 110.79 -172.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.23 117.0 17.47 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.578 HG23 HG12 ' A' ' 113' ' ' ILE . 16.7 t -123.74 158.88 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.649 1.18 . . . . 0.0 108.768 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -118.16 99.93 7.19 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 169.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 93.5 m -95.05 107.52 19.57 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.563 ' HB ' HD12 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -96.17 138.12 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.988 0.915 . . . . 0.0 109.412 -177.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -127.42 119.98 27.38 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.619 0.768 . . . . 0.0 108.993 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 43.2 tt0 -97.14 112.48 24.25 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 48.7 t -95.5 139.54 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.166 1.386 . . . . 0.0 109.778 -175.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.449 ' HG3' HD21 ' A' ' 103' ' ' ASN . 8.9 tp10 -129.79 100.44 5.49 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.553 1.141 . . . . 0.0 108.416 -175.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.449 HD21 ' HG3' ' A' ' 102' ' ' GLU . 24.7 m-80 59.79 32.7 21.48 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.82 1.248 . . . . 0.0 112.117 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.24 -7.62 54.57 Favored Glycine 0 N--CA 1.475 1.244 0 N-CA-C 114.317 0.487 . . . . 0.0 114.317 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.9 mmt-85 -127.53 133.24 49.82 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.446 0.623 . . . . 0.0 109.821 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.466 HD13 ' HB2' ' A' ' 8' ' ' PRO . 68.2 mt -70.02 106.27 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.189 0.996 . . . . 0.0 110.447 -173.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -82.69 -18.88 39.37 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.981 0.512 . . . . 0.0 111.671 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 75.1 mttt -151.99 134.14 15.09 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -139.52 129.02 24.31 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 172.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.406 ' CE3' HD13 ' A' ' 98' ' ' ILE . 1.5 m0 -130.52 159.06 38.23 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -176.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -142.79 146.38 34.18 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -137.29 127.41 26.08 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.578 HG12 HG23 ' A' ' 95' ' ' VAL . 89.3 mt -88.75 125.75 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.55 -60.53 8.6 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 114.869 -1.06 . . . . 0.0 113.09 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -160.56 168.32 12.05 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.457 0.703 . . . . 0.0 109.819 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.574 ' HA ' HG13 ' A' ' 93' ' ' VAL . 65.7 Cg_endo -85.76 130.98 3.79 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.718 2.279 . . . . 0.0 112.188 163.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -127.53 157.96 38.71 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.916 0.487 . . . . 0.0 110.693 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.4 mm -133.67 127.37 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.1 t . . . . . 0 N--CA 1.491 1.62 0 C-N-CA 123.876 0.87 . . . . 0.0 111.094 178.723 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.547 ' HB3' HD11 ' A' ' 71' ' ' ILE . 81.8 m-20 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.458 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 23.4 m -66.47 -40.71 89.49 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.76 0.824 . . . . 0.0 111.261 -174.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -14.23 62.85 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 122.98 0.512 . . . . 0.0 111.697 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.475 HG23 HG21 ' A' ' 76' ' ' VAL . 22.8 mm -95.08 -29.49 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.811 0.844 . . . . 0.0 109.832 175.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -84.25 -20.94 31.38 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.077 0.951 . . . . 0.0 112.167 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 3' ' ' SER . 68.4 mt -67.23 -48.99 46.3 Favored Pre-proline 0 N--CA 1.486 1.338 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.092 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.597 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 10.8 Cg_endo -54.47 -52.9 7.12 Favored 'Trans proline' 0 C--N 1.391 2.771 0 C-N-CA 121.708 1.605 . . . . 0.0 111.291 172.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.8 t -57.98 -43.2 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.323 1.049 . . . . 0.0 112.81 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.402 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -64.98 -54.93 22.72 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.352 0.661 . . . . 0.0 110.201 -176.348 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -71.91 -35.14 69.61 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.873 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.441 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 1.0 OUTLIER -72.73 -30.42 64.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.76 0.824 . . . . 0.0 110.946 -176.433 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.49 HD23 HD11 ' A' ' 66' ' ' LEU . 59.4 tp -62.36 -52.13 64.84 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.18 0.592 . . . . 0.0 109.657 173.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 14.7 mm-40 -53.34 -45.81 69.24 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.05 175.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 20' ' ' ASP . . . -64.92 -30.26 71.25 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.349 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -69.02 -46.38 68.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.139 0.575 . . . . 0.0 110.578 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -84.24 -24.18 30.11 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.956 0.502 . . . . 0.0 111.525 -177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.09 2.06 55.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.259 0.624 . . . . 0.0 112.141 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.7 mmt-85 68.53 15.02 9.15 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.894 1.278 . . . . 0.0 112.948 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 10.0 m-20 -77.13 96.53 4.5 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.868 0.467 . . . . 0.0 110.738 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.8 mm -64.34 -33.55 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.553 0.741 . . . . 0.0 111.122 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.13 -48.62 79.65 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.144 0.578 . . . . 0.0 111.664 -175.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.73 -29.8 40.68 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.197 0.599 . . . . 0.0 110.737 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -69.29 -13.05 62.18 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.817 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.628 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 3.8 mmt -116.6 -15.61 10.81 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.61 0.764 . . . . 0.0 112.344 175.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.04 99.79 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.639 0.776 . . . . 0.0 112.295 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.597 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 86.3 m95 -92.95 0.97 57.52 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.379 -172.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.441 ' HE1' ' HG3' ' A' ' 12' ' ' GLN . 17.8 m95 -96.67 148.8 22.49 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.56 0.744 . . . . 0.0 109.992 -177.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.9 149.41 39.48 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.78 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.27 -20.75 64.81 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.462 0.305 . . . . 0.0 111.755 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -104.86 18.71 21.83 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.819 0.847 . . . . 0.0 111.799 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 43.0 t -62.6 127.08 29.62 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -172.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.555 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 57.7 mm-40 -96.16 104.57 16.53 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.839 0.856 . . . . 0.0 109.922 -176.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -98.18 115.33 28.1 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 124.463 1.105 . . . . 0.0 109.938 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.458 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 80.7 m-85 -114.62 154.63 28.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.954 0.902 . . . . 0.0 110.936 177.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.21 155.92 19.4 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.791 167.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.522 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 71.6 t80 -62.0 133.24 93.91 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 123.275 0.63 . . . . 0.0 110.978 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.54 -45.26 0.43 Allowed 'Cis proline' 0 C--N 1.383 2.36 0 CA-C-N 120.235 1.12 . . . . 0.0 113.95 -4.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.76 67.33 0.44 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.35 0.595 . . . . 0.0 110.285 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 33.9 m -105.98 115.77 30.79 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.1 tp -75.26 103.87 5.6 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.79 -36.48 50.32 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.473 0.709 . . . . 0.0 109.542 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . . . -157.74 122.27 4.3 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.4 -176.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.75 26.0 24.09 Favored Glycine 0 N--CA 1.477 1.383 0 O-C-N 123.224 0.328 . . . . 0.0 113.897 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.0 p30 178.93 156.73 0.49 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.164 1.385 . . . . 0.0 109.628 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.02 -34.01 71.39 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.23 1.012 . . . . 0.0 113.143 -172.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.57 -44.27 97.34 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.783 0.433 . . . . 0.0 111.148 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 38.1 mt-10 -75.67 -30.06 59.28 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.661 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 79.8 mt -63.33 -40.82 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 123.134 0.574 . . . . 0.0 109.492 176.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.628 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 39.8 ttt180 -55.6 -56.1 24.25 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.41 175.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.06 -43.97 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 124.487 1.117 . . . . 0.0 111.183 -173.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.428 ' HA ' ' HE ' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -60.65 -42.6 97.3 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.844 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -78.97 -26.8 43.45 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-O 118.452 -0.785 . . . . 0.0 112.347 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.415 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 66.2 mt -57.34 -43.38 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.113 0.869 . . . . 0.0 108.971 173.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -62.32 -34.7 77.13 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.097 0.959 . . . . 0.0 111.368 177.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -77.71 -25.14 49.14 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 123.413 0.685 . . . . 0.0 111.036 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -84.12 -14.25 50.82 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.36 0.664 . . . . 0.0 110.491 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 10.4 mmpt? -69.14 -21.15 64.03 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.226 0.61 . . . . 0.0 110.583 171.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.84 114.27 12.94 Favored Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 124.152 0.981 . . . . 0.0 109.739 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.73 -22.1 24.32 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.483 2.122 . . . . 0.0 111.953 177.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.57 6.9 47.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.215 1.006 . . . . 0.0 111.634 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 tp -66.97 112.29 4.26 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-O 120.978 0.418 . . . . 0.0 109.938 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -144.2 115.89 8.2 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.29 100.74 2.13 Favored Glycine 0 C--N 1.342 0.861 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 174.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -88.0 101.5 13.83 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.49 HD11 HD23 ' A' ' 13' ' ' LEU . 8.5 tt -75.32 115.95 15.52 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.34 -33.46 8.18 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.914 -175.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.0 m -139.78 138.52 35.93 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.302 0.641 . . . . 0.0 109.796 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -142.91 133.81 25.52 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.759 0.823 . . . . 0.0 109.556 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.498 HG22 ' HB ' ' A' ' 77' ' ' ILE . 20.1 m -126.63 155.7 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.253 1.021 . . . . 0.0 108.658 173.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.547 HD11 ' HB3' ' A' ' 2' ' ' ASN . 15.1 tt -137.75 140.32 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.107 0.48 . . . . 0.0 111.081 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 p -144.48 107.24 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 125.144 1.377 . . . . 0.0 108.443 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.55 -119.25 14.7 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.839 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 17.0 p-10 -99.72 18.77 17.33 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.039 0.536 . . . . 0.0 111.407 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.2 t -126.73 136.75 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.45 1.1 . . . . 0.0 110.097 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.475 HG21 HG23 ' A' ' 5' ' ' ILE . 62.3 t -123.7 137.3 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.437 0.695 . . . . 0.0 109.646 173.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.498 ' HB ' HG22 ' A' ' 70' ' ' VAL . 7.8 mm -98.01 103.75 15.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 165.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -101.18 105.39 16.52 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.496 ' HE1' ' HB2' ' A' ' 94' ' ' ASP . 40.5 t-80 -99.79 113.71 26.4 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.0 -176.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.97 154.14 45.92 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.894 1.277 . . . . 0.0 110.564 -176.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.409 HG22 ' HB2' ' A' ' 92' ' ' GLU . 39.0 m -100.46 111.69 23.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.699 0.799 . . . . 0.0 109.556 172.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.99 115.54 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.503 1.121 . . . . 0.0 110.038 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.8 m -77.81 121.52 24.19 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 122.813 0.445 . . . . 0.0 110.695 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -122.9 -177.05 3.55 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.395 1.078 . . . . 0.0 108.289 172.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -115.73 103.68 10.92 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.929 0.491 . . . . 0.0 110.112 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -109.48 138.62 20.61 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 123.539 0.736 . . . . 0.0 109.133 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.65 -17.66 60.9 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.306 2.671 . . . . 0.0 114.274 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -82.87 -10.89 58.61 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 122.861 0.465 . . . . 0.0 112.138 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.48 -123.84 1.06 Allowed Glycine 0 C--N 1.346 1.123 0 CA-C-O 119.852 -0.415 . . . . 0.0 112.517 171.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -66.66 -76.63 0.08 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.9 0.88 . . . . 0.0 110.505 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.23 27.06 4.07 Favored Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.699 -0.228 . . . . 0.0 113.085 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.409 ' HB2' HG22 ' A' ' 81' ' ' THR . 9.8 pt-20 -91.12 115.96 28.43 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -175.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 116' ' ' PRO . 11.5 m -104.07 134.48 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -175.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.496 ' HB2' ' HE1' ' A' ' 79' ' ' HIS . 2.4 p-10 -81.74 143.85 31.54 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.565 HG21 HG12 ' A' ' 113' ' ' ILE . 39.5 t -141.45 143.63 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -105.93 107.5 18.53 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 164.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 5.9 t -94.19 138.07 32.65 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.423 ' HB ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -131.17 121.31 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.586 0.754 . . . . 0.0 109.625 -175.6 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -108.9 139.06 44.26 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.228 0.611 . . . . 0.0 109.647 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -104.51 111.22 23.81 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 165.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 61.7 t -96.13 110.67 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.351 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.507 ' HB3' ' HB1' ' A' ' 107' ' ' ALA . 35.3 tt0 -111.04 128.45 55.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.679 0.792 . . . . 0.0 109.155 176.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 62.83 30.44 16.63 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.89 0.876 . . . . 0.0 111.661 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.37 9.9 86.63 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.898 -0.592 . . . . 0.0 113.76 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 63.5 mmt-85 -129.03 135.14 48.53 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.158 0.983 . . . . 0.0 109.211 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.414 HG12 HG22 ' A' ' 101' ' ' VAL . 79.2 mt -63.55 100.7 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 102' ' ' GLU . . . -76.59 -31.98 57.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.49 -173.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.555 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 98.7 mttt -153.85 153.8 32.77 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.628 1.171 . . . . 0.0 108.566 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.79 135.31 20.77 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.458 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 5.4 m-90 -134.25 153.92 51.58 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -142.61 147.3 35.6 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 118.646 0.657 . . . . 0.0 110.605 173.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 17.6 ptpt -131.74 123.87 28.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.327 1.051 . . . . 0.0 109.227 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.565 HG12 HG21 ' A' ' 95' ' ' VAL . 96.9 mt -89.13 127.39 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -176.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.36 -81.12 0.09 OUTLIER Glycine 0 CA--C 1.532 1.148 0 O-C-N 123.957 0.786 . . . . 0.0 112.866 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.437 ' HB2' ' HD2' ' A' ' 116' ' ' PRO . 0.4 OUTLIER -160.18 171.58 7.02 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.398 0.679 . . . . 0.0 109.312 167.156 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.653 ' HA ' HG12 ' A' ' 93' ' ' VAL . 36.3 Cg_endo -63.49 131.43 31.75 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.037 1.825 . . . . 0.0 112.738 167.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -118.55 139.55 51.29 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.336 0.655 . . . . 0.0 109.939 173.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.8 mm -122.04 135.07 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.479 1.005 0 O-C-N 123.539 0.524 . . . . 0.0 110.673 -177.092 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.425 ' HB2' HD13 ' A' ' 71' ' ' ILE . 14.0 m120 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.518 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 15.0 m -57.34 -49.51 75.91 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.223 -174.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -57.16 -17.57 11.6 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.997 0.919 . . . . 0.0 113.125 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.442 HG13 ' HA ' ' A' ' 74' ' ' ASN . 22.8 mm -96.13 -34.4 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.953 0.901 . . . . 0.0 110.231 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -83.74 -24.85 30.97 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.661 0.784 . . . . 0.0 112.421 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 3' ' ' SER . 54.8 mt -66.58 -53.37 29.63 Favored Pre-proline 0 CA--C 1.561 1.388 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.291 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.625 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 9.5 Cg_endo -52.64 -50.63 13.4 Favored 'Trans proline' 0 C--N 1.399 3.214 0 C-N-CA 122.545 2.164 . . . . 0.0 112.219 175.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.463 HG11 HG13 ' A' ' 76' ' ' VAL . 7.7 t -54.79 -48.51 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 125.068 1.347 . . . . 0.0 113.27 -177.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -44.77 69.42 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.491 0.316 . . . . 0.0 111.262 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.7 mmtt -65.64 -35.55 81.12 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.746 0.419 . . . . 0.0 110.895 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.436 HE21 ' HA ' ' A' ' 9' ' ' VAL . 43.6 mt-30 -59.4 -49.79 76.46 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.946 0.779 . . . . 0.0 110.788 175.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.0 tp -55.89 -51.71 66.64 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.268 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -56.85 -46.95 81.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.536 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -67.31 -26.36 66.48 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.337 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -71.91 -48.52 44.92 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.097 0.559 . . . . 0.0 110.576 -173.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.06 -29.07 35.09 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.672 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.87 -3.42 58.91 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.401 0.68 . . . . 0.0 111.636 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 71.95 12.63 6.07 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.38 1.472 . . . . 0.0 113.065 172.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.475 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 5.9 m-20 -73.15 96.6 2.25 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.265 0.626 . . . . 0.0 111.11 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.5 mm -66.26 -29.75 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.452 0.701 . . . . 0.0 111.687 175.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.04 -48.56 81.17 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.023 0.529 . . . . 0.0 112.113 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.45 -30.1 33.57 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.866 0.466 . . . . 0.0 110.899 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -73.25 -7.86 53.31 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.924 177.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.796 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -114.22 -30.55 6.59 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.16 0.584 . . . . 0.0 112.197 173.168 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.66 -33.32 60.55 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -170.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.8 m95 -99.78 14.2 31.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.906 0.882 . . . . 0.0 112.651 -170.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -105.51 155.84 18.79 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.828 0.851 . . . . 0.0 109.949 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.463 ' O ' ' HB1' ' A' ' 46' ' ' ALA . . . -85.36 148.32 26.08 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.478 0.711 . . . . 0.0 109.752 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -58.14 -30.94 66.74 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.894 0.878 . . . . 0.0 111.955 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -103.05 19.29 19.79 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.025 0.93 . . . . 0.0 111.737 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 53.7 t -64.05 132.23 49.94 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.481 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 36.3 mm-40 -101.44 105.25 16.25 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.64 0.776 . . . . 0.0 110.245 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -96.56 112.52 24.23 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.936 0.894 . . . . 0.0 110.26 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.471 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 89.2 m-85 -110.3 153.48 24.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.236 1.015 . . . . 0.0 111.378 178.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.524 ' HB2' HD22 ' A' ' 42' ' ' LEU . . . -102.08 150.95 22.73 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 113.996 -1.457 . . . . 0.0 107.717 165.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -50.48 128.63 25.18 Favored Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 124.748 1.219 . . . . 0.0 114.1 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.3 -36.7 2.15 Favored 'Cis proline' 0 C--N 1.385 2.482 0 C-N-CA 124.817 -0.91 . . . . 0.0 113.06 -9.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.13 81.64 0.99 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.51 0.724 . . . . 0.0 109.811 -174.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.459 ' HB ' ' HB1' ' A' ' 36' ' ' ALA . 40.6 m -121.74 100.1 6.82 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.2 tp -71.34 100.83 2.23 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -173.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.524 HD22 ' HB2' ' A' ' 36' ' ' ALA . 1.1 mm? -77.27 -45.26 26.92 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.45 115.85 15.29 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.958 -172.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.6 45.94 1.39 Allowed Glycine 0 C--N 1.346 1.085 0 CA-C-O 119.838 -0.423 . . . . 0.0 112.91 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.3 p30 160.36 160.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 126.495 1.918 . . . . 0.0 108.771 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 29' ' ' ALA . . . -66.94 -31.61 72.3 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.888 0.875 . . . . 0.0 113.158 -172.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.75 -43.81 98.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.131 0.572 . . . . 0.0 111.171 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -75.24 -30.69 60.6 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.985 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.2 mt -63.2 -45.11 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.523 0.729 . . . . 0.0 110.143 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.796 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 21.9 ttt180 -59.46 -55.44 34.6 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.653 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.46 ' HA ' HD12 ' A' ' 54' ' ' ILE . 34.3 m -66.34 -34.43 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 124.515 1.135 . . . . 0.0 112.822 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -71.24 -32.94 69.35 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.964 0.411 . . . . 0.0 110.456 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -75.03 -33.73 61.8 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.45 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 51' ' ' VAL . 39.6 mt -55.87 -39.62 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.782 0.833 . . . . 0.0 110.228 173.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 51' ' ' VAL . 34.6 mm-40 -59.06 -46.92 87.03 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.467 0.707 . . . . 0.0 111.118 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 -66.15 -30.21 70.64 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.535 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -81.29 -11.1 59.45 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 123.932 0.893 . . . . 0.0 111.651 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 72.2 mmtt -71.67 -22.3 61.68 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.788 0.435 . . . . 0.0 111.39 170.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -81.11 115.7 57.83 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.687 0.795 . . . . 0.0 110.392 -176.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.46 -30.05 79.64 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.238 2.625 . . . . 0.0 113.757 -174.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -86.75 3.73 43.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.268 0.627 . . . . 0.0 112.561 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.9 tp -67.28 118.05 10.13 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.706 0.289 . . . . 0.0 110.805 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -150.51 119.11 6.5 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 167.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.22 103.96 3.09 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 174.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -89.38 106.55 18.52 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.0 tt -80.88 128.57 33.82 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.08 -34.96 4.87 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.733 0.813 . . . . 0.0 111.137 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.1 m -132.25 139.0 48.11 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.579 0.752 . . . . 0.0 109.67 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.01 139.12 37.76 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 167.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.51 144.93 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.248 1.019 . . . . 0.0 109.347 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.425 HD13 ' HB2' ' A' ' 2' ' ' ASN . 15.1 tt -122.76 141.43 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-O 121.338 0.59 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 p -143.5 98.01 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 125.239 1.415 . . . . 0.0 108.105 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.92 -120.57 19.12 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.185 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.442 ' HA ' HG13 ' A' ' 5' ' ' ILE . 3.3 p-10 -93.69 13.4 22.34 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.477 0.711 . . . . 0.0 111.913 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.2 t -130.29 136.14 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.25 1.02 . . . . 0.0 109.664 -174.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.463 HG13 HG11 ' A' ' 9' ' ' VAL . 87.0 t -125.16 135.82 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.774 0.83 . . . . 0.0 109.796 176.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.542 HG12 ' HB ' ' A' ' 98' ' ' ILE . 2.2 mt -100.13 108.01 22.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 168.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -88.07 109.16 19.65 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 168.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -99.15 110.51 23.07 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 122.041 0.924 . . . . 0.0 108.788 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.47 165.45 18.42 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.868 -1.515 . . . . 0.0 109.533 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.7 m -114.65 103.2 10.76 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 167.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.9 m -85.44 130.55 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 120.928 0.394 . . . . 0.0 110.391 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.6 m -79.05 118.96 21.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.295 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -111.81 -166.93 1.12 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 168.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -124.23 108.18 11.99 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 121.823 -0.548 . . . . 0.0 110.323 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -106.31 144.47 29.04 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 123.544 0.738 . . . . 0.0 109.059 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.84 -12.31 32.49 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.724 2.283 . . . . 0.0 112.907 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -87.61 -2.78 58.85 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.669 0.787 . . . . 0.0 112.225 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.92 -119.55 0.9 Allowed Glycine 0 C--N 1.348 1.225 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.769 170.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -65.31 -79.08 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.867 0.867 . . . . 0.0 110.536 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 117.57 22.79 3.93 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.323 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.29 141.9 28.25 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.644 HG13 ' HA ' ' A' ' 116' ' ' PRO . 22.4 m -132.97 138.64 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.156 0.435 . . . . 0.0 111.247 -171.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -75.65 109.33 9.13 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.454 HG21 HG12 ' A' ' 113' ' ' ILE . 21.4 t -114.7 155.66 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.14 105.75 9.78 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 82.5 m -94.96 107.46 19.49 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.631 HG22 ' HB2' ' A' ' 110' ' ' TRP . 7.3 tt -105.25 106.55 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.634 -173.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -99.9 137.27 38.58 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.662 0.785 . . . . 0.0 110.645 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -100.47 114.41 27.98 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.292 1.037 . . . . 0.0 109.166 168.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.507 HG23 HG12 ' A' ' 106' ' ' ILE . 46.4 t -102.31 117.66 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 123.319 0.648 . . . . 0.0 109.548 175.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.497 ' HB3' ' HB1' ' A' ' 107' ' ' ALA . 19.7 tt0 -128.54 138.71 52.38 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.832 1.253 . . . . 0.0 109.138 175.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 63.43 30.9 15.31 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.897 0.879 . . . . 0.0 111.32 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.28 7.59 82.53 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.401 -0.818 . . . . 0.0 114.058 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 57.3 mmt-85 -137.56 153.77 49.91 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.635 1.174 . . . . 0.0 108.902 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.507 HG12 HG23 ' A' ' 101' ' ' VAL . 65.3 mt -73.45 105.74 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 102' ' ' GLU . . . -79.53 -28.99 41.3 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.444 0.697 . . . . 0.0 111.353 -178.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.481 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 91.3 mttt -150.25 152.6 34.8 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.85 134.41 22.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 174.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.631 ' HB2' HG22 ' A' ' 98' ' ' ILE . 2.6 m-90 -126.08 152.99 45.1 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -142.65 147.06 35.13 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 172.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -134.85 117.68 16.16 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.082 0.553 . . . . 0.0 110.294 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.454 HG12 HG21 ' A' ' 95' ' ' VAL . 95.6 mt -89.02 110.82 21.92 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.2 -93.27 0.06 OUTLIER Glycine 0 CA--C 1.533 1.196 0 CA-C-N 114.289 -1.323 . . . . 0.0 114.327 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -126.79 140.33 37.3 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 123.455 0.702 . . . . 0.0 111.268 -169.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.644 ' HA ' HG13 ' A' ' 93' ' ' VAL . 48.0 Cg_endo -67.79 125.5 13.28 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.241 2.628 . . . . 0.0 111.947 173.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -111.46 124.47 52.34 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.41 1.084 . . . . 0.0 109.312 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.1 mm -124.05 124.86 69.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.1 t . . . . . 0 N--CA 1.481 1.098 0 O-C-N 124.005 0.816 . . . . 0.0 111.281 -173.599 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 CA--C 1.56 1.359 0 CA-C-O 121.39 0.614 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.1 p -72.94 -35.06 66.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.663 0.785 . . . . 0.0 111.547 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.09 -5.1 32.9 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.895 0.478 . . . . 0.0 111.9 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.534 HG21 HG22 ' A' ' 76' ' ' VAL . 22.9 mm -94.29 -30.47 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.968 0.907 . . . . 0.0 109.701 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -72.74 -34.19 66.88 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.7 0.8 . . . . 0.0 111.636 174.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.69 -50.58 81.37 Favored Pre-proline 0 CA--C 1.558 1.283 0 CA-C-O 118.089 -0.958 . . . . 0.0 112.46 -172.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 12.7 Cg_endo -54.84 -56.49 2.37 Favored 'Trans proline' 0 C--N 1.398 3.155 0 C-N-CA 122.123 1.882 . . . . 0.0 111.072 177.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 76' ' ' VAL . 98.8 t -53.45 -44.56 56.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.303 1.441 . . . . 0.0 112.411 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -62.63 -51.47 67.17 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.946 -178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -68.86 -34.39 75.37 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.18 0.592 . . . . 0.0 111.436 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -65.03 -43.41 92.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.973 0.909 . . . . 0.0 111.254 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.8 -52.06 67.1 Favored 'General case' 0 C--O 1.242 0.688 0 O-C-N 123.716 0.635 . . . . 0.0 109.398 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -54.13 -45.93 72.05 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 124.789 1.306 . . . . 0.0 109.258 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 20' ' ' ASP . . . -68.64 -27.01 65.62 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.804 -1.544 . . . . 0.0 112.52 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.435 ' HH ' HD13 ' A' ' 62' ' ' LEU . 65.8 t80 -71.97 -41.01 68.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.532 0.333 . . . . 0.0 110.32 -174.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -90.76 -28.99 17.9 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.227 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.6 -2.18 57.05 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.244 0.618 . . . . 0.0 111.655 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 68.27 24.03 7.57 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.075 1.35 . . . . 0.0 112.958 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 21.6 m-20 -88.06 95.61 10.21 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.187 0.595 . . . . 0.0 109.765 175.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.403 HG13 HG12 ' A' ' 54' ' ' ILE . 13.2 mm -65.78 -28.34 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.697 0.399 . . . . 0.0 110.921 174.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.08 -48.15 81.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.194 0.597 . . . . 0.0 111.674 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.67 -30.87 36.49 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.83 0.452 . . . . 0.0 110.841 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -72.86 -7.57 51.49 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.248 0.619 . . . . 0.0 110.881 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.745 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -113.59 -29.64 7.09 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.395 0.678 . . . . 0.0 112.318 174.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.16 -34.91 70.82 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.873 0.869 . . . . 0.0 113.186 -169.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 96.1 m95 -93.75 8.29 41.62 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.722 0.809 . . . . 0.0 112.901 -173.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.527 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 21.8 m95 -102.84 158.81 16.01 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.667 0.787 . . . . 0.0 109.375 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -86.65 162.24 18.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.106 0.562 . . . . 0.0 110.408 177.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.57 -34.22 75.44 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.139 0.576 . . . . 0.0 111.347 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -98.06 15.74 23.27 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.619 0.768 . . . . 0.0 110.534 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.527 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 43.2 t -59.93 117.47 5.09 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-O 121.137 0.494 . . . . 0.0 111.745 -173.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.568 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 57.1 mm-40 -83.78 154.27 23.64 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.701 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -144.81 111.69 5.85 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.496 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 85.3 m-85 -118.12 146.59 44.03 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.973 0.909 . . . . 0.0 110.697 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.512 ' HB1' HD22 ' A' ' 42' ' ' LEU . . . -95.69 157.43 15.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.154 -1.384 . . . . 0.0 108.202 170.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.429 ' HB3' ' HA ' ' A' ' 112' ' ' LYS . 30.9 p90 -55.6 130.19 70.77 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 123.658 0.783 . . . . 0.0 112.248 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.87 -42.42 0.78 Allowed 'Cis proline' 0 C--N 1.385 2.472 0 CA-C-N 119.923 1.008 . . . . 0.0 113.09 -4.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.09 65.15 0.16 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.697 0.799 . . . . 0.0 109.613 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.9 m -105.79 118.38 36.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.938 0.895 . . . . 0.0 109.49 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.83 110.83 8.43 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.672 0.789 . . . . 0.0 110.971 -169.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.512 HD22 ' HB1' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -88.37 -51.63 5.63 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 170.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.24 116.63 12.75 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.233 -168.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.73 22.32 40.96 Favored Glycine 0 N--CA 1.478 1.486 0 N-CA-C 114.553 0.581 . . . . 0.0 114.553 -173.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -177.89 163.6 1.81 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.235 1.414 . . . . 0.0 109.479 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -59.67 -36.65 76.86 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.938 0.895 . . . . 0.0 112.695 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.11 -44.35 97.49 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.034 0.534 . . . . 0.0 111.802 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -72.85 -36.01 67.34 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.484 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.41 -42.62 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.264 0.626 . . . . 0.0 110.019 174.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.745 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 79.2 ttt180 -62.49 -58.16 8.61 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.547 -175.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.1 m -69.86 -35.0 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 124.248 0.967 . . . . 0.0 112.879 -170.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -67.43 -36.39 81.13 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.642 0.377 . . . . 0.0 110.163 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -77.14 -30.09 54.92 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.357 176.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 50' ' ' ARG . 91.6 mt -57.82 -42.58 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 118.84 0.745 . . . . 0.0 109.922 174.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.0 -32.8 73.44 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.576 0.75 . . . . 0.0 111.616 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -74.85 -28.8 60.82 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.939 0.495 . . . . 0.0 110.706 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -81.15 -3.71 52.99 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.217 0.607 . . . . 0.0 110.995 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -77.03 -29.34 55.26 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.007 0.523 . . . . 0.0 110.802 169.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -59.93 118.79 35.53 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 123.91 0.884 . . . . 0.0 110.753 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -64.39 -35.72 48.52 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.828 2.352 . . . . 0.0 113.118 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -93.14 8.4 40.26 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.966 0.506 . . . . 0.0 112.154 -173.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.435 HD13 ' HH ' ' A' ' 16' ' ' TYR . 34.4 tp -67.85 113.87 5.95 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 173.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -148.31 116.34 6.43 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.73 104.88 3.13 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 174.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -97.61 105.18 17.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 80' ' ' GLU . 8.1 tt -78.94 127.45 32.02 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.023 0.44 . . . . 0.0 110.095 -177.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.18 -48.11 5.78 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.202 1.001 . . . . 0.0 108.737 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 92.4 m -143.93 134.22 24.49 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.633 -170.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 10.8 ptt180 -131.44 129.27 41.0 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 166.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.563 HG22 ' HB ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -107.24 156.26 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.115 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.406 HD13 ' HB ' ' A' ' 5' ' ' ILE . 18.7 tt -134.7 137.67 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.127 0.489 . . . . 0.0 110.754 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 p -147.16 102.36 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.527 1.131 . . . . 0.0 108.636 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.8 -115.94 8.09 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.497 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -99.55 12.35 36.71 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.089 0.556 . . . . 0.0 111.728 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.92 139.35 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.899 0.879 . . . . 0.0 110.09 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.534 HG22 HG21 ' A' ' 5' ' ' ILE . 53.2 t -126.13 140.11 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.525 0.73 . . . . 0.0 109.77 174.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.563 ' HB ' HG22 ' A' ' 70' ' ' VAL . 24.4 mm -98.22 101.69 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 165.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -95.31 104.48 16.37 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -100.48 109.0 21.11 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.722 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -120.34 165.63 14.62 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.678 1.191 . . . . 0.0 110.412 -179.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.9 m -116.24 105.54 12.67 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.314 1.046 . . . . 0.0 109.083 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.2 125.69 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.291 0.567 . . . . 0.0 111.079 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.5 m -74.63 132.07 41.43 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.365 1.066 . . . . 0.0 110.178 175.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -130.31 -168.24 1.94 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.204 1.002 . . . . 0.0 109.282 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -128.43 100.29 5.73 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.657 0.783 . . . . 0.0 109.413 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -108.84 149.65 39.82 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.389 0.676 . . . . 0.0 110.398 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.86 -27.07 51.56 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.784 2.323 . . . . 0.0 113.234 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -86.84 -9.43 55.8 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.02 -140.25 6.31 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 120.094 -0.281 . . . . 0.0 112.728 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -66.07 -81.08 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.691 0.797 . . . . 0.0 111.548 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.45 28.21 1.66 Allowed Glycine 0 C--N 1.347 1.187 0 C-N-CA 121.341 -0.457 . . . . 0.0 113.77 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 117' ' ' ARG . 0.3 OUTLIER -88.81 100.2 12.97 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 122.368 1.08 . . . . 0.0 108.234 -174.452 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.9 m -105.18 143.41 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.719 -169.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.41 141.26 34.1 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.529 HG22 HG12 ' A' ' 113' ' ' ILE . 35.5 t -138.06 142.04 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -109.92 105.24 14.34 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 170.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 74.9 m -92.74 136.7 33.0 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.539 ' HB ' HD12 ' A' ' 77' ' ' ILE . 7.3 tt -122.11 111.72 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 124.374 1.069 . . . . 0.0 109.768 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.401 ' HD2' HG22 ' A' ' 9' ' ' VAL . 12.7 m-85 -99.85 142.85 30.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.871 0.469 . . . . 0.0 109.844 176.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -111.64 113.92 26.63 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.0 t -97.73 141.79 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 124.646 1.179 . . . . 0.0 110.265 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.401 ' HG3' HD21 ' A' ' 103' ' ' ASN . 11.0 tp10 -141.63 105.6 4.76 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.917 1.287 . . . . 0.0 108.206 -172.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.401 HD21 ' HG3' ' A' ' 102' ' ' GLU . 37.9 m-80 61.49 30.96 19.04 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.539 1.136 . . . . 0.0 111.837 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.0 4.68 78.15 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.335 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -126.5 132.56 51.37 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.649 0.78 . . . . 0.0 109.697 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 62.9 mt -68.47 112.57 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 122.986 0.514 . . . . 0.0 110.088 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -76.91 -37.79 54.74 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.361 0.664 . . . . 0.0 110.434 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.568 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 98.0 mttt -151.59 150.16 29.98 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.81 0.844 . . . . 0.0 109.279 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.0 135.35 32.62 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.496 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 3.1 m-90 -132.66 156.03 47.7 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -145.39 148.6 33.53 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.538 0.608 . . . . 0.0 110.959 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.429 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 8.4 ptpp? -126.5 129.98 49.72 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.162 0.985 . . . . 0.0 108.825 172.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.529 HG12 HG22 ' A' ' 95' ' ' VAL . 95.8 mt -90.85 129.65 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.54 -80.18 0.12 Allowed Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.64 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.25 161.12 30.14 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.52 121.0 7.06 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.481 2.121 . . . . 0.0 112.262 170.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 78.0 mtt-85 -122.56 153.48 39.2 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.52 0.728 . . . . 0.0 110.661 -177.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.1 mm -136.51 139.58 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.6 1.16 . . . . 0.0 109.648 -176.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.7 t . . . . . 0 N--CA 1.49 1.563 0 C-N-CA 123.656 0.782 . . . . 0.0 111.021 174.78 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.3 p -64.63 -37.64 88.26 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.879 0.472 . . . . 0.0 110.039 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.04 -23.1 61.7 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.127 1.371 . . . . 0.0 112.977 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.527 HG22 ' HB ' ' A' ' 101' ' ' VAL . 29.1 mm -93.18 -29.27 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.386 1.074 . . . . 0.0 109.771 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -77.94 -24.16 48.29 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.704 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.443 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 88.2 mt -61.71 -57.67 23.12 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-O 118.136 -0.935 . . . . 0.0 112.012 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.577 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 14.1 Cg_endo -54.37 -50.11 14.61 Favored 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 122.766 2.31 . . . . 0.0 112.706 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.609 ' HA ' HE21 ' A' ' 12' ' ' GLN . 15.6 m -65.65 -32.4 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.901 -174.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.18 -50.63 31.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.583 0.753 . . . . 0.0 110.336 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.1 mmtt -66.84 -30.62 70.84 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.018 -176.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.609 HE21 ' HA ' ' A' ' 9' ' ' VAL . 37.1 mt-30 -59.17 -49.2 78.77 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 124.039 0.837 . . . . 0.0 111.288 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.75 -48.33 79.94 Favored 'General case' 0 C--O 1.246 0.897 0 O-C-N 123.774 0.671 . . . . 0.0 110.069 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -58.27 -42.61 86.87 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 124.904 1.377 . . . . 0.0 109.055 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 20' ' ' ASP . . . -72.91 -25.78 61.17 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.753 -1.567 . . . . 0.0 112.796 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -68.14 -44.43 76.05 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.06 0.457 . . . . 0.0 110.324 -173.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -85.49 -29.58 24.16 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.644 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.87 -4.19 57.8 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.35 0.66 . . . . 0.0 111.497 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.406 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 23.6 mmt85 69.99 23.6 5.38 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.225 1.41 . . . . 0.0 112.796 171.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.441 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 19.7 m-20 -91.24 94.61 9.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.05 0.54 . . . . 0.0 110.541 177.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.449 HG13 HG12 ' A' ' 54' ' ' ILE . 20.2 mm -66.37 -28.7 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 123.514 0.726 . . . . 0.0 111.208 173.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -58.76 -47.15 85.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.945 0.498 . . . . 0.0 111.351 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.04 -33.97 33.16 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.421 0.689 . . . . 0.0 111.052 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -68.18 -8.88 42.63 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.777 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.714 ' SD ' ' HB3' ' A' ' 46' ' ' ALA . 24.9 tpp -120.53 -22.26 6.48 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 174.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.08 -28.79 69.86 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -175.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 96.1 m95 -94.17 9.63 37.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.786 0.834 . . . . 0.0 112.539 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -102.77 153.09 20.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.662 0.785 . . . . 0.0 110.002 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.47 140.43 44.59 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 168.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -67.81 -11.69 59.04 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.306 0.642 . . . . 0.0 112.37 -174.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -116.18 21.08 13.94 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.077 0.951 . . . . 0.0 111.232 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.7 t -59.76 147.55 37.55 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.45 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 33.8 mm-40 -107.21 105.42 15.39 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.171 0.988 . . . . 0.0 110.043 -175.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -102.55 112.63 25.46 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.587 0.755 . . . . 0.0 110.521 -173.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.433 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 13.9 m-85 -106.51 152.69 23.34 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.874 0.87 . . . . 0.0 110.322 175.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.64 161.95 18.4 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.355 1.062 . . . . 0.0 109.776 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.505 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 68.3 t80 -57.06 125.56 70.58 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 123.696 0.798 . . . . 0.0 110.26 174.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.24 -56.75 0.14 OUTLIER 'Cis proline' 0 C--N 1.386 2.545 0 CA-C-N 120.59 1.246 . . . . 0.0 113.898 2.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.9 57.72 0.37 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.558 0.743 . . . . 0.0 109.51 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.9 m -98.84 113.68 25.92 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.091 0.957 . . . . 0.0 110.533 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.47 102.46 0.7 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.9 mt -78.37 -42.26 30.91 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.621 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -140.19 115.55 9.95 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.001 -169.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.7 46.13 1.66 Allowed Glycine 0 C--N 1.344 1.006 0 O-C-N 123.386 0.429 . . . . 0.0 112.284 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 p30 163.26 153.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 126.491 1.916 . . . . 0.0 108.561 -172.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.714 ' HB3' ' SD ' ' A' ' 25' ' ' MET . . . -68.56 -23.66 64.53 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.876 0.87 . . . . 0.0 113.328 -174.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.5 -48.76 80.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.753 0.421 . . . . 0.0 111.239 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.465 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 27.3 mt-10 -70.67 -30.17 66.69 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.652 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 46' ' ' ALA . 63.9 mt -64.66 -52.43 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.487 0.715 . . . . 0.0 110.679 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.488 ' O ' HG13 ' A' ' 54' ' ' ILE . 6.4 ptp180 -64.2 -43.12 96.03 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.443 -175.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.9 t -67.91 -39.33 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.13 0.972 . . . . 0.0 111.743 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -71.33 -29.74 65.37 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.627 0.371 . . . . 0.0 110.851 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -73.61 -30.57 63.06 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 119.114 -0.469 . . . . 0.0 111.346 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 50' ' ' ARG . 77.6 mt -58.59 -38.75 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -57.2 -41.91 80.27 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.916 0.76 . . . . 0.0 111.717 174.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -73.59 -31.03 63.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.119 0.568 . . . . 0.0 110.722 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' A' ' 19' ' ' ARG . 2.6 m-30 -78.42 3.21 16.4 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.35 0.66 . . . . 0.0 111.478 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.411 ' HE2' HG21 ' A' ' 54' ' ' ILE . 73.4 mmtt -81.67 -18.38 44.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.312 0.645 . . . . 0.0 112.183 171.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.65 121.03 79.51 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-O 119.205 -0.426 . . . . 0.0 110.188 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.95 -20.05 34.42 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.357 2.038 . . . . 0.0 111.687 177.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -84.87 -13.36 51.16 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.885 0.874 . . . . 0.0 111.676 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 83' ' ' THR . 30.2 tp -62.85 112.56 2.6 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -173.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -145.5 118.03 8.56 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.18 105.54 3.31 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -96.3 105.73 17.84 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 tt -85.88 119.83 26.62 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.44 -31.43 8.16 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.706 0.802 . . . . 0.0 111.231 -174.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 84.7 m -142.87 132.38 23.66 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.923 0.889 . . . . 0.0 109.805 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -135.67 135.07 39.82 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 164.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.478 HG22 ' HB ' ' A' ' 77' ' ' ILE . 20.4 m -122.56 142.41 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.5 tt -124.84 138.47 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 121.229 0.538 . . . . 0.0 111.219 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -139.76 99.41 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 125.284 1.434 . . . . 0.0 107.999 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.29 -126.79 23.15 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.718 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.431 ' HA ' HG13 ' A' ' 5' ' ' ILE . 21.1 p-10 -94.78 24.27 4.84 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.228 0.611 . . . . 0.0 111.411 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.2 t -131.43 130.75 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.404 1.082 . . . . 0.0 109.433 -174.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.9 t -120.93 142.53 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 122.982 0.513 . . . . 0.0 110.043 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.543 HD12 ' HB ' ' A' ' 98' ' ' ILE . 5.3 mm -98.28 107.69 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 165.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -91.57 109.38 20.68 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 167.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -100.72 108.51 20.38 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 175.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.53 129.35 42.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.757 1.223 . . . . 0.0 109.734 -174.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.5 m -83.91 103.02 12.83 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 172.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.6 m -89.33 137.71 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 29.2 m -95.58 135.45 37.23 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.195 0.598 . . . . 0.0 109.688 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -131.45 -166.11 1.66 Allowed 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -125.45 99.57 6.09 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 122.122 -0.361 . . . . 0.0 110.061 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.406 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 20.7 m-30 -99.53 135.74 20.54 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 172.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.03 -12.5 35.68 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.997 2.465 . . . . 0.0 113.812 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -83.98 -11.2 57.17 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.09 -119.3 0.75 Allowed Glycine 0 C--N 1.35 1.34 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.346 171.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -71.4 -80.61 0.06 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.215 0.606 . . . . 0.0 110.998 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.406 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 123.22 27.0 1.57 Allowed Glycine 0 C--N 1.344 0.978 0 N-CA-C 114.032 0.373 . . . . 0.0 114.032 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -89.53 141.12 28.87 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.6 HG13 ' HA ' ' A' ' 116' ' ' PRO . 30.4 m -133.49 133.37 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.199 0.599 . . . . 0.0 109.557 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.51 109.24 15.79 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 113' ' ' ILE . 39.0 t -112.43 156.65 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -175.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -128.69 101.93 6.35 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 111' ' ' PHE . 76.2 m -92.08 105.7 17.88 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.543 ' HB ' HD12 ' A' ' 77' ' ' ILE . 8.5 tt -92.2 112.19 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.044 0.938 . . . . 0.0 109.58 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -99.94 148.84 24.05 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.571 0.748 . . . . 0.0 110.127 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -118.69 111.85 19.04 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.527 ' HB ' HG22 ' A' ' 5' ' ' ILE . 53.6 t -98.31 112.18 29.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.012 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -117.18 130.9 56.9 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 62.7 32.1 16.34 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.581 0.752 . . . . 0.0 111.386 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.63 -5.88 82.19 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 115.657 -0.702 . . . . 0.0 114.58 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 63.5 mmt-85 -132.22 147.44 52.41 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.6 0.76 . . . . 0.0 109.281 -175.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.515 HG12 HG23 ' A' ' 101' ' ' VAL . 66.4 mt -68.94 100.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.395 0.678 . . . . 0.0 110.256 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.68 -25.71 35.31 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.563 0.745 . . . . 0.0 111.312 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 96.8 mttt -145.58 150.03 35.63 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.788 0.835 . . . . 0.0 108.751 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.36 135.11 14.51 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.507 0.723 . . . . 0.0 109.408 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.433 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 2.5 m-90 -133.06 130.63 39.62 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.462 ' HB2' ' SG ' ' A' ' 97' ' ' CYS . 11.8 p90 -119.66 138.95 52.94 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.252 0.933 . . . . 0.0 109.583 175.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.631 ' HZ2' ' HB3' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -127.36 119.9 27.29 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.371 0.668 . . . . 0.0 109.213 -178.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 95' ' ' VAL . 88.7 mt -88.75 130.1 38.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.04 -78.8 0.17 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.153 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -158.38 163.26 24.96 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.6 ' HA ' HG13 ' A' ' 93' ' ' VAL . 74.5 Cg_endo -71.04 114.74 4.0 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.28 1.987 . . . . 0.0 112.189 170.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -107.05 150.68 26.27 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.887 0.875 . . . . 0.0 108.973 176.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 32.2 mm -138.11 121.35 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.875 0.87 . . . . 0.0 108.98 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.488 1.427 0 C-N-CA 123.024 0.53 . . . . 0.0 110.752 177.831 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -109.54 44.94 1.12 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.454 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 50.7 p -65.98 -43.62 87.28 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.407 -1.269 . . . . 0.0 111.749 -172.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.21 -6.82 31.46 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.622 0.769 . . . . 0.0 112.722 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.438 ' HB ' HD13 ' A' ' 71' ' ' ILE . 14.4 mm -95.78 -29.64 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.649 0.78 . . . . 0.0 109.016 174.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -77.73 -33.01 53.15 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.701 0.801 . . . . 0.0 111.492 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 3' ' ' SER . 93.0 mt -58.91 -49.54 92.81 Favored Pre-proline 0 N--CA 1.489 1.492 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.384 -176.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.599 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 11.9 Cg_endo -56.29 -60.92 0.39 Allowed 'Trans proline' 0 C--N 1.392 2.816 0 C-N-CA 122.245 1.964 . . . . 0.0 112.303 175.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.447 HG22 HG11 ' A' ' 76' ' ' VAL . 22.6 m -64.27 -29.54 47.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.848 -167.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -68.72 -55.18 12.19 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.564 0.745 . . . . 0.0 109.88 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -62.97 -35.08 78.96 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.892 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -74.79 -42.52 57.97 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.6 0.76 . . . . 0.0 111.438 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 66' ' ' LEU . 22.9 tp -60.76 -46.79 89.11 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.851 0.46 . . . . 0.0 110.401 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.22 -49.94 74.43 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.94 173.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.85 -25.91 68.38 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.267 1.027 . . . . 0.0 112.3 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -63.75 -44.1 94.51 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.595 0.758 . . . . 0.0 110.71 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -91.25 -28.24 17.92 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.814 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.85 -10.23 59.74 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.831 0.852 . . . . 0.0 112.111 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 69.11 44.68 0.97 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.876 1.27 . . . . 0.0 112.095 173.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -115.77 93.81 4.42 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.261 0.624 . . . . 0.0 109.566 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.524 HG13 HG12 ' A' ' 54' ' ' ILE . 12.8 mm -71.62 -29.63 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 122.864 0.466 . . . . 0.0 111.35 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.78 -45.12 93.27 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.458 0.303 . . . . 0.0 111.4 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.43 -32.36 42.79 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.991 0.516 . . . . 0.0 110.94 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.488 ' HB3' ' HA ' ' A' ' 21' ' ' ILE . 50.8 t80 -70.05 -10.33 58.34 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.888 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.661 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -111.53 -29.74 7.64 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.453 0.701 . . . . 0.0 111.24 174.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.04 -54.25 32.31 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.808 0.843 . . . . 0.0 112.241 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.599 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 95.5 m95 -78.39 4.64 12.49 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.467 -1.242 . . . . 0.0 113.452 -169.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.482 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 28.3 m95 -93.29 162.37 14.03 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.54 0.736 . . . . 0.0 109.521 174.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -79.67 152.16 30.11 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.793 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.41 -27.24 66.91 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 120.782 0.325 . . . . 0.0 111.3 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.32 18.86 21.39 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.633 0.773 . . . . 0.0 110.791 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.482 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 53.2 t -60.72 133.8 56.45 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.069 0.548 . . . . 0.0 112.12 -174.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -88.08 148.96 24.23 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 43' ' ' ALA . 56.6 t80 -140.53 112.85 7.87 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.436 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 27.0 m-85 -108.25 154.88 21.14 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.037 0.935 . . . . 0.0 110.83 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.451 ' HB1' HD13 ' A' ' 42' ' ' LEU . . . -113.39 155.31 25.46 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.872 1.269 . . . . 0.0 109.341 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.703 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 69.3 t80 -53.54 125.49 44.96 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.398 1.079 . . . . 0.0 111.971 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -76.85 -58.4 0.14 OUTLIER 'Cis proline' 0 C--N 1.383 2.362 0 CA-C-N 120.344 1.159 . . . . 0.0 113.986 -4.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -145.3 78.85 1.56 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.473 0.709 . . . . 0.0 109.819 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 94.5 m -125.95 106.05 9.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.473 0.709 . . . . 0.0 109.709 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.5 tp -66.12 102.41 0.82 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.549 0.74 . . . . 0.0 110.937 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.451 HD13 ' HB1' ' A' ' 36' ' ' ALA . 41.2 mt -79.79 -35.86 37.92 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.384 0.673 . . . . 0.0 110.553 175.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 34' ' ' TYR . . . -142.49 121.32 12.71 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.436 -171.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.91 35.38 4.9 Favored Glycine 0 C--N 1.347 1.176 0 C-N-CA 123.239 0.447 . . . . 0.0 112.754 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 p30 168.45 161.31 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.65 1.58 . . . . 0.0 109.79 -172.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -64.96 -36.93 85.96 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.407 1.083 . . . . 0.0 112.918 -173.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.28 82.86 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.124 0.569 . . . . 0.0 111.84 -173.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.413 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 27.4 mt-10 -77.02 -33.29 57.44 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.988 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.8 mt -61.64 -50.44 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.676 0.79 . . . . 0.0 110.756 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.661 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 21.3 ptt180 -61.91 -49.93 74.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 118.841 -0.599 . . . . 0.0 110.525 -177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.5 t -59.29 -42.82 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.531 0.732 . . . . 0.0 110.668 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HA ' ' HE ' ' A' ' 52' ' ' ARG . 2.1 tpm_? -55.17 -43.72 74.54 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.024 0.827 . . . . 0.0 110.704 176.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -78.24 -29.78 48.34 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.387 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.524 HG12 HG13 ' A' ' 21' ' ' ILE . 95.7 mt -61.42 -38.47 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 118.414 0.552 . . . . 0.0 109.673 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -58.88 -40.17 83.59 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.653 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -70.47 -32.95 70.69 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.074 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -74.66 -8.66 57.08 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.811 0.844 . . . . 0.0 111.832 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.457 ' HE2' HG23 ' A' ' 54' ' ' ILE . 72.6 mmtt -71.12 -27.27 63.46 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.775 0.43 . . . . 0.0 111.542 174.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.44 117.05 43.25 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.97 -22.08 42.51 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.302 2.002 . . . . 0.0 110.885 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -85.84 -5.54 59.23 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.618 1.567 . . . . 0.0 112.603 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.79 120.9 12.17 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.418 0.287 . . . . 0.0 110.314 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -150.93 117.67 5.8 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.3 102.64 2.95 Favored Glycine 0 C--N 1.344 1.002 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -95.3 103.07 14.92 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.4 ' HB2' HD21 ' A' ' 13' ' ' LEU . 8.7 tp -68.02 139.88 56.32 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.134 0.492 . . . . 0.0 110.81 -177.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mt -107.39 -53.01 2.68 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.463 1.105 . . . . 0.0 108.392 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.8 m -148.11 144.69 27.99 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 113.613 -1.631 . . . . 0.0 109.739 -172.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 25.2 ptt180 -140.7 128.55 21.81 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.115 0.966 . . . . 0.0 108.739 173.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.475 HG21 ' HB ' ' A' ' 77' ' ' ILE . 33.1 m -123.83 152.08 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.438 HD13 ' HB ' ' A' ' 5' ' ' ILE . 11.2 tt -133.35 118.72 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.25 0.548 . . . . 0.0 110.401 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.6 t -112.18 95.27 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.368 1.067 . . . . 0.0 108.429 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.92 -111.1 3.8 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 116.027 -0.533 . . . . 0.0 113.433 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -93.44 12.43 25.0 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.769 0.828 . . . . 0.0 111.615 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.1 t -125.72 134.25 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.74 0.816 . . . . 0.0 109.52 -171.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.447 HG11 HG22 ' A' ' 9' ' ' VAL . 24.5 t -125.69 135.17 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 122.807 0.443 . . . . 0.0 110.355 175.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.559 HD11 ' HB ' ' A' ' 98' ' ' ILE . 9.0 mm -99.81 105.06 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.092 1.357 . . . . 0.0 108.006 169.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.01 105.87 17.86 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 167.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.451 ' HE1' ' HB3' ' A' ' 94' ' ' ASP . 1.8 t60 -100.21 106.78 18.49 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.95 169.18 12.95 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.942 1.297 . . . . 0.0 110.18 -176.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.6 m -116.71 110.16 18.09 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.2 t -81.29 103.41 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.362 0.665 . . . . 0.0 110.123 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 88.0 m -66.24 118.81 10.48 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -123.98 -169.29 1.93 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.572 1.149 . . . . 0.0 108.031 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.1 109.37 16.33 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.39 0.676 . . . . 0.0 109.424 169.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -103.81 147.02 33.62 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 123.655 0.782 . . . . 0.0 110.015 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.02 -9.86 27.54 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.876 2.384 . . . . 0.0 114.216 -175.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -92.35 -15.14 27.7 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.419 0.287 . . . . 0.0 111.66 173.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.05 -121.66 1.03 Allowed Glycine 0 C--N 1.355 1.626 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.956 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -53.79 -84.57 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.503 1.121 . . . . 0.0 111.994 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.58 28.54 2.72 Favored Glycine 0 C--N 1.349 1.276 0 C-N-CA 121.686 -0.292 . . . . 0.0 113.575 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -89.77 119.57 30.27 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -173.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 116' ' ' PRO . 33.4 m -116.49 123.16 71.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 CA-C-O 121.114 0.483 . . . . 0.0 110.045 -175.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.451 ' HB3' ' HE1' ' A' ' 79' ' ' HIS . 2.8 m-20 -84.19 108.0 16.83 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.46 HG22 HG12 ' A' ' 113' ' ' ILE . 24.0 t -113.14 149.42 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.788 1.235 . . . . 0.0 109.432 -174.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -112.84 103.19 11.18 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 167.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 76.7 m -93.76 109.05 20.74 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.559 ' HB ' HD11 ' A' ' 77' ' ' ILE . 4.9 tt -99.3 134.6 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.244 1.018 . . . . 0.0 109.739 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -123.22 155.6 36.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.773 0.829 . . . . 0.0 109.866 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -129.07 119.42 24.17 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.892 1.277 . . . . 0.0 107.645 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.479 HG21 HG12 ' A' ' 106' ' ' ILE . 97.1 t -107.46 117.62 53.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.226 1.01 . . . . 0.0 109.695 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.519 ' HG2' ' ND2' ' A' ' 103' ' ' ASN . 43.0 tt0 -126.95 133.26 50.66 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.92 0.888 . . . . 0.0 109.23 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.519 ' ND2' ' HG2' ' A' ' 102' ' ' GLU . 48.1 m-80 61.54 28.62 17.84 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.027 1.331 . . . . 0.0 111.798 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.05 -7.56 80.0 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -121.27 149.29 43.1 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.479 HG12 HG21 ' A' ' 101' ' ' VAL . 47.7 mt -66.41 109.77 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 102' ' ' GLU . . . -75.78 -38.41 58.31 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.865 0.866 . . . . 0.0 110.608 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -149.12 146.7 27.82 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.191 0.996 . . . . 0.0 109.059 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -145.84 139.68 26.52 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.154 0.582 . . . . 0.0 109.504 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.436 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 2.0 m-90 -131.78 155.8 47.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -142.24 145.02 33.62 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 171.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.703 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 59.9 pttt -129.06 124.27 34.42 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.627 0.771 . . . . 0.0 109.066 175.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.46 HG12 HG22 ' A' ' 95' ' ' VAL . 96.5 mt -88.63 123.94 41.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.9 -66.84 2.24 Favored Glycine 0 C--O 1.242 0.607 0 O-C-N 124.39 1.056 . . . . 0.0 112.876 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -158.55 163.77 23.27 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.084 0.554 . . . . 0.0 109.653 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.662 ' HA ' HG12 ' A' ' 93' ' ' VAL . 88.7 Cg_endo -82.23 137.29 9.39 Favored 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.561 2.174 . . . . 0.0 112.475 163.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -132.82 158.74 41.73 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.74 0.781 . . . . 0.0 111.934 175.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.3 mm -138.54 139.63 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.235 1.414 . . . . 0.0 108.375 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.5 t -60.08 -39.01 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 124.001 0.921 . . . . 0.0 111.827 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.4 t -66.32 -23.73 66.42 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.169 0.588 . . . . 0.0 112.127 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -108.58 7.29 26.61 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.698 0.799 . . . . 0.0 111.287 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -131.23 148.95 52.75 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.066 0.946 . . . . 0.0 109.463 -175.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 CA--C 1.558 1.253 0 C-N-CA 122.852 0.461 . . . . 0.0 109.758 173.407 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttp . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.49 ' HB2' HD11 ' A' ' 71' ' ' ILE . 11.1 m120 -83.38 72.64 10.21 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.596 0.758 . . . . 0.0 109.248 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.467 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 45.7 m -67.42 -33.22 74.71 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.547 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.29 -11.27 30.16 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.618 0.767 . . . . 0.0 112.408 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.504 HG13 ' HA ' ' A' ' 74' ' ' ASN . 16.3 mm -98.06 -32.55 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.742 0.817 . . . . 0.0 109.824 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -69.18 -33.81 73.94 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.66 0.784 . . . . 0.0 112.099 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.9 mt -66.83 -50.33 44.33 Favored Pre-proline 0 N--CA 1.486 1.331 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.182 -173.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.568 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 12.2 Cg_endo -54.83 -52.23 8.5 Favored 'Trans proline' 0 C--N 1.398 3.132 0 C-N-CA 122.136 1.891 . . . . 0.0 111.525 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.439 HG13 HG12 ' A' ' 76' ' ' VAL . 72.4 t -58.08 -43.64 85.66 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 C-N-CA 124.774 1.23 . . . . 0.0 112.496 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.402 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 24.4 tp60 -66.13 -55.87 14.25 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.409 0.684 . . . . 0.0 111.472 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 27' ' ' TRP . 73.4 mmtt -65.33 -38.34 89.85 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.325 0.65 . . . . 0.0 110.817 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -62.89 -39.49 94.65 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.523 1.129 . . . . 0.0 111.343 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.81 -52.81 63.88 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 20.5 mm-40 -61.57 -32.03 72.09 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.806 -174.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.57 -27.64 55.93 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.588 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -63.66 -47.36 81.6 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.218 1.007 . . . . 0.0 110.812 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -84.76 -23.49 29.2 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.17 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.64 -6.8 58.76 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.153 0.581 . . . . 0.0 112.337 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 71.8 12.59 6.22 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.268 1.427 . . . . 0.0 113.042 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -76.28 94.46 3.57 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.457 HG13 HG12 ' A' ' 54' ' ' ILE . 12.5 mm -66.95 -28.54 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.728 0.811 . . . . 0.0 110.883 173.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -58.62 -46.63 86.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.851 0.46 . . . . 0.0 111.1 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.6 -30.88 41.64 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.365 0.666 . . . . 0.0 110.972 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -72.87 -7.66 51.94 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.49 0.716 . . . . 0.0 110.514 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.729 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -116.35 -25.31 7.56 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.409 0.684 . . . . 0.0 112.034 175.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.6 -40.53 79.28 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.835 0.854 . . . . 0.0 113.123 -171.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 90.5 m95 -89.69 1.7 55.71 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.404 -173.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 14.2 m95 -99.05 138.6 35.92 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.576 0.75 . . . . 0.0 109.141 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -71.46 160.66 32.35 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.443 0.697 . . . . 0.0 111.174 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -61.25 -39.82 91.74 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.398 0.679 . . . . 0.0 111.546 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -99.12 19.98 14.25 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.463 1.105 . . . . 0.0 110.856 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 50.1 t -58.03 115.12 2.68 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.224 0.609 . . . . 0.0 111.714 -176.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -75.68 153.2 37.3 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 59.8 t80 -142.07 118.67 11.0 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -115.82 153.1 32.08 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.476 1.11 . . . . 0.0 109.673 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.39 161.23 23.84 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.232 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -57.99 128.97 81.96 Favored Pre-proline 0 CA--C 1.562 1.404 0 O-C-N 124.327 1.017 . . . . 0.0 110.77 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -75.9 -51.16 0.16 OUTLIER 'Cis proline' 0 C--N 1.384 2.44 0 CA-C-N 120.185 1.102 . . . . 0.0 114.03 -0.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.0 86.4 0.62 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.2 m -141.88 117.7 10.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.38 0.672 . . . . 0.0 109.977 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 tt -68.84 106.76 2.81 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.258 1.023 . . . . 0.0 109.899 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.3 mt -82.29 -42.52 18.72 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.397 0.679 . . . . 0.0 111.345 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . . . -141.47 117.22 10.39 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.872 0.469 . . . . 0.0 111.113 -170.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.27 42.72 1.9 Allowed Glycine 0 N--CA 1.478 1.441 0 O-C-N 123.117 0.26 . . . . 0.0 113.014 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 p30 167.69 156.51 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.649 1.579 . . . . 0.0 108.934 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -63.61 -32.88 74.48 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.782 0.833 . . . . 0.0 112.776 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.79 90.99 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.156 0.582 . . . . 0.0 112.221 -173.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 30.2 mt-10 -74.16 -34.86 63.96 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.617 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.8 mt -58.59 -45.41 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.049 0.94 . . . . 0.0 110.432 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.729 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 21.6 ttt180 -54.33 -56.71 15.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.43 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.7 t -54.77 -49.47 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 124.708 1.255 . . . . 0.0 111.568 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -62.18 -36.97 83.51 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.345 -174.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -77.55 -34.57 53.75 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 118.894 -0.574 . . . . 0.0 111.842 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 50' ' ' ARG . 77.5 mt -56.42 -40.32 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.053 0.454 . . . . 0.0 109.867 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -57.26 -43.0 82.62 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.506 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -76.25 -22.33 55.28 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 120.801 0.334 . . . . 0.0 111.282 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.457 ' HA ' HD23 ' A' ' 62' ' ' LEU . 3.5 m-30 -79.76 -0.5 34.62 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.527 0.731 . . . . 0.0 112.032 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -73.55 -30.63 63.19 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.097 0.559 . . . . 0.0 111.28 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -63.08 121.04 66.65 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.278 0.631 . . . . 0.0 110.883 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.75 -23.67 26.01 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.263 1.976 . . . . 0.0 110.773 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.34 -10.53 59.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.015 1.326 . . . . 0.0 111.477 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 57' ' ' PHE . 42.7 tp -59.29 112.63 1.81 Allowed 'General case' 0 C--N 1.36 1.024 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -148.76 130.37 14.95 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.259 1.023 . . . . 0.0 108.332 -175.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.16 127.15 8.24 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -122.56 102.99 8.4 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.512 HD11 ' HG2' ' A' ' 80' ' ' GLU . 6.3 tp -69.72 138.11 52.6 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.403 0.62 . . . . 0.0 111.208 -175.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.467 HD11 ' HG1' ' A' ' 81' ' ' THR . 7.7 mt -105.88 -50.85 3.09 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.822 1.249 . . . . 0.0 108.253 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.7 m -150.11 141.44 23.25 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 113.24 -1.8 . . . . 0.0 109.844 -173.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -131.38 130.43 42.6 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 165.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.59 127.6 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.884 1.274 . . . . 0.0 110.273 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.49 HD11 ' HB2' ' A' ' 2' ' ' ASN . 15.7 tt -102.89 120.67 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.145 0.578 . . . . 0.0 109.7 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.43 94.54 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 124.194 0.998 . . . . 0.0 108.486 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.37 -118.02 11.91 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 123.323 0.389 . . . . 0.0 112.669 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.504 ' HA ' HG13 ' A' ' 5' ' ' ILE . 2.5 p-10 -95.04 7.99 44.36 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.325 0.65 . . . . 0.0 111.689 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.6 t -116.31 141.54 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.59 1.156 . . . . 0.0 108.581 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.454 HG21 HG21 ' A' ' 5' ' ' ILE . 70.0 t -126.29 133.5 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.004 0.522 . . . . 0.0 109.615 170.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.48 HG12 ' HB ' ' A' ' 98' ' ' ILE . 5.2 mt -100.65 114.84 40.79 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 164.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -96.65 150.84 20.22 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 166.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -138.09 106.34 5.77 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.512 ' HG2' HD11 ' A' ' 66' ' ' LEU . 6.6 mt-10 -115.75 158.98 22.02 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.344 0.658 . . . . 0.0 109.558 176.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.467 ' HG1' HD11 ' A' ' 67' ' ' LEU . 56.9 m -97.05 103.14 15.04 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 163.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.53 125.2 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.452 0.644 . . . . 0.0 111.319 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.9 m -76.28 122.92 25.11 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.121 0.969 . . . . 0.0 111.708 -175.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.2 mmt-85 -119.97 -168.29 1.58 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.623 1.169 . . . . 0.0 109.189 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.81 104.99 9.29 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.275 1.03 . . . . 0.0 109.539 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.408 ' HE2' ' HB3' ' A' ' 116' ' ' PRO . 12.6 m-30 -112.4 149.46 41.09 Favored Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 123.558 0.743 . . . . 0.0 111.054 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.61 -18.84 64.05 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.952 2.435 . . . . 0.0 113.608 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -87.0 -4.38 59.17 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.44 -122.68 1.48 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.931 -0.372 . . . . 0.0 112.466 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -60.43 -82.14 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.983 0.913 . . . . 0.0 111.5 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.41 26.92 3.27 Favored Glycine 0 C--N 1.343 0.952 0 O-C-N 122.953 0.158 . . . . 0.0 113.205 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.453 ' HB2' HG23 ' A' ' 81' ' ' THR . 16.9 pt-20 -89.21 104.7 17.22 Favored 'General case' 0 C--O 1.207 -1.138 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -174.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.691 HG13 ' HA ' ' A' ' 116' ' ' PRO . 20.3 m -105.16 131.12 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 121.33 -0.856 . . . . 0.0 109.973 -171.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -78.33 127.91 32.91 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.503 HG23 HG12 ' A' ' 113' ' ' ILE . 43.1 t -131.57 126.25 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.09 99.41 12.43 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 172.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.6 m -94.81 108.51 20.53 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.152 0.981 . . . . 0.0 108.843 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.586 HG21 ' HB2' ' A' ' 110' ' ' TRP . 11.1 tt -105.86 107.23 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 C-N-CA 124.403 1.081 . . . . 0.0 110.735 -172.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -104.14 131.17 51.7 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.35 1.06 . . . . 0.0 110.024 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -97.82 112.03 24.09 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 168.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 106' ' ' ILE . 75.2 t -99.62 125.1 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.077 0.951 . . . . 0.0 109.15 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.523 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 11.4 tp10 -125.81 127.94 46.9 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.476 0.71 . . . . 0.0 109.981 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.523 ' ND2' ' HG3' ' A' ' 102' ' ' GLU . 43.5 m-80 61.48 30.43 18.82 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.45 1.5 . . . . 0.0 112.116 -176.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.54 1.95 90.56 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 113.781 0.272 . . . . 0.0 113.781 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -124.79 136.0 53.46 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.047 0.939 . . . . 0.0 109.007 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.491 HG12 HG22 ' A' ' 101' ' ' VAL . 68.8 mt -62.43 102.86 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.252 1.021 . . . . 0.0 109.811 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -78.47 -29.89 47.09 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.291 0.636 . . . . 0.0 110.765 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -148.57 143.26 26.49 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -137.05 131.03 32.22 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.586 ' HB2' HG21 ' A' ' 98' ' ' ILE . 0.9 OUTLIER -135.37 152.86 51.84 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -176.319 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -143.0 144.85 32.46 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -130.82 123.7 29.69 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.503 HG12 HG23 ' A' ' 95' ' ' VAL . 96.7 mt -88.22 127.48 41.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.93 -78.82 0.16 Allowed Glycine 0 N--CA 1.468 0.826 0 O-C-N 124.331 1.019 . . . . 0.0 112.667 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -158.83 164.58 20.65 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.691 ' HA ' HG13 ' A' ' 93' ' ' VAL . 72.3 Cg_endo -72.2 117.69 5.26 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.433 2.089 . . . . 0.0 112.581 169.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.403 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 15.6 mmt180 -102.11 144.11 31.09 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 49.4 mm -122.83 152.37 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 173.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.0 t -59.43 -26.8 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 122.646 0.378 . . . . 0.0 111.402 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 83.3 p -64.17 -41.13 97.26 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.399 0.68 . . . . 0.0 110.725 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -96.92 3.0 52.31 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.438 1.095 . . . . 0.0 111.888 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -132.06 -166.81 1.78 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--O 1.249 1.073 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 171.763 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -155.28 -2.32 0.15 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.365 0.666 . . . . 0.0 111.438 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.43 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 78.7 p -63.78 -37.79 88.69 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.461 ' HG3' HG12 ' A' ' 5' ' ' ILE . 9.5 pt-20 -55.8 -28.28 55.41 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.72 1.208 . . . . 0.0 112.716 174.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.575 HG13 ' HA ' ' A' ' 74' ' ' ASN . 32.8 mm -89.83 -27.88 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.492 1.117 . . . . 0.0 109.826 -177.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.39 -24.04 60.25 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.117 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 3' ' ' SER . 79.5 mt -63.6 -50.65 71.34 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.725 -175.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.466 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 11.6 Cg_endo -55.96 -60.4 0.52 Allowed 'Trans proline' 0 C--N 1.394 2.932 0 C-N-CA 121.866 1.711 . . . . 0.0 111.984 172.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.3 t -51.07 -48.95 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 C-N-CA 124.509 1.123 . . . . 0.0 113.347 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.417 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -63.09 -52.21 63.56 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.173 0.989 . . . . 0.0 110.937 -176.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -63.54 -37.17 86.29 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.029 0.532 . . . . 0.0 111.282 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -68.26 -38.1 81.42 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.116 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 66' ' ' LEU . 50.8 tp -62.53 -50.86 69.69 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.524 0.73 . . . . 0.0 110.872 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 4.0 mm-40 -55.42 -47.23 76.27 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.31 1.007 . . . . 0.0 109.477 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 20' ' ' ASP . . . -66.22 -28.79 69.01 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.229 -1.35 . . . . 0.0 112.329 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -67.45 -48.26 67.76 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.176 0.59 . . . . 0.0 110.488 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -83.71 -14.67 51.11 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.251 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.96 0.4 55.95 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.425 0.69 . . . . 0.0 111.992 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 62.71 26.0 15.4 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.463 1.105 . . . . 0.0 111.851 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 13.1 t70 -96.48 110.57 22.92 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.793 1.237 . . . . 0.0 109.31 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.4 mm -76.84 -32.89 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.1 0.56 . . . . 0.0 110.999 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 24.8 t70 -58.19 -49.06 78.38 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.745 0.653 . . . . 0.0 112.161 -168.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.81 -35.63 22.2 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.177 0.991 . . . . 0.0 111.392 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -63.01 -14.18 44.67 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.293 0.371 . . . . 0.0 112.0 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 68.2 mmm -120.66 -14.4 8.6 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -60.79 -36.51 79.19 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.552 0.691 . . . . 0.0 112.304 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 91.8 m95 -93.57 14.03 20.13 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.718 -170.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.429 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 19.3 m95 -99.12 152.45 19.85 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.778 0.831 . . . . 0.0 109.267 174.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -78.92 154.54 29.58 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.262 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.44 -32.04 72.84 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.118 0.567 . . . . 0.0 111.184 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -99.42 17.9 19.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.889 0.875 . . . . 0.0 111.337 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.429 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 46.9 t -64.54 117.92 8.06 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 123.209 0.318 . . . . 0.0 111.549 -174.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.411 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 33.2 mm-40 -77.68 154.09 32.47 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -139.39 110.44 6.87 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.468 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 96.4 m-85 -113.37 138.33 50.22 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.818 0.847 . . . . 0.0 110.572 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.508 ' HB1' HD22 ' A' ' 42' ' ' LEU . . . -92.21 154.95 18.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.459 166.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -50.04 130.03 22.73 Favored Pre-proline 0 CA--C 1.567 1.617 0 C-N-CA 124.268 1.027 . . . . 0.0 112.508 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.43 -36.34 2.15 Favored 'Cis proline' 0 C--N 1.383 2.371 0 CA-C-N 119.967 1.024 . . . . 0.0 112.134 -4.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.62 94.57 1.16 Allowed 'General case' 0 C--N 1.345 0.41 0 C-N-CA 124.821 1.248 . . . . 0.0 107.748 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 7.2 m -130.18 102.4 6.21 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.5 tp -73.1 100.89 3.15 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 117.961 0.346 . . . . 0.0 110.447 -175.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.508 HD22 ' HB1' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -83.36 -34.31 25.63 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.044 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -146.37 116.91 7.54 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.81 -173.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -107.53 46.66 1.14 Allowed Glycine 0 C--N 1.347 1.147 0 C-N-CA 123.032 0.349 . . . . 0.0 113.034 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.43 ' O ' HG13 ' A' ' 49' ' ' ILE . 9.6 p30 162.08 154.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 126.149 1.78 . . . . 0.0 109.227 -171.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -63.5 -26.28 68.64 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -175.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.22 -51.4 67.93 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.803 0.441 . . . . 0.0 110.98 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.429 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.0 mt-10 -68.41 -33.43 74.21 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.108 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 45' ' ' ASN . 54.2 mt -69.2 -43.14 81.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 122.962 0.505 . . . . 0.0 110.264 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.484 ' O ' HG13 ' A' ' 54' ' ' ILE . 32.0 ptt180 -69.87 -45.18 68.28 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.605 -173.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.8 m -68.95 -35.03 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 122.859 0.463 . . . . 0.0 111.894 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -71.41 -40.1 70.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.297 0.639 . . . . 0.0 110.357 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -64.61 -33.33 75.68 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.57 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 50' ' ' ARG . 97.0 mt -58.16 -47.07 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 122.557 0.343 . . . . 0.0 110.184 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.21 -33.3 75.09 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.455 0.702 . . . . 0.0 111.498 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -66.79 -35.04 79.15 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.174 0.59 . . . . 0.0 110.956 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -78.75 -2.45 39.47 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.21 0.604 . . . . 0.0 112.02 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -84.58 -19.71 32.63 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.948 0.499 . . . . 0.0 110.756 171.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.11 113.55 8.17 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 123.694 0.798 . . . . 0.0 109.813 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -61.35 -32.23 89.37 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 123.107 2.538 . . . . 0.0 113.547 -169.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.22 -0.6 56.79 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.723 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.6 tp -62.82 118.9 8.37 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.202 0.455 . . . . 0.0 111.359 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.476 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 76.3 t80 -151.02 127.56 10.77 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.84 104.2 2.53 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -97.83 100.89 12.27 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.168 0.587 . . . . 0.0 109.51 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.424 ' HB2' HD12 ' A' ' 13' ' ' LEU . 7.7 tt -79.53 129.7 34.71 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.442 HD11 ' CD2' ' A' ' 79' ' ' HIS . 1.7 pp -115.9 -29.8 6.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.468 -175.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.5 m -150.69 143.79 24.77 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.957 0.903 . . . . 0.0 109.559 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -143.61 136.92 27.93 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.56 0.744 . . . . 0.0 109.326 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.78 130.88 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.493 HD13 ' HB ' ' A' ' 5' ' ' ILE . 9.5 tt -121.98 136.51 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.031 0.532 . . . . 0.0 110.258 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 p -143.35 110.05 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 124.678 1.191 . . . . 0.0 109.186 -176.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.78 -119.71 9.26 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.202 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.575 ' HA ' HG13 ' A' ' 5' ' ' ILE . 27.0 p-10 -108.63 19.86 19.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.275 0.63 . . . . 0.0 111.077 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -127.48 133.63 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.09 0.956 . . . . 0.0 109.251 -175.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 15.1 t -122.57 138.97 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.175 0.59 . . . . 0.0 110.255 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.516 HD13 ' HB ' ' A' ' 98' ' ' ILE . 6.7 mm -104.96 111.9 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.061 1.344 . . . . 0.0 107.708 167.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -106.35 116.06 31.28 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.443 ' HE1' ' HB3' ' A' ' 94' ' ' ASP . 1.5 t60 -99.83 109.01 21.43 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.36 140.05 52.06 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.947 1.299 . . . . 0.0 110.624 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.1 m -86.1 106.5 17.28 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.82 0.848 . . . . 0.0 109.131 169.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.4 t -82.79 104.08 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.754 0.822 . . . . 0.0 110.441 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 63' ' ' TYR . 25.3 m -68.06 127.99 34.89 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.089 0.556 . . . . 0.0 110.425 170.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -139.07 -170.24 2.83 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.801 0.84 . . . . 0.0 109.097 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -119.3 100.55 7.38 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.877 0.471 . . . . 0.0 110.648 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -100.22 142.6 24.92 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 123.714 0.806 . . . . 0.0 109.65 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.04 -23.03 66.79 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.983 2.455 . . . . 0.0 114.026 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -86.54 -4.91 59.24 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.22 -134.24 3.41 Favored Glycine 0 N--CA 1.474 1.174 0 CA-C-O 119.566 -0.574 . . . . 0.0 111.83 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.404 ' CG ' ' HG3' ' A' ' 92' ' ' GLU . 3.0 tppp? -53.15 -87.24 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.659 0.784 . . . . 0.0 112.804 172.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 124.37 26.69 1.44 Allowed Glycine 0 C--N 1.347 1.155 0 N-CA-C 113.761 0.265 . . . . 0.0 113.761 -174.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.454 ' HG2' ' HA ' ' A' ' 83' ' ' THR . 46.8 mt-10 -89.61 115.51 27.06 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 117.099 0.45 . . . . 0.0 109.943 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 116' ' ' PRO . 17.2 m -108.96 130.12 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.432 0.693 . . . . 0.0 109.613 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.443 ' HB3' ' HE1' ' A' ' 79' ' ' HIS . 1.3 m-20 -85.45 108.81 18.06 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.408 HG21 HG12 ' A' ' 113' ' ' ILE . 34.6 t -113.18 162.55 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.108 1.363 . . . . 0.0 108.995 -171.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.18 102.71 6.35 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.573 1.149 . . . . 0.0 108.029 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 80.6 m -93.1 107.92 19.62 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.685 HG22 ' HB2' ' A' ' 110' ' ' TRP . 5.7 tt -102.59 111.05 31.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.148 -176.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -100.46 153.85 19.02 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.618 0.767 . . . . 0.0 110.601 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -126.66 117.45 22.77 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.263 1.425 . . . . 0.0 107.47 171.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.454 ' HB ' HG21 ' A' ' 5' ' ' ILE . 86.2 t -109.02 124.31 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.266 1.026 . . . . 0.0 110.254 -173.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.515 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 10.6 tp10 -131.57 135.5 47.05 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.032 0.933 . . . . 0.0 109.406 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.515 ' ND2' ' HG3' ' A' ' 102' ' ' GLU . 54.1 m-80 62.5 30.02 17.13 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.726 1.211 . . . . 0.0 112.488 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.47 7.82 79.43 Favored Glycine 0 N--CA 1.478 1.499 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.843 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -127.26 148.12 50.22 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.994 1.318 . . . . 0.0 108.149 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.454 HG12 HG22 ' A' ' 101' ' ' VAL . 53.0 mt -69.29 113.72 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 102' ' ' GLU . . . -78.03 -36.66 48.33 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.703 0.801 . . . . 0.0 111.105 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.532 ' HE2' ' HE1' ' A' ' 110' ' ' TRP . 61.4 mtpt -150.59 132.49 15.12 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.055 0.942 . . . . 0.0 108.66 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -124.69 132.58 53.38 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.685 ' HB2' HG22 ' A' ' 98' ' ' ILE . 1.6 m-90 -130.77 152.45 50.1 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -176.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -144.25 147.02 33.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.797 0.332 . . . . 0.0 110.201 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -128.95 117.92 21.77 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.965 0.906 . . . . 0.0 109.064 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.408 HG12 HG21 ' A' ' 95' ' ' VAL . 94.5 mt -86.79 132.72 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.74 -83.12 0.09 OUTLIER Glycine 0 CA--C 1.526 0.778 0 O-C-N 123.708 0.63 . . . . 0.0 112.05 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.15 166.29 16.84 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.498 0.719 . . . . 0.0 109.463 175.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.547 ' HA ' HG12 ' A' ' 93' ' ' VAL . 51.5 Cg_endo -65.85 110.42 1.69 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.532 2.155 . . . . 0.0 113.111 168.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -109.6 149.83 29.09 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.83 0.852 . . . . 0.0 110.232 173.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 50.4 mm -124.68 154.93 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.4 t -70.98 -47.17 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.0 t -68.26 -16.3 63.91 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.344 0.658 . . . . 0.0 111.773 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.431 ' HB3' ' O ' ' A' ' 118' ' ' ILE . 34.4 tt0 -59.41 -41.63 89.92 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.901 0.88 . . . . 0.0 110.324 170.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.464 ' HZ1' ' HB2' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -99.85 80.33 2.31 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 172.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 C--O 1.254 1.304 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.8 -178.168 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.1 m120 57.93 53.75 6.64 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.677 1.191 . . . . 0.0 112.219 167.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 m -66.31 -39.05 89.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.711 0.804 . . . . 0.0 111.345 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.18 -12.37 60.82 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.112 0.565 . . . . 0.0 111.808 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.9 mm -98.02 -39.15 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.927 0.891 . . . . 0.0 109.391 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -58.91 -44.58 91.28 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.54 1.136 . . . . 0.0 112.338 177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.53 -57.11 24.2 Favored Pre-proline 0 CA--C 1.561 1.391 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.883 -171.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.572 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 21.1 Cg_endo -58.27 -48.76 14.47 Favored 'Trans proline' 0 C--N 1.395 3.022 0 C-N-CA 122.401 2.067 . . . . 0.0 112.28 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.2 t -59.27 -44.06 91.26 Favored 'Isoleucine or valine' 0 C--O 1.247 0.956 0 C-N-CA 124.91 1.284 . . . . 0.0 112.605 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -46.07 67.06 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -63.35 -27.74 69.52 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.786 0.834 . . . . 0.0 111.919 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -63.2 -46.18 88.24 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.684 0.615 . . . . 0.0 110.221 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.16 -53.76 52.95 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.153 0.908 . . . . 0.0 109.218 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -52.17 -36.37 51.5 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 124.653 1.221 . . . . 0.0 111.089 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -81.75 -27.96 33.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.651 1.18 . . . . 0.0 112.195 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -69.66 -48.41 59.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.721 0.409 . . . . 0.0 110.267 -172.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -76.07 -28.97 57.8 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.932 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.46 1.16 56.92 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.55 0.74 . . . . 0.0 112.051 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 67.64 18.79 9.87 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.577 1.151 . . . . 0.0 112.797 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.476 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 67.9 m-20 -88.59 95.3 10.19 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.964 0.506 . . . . 0.0 110.467 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.9 mm -67.77 -26.87 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 123.024 0.53 . . . . 0.0 110.648 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -52.44 -48.38 65.84 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.485 0.714 . . . . 0.0 111.59 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.37 -35.0 31.34 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.883 0.473 . . . . 0.0 110.952 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -71.07 -5.84 34.52 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.617 0.767 . . . . 0.0 111.279 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.583 ' SD ' ' HB2' ' A' ' 46' ' ' ALA . 19.6 tpp -121.03 -25.62 5.3 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.173 0.589 . . . . 0.0 112.456 172.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.13 -44.22 74.84 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.572 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.1 m95 -82.71 -3.79 56.94 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -172.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -91.36 149.16 21.85 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.387 0.675 . . . . 0.0 109.8 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.419 ' O ' ' HB1' ' A' ' 46' ' ' ALA . . . -74.05 152.26 40.01 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.349 0.66 . . . . 0.0 110.033 176.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.94 -23.93 65.13 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.112 0.482 . . . . 0.0 110.929 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -102.26 18.61 20.52 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.68 1.192 . . . . 0.0 111.114 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 42.1 t -64.57 122.98 18.07 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.931 0.396 . . . . 0.0 111.916 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -83.11 154.38 24.38 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.493 0.717 . . . . 0.0 109.481 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 33.9 t80 -145.68 120.69 10.05 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.415 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 43.3 m-85 -121.18 153.92 36.92 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.279 1.032 . . . . 0.0 110.484 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.499 ' HB3' HD12 ' A' ' 42' ' ' LEU . . . -120.44 159.83 24.34 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.385 1.074 . . . . 0.0 110.702 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.633 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 82.9 t80 -62.37 130.71 93.44 Favored Pre-proline 0 CA--C 1.56 1.36 0 O-C-N 124.18 0.925 . . . . 0.0 110.383 174.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.67 -47.43 0.31 Allowed 'Cis proline' 0 C--N 1.386 2.506 0 CA-C-N 120.697 1.285 . . . . 0.0 113.447 -1.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.68 93.35 0.82 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 98.3 m -141.33 115.79 9.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.155 0.582 . . . . 0.0 109.6 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 tt -70.8 101.71 2.17 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.499 HD12 ' HB3' ' A' ' 36' ' ' ALA . 94.7 mt -80.64 -37.84 30.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.554 0.741 . . . . 0.0 110.868 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 34' ' ' TYR . . . -148.23 121.24 8.82 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.421 0.451 . . . . 0.0 111.185 -171.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.4 39.55 2.81 Favored Glycine 0 C--N 1.35 1.327 0 C-N-CA 123.116 0.389 . . . . 0.0 113.26 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 166.06 165.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 125.847 1.659 . . . . 0.0 109.155 -171.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.583 ' HB2' ' SD ' ' A' ' 25' ' ' MET . . . -66.54 -36.81 83.59 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.749 0.82 . . . . 0.0 112.748 -175.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.11 -46.87 84.82 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.15 0.58 . . . . 0.0 111.743 -174.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 31.1 mt-10 -72.85 -29.99 63.65 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.487 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.1 mt -67.43 -44.41 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.007 0.523 . . . . 0.0 109.704 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.429 ' O ' HG13 ' A' ' 54' ' ' ILE . 76.6 ttt180 -59.83 -56.1 26.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.552 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.5 m -61.58 -41.59 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 124.429 1.081 . . . . 0.0 112.563 -173.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -72.17 -29.15 63.73 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.145 0.578 . . . . 0.0 110.96 -176.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -77.94 -30.83 50.63 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 118.929 -0.558 . . . . 0.0 111.2 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 50' ' ' ARG . 99.0 mt -59.69 -41.28 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.9 -38.36 88.08 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.919 0.888 . . . . 0.0 111.414 175.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -78.84 -23.33 45.09 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.141 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -84.12 0.62 47.76 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.295 0.638 . . . . 0.0 110.931 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -79.76 -20.36 46.49 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.064 0.545 . . . . 0.0 111.673 170.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.631 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 7.3 mm-40 -64.45 112.86 8.67 Favored Pre-proline 0 CA--C 1.547 0.846 0 O-C-N 123.805 0.691 . . . . 0.0 109.802 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -65.63 -18.34 58.71 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.333 2.022 . . . . 0.0 112.24 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.02 2.85 46.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.377 1.071 . . . . 0.0 111.714 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.631 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 19.4 tp -66.28 116.14 7.0 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.627 0.371 . . . . 0.0 110.15 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -145.02 117.87 8.74 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.437 ' HA2' HG12 ' A' ' 82' ' ' VAL . . . -93.45 103.48 3.04 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 175.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.44 98.14 10.01 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.5 tt -86.72 126.47 34.59 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.427 HD13 ' CD2' ' A' ' 79' ' ' HIS . 2.3 pp -114.32 -30.17 6.68 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.276 1.03 . . . . 0.0 110.438 -171.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.8 m -155.17 132.85 11.29 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.429 1.092 . . . . 0.0 109.055 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 0.8 OUTLIER -132.45 134.71 45.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.59 0.756 . . . . 0.0 109.288 167.181 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -118.88 119.8 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.561 0.745 . . . . 0.0 109.807 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.444 HG13 HG21 ' A' ' 76' ' ' VAL . 17.3 tt -95.29 129.4 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-O 121.321 0.581 . . . . 0.0 109.504 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 p -141.01 96.41 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.515 1.126 . . . . 0.0 108.65 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.76 -128.08 31.67 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.337 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -83.43 3.47 31.83 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.698 0.799 . . . . 0.0 112.578 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.1 t -126.45 134.97 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.811 0.844 . . . . 0.0 109.765 -171.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.444 HG21 HG13 ' A' ' 71' ' ' ILE . 21.6 t -124.18 140.6 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 122.988 0.515 . . . . 0.0 109.627 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.488 HD13 ' HB ' ' A' ' 98' ' ' ILE . 16.2 mm -99.27 103.26 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 172.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -90.35 104.65 17.2 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.427 ' CD2' HD13 ' A' ' 67' ' ' LEU . 2.0 t60 -98.07 108.36 21.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -117.41 152.29 35.28 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.288 -1.324 . . . . 0.0 109.611 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.5 m -103.19 101.87 11.83 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 159.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.437 HG12 ' HA2' ' A' ' 64' ' ' GLY . 32.8 m -91.97 127.81 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.065 0.459 . . . . 0.0 110.367 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.3 m -75.71 120.49 21.17 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.149 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.554 HH21 HG11 ' A' ' 93' ' ' VAL . 61.3 mtm180 -125.05 -163.51 1.19 Allowed 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -127.8 109.24 11.43 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 118.284 0.493 . . . . 0.0 111.074 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.409 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 19.2 m-30 -108.34 144.6 29.81 Favored Pre-proline 0 N--CA 1.481 1.095 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.57 -7.52 20.98 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.791 2.328 . . . . 0.0 112.807 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -84.17 -20.72 31.92 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.065 0.946 . . . . 0.0 111.804 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.07 -125.15 1.09 Allowed Glycine 0 C--N 1.349 1.256 0 CA-C-O 119.549 -0.584 . . . . 0.0 111.962 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -59.61 -80.54 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.188 0.995 . . . . 0.0 111.931 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.409 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 118.52 24.12 3.24 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 116.308 -0.405 . . . . 0.0 113.048 -177.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.539 ' HG3' ' HB2' ' A' ' 117' ' ' ARG . 7.1 pt-20 -87.54 147.68 25.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.566 HG13 ' HA ' ' A' ' 116' ' ' PRO . 7.5 m -138.59 134.96 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 121.975 -0.453 . . . . 0.0 111.388 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.67 111.08 13.07 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.329 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.458 HG21 HG12 ' A' ' 113' ' ' ILE . 48.9 t -124.64 144.93 32.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 124.169 0.988 . . . . 0.0 108.95 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -106.5 107.3 18.24 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 170.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 56.5 m -93.12 104.34 16.55 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.584 HG22 ' HB2' ' A' ' 110' ' ' TRP . 5.5 tt -105.99 109.82 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.217 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -104.13 151.47 23.27 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.528 0.731 . . . . 0.0 110.549 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -121.43 114.33 21.12 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.144 0.978 . . . . 0.0 108.628 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.51 HG22 HG12 ' A' ' 106' ' ' ILE . 45.1 t -101.74 115.21 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.077 0.951 . . . . 0.0 109.2 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 41.7 tt0 -116.75 128.77 55.62 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.151 0.981 . . . . 0.0 109.006 176.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 62.25 32.37 17.18 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.951 0.901 . . . . 0.0 111.462 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.42 11.67 84.13 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 114.595 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -133.02 136.73 46.18 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.485 1.114 . . . . 0.0 108.679 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.51 HG12 HG22 ' A' ' 101' ' ' VAL . 60.0 mt -66.63 100.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . . . -78.05 -28.07 48.86 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.227 0.611 . . . . 0.0 110.967 -175.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -149.58 153.77 37.64 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.076 0.951 . . . . 0.0 108.592 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -148.67 134.54 18.99 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.584 ' HB2' HG22 ' A' ' 98' ' ' ILE . 1.7 m-90 -135.53 154.8 51.27 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -143.03 146.37 33.78 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 169.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.633 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 17.1 ptpt -129.34 124.52 34.49 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.916 0.886 . . . . 0.0 109.182 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 95' ' ' VAL . 92.1 mt -88.19 119.19 35.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.26 -63.41 3.27 Favored Glycine 0 N--CA 1.465 0.624 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.684 -177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -157.16 166.4 16.72 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 122.768 0.427 . . . . 0.0 110.35 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.566 ' HA ' HG13 ' A' ' 93' ' ' VAL . 97.2 Cg_endo -75.67 132.69 14.81 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.653 2.235 . . . . 0.0 112.069 163.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.539 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 15.6 mmt180 -115.84 140.84 48.84 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.381 1.072 . . . . 0.0 108.567 175.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 121' ' ' GLN . 42.2 mm -132.04 149.8 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.3 t -60.91 -42.98 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 120.732 0.301 . . . . 0.0 110.466 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.6 t -76.7 -62.75 1.53 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.334 0.653 . . . . 0.0 109.793 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.482 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 41.5 mt-30 -80.87 81.16 7.19 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -118.75 113.81 21.72 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.821 0.848 . . . . 0.0 109.604 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.1 t . . . . . 0 CA--C 1.553 1.06 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.627 174.691 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.467 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 121.201 0.524 . . . . 0.0 110.611 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.497 ' HB2' HD11 ' A' ' 71' ' ' ILE . 3.3 p-10 -172.51 -23.14 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.376 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.414 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 81.8 p -62.26 -43.98 97.58 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.977 0.511 . . . . 0.0 110.084 -177.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -64.37 -14.68 57.82 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.676 1.19 . . . . 0.0 112.679 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.534 HG13 ' HA ' ' A' ' 74' ' ' ASN . 44.0 mm -89.85 -34.21 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.864 0.866 . . . . 0.0 109.992 174.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -84.97 -10.09 57.4 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.256 0.622 . . . . 0.0 111.709 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 3' ' ' SER . 65.3 mt -65.93 -54.46 27.78 Favored Pre-proline 0 N--CA 1.481 1.123 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.092 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.502 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 13.0 Cg_endo -56.32 -46.73 28.4 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 121.752 1.635 . . . . 0.0 112.572 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.589 ' HA ' HE21 ' A' ' 12' ' ' GLN . 54.8 t -64.48 -45.89 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 124.048 0.939 . . . . 0.0 113.215 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -41.33 65.78 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -176.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -66.6 -26.39 67.07 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.907 0.483 . . . . 0.0 111.329 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.589 HE21 ' HA ' ' A' ' 9' ' ' VAL . 39.6 mt-30 -60.89 -46.53 90.25 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.168 0.292 . . . . 0.0 110.232 171.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.93 -51.97 67.41 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 123.516 0.51 . . . . 0.0 109.702 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -55.19 -34.39 63.84 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 124.684 1.24 . . . . 0.0 110.145 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -82.45 -27.65 31.77 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.776 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -71.01 -44.07 66.64 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.871 0.469 . . . . 0.0 110.298 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -79.39 -28.55 41.85 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.004 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.2 5.02 52.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.578 0.751 . . . . 0.0 112.24 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 64.79 13.26 8.33 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.035 1.334 . . . . 0.0 113.992 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.511 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 18.6 m-20 -76.91 95.13 4.04 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.297 0.57 . . . . 0.0 111.583 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.406 HG13 HG12 ' A' ' 54' ' ' ILE . 29.5 mm -64.33 -25.49 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.144 0.578 . . . . 0.0 110.365 167.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -50.44 -50.55 51.84 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.99 0.916 . . . . 0.0 111.194 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . . . -82.68 -37.72 24.41 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.181 0.592 . . . . 0.0 110.762 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -66.83 -6.63 16.96 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.215 0.606 . . . . 0.0 111.565 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.761 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -120.56 -30.63 4.48 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 171.325 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.44 -34.92 73.11 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.166 0.507 . . . . 0.0 112.303 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.502 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 99.4 m95 -88.54 4.0 48.33 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.867 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -102.97 157.31 17.07 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.64 0.776 . . . . 0.0 109.9 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -81.8 148.84 28.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.825 0.85 . . . . 0.0 109.404 171.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -66.45 -24.1 66.38 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.336 0.589 . . . . 0.0 111.031 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -86.51 -2.26 58.32 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.143 1.377 . . . . 0.0 111.724 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 42.3 t -59.89 132.89 55.33 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -167.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -88.12 154.7 20.25 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.453 0.701 . . . . 0.0 109.957 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -145.19 110.08 5.11 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.424 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 36.7 m-85 -111.1 155.19 23.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.951 0.9 . . . . 0.0 110.644 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.407 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -114.32 159.52 20.12 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.278 173.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.543 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 90.5 t80 -52.06 127.32 36.79 Favored Pre-proline 0 N--CA 1.486 1.342 0 C-N-CA 123.95 0.9 . . . . 0.0 111.149 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.8 -47.56 0.31 Allowed 'Cis proline' 0 C--N 1.387 2.556 0 CA-C-N 120.614 1.255 . . . . 0.0 113.681 -1.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.44 79.26 0.44 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.0 m -123.33 106.96 11.13 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.703 0.801 . . . . 0.0 109.282 -176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.2 tp -67.0 102.34 0.97 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.032 0.533 . . . . 0.0 110.198 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD12 ' HB1' ' A' ' 36' ' ' ALA . 65.6 mt -81.85 -36.67 28.0 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.973 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -145.57 116.56 7.81 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.372 -174.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.46 41.07 2.22 Favored Glycine 0 N--CA 1.474 1.181 0 C-N-CA 122.986 0.327 . . . . 0.0 113.398 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.5 p30 164.82 152.18 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 126.226 1.81 . . . . 0.0 108.852 -173.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -61.98 -26.78 68.42 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.965 0.906 . . . . 0.0 113.149 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.32 90.66 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.44 0.296 . . . . 0.0 111.547 -177.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.497 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 27.2 mt-10 -77.77 -31.22 51.83 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.997 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.7 mt -68.62 -41.36 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.759 0.824 . . . . 0.0 111.265 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.761 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 5.7 ptp180 -62.8 -45.9 90.47 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.069 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.411 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 96.5 t -54.8 -55.29 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.686 0.795 . . . . 0.0 110.29 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -52.07 -44.1 64.16 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.926 1.29 . . . . 0.0 111.963 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -78.35 -34.64 48.28 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.025 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 50' ' ' ARG . 97.0 mt -60.77 -45.3 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-N 118.982 0.81 . . . . 0.0 109.472 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 51' ' ' VAL . 43.4 mt-10 -63.77 -32.84 74.47 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.355 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -88.22 -15.98 34.47 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -85.97 -4.53 59.19 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.107 0.563 . . . . 0.0 110.556 173.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.71 -20.21 63.54 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.265 0.626 . . . . 0.0 111.533 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 20.3 mm-40 -65.97 120.21 67.49 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.431 0.692 . . . . 0.0 110.314 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.14 -18.75 18.18 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.222 1.948 . . . . 0.0 112.249 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -81.62 -22.9 37.36 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.24 0.616 . . . . 0.0 110.775 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 30.8 tp -56.29 129.97 42.56 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.808 0.843 . . . . 0.0 112.024 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.437 ' CE2' ' HB2' ' A' ' 65' ' ' GLU . 46.2 t80 -151.24 144.35 24.65 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.595 0.758 . . . . 0.0 109.617 175.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.58 118.78 5.08 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.844 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 63' ' ' TYR . 35.6 tt0 -126.32 99.77 6.0 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.8 tt -80.43 140.31 36.04 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.185 0.517 . . . . 0.0 110.169 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.533 HD12 ' HG1' ' A' ' 81' ' ' THR . 6.3 mt -109.46 -51.84 2.83 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.285 -173.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.0 m -147.99 139.5 23.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.909 -172.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 14.1 ptt180 -131.6 119.65 21.76 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.321 0.648 . . . . 0.0 109.693 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -115.84 127.16 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.034 0.934 . . . . 0.0 109.044 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.497 HD11 ' HB2' ' A' ' 2' ' ' ASN . 13.8 tt -114.96 132.98 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-O 121.386 0.613 . . . . 0.0 111.534 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.9 t -117.75 103.33 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 125.42 1.488 . . . . 0.0 107.851 172.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.6 -102.81 0.42 Allowed Glycine 0 N--CA 1.476 1.345 0 N-CA-C 113.994 0.357 . . . . 0.0 113.994 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.534 ' HA ' HG13 ' A' ' 5' ' ' ILE . 23.4 p-10 -111.67 21.19 16.36 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.121 0.568 . . . . 0.0 112.284 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.0 p -135.6 135.04 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.025 0.53 . . . . 0.0 110.012 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -117.75 137.43 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.265 0.626 . . . . 0.0 109.663 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.571 HD13 ' HB ' ' A' ' 98' ' ' ILE . 7.7 mm -98.95 102.68 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 165.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -102.54 105.69 16.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -98.4 107.02 19.38 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.205 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -103.87 172.77 6.62 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.547 1.139 . . . . 0.0 110.955 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.533 ' HG1' HD12 ' A' ' 67' ' ' LEU . 97.2 m -116.14 102.69 9.83 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 160.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.7 m -88.5 133.38 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.661 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.0 m -88.12 128.37 35.43 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -155.27 146.98 23.2 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -77.94 103.74 8.07 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -166.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -92.37 127.6 48.13 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 165.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -62.41 -15.97 48.71 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.465 2.777 . . . . 0.0 114.224 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -83.59 -32.12 25.95 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.405 0.282 . . . . 0.0 111.636 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.84 -136.35 2.1 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-O 119.456 -0.636 . . . . 0.0 111.65 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -72.54 -79.41 0.08 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 117.318 0.559 . . . . 0.0 110.468 171.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.1 30.43 2.3 Favored Glycine 0 C--N 1.346 1.091 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.713 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -88.82 98.48 11.74 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 122.456 1.122 . . . . 0.0 108.227 -174.495 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.444 HG13 ' H ' ' A' ' 117' ' ' ARG . 20.7 m -104.59 145.61 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.374 -0.829 . . . . 0.0 111.14 -165.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -78.11 132.4 37.68 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 176.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.562 HG23 HG12 ' A' ' 113' ' ' ILE . 46.8 t -136.27 124.39 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.01 100.53 11.12 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.6 m -94.08 122.79 36.96 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.631 HG23 ' HB2' ' A' ' 110' ' ' TRP . 6.2 tt -123.87 115.38 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.925 0.89 . . . . 0.0 109.814 -173.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -116.86 127.22 54.07 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.849 0.859 . . . . 0.0 110.41 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -98.57 111.1 23.57 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.532 ' HB ' HG22 ' A' ' 5' ' ' ILE . 99.5 t -98.39 130.45 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.691 1.196 . . . . 0.0 109.977 -174.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.468 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 10.8 tp10 -129.42 124.65 34.68 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.229 1.012 . . . . 0.0 109.298 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.468 ' ND2' ' HG3' ' A' ' 102' ' ' GLU . 52.9 m-80 62.65 37.25 13.0 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.876 1.271 . . . . 0.0 112.45 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.11 5.25 65.29 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 113.884 0.314 . . . . 0.0 113.884 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.8 mmt85 -122.79 135.13 54.45 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.614 1.166 . . . . 0.0 108.285 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.423 HG12 HG23 ' A' ' 101' ' ' VAL . 77.8 mt -65.56 105.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -86.4 -23.35 26.14 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.764 0.426 . . . . 0.0 111.2 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -147.1 149.26 32.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.813 0.845 . . . . 0.0 109.711 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.92 137.4 24.9 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.744 0.818 . . . . 0.0 109.088 -176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.631 ' HB2' HG23 ' A' ' 98' ' ' ILE . 4.5 m-90 -139.0 152.71 47.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -142.3 137.1 30.35 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 169.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 51.6 mtmt -126.15 129.65 49.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.562 HG12 HG23 ' A' ' 95' ' ' VAL . 90.8 mt -88.35 131.94 34.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.93 -75.24 0.28 Allowed Glycine 0 CA--C 1.527 0.783 0 O-C-N 124.12 0.888 . . . . 0.0 112.354 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.91 166.44 16.43 Favored Pre-proline 0 CA--C 1.554 1.096 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.35 137.6 51.97 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.307 2.005 . . . . 0.0 112.289 173.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 19.8 mmt180 -135.35 138.89 43.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.258 1.023 . . . . 0.0 109.078 -174.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' A' ' 121' ' ' GLN . 46.9 mm -126.62 143.53 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.7 t -57.18 -44.2 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.281 0.562 . . . . 0.0 110.679 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.433 ' H ' HG22 ' A' ' 118' ' ' ILE . 20.0 m -88.01 10.09 20.19 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.236 1.014 . . . . 0.0 112.931 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.589 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 35.2 tt0 -65.73 -40.26 91.97 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.243 0.617 . . . . 0.0 109.908 176.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -106.41 154.49 20.74 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.309 1.044 . . . . 0.0 109.337 171.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.251 1.153 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.807 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ppp? . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 112.027 0.381 . . . . 0.0 112.027 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -117.05 36.77 4.08 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.691 0.797 . . . . 0.0 109.698 176.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.2 m -63.31 -42.39 99.03 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.005 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -13.68 62.49 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.411 0.684 . . . . 0.0 112.374 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.521 HG23 ' HB ' ' A' ' 101' ' ' VAL . 26.9 mm -85.09 -32.05 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 122.94 0.496 . . . . 0.0 110.006 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HG3' HD12 ' A' ' 71' ' ' ILE . 58.1 mt-10 -87.74 -10.02 52.32 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.2 mt -61.37 -50.24 84.11 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.256 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.465 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 18.4 Cg_endo -59.18 -50.95 7.46 Favored 'Trans proline' 0 C--N 1.389 2.697 0 CA-C-N 120.907 1.36 . . . . 0.0 111.285 172.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.467 HG23 HG21 ' A' ' 76' ' ' VAL . 63.4 t -50.55 -53.22 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 124.654 1.181 . . . . 0.0 113.029 -173.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 25.8 tp60 -61.77 -47.26 85.96 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.066 -177.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -71.18 -29.62 65.41 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.227 0.611 . . . . 0.0 111.824 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' HG2' ' HE1' ' A' ' 28' ' ' TRP . 44.8 mt-30 -62.4 -49.5 75.25 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.568 0.747 . . . . 0.0 109.775 176.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.485 HD23 HD11 ' A' ' 66' ' ' LEU . 31.9 tp -57.61 -52.06 66.97 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.47 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 13.4 mm-40 -58.38 -41.87 85.76 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.369 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 20' ' ' ASP . . . -71.22 -28.28 64.09 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.25 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -68.43 -41.45 80.34 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.979 0.911 . . . . 0.0 110.54 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -83.61 -29.59 27.61 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.682 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.02 2.53 53.88 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.118 0.567 . . . . 0.0 112.462 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.414 HH21 ' HA ' ' A' ' 60' ' ' PRO . 37.7 mmt-85 69.77 8.11 6.56 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.118 1.367 . . . . 0.0 113.362 176.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.516 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 20.7 m-20 -77.27 94.57 4.17 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.219 0.533 . . . . 0.0 110.391 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.433 HG13 HG12 ' A' ' 54' ' ' ILE . 15.6 mm -67.81 -23.71 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 123.197 0.599 . . . . 0.0 109.705 167.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -54.56 -50.6 67.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.066 0.946 . . . . 0.0 112.196 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.5 -37.02 25.89 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.108 0.48 . . . . 0.0 110.496 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -65.92 -7.69 18.11 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.562 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.688 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -118.01 -30.88 5.23 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.957 -0.464 . . . . 0.0 112.22 172.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -30.96 69.48 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.05 0.54 . . . . 0.0 112.347 -175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 97.5 m95 -92.78 9.5 34.87 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.593 0.757 . . . . 0.0 112.693 -176.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.47 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 10.0 m95 -110.51 164.6 12.55 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.228 1.011 . . . . 0.0 108.906 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -82.78 153.78 25.07 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.836 0.454 . . . . 0.0 110.138 175.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.99 -27.67 68.99 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.976 0.511 . . . . 0.0 111.407 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -105.79 20.48 18.85 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.886 0.875 . . . . 0.0 110.697 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.47 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 44.0 t -57.7 113.1 1.68 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.867 0.365 . . . . 0.0 111.598 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -74.2 151.35 40.0 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -145.45 115.76 7.53 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -174.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.46 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 14.0 m-85 -115.06 156.38 25.27 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.949 1.3 . . . . 0.0 110.712 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.505 ' HB2' HD13 ' A' ' 42' ' ' LEU . . . -119.82 155.11 33.23 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.536 173.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.463 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 70.1 t80 -64.25 132.13 95.23 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.698 0.799 . . . . 0.0 111.477 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.81 -56.65 0.14 OUTLIER 'Cis proline' 0 C--N 1.386 2.505 0 CA-C-N 120.599 1.25 . . . . 0.0 113.958 -1.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.35 92.84 1.54 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.963 0.505 . . . . 0.0 109.665 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.0 m -135.72 109.16 7.88 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.595 0.758 . . . . 0.0 109.5 174.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.5 tt -69.11 103.11 1.8 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' A' ' 36' ' ' ALA . 52.0 mt -78.58 -45.86 20.75 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.999 0.92 . . . . 0.0 109.951 178.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.1 124.96 25.51 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.475 -171.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.41 36.15 4.59 Favored Glycine 0 N--CA 1.475 1.297 0 O-C-N 123.076 0.235 . . . . 0.0 113.271 -174.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 167.93 158.63 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.503 1.521 . . . . 0.0 108.727 -171.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.465 ' HB3' ' SD ' ' A' ' 25' ' ' MET . . . -57.95 -43.54 86.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.804 0.841 . . . . 0.0 112.532 -176.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.11 76.18 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.933 0.493 . . . . 0.0 112.091 -171.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -76.65 -31.46 57.35 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.831 0.452 . . . . 0.0 111.559 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.405 ' HB ' ' HE1' ' A' ' 25' ' ' MET . 74.4 mt -65.1 -51.88 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.083 0.553 . . . . 0.0 110.271 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.688 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 21.2 ptt180 -64.63 -43.45 93.65 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.736 -172.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.503 ' HA ' HD12 ' A' ' 54' ' ' ILE . 30.2 m -66.29 -33.21 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 123.336 0.397 . . . . 0.0 111.696 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -71.75 -35.75 70.2 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.273 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -75.64 -29.37 59.13 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.439 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 51' ' ' VAL . 74.4 mt -55.32 -42.87 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 118.55 0.614 . . . . 0.0 109.973 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.98 -40.03 87.72 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.965 0.906 . . . . 0.0 111.328 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.0 tpp85 -73.44 -28.62 62.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.718 0.807 . . . . 0.0 111.095 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -82.1 -9.05 59.66 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.829 0.852 . . . . 0.0 110.991 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -76.85 -34.24 57.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.477 0.311 . . . . 0.0 111.382 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -83.99 118.25 70.82 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HA ' HH21 ' A' ' 19' ' ' ARG . 89.7 Cg_endo -74.13 -9.15 21.78 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.433 2.755 . . . . 0.0 114.193 -166.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -77.87 -13.54 59.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.737 0.815 . . . . 0.0 111.097 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.3 tp -58.71 111.51 1.29 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.218 0.607 . . . . 0.0 110.603 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 91.3 t80 -149.91 115.4 5.51 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.09 101.96 2.06 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -84.49 101.51 12.12 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 78' ' ' ASP . 6.7 tt -84.79 128.31 34.55 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -176.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.84 -32.86 4.97 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.853 -167.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 99.0 m -147.9 138.56 23.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.087 0.955 . . . . 0.0 109.556 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -133.31 129.49 37.61 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 167.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.8 m -107.29 129.45 61.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 123.716 0.806 . . . . 0.0 109.593 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.449 HD12 ' HG3' ' A' ' 6' ' ' GLU . 10.5 tt -113.19 122.85 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.136 0.493 . . . . 0.0 110.145 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.28 94.13 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 56.66 -112.03 3.14 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 123.23 0.331 . . . . 0.0 113.664 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -99.15 15.82 24.76 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.452 0.701 . . . . 0.0 112.297 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.8 p -134.97 133.74 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.381 0.672 . . . . 0.0 109.19 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.467 HG21 HG23 ' A' ' 9' ' ' VAL . 64.4 t -123.01 136.03 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.98 0.512 . . . . 0.0 110.789 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.562 HG12 ' HB ' ' A' ' 98' ' ' ILE . 6.4 mt -103.11 119.9 52.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 163.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.519 ' HB2' HD13 ' A' ' 66' ' ' LEU . 6.9 p-10 -97.4 155.09 17.06 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 168.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -137.53 108.45 6.7 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.45 168.72 11.76 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.083 1.353 . . . . 0.0 109.715 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.2 m -115.65 105.58 12.92 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.107 168.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 63' ' ' TYR . 4.0 m -86.38 125.25 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.179 0.514 . . . . 0.0 110.944 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 62.8 m -72.35 117.63 14.24 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 170.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -125.46 120.92 32.31 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.39 89.29 2.1 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.194 0.521 . . . . 0.0 110.95 -172.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -82.66 144.95 49.71 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.515 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.84 -20.21 58.26 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 123.158 2.572 . . . . 0.0 113.88 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -82.25 -27.44 32.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.114 0.565 . . . . 0.0 112.521 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.52 -134.62 2.96 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.823 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -55.74 -71.23 0.09 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.165 0.986 . . . . 0.0 111.28 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.418 ' H ' HD11 ' A' ' 118' ' ' ILE . . . 94.21 32.34 7.49 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.397 0.436 . . . . 0.0 113.066 175.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -86.89 107.89 18.54 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.745 0.783 . . . . 0.0 108.996 -173.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.686 HG13 ' HA ' ' A' ' 116' ' ' PRO . 5.3 m -105.77 143.85 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.413 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -91.54 142.12 27.99 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.0 t -130.44 149.52 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.78 101.74 8.56 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.7 m -98.14 108.03 20.64 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.627 HG21 ' HB2' ' A' ' 110' ' ' TRP . 12.1 tt -98.82 112.46 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.066 0.946 . . . . 0.0 109.04 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.45 138.54 52.36 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.166 0.508 . . . . 0.0 110.938 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -98.7 113.3 25.32 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.342 1.057 . . . . 0.0 109.445 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.521 ' HB ' HG23 ' A' ' 5' ' ' ILE . 92.2 t -88.82 116.1 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.017 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -124.44 128.61 49.28 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.153 0.981 . . . . 0.0 109.497 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 59.18 31.04 20.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.784 1.234 . . . . 0.0 111.856 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.04 -20.1 30.93 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 115.568 -0.742 . . . . 0.0 113.738 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -107.07 140.46 39.85 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.319 1.048 . . . . 0.0 108.834 -172.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.1 mt -67.36 106.21 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.93 -34.07 44.87 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.281 0.633 . . . . 0.0 111.241 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -144.31 146.75 32.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.082 0.953 . . . . 0.0 108.685 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.9 137.9 35.21 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.674 0.789 . . . . 0.0 109.516 -177.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.627 ' HB2' HG21 ' A' ' 98' ' ' ILE . 2.5 m-90 -140.33 148.41 41.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -144.45 147.17 32.98 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.077 0.853 . . . . 0.0 111.097 174.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 21.5 ptmt -127.25 127.9 45.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.36 0.664 . . . . 0.0 109.494 172.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 80.0 mt -89.42 121.75 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.35 -94.72 0.02 OUTLIER Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.564 1.165 . . . . 0.0 114.497 -174.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -134.56 155.11 79.88 Favored Pre-proline 0 CA--C 1.547 0.827 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.686 ' HA ' HG13 ' A' ' 93' ' ' VAL . 41.4 Cg_endo -90.0 114.72 0.55 Allowed 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.908 2.405 . . . . 0.0 113.394 174.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -111.79 153.4 26.61 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.415 0.626 . . . . 0.0 111.114 -175.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 121' ' ' GLN . 35.2 mm -131.11 156.06 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 124.572 1.149 . . . . 0.0 108.181 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.31 -43.97 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 122.654 0.381 . . . . 0.0 110.573 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.45 ' H ' HG21 ' A' ' 118' ' ' ILE . 32.8 t -72.46 -7.91 52.31 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.364 0.666 . . . . 0.0 112.102 177.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.517 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 36.5 tt0 -68.29 -34.03 75.43 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.682 0.793 . . . . 0.0 110.327 172.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.0 pttt -107.83 -172.18 2.02 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.19 0.996 . . . . 0.0 109.222 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.251 1.161 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.891 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -134.38 25.31 3.8 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.175 0.99 . . . . 0.0 109.06 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.482 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 13.1 m -61.7 -48.87 78.82 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.962 0.905 . . . . 0.0 110.719 -175.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -7.59 25.92 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.899 0.88 . . . . 0.0 113.026 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.4 mm -94.39 -31.34 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.639 0.775 . . . . 0.0 109.705 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.29 -32.85 32.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.274 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.2 mt -58.44 -47.64 98.41 Favored Pre-proline 0 CA--C 1.563 1.46 0 CA-C-O 118.405 -0.807 . . . . 0.0 112.185 -177.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.529 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 10.1 Cg_endo -56.2 -63.07 0.19 Allowed 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 121.885 1.723 . . . . 0.0 112.379 172.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.41 -27.08 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -168.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.24 -55.39 6.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.449 0.7 . . . . 0.0 109.728 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -68.8 -29.82 68.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.983 0.513 . . . . 0.0 111.583 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -74.8 -36.85 62.48 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.827 0.851 . . . . 0.0 111.527 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.56 -48.77 80.31 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -57.87 -45.31 86.51 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 124.561 1.163 . . . . 0.0 109.315 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.78 -24.81 66.24 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.033 -1.44 . . . . 0.0 112.722 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -67.68 -40.61 84.39 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.579 0.352 . . . . 0.0 110.32 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -91.73 -25.73 18.93 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.429 0.692 . . . . 0.0 110.936 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.04 -6.38 59.47 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.493 0.717 . . . . 0.0 111.846 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 69.39 14.87 8.45 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.081 1.352 . . . . 0.0 112.929 171.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -83.81 95.3 8.41 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.471 HG13 HG12 ' A' ' 54' ' ' ILE . 20.7 mm -64.8 -29.77 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.427 0.691 . . . . 0.0 110.43 173.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -55.96 -47.04 78.34 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.902 0.481 . . . . 0.0 111.384 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.43 -32.89 28.78 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.306 0.642 . . . . 0.0 111.42 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -72.94 -8.82 57.39 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.104 0.562 . . . . 0.0 110.828 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.708 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 27.7 tpp -120.96 -15.76 8.21 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.909 0.484 . . . . 0.0 112.287 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.06 -50.46 61.46 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.492 0.717 . . . . 0.0 112.548 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 85.3 m95 -87.18 6.92 30.54 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.989 -168.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.436 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 12.9 m95 -93.96 149.81 20.9 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.415 0.686 . . . . 0.0 109.482 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -75.64 152.11 37.66 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.153 0.581 . . . . 0.0 109.976 171.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -64.16 -29.79 70.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.884 0.474 . . . . 0.0 111.249 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -96.91 20.36 11.23 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.816 0.846 . . . . 0.0 111.385 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.436 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 48.6 t -61.85 115.63 4.18 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -71.57 148.58 46.51 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.649 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 42.8 t80 -141.67 118.1 10.85 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.416 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 11.8 m-85 -117.51 148.82 41.5 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.692 0.797 . . . . 0.0 110.081 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.497 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -103.12 153.48 20.27 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.601 171.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.515 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 90.4 t80 -56.59 128.94 75.77 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.87 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.46 -60.46 0.08 OUTLIER 'Cis proline' 0 C--N 1.384 2.43 0 CA-C-N 120.583 1.244 . . . . 0.0 113.488 0.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.35 74.06 0.68 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.652 0.781 . . . . 0.0 108.991 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 55.3 m -105.54 111.69 24.49 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.167 0.987 . . . . 0.0 109.016 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 tt -66.35 103.06 0.94 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.497 HD12 ' HB1' ' A' ' 36' ' ' ALA . 78.7 mt -82.67 -43.47 16.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.656 0.783 . . . . 0.0 110.649 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . . . -139.73 116.58 10.93 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.787 0.435 . . . . 0.0 111.083 -171.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.07 32.61 5.31 Favored Glycine 0 N--CA 1.482 1.708 0 C-N-CA 122.811 0.243 . . . . 0.0 113.064 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.487 HD22 ' HG3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER 169.5 153.4 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.035 1.334 . . . . 0.0 109.645 -165.322 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.708 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -67.98 -24.61 65.16 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.079 0.952 . . . . 0.0 112.911 -176.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.52 -47.61 78.99 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.504 0.721 . . . . 0.0 112.141 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.487 ' HG3' HD22 ' A' ' 45' ' ' ASN . 35.2 mt-10 -74.21 -31.33 62.59 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.494 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.9 mt -64.81 -49.24 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.13 0.572 . . . . 0.0 111.188 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.483 ' O ' HG13 ' A' ' 54' ' ' ILE . 6.9 ptm180 -62.78 -49.21 75.86 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 123.498 0.499 . . . . 0.0 110.724 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.402 ' HA ' HD11 ' A' ' 54' ' ' ILE . 76.3 t -63.47 -42.53 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.779 0.832 . . . . 0.0 111.399 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -68.36 -31.62 71.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.577 0.751 . . . . 0.0 110.879 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -77.91 -28.94 49.91 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.721 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 50' ' ' ARG . 98.1 mt -57.88 -38.92 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 118.711 0.687 . . . . 0.0 109.729 174.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.38 -34.52 78.35 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.314 1.046 . . . . 0.0 111.38 175.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -78.66 -24.48 45.14 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.163 0.585 . . . . 0.0 110.916 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -83.53 -5.16 59.09 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.37 0.668 . . . . 0.0 110.631 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 70.4 mmtt -78.02 -9.99 59.39 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.096 0.558 . . . . 0.0 111.89 169.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.606 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 8.5 mm-40 -71.94 111.02 9.08 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 170.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.95 -28.14 74.97 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.297 1.998 . . . . 0.0 112.232 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -92.19 4.84 52.39 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.803 0.841 . . . . 0.0 112.048 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.606 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 28.4 tp -64.75 111.82 2.95 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-O 120.757 0.313 . . . . 0.0 110.213 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -148.07 116.15 6.47 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.98 101.14 2.71 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 174.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -81.51 99.95 9.07 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.2 tp -76.25 126.62 31.32 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.73 -33.99 5.94 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.956 0.902 . . . . 0.0 109.638 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 96.8 m -152.93 139.75 19.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.341 1.056 . . . . 0.0 108.99 -176.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -142.3 125.64 16.57 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 163.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.8 m -106.72 119.08 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.939 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.03 143.42 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 121.338 0.59 . . . . 0.0 110.033 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 p -148.32 97.49 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.263 1.425 . . . . 0.0 107.832 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.53 -116.2 7.27 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.673 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -101.89 18.7 19.91 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.072 0.549 . . . . 0.0 111.688 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.0 t -131.92 136.01 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.137 0.975 . . . . 0.0 109.5 -174.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -125.29 137.05 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 123.254 0.622 . . . . 0.0 110.012 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.541 HD12 ' HB ' ' A' ' 98' ' ' ILE . 2.5 mm -98.17 103.96 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 169.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.93 108.18 19.42 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -98.31 107.45 19.92 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 133.76 49.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.489 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.0 m -80.1 103.98 10.35 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 172.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -80.91 116.24 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.469 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.4 m -71.12 118.29 13.72 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.353 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 43.3 mmm-85 -119.02 -171.21 2.06 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -122.53 112.74 18.38 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.957 0.503 . . . . 0.0 109.763 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -113.44 137.35 22.08 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.032 0.933 . . . . 0.0 108.658 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -59.98 -18.94 53.05 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 123.218 2.612 . . . . 0.0 114.306 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -79.2 -25.94 42.65 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.044 0.538 . . . . 0.0 112.299 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.34 -117.39 0.58 Allowed Glycine 0 C--N 1.348 1.245 0 CA-C-O 119.683 -0.51 . . . . 0.0 112.914 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -68.83 -84.03 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.469 0.707 . . . . 0.0 111.88 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 116.93 26.69 2.95 Favored Glycine 0 C--N 1.343 0.947 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 -173.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.66 104.15 16.59 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.978 0.894 . . . . 0.0 108.591 -172.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.595 HG11 ' HA ' ' A' ' 116' ' ' PRO . 21.7 m -103.7 136.59 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.509 -172.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -75.64 133.18 40.93 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.667 HG22 HG12 ' A' ' 113' ' ' ILE . 18.6 t -132.86 147.28 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.99 103.06 9.56 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 166.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 83.9 m -93.7 108.41 20.16 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.541 ' HB ' HD12 ' A' ' 77' ' ' ILE . 4.8 tt -102.11 111.94 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.631 1.172 . . . . 0.0 110.416 -173.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -103.43 129.95 50.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.902 0.881 . . . . 0.0 109.877 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 30.8 tt0 -100.22 111.92 24.22 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 168.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.552 HG22 HG12 ' A' ' 106' ' ' ILE . 48.7 t -94.59 113.79 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.488 1.115 . . . . 0.0 109.4 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -121.06 133.31 55.23 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.963 0.905 . . . . 0.0 109.185 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 62.63 30.42 16.95 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.244 1.017 . . . . 0.0 111.574 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.12 -7.09 79.56 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.268 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -130.75 147.5 52.42 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.943 0.897 . . . . 0.0 109.292 -173.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.552 HG12 HG22 ' A' ' 101' ' ' VAL . 45.7 mt -68.08 102.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 122.876 0.47 . . . . 0.0 110.677 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.16 -22.47 38.94 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.205 0.602 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 81.3 mttt -149.28 143.01 25.58 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.192 0.997 . . . . 0.0 108.781 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -146.67 134.23 20.94 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.495 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.1 m-90 -132.76 149.51 52.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -133.57 146.47 51.03 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 19.9 pttp -144.83 129.58 18.19 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.667 HG12 HG22 ' A' ' 95' ' ' VAL . 91.7 mt -89.84 120.53 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.03 -68.67 1.57 Allowed Glycine 0 C--N 1.344 1.024 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.354 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.96 163.61 23.57 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.595 ' HA ' HG11 ' A' ' 93' ' ' VAL . 83.5 Cg_endo -80.18 144.99 16.93 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 121.938 1.759 . . . . 0.0 111.9 165.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 47.4 mtm105 -132.81 142.81 49.17 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.495 0.664 . . . . 0.0 110.652 169.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.41 HG23 ' H ' ' A' ' 121' ' ' GLN . 29.2 mm -128.28 124.84 63.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.678 1.191 . . . . 0.0 108.094 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.95 -33.83 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 123.51 0.506 . . . . 0.0 109.909 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.6 m -73.9 -19.19 60.78 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.377 1.071 . . . . 0.0 112.488 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.41 ' H ' HG23 ' A' ' 118' ' ' ILE . 7.0 tp-100 -72.33 -23.15 61.11 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.599 0.76 . . . . 0.0 110.195 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -109.27 134.86 51.24 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.616 1.166 . . . . 0.0 108.556 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.254 1.303 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.511 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 39.5 p30 177.98 -19.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.861 1.664 . . . . 0.0 109.55 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 p -63.04 -43.57 98.31 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.132 0.973 . . . . 0.0 111.557 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.35 -2.31 18.75 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.599 0.76 . . . . 0.0 112.506 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.592 HG22 HG22 ' A' ' 76' ' ' VAL . 26.3 mm -94.81 -32.72 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.871 0.868 . . . . 0.0 109.264 174.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.95 -32.14 39.97 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.053 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 72.1 mt -57.97 -49.33 94.27 Favored Pre-proline 0 CA--C 1.564 1.484 0 CA-C-O 118.051 -0.976 . . . . 0.0 112.592 -177.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.55 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 9.3 Cg_endo -54.2 -61.79 0.38 Allowed 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 122.205 1.936 . . . . 0.0 111.648 175.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.493 HG12 ' HB ' ' A' ' 76' ' ' VAL . 16.7 m -64.12 -22.54 31.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.669 -171.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.519 ' HG2' HH22 ' A' ' 69' ' ' ARG . 0.9 OUTLIER -72.76 -55.62 6.46 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.552 0.741 . . . . 0.0 109.587 178.482 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 72.2 mmtt -70.28 -37.26 74.81 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.148 0.579 . . . . 0.0 110.972 -173.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -65.44 -39.31 91.91 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.052 0.941 . . . . 0.0 111.061 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.409 HD12 ' HB2' ' A' ' 66' ' ' LEU . 22.9 tp -57.89 -50.85 71.94 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.003 0.815 . . . . 0.0 110.09 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.44 -52.37 64.92 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.525 1.141 . . . . 0.0 109.444 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -60.92 -27.86 68.5 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.786 1.234 . . . . 0.0 112.182 -176.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -70.93 -39.73 72.51 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.757 0.823 . . . . 0.0 110.806 -177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -94.06 -17.71 22.57 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.987 0.515 . . . . 0.0 111.179 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.74 -3.58 54.55 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.349 0.66 . . . . 0.0 111.884 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 70.93 28.42 3.24 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.816 1.247 . . . . 0.0 112.39 174.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.419 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 17.6 m-20 -101.0 112.8 25.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.529 0.732 . . . . 0.0 110.067 174.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.0 mm -77.45 -31.46 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 122.719 0.408 . . . . 0.0 110.335 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -55.44 -48.38 74.54 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.848 0.459 . . . . 0.0 111.888 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.56 -29.64 33.37 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.638 0.375 . . . . 0.0 111.287 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -73.06 -8.17 54.53 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.136 0.574 . . . . 0.0 111.08 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.515 ' SD ' ' HB2' ' A' ' 46' ' ' ALA . 25.4 tpp -121.99 -15.55 7.77 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 173.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.46 -32.71 68.98 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -174.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.55 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 90.2 m95 -104.0 9.75 36.43 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.46 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 24.1 m95 -95.55 153.19 17.83 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.869 0.468 . . . . 0.0 110.102 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.434 ' O ' ' HB1' ' A' ' 46' ' ' ALA . . . -80.0 151.18 30.13 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.341 0.656 . . . . 0.0 109.954 173.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -61.71 -31.11 71.24 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.449 0.699 . . . . 0.0 112.454 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -102.66 19.68 18.67 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.456 0.702 . . . . 0.0 111.303 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.46 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 46.1 t -60.49 119.25 7.67 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 121.074 0.464 . . . . 0.0 112.238 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.565 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 77.9 mm-40 -81.21 144.07 31.87 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.182 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -134.83 113.6 11.76 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.482 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 31.6 m-85 -115.88 155.11 28.53 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.922 0.889 . . . . 0.0 111.602 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.9 159.99 22.18 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.682 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.445 ' HB3' ' HA ' ' A' ' 112' ' ' LYS . 18.3 p90 -55.27 136.41 68.71 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 123.993 0.917 . . . . 0.0 111.925 176.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -77.71 -40.27 1.16 Allowed 'Cis proline' 0 C--N 1.379 2.159 0 CA-C-N 119.854 0.984 . . . . 0.0 112.691 -7.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.71 66.66 0.21 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.832 0.853 . . . . 0.0 109.36 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 25.1 m -107.52 119.27 38.95 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.138 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tt -82.67 102.69 11.65 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.4 -45.18 16.47 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.836 0.454 . . . . 0.0 110.259 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . . . -142.01 120.1 12.12 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -171.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.86 28.1 15.15 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.268 0.355 . . . . 0.0 113.898 -174.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.6 p30 176.18 157.77 0.26 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.254 1.422 . . . . 0.0 109.835 -174.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.515 ' HB2' ' SD ' ' A' ' 25' ' ' MET . . . -60.48 -32.12 71.11 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.48 1.112 . . . . 0.0 113.378 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.449 ' O ' HG21 ' A' ' 51' ' ' VAL . . . -60.55 -51.77 68.03 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.97 0.508 . . . . 0.0 111.124 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 33.9 mt-10 -69.27 -29.07 66.89 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.806 -175.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.1 mt -63.9 -52.11 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.329 0.652 . . . . 0.0 110.4 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.488 ' O ' HG13 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -67.19 -38.79 85.94 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.64 -175.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.472 ' HA ' HD11 ' A' ' 54' ' ' ILE . 70.9 t -59.54 -49.37 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.481 0.712 . . . . 0.0 111.605 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -69.01 -29.41 67.59 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.765 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -77.87 -29.8 50.54 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 118.537 -0.745 . . . . 0.0 111.483 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 50' ' ' ARG . 76.2 mt -55.44 -46.78 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-N 118.645 0.657 . . . . 0.0 109.597 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -56.44 -42.44 78.11 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 124.413 1.071 . . . . 0.0 111.425 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.428 ' HG3' HD21 ' A' ' 62' ' ' LEU . 14.8 tpp180 -70.5 -31.5 68.62 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.414 0.686 . . . . 0.0 110.873 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -75.65 -14.31 60.36 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.534 0.734 . . . . 0.0 110.846 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 69.2 mmtt -91.6 -5.03 54.62 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.332 0.653 . . . . 0.0 111.565 170.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -105.49 122.1 43.91 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 122.985 0.514 . . . . 0.0 109.951 -175.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.54 -19.05 48.96 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.665 2.91 . . . . 0.0 115.165 -164.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -72.24 -24.42 61.37 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.629 0.372 . . . . 0.0 111.304 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.428 HD21 ' HG3' ' A' ' 56' ' ' ARG . 55.3 tp -56.19 120.66 7.9 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.661 0.784 . . . . 0.0 112.364 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -151.96 144.27 24.03 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.26 105.09 0.67 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -101.24 107.18 18.5 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.652 0.781 . . . . 0.0 109.525 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.409 ' HB2' HD12 ' A' ' 13' ' ' LEU . 14.3 tp -78.59 131.74 36.85 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 pp -111.98 -28.68 7.92 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.452 0.701 . . . . 0.0 110.206 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.9 m -157.47 143.69 17.76 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.288 1.035 . . . . 0.0 109.287 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.519 HH22 ' HG2' ' A' ' 10' ' ' GLN . 12.1 ptt180 -142.14 139.59 32.19 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.236 0.541 . . . . 0.0 110.315 162.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.11 143.7 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.843 1.257 . . . . 0.0 109.56 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.1 tt -115.85 134.07 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-O 121.309 0.576 . . . . 0.0 110.709 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -126.56 95.59 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 125.31 1.444 . . . . 0.0 107.81 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.2 -103.24 0.51 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 123.561 0.538 . . . . 0.0 113.369 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -106.46 18.18 22.31 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.529 0.732 . . . . 0.0 111.38 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.5 t -133.3 140.61 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.976 0.91 . . . . 0.0 109.071 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.592 HG22 HG22 ' A' ' 5' ' ' ILE . 57.1 t -125.86 137.82 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 118.516 0.598 . . . . 0.0 109.928 172.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.493 HG12 ' HB ' ' A' ' 98' ' ' ILE . 1.6 mt -99.86 110.0 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 167.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.435 ' HB2' ' SG ' ' A' ' 97' ' ' CYS . 1.3 m-20 -88.67 108.03 19.24 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 167.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.416 ' HE1' ' HB3' ' A' ' 94' ' ' ASP . 0.9 OUTLIER -98.5 108.71 21.46 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.318 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.99 163.67 21.82 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.516 1.127 . . . . 0.0 110.632 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.8 m -108.18 106.17 16.23 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.406 1.082 . . . . 0.0 108.582 165.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 m -90.52 134.05 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 122.481 0.313 . . . . 0.0 111.114 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 49.0 m -76.59 127.89 33.68 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.706 0.402 . . . . 0.0 109.994 175.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.4 mtm105 -126.72 161.48 28.04 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -90.17 99.31 12.35 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.825 0.345 . . . . 0.0 111.402 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -103.37 125.13 35.89 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.07 -16.17 53.42 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.087 2.525 . . . . 0.0 113.877 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -85.3 -9.03 58.18 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.912 0.485 . . . . 0.0 111.756 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.83 -127.14 1.18 Allowed Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.529 -0.595 . . . . 0.0 111.7 172.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -75.97 -83.34 0.07 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 117.282 0.541 . . . . 0.0 111.27 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.97 29.12 1.56 Allowed Glycine 0 C--N 1.354 1.542 0 N-CA-C 114.388 0.515 . . . . 0.0 114.388 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -89.82 99.28 12.32 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 122.136 0.969 . . . . 0.0 110.027 -172.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.9 m -102.75 137.5 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 121.616 -0.678 . . . . 0.0 111.444 -165.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB3' ' HE1' ' A' ' 79' ' ' HIS . 13.1 m-20 -79.31 115.01 18.7 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.686 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.5 HG21 HG12 ' A' ' 113' ' ' ILE . 35.2 t -119.17 156.17 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 125.12 1.368 . . . . 0.0 109.156 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.03 106.11 10.12 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 78' ' ' ASP . 20.5 p -97.23 109.06 21.89 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.527 HG23 ' HB2' ' A' ' 110' ' ' TRP . 7.1 tt -100.4 114.76 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.353 1.061 . . . . 0.0 109.622 -177.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -107.91 132.54 53.36 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.757 0.823 . . . . 0.0 109.71 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -98.4 112.83 24.71 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.497 HG23 HG12 ' A' ' 106' ' ' ILE . 42.1 t -95.08 113.85 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.192 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 41.7 tt0 -119.61 128.05 53.51 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.865 0.866 . . . . 0.0 109.511 175.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 64.37 31.35 12.81 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.391 1.077 . . . . 0.0 111.903 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.81 6.52 89.04 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.726 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -134.1 139.43 45.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.537 1.135 . . . . 0.0 108.957 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.497 HG12 HG23 ' A' ' 101' ' ' VAL . 45.9 mt -68.28 104.86 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 122.429 0.291 . . . . 0.0 110.316 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.492 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . . . -78.33 -30.25 48.08 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.68 0.792 . . . . 0.0 111.175 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.565 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 97.9 mttt -149.48 152.18 35.19 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.877 0.871 . . . . 0.0 109.091 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -146.17 137.42 24.6 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.963 0.905 . . . . 0.0 108.824 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.527 ' HB2' HG23 ' A' ' 98' ' ' ILE . 4.0 m-90 -135.56 150.95 49.86 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -142.43 146.41 34.8 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 171.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 20.5 ptmt -131.19 125.36 32.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.537 176.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.5 HG12 HG21 ' A' ' 95' ' ' VAL . 87.2 mt -87.44 123.92 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.26 -65.94 2.97 Favored Glycine 0 CA--C 1.526 0.754 0 O-C-N 124.451 1.094 . . . . 0.0 113.187 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -159.5 167.63 13.81 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.19 138.31 33.08 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.558 2.172 . . . . 0.0 112.334 165.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 30.1 mmt180 -135.52 146.38 48.01 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.81 0.844 . . . . 0.0 111.213 -175.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.5 mm -136.83 132.65 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.855 1.262 . . . . 0.0 108.445 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.9 t -53.13 -44.4 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 123.734 0.813 . . . . 0.0 111.944 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.3 t -61.46 -23.33 65.79 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.701 0.801 . . . . 0.0 111.763 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -115.76 4.37 13.99 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.096 0.958 . . . . 0.0 111.336 -176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -107.83 158.72 17.09 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.324 0.65 . . . . 0.0 110.598 -175.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.95 0.9 . . . . 0.0 108.76 -179.843 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtm . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.595 0.236 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -124.19 78.19 1.62 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.822 0.82 . . . . 0.0 110.292 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.5 m -75.78 -49.17 18.89 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.637 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -12.86 58.41 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.173 0.989 . . . . 0.0 113.387 -175.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.518 HG23 HG23 ' A' ' 76' ' ' VAL . 33.2 mm -87.1 -34.26 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.472 ' HG3' HD13 ' A' ' 71' ' ' ILE . 44.3 mt-10 -84.55 -22.33 30.15 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.5 -53.91 61.41 Favored Pre-proline 0 CA--C 1.568 1.639 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.662 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.53 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 33.6 Cg_endo -62.27 -49.56 5.97 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 122.156 1.904 . . . . 0.0 113.052 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.639 ' HA ' HE21 ' A' ' 12' ' ' GLN . 15.6 m -66.95 -37.87 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -169.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -43.67 62.85 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.423 0.689 . . . . 0.0 109.977 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -68.68 -29.72 68.24 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.326 0.651 . . . . 0.0 112.065 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.639 HE21 ' HA ' ' A' ' 9' ' ' VAL . 44.9 mt-30 -59.47 -48.03 83.23 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.904 0.752 . . . . 0.0 110.308 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.55 -51.75 68.51 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 124.012 0.82 . . . . 0.0 110.092 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.62 -27.1 66.02 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 124.029 0.831 . . . . 0.0 110.896 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.493 ' HB1' ' HB1' ' A' ' 23' ' ' ALA . . . -83.08 -32.31 26.85 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.389 1.076 . . . . 0.0 112.285 175.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -72.02 -39.66 68.99 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.256 0.622 . . . . 0.0 110.534 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.67 1.07 54.73 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.887 0.875 . . . . 0.0 111.834 177.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.56 3.17 10.72 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.999 0.92 . . . . 0.0 111.171 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 70.28 9.53 7.02 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.127 1.371 . . . . 0.0 113.695 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 8.9 m-20 -81.13 116.86 21.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.14 0.495 . . . . 0.0 110.916 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.505 HG13 HG12 ' A' ' 54' ' ' ILE . 22.8 mm -82.58 -25.6 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.093 0.957 . . . . 0.0 110.073 171.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -54.74 -48.82 72.11 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.038 0.935 . . . . 0.0 112.097 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.493 ' HB1' ' HB1' ' A' ' 15' ' ' ALA . . . -79.4 -35.18 41.07 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.94 0.496 . . . . 0.0 110.623 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -69.93 -8.26 47.37 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.178 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.649 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 16.6 tpp -119.87 -28.64 5.15 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.447 0.699 . . . . 0.0 112.401 173.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.4 -47.42 75.9 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.036 0.534 . . . . 0.0 112.087 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 98.4 m95 -79.43 1.62 24.81 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -170.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -95.05 168.34 10.83 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.373 0.669 . . . . 0.0 110.045 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -87.1 148.35 25.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.54 0.736 . . . . 0.0 109.353 171.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.16 -25.79 67.96 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.316 0.646 . . . . 0.0 111.706 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -109.19 18.97 19.98 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.976 1.311 . . . . 0.0 111.381 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.7 t -60.84 133.93 56.58 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -173.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.555 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 36.6 mm-40 -95.44 105.46 17.43 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.567 0.747 . . . . 0.0 109.967 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.425 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 48.4 t80 -94.6 111.44 23.2 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.635 0.774 . . . . 0.0 110.246 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -105.16 139.89 39.14 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.287 1.035 . . . . 0.0 110.029 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.6 161.48 14.82 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.24 1.016 . . . . 0.0 110.345 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.437 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 71.3 t80 -50.26 127.58 22.74 Favored Pre-proline 0 CA--C 1.566 1.593 0 O-C-N 124.285 0.99 . . . . 0.0 112.039 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.23 -50.29 0.19 OUTLIER 'Cis proline' 0 C--N 1.386 2.519 0 CA-C-N 119.77 0.953 . . . . 0.0 113.513 -5.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.33 78.83 0.81 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.8 m -117.48 114.03 22.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.033 0.933 . . . . 0.0 109.237 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.74 101.48 0.81 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.8 mt -79.63 -36.36 38.02 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.275 0.63 . . . . 0.0 109.93 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.446 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . . . -142.45 116.3 9.29 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.612 -170.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.0 33.21 4.77 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 123.374 0.421 . . . . 0.0 112.771 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.434 ' O ' HG13 ' A' ' 49' ' ' ILE . 8.9 p30 167.05 158.29 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.204 1.402 . . . . 0.0 109.816 -167.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.649 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -70.65 -25.2 62.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.245 1.018 . . . . 0.0 113.148 -175.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.4 98.27 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.861 0.465 . . . . 0.0 111.259 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 26.6 mt-10 -75.39 -32.36 60.75 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.611 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.448 HD11 ' HA ' ' A' ' 46' ' ' ALA . 72.4 mt -65.44 -46.29 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.197 0.599 . . . . 0.0 110.945 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 54' ' ' ILE . 14.0 ptm180 -64.67 -51.43 62.56 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.686 0.616 . . . . 0.0 110.641 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.412 ' HA ' HD13 ' A' ' 54' ' ' ILE . 20.6 m -65.61 -35.23 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 122.97 0.508 . . . . 0.0 111.825 -175.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -71.41 -34.92 70.77 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.855 0.862 . . . . 0.0 110.476 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -75.08 -32.61 61.52 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.642 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.514 HG22 ' HE2' ' A' ' 58' ' ' LYS . 97.7 mt -58.15 -37.76 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.672 0.389 . . . . 0.0 110.026 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.12 -34.56 78.34 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.654 0.782 . . . . 0.0 111.6 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -75.2 -25.98 58.63 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.867 0.467 . . . . 0.0 110.157 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.509 ' HA ' HD23 ' A' ' 62' ' ' LEU . 2.8 m-85 -83.9 -4.42 58.68 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.59 0.756 . . . . 0.0 111.347 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.514 ' HE2' HG22 ' A' ' 54' ' ' ILE . 74.5 mmtt -73.07 -25.84 61.05 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.717 0.407 . . . . 0.0 111.109 169.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 50.4 mm-40 -57.42 116.7 14.7 Favored Pre-proline 0 N--CA 1.481 1.113 0 C-N-CA 123.583 0.753 . . . . 0.0 110.748 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.23 -26.61 41.91 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.321 2.014 . . . . 0.0 112.609 -175.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.42 2.25 55.77 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.053 0.941 . . . . 0.0 111.484 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 57' ' ' PHE . 17.6 tp -62.23 114.02 3.21 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.932 0.493 . . . . 0.0 111.276 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -151.65 115.62 4.95 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.535 0.734 . . . . 0.0 109.084 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.12 104.59 3.11 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -91.68 101.82 14.45 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.7 tt -79.26 124.88 28.8 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.52 -32.79 5.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.736 -172.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.7 m -148.69 134.86 19.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.367 1.067 . . . . 0.0 108.558 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.403 HH12 ' HG2' ' A' ' 6' ' ' GLU . 52.3 ptt85 -137.76 133.31 33.94 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 166.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -121.56 128.09 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.511 1.124 . . . . 0.0 109.43 -172.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.472 HD13 ' HG3' ' A' ' 6' ' ' GLU . 11.9 tt -108.7 128.77 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 121.253 0.549 . . . . 0.0 110.657 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.1 p -123.89 94.46 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 173.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.27 -110.83 3.15 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.823 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -87.99 -1.1 57.78 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.609 1.163 . . . . 0.0 111.8 -172.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.3 t -128.77 140.18 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.074 0.95 . . . . 0.0 109.786 -172.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.518 HG23 HG23 ' A' ' 5' ' ' ILE . 33.2 t -125.29 134.65 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.349 0.66 . . . . 0.0 109.512 172.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.457 HG12 ' HB ' ' A' ' 98' ' ' ILE . 2.4 mt -99.58 107.04 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 165.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.75 109.32 20.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -98.74 109.69 22.41 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.25 159.24 36.73 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.467 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.2 m -107.43 110.05 21.91 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.121 172.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.0 t -81.77 103.25 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 123.293 0.637 . . . . 0.0 110.258 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.3 m -66.75 129.56 40.27 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.854 0.862 . . . . 0.0 110.205 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 91' ' ' GLY . 80.7 mtp180 -133.56 -162.53 1.25 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -130.21 83.5 2.13 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.917 0.389 . . . . 0.0 110.357 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -90.18 137.83 27.64 Favored Pre-proline 0 N--CA 1.475 0.8 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.3 8.15 1.56 Allowed 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.839 2.359 . . . . 0.0 113.046 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.91 -32.68 57.56 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.082 0.953 . . . . 0.0 109.314 169.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.09 -98.03 0.13 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.355 175.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -76.91 -82.41 0.08 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.786 0.834 . . . . 0.0 110.281 175.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 84' ' ' ARG . . . 117.43 28.59 2.31 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 121.312 -0.47 . . . . 0.0 113.877 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -88.1 140.95 28.97 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -174.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.588 HG13 ' HA ' ' A' ' 116' ' ' PRO . 29.1 m -127.43 129.27 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 122.04 -0.413 . . . . 0.0 110.817 -176.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -77.34 110.43 12.07 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.039 0.536 . . . . 0.0 109.703 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.447 HG21 HG12 ' A' ' 113' ' ' ILE . 33.8 t -114.15 156.55 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.607 1.163 . . . . 0.0 108.859 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.88 103.32 6.73 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 71.6 m -96.35 111.84 23.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.235 1.014 . . . . 0.0 109.959 -174.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.457 ' HB ' HG12 ' A' ' 77' ' ' ILE . 8.6 tt -103.42 110.96 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 124.602 1.161 . . . . 0.0 110.155 -175.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -105.69 133.64 50.1 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.167 0.587 . . . . 0.0 110.905 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -100.45 119.68 38.84 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.195 0.998 . . . . 0.0 108.474 169.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.5 t -110.28 115.25 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.014 0.926 . . . . 0.0 110.536 -173.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 11.4 tp10 -118.68 126.39 51.82 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.145 0.578 . . . . 0.0 109.806 177.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.411 HD21 ' HG3' ' A' ' 102' ' ' GLU . 54.9 m-80 61.55 30.25 18.62 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.892 1.277 . . . . 0.0 112.174 -177.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.45 0.03 86.03 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 116.379 -0.373 . . . . 0.0 113.774 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -117.38 138.41 51.82 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 67.1 mt -68.56 105.91 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . . . -78.11 -32.13 50.36 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.056 0.542 . . . . 0.0 110.705 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.555 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 62.4 mtpt -150.2 134.23 16.98 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -130.4 132.28 45.68 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.401 ' HB2' HG22 ' A' ' 98' ' ' ILE . 0.7 OUTLIER -132.42 148.64 52.41 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -177.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -142.62 146.69 34.78 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.284 0.493 . . . . 0.0 110.03 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 25.1 pttm -121.19 127.68 51.73 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.447 HG12 HG21 ' A' ' 95' ' ' VAL . 88.3 mt -89.69 124.99 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.21 -73.88 0.52 Allowed Glycine 0 CA--C 1.526 0.765 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.914 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -160.69 170.3 8.71 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.134 0.574 . . . . 0.0 109.676 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.588 ' HA ' HG13 ' A' ' 93' ' ' VAL . 72.4 Cg_endo -73.84 123.74 8.68 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.215 1.943 . . . . 0.0 112.225 165.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.8 mmt85 -110.01 147.58 33.25 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.212 1.005 . . . . 0.0 109.243 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.9 mm -139.05 127.79 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.51 -30.57 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.711 0.805 . . . . 0.0 111.74 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -68.42 -31.51 70.9 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.038 0.535 . . . . 0.0 110.654 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -82.04 -37.03 27.1 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.154 0.982 . . . . 0.0 110.765 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -98.16 103.37 15.31 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.593 0.757 . . . . 0.0 109.0 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 C--O 1.255 1.36 0 C-N-CA 123.498 0.719 . . . . 0.0 109.482 -177.921 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -110.06 49.37 0.85 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.552 0.691 . . . . 0.0 110.722 -175.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.408 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 33.8 p -67.74 -33.02 74.05 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.702 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.65 -20.32 63.27 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.49 1.116 . . . . 0.0 112.578 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 74' ' ' ASN . 30.0 mm -91.79 -28.98 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.946 0.898 . . . . 0.0 109.409 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -75.0 -27.39 60.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.965 174.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 3' ' ' SER . 83.7 mt -59.92 -55.21 47.83 Favored Pre-proline 0 CA--C 1.564 1.484 0 CA-C-O 117.884 -1.055 . . . . 0.0 112.032 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 19.3 Cg_endo -56.91 -55.59 2.55 Favored 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 122.111 1.874 . . . . 0.0 112.613 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.5 m -62.98 -35.36 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.489 -171.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -73.66 -52.2 14.12 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.163 0.585 . . . . 0.0 110.394 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -62.86 -28.29 69.93 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -75.42 -43.56 49.27 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.853 0.861 . . . . 0.0 111.422 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.14 -52.05 65.38 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.003 0.521 . . . . 0.0 110.331 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.71 -25.81 68.37 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.021 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . . . -80.76 -27.64 36.68 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.372 1.069 . . . . 0.0 112.177 172.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.532 ' HH ' HD12 ' A' ' 62' ' ' LEU . 70.6 t80 -66.91 -47.52 71.52 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.252 0.548 . . . . 0.0 109.885 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.62 -14.57 59.6 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.847 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.43 -2.77 41.45 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.449 0.699 . . . . 0.0 112.118 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 67.55 25.48 8.35 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.791 1.237 . . . . 0.0 112.835 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.521 ' HB2' ' HB2' ' A' ' 15' ' ' ALA . 11.0 m-20 -92.8 100.04 12.6 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.311 0.644 . . . . 0.0 110.011 173.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.403 HG13 HG12 ' A' ' 54' ' ' ILE . 12.6 mm -70.39 -31.17 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.001 0.52 . . . . 0.0 110.787 170.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -61.36 -45.11 95.77 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.014 0.525 . . . . 0.0 111.691 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.03 -30.82 44.39 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.134 0.574 . . . . 0.0 110.977 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -72.94 -5.94 41.93 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.855 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.748 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -112.75 -30.52 7.04 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.217 0.607 . . . . 0.0 112.215 172.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.75 -32.7 67.72 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -169.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.484 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.9 m95 -97.97 7.83 45.7 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -173.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.473 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 46.8 m95 -94.25 157.51 16.01 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.01 0.524 . . . . 0.0 110.288 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.402 ' O ' ' HB1' ' A' ' 46' ' ' ALA . . . -76.76 148.49 36.66 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.322 169.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -67.83 -24.29 65.26 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.158 0.583 . . . . 0.0 111.32 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -106.18 18.33 22.18 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.312 1.045 . . . . 0.0 111.236 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.473 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 51.5 t -64.93 138.99 58.71 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -174.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -98.21 136.61 38.17 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.763 0.825 . . . . 0.0 108.847 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.458 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 56.4 t80 -130.92 110.98 11.66 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -109.64 151.81 26.38 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.602 0.761 . . . . 0.0 110.512 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.25 158.47 19.67 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.634 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.633 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 87.2 t80 -61.29 130.82 91.97 Favored Pre-proline 0 CA--C 1.558 1.276 0 O-C-N 123.899 0.749 . . . . 0.0 110.335 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.38 -57.25 0.14 OUTLIER 'Cis proline' 0 C--N 1.383 2.39 0 CA-C-N 120.138 1.085 . . . . 0.0 113.6 -1.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.26 81.53 1.42 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.7 m -129.19 108.21 10.17 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.497 0.719 . . . . 0.0 109.915 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.5 tp -65.78 102.57 0.77 Allowed 'General case' 0 CA--C 1.535 0.377 0 O-C-N 123.572 0.545 . . . . 0.0 109.824 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.9 mt -78.68 -25.74 44.87 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.531 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -157.3 117.05 3.41 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.85 35.34 4.59 Favored Glycine 0 C--N 1.346 1.119 0 C-N-CA 123.28 0.467 . . . . 0.0 112.926 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 p30 163.96 160.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 126.306 1.843 . . . . 0.0 108.426 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 29' ' ' ALA . . . -69.55 -26.14 64.35 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -171.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.69 -41.65 99.22 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.331 0.586 . . . . 0.0 110.884 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -76.28 -29.19 57.31 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.922 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.449 ' HB ' ' HE1' ' A' ' 25' ' ' MET . 69.0 mt -64.24 -50.96 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 122.916 0.486 . . . . 0.0 110.639 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.748 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 30.8 ptt180 -60.68 -51.59 68.75 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.904 0.752 . . . . 0.0 110.671 -176.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.44 ' HA ' HD12 ' A' ' 54' ' ' ILE . 35.5 m -63.97 -38.22 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -174.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -61.87 -38.08 86.96 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 123.815 0.697 . . . . 0.0 110.376 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -78.22 -34.32 49.37 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.121 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 50' ' ' ARG . 98.0 mt -56.46 -39.99 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.089 0.556 . . . . 0.0 110.182 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.87 -41.01 95.11 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.139 0.976 . . . . 0.0 111.576 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -73.9 -29.27 61.97 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.409 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -73.49 -4.66 35.15 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.002 0.521 . . . . 0.0 111.62 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -74.46 -36.22 63.33 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.962 0.505 . . . . 0.0 111.011 172.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.53 115.78 12.8 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 123.493 0.717 . . . . 0.0 110.919 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.89 -25.07 28.4 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.482 2.121 . . . . 0.0 112.49 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.78 -7.79 58.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.821 0.848 . . . . 0.0 111.69 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.532 HD12 ' HH ' ' A' ' 16' ' ' TYR . 56.1 tp -64.55 120.56 12.56 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 122.477 0.311 . . . . 0.0 110.547 176.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -151.2 115.55 5.08 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 169.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.91 102.97 2.75 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -100.87 109.77 21.76 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 80' ' ' GLU . 13.8 tp -66.7 140.33 57.88 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.164 0.507 . . . . 0.0 110.089 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.553 HD11 ' HG1' ' A' ' 81' ' ' THR . 5.7 mt -107.0 -51.1 2.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.457 1.122 . . . . 0.0 107.989 -177.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.9 m -154.54 141.07 18.85 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 113.024 -1.898 . . . . 0.0 109.032 -172.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -135.14 121.83 20.83 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 168.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.468 HG21 ' HB ' ' A' ' 77' ' ' ILE . 19.3 m -107.96 136.07 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.5 tt -120.71 129.83 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.274 0.559 . . . . 0.0 110.775 -175.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.95 99.35 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 C-N-CA 124.859 1.264 . . . . 0.0 108.393 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.79 -125.66 22.92 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.583 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.446 ' HA ' HG13 ' A' ' 5' ' ' ILE . 26.3 p-10 -91.48 17.98 7.9 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.307 0.643 . . . . 0.0 111.88 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.6 t -127.45 135.76 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.162 0.985 . . . . 0.0 109.8 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.2 t -125.37 139.66 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.006 0.522 . . . . 0.0 109.788 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.468 ' HB ' HG21 ' A' ' 70' ' ' VAL . 10.0 mm -98.81 104.33 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 167.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -94.87 105.16 17.07 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -100.19 105.81 17.44 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -121.28 171.16 8.93 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.156 1.382 . . . . 0.0 109.918 -178.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.553 ' HG1' HD11 ' A' ' 67' ' ' LEU . 98.4 m -118.09 106.23 12.66 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.924 0.89 . . . . 0.0 108.935 172.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.0 m -82.47 124.16 39.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-O 121.613 0.721 . . . . 0.0 109.194 170.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.9 m -83.09 119.42 24.48 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.681 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.628 HH21 ' HZ ' ' A' ' 86' ' ' PHE . 61.9 mtm180 -119.06 -160.89 0.82 Allowed 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -139.59 111.47 7.36 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.773 0.715 . . . . 0.0 110.32 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.628 ' HZ ' HH21 ' A' ' 84' ' ' ARG . 17.3 m-30 -109.28 151.49 42.09 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.745 0.818 . . . . 0.0 110.127 -178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.37 -28.82 88.58 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.649 2.232 . . . . 0.0 113.736 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -88.53 2.74 52.35 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.06 -146.56 16.09 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-O 119.479 -0.623 . . . . 0.0 113.235 173.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -39.07 -72.92 0.05 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.316 1.446 . . . . 0.0 113.059 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 103.62 25.7 7.17 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 113.897 0.319 . . . . 0.0 113.897 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -92.84 129.25 38.82 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.584 HG11 ' HA ' ' A' ' 116' ' ' PRO . 20.7 m -123.05 143.88 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.511 ' HB3' HH21 ' A' ' 117' ' ' ARG . 9.8 p-10 -85.89 122.95 30.67 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 174.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.432 HG21 HG12 ' A' ' 113' ' ' ILE . 44.2 t -113.68 142.33 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -106.12 97.65 7.43 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 94.1 m -93.49 108.28 19.99 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.357 0.663 . . . . 0.0 109.214 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.78 115.75 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.897 0.879 . . . . 0.0 108.979 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -107.39 133.91 51.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.684 0.794 . . . . 0.0 109.711 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -103.31 113.37 26.81 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 168.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.584 HG23 HG12 ' A' ' 106' ' ' ILE . 96.9 t -100.0 135.29 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.204 1.001 . . . . 0.0 110.035 -176.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -133.27 119.2 19.49 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.959 0.904 . . . . 0.0 109.866 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 61.12 30.54 19.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.927 1.291 . . . . 0.0 112.375 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.67 -6.64 83.13 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.009 -0.542 . . . . 0.0 113.858 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -113.86 133.51 55.38 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.584 HG12 HG23 ' A' ' 101' ' ' VAL . 57.5 mt -67.68 107.59 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.53 -32.1 47.84 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.495 0.718 . . . . 0.0 110.997 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -150.09 152.32 34.6 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.068 0.947 . . . . 0.0 108.821 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.66 135.49 12.73 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -136.75 151.79 49.61 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -139.57 144.79 37.96 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.249 0.547 . . . . 0.0 110.31 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.633 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 16.8 ttpt -117.03 125.6 51.59 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 172.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.432 HG12 HG21 ' A' ' 95' ' ' VAL . 62.0 mt -86.44 125.56 40.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.86 -132.21 1.47 Allowed Glycine 0 CA--C 1.52 0.4 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.938 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -83.5 134.26 45.5 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.591 0.756 . . . . 0.0 111.325 -169.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.584 ' HA ' HG11 ' A' ' 93' ' ' VAL . 77.5 Cg_endo -74.07 93.37 0.88 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 123.346 2.697 . . . . 0.0 111.435 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.511 HH21 ' HB3' ' A' ' 94' ' ' ASP . 49.5 mtm105 -100.45 141.48 33.24 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.532 0.682 . . . . 0.0 111.216 -169.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.3 mm -127.8 124.72 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.732 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.62 -23.06 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.834 0.853 . . . . 0.0 110.258 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.6 m -78.41 18.64 0.53 Allowed 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.841 1.257 . . . . 0.0 112.949 -174.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -97.75 156.71 16.44 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.538 0.735 . . . . 0.0 110.731 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -138.45 152.13 48.05 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.528 0.731 . . . . 0.0 110.288 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.252 1.215 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.68 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 ttm . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 61.28 15.87 6.84 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.093 1.357 . . . . 0.0 111.514 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.412 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 13.8 m -65.68 -42.59 91.1 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.465 1.106 . . . . 0.0 111.348 -169.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.77 -19.17 64.78 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.038 0.935 . . . . 0.0 112.72 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 mm -96.1 -29.69 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.177 0.991 . . . . 0.0 109.617 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -71.53 -36.94 71.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.247 1.019 . . . . 0.0 111.212 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.456 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 91.4 mt -58.15 -52.76 72.18 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.061 -175.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.418 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 16.9 Cg_endo -57.19 -59.77 0.55 Allowed 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 121.6 1.533 . . . . 0.0 112.271 176.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.5 m -62.42 -29.81 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -169.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 26.2 tp60 -73.44 -55.61 6.13 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 122.852 0.461 . . . . 0.0 110.399 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.2 mmtt -63.68 -36.33 83.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 123.752 0.658 . . . . 0.0 111.002 -175.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.38 -46.0 90.59 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.136 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.44 -48.78 80.33 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 55.7 mm-40 -58.44 -33.72 70.02 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.508 1.13 . . . . 0.0 110.488 -176.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.71 -26.06 32.35 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.574 1.15 . . . . 0.0 112.417 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -69.7 -44.36 70.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.977 0.511 . . . . 0.0 109.945 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.87 -22.79 52.94 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.272 175.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.79 -0.78 57.81 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.28 0.632 . . . . 0.0 112.19 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 mmt85 68.96 7.72 6.39 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.009 1.324 . . . . 0.0 113.323 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.95 98.69 6.51 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.231 0.612 . . . . 0.0 110.228 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.415 HG13 HG12 ' A' ' 54' ' ' ILE . 12.5 mm -63.06 -36.02 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.02 0.528 . . . . 0.0 110.77 172.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -57.52 -49.17 77.21 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.505 0.722 . . . . 0.0 111.405 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.0 -30.79 27.87 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.136 0.575 . . . . 0.0 111.963 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -65.93 -20.68 66.3 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.11 0.256 . . . . 0.0 110.646 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 67.7 mmm -120.16 6.19 10.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.701 0.8 . . . . 0.0 112.107 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.84 -47.57 58.63 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.295 0.569 . . . . 0.0 110.426 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 92.0 m95 -86.95 9.3 19.85 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.349 -169.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.438 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 30.1 m95 -89.29 156.74 18.55 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 173.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -76.72 149.96 36.33 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 173.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.71 -27.4 68.3 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.74 0.416 . . . . 0.0 110.645 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.97 19.37 19.58 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.596 1.158 . . . . 0.0 111.017 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.438 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 52.1 t -63.5 123.57 19.11 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.058 0.456 . . . . 0.0 111.815 -174.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -85.73 140.44 30.5 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.411 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 63.0 t80 -132.87 110.08 10.06 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -172.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.404 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 24.2 m-85 -111.03 155.91 22.06 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.364 1.065 . . . . 0.0 110.955 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.26 160.29 29.6 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.67 170.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -50.93 132.5 29.53 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 124.674 1.19 . . . . 0.0 112.156 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.85 -41.49 0.9 Allowed 'Cis proline' 0 C--N 1.379 2.145 0 CA-C-N 119.961 1.022 . . . . 0.0 113.801 -2.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.06 56.89 0.12 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.215 0.606 . . . . 0.0 110.894 -177.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 75.5 m -109.33 114.22 27.71 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.67 0.788 . . . . 0.0 110.218 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.4 tt -76.5 109.48 10.27 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.17 -44.54 14.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.224 0.61 . . . . 0.0 109.664 174.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . . . -132.13 122.34 25.2 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.742 -171.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.21 46.74 1.13 Allowed Glycine 0 N--CA 1.478 1.448 0 C-N-CA 122.612 0.148 . . . . 0.0 112.793 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.438 ' O ' HG13 ' A' ' 49' ' ' ILE . 9.5 p30 162.34 152.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 126.341 1.856 . . . . 0.0 108.319 -171.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -63.44 -25.38 68.24 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.765 0.826 . . . . 0.0 113.194 -174.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.422 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -64.07 -44.27 92.92 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.942 0.497 . . . . 0.0 111.331 -177.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 33.0 mt-10 -75.68 -33.53 60.39 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 45' ' ' ASN . 53.2 mt -65.77 -42.81 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.098 0.559 . . . . 0.0 110.598 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.458 ' O ' HG13 ' A' ' 54' ' ' ILE . 14.0 ptm180 -66.44 -42.8 87.11 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.952 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 47' ' ' ALA . 97.8 t -61.04 -44.56 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 123.787 0.68 . . . . 0.0 110.572 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -63.59 -34.7 78.4 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.19 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -77.2 -35.55 55.64 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.038 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.477 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 78.9 mt -55.5 -44.22 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 123.195 0.598 . . . . 0.0 110.124 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -54.98 -43.15 73.26 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 124.377 1.048 . . . . 0.0 111.203 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.3 tpp85 -72.68 -30.7 64.47 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.619 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -78.22 -6.63 55.47 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.71 0.404 . . . . 0.0 111.596 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 69.4 mmtt -87.11 -12.63 46.52 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.229 0.612 . . . . 0.0 111.645 171.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.71 114.73 18.96 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.733 0.813 . . . . 0.0 108.886 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.62 -27.21 38.92 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.632 2.221 . . . . 0.0 113.157 -170.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -89.16 -6.54 56.87 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.625 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.4 tp -56.99 121.95 11.17 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.48 0.488 . . . . 0.0 111.571 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -149.31 119.47 7.24 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.498 ' HA2' HG13 ' A' ' 82' ' ' VAL . . . -88.8 104.93 3.13 Favored Glycine 0 C--N 1.34 0.778 0 O-C-N 123.524 0.515 . . . . 0.0 112.197 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -102.43 101.93 12.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 tt -83.74 131.24 34.93 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.65 -30.73 6.07 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.175 0.99 . . . . 0.0 111.136 -173.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.6 m -149.35 130.68 14.67 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.4 0.68 . . . . 0.0 109.344 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -137.82 117.58 13.16 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.43 115.69 47.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.778 0.831 . . . . 0.0 109.573 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.5 tt -106.51 123.9 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 122.935 0.494 . . . . 0.0 109.983 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 t -118.75 95.73 3.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.1 -95.33 0.2 Allowed Glycine 0 CA--C 1.531 1.077 0 O-C-N 123.661 0.601 . . . . 0.0 113.78 176.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -108.39 4.23 24.17 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.456 1.102 . . . . 0.0 111.495 -171.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.93 138.53 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.511 1.124 . . . . 0.0 109.631 -173.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.01 127.62 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.497 0.719 . . . . 0.0 109.388 173.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.484 HG12 ' HB ' ' A' ' 98' ' ' ILE . 4.0 mt -99.03 106.54 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 163.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -89.99 132.5 35.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 172.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -128.58 110.54 12.35 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.24 171.08 8.55 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.366 1.466 . . . . 0.0 109.282 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.416 HG22 ' HB2' ' A' ' 92' ' ' GLU . 97.1 m -125.9 102.64 7.37 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 164.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.498 HG13 ' HA2' ' A' ' 64' ' ' GLY . 15.0 m -84.22 124.37 39.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.843 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.439 HG22 ' HD2' ' A' ' 90' ' ' LYS . 88.2 m -66.4 123.9 21.26 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.958 170.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -129.81 -170.61 2.34 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -126.06 97.29 5.04 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 118.974 0.806 . . . . 0.0 111.018 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -100.92 140.32 21.23 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.093 0.957 . . . . 0.0 108.952 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -64.69 -17.74 60.47 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.687 2.258 . . . . 0.0 113.637 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -83.59 -9.24 59.05 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.925 0.49 . . . . 0.0 112.093 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.66 -120.49 0.94 Allowed Glycine 0 C--N 1.349 1.295 0 CA-C-O 120.041 -0.31 . . . . 0.0 112.495 172.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.439 ' HD2' HG22 ' A' ' 83' ' ' THR . 16.0 tppt? -66.76 -83.28 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.841 0.856 . . . . 0.0 111.317 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 119.44 27.06 2.26 Favored Glycine 0 C--N 1.346 1.086 0 O-C-N 123.094 0.246 . . . . 0.0 112.558 -174.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.416 ' HB2' HG22 ' A' ' 81' ' ' THR . 9.7 pt-20 -89.45 108.62 19.75 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.566 0.698 . . . . 0.0 109.441 -172.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.625 HG12 ' HA ' ' A' ' 116' ' ' PRO . 4.8 m -112.64 142.32 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 122.858 0.463 . . . . 0.0 109.849 -175.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -96.77 144.37 26.82 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.537 HG22 HG12 ' A' ' 113' ' ' ILE . 15.3 t -136.82 136.63 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.608 0.763 . . . . 0.0 109.17 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.32 98.83 9.44 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 170.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 63.1 m -98.22 112.69 24.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.598 0.759 . . . . 0.0 109.641 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.526 HG23 ' HB2' ' A' ' 110' ' ' TRP . 6.3 tt -97.56 110.8 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 123.58 0.752 . . . . 0.0 109.989 177.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -98.32 154.83 17.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.456 0.702 . . . . 0.0 109.843 174.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -132.88 119.41 20.17 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.18 0.992 . . . . 0.0 108.452 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 56.6 t -94.54 140.03 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.909 0.883 . . . . 0.0 110.254 -174.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 24.3 tt0 -138.98 123.03 17.91 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.82 31.1 16.6 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.537 0.735 . . . . 0.0 110.934 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.49 -5.73 83.91 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.929 -0.578 . . . . 0.0 114.161 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -125.39 134.6 52.09 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.779 0.831 . . . . 0.0 109.748 -175.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 64.2 mt -63.66 103.61 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 122.854 0.462 . . . . 0.0 110.397 -178.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . . . -81.28 -24.84 36.98 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.168 0.587 . . . . 0.0 111.559 -176.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -149.25 139.81 22.54 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.572 0.749 . . . . 0.0 109.405 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.88 138.25 33.79 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.08 0.952 . . . . 0.0 108.786 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.526 ' HB2' HG23 ' A' ' 98' ' ' ILE . 3.2 m-90 -136.84 142.8 42.86 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -142.64 147.1 35.2 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 119.181 0.901 . . . . 0.0 111.233 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -131.91 130.35 41.47 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.852 0.861 . . . . 0.0 108.839 173.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.537 HG12 HG22 ' A' ' 95' ' ' VAL . 95.9 mt -87.85 127.17 41.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.86 -80.22 0.12 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 114.923 -1.035 . . . . 0.0 113.355 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -158.55 163.67 23.58 Favored Pre-proline 0 C--O 1.243 0.745 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.625 ' HA ' HG12 ' A' ' 93' ' ' VAL . 97.8 Cg_endo -81.35 141.5 12.73 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.061 1.841 . . . . 0.0 112.495 166.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -132.67 157.63 44.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.893 0.877 . . . . 0.0 110.335 174.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.417 HG23 ' H ' ' A' ' 90' ' ' LYS . 45.9 mm -133.43 144.47 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.891 1.276 . . . . 0.0 107.825 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.0 t -64.98 -43.04 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 122.948 0.499 . . . . 0.0 110.915 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.0 t -64.13 -30.15 71.23 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.484 0.713 . . . . 0.0 110.847 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -71.13 83.27 0.71 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.58 0.752 . . . . 0.0 109.051 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -166.9 139.59 3.57 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.604 -170.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 C--O 1.253 1.265 0 C-N-CA 123.84 0.856 . . . . 0.0 109.693 176.721 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.3 mtm . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -144.04 25.72 1.56 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.514 1.126 . . . . 0.0 108.054 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.9 m -52.4 -53.17 48.46 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.254 1.422 . . . . 0.0 113.89 -163.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.96 -11.88 59.66 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.421 ' HB ' HD11 ' A' ' 71' ' ' ILE . 13.3 mm -98.38 -30.51 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.978 0.911 . . . . 0.0 109.984 175.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.12 -35.9 71.92 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.137 0.975 . . . . 0.0 110.632 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -65.71 -46.71 67.13 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.219 1.407 . . . . 0.0 112.579 -168.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.525 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 11.6 Cg_endo -55.13 -57.81 1.49 Allowed 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 121.561 1.507 . . . . 0.0 111.425 171.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.404 HG13 HG11 ' A' ' 76' ' ' VAL . 73.6 t -59.63 -33.37 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.506 1.122 . . . . 0.0 112.407 -173.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.547 ' HA ' HH12 ' A' ' 69' ' ' ARG . 0.9 OUTLIER -69.43 -56.07 8.49 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.532 0.733 . . . . 0.0 110.306 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -66.34 -35.4 80.25 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.414 0.686 . . . . 0.0 111.423 -174.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.04 -39.29 93.13 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.615 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.656 ' HB2' HH22 ' A' ' 69' ' ' ARG . 58.1 tp -59.02 -52.55 65.28 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.671 0.607 . . . . 0.0 110.666 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -54.97 -46.92 75.11 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.969 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.54 -30.69 71.47 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.336 1.054 . . . . 0.0 112.307 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -68.74 -48.54 63.51 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.154 0.582 . . . . 0.0 110.467 -175.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -82.21 -19.79 39.04 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.098 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.01 -3.56 58.89 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.408 0.683 . . . . 0.0 112.124 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 68.2 21.24 8.62 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.773 1.229 . . . . 0.0 112.171 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -90.05 123.21 33.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.934 0.894 . . . . 0.0 110.506 174.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.5 mm -87.15 -28.32 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.47 0.708 . . . . 0.0 110.736 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.44 -47.29 86.04 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.325 0.65 . . . . 0.0 111.981 -170.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.64 -32.24 41.62 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.072 0.549 . . . . 0.0 110.66 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -73.27 -7.18 50.44 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.088 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.729 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 1.1 tpt -116.94 -33.95 4.58 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.303 0.641 . . . . 0.0 111.864 176.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.09 -48.53 78.36 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.338 0.655 . . . . 0.0 112.066 -172.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 99.1 m95 -76.43 -0.67 23.71 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.236 -173.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.456 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 14.8 m95 -91.99 149.4 21.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 173.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 107' ' ' ALA . . . -75.42 155.15 36.64 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.975 0.51 . . . . 0.0 110.651 176.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.75 -24.55 66.98 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.451 0.701 . . . . 0.0 111.384 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -104.56 19.19 20.81 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 124.366 1.066 . . . . 0.0 110.465 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.456 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 49.0 t -60.52 114.86 3.19 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -173.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -92.49 102.87 15.32 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.887 0.875 . . . . 0.0 110.099 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.459 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 78.4 t80 -97.08 111.28 23.58 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 125.265 1.426 . . . . 0.0 110.242 -173.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.488 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 45.5 m-85 -111.08 155.59 22.58 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.53 1.132 . . . . 0.0 110.55 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.69 157.05 23.67 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.242 170.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -55.81 134.3 72.71 Favored Pre-proline 0 CA--C 1.564 1.497 0 C-N-CA 124.374 1.07 . . . . 0.0 112.251 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.33 -40.83 1.11 Allowed 'Cis proline' 0 C--N 1.381 2.289 0 CA-C-N 120.146 1.088 . . . . 0.0 113.011 -8.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.16 92.62 0.75 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.983 0.913 . . . . 0.0 108.945 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 90.5 m -139.0 117.38 11.98 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.729 0.812 . . . . 0.0 108.863 176.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 tt -81.93 103.14 11.37 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -176.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.403 HD21 ' O ' ' A' ' 40' ' ' THR . 2.4 mm? -89.73 -29.42 18.73 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.509 0.323 . . . . 0.0 110.785 177.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -146.83 116.34 7.09 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -175.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.96 36.26 4.22 Favored Glycine 0 N--CA 1.478 1.478 0 C-N-CA 123.19 0.424 . . . . 0.0 113.396 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 p30 168.94 163.28 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.473 1.509 . . . . 0.0 109.438 -172.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -64.0 -35.42 80.66 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.945 0.898 . . . . 0.0 112.602 -177.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.86 -45.61 91.89 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.164 0.586 . . . . 0.0 111.717 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -71.67 -31.82 67.22 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.709 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.3 mt -66.04 -38.73 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.55 0.74 . . . . 0.0 110.097 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.729 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 75.3 ttt180 -62.27 -57.05 12.82 Favored 'General case' 0 C--N 1.348 0.53 0 O-C-N 123.994 0.809 . . . . 0.0 110.091 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.2 t -55.34 -48.41 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 125.043 1.464 . . . . 0.0 110.843 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.1 ttt-85 -61.33 -37.74 84.38 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.325 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -78.75 -28.37 44.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 118.889 -0.577 . . . . 0.0 112.136 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 50' ' ' ARG . 97.2 mt -61.64 -44.43 98.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 118.879 0.763 . . . . 0.0 109.06 174.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -65.33 -34.33 78.08 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.978 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -71.16 -30.33 66.32 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.2 0.6 . . . . 0.0 110.961 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -79.55 -5.7 55.47 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.127 0.571 . . . . 0.0 111.304 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -82.53 -8.57 59.61 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.875 0.47 . . . . 0.0 111.577 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 24.0 mm-40 -70.1 118.64 65.62 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.81 -22.25 27.52 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.32 2.013 . . . . 0.0 112.76 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.07 -6.97 49.99 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.727 0.811 . . . . 0.0 111.731 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 21.7 tp -58.43 111.89 1.39 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.222 0.464 . . . . 0.0 111.282 -175.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -148.23 117.01 6.68 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.99 126.71 8.19 Favored Glycine 0 C--O 1.24 0.482 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 171.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -119.46 100.9 7.58 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.8 tt -91.29 117.87 30.01 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.45 -47.01 5.56 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.378 1.071 . . . . 0.0 109.559 175.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.3 m -121.69 139.42 53.59 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.601 0.76 . . . . 0.0 111.672 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.656 HH22 ' HB2' ' A' ' 13' ' ' LEU . 2.2 ptp180 -144.07 125.17 14.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.455 0.702 . . . . 0.0 109.322 159.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' A' ' 77' ' ' ILE . 20.4 m -110.71 152.4 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.999 0.919 . . . . 0.0 108.88 175.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.423 HG13 HG22 ' A' ' 76' ' ' VAL . 19.7 tt -138.53 144.97 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 122.604 0.361 . . . . 0.0 110.812 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.444 HG11 HG12 ' A' ' 75' ' ' VAL . 2.1 p -149.46 101.67 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 124.431 1.093 . . . . 0.0 109.075 -177.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.2 -123.35 20.78 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.488 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -98.76 19.32 15.05 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.831 0.453 . . . . 0.0 111.749 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.444 HG12 HG11 ' A' ' 72' ' ' VAL . 3.0 p -135.28 139.32 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.102 0.561 . . . . 0.0 110.785 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.423 HG22 HG13 ' A' ' 71' ' ' ILE . 15.8 t -124.86 141.86 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.047 0.939 . . . . 0.0 110.165 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.473 HD11 ' HB ' ' A' ' 98' ' ' ILE . 8.4 mm -107.28 104.4 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 165.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -100.95 114.17 27.81 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -106.11 112.07 24.96 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.875 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -108.42 166.69 10.58 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.22 171.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.5 m -99.98 100.87 11.82 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 152.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.0 m -86.82 138.59 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 37.6 m -95.99 120.11 35.68 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.055 0.455 . . . . 0.0 110.664 -173.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -111.46 -162.8 0.81 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 175.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 3.4 t-20 -132.57 110.1 10.22 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.226 -0.296 . . . . 0.0 110.474 172.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -104.96 143.3 26.42 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 124.425 1.09 . . . . 0.0 108.741 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.05 -9.9 26.49 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.663 2.242 . . . . 0.0 113.706 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -85.48 -13.09 50.21 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.782 0.433 . . . . 0.0 112.085 175.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.68 -129.86 1.56 Allowed Glycine 0 C--N 1.349 1.262 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.981 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 15.8 tppt? -75.25 -72.32 0.31 Allowed 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.196 0.598 . . . . 0.0 110.428 174.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.92 26.94 3.13 Favored Glycine 0 C--N 1.341 0.836 0 O-C-N 123.277 0.361 . . . . 0.0 113.723 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 117' ' ' ARG . 4.8 pm0 -90.29 122.37 33.14 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -174.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.563 HG13 ' HA ' ' A' ' 116' ' ' PRO . 34.1 m -123.57 143.63 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.448 0.699 . . . . 0.0 110.619 -169.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -79.34 108.4 12.83 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.139 0.575 . . . . 0.0 109.657 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.466 HG22 HG12 ' A' ' 113' ' ' ILE . 59.8 t -123.41 138.81 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.84 0.856 . . . . 0.0 110.078 -176.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.34 117.91 30.81 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.528 0.731 . . . . 0.0 109.399 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 64.2 m -94.27 123.29 37.58 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.602 HG21 ' HB2' ' A' ' 110' ' ' TRP . 10.3 tt -104.78 105.23 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.369 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -99.53 127.88 45.62 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.613 0.765 . . . . 0.0 109.996 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -100.42 113.26 25.88 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 168.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.505 HG22 HG12 ' A' ' 106' ' ' ILE . 60.8 t -97.28 126.05 50.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 125.123 1.369 . . . . 0.0 110.508 -175.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.457 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 8.5 tp10 -133.15 139.28 46.99 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.108 0.963 . . . . 0.0 109.635 174.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.457 ' ND2' ' HG3' ' A' ' 102' ' ' GLU . 37.0 m-80 63.21 29.46 15.97 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.736 1.214 . . . . 0.0 111.644 -173.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.51 8.42 62.87 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.893 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -128.46 145.24 51.16 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.759 1.224 . . . . 0.0 108.4 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.505 HG12 HG22 ' A' ' 101' ' ' VAL . 57.5 mt -69.78 100.53 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 118.435 0.562 . . . . 0.0 109.832 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.459 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . . . -87.61 -15.31 37.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.723 0.409 . . . . 0.0 111.626 -177.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -148.33 129.73 14.79 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.4 132.93 48.51 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.602 ' HB2' HG21 ' A' ' 98' ' ' ILE . 1.6 m-90 -133.98 152.59 51.91 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -143.72 148.55 35.87 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 118.805 0.73 . . . . 0.0 111.251 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.6 ' HZ1' ' HB3' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -123.7 129.72 51.53 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.422 1.089 . . . . 0.0 109.546 176.115 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.466 HG12 HG22 ' A' ' 95' ' ' VAL . 75.2 mt -90.23 127.76 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 171.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.53 -74.11 0.93 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.24 -176.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.96 167.41 13.23 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.099 0.56 . . . . 0.0 109.49 -175.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.563 ' HA ' HG13 ' A' ' 93' ' ' VAL . 56.8 Cg_endo -84.21 137.79 7.39 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.428 2.086 . . . . 0.0 113.001 168.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 29.3 mmt180 -131.22 149.64 52.49 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.974 0.91 . . . . 0.0 109.126 173.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.6 mm -131.58 131.55 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.033 0.933 . . . . 0.0 108.608 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.67 -37.85 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 C-N-CA 123.218 0.607 . . . . 0.0 111.64 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.1 m -76.04 -18.81 59.08 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.167 0.587 . . . . 0.0 111.466 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.69 98.82 0.55 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.594 0.758 . . . . 0.0 109.107 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.472 ' HZ2' ' HA ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -148.48 113.12 5.36 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.859 0.463 . . . . 0.0 109.848 -175.421 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 C--O 1.255 1.389 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.776 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 tmm? . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 60.56 14.24 4.76 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 124.433 1.093 . . . . 0.0 111.894 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.454 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 14.4 m -75.75 -20.31 58.39 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.235 1.014 . . . . 0.0 112.483 -167.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -72.76 -19.77 61.31 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.527 0.331 . . . . 0.0 111.358 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.471 ' HB ' HD13 ' A' ' 71' ' ' ILE . 37.5 mm -88.88 -27.41 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 173.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.633 ' HG2' HH12 ' A' ' 69' ' ' ARG . 40.2 mt-10 -78.45 -19.79 52.4 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.663 173.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 3' ' ' SER . 77.6 mt -61.5 -50.75 81.38 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-O 118.736 -0.649 . . . . 0.0 111.729 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 19.6 Cg_endo -59.09 -55.33 1.98 Allowed 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 121.745 1.63 . . . . 0.0 111.709 173.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.1 t -54.4 -47.97 69.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 125.681 1.592 . . . . 0.0 113.576 -172.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -62.22 -47.4 84.59 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.859 0.864 . . . . 0.0 110.212 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -68.63 -35.18 76.95 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.632 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.29 -51.79 67.41 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.475 0.71 . . . . 0.0 111.033 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.66 -49.37 78.0 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.963 0.789 . . . . 0.0 109.494 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.42 ' HA ' HD22 ' A' ' 17' ' ' ASN . 22.3 mm-40 -60.11 -35.0 74.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 123.972 0.795 . . . . 0.0 111.03 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -74.17 -28.0 61.09 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.058 0.943 . . . . 0.0 111.395 175.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -70.36 -42.59 71.63 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.369 0.668 . . . . 0.0 110.238 -174.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.42 HD22 ' HA ' ' A' ' 14' ' ' GLU . 9.2 p30 -82.04 -28.33 32.54 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.433 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.92 11.38 27.48 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 63.74 20.69 12.35 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.351 1.06 . . . . 0.0 112.412 172.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.457 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 4.5 t70 -91.38 100.62 13.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.54 0.736 . . . . 0.0 109.406 -178.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.467 HG13 HG12 ' A' ' 54' ' ' ILE . 10.4 mm -74.47 -28.8 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.255 0.222 . . . . 0.0 110.974 173.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -62.72 -45.42 92.84 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.501 0.721 . . . . 0.0 110.891 -172.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.89 -36.05 31.76 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.787 0.835 . . . . 0.0 110.569 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -64.94 -8.8 17.17 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.25 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.743 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -112.27 -31.48 6.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.538 0.735 . . . . 0.0 111.855 174.033 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.07 -28.77 66.79 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -170.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 96.7 m95 -96.82 13.85 27.22 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.81 0.844 . . . . 0.0 112.782 -175.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.408 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 13.3 m95 -112.83 147.54 36.74 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.834 0.853 . . . . 0.0 109.011 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.412 ' O ' ' HB1' ' A' ' 46' ' ' ALA . . . -72.48 152.86 41.67 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.402 0.681 . . . . 0.0 110.517 175.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.67 -27.72 69.43 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.264 0.625 . . . . 0.0 111.642 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -101.45 12.26 37.65 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.153 0.981 . . . . 0.0 111.345 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.408 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 53.4 t -59.69 125.89 25.42 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -169.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -81.08 150.41 28.8 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.593 0.757 . . . . 0.0 109.562 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.404 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 59.6 t80 -146.73 112.88 5.83 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.344 0.658 . . . . 0.0 109.309 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.413 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 34.1 m-85 -114.26 150.77 33.88 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.003 0.921 . . . . 0.0 111.331 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.513 ' HB1' HD11 ' A' ' 42' ' ' LEU . . . -99.03 159.44 14.97 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 113.942 -1.481 . . . . 0.0 108.294 165.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -58.65 136.83 86.44 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-O 119.116 -0.468 . . . . 0.0 110.269 173.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.83 -55.97 0.14 OUTLIER 'Cis proline' 0 C--N 1.381 2.263 0 CA-C-N 120.406 1.181 . . . . 0.0 112.556 -7.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -148.2 58.92 1.1 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.708 0.766 . . . . 0.0 109.865 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.4 m -95.65 104.0 15.9 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.407 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.64 104.29 1.58 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.513 HD11 ' HB1' ' A' ' 36' ' ' ALA . 56.9 mt -82.1 -45.68 14.88 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.153 177.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . . . -143.46 117.1 9.21 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.992 -172.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.77 37.05 3.89 Favored Glycine 0 N--CA 1.478 1.465 0 C-N-CA 122.874 0.273 . . . . 0.0 113.536 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.3 p30 168.74 156.26 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.786 1.634 . . . . 0.0 109.013 -171.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 29' ' ' ALA . . . -58.97 -36.11 74.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.806 0.842 . . . . 0.0 112.82 -174.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.17 94.68 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.073 0.549 . . . . 0.0 112.082 -173.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 29.1 mt-10 -76.24 -32.54 58.95 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.969 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.417 ' HB ' ' HE3' ' A' ' 25' ' ' MET . 78.5 mt -63.54 -42.83 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.396 0.679 . . . . 0.0 109.97 176.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.743 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 74.6 ttt180 -56.03 -58.51 7.61 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.913 1.285 . . . . 0.0 110.861 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.32 -35.55 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.876 -168.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -72.0 -34.11 68.61 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.857 0.463 . . . . 0.0 110.334 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -74.57 -27.07 60.34 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.742 -0.646 . . . . 0.0 111.548 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 50' ' ' ARG . 85.1 mt -56.99 -42.72 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 118.453 0.57 . . . . 0.0 109.837 173.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -61.09 -37.24 82.02 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.009 0.818 . . . . 0.0 111.151 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -64.97 -39.15 93.05 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.571 0.749 . . . . 0.0 110.064 174.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -81.3 1.85 30.71 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.1 0.96 . . . . 0.0 112.17 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 9.8 mmpt? -95.97 -16.04 21.95 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.805 0.442 . . . . 0.0 111.177 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -70.54 122.64 87.19 Favored Pre-proline 0 N--CA 1.482 1.138 0 CA-C-O 119.023 -0.513 . . . . 0.0 109.965 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.22 -26.02 72.3 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.59 2.194 . . . . 0.0 112.374 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -86.12 -5.82 59.13 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.871 0.868 . . . . 0.0 112.137 -177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.4 tp -57.87 114.39 2.29 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 120.969 0.414 . . . . 0.0 110.575 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -147.5 117.03 7.02 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 169.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.96 102.29 1.74 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -97.07 102.86 14.73 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 69' ' ' ARG . 8.2 tt -74.59 115.61 14.34 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 171.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.41 ' H ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -101.45 -29.86 11.76 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.52 0.728 . . . . 0.0 110.695 -177.087 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.2 m -150.19 133.15 16.1 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.865 0.866 . . . . 0.0 110.008 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.633 HH12 ' HG2' ' A' ' 6' ' ' GLU . 52.5 ptt85 -139.56 139.69 36.91 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.139 0.576 . . . . 0.0 109.637 170.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.9 m -121.95 125.64 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.951 0.901 . . . . 0.0 109.455 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.471 HD13 ' HB ' ' A' ' 5' ' ' ILE . 14.0 tt -108.21 135.87 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 121.005 0.431 . . . . 0.0 110.713 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 p -142.68 96.24 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 124.778 1.231 . . . . 0.0 108.557 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.44 -124.69 22.41 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.616 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -88.25 7.51 31.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.17 0.588 . . . . 0.0 112.559 -175.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.16 142.86 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 122.989 0.516 . . . . 0.0 110.952 -175.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.13 141.88 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.796 0.839 . . . . 0.0 109.745 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.514 HD11 ' HB ' ' A' ' 98' ' ' ILE . 5.2 mm -99.25 105.88 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 168.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -99.34 105.43 17.41 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.498 0.719 . . . . 0.0 109.668 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -98.83 104.47 16.52 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -102.09 164.1 11.88 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.421 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.6 m -105.68 101.88 11.37 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 158.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.0 t -85.87 103.43 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.883 1.273 . . . . 0.0 110.028 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 48.3 m -71.12 127.16 31.64 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.624 0.77 . . . . 0.0 111.276 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -117.25 -161.37 0.81 Allowed 'General case' 0 C--O 1.247 0.931 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -131.65 103.82 6.59 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 172.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -108.37 134.96 20.03 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 123.861 0.864 . . . . 0.0 109.528 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.74 -10.98 24.41 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.426 2.751 . . . . 0.0 114.359 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -79.61 -28.31 40.98 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.94 0.496 . . . . 0.0 111.337 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.28 -115.63 0.49 Allowed Glycine 0 C--N 1.35 1.328 0 C-N-CA 121.497 -0.383 . . . . 0.0 112.873 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -70.02 -80.81 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.12 0.968 . . . . 0.0 111.437 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 116.15 26.45 3.22 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 116.437 -0.347 . . . . 0.0 113.221 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 9.3 pt-20 -89.0 114.54 25.73 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.416 0.627 . . . . 0.0 109.872 -172.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.667 HG13 ' HA ' ' A' ' 116' ' ' PRO . 33.6 m -111.0 126.15 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.183 0.593 . . . . 0.0 109.637 -173.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.19 109.28 13.37 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.1 t -113.06 131.8 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.321 0.648 . . . . 0.0 110.248 -172.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.1 99.87 12.38 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.756 0.822 . . . . 0.0 109.323 173.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 56.9 m -94.47 108.2 20.14 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.433 1.093 . . . . 0.0 108.436 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.514 ' HB ' HD11 ' A' ' 77' ' ' ILE . 5.1 tt -106.37 115.21 47.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.937 0.895 . . . . 0.0 110.205 -174.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -112.47 133.79 54.35 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.33 0.652 . . . . 0.0 110.025 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -106.96 112.88 26.04 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.766 0.826 . . . . 0.0 108.803 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 50.1 t -85.18 140.12 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.137 1.375 . . . . 0.0 110.332 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.403 ' HG3' HD21 ' A' ' 103' ' ' ASN . 9.7 tp10 -141.31 105.64 4.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.287 1.035 . . . . 0.0 108.866 -173.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.403 HD21 ' HG3' ' A' ' 102' ' ' GLU . 33.4 m-80 62.4 31.67 17.13 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.651 1.18 . . . . 0.0 112.11 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.86 -7.58 67.69 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.78 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -131.72 133.37 44.75 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.725 0.81 . . . . 0.0 109.653 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 67.1 mt -67.57 112.11 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.507 0.723 . . . . 0.0 110.191 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.25 -10.98 26.67 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -150.28 131.13 14.18 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.58 139.78 31.48 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.629 0.772 . . . . 0.0 109.232 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.424 ' HB2' HG23 ' A' ' 98' ' ' ILE . 3.1 m-90 -138.29 156.99 47.12 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -143.5 147.09 33.98 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.028 0.442 . . . . 0.0 110.149 171.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -129.02 122.51 30.19 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.245 1.018 . . . . 0.0 108.363 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.7 mt -87.69 130.38 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.35 -129.87 0.56 Allowed Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.469 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -90.18 161.11 38.59 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.667 ' HA ' HG13 ' A' ' 93' ' ' VAL . 76.2 Cg_endo -83.96 114.79 1.98 Allowed 'Trans proline' 0 CA--C 1.551 1.357 0 C-N-CA 122.234 1.956 . . . . 0.0 112.136 167.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.416 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 34.6 mtm180 -107.0 148.42 28.71 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 121.852 0.834 . . . . 0.0 110.759 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.3 mm -128.65 147.09 33.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.682 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 58.5 t -55.07 -29.34 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.553 0.741 . . . . 0.0 112.488 -177.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 80.4 p -73.09 -45.33 57.78 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.789 0.835 . . . . 0.0 112.335 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -104.3 -4.37 23.04 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -168.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.682 ' HE3' ' HA ' ' A' ' 119' ' ' VAL . 19.1 ptpt -61.36 149.07 39.36 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -173.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.2 p . . . . . 0 CA--C 1.559 1.291 0 C-N-CA 123.714 0.806 . . . . 0.0 109.966 -177.944 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 121.255 0.55 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -132.18 21.62 4.45 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.113 0.965 . . . . 0.0 109.54 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.434 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 22.2 t -68.73 -45.78 70.61 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 123.963 0.905 . . . . 0.0 110.902 -175.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -60.63 -17.33 46.41 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.886 0.875 . . . . 0.0 112.909 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.42 HG21 ' HB ' ' A' ' 101' ' ' VAL . 28.1 mm -87.29 -34.6 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.239 0.616 . . . . 0.0 109.574 178.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.91 -17.78 32.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 118.652 -0.69 . . . . 0.0 112.053 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.2 mt -62.7 -50.36 78.32 Favored Pre-proline 0 N--CA 1.488 1.465 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.635 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.634 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 14.1 Cg_endo -57.25 -51.92 7.59 Favored 'Trans proline' 0 C--N 1.388 2.642 0 C-N-CA 122.089 1.86 . . . . 0.0 112.047 172.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.402 ' HA ' ' OE1' ' A' ' 12' ' ' GLN . 85.5 t -63.96 -31.31 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 C-N-CA 124.55 1.14 . . . . 0.0 112.733 -172.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.61 -47.86 44.42 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.82 0.848 . . . . 0.0 109.519 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.1 mmtt -70.62 -25.56 63.09 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.947 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 9' ' ' VAL . 45.7 mt-30 -61.1 -46.77 89.26 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.654 0.597 . . . . 0.0 110.39 175.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.39 -50.45 71.56 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.144 0.903 . . . . 0.0 109.54 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -57.57 -45.78 84.77 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 124.656 1.222 . . . . 0.0 109.524 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 20' ' ' ASP . . . -68.82 -26.62 65.26 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.932 -1.485 . . . . 0.0 112.161 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -73.39 -38.71 65.54 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.022 0.529 . . . . 0.0 109.667 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -91.08 -29.9 17.06 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.563 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.69 0.29 57.45 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.361 0.664 . . . . 0.0 111.989 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.9 mmt-85 65.96 24.26 11.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.523 1.129 . . . . 0.0 113.121 172.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 48.1 m-20 -87.97 95.26 10.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.954 0.406 . . . . 0.0 110.724 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.498 HG13 HG12 ' A' ' 54' ' ' ILE . 8.3 mm -64.05 -30.44 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.568 0.747 . . . . 0.0 111.314 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.87 -45.63 92.93 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.313 0.383 . . . . 0.0 111.116 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.82 -35.99 62.43 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.259 0.624 . . . . 0.0 110.711 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -71.73 -4.4 27.36 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.845 0.858 . . . . 0.0 111.052 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.75 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -120.95 -23.2 5.94 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 172.198 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.74 -35.79 75.28 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.672 0.789 . . . . 0.0 112.82 -173.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.634 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 97.2 m95 -89.89 -7.69 53.6 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.41 ' CZ3' HG23 ' A' ' 49' ' ' ILE . 14.6 m95 -91.91 143.75 26.17 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.288 0.635 . . . . 0.0 110.049 -173.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.72 152.31 45.5 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.216 0.607 . . . . 0.0 110.066 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -68.82 -24.2 64.36 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 120.932 0.396 . . . . 0.0 110.689 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.59 19.32 16.01 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.727 1.211 . . . . 0.0 110.69 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.7 t -65.04 122.49 17.15 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 122.073 -0.392 . . . . 0.0 111.628 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -87.39 154.61 20.53 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.745 0.818 . . . . 0.0 109.331 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 48.2 t80 -145.06 114.28 7.03 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.413 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 17.3 m-85 -109.23 153.91 23.16 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.51 0.724 . . . . 0.0 110.288 176.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.408 ' HB2' HD12 ' A' ' 42' ' ' LEU . . . -112.84 151.28 30.58 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.066 173.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.635 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 84.7 t80 -57.64 128.84 80.47 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 123.656 0.782 . . . . 0.0 111.581 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.92 -50.32 0.19 OUTLIER 'Cis proline' 0 C--N 1.389 2.666 0 CA-C-N 120.464 1.201 . . . . 0.0 114.046 0.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.41 91.63 0.93 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.958 0.903 . . . . 0.0 108.757 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.3 m -136.7 107.84 6.78 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.5 103.97 1.8 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.271 0.628 . . . . 0.0 109.695 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 36' ' ' ALA . 49.5 mt -80.63 -36.55 32.45 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.948 0.899 . . . . 0.0 110.71 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 34' ' ' TYR . . . -140.09 121.18 14.72 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.154 0.582 . . . . 0.0 111.436 -171.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -107.62 40.01 2.68 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 123.401 0.524 . . . . 0.0 113.042 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.9 p30 165.64 164.67 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 126.023 1.729 . . . . 0.0 108.963 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.15 -37.86 88.73 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.777 0.831 . . . . 0.0 112.556 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.46 -43.26 99.18 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.294 0.638 . . . . 0.0 112.337 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -73.08 -30.0 63.35 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.711 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.41 HG23 ' CZ3' ' A' ' 28' ' ' TRP . 85.9 mt -66.58 -46.15 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.517 0.727 . . . . 0.0 109.871 173.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.75 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 36.8 ttt180 -56.28 -56.4 21.46 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.837 -176.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.438 ' HA ' HD12 ' A' ' 54' ' ' ILE . 29.4 m -63.48 -37.31 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 124.543 1.152 . . . . 0.0 113.147 -172.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -71.37 -34.51 70.5 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.028 0.442 . . . . 0.0 110.753 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -76.5 -26.96 55.84 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 118.965 -0.541 . . . . 0.0 111.2 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.498 HG12 HG13 ' A' ' 21' ' ' ILE . 85.6 mt -59.66 -47.82 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 172.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.03 -42.25 89.76 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.998 0.919 . . . . 0.0 111.179 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -66.44 -32.71 74.26 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.104 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -82.04 -13.31 57.53 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.259 0.624 . . . . 0.0 111.356 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 67.4 mmtt -73.13 -28.82 62.47 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.737 0.415 . . . . 0.0 110.486 170.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.53 115.38 21.56 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.987 0.915 . . . . 0.0 109.991 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.1 -22.76 18.96 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.578 2.185 . . . . 0.0 112.693 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.85 -12.09 59.48 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.786 0.834 . . . . 0.0 111.508 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.7 tp -60.02 117.17 4.77 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 123.515 0.509 . . . . 0.0 109.975 175.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -149.87 117.11 6.03 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.7 103.08 2.91 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -94.47 102.06 13.99 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 tt -82.83 125.39 31.27 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -29.98 5.97 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.01 0.924 . . . . 0.0 111.077 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 92.2 m -144.96 133.59 22.12 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.428 0.691 . . . . 0.0 109.991 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.495 ' NH2' HG13 ' A' ' 76' ' ' VAL . 7.4 ptm180 -142.87 138.35 30.2 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.929 0.492 . . . . 0.0 110.429 171.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.439 HG21 ' HB ' ' A' ' 77' ' ' ILE . 15.0 m -128.67 158.35 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 124.517 1.127 . . . . 0.0 108.761 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -129.75 142.53 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-O 121.025 0.44 . . . . 0.0 110.085 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.462 HG11 HG13 ' A' ' 75' ' ' VAL . 2.2 p -137.1 95.85 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 124.509 1.124 . . . . 0.0 108.945 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.71 -120.14 8.73 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.024 -0.535 . . . . 0.0 113.154 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -97.47 15.0 24.46 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.108 0.563 . . . . 0.0 112.063 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.462 HG13 HG11 ' A' ' 72' ' ' VAL . 4.4 p -135.88 135.5 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.526 0.73 . . . . 0.0 110.255 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.495 HG13 ' NH2' ' A' ' 69' ' ' ARG . 5.1 t -114.05 141.92 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.354 0.662 . . . . 0.0 110.245 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.452 HD13 ' HB ' ' A' ' 98' ' ' ILE . 17.7 mm -99.67 114.73 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.929 1.292 . . . . 0.0 107.896 168.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -112.21 106.03 14.51 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.468 ' HE2' ' HB3' ' A' ' 94' ' ' ASP . 51.9 t-80 -97.62 107.17 19.61 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -112.78 144.58 42.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.168 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.1 m -91.55 102.08 14.73 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 162.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.8 m -92.83 133.36 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.104 0.478 . . . . 0.0 110.791 -176.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 73.0 m -81.31 120.73 25.3 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.771 -177.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.581 HH21 HG12 ' A' ' 93' ' ' VAL . 72.9 mtm180 -118.84 -162.86 0.92 Allowed 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.693 1.197 . . . . 0.0 107.911 170.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -125.09 108.54 11.9 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 118.477 0.58 . . . . 0.0 110.994 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -109.95 145.03 31.21 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 123.794 0.838 . . . . 0.0 109.824 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.94 -19.03 67.94 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 123.369 2.713 . . . . 0.0 114.164 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -79.57 -20.04 47.97 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.29 -111.36 0.46 Allowed Glycine 0 C--N 1.348 1.242 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.726 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -62.37 -82.32 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.957 0.903 . . . . 0.0 111.693 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 117.14 26.1 3.06 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.994 -176.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -87.22 138.83 31.15 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.607 HG11 ' HA ' ' A' ' 116' ' ' PRO . 13.9 m -137.12 140.95 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 121.988 -0.445 . . . . 0.0 111.316 -173.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.468 ' HB3' ' HE2' ' A' ' 79' ' ' HIS . 72.9 m-20 -75.6 112.79 12.31 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 174.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.24 133.6 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.079 0.952 . . . . 0.0 108.499 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.77 111.13 23.47 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.4 m -94.08 107.49 19.41 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.617 HG23 ' HB2' ' A' ' 110' ' ' TRP . 5.4 tt -112.87 107.94 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 124.35 1.06 . . . . 0.0 109.82 -169.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -109.93 127.91 55.05 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.815 0.846 . . . . 0.0 110.408 -174.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 33.6 tt0 -99.26 112.81 24.89 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 173.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.433 HG22 HG12 ' A' ' 106' ' ' ILE . 60.7 t -96.98 113.14 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.322 1.049 . . . . 0.0 109.492 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 35.0 tt0 -113.54 126.88 55.79 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.835 0.854 . . . . 0.0 108.94 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 63.09 33.67 14.39 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.262 1.025 . . . . 0.0 112.096 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.86 7.2 88.7 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.807 -0.633 . . . . 0.0 114.336 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -133.84 143.76 48.53 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.161 0.984 . . . . 0.0 108.852 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' A' ' 8' ' ' PRO . 55.2 mt -67.95 102.7 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.42 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -84.06 -23.02 31.03 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.165 0.586 . . . . 0.0 111.02 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 79.5 mttt -149.28 146.47 27.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.01 0.924 . . . . 0.0 109.061 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -142.81 133.07 24.66 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.617 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.0 m-90 -135.68 159.49 41.48 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -142.78 145.6 33.42 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 169.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.635 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 14.4 ptmm? -126.86 123.52 37.48 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 95.1 mt -89.33 116.16 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.4 -71.8 1.03 Allowed Glycine 0 CA--C 1.523 0.561 0 CA-C-N 114.24 -1.345 . . . . 0.0 113.592 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -157.01 162.86 26.84 Favored Pre-proline 0 CA--C 1.548 0.904 0 CA-C-N 116.825 0.313 . . . . 0.0 110.723 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.607 ' HA ' HG11 ' A' ' 93' ' ' VAL . 92.7 Cg_endo -77.37 137.01 16.36 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.598 2.199 . . . . 0.0 113.596 171.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.459 ' HA ' ' NE2' ' A' ' 121' ' ' GLN . 34.6 mmt180 -129.26 153.56 47.67 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.438 1.095 . . . . 0.0 109.98 176.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.41 HG21 ' H ' ' A' ' 120' ' ' SER . 30.4 mm -138.98 151.51 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.5 t -56.94 -45.98 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 122.999 0.52 . . . . 0.0 111.259 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.41 ' H ' HG21 ' A' ' 118' ' ' ILE . 22.7 t -78.62 -11.43 59.97 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.84 0.856 . . . . 0.0 112.763 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.459 ' NE2' ' HA ' ' A' ' 117' ' ' ARG . 31.4 tt0 -51.91 -53.22 43.53 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.699 0.8 . . . . 0.0 111.456 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -84.73 100.27 11.39 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 173.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.4 t . . . . . 0 C--O 1.255 1.372 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.56 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.733 0.301 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -102.68 27.12 7.22 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.584 0.753 . . . . 0.0 110.882 -170.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.4 m -71.8 -35.07 69.85 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.405 0.682 . . . . 0.0 112.693 -169.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -14.36 62.02 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.649 0.38 . . . . 0.0 111.718 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.491 HG13 ' HA ' ' A' ' 74' ' ' ASN . 27.2 mm -90.68 -28.45 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.866 0.867 . . . . 0.0 110.111 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.28 -32.08 71.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.676 0.79 . . . . 0.0 111.615 173.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.6 mt -61.94 -52.1 70.46 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-O 118.675 -0.678 . . . . 0.0 112.358 -175.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 23.0 Cg_endo -60.35 -51.1 5.8 Favored 'Trans proline' 0 C--N 1.396 3.063 0 C-N-CA 122.493 2.129 . . . . 0.0 113.739 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.5 m -67.81 -32.72 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 122.699 0.4 . . . . 0.0 112.025 -170.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -73.38 -50.68 20.61 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.255 0.622 . . . . 0.0 111.076 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -70.96 -30.64 66.98 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.5 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -69.6 -39.6 77.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.142 0.577 . . . . 0.0 109.477 177.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -58.87 -52.28 66.41 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.219 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.44 -29.57 64.28 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.824 0.702 . . . . 0.0 111.202 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 20' ' ' ASP . . . -79.47 -31.57 42.44 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.997 0.919 . . . . 0.0 111.881 176.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -62.94 -51.29 67.48 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.173 0.589 . . . . 0.0 111.271 -173.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -75.96 -20.94 57.52 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.691 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.9 1.23 54.57 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.515 0.726 . . . . 0.0 112.401 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 62.86 22.79 13.63 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.656 1.182 . . . . 0.0 111.936 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 5.8 t70 -89.86 131.74 35.63 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.433 ' HA ' ' HB3' ' A' ' 24' ' ' PHE . 14.9 mm -104.12 -27.46 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.292 0.637 . . . . 0.0 110.816 174.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.27 -48.36 81.78 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.85 0.46 . . . . 0.0 111.58 -176.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.46 -33.76 36.44 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.749 0.82 . . . . 0.0 110.637 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.433 ' HB3' ' HA ' ' A' ' 21' ' ' ILE . 49.8 t80 -59.87 -24.7 64.46 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.39 175.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 79.6 mmm -120.44 0.6 10.57 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.09 -41.16 77.86 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.367 0.603 . . . . 0.0 111.608 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 89.9 m95 -83.42 -0.02 48.15 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.654 -173.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.5 ' HE1' ' HG3' ' A' ' 12' ' ' GLN . 21.7 m95 -91.24 143.17 26.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.225 0.61 . . . . 0.0 110.352 -175.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -70.5 148.55 48.12 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.9 173.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.56 -28.64 70.01 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 120.84 0.353 . . . . 0.0 111.588 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -97.4 19.08 13.85 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.205 1.002 . . . . 0.0 110.973 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 48.6 t -62.62 123.52 18.58 Favored 'General case' 0 C--N 1.357 0.909 0 O-C-N 121.913 -0.492 . . . . 0.0 111.987 -174.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -89.72 151.4 21.86 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.294 1.038 . . . . 0.0 109.31 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -139.34 119.25 13.36 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.462 ' HH ' HD13 ' A' ' 41' ' ' LEU . 61.9 m-85 -122.34 154.8 37.16 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.13 0.972 . . . . 0.0 111.197 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.46 ' HB3' HD21 ' A' ' 42' ' ' LEU . . . -128.75 160.12 33.53 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.769 1.228 . . . . 0.0 109.625 177.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -63.18 139.71 97.58 Favored Pre-proline 0 CA--C 1.561 1.385 0 C-N-CA 124.114 0.966 . . . . 0.0 111.538 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.89 -44.59 0.51 Allowed 'Cis proline' 0 C--N 1.381 2.287 0 CA-C-N 120.152 1.09 . . . . 0.0 113.183 -9.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.53 79.58 0.5 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.132 0.573 . . . . 0.0 110.382 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.9 m -123.44 125.22 44.55 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.688 0.795 . . . . 0.0 109.588 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.462 HD13 ' HH ' ' A' ' 35' ' ' TYR . 3.8 tt -84.33 110.95 18.99 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 173.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.46 HD21 ' HB3' ' A' ' 36' ' ' ALA . 1.4 mm? -85.55 -51.1 6.72 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.27 0.628 . . . . 0.0 109.363 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . . . -140.13 120.73 14.23 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.219 -168.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.28 37.42 3.83 Favored Glycine 0 N--CA 1.477 1.372 0 O-C-N 123.135 0.272 . . . . 0.0 113.539 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.5 p30 175.45 155.22 0.17 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.02 1.728 . . . . 0.0 108.722 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -64.12 -25.89 68.3 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.806 0.843 . . . . 0.0 113.162 -172.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.93 -47.25 81.26 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.928 0.491 . . . . 0.0 110.78 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 31.7 mt-10 -70.83 -37.97 73.22 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.771 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.5 mt -61.68 -43.25 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.262 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.482 ' O ' HG13 ' A' ' 54' ' ' ILE . 69.4 ttt-85 -60.17 -56.25 23.94 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.272 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.8 t -53.8 -49.06 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 124.546 1.154 . . . . 0.0 111.98 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -61.14 -36.26 79.29 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.183 0.593 . . . . 0.0 111.383 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -75.97 -32.7 59.62 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.748 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 50' ' ' ARG . 64.4 mt -64.64 -42.67 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -62.98 -31.25 72.32 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.096 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -85.33 -11.18 55.23 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.324 0.65 . . . . 0.0 111.525 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.451 ' HA ' HD21 ' A' ' 62' ' ' LEU . 3.3 m-85 -89.99 -0.7 57.73 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.471 0.709 . . . . 0.0 110.876 172.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.446 ' HE2' HG22 ' A' ' 54' ' ' ILE . 72.6 mmtt -82.56 -4.13 57.12 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.28 0.632 . . . . 0.0 112.091 173.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.716 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 22.5 mm-40 -67.66 120.13 71.13 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -65.62 -24.33 55.74 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.058 1.838 . . . . 0.0 112.693 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -111.54 21.76 15.81 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.596 0.758 . . . . 0.0 111.611 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.716 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 39.4 tp -67.2 111.62 4.04 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 120.795 0.331 . . . . 0.0 110.235 175.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -138.11 136.41 36.7 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.514 0.726 . . . . 0.0 109.301 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.32 128.06 8.93 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.329 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -127.74 99.91 5.74 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 tt -81.35 134.75 35.62 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-O 121.452 0.644 . . . . 0.0 110.354 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.446 HD22 ' HG1' ' A' ' 81' ' ' THR . 7.8 mt -107.05 -50.7 3.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.161 -171.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.2 m -152.48 125.89 8.76 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.243 -1.799 . . . . 0.0 109.136 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -118.18 132.92 56.29 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 167.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.3 m -118.8 122.52 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.006 0.923 . . . . 0.0 109.285 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.472 HD13 ' HB ' ' A' ' 5' ' ' ILE . 17.4 tt -105.74 136.77 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 122.782 0.433 . . . . 0.0 110.796 -175.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.411 HG12 HG12 ' A' ' 75' ' ' VAL . 2.1 p -146.38 112.87 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.419 1.087 . . . . 0.0 109.488 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.83 -104.73 1.06 Allowed Glycine 0 C--N 1.346 1.098 0 CA-C-N 116.384 -0.371 . . . . 0.0 112.743 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.491 ' HA ' HG13 ' A' ' 5' ' ' ILE . 4.0 p-10 -122.55 15.61 10.34 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.096 0.559 . . . . 0.0 111.074 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.411 HG12 HG12 ' A' ' 72' ' ' VAL . 3.0 p -135.37 132.64 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.766 0.826 . . . . 0.0 110.173 -173.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.03 141.22 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.65 0.78 . . . . 0.0 110.239 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.561 HG12 ' HB ' ' A' ' 98' ' ' ILE . 3.1 mt -100.58 103.93 15.49 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 165.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -93.38 106.22 18.21 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -100.09 109.35 21.64 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.691 -176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.15 171.14 7.61 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.103 0.961 . . . . 0.0 111.057 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.446 ' HG1' HD22 ' A' ' 67' ' ' LEU . 18.0 m -109.13 102.23 11.21 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 161.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -81.98 108.91 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.659 1.184 . . . . 0.0 110.029 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 75.7 m -68.59 119.02 12.36 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 122.952 0.501 . . . . 0.0 110.502 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -117.06 -169.13 1.59 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.396 1.078 . . . . 0.0 109.787 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -118.34 102.91 9.31 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.63 0.772 . . . . 0.0 110.448 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -112.07 134.07 21.52 Favored Pre-proline 0 N--CA 1.474 0.728 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 171.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.74 -12.4 32.84 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.827 2.351 . . . . 0.0 113.409 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -83.1 -10.86 58.45 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.657 0.383 . . . . 0.0 111.902 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.86 -125.75 1.09 Allowed Glycine 0 C--N 1.349 1.269 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.691 172.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -71.01 -80.1 0.06 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.84 0.856 . . . . 0.0 110.704 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.33 27.15 2.06 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 113.455 0.142 . . . . 0.0 113.455 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 1.5 pm0 -88.95 112.28 23.14 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.762 0.791 . . . . 0.0 109.501 -171.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 116' ' ' PRO . 30.2 m -106.43 141.12 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.594 0.757 . . . . 0.0 110.313 -172.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -83.62 124.1 30.47 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.0 127.65 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.051 0.541 . . . . 0.0 109.649 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.47 102.59 14.41 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.627 0.771 . . . . 0.0 109.235 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.4 m -98.31 118.28 34.6 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.561 ' HB ' HG12 ' A' ' 77' ' ' ILE . 11.3 tt -111.75 105.77 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 C-N-CA 123.94 0.896 . . . . 0.0 110.81 -177.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -99.29 129.07 45.48 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.098 0.959 . . . . 0.0 110.457 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 34.8 tt0 -97.72 114.44 26.44 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.237 0.541 . . . . 0.0 109.68 170.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 61.7 t -99.86 111.65 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 124.562 1.145 . . . . 0.0 110.133 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 34.5 tt0 -112.18 132.97 54.59 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.253 1.021 . . . . 0.0 109.942 174.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 63.46 30.34 15.33 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.604 1.161 . . . . 0.0 111.46 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.99 14.0 75.98 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.051 -0.522 . . . . 0.0 113.458 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -129.79 134.66 47.71 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.803 1.241 . . . . 0.0 108.96 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 70.6 mt -63.95 99.39 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -82.7 -24.31 33.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.423 0.689 . . . . 0.0 110.912 -177.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 74.2 mttt -147.88 148.47 30.88 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.378 1.071 . . . . 0.0 108.216 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.78 132.19 20.79 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 172.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.539 ' HB2' HG23 ' A' ' 98' ' ' ILE . 1.5 m-90 -128.62 146.76 50.76 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -177.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -142.47 146.88 35.23 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.381 0.991 . . . . 0.0 110.97 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -129.91 122.14 28.02 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.073 0.949 . . . . 0.0 108.663 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.35 128.96 41.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.47 -121.24 0.55 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.099 -0.955 . . . . 0.0 113.448 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -97.91 141.09 22.42 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.22 1.008 . . . . 0.0 110.459 -172.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.565 ' HA ' HG11 ' A' ' 93' ' ' VAL . 55.9 Cg_endo -71.51 115.86 4.46 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.006 2.471 . . . . 0.0 110.492 170.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -121.22 153.87 37.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.273 0.629 . . . . 0.0 111.377 -174.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.5 mm -129.77 132.84 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.806 1.242 . . . . 0.0 108.966 174.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.6 t -55.1 -38.94 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.999 0.92 . . . . 0.0 112.197 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.9 t -72.58 -32.16 65.79 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.161 0.584 . . . . 0.0 111.695 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -91.83 79.85 5.29 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.404 0.682 . . . . 0.0 110.115 -173.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.537 ' HB3' ' HZ2' ' A' ' 122' ' ' LYS . 9.7 mtpm? -134.08 138.89 45.6 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.336 0.654 . . . . 0.0 110.37 -177.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 CA--C 1.557 1.221 0 C-N-CA 123.899 0.88 . . . . 0.0 109.29 -177.494 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.474 ' HB2' HD12 ' A' ' 71' ' ' ILE . 16.3 m120 -89.53 76.89 7.34 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.766 0.826 . . . . 0.0 110.145 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 66.6 m -69.36 -41.02 77.13 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.8 0.84 . . . . 0.0 111.736 -176.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -11.73 58.23 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.04 0.536 . . . . 0.0 112.208 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.443 HG22 HG23 ' A' ' 76' ' ' VAL . 37.8 mm -91.09 -33.11 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.57 0.748 . . . . 0.0 109.918 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -79.9 -17.59 52.72 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 119.099 -0.477 . . . . 0.0 112.225 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 3' ' ' SER . 93.5 mt -62.74 -52.1 67.0 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.963 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.573 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 24.4 Cg_endo -60.76 -47.37 13.48 Favored 'Trans proline' 0 C--N 1.395 2.988 0 C-N-CA 121.797 1.664 . . . . 0.0 111.887 173.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.431 ' HA ' HE21 ' A' ' 12' ' ' GLN . 73.5 t -59.02 -43.73 89.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 124.226 1.011 . . . . 0.0 112.285 -173.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.665 ' HG2' HH12 ' A' ' 69' ' ' ARG . 6.7 mm100 -68.47 -49.36 60.33 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.082 0.553 . . . . 0.0 111.767 175.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -63.81 -27.71 69.37 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -175.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.431 HE21 ' HA ' ' A' ' 9' ' ' VAL . 46.7 mt-30 -69.0 -47.32 65.82 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 123.489 0.493 . . . . 0.0 109.768 174.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.502 HD12 ' HB2' ' A' ' 66' ' ' LEU . 2.7 tt -57.1 -54.16 49.92 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.782 1.301 . . . . 0.0 109.442 -177.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.44 ' HA ' HD22 ' A' ' 17' ' ' ASN . 16.0 mm-40 -61.17 -37.8 84.19 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.859 -176.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -71.07 -27.4 63.6 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.55 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.406 ' CZ ' HD11 ' A' ' 62' ' ' LEU . 84.8 t80 -73.08 -38.57 66.37 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.006 0.922 . . . . 0.0 110.522 -175.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.44 HD22 ' HA ' ' A' ' 14' ' ' GLU . 10.0 p30 -88.42 -28.3 21.0 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.983 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.84 0.84 57.47 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.366 0.666 . . . . 0.0 112.265 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 64.7 mmt-85 71.33 12.6 6.68 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.058 1.343 . . . . 0.0 113.619 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.527 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 10.2 m-20 -74.37 95.12 2.64 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.824 0.449 . . . . 0.0 110.917 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.2 mm -66.22 -26.19 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 122.942 0.497 . . . . 0.0 110.574 169.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -60.14 -48.78 80.27 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.164 0.586 . . . . 0.0 111.142 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.62 -30.31 36.76 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.18 0.592 . . . . 0.0 110.767 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -72.56 -6.78 46.39 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.224 0.61 . . . . 0.0 110.967 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.739 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -119.26 -27.25 5.68 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 173.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.94 -30.09 70.01 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -172.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.573 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.3 m95 -95.37 -0.12 52.95 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.355 0.662 . . . . 0.0 112.575 -175.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -97.55 148.66 23.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.435 0.694 . . . . 0.0 109.219 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.68 154.74 29.88 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.42 0.688 . . . . 0.0 109.402 172.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -69.84 -23.66 63.33 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.81 0.444 . . . . 0.0 111.468 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -95.59 17.99 13.73 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.079 0.952 . . . . 0.0 111.073 177.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 45.4 t -64.21 123.24 18.58 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.006 0.431 . . . . 0.0 111.95 -174.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.406 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . 35.4 mm-40 -96.17 103.74 15.66 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.06 0.944 . . . . 0.0 109.743 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 55.2 t80 -96.37 111.86 23.8 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.001 0.92 . . . . 0.0 110.276 -177.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.406 ' HE1' ' HB3' ' A' ' 33' ' ' GLN . 80.5 m-85 -116.05 155.16 28.62 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.719 0.808 . . . . 0.0 110.498 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.91 160.67 17.19 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.691 1.196 . . . . 0.0 108.332 167.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -52.04 133.19 40.14 Favored Pre-proline 0 CA--C 1.568 1.635 0 C-N-CA 123.599 0.759 . . . . 0.0 112.431 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.48 -40.95 1.02 Allowed 'Cis proline' 0 C--N 1.384 2.398 0 C-N-CA 124.759 -0.934 . . . . 0.0 112.963 -7.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.83 56.86 0.2 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.631 0.772 . . . . 0.0 109.861 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.2 m -92.9 114.4 26.95 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.134 0.973 . . . . 0.0 109.484 176.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.7 tp -78.16 103.82 8.34 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.447 0.567 . . . . 0.0 109.595 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.04 -37.89 33.06 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 34' ' ' TYR . . . -146.38 117.17 7.65 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.14 -172.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.24 45.23 1.39 Allowed Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.989 -0.339 . . . . 0.0 112.322 -176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 161.35 161.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 126.233 1.813 . . . . 0.0 109.066 -171.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.443 ' HA ' HD13 ' A' ' 49' ' ' ILE . . . -64.75 -35.52 81.34 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.857 0.863 . . . . 0.0 113.049 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.65 -46.91 87.61 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.041 0.536 . . . . 0.0 112.092 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.6 mt-10 -72.45 -29.41 63.65 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.823 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 46' ' ' ALA . 94.6 mt -63.97 -49.19 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.788 0.835 . . . . 0.0 110.264 175.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.739 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 77.4 ttt180 -55.76 -56.63 18.21 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.152 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.454 ' HA ' HD12 ' A' ' 54' ' ' ILE . 26.8 m -65.21 -35.99 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 124.433 1.083 . . . . 0.0 112.698 -173.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -69.06 -34.95 75.98 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.195 0.598 . . . . 0.0 110.423 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -78.42 -28.49 46.79 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 118.455 -0.784 . . . . 0.0 111.785 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 51' ' ' VAL . 94.2 mt -57.34 -41.19 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-N 118.593 0.633 . . . . 0.0 109.514 173.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.16 -37.72 86.29 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.349 1.06 . . . . 0.0 111.735 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -79.43 -25.98 41.92 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.387 0.675 . . . . 0.0 111.014 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -79.8 -15.97 56.41 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.818 0.447 . . . . 0.0 110.649 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -62.61 -28.47 69.91 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.941 0.497 . . . . 0.0 110.823 168.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -66.26 118.61 54.75 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.617 0.767 . . . . 0.0 110.581 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.29 -29.2 17.41 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.541 2.161 . . . . 0.0 111.704 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.14 -18.02 63.21 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.322 1.049 . . . . 0.0 111.504 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.406 HD11 ' CZ ' ' A' ' 16' ' ' TYR . 46.1 tp -59.17 123.57 17.11 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.595 0.758 . . . . 0.0 111.511 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.496 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 69.9 t80 -152.21 125.49 8.72 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.49 109.22 3.39 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -118.4 110.93 18.05 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.316 0.647 . . . . 0.0 109.731 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.502 ' HB2' HD12 ' A' ' 13' ' ' LEU . 17.4 tp -76.91 146.53 37.55 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.428 0.455 . . . . 0.0 111.155 -177.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mt -112.69 -51.45 2.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.815 0.846 . . . . 0.0 109.346 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.7 m -157.45 153.11 26.61 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.758 -1.564 . . . . 0.0 108.922 -170.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.665 HH12 ' HG2' ' A' ' 10' ' ' GLN . 4.3 ptp180 -142.27 139.2 31.84 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.921 0.488 . . . . 0.0 109.901 169.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.479 HG22 ' HB ' ' A' ' 77' ' ' ILE . 17.8 m -112.42 111.28 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 122.159 0.98 . . . . 0.0 108.592 173.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 2' ' ' ASN . 11.7 tt -99.93 139.13 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.038 -177.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.453 HG11 HG11 ' A' ' 75' ' ' VAL . 2.5 p -145.9 99.45 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.801 1.24 . . . . 0.0 108.666 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.12 -120.82 21.2 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.986 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -86.44 2.44 47.72 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.496 0.718 . . . . 0.0 112.777 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.453 HG11 HG11 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -129.19 132.46 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.309 0.643 . . . . 0.0 110.716 -173.055 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.443 HG23 HG22 ' A' ' 5' ' ' ILE . 59.2 t -116.0 138.85 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.925 0.89 . . . . 0.0 109.074 174.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.563 HD12 ' HB ' ' A' ' 98' ' ' ILE . 9.6 mm -97.11 103.15 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 164.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -95.68 104.19 16.1 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -177.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -99.92 107.96 20.08 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.581 0.705 . . . . 0.0 109.846 -173.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.32 168.5 12.41 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.132 -177.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 m -117.47 104.27 10.92 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 168.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.0 m -91.22 125.17 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.274 0.559 . . . . 0.0 111.463 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 63' ' ' TYR . 34.9 m -76.86 133.66 39.25 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.073 176.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -133.12 -160.72 1.07 Allowed 'General case' 0 C--O 1.247 0.944 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -128.89 105.52 8.28 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.446 0.566 . . . . 0.0 110.193 174.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -106.32 135.03 19.53 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.88 -21.12 71.63 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.921 2.414 . . . . 0.0 113.446 -174.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -74.64 -25.81 59.46 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.01 0.524 . . . . 0.0 111.693 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.14 -120.08 0.6 Allowed Glycine 0 C--N 1.352 1.463 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.709 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -72.53 -81.0 0.06 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.605 0.762 . . . . 0.0 111.3 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.19 27.24 2.07 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 113.722 0.249 . . . . 0.0 113.722 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -90.7 133.39 35.18 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.574 HG13 ' HA ' ' A' ' 116' ' ' PRO . 35.9 m -130.66 134.62 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 122.464 0.306 . . . . 0.0 110.79 -172.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.23 117.0 17.47 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.578 HG23 HG12 ' A' ' 113' ' ' ILE . 16.7 t -123.74 158.88 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.649 1.18 . . . . 0.0 108.768 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -118.16 99.93 7.19 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 169.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 93.5 m -95.05 107.52 19.57 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.563 ' HB ' HD12 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -96.17 138.12 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.988 0.915 . . . . 0.0 109.412 -177.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -127.42 119.98 27.38 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.619 0.768 . . . . 0.0 108.993 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 43.2 tt0 -97.14 112.48 24.25 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 48.7 t -95.5 139.54 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.166 1.386 . . . . 0.0 109.778 -175.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.449 ' HG3' HD21 ' A' ' 103' ' ' ASN . 8.9 tp10 -129.79 100.44 5.49 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.553 1.141 . . . . 0.0 108.416 -175.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.449 HD21 ' HG3' ' A' ' 102' ' ' GLU . 24.7 m-80 59.79 32.7 21.48 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.82 1.248 . . . . 0.0 112.117 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.24 -7.62 54.57 Favored Glycine 0 N--CA 1.475 1.244 0 N-CA-C 114.317 0.487 . . . . 0.0 114.317 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.9 mmt-85 -127.53 133.24 49.82 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.446 0.623 . . . . 0.0 109.821 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.466 HD13 ' HB2' ' A' ' 8' ' ' PRO . 68.2 mt -70.02 106.27 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.189 0.996 . . . . 0.0 110.447 -173.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -82.69 -18.88 39.37 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.981 0.512 . . . . 0.0 111.671 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 75.1 mttt -151.99 134.14 15.09 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -139.52 129.02 24.31 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 172.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.406 ' CE3' HD13 ' A' ' 98' ' ' ILE . 1.5 m0 -130.52 159.06 38.23 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -176.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -142.79 146.38 34.18 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -137.29 127.41 26.08 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.578 HG12 HG23 ' A' ' 95' ' ' VAL . 89.3 mt -88.75 125.75 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.55 -60.53 8.6 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 114.869 -1.06 . . . . 0.0 113.09 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -160.56 168.32 12.05 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.457 0.703 . . . . 0.0 109.819 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.574 ' HA ' HG13 ' A' ' 93' ' ' VAL . 65.7 Cg_endo -85.76 130.98 3.79 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.718 2.279 . . . . 0.0 112.188 163.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -127.53 157.96 38.71 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.916 0.487 . . . . 0.0 110.693 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.4 mm -133.67 127.37 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.64 -41.52 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 123.876 0.87 . . . . 0.0 111.094 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.9 t -64.23 -21.13 66.47 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.785 0.834 . . . . 0.0 112.207 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -94.35 86.32 4.85 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.007 0.523 . . . . 0.0 109.867 177.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -81.94 90.37 6.45 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 C--O 1.255 1.346 0 C-N-CA 123.341 0.657 . . . . 0.0 109.718 -179.462 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.547 ' HB3' HD11 ' A' ' 71' ' ' ILE . 81.8 m-20 71.12 -12.86 0.55 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 168.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.458 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 23.4 m -66.47 -40.71 89.49 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.76 0.824 . . . . 0.0 111.261 -174.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -14.23 62.85 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 122.98 0.512 . . . . 0.0 111.697 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.475 HG23 HG21 ' A' ' 76' ' ' VAL . 22.8 mm -95.08 -29.49 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.811 0.844 . . . . 0.0 109.832 175.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -84.25 -20.94 31.38 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.077 0.951 . . . . 0.0 112.167 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 3' ' ' SER . 68.4 mt -67.23 -48.99 46.3 Favored Pre-proline 0 N--CA 1.486 1.338 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.092 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.597 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 10.8 Cg_endo -54.47 -52.9 7.12 Favored 'Trans proline' 0 C--N 1.391 2.771 0 C-N-CA 121.708 1.605 . . . . 0.0 111.291 172.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.8 t -57.98 -43.2 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.323 1.049 . . . . 0.0 112.81 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.402 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -64.98 -54.93 22.72 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.352 0.661 . . . . 0.0 110.201 -176.348 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -71.91 -35.14 69.61 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.873 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.441 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 1.0 OUTLIER -72.73 -30.42 64.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.76 0.824 . . . . 0.0 110.946 -176.433 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.49 HD23 HD11 ' A' ' 66' ' ' LEU . 59.4 tp -62.36 -52.13 64.84 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.18 0.592 . . . . 0.0 109.657 173.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 14.7 mm-40 -53.34 -45.81 69.24 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.05 175.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 20' ' ' ASP . . . -64.92 -30.26 71.25 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.349 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -69.02 -46.38 68.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.139 0.575 . . . . 0.0 110.578 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -84.24 -24.18 30.11 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.956 0.502 . . . . 0.0 111.525 -177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.09 2.06 55.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.259 0.624 . . . . 0.0 112.141 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.7 mmt-85 68.53 15.02 9.15 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.894 1.278 . . . . 0.0 112.948 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 10.0 m-20 -77.13 96.53 4.5 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.868 0.467 . . . . 0.0 110.738 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.8 mm -64.34 -33.55 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.553 0.741 . . . . 0.0 111.122 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.13 -48.62 79.65 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.144 0.578 . . . . 0.0 111.664 -175.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.73 -29.8 40.68 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.197 0.599 . . . . 0.0 110.737 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -69.29 -13.05 62.18 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.817 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.628 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 3.8 mmt -116.6 -15.61 10.81 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.61 0.764 . . . . 0.0 112.344 175.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.04 99.79 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.639 0.776 . . . . 0.0 112.295 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.597 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 86.3 m95 -92.95 0.97 57.52 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.379 -172.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.441 ' HE1' ' HG3' ' A' ' 12' ' ' GLN . 17.8 m95 -96.67 148.8 22.49 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.56 0.744 . . . . 0.0 109.992 -177.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.9 149.41 39.48 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.78 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.27 -20.75 64.81 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.462 0.305 . . . . 0.0 111.755 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -104.86 18.71 21.83 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.819 0.847 . . . . 0.0 111.799 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 43.0 t -62.6 127.08 29.62 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -172.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.555 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 57.7 mm-40 -96.16 104.57 16.53 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.839 0.856 . . . . 0.0 109.922 -176.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -98.18 115.33 28.1 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 124.463 1.105 . . . . 0.0 109.938 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.458 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 80.7 m-85 -114.62 154.63 28.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.954 0.902 . . . . 0.0 110.936 177.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.21 155.92 19.4 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.791 167.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.522 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 71.6 t80 -62.0 133.24 93.91 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 123.275 0.63 . . . . 0.0 110.978 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.54 -45.26 0.43 Allowed 'Cis proline' 0 C--N 1.383 2.36 0 CA-C-N 120.235 1.12 . . . . 0.0 113.95 -4.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.76 67.33 0.44 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.35 0.595 . . . . 0.0 110.285 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 33.9 m -105.98 115.77 30.79 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.1 tp -75.26 103.87 5.6 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.79 -36.48 50.32 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.473 0.709 . . . . 0.0 109.542 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . . . -157.74 122.27 4.3 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.4 -176.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.75 26.0 24.09 Favored Glycine 0 N--CA 1.477 1.383 0 O-C-N 123.224 0.328 . . . . 0.0 113.897 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.0 p30 178.93 156.73 0.49 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.164 1.385 . . . . 0.0 109.628 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.02 -34.01 71.39 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.23 1.012 . . . . 0.0 113.143 -172.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.57 -44.27 97.34 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.783 0.433 . . . . 0.0 111.148 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . 38.1 mt-10 -75.67 -30.06 59.28 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.661 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 79.8 mt -63.33 -40.82 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 123.134 0.574 . . . . 0.0 109.492 176.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.628 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 39.8 ttt180 -55.6 -56.1 24.25 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.41 175.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.06 -43.97 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 124.487 1.117 . . . . 0.0 111.183 -173.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.428 ' HA ' ' HE ' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -60.65 -42.6 97.3 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.844 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -78.97 -26.8 43.45 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-O 118.452 -0.785 . . . . 0.0 112.347 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.415 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 66.2 mt -57.34 -43.38 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.113 0.869 . . . . 0.0 108.971 173.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -62.32 -34.7 77.13 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.097 0.959 . . . . 0.0 111.368 177.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -77.71 -25.14 49.14 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 123.413 0.685 . . . . 0.0 111.036 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -84.12 -14.25 50.82 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.36 0.664 . . . . 0.0 110.491 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 10.4 mmpt? -69.14 -21.15 64.03 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.226 0.61 . . . . 0.0 110.583 171.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.84 114.27 12.94 Favored Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 124.152 0.981 . . . . 0.0 109.739 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.73 -22.1 24.32 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.483 2.122 . . . . 0.0 111.953 177.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.57 6.9 47.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.215 1.006 . . . . 0.0 111.634 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 tp -66.97 112.29 4.26 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-O 120.978 0.418 . . . . 0.0 109.938 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -144.2 115.89 8.2 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.29 100.74 2.13 Favored Glycine 0 C--N 1.342 0.861 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 174.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -88.0 101.5 13.83 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.49 HD11 HD23 ' A' ' 13' ' ' LEU . 8.5 tt -75.32 115.95 15.52 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.34 -33.46 8.18 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.914 -175.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.0 m -139.78 138.52 35.93 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.302 0.641 . . . . 0.0 109.796 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -142.91 133.81 25.52 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.759 0.823 . . . . 0.0 109.556 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.498 HG22 ' HB ' ' A' ' 77' ' ' ILE . 20.1 m -126.63 155.7 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.253 1.021 . . . . 0.0 108.658 173.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.547 HD11 ' HB3' ' A' ' 2' ' ' ASN . 15.1 tt -137.75 140.32 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.107 0.48 . . . . 0.0 111.081 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 p -144.48 107.24 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 125.144 1.377 . . . . 0.0 108.443 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.55 -119.25 14.7 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.839 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 17.0 p-10 -99.72 18.77 17.33 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.039 0.536 . . . . 0.0 111.407 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.2 t -126.73 136.75 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.45 1.1 . . . . 0.0 110.097 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.475 HG21 HG23 ' A' ' 5' ' ' ILE . 62.3 t -123.7 137.3 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.437 0.695 . . . . 0.0 109.646 173.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.498 ' HB ' HG22 ' A' ' 70' ' ' VAL . 7.8 mm -98.01 103.75 15.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 165.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -101.18 105.39 16.52 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.496 ' HE1' ' HB2' ' A' ' 94' ' ' ASP . 40.5 t-80 -99.79 113.71 26.4 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.0 -176.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.97 154.14 45.92 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.894 1.277 . . . . 0.0 110.564 -176.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.409 HG22 ' HB2' ' A' ' 92' ' ' GLU . 39.0 m -100.46 111.69 23.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.699 0.799 . . . . 0.0 109.556 172.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.99 115.54 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.503 1.121 . . . . 0.0 110.038 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.8 m -77.81 121.52 24.19 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 122.813 0.445 . . . . 0.0 110.695 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -122.9 -177.05 3.55 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.395 1.078 . . . . 0.0 108.289 172.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -115.73 103.68 10.92 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.929 0.491 . . . . 0.0 110.112 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -109.48 138.62 20.61 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 123.539 0.736 . . . . 0.0 109.133 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.65 -17.66 60.9 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.306 2.671 . . . . 0.0 114.274 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -82.87 -10.89 58.61 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 122.861 0.465 . . . . 0.0 112.138 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.48 -123.84 1.06 Allowed Glycine 0 C--N 1.346 1.123 0 CA-C-O 119.852 -0.415 . . . . 0.0 112.517 171.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -66.66 -76.63 0.08 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.9 0.88 . . . . 0.0 110.505 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.23 27.06 4.07 Favored Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.699 -0.228 . . . . 0.0 113.085 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.409 ' HB2' HG22 ' A' ' 81' ' ' THR . 9.8 pt-20 -91.12 115.96 28.43 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -175.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 116' ' ' PRO . 11.5 m -104.07 134.48 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -175.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.496 ' HB2' ' HE1' ' A' ' 79' ' ' HIS . 2.4 p-10 -81.74 143.85 31.54 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.565 HG21 HG12 ' A' ' 113' ' ' ILE . 39.5 t -141.45 143.63 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -105.93 107.5 18.53 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 164.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 5.9 t -94.19 138.07 32.65 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.423 ' HB ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -131.17 121.31 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.586 0.754 . . . . 0.0 109.625 -175.6 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -108.9 139.06 44.26 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.228 0.611 . . . . 0.0 109.647 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -104.51 111.22 23.81 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 165.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 61.7 t -96.13 110.67 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.351 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.507 ' HB3' ' HB1' ' A' ' 107' ' ' ALA . 35.3 tt0 -111.04 128.45 55.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.679 0.792 . . . . 0.0 109.155 176.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 62.83 30.44 16.63 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.89 0.876 . . . . 0.0 111.661 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.37 9.9 86.63 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.898 -0.592 . . . . 0.0 113.76 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 63.5 mmt-85 -129.03 135.14 48.53 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.158 0.983 . . . . 0.0 109.211 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.414 HG12 HG22 ' A' ' 101' ' ' VAL . 79.2 mt -63.55 100.7 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 102' ' ' GLU . . . -76.59 -31.98 57.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.49 -173.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.555 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 98.7 mttt -153.85 153.8 32.77 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.628 1.171 . . . . 0.0 108.566 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.79 135.31 20.77 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.458 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 5.4 m-90 -134.25 153.92 51.58 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -142.61 147.3 35.6 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 118.646 0.657 . . . . 0.0 110.605 173.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 17.6 ptpt -131.74 123.87 28.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.327 1.051 . . . . 0.0 109.227 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.565 HG12 HG21 ' A' ' 95' ' ' VAL . 96.9 mt -89.13 127.39 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -176.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.36 -81.12 0.09 OUTLIER Glycine 0 CA--C 1.532 1.148 0 O-C-N 123.957 0.786 . . . . 0.0 112.866 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.437 ' HB2' ' HD2' ' A' ' 116' ' ' PRO . 0.4 OUTLIER -160.18 171.58 7.02 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.398 0.679 . . . . 0.0 109.312 167.156 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.653 ' HA ' HG12 ' A' ' 93' ' ' VAL . 36.3 Cg_endo -63.49 131.43 31.75 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.037 1.825 . . . . 0.0 112.738 167.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -118.55 139.55 51.29 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.336 0.655 . . . . 0.0 109.939 173.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.8 mm -122.04 135.07 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.6 t -67.9 -44.57 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 123.539 0.524 . . . . 0.0 110.673 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.0 p -77.63 4.76 10.61 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.743 0.817 . . . . 0.0 112.851 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -74.88 -13.32 60.54 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.768 0.827 . . . . 0.0 111.255 176.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -72.0 154.16 41.33 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.443 0.697 . . . . 0.0 111.0 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 C--O 1.251 1.15 0 C-N-CA 123.554 0.742 . . . . 0.0 109.291 -175.582 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.7 ttp . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.425 ' HB2' HD13 ' A' ' 71' ' ' ILE . 14.0 m120 -89.35 69.08 8.08 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.79 0.836 . . . . 0.0 108.897 -178.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.518 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 15.0 m -57.34 -49.51 75.91 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.223 -174.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -57.16 -17.57 11.6 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.997 0.919 . . . . 0.0 113.125 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.442 HG13 ' HA ' ' A' ' 74' ' ' ASN . 22.8 mm -96.13 -34.4 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.953 0.901 . . . . 0.0 110.231 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -83.74 -24.85 30.97 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.661 0.784 . . . . 0.0 112.421 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 3' ' ' SER . 54.8 mt -66.58 -53.37 29.63 Favored Pre-proline 0 CA--C 1.561 1.388 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.291 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.625 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 9.5 Cg_endo -52.64 -50.63 13.4 Favored 'Trans proline' 0 C--N 1.399 3.214 0 C-N-CA 122.545 2.164 . . . . 0.0 112.219 175.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.463 HG11 HG13 ' A' ' 76' ' ' VAL . 7.7 t -54.79 -48.51 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 125.068 1.347 . . . . 0.0 113.27 -177.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -44.77 69.42 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.491 0.316 . . . . 0.0 111.262 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.7 mmtt -65.64 -35.55 81.12 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.746 0.419 . . . . 0.0 110.895 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.436 HE21 ' HA ' ' A' ' 9' ' ' VAL . 43.6 mt-30 -59.4 -49.79 76.46 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.946 0.779 . . . . 0.0 110.788 175.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.0 tp -55.89 -51.71 66.64 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.268 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -56.85 -46.95 81.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.536 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -67.31 -26.36 66.48 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.337 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -71.91 -48.52 44.92 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.097 0.559 . . . . 0.0 110.576 -173.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.06 -29.07 35.09 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.672 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.87 -3.42 58.91 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.401 0.68 . . . . 0.0 111.636 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 71.95 12.63 6.07 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.38 1.472 . . . . 0.0 113.065 172.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.475 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 5.9 m-20 -73.15 96.6 2.25 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.265 0.626 . . . . 0.0 111.11 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.5 mm -66.26 -29.75 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.452 0.701 . . . . 0.0 111.687 175.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.04 -48.56 81.17 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.023 0.529 . . . . 0.0 112.113 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.45 -30.1 33.57 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.866 0.466 . . . . 0.0 110.899 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -73.25 -7.86 53.31 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.924 177.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.796 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -114.22 -30.55 6.59 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.16 0.584 . . . . 0.0 112.197 173.168 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.66 -33.32 60.55 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -170.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.8 m95 -99.78 14.2 31.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.906 0.882 . . . . 0.0 112.651 -170.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -105.51 155.84 18.79 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.828 0.851 . . . . 0.0 109.949 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.463 ' O ' ' HB1' ' A' ' 46' ' ' ALA . . . -85.36 148.32 26.08 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.478 0.711 . . . . 0.0 109.752 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -58.14 -30.94 66.74 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.894 0.878 . . . . 0.0 111.955 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -103.05 19.29 19.79 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.025 0.93 . . . . 0.0 111.737 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 53.7 t -64.05 132.23 49.94 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.481 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 36.3 mm-40 -101.44 105.25 16.25 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.64 0.776 . . . . 0.0 110.245 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -96.56 112.52 24.23 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.936 0.894 . . . . 0.0 110.26 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.471 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 89.2 m-85 -110.3 153.48 24.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.236 1.015 . . . . 0.0 111.378 178.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.524 ' HB2' HD22 ' A' ' 42' ' ' LEU . . . -102.08 150.95 22.73 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 113.996 -1.457 . . . . 0.0 107.717 165.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -50.48 128.63 25.18 Favored Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 124.748 1.219 . . . . 0.0 114.1 -176.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.3 -36.7 2.15 Favored 'Cis proline' 0 C--N 1.385 2.482 0 C-N-CA 124.817 -0.91 . . . . 0.0 113.06 -9.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.13 81.64 0.99 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.51 0.724 . . . . 0.0 109.811 -174.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.459 ' HB ' ' HB1' ' A' ' 36' ' ' ALA . 40.6 m -121.74 100.1 6.82 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.2 tp -71.34 100.83 2.23 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -173.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.524 HD22 ' HB2' ' A' ' 36' ' ' ALA . 1.1 mm? -77.27 -45.26 26.92 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.45 115.85 15.29 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.958 -172.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.6 45.94 1.39 Allowed Glycine 0 C--N 1.346 1.085 0 CA-C-O 119.838 -0.423 . . . . 0.0 112.91 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.3 p30 160.36 160.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 126.495 1.918 . . . . 0.0 108.771 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 29' ' ' ALA . . . -66.94 -31.61 72.3 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.888 0.875 . . . . 0.0 113.158 -172.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.75 -43.81 98.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.131 0.572 . . . . 0.0 111.171 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -75.24 -30.69 60.6 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.985 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.2 mt -63.2 -45.11 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.523 0.729 . . . . 0.0 110.143 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.796 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 21.9 ttt180 -59.46 -55.44 34.6 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.653 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.46 ' HA ' HD12 ' A' ' 54' ' ' ILE . 34.3 m -66.34 -34.43 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 124.515 1.135 . . . . 0.0 112.822 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -71.24 -32.94 69.35 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.964 0.411 . . . . 0.0 110.456 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -75.03 -33.73 61.8 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.45 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 51' ' ' VAL . 39.6 mt -55.87 -39.62 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.782 0.833 . . . . 0.0 110.228 173.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 51' ' ' VAL . 34.6 mm-40 -59.06 -46.92 87.03 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.467 0.707 . . . . 0.0 111.118 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 -66.15 -30.21 70.64 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.535 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -81.29 -11.1 59.45 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 123.932 0.893 . . . . 0.0 111.651 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 72.2 mmtt -71.67 -22.3 61.68 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.788 0.435 . . . . 0.0 111.39 170.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -81.11 115.7 57.83 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.687 0.795 . . . . 0.0 110.392 -176.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.46 -30.05 79.64 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.238 2.625 . . . . 0.0 113.757 -174.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -86.75 3.73 43.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.268 0.627 . . . . 0.0 112.561 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.9 tp -67.28 118.05 10.13 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.706 0.289 . . . . 0.0 110.805 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -150.51 119.11 6.5 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 167.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.22 103.96 3.09 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 174.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -89.38 106.55 18.52 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.0 tt -80.88 128.57 33.82 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.08 -34.96 4.87 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.733 0.813 . . . . 0.0 111.137 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.1 m -132.25 139.0 48.11 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.579 0.752 . . . . 0.0 109.67 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.01 139.12 37.76 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 167.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.51 144.93 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.248 1.019 . . . . 0.0 109.347 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.425 HD13 ' HB2' ' A' ' 2' ' ' ASN . 15.1 tt -122.76 141.43 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-O 121.338 0.59 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 p -143.5 98.01 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 125.239 1.415 . . . . 0.0 108.105 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.92 -120.57 19.12 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.185 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.442 ' HA ' HG13 ' A' ' 5' ' ' ILE . 3.3 p-10 -93.69 13.4 22.34 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.477 0.711 . . . . 0.0 111.913 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.2 t -130.29 136.14 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.25 1.02 . . . . 0.0 109.664 -174.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.463 HG13 HG11 ' A' ' 9' ' ' VAL . 87.0 t -125.16 135.82 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.774 0.83 . . . . 0.0 109.796 176.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.542 HG12 ' HB ' ' A' ' 98' ' ' ILE . 2.2 mt -100.13 108.01 22.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 168.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -88.07 109.16 19.65 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 168.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -99.15 110.51 23.07 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 122.041 0.924 . . . . 0.0 108.788 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.47 165.45 18.42 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.868 -1.515 . . . . 0.0 109.533 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.7 m -114.65 103.2 10.76 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 167.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.9 m -85.44 130.55 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 120.928 0.394 . . . . 0.0 110.391 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.6 m -79.05 118.96 21.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.295 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -111.81 -166.93 1.12 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 168.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -124.23 108.18 11.99 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 121.823 -0.548 . . . . 0.0 110.323 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -106.31 144.47 29.04 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 123.544 0.738 . . . . 0.0 109.059 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.84 -12.31 32.49 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.724 2.283 . . . . 0.0 112.907 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -87.61 -2.78 58.85 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.669 0.787 . . . . 0.0 112.225 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.92 -119.55 0.9 Allowed Glycine 0 C--N 1.348 1.225 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.769 170.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -65.31 -79.08 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.867 0.867 . . . . 0.0 110.536 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 117.57 22.79 3.93 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.323 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.29 141.9 28.25 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.644 HG13 ' HA ' ' A' ' 116' ' ' PRO . 22.4 m -132.97 138.64 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.156 0.435 . . . . 0.0 111.247 -171.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -75.65 109.33 9.13 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.454 HG21 HG12 ' A' ' 113' ' ' ILE . 21.4 t -114.7 155.66 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.14 105.75 9.78 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 82.5 m -94.96 107.46 19.49 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.631 HG22 ' HB2' ' A' ' 110' ' ' TRP . 7.3 tt -105.25 106.55 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.634 -173.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -99.9 137.27 38.58 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.662 0.785 . . . . 0.0 110.645 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -100.47 114.41 27.98 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.292 1.037 . . . . 0.0 109.166 168.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.507 HG23 HG12 ' A' ' 106' ' ' ILE . 46.4 t -102.31 117.66 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 123.319 0.648 . . . . 0.0 109.548 175.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.497 ' HB3' ' HB1' ' A' ' 107' ' ' ALA . 19.7 tt0 -128.54 138.71 52.38 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.832 1.253 . . . . 0.0 109.138 175.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 63.43 30.9 15.31 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.897 0.879 . . . . 0.0 111.32 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.28 7.59 82.53 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.401 -0.818 . . . . 0.0 114.058 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 57.3 mmt-85 -137.56 153.77 49.91 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.635 1.174 . . . . 0.0 108.902 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.507 HG12 HG23 ' A' ' 101' ' ' VAL . 65.3 mt -73.45 105.74 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.497 ' HB1' ' HB3' ' A' ' 102' ' ' GLU . . . -79.53 -28.99 41.3 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.444 0.697 . . . . 0.0 111.353 -178.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.481 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 91.3 mttt -150.25 152.6 34.8 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.85 134.41 22.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 174.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.631 ' HB2' HG22 ' A' ' 98' ' ' ILE . 2.6 m-90 -126.08 152.99 45.1 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -142.65 147.06 35.13 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 172.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -134.85 117.68 16.16 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.082 0.553 . . . . 0.0 110.294 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.454 HG12 HG21 ' A' ' 95' ' ' VAL . 95.6 mt -89.02 110.82 21.92 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.2 -93.27 0.06 OUTLIER Glycine 0 CA--C 1.533 1.196 0 CA-C-N 114.289 -1.323 . . . . 0.0 114.327 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -126.79 140.33 37.3 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 123.455 0.702 . . . . 0.0 111.268 -169.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.644 ' HA ' HG13 ' A' ' 93' ' ' VAL . 48.0 Cg_endo -67.79 125.5 13.28 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.241 2.628 . . . . 0.0 111.947 173.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -111.46 124.47 52.34 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.41 1.084 . . . . 0.0 109.312 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.1 mm -124.05 124.86 69.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.1 t -59.23 -42.66 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 124.005 0.816 . . . . 0.0 111.281 -173.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.3 t -82.32 -70.56 0.54 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.253 0.621 . . . . 0.0 110.085 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -75.33 90.83 2.65 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.82 0.848 . . . . 0.0 110.4 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -159.69 143.89 14.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.897 0.479 . . . . 0.0 109.984 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.3 t . . . . . 0 C--O 1.252 1.191 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.96 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mtp . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -82.44 43.1 0.79 Allowed 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.705 0.802 . . . . 0.0 111.742 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.1 p -72.94 -35.06 66.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.663 0.785 . . . . 0.0 111.547 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.09 -5.1 32.9 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.895 0.478 . . . . 0.0 111.9 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.534 HG21 HG22 ' A' ' 76' ' ' VAL . 22.9 mm -94.29 -30.47 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.968 0.907 . . . . 0.0 109.701 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -72.74 -34.19 66.88 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.7 0.8 . . . . 0.0 111.636 174.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.69 -50.58 81.37 Favored Pre-proline 0 CA--C 1.558 1.283 0 CA-C-O 118.089 -0.958 . . . . 0.0 112.46 -172.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 12.7 Cg_endo -54.84 -56.49 2.37 Favored 'Trans proline' 0 C--N 1.398 3.155 0 C-N-CA 122.123 1.882 . . . . 0.0 111.072 177.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 76' ' ' VAL . 98.8 t -53.45 -44.56 56.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.303 1.441 . . . . 0.0 112.411 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -62.63 -51.47 67.17 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.946 -178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -68.86 -34.39 75.37 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.18 0.592 . . . . 0.0 111.436 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -65.03 -43.41 92.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.973 0.909 . . . . 0.0 111.254 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.8 -52.06 67.1 Favored 'General case' 0 C--O 1.242 0.688 0 O-C-N 123.716 0.635 . . . . 0.0 109.398 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -54.13 -45.93 72.05 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 124.789 1.306 . . . . 0.0 109.258 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 20' ' ' ASP . . . -68.64 -27.01 65.62 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.804 -1.544 . . . . 0.0 112.52 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.435 ' HH ' HD13 ' A' ' 62' ' ' LEU . 65.8 t80 -71.97 -41.01 68.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.532 0.333 . . . . 0.0 110.32 -174.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -90.76 -28.99 17.9 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.227 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.6 -2.18 57.05 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.244 0.618 . . . . 0.0 111.655 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 68.27 24.03 7.57 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.075 1.35 . . . . 0.0 112.958 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 21.6 m-20 -88.06 95.61 10.21 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.187 0.595 . . . . 0.0 109.765 175.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.403 HG13 HG12 ' A' ' 54' ' ' ILE . 13.2 mm -65.78 -28.34 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.697 0.399 . . . . 0.0 110.921 174.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.08 -48.15 81.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.194 0.597 . . . . 0.0 111.674 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.67 -30.87 36.49 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.83 0.452 . . . . 0.0 110.841 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -72.86 -7.57 51.49 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.248 0.619 . . . . 0.0 110.881 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.745 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -113.59 -29.64 7.09 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.395 0.678 . . . . 0.0 112.318 174.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.16 -34.91 70.82 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.873 0.869 . . . . 0.0 113.186 -169.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 96.1 m95 -93.75 8.29 41.62 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.722 0.809 . . . . 0.0 112.901 -173.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.527 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 21.8 m95 -102.84 158.81 16.01 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.667 0.787 . . . . 0.0 109.375 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 46' ' ' ALA . . . -86.65 162.24 18.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.106 0.562 . . . . 0.0 110.408 177.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.57 -34.22 75.44 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.139 0.576 . . . . 0.0 111.347 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -98.06 15.74 23.27 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.619 0.768 . . . . 0.0 110.534 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.527 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 43.2 t -59.93 117.47 5.09 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-O 121.137 0.494 . . . . 0.0 111.745 -173.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.568 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 57.1 mm-40 -83.78 154.27 23.64 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.701 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -144.81 111.69 5.85 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.496 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 85.3 m-85 -118.12 146.59 44.03 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.973 0.909 . . . . 0.0 110.697 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.512 ' HB1' HD22 ' A' ' 42' ' ' LEU . . . -95.69 157.43 15.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.154 -1.384 . . . . 0.0 108.202 170.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.429 ' HB3' ' HA ' ' A' ' 112' ' ' LYS . 30.9 p90 -55.6 130.19 70.77 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 123.658 0.783 . . . . 0.0 112.248 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.87 -42.42 0.78 Allowed 'Cis proline' 0 C--N 1.385 2.472 0 CA-C-N 119.923 1.008 . . . . 0.0 113.09 -4.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.09 65.15 0.16 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.697 0.799 . . . . 0.0 109.613 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.9 m -105.79 118.38 36.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.938 0.895 . . . . 0.0 109.49 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.83 110.83 8.43 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.672 0.789 . . . . 0.0 110.971 -169.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.512 HD22 ' HB1' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -88.37 -51.63 5.63 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 170.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.24 116.63 12.75 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.233 -168.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.73 22.32 40.96 Favored Glycine 0 N--CA 1.478 1.486 0 N-CA-C 114.553 0.581 . . . . 0.0 114.553 -173.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -177.89 163.6 1.81 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.235 1.414 . . . . 0.0 109.479 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 29' ' ' ALA . . . -59.67 -36.65 76.86 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.938 0.895 . . . . 0.0 112.695 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.11 -44.35 97.49 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.034 0.534 . . . . 0.0 111.802 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -72.85 -36.01 67.34 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.484 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.41 -42.62 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.264 0.626 . . . . 0.0 110.019 174.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.745 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 79.2 ttt180 -62.49 -58.16 8.61 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.547 -175.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.1 m -69.86 -35.0 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 124.248 0.967 . . . . 0.0 112.879 -170.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -67.43 -36.39 81.13 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.642 0.377 . . . . 0.0 110.163 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -77.14 -30.09 54.92 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.357 176.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 50' ' ' ARG . 91.6 mt -57.82 -42.58 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 118.84 0.745 . . . . 0.0 109.922 174.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.0 -32.8 73.44 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.576 0.75 . . . . 0.0 111.616 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -74.85 -28.8 60.82 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.939 0.495 . . . . 0.0 110.706 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -81.15 -3.71 52.99 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.217 0.607 . . . . 0.0 110.995 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -77.03 -29.34 55.26 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.007 0.523 . . . . 0.0 110.802 169.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -59.93 118.79 35.53 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 123.91 0.884 . . . . 0.0 110.753 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -64.39 -35.72 48.52 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.828 2.352 . . . . 0.0 113.118 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -93.14 8.4 40.26 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.966 0.506 . . . . 0.0 112.154 -173.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.435 HD13 ' HH ' ' A' ' 16' ' ' TYR . 34.4 tp -67.85 113.87 5.95 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 173.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -148.31 116.34 6.43 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.73 104.88 3.13 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 174.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -97.61 105.18 17.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 80' ' ' GLU . 8.1 tt -78.94 127.45 32.02 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.023 0.44 . . . . 0.0 110.095 -177.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.18 -48.11 5.78 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.202 1.001 . . . . 0.0 108.737 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 92.4 m -143.93 134.22 24.49 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.633 -170.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 10.8 ptt180 -131.44 129.27 41.0 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 166.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.563 HG22 ' HB ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -107.24 156.26 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.115 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.406 HD13 ' HB ' ' A' ' 5' ' ' ILE . 18.7 tt -134.7 137.67 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.127 0.489 . . . . 0.0 110.754 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 p -147.16 102.36 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.527 1.131 . . . . 0.0 108.636 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.8 -115.94 8.09 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.497 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -99.55 12.35 36.71 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.089 0.556 . . . . 0.0 111.728 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.92 139.35 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.899 0.879 . . . . 0.0 110.09 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.534 HG22 HG21 ' A' ' 5' ' ' ILE . 53.2 t -126.13 140.11 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.525 0.73 . . . . 0.0 109.77 174.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.563 ' HB ' HG22 ' A' ' 70' ' ' VAL . 24.4 mm -98.22 101.69 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 165.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -95.31 104.48 16.37 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -100.48 109.0 21.11 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.722 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -120.34 165.63 14.62 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.678 1.191 . . . . 0.0 110.412 -179.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.9 m -116.24 105.54 12.67 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.314 1.046 . . . . 0.0 109.083 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.2 125.69 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.291 0.567 . . . . 0.0 111.079 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.5 m -74.63 132.07 41.43 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.365 1.066 . . . . 0.0 110.178 175.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -130.31 -168.24 1.94 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.204 1.002 . . . . 0.0 109.282 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -128.43 100.29 5.73 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.657 0.783 . . . . 0.0 109.413 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -108.84 149.65 39.82 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.389 0.676 . . . . 0.0 110.398 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.86 -27.07 51.56 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.784 2.323 . . . . 0.0 113.234 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -86.84 -9.43 55.8 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.02 -140.25 6.31 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 120.094 -0.281 . . . . 0.0 112.728 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -66.07 -81.08 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.691 0.797 . . . . 0.0 111.548 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.45 28.21 1.66 Allowed Glycine 0 C--N 1.347 1.187 0 C-N-CA 121.341 -0.457 . . . . 0.0 113.77 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 117' ' ' ARG . 0.3 OUTLIER -88.81 100.2 12.97 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 122.368 1.08 . . . . 0.0 108.234 -174.452 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.9 m -105.18 143.41 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.719 -169.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.41 141.26 34.1 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.529 HG22 HG12 ' A' ' 113' ' ' ILE . 35.5 t -138.06 142.04 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -109.92 105.24 14.34 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 170.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 74.9 m -92.74 136.7 33.0 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.539 ' HB ' HD12 ' A' ' 77' ' ' ILE . 7.3 tt -122.11 111.72 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 124.374 1.069 . . . . 0.0 109.768 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.401 ' HD2' HG22 ' A' ' 9' ' ' VAL . 12.7 m-85 -99.85 142.85 30.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.871 0.469 . . . . 0.0 109.844 176.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -111.64 113.92 26.63 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.0 t -97.73 141.79 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 124.646 1.179 . . . . 0.0 110.265 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.401 ' HG3' HD21 ' A' ' 103' ' ' ASN . 11.0 tp10 -141.63 105.6 4.76 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.917 1.287 . . . . 0.0 108.206 -172.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.401 HD21 ' HG3' ' A' ' 102' ' ' GLU . 37.9 m-80 61.49 30.96 19.04 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.539 1.136 . . . . 0.0 111.837 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.0 4.68 78.15 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.335 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -126.5 132.56 51.37 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.649 0.78 . . . . 0.0 109.697 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 62.9 mt -68.47 112.57 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 122.986 0.514 . . . . 0.0 110.088 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -76.91 -37.79 54.74 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.361 0.664 . . . . 0.0 110.434 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.568 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 98.0 mttt -151.59 150.16 29.98 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.81 0.844 . . . . 0.0 109.279 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.0 135.35 32.62 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.496 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 3.1 m-90 -132.66 156.03 47.7 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -145.39 148.6 33.53 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.538 0.608 . . . . 0.0 110.959 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.429 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 8.4 ptpp? -126.5 129.98 49.72 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.162 0.985 . . . . 0.0 108.825 172.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.529 HG12 HG22 ' A' ' 95' ' ' VAL . 95.8 mt -90.85 129.65 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.54 -80.18 0.12 Allowed Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.64 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.25 161.12 30.14 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.52 121.0 7.06 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.481 2.121 . . . . 0.0 112.262 170.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 78.0 mtt-85 -122.56 153.48 39.2 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.52 0.728 . . . . 0.0 110.661 -177.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 120' ' ' SER . 40.1 mm -136.51 139.58 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.6 1.16 . . . . 0.0 109.648 -176.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.7 t -65.18 -41.89 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 123.656 0.782 . . . . 0.0 111.021 174.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.409 ' N ' HG23 ' A' ' 118' ' ' ILE . 45.5 t -63.32 -24.77 68.0 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.719 0.808 . . . . 0.0 112.073 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 61.1 mm-40 -104.06 20.02 19.01 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.973 0.509 . . . . 0.0 110.554 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.41 ' HZ1' ' HB3' ' A' ' 122' ' ' LYS . 6.2 ttpm? -142.78 152.68 42.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.1 0.96 . . . . 0.0 110.01 -178.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.4 p . . . . . 0 CA--C 1.561 1.386 0 C-N-CA 123.111 0.565 . . . . 0.0 109.623 172.073 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.484 1.246 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.18 24.7 0.42 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.586 0.354 . . . . 0.0 111.627 -175.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.3 p -64.63 -37.64 88.26 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.879 0.472 . . . . 0.0 110.039 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.04 -23.1 61.7 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.127 1.371 . . . . 0.0 112.977 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.527 HG22 ' HB ' ' A' ' 101' ' ' VAL . 29.1 mm -93.18 -29.27 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.386 1.074 . . . . 0.0 109.771 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -77.94 -24.16 48.29 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.704 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.443 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 88.2 mt -61.71 -57.67 23.12 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-O 118.136 -0.935 . . . . 0.0 112.012 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.577 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 14.1 Cg_endo -54.37 -50.11 14.61 Favored 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 122.766 2.31 . . . . 0.0 112.706 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.609 ' HA ' HE21 ' A' ' 12' ' ' GLN . 15.6 m -65.65 -32.4 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.901 -174.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.18 -50.63 31.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.583 0.753 . . . . 0.0 110.336 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.1 mmtt -66.84 -30.62 70.84 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.018 -176.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.609 HE21 ' HA ' ' A' ' 9' ' ' VAL . 37.1 mt-30 -59.17 -49.2 78.77 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 124.039 0.837 . . . . 0.0 111.288 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.75 -48.33 79.94 Favored 'General case' 0 C--O 1.246 0.897 0 O-C-N 123.774 0.671 . . . . 0.0 110.069 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -58.27 -42.61 86.87 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 124.904 1.377 . . . . 0.0 109.055 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 20' ' ' ASP . . . -72.91 -25.78 61.17 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.753 -1.567 . . . . 0.0 112.796 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -68.14 -44.43 76.05 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.06 0.457 . . . . 0.0 110.324 -173.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -85.49 -29.58 24.16 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.644 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.87 -4.19 57.8 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.35 0.66 . . . . 0.0 111.497 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.406 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 23.6 mmt85 69.99 23.6 5.38 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.225 1.41 . . . . 0.0 112.796 171.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.441 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 19.7 m-20 -91.24 94.61 9.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.05 0.54 . . . . 0.0 110.541 177.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.449 HG13 HG12 ' A' ' 54' ' ' ILE . 20.2 mm -66.37 -28.7 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 123.514 0.726 . . . . 0.0 111.208 173.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -58.76 -47.15 85.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.945 0.498 . . . . 0.0 111.351 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.04 -33.97 33.16 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.421 0.689 . . . . 0.0 111.052 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -68.18 -8.88 42.63 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.777 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.714 ' SD ' ' HB3' ' A' ' 46' ' ' ALA . 24.9 tpp -120.53 -22.26 6.48 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 174.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.08 -28.79 69.86 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -175.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 96.1 m95 -94.17 9.63 37.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.786 0.834 . . . . 0.0 112.539 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -102.77 153.09 20.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.662 0.785 . . . . 0.0 110.002 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.47 140.43 44.59 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 168.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -67.81 -11.69 59.04 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.306 0.642 . . . . 0.0 112.37 -174.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -116.18 21.08 13.94 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.077 0.951 . . . . 0.0 111.232 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.7 t -59.76 147.55 37.55 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.45 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 33.8 mm-40 -107.21 105.42 15.39 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.171 0.988 . . . . 0.0 110.043 -175.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -102.55 112.63 25.46 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.587 0.755 . . . . 0.0 110.521 -173.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.433 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 13.9 m-85 -106.51 152.69 23.34 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.874 0.87 . . . . 0.0 110.322 175.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.64 161.95 18.4 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.355 1.062 . . . . 0.0 109.776 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.505 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 68.3 t80 -57.06 125.56 70.58 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 123.696 0.798 . . . . 0.0 110.26 174.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.24 -56.75 0.14 OUTLIER 'Cis proline' 0 C--N 1.386 2.545 0 CA-C-N 120.59 1.246 . . . . 0.0 113.898 2.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.9 57.72 0.37 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.558 0.743 . . . . 0.0 109.51 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.9 m -98.84 113.68 25.92 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.091 0.957 . . . . 0.0 110.533 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.47 102.46 0.7 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.9 mt -78.37 -42.26 30.91 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.621 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -140.19 115.55 9.95 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.001 -169.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.7 46.13 1.66 Allowed Glycine 0 C--N 1.344 1.006 0 O-C-N 123.386 0.429 . . . . 0.0 112.284 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 p30 163.26 153.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 126.491 1.916 . . . . 0.0 108.561 -172.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.714 ' HB3' ' SD ' ' A' ' 25' ' ' MET . . . -68.56 -23.66 64.53 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.876 0.87 . . . . 0.0 113.328 -174.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.5 -48.76 80.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.753 0.421 . . . . 0.0 111.239 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.465 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 27.3 mt-10 -70.67 -30.17 66.69 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.652 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 46' ' ' ALA . 63.9 mt -64.66 -52.43 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.487 0.715 . . . . 0.0 110.679 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.488 ' O ' HG13 ' A' ' 54' ' ' ILE . 6.4 ptp180 -64.2 -43.12 96.03 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.443 -175.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.9 t -67.91 -39.33 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.13 0.972 . . . . 0.0 111.743 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -71.33 -29.74 65.37 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.627 0.371 . . . . 0.0 110.851 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -73.61 -30.57 63.06 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 119.114 -0.469 . . . . 0.0 111.346 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 50' ' ' ARG . 77.6 mt -58.59 -38.75 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -57.2 -41.91 80.27 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.916 0.76 . . . . 0.0 111.717 174.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -73.59 -31.03 63.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.119 0.568 . . . . 0.0 110.722 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' A' ' 19' ' ' ARG . 2.6 m-30 -78.42 3.21 16.4 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.35 0.66 . . . . 0.0 111.478 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.411 ' HE2' HG21 ' A' ' 54' ' ' ILE . 73.4 mmtt -81.67 -18.38 44.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.312 0.645 . . . . 0.0 112.183 171.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.65 121.03 79.51 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-O 119.205 -0.426 . . . . 0.0 110.188 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.95 -20.05 34.42 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.357 2.038 . . . . 0.0 111.687 177.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -84.87 -13.36 51.16 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.885 0.874 . . . . 0.0 111.676 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 83' ' ' THR . 30.2 tp -62.85 112.56 2.6 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -173.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -145.5 118.03 8.56 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.18 105.54 3.31 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -96.3 105.73 17.84 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 tt -85.88 119.83 26.62 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.44 -31.43 8.16 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.706 0.802 . . . . 0.0 111.231 -174.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 84.7 m -142.87 132.38 23.66 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.923 0.889 . . . . 0.0 109.805 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -135.67 135.07 39.82 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 164.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.478 HG22 ' HB ' ' A' ' 77' ' ' ILE . 20.4 m -122.56 142.41 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.5 tt -124.84 138.47 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 121.229 0.538 . . . . 0.0 111.219 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -139.76 99.41 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 125.284 1.434 . . . . 0.0 107.999 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.29 -126.79 23.15 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.718 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.431 ' HA ' HG13 ' A' ' 5' ' ' ILE . 21.1 p-10 -94.78 24.27 4.84 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.228 0.611 . . . . 0.0 111.411 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.2 t -131.43 130.75 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.404 1.082 . . . . 0.0 109.433 -174.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.9 t -120.93 142.53 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 122.982 0.513 . . . . 0.0 110.043 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.543 HD12 ' HB ' ' A' ' 98' ' ' ILE . 5.3 mm -98.28 107.69 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 165.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -91.57 109.38 20.68 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 167.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -100.72 108.51 20.38 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 175.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.53 129.35 42.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.757 1.223 . . . . 0.0 109.734 -174.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.5 m -83.91 103.02 12.83 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 172.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.6 m -89.33 137.71 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 29.2 m -95.58 135.45 37.23 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.195 0.598 . . . . 0.0 109.688 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -131.45 -166.11 1.66 Allowed 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -125.45 99.57 6.09 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 122.122 -0.361 . . . . 0.0 110.061 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.406 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 20.7 m-30 -99.53 135.74 20.54 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 172.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.03 -12.5 35.68 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.997 2.465 . . . . 0.0 113.812 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -83.98 -11.2 57.17 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.09 -119.3 0.75 Allowed Glycine 0 C--N 1.35 1.34 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.346 171.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -71.4 -80.61 0.06 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.215 0.606 . . . . 0.0 110.998 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.406 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 123.22 27.0 1.57 Allowed Glycine 0 C--N 1.344 0.978 0 N-CA-C 114.032 0.373 . . . . 0.0 114.032 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -89.53 141.12 28.87 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.6 HG13 ' HA ' ' A' ' 116' ' ' PRO . 30.4 m -133.49 133.37 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.199 0.599 . . . . 0.0 109.557 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.51 109.24 15.79 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 113' ' ' ILE . 39.0 t -112.43 156.65 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -175.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -128.69 101.93 6.35 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 111' ' ' PHE . 76.2 m -92.08 105.7 17.88 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.543 ' HB ' HD12 ' A' ' 77' ' ' ILE . 8.5 tt -92.2 112.19 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.044 0.938 . . . . 0.0 109.58 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -99.94 148.84 24.05 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.571 0.748 . . . . 0.0 110.127 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -118.69 111.85 19.04 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.527 ' HB ' HG22 ' A' ' 5' ' ' ILE . 53.6 t -98.31 112.18 29.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.012 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -117.18 130.9 56.9 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 62.7 32.1 16.34 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.581 0.752 . . . . 0.0 111.386 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.63 -5.88 82.19 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 115.657 -0.702 . . . . 0.0 114.58 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 63.5 mmt-85 -132.22 147.44 52.41 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.6 0.76 . . . . 0.0 109.281 -175.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.515 HG12 HG23 ' A' ' 101' ' ' VAL . 66.4 mt -68.94 100.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.395 0.678 . . . . 0.0 110.256 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.68 -25.71 35.31 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.563 0.745 . . . . 0.0 111.312 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 96.8 mttt -145.58 150.03 35.63 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.788 0.835 . . . . 0.0 108.751 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.36 135.11 14.51 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.507 0.723 . . . . 0.0 109.408 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.433 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 2.5 m-90 -133.06 130.63 39.62 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.462 ' HB2' ' SG ' ' A' ' 97' ' ' CYS . 11.8 p90 -119.66 138.95 52.94 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.252 0.933 . . . . 0.0 109.583 175.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.631 ' HZ2' ' HB3' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -127.36 119.9 27.29 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.371 0.668 . . . . 0.0 109.213 -178.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 95' ' ' VAL . 88.7 mt -88.75 130.1 38.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.04 -78.8 0.17 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.153 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -158.38 163.26 24.96 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.6 ' HA ' HG13 ' A' ' 93' ' ' VAL . 74.5 Cg_endo -71.04 114.74 4.0 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.28 1.987 . . . . 0.0 112.189 170.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -107.05 150.68 26.27 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.887 0.875 . . . . 0.0 108.973 176.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.498 HG21 ' H ' ' A' ' 121' ' ' GLN . 32.2 mm -138.11 121.35 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.875 0.87 . . . . 0.0 108.98 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.77 -40.96 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.024 0.53 . . . . 0.0 110.752 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.2 m -58.26 -66.38 0.49 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.85 0.86 . . . . 0.0 110.99 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.498 ' H ' HG21 ' A' ' 118' ' ' ILE . 9.7 tt0 -87.66 94.82 9.85 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.848 0.859 . . . . 0.0 109.397 175.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -147.1 120.78 9.18 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.8 t . . . . . 0 C--O 1.252 1.21 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -177.559 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 50.7 p -65.98 -43.62 87.28 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.407 -1.269 . . . . 0.0 111.749 -172.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.21 -6.82 31.46 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.622 0.769 . . . . 0.0 112.722 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.453 ' HB ' HD11 ' A' ' 71' ' ' ILE . 14.4 mm -95.78 -29.64 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.649 0.78 . . . . 0.0 109.016 174.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -77.73 -33.01 53.15 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.701 0.801 . . . . 0.0 111.492 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 3' ' ' SER . 93.0 mt -58.91 -49.54 92.81 Favored Pre-proline 0 N--CA 1.489 1.492 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.384 -176.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.6 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 11.9 Cg_endo -56.29 -60.92 0.39 Allowed 'Trans proline' 0 C--N 1.392 2.816 0 C-N-CA 122.245 1.964 . . . . 0.0 112.303 175.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.49 HG21 HG11 ' A' ' 76' ' ' VAL . 22.6 m -64.27 -29.54 47.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.848 -167.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -68.72 -55.18 12.19 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.564 0.745 . . . . 0.0 109.88 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -62.97 -35.08 78.96 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.892 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -74.79 -42.52 57.97 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.6 0.76 . . . . 0.0 111.438 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.459 HD21 ' HB2' ' A' ' 66' ' ' LEU . 22.9 tp -60.76 -46.79 89.11 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.851 0.46 . . . . 0.0 110.401 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.22 -49.94 74.43 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.94 173.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.85 -25.91 68.38 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.267 1.027 . . . . 0.0 112.3 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -63.75 -44.1 94.51 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.595 0.758 . . . . 0.0 110.71 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -91.25 -28.24 17.92 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.814 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.85 -10.23 59.74 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.831 0.852 . . . . 0.0 112.111 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 69.11 44.68 0.97 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.876 1.27 . . . . 0.0 112.095 173.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -115.77 93.81 4.42 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.261 0.624 . . . . 0.0 109.566 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.531 HG13 HG12 ' A' ' 54' ' ' ILE . 12.8 mm -71.62 -29.63 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 122.864 0.466 . . . . 0.0 111.35 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.78 -45.12 93.27 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.458 0.303 . . . . 0.0 111.4 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.43 -32.36 42.79 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.991 0.516 . . . . 0.0 110.94 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.488 ' HB3' ' HA ' ' A' ' 21' ' ' ILE . 50.8 t80 -70.05 -10.33 58.34 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.888 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.659 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -111.53 -29.74 7.64 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.453 0.701 . . . . 0.0 111.24 174.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.04 -54.25 32.31 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.808 0.843 . . . . 0.0 112.241 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.6 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 95.5 m95 -78.39 4.64 12.49 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.467 -1.242 . . . . 0.0 113.452 -169.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.711 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 28.3 m95 -93.29 162.37 14.03 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.54 0.736 . . . . 0.0 109.521 174.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -79.67 152.16 30.11 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.793 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.41 -27.24 66.91 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 120.782 0.325 . . . . 0.0 111.3 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.32 18.86 21.39 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.633 0.773 . . . . 0.0 110.791 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.711 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 53.2 t -60.72 133.8 56.45 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.069 0.548 . . . . 0.0 112.12 -174.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -88.08 148.96 24.23 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 56.6 t80 -140.53 112.85 7.87 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.432 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 27.0 m-85 -108.25 154.88 21.14 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.037 0.935 . . . . 0.0 110.83 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -113.39 155.31 25.46 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.872 1.269 . . . . 0.0 109.341 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.718 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 69.3 t80 -53.54 125.49 44.96 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.398 1.079 . . . . 0.0 111.971 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -76.85 -58.4 0.14 OUTLIER 'Cis proline' 0 C--N 1.383 2.362 0 CA-C-N 120.344 1.159 . . . . 0.0 113.986 -4.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -145.3 78.85 1.56 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.473 0.709 . . . . 0.0 109.819 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 94.5 m -125.95 106.05 9.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.473 0.709 . . . . 0.0 109.709 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.5 tp -66.12 102.41 0.82 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.549 0.74 . . . . 0.0 110.937 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 36' ' ' ALA . 41.2 mt -79.79 -35.86 37.92 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.384 0.673 . . . . 0.0 110.553 175.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -142.49 121.32 12.71 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.436 -171.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.91 35.38 4.9 Favored Glycine 0 C--N 1.347 1.176 0 C-N-CA 123.239 0.447 . . . . 0.0 112.754 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 p30 168.45 161.31 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.65 1.58 . . . . 0.0 109.79 -172.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -64.96 -36.93 85.96 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.407 1.083 . . . . 0.0 112.918 -173.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.28 82.86 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.124 0.569 . . . . 0.0 111.84 -173.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.403 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 27.4 mt-10 -77.02 -33.29 57.44 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.988 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.8 mt -61.64 -50.44 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.676 0.79 . . . . 0.0 110.756 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.659 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 21.3 ptt180 -61.91 -49.93 74.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 118.841 -0.599 . . . . 0.0 110.525 -177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.5 t -59.29 -42.82 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.531 0.732 . . . . 0.0 110.668 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.454 ' HE ' ' HA ' ' A' ' 52' ' ' ARG . 2.1 tpm_? -55.17 -43.72 74.54 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.024 0.827 . . . . 0.0 110.704 176.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -78.24 -29.78 48.34 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.387 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.531 HG12 HG13 ' A' ' 21' ' ' ILE . 95.7 mt -61.42 -38.47 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 118.414 0.552 . . . . 0.0 109.673 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -58.88 -40.17 83.59 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.653 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -70.47 -32.95 70.69 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.074 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -74.66 -8.66 57.08 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.811 0.844 . . . . 0.0 111.832 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.462 ' HE2' HG22 ' A' ' 54' ' ' ILE . 72.6 mmtt -71.12 -27.27 63.46 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.775 0.43 . . . . 0.0 111.542 174.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.44 117.05 43.25 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.97 -22.08 42.51 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.302 2.002 . . . . 0.0 110.885 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -85.84 -5.54 59.23 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.618 1.567 . . . . 0.0 112.603 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.79 120.9 12.17 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.418 0.287 . . . . 0.0 110.314 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -150.93 117.67 5.8 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.3 102.64 2.95 Favored Glycine 0 C--N 1.344 1.002 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -95.3 103.07 14.92 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.459 ' HB2' HD21 ' A' ' 13' ' ' LEU . 8.7 tp -68.02 139.88 56.32 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.134 0.492 . . . . 0.0 110.81 -177.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mt -107.39 -53.01 2.68 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.463 1.105 . . . . 0.0 108.392 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.8 m -148.11 144.69 27.99 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 113.613 -1.631 . . . . 0.0 109.739 -172.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 25.2 ptt180 -140.7 128.55 21.81 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.115 0.966 . . . . 0.0 108.739 173.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.522 HG22 ' HB ' ' A' ' 77' ' ' ILE . 33.1 m -123.83 152.08 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.453 HD11 ' HB ' ' A' ' 5' ' ' ILE . 11.2 tt -133.35 118.72 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.25 0.548 . . . . 0.0 110.401 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.6 t -112.18 95.27 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.368 1.067 . . . . 0.0 108.429 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.92 -111.1 3.8 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 116.027 -0.533 . . . . 0.0 113.433 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -93.44 12.43 25.0 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.769 0.828 . . . . 0.0 111.615 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.1 t -125.72 134.25 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.74 0.816 . . . . 0.0 109.52 -171.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 9' ' ' VAL . 24.5 t -125.69 135.17 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 122.807 0.443 . . . . 0.0 110.355 175.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.62 HD13 ' HB ' ' A' ' 98' ' ' ILE . 9.0 mm -99.81 105.06 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.092 1.357 . . . . 0.0 108.006 169.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.01 105.87 17.86 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 167.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.44 ' HE1' ' HB3' ' A' ' 94' ' ' ASP . 1.8 t60 -100.21 106.78 18.49 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.95 169.18 12.95 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.942 1.297 . . . . 0.0 110.18 -176.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.6 m -116.71 110.16 18.09 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.2 t -81.29 103.41 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.362 0.665 . . . . 0.0 110.123 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 88.0 m -66.24 118.81 10.48 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -123.98 -169.29 1.93 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.572 1.149 . . . . 0.0 108.031 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -118.1 109.37 16.33 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.39 0.676 . . . . 0.0 109.424 169.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -103.81 147.02 33.62 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 123.655 0.782 . . . . 0.0 110.015 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.02 -9.86 27.54 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.876 2.384 . . . . 0.0 114.216 -175.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -92.35 -15.14 27.7 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.419 0.287 . . . . 0.0 111.66 173.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.05 -121.66 1.03 Allowed Glycine 0 C--N 1.355 1.626 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.956 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -53.79 -84.57 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.503 1.121 . . . . 0.0 111.994 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.58 28.54 2.72 Favored Glycine 0 C--N 1.349 1.276 0 C-N-CA 121.686 -0.292 . . . . 0.0 113.575 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -89.77 119.57 30.27 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -173.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 116' ' ' PRO . 33.4 m -116.49 123.16 71.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 CA-C-O 121.114 0.483 . . . . 0.0 110.045 -175.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.44 ' HB3' ' HE1' ' A' ' 79' ' ' HIS . 2.8 m-20 -84.19 108.0 16.83 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 113' ' ' ILE . 24.0 t -113.14 149.42 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.788 1.235 . . . . 0.0 109.432 -174.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -112.84 103.19 11.18 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 167.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 76.7 m -93.76 109.05 20.74 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.62 ' HB ' HD13 ' A' ' 77' ' ' ILE . 4.9 tt -99.3 134.6 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.244 1.018 . . . . 0.0 109.739 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -123.22 155.6 36.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.773 0.829 . . . . 0.0 109.866 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -129.07 119.42 24.17 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.892 1.277 . . . . 0.0 107.645 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.534 HG22 HG12 ' A' ' 106' ' ' ILE . 97.1 t -107.46 117.62 53.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.226 1.01 . . . . 0.0 109.695 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 43.0 tt0 -126.95 133.26 50.66 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.92 0.888 . . . . 0.0 109.23 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.0 m120 61.54 28.62 17.84 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.027 1.331 . . . . 0.0 111.798 -175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.05 -7.56 80.0 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -121.27 149.29 43.1 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 101' ' ' VAL . 47.7 mt -66.41 109.77 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -75.78 -38.41 58.31 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.865 0.866 . . . . 0.0 110.608 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -149.12 146.7 27.82 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.191 0.996 . . . . 0.0 109.059 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -145.84 139.68 26.52 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.154 0.582 . . . . 0.0 109.504 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.432 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 2.0 m-90 -131.78 155.8 47.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -142.24 145.02 33.62 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 171.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.718 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 59.9 pttt -129.06 124.27 34.42 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.627 0.771 . . . . 0.0 109.066 175.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.461 HG12 HG22 ' A' ' 95' ' ' VAL . 96.5 mt -88.63 123.94 41.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.9 -66.84 2.24 Favored Glycine 0 C--O 1.242 0.607 0 O-C-N 124.39 1.056 . . . . 0.0 112.876 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -158.55 163.77 23.27 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.084 0.554 . . . . 0.0 109.653 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.627 ' HA ' HG12 ' A' ' 93' ' ' VAL . 88.7 Cg_endo -82.23 137.29 9.39 Favored 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.561 2.174 . . . . 0.0 112.475 163.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -132.82 158.74 41.73 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.74 0.781 . . . . 0.0 111.934 175.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.3 mm -138.54 139.63 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.235 1.414 . . . . 0.0 108.375 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.493 1.709 0 C-N-CA 124.001 0.921 . . . . 0.0 111.827 -179.384 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.55 ' HB2' HD11 ' A' ' 71' ' ' ILE . 11.1 m120 . . . . . 0 N--CA 1.474 0.752 0 CA-C-O 121.617 0.722 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.477 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 45.7 m -67.42 -33.22 74.71 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.547 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.29 -11.27 30.16 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.618 0.767 . . . . 0.0 112.408 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.559 HG22 HG23 ' A' ' 76' ' ' VAL . 16.3 mm -98.06 -32.55 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.742 0.817 . . . . 0.0 109.824 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -69.18 -33.81 73.94 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.66 0.784 . . . . 0.0 112.099 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.9 mt -66.83 -50.33 44.33 Favored Pre-proline 0 N--CA 1.486 1.331 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.182 -173.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 12.2 Cg_endo -54.83 -52.23 8.5 Favored 'Trans proline' 0 C--N 1.398 3.132 0 C-N-CA 122.136 1.891 . . . . 0.0 111.525 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.471 HG11 HG11 ' A' ' 76' ' ' VAL . 72.4 t -58.08 -43.64 85.66 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 C-N-CA 124.774 1.23 . . . . 0.0 112.496 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 24.4 tp60 -66.13 -55.87 14.25 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.409 0.684 . . . . 0.0 111.472 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.425 ' HG3' ' CZ2' ' A' ' 27' ' ' TRP . 73.4 mmtt -65.33 -38.34 89.85 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.325 0.65 . . . . 0.0 110.817 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -62.89 -39.49 94.65 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.523 1.129 . . . . 0.0 111.343 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' A' ' 16' ' ' TYR . 5.0 tt -59.81 -52.81 63.88 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 20.5 mm-40 -61.57 -32.03 72.09 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.806 -174.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.57 -27.64 55.93 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.588 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.4 ' HB3' ' O ' ' A' ' 13' ' ' LEU . 68.0 t80 -63.66 -47.36 81.6 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.218 1.007 . . . . 0.0 110.812 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -84.76 -23.49 29.2 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.17 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.64 -6.8 58.76 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.153 0.581 . . . . 0.0 112.337 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 71.8 12.59 6.22 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.268 1.427 . . . . 0.0 113.042 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -76.28 94.46 3.57 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.476 HG13 HG12 ' A' ' 54' ' ' ILE . 12.5 mm -66.95 -28.54 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.728 0.811 . . . . 0.0 110.883 173.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -58.62 -46.63 86.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.851 0.46 . . . . 0.0 111.1 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.6 -30.88 41.64 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.365 0.666 . . . . 0.0 110.972 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -72.87 -7.66 51.94 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.49 0.716 . . . . 0.0 110.514 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.732 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -116.35 -25.31 7.56 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.409 0.684 . . . . 0.0 112.034 175.053 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.6 -40.53 79.28 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.835 0.854 . . . . 0.0 113.123 -171.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 90.5 m95 -89.69 1.7 55.71 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.404 -173.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.567 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 14.2 m95 -99.05 138.6 35.92 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.576 0.75 . . . . 0.0 109.141 -177.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -71.46 160.66 32.35 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.443 0.697 . . . . 0.0 111.174 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -61.25 -39.82 91.74 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.398 0.679 . . . . 0.0 111.546 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -99.12 19.98 14.25 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.463 1.105 . . . . 0.0 110.856 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.567 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 50.1 t -58.03 115.12 2.68 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.224 0.609 . . . . 0.0 111.714 -176.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -75.68 153.2 37.3 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 59.8 t80 -142.07 118.67 11.0 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -115.82 153.1 32.08 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.476 1.11 . . . . 0.0 109.673 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.39 161.23 23.84 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.232 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -57.99 128.97 81.96 Favored Pre-proline 0 CA--C 1.562 1.404 0 O-C-N 124.327 1.017 . . . . 0.0 110.77 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -75.9 -51.16 0.16 OUTLIER 'Cis proline' 0 C--N 1.384 2.44 0 CA-C-N 120.185 1.102 . . . . 0.0 114.03 -0.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.0 86.4 0.62 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.2 m -141.88 117.7 10.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.38 0.672 . . . . 0.0 109.977 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 tt -68.84 106.76 2.81 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.258 1.023 . . . . 0.0 109.899 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.3 mt -82.29 -42.52 18.72 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.397 0.679 . . . . 0.0 111.345 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -141.47 117.22 10.39 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.872 0.469 . . . . 0.0 111.113 -170.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.27 42.72 1.9 Allowed Glycine 0 N--CA 1.478 1.441 0 O-C-N 123.117 0.26 . . . . 0.0 113.014 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 p30 167.69 156.51 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.649 1.579 . . . . 0.0 108.934 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -63.61 -32.88 74.48 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.782 0.833 . . . . 0.0 112.776 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.79 90.99 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.156 0.582 . . . . 0.0 112.221 -173.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.501 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 30.2 mt-10 -74.16 -34.86 63.96 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.617 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.8 mt -58.59 -45.41 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.049 0.94 . . . . 0.0 110.432 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.732 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 21.6 ttt180 -54.33 -56.71 15.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.43 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.7 t -54.77 -49.47 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 124.708 1.255 . . . . 0.0 111.568 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -62.18 -36.97 83.51 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.345 -174.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -77.55 -34.57 53.75 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 118.894 -0.574 . . . . 0.0 111.842 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 50' ' ' ARG . 77.5 mt -56.42 -40.32 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.053 0.454 . . . . 0.0 109.867 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -57.26 -43.0 82.62 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.506 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -76.25 -22.33 55.28 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 120.801 0.334 . . . . 0.0 111.282 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.473 ' HA ' HD22 ' A' ' 62' ' ' LEU . 3.5 m-30 -79.76 -0.5 34.62 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.527 0.731 . . . . 0.0 112.032 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -73.55 -30.63 63.19 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.097 0.559 . . . . 0.0 111.28 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -63.08 121.04 66.65 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.278 0.631 . . . . 0.0 110.883 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.75 -23.67 26.01 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.263 1.976 . . . . 0.0 110.773 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.34 -10.53 59.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.015 1.326 . . . . 0.0 111.477 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 57' ' ' PHE . 42.7 tp -59.29 112.63 1.81 Allowed 'General case' 0 C--N 1.36 1.024 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -148.76 130.37 14.95 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.259 1.023 . . . . 0.0 108.332 -175.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.16 127.15 8.24 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -122.56 102.99 8.4 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.62 HD12 ' HG2' ' A' ' 80' ' ' GLU . 6.3 tp -69.72 138.11 52.6 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.403 0.62 . . . . 0.0 111.208 -175.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mt -105.88 -50.85 3.09 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.822 1.249 . . . . 0.0 108.253 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.7 m -150.11 141.44 23.25 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 113.24 -1.8 . . . . 0.0 109.844 -173.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -131.38 130.43 42.6 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 165.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.59 127.6 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.884 1.274 . . . . 0.0 110.273 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.55 HD11 ' HB2' ' A' ' 2' ' ' ASN . 15.7 tt -102.89 120.67 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.145 0.578 . . . . 0.0 109.7 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.43 94.54 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 124.194 0.998 . . . . 0.0 108.486 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.37 -118.02 11.91 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 123.323 0.389 . . . . 0.0 112.669 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.5 ' HA ' HG13 ' A' ' 5' ' ' ILE . 10.9 p30 -95.04 7.99 44.36 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.325 0.65 . . . . 0.0 111.689 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.6 t -116.31 141.54 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.59 1.156 . . . . 0.0 108.581 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.559 HG23 HG22 ' A' ' 5' ' ' ILE . 70.0 t -126.29 133.5 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.004 0.522 . . . . 0.0 109.615 170.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.466 HG12 ' HB ' ' A' ' 98' ' ' ILE . 5.2 mt -100.65 114.84 40.79 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 164.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -96.65 150.84 20.22 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 166.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -138.09 106.34 5.77 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.62 ' HG2' HD12 ' A' ' 66' ' ' LEU . 6.6 mt-10 -115.75 158.98 22.02 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.344 0.658 . . . . 0.0 109.558 176.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 92' ' ' GLU . 56.9 m -97.05 103.14 15.04 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 163.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.53 125.2 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.452 0.644 . . . . 0.0 111.319 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.9 m -76.28 122.92 25.11 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.121 0.969 . . . . 0.0 111.708 -175.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.2 mmt-85 -119.97 -168.29 1.58 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.623 1.169 . . . . 0.0 109.189 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -123.81 104.99 9.29 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.275 1.03 . . . . 0.0 109.539 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.435 ' HE2' ' HB3' ' A' ' 116' ' ' PRO . 12.6 m-30 -112.4 149.46 41.09 Favored Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 123.558 0.743 . . . . 0.0 111.054 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.61 -18.84 64.05 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.952 2.435 . . . . 0.0 113.608 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -87.0 -4.38 59.17 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.44 -122.68 1.48 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.931 -0.372 . . . . 0.0 112.466 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.414 ' H ' HG23 ' A' ' 118' ' ' ILE . 16.2 tppt? -60.43 -82.14 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.983 0.913 . . . . 0.0 111.5 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.415 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 115.41 26.92 3.27 Favored Glycine 0 C--N 1.343 0.952 0 O-C-N 122.953 0.158 . . . . 0.0 113.205 -175.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.458 ' HB2' HG22 ' A' ' 81' ' ' THR . 16.9 pt-20 -89.21 104.7 17.22 Favored 'General case' 0 C--O 1.207 -1.138 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -174.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 116' ' ' PRO . 20.3 m -105.16 131.12 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 121.33 -0.856 . . . . 0.0 109.973 -171.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -78.33 127.91 32.91 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.518 HG22 HG12 ' A' ' 113' ' ' ILE . 43.1 t -131.57 126.25 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.09 99.41 12.43 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 172.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.6 m -94.81 108.51 20.53 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.152 0.981 . . . . 0.0 108.843 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.611 HG23 ' HB2' ' A' ' 110' ' ' TRP . 11.1 tt -105.86 107.23 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 C-N-CA 124.403 1.081 . . . . 0.0 110.735 -172.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -104.14 131.17 51.7 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.35 1.06 . . . . 0.0 110.024 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -97.82 112.03 24.09 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 168.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.52 HG22 HG12 ' A' ' 106' ' ' ILE . 75.2 t -99.62 125.1 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.077 0.951 . . . . 0.0 109.15 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -125.81 127.94 46.9 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.476 0.71 . . . . 0.0 109.981 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.6 m120 61.48 30.43 18.82 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.45 1.5 . . . . 0.0 112.116 -176.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.54 1.95 90.56 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 113.781 0.272 . . . . 0.0 113.781 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -124.79 136.0 53.46 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.047 0.939 . . . . 0.0 109.007 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.52 HG12 HG22 ' A' ' 101' ' ' VAL . 68.8 mt -62.43 102.86 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.252 1.021 . . . . 0.0 109.811 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -78.47 -29.89 47.09 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.291 0.636 . . . . 0.0 110.765 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -148.57 143.26 26.49 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -137.05 131.03 32.22 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.611 ' HB2' HG23 ' A' ' 98' ' ' ILE . 0.9 OUTLIER -135.37 152.86 51.84 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -176.319 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -143.0 144.85 32.46 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -130.82 123.7 29.69 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.518 HG12 HG22 ' A' ' 95' ' ' VAL . 96.7 mt -88.22 127.48 41.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.93 -78.82 0.16 Allowed Glycine 0 N--CA 1.468 0.826 0 O-C-N 124.331 1.019 . . . . 0.0 112.667 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -158.83 164.58 20.65 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.712 ' HA ' HG12 ' A' ' 93' ' ' VAL . 72.3 Cg_endo -72.2 117.69 5.26 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.433 2.089 . . . . 0.0 112.581 169.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.422 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 15.6 mmt180 -102.11 144.11 31.09 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.414 HG23 ' H ' ' A' ' 90' ' ' LYS . 49.4 mm -122.83 152.37 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 173.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 N--CA 1.493 1.715 0 C-N-CA 122.646 0.378 . . . . 0.0 111.402 -178.741 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.1 p30 . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 119.747 -0.168 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.44 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 78.7 p -63.78 -37.79 88.69 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.463 ' HG3' HG12 ' A' ' 5' ' ' ILE . 9.5 pt-20 -55.8 -28.28 55.41 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.72 1.208 . . . . 0.0 112.716 174.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.575 HG13 ' HA ' ' A' ' 74' ' ' ASN . 32.8 mm -89.83 -27.88 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.492 1.117 . . . . 0.0 109.826 -177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.39 -24.04 60.25 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.117 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 3' ' ' SER . 79.5 mt -63.6 -50.65 71.34 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.725 -175.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.465 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 11.6 Cg_endo -55.96 -60.4 0.52 Allowed 'Trans proline' 0 C--N 1.394 2.932 0 C-N-CA 121.866 1.711 . . . . 0.0 111.984 172.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.3 t -51.07 -48.95 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 C-N-CA 124.509 1.123 . . . . 0.0 113.347 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -63.09 -52.21 63.56 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.173 0.989 . . . . 0.0 110.937 -176.664 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -63.54 -37.17 86.29 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.029 0.532 . . . . 0.0 111.282 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -68.26 -38.1 81.42 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.116 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' A' ' 66' ' ' LEU . 50.8 tp -62.53 -50.86 69.69 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.524 0.73 . . . . 0.0 110.872 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 4.0 mm-40 -55.42 -47.23 76.27 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.31 1.007 . . . . 0.0 109.477 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 20' ' ' ASP . . . -66.22 -28.79 69.01 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.229 -1.35 . . . . 0.0 112.329 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -67.45 -48.26 67.76 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.176 0.59 . . . . 0.0 110.488 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -83.71 -14.67 51.11 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.251 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.96 0.4 55.95 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.425 0.69 . . . . 0.0 111.992 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 62.71 26.0 15.4 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.463 1.105 . . . . 0.0 111.851 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.402 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 13.1 t70 -96.48 110.57 22.92 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.793 1.237 . . . . 0.0 109.31 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.408 HG13 HG12 ' A' ' 54' ' ' ILE . 23.4 mm -76.84 -32.89 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.1 0.56 . . . . 0.0 110.999 173.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 24.8 t70 -58.19 -49.06 78.38 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.745 0.653 . . . . 0.0 112.161 -168.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.81 -35.63 22.2 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.177 0.991 . . . . 0.0 111.392 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -63.01 -14.18 44.67 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.293 0.371 . . . . 0.0 112.0 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 68.2 mmm -120.66 -14.4 8.6 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -60.79 -36.51 79.19 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.552 0.691 . . . . 0.0 112.304 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 91.8 m95 -93.57 14.03 20.13 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.718 -170.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.614 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 19.3 m95 -99.12 152.45 19.85 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.778 0.831 . . . . 0.0 109.267 174.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -78.92 154.54 29.58 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.262 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.44 -32.04 72.84 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.118 0.567 . . . . 0.0 111.184 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -99.42 17.9 19.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.889 0.875 . . . . 0.0 111.337 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.614 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 46.9 t -64.54 117.92 8.06 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 123.209 0.318 . . . . 0.0 111.549 -174.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -77.68 154.09 32.47 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -139.39 110.44 6.87 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.475 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 96.4 m-85 -113.37 138.33 50.22 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.818 0.847 . . . . 0.0 110.572 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.537 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -92.21 154.95 18.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.459 166.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -50.04 130.03 22.73 Favored Pre-proline 0 CA--C 1.567 1.617 0 C-N-CA 124.268 1.027 . . . . 0.0 112.508 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.43 -36.34 2.15 Favored 'Cis proline' 0 C--N 1.383 2.371 0 CA-C-N 119.967 1.024 . . . . 0.0 112.134 -4.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . . . -159.62 94.57 1.16 Allowed 'General case' 0 C--N 1.345 0.41 0 C-N-CA 124.821 1.248 . . . . 0.0 107.748 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 7.2 m -130.18 102.4 6.21 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.5 tp -73.1 100.89 3.15 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 117.961 0.346 . . . . 0.0 110.447 -175.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -83.36 -34.31 25.63 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.044 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -146.37 116.91 7.54 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.81 -173.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -107.53 46.66 1.14 Allowed Glycine 0 C--N 1.347 1.147 0 C-N-CA 123.032 0.349 . . . . 0.0 113.034 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.425 ' O ' HG13 ' A' ' 49' ' ' ILE . 9.6 p30 162.08 154.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 126.149 1.78 . . . . 0.0 109.227 -171.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -63.5 -26.28 68.64 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -175.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -62.22 -51.4 67.93 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.803 0.441 . . . . 0.0 110.98 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.443 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.0 mt-10 -68.41 -33.43 74.21 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.108 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 45' ' ' ASN . 54.2 mt -69.2 -43.14 81.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 122.962 0.505 . . . . 0.0 110.264 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.487 ' O ' HG13 ' A' ' 54' ' ' ILE . 32.0 ptt180 -69.87 -45.18 68.28 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.605 -173.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.8 m -68.95 -35.03 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 122.859 0.463 . . . . 0.0 111.894 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -71.41 -40.1 70.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.297 0.639 . . . . 0.0 110.357 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -64.61 -33.33 75.68 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.57 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 50' ' ' ARG . 97.0 mt -58.16 -47.07 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 122.557 0.343 . . . . 0.0 110.184 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.21 -33.3 75.09 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.455 0.702 . . . . 0.0 111.498 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -66.79 -35.04 79.15 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.174 0.59 . . . . 0.0 110.956 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -78.75 -2.45 39.47 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.21 0.604 . . . . 0.0 112.02 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -84.58 -19.71 32.63 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.948 0.499 . . . . 0.0 110.756 171.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.11 113.55 8.17 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 123.694 0.798 . . . . 0.0 109.813 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -61.35 -32.23 89.37 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 123.107 2.538 . . . . 0.0 113.547 -169.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.22 -0.6 56.79 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.723 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.6 tp -62.82 118.9 8.37 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.202 0.455 . . . . 0.0 111.359 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.456 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 76.3 t80 -151.02 127.56 10.77 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.84 104.2 2.53 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -97.83 100.89 12.27 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.168 0.587 . . . . 0.0 109.51 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HB2' HD11 ' A' ' 13' ' ' LEU . 7.7 tt -79.53 129.7 34.71 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.458 HD11 ' CD2' ' A' ' 79' ' ' HIS . 1.7 pp -115.9 -29.8 6.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.468 -175.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.5 m -150.69 143.79 24.77 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.957 0.903 . . . . 0.0 109.559 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -143.61 136.92 27.93 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.56 0.744 . . . . 0.0 109.326 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.78 130.88 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' A' ' 5' ' ' ILE . 9.5 tt -121.98 136.51 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.031 0.532 . . . . 0.0 110.258 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 p -143.35 110.05 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 124.678 1.191 . . . . 0.0 109.186 -176.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.78 -119.71 9.26 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.202 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.575 ' HA ' HG13 ' A' ' 5' ' ' ILE . 27.0 p-10 -108.63 19.86 19.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.275 0.63 . . . . 0.0 111.077 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -127.48 133.63 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.09 0.956 . . . . 0.0 109.251 -175.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 15.1 t -122.57 138.97 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.175 0.59 . . . . 0.0 110.255 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.639 HD13 ' HB ' ' A' ' 98' ' ' ILE . 6.7 mm -104.96 111.9 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.061 1.344 . . . . 0.0 107.708 167.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -106.35 116.06 31.28 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.458 ' CD2' HD11 ' A' ' 67' ' ' LEU . 1.5 t60 -99.83 109.01 21.43 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.36 140.05 52.06 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.947 1.299 . . . . 0.0 110.624 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.1 m -86.1 106.5 17.28 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.82 0.848 . . . . 0.0 109.131 169.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.4 t -82.79 104.08 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.754 0.822 . . . . 0.0 110.441 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.47 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 25.3 m -68.06 127.99 34.89 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.089 0.556 . . . . 0.0 110.425 170.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -139.07 -170.24 2.83 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.801 0.84 . . . . 0.0 109.097 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -119.3 100.55 7.38 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.877 0.471 . . . . 0.0 110.648 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.404 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 13.4 m-30 -100.22 142.6 24.92 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 123.714 0.806 . . . . 0.0 109.65 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.04 -23.03 66.79 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.983 2.455 . . . . 0.0 114.026 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -86.54 -4.91 59.24 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.22 -134.24 3.41 Favored Glycine 0 N--CA 1.474 1.174 0 CA-C-O 119.566 -0.574 . . . . 0.0 111.83 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.411 ' CG ' ' HG3' ' A' ' 92' ' ' GLU . 3.0 tppp? -53.15 -87.24 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.659 0.784 . . . . 0.0 112.804 172.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.404 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 124.37 26.69 1.44 Allowed Glycine 0 C--N 1.347 1.155 0 N-CA-C 113.761 0.265 . . . . 0.0 113.761 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.47 ' HG2' ' HA ' ' A' ' 83' ' ' THR . 46.8 mt-10 -89.61 115.51 27.06 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 117.099 0.45 . . . . 0.0 109.943 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.554 HG12 ' HA ' ' A' ' 116' ' ' PRO . 17.2 m -108.96 130.12 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.432 0.693 . . . . 0.0 109.613 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.435 ' HB3' ' HE1' ' A' ' 79' ' ' HIS . 1.3 m-20 -85.45 108.81 18.06 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.408 HG22 HG12 ' A' ' 113' ' ' ILE . 34.6 t -113.18 162.55 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.108 1.363 . . . . 0.0 108.995 -171.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.18 102.71 6.35 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.573 1.149 . . . . 0.0 108.029 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 80.6 m -93.1 107.92 19.62 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.712 HG23 ' HB2' ' A' ' 110' ' ' TRP . 5.7 tt -102.59 111.05 31.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.148 -176.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -100.46 153.85 19.02 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.618 0.767 . . . . 0.0 110.601 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -126.66 117.45 22.77 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.263 1.425 . . . . 0.0 107.47 171.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.484 HG22 HG12 ' A' ' 106' ' ' ILE . 86.2 t -109.02 124.31 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.266 1.026 . . . . 0.0 110.254 -173.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 10.6 tp10 -131.57 135.5 47.05 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.032 0.933 . . . . 0.0 109.406 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.0 m120 62.5 30.02 17.13 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.726 1.211 . . . . 0.0 112.488 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.47 7.82 79.43 Favored Glycine 0 N--CA 1.478 1.499 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.843 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -127.26 148.12 50.22 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.994 1.318 . . . . 0.0 108.149 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.484 HG12 HG22 ' A' ' 101' ' ' VAL . 53.0 mt -69.29 113.72 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -78.03 -36.66 48.33 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.703 0.801 . . . . 0.0 111.105 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.584 ' HE2' ' HE1' ' A' ' 110' ' ' TRP . 61.4 mtpt -150.59 132.49 15.12 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.055 0.942 . . . . 0.0 108.66 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -124.69 132.58 53.38 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.712 ' HB2' HG23 ' A' ' 98' ' ' ILE . 1.6 m-90 -130.77 152.45 50.1 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -176.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -144.25 147.02 33.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.797 0.332 . . . . 0.0 110.201 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -128.95 117.92 21.77 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.965 0.906 . . . . 0.0 109.064 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.408 HG12 HG22 ' A' ' 95' ' ' VAL . 94.5 mt -86.79 132.72 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.74 -83.12 0.09 OUTLIER Glycine 0 CA--C 1.526 0.778 0 O-C-N 123.708 0.63 . . . . 0.0 112.05 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.15 166.29 16.84 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.498 0.719 . . . . 0.0 109.463 175.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.554 ' HA ' HG12 ' A' ' 93' ' ' VAL . 51.5 Cg_endo -65.85 110.42 1.69 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.532 2.155 . . . . 0.0 113.111 168.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -109.6 149.83 29.09 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.83 0.852 . . . . 0.0 110.232 173.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.4 mm -124.68 154.93 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.4 t . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.516 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.1 m120 . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 121.299 0.571 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 m -66.31 -39.05 89.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.711 0.804 . . . . 0.0 111.345 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.18 -12.37 60.82 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.112 0.565 . . . . 0.0 111.808 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.9 mm -98.02 -39.15 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.927 0.891 . . . . 0.0 109.391 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -58.91 -44.58 91.28 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.54 1.136 . . . . 0.0 112.338 177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.53 -57.11 24.2 Favored Pre-proline 0 CA--C 1.561 1.391 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.883 -171.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.575 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 21.1 Cg_endo -58.27 -48.76 14.47 Favored 'Trans proline' 0 C--N 1.395 3.022 0 C-N-CA 122.401 2.067 . . . . 0.0 112.28 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.2 t -59.27 -44.06 91.26 Favored 'Isoleucine or valine' 0 C--O 1.247 0.956 0 C-N-CA 124.91 1.284 . . . . 0.0 112.605 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -46.07 67.06 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -63.35 -27.74 69.52 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.786 0.834 . . . . 0.0 111.919 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -63.2 -46.18 88.24 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.684 0.615 . . . . 0.0 110.221 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.16 -53.76 52.95 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.153 0.908 . . . . 0.0 109.218 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -52.17 -36.37 51.5 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 124.653 1.221 . . . . 0.0 111.089 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -81.75 -27.96 33.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.651 1.18 . . . . 0.0 112.195 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -69.66 -48.41 59.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.721 0.409 . . . . 0.0 110.267 -172.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -76.07 -28.97 57.8 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.932 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.46 1.16 56.92 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.55 0.74 . . . . 0.0 112.051 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 67.64 18.79 9.87 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.577 1.151 . . . . 0.0 112.797 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.48 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 67.9 m-20 -88.59 95.3 10.19 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.964 0.506 . . . . 0.0 110.467 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.404 ' HA ' ' HB3' ' A' ' 24' ' ' PHE . 23.9 mm -67.77 -26.87 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 123.024 0.53 . . . . 0.0 110.648 172.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -52.44 -48.38 65.84 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.485 0.714 . . . . 0.0 111.59 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.37 -35.0 31.34 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.883 0.473 . . . . 0.0 110.952 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.404 ' HB3' ' HA ' ' A' ' 21' ' ' ILE . 16.2 t80 -71.07 -5.84 34.52 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.617 0.767 . . . . 0.0 111.279 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.57 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 19.6 tpp -121.03 -25.62 5.3 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.173 0.589 . . . . 0.0 112.456 172.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.13 -44.22 74.84 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.1 m95 -82.71 -3.79 56.94 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -172.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -91.36 149.16 21.85 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.387 0.675 . . . . 0.0 109.8 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -74.05 152.26 40.01 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.349 0.66 . . . . 0.0 110.033 176.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.94 -23.93 65.13 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.112 0.482 . . . . 0.0 110.929 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -102.26 18.61 20.52 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.68 1.192 . . . . 0.0 111.114 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 42.1 t -64.57 122.98 18.07 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.931 0.396 . . . . 0.0 111.916 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -83.11 154.38 24.38 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.493 0.717 . . . . 0.0 109.481 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 33.9 t80 -145.68 120.69 10.05 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.407 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 43.3 m-85 -121.18 153.92 36.92 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.279 1.032 . . . . 0.0 110.484 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -120.44 159.83 24.34 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.385 1.074 . . . . 0.0 110.702 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.641 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 82.9 t80 -62.37 130.71 93.44 Favored Pre-proline 0 CA--C 1.56 1.36 0 O-C-N 124.18 0.925 . . . . 0.0 110.383 174.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.67 -47.43 0.31 Allowed 'Cis proline' 0 C--N 1.386 2.506 0 CA-C-N 120.697 1.285 . . . . 0.0 113.447 -1.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.68 93.35 0.82 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 98.3 m -141.33 115.79 9.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.155 0.582 . . . . 0.0 109.6 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 tt -70.8 101.71 2.17 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 36' ' ' ALA . 94.7 mt -80.64 -37.84 30.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.554 0.741 . . . . 0.0 110.868 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -148.23 121.24 8.82 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.421 0.451 . . . . 0.0 111.185 -171.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.4 39.55 2.81 Favored Glycine 0 C--N 1.35 1.327 0 C-N-CA 123.116 0.389 . . . . 0.0 113.26 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 166.06 165.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 125.847 1.659 . . . . 0.0 109.155 -171.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.57 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -66.54 -36.81 83.59 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.749 0.82 . . . . 0.0 112.748 -175.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.11 -46.87 84.82 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.15 0.58 . . . . 0.0 111.743 -174.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.1 mt-10 -72.85 -29.99 63.65 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.487 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.1 mt -67.43 -44.41 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.007 0.523 . . . . 0.0 109.704 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.43 ' O ' HG13 ' A' ' 54' ' ' ILE . 76.6 ttt180 -59.83 -56.1 26.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.552 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.5 m -61.58 -41.59 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 124.429 1.081 . . . . 0.0 112.563 -173.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -72.17 -29.15 63.73 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.145 0.578 . . . . 0.0 110.96 -176.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -77.94 -30.83 50.63 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 118.929 -0.558 . . . . 0.0 111.2 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 50' ' ' ARG . 99.0 mt -59.69 -41.28 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.9 -38.36 88.08 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.919 0.888 . . . . 0.0 111.414 175.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -78.84 -23.33 45.09 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.141 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -84.12 0.62 47.76 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.295 0.638 . . . . 0.0 110.931 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -79.76 -20.36 46.49 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.064 0.545 . . . . 0.0 111.673 170.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 7.3 mm-40 -64.45 112.86 8.67 Favored Pre-proline 0 CA--C 1.547 0.846 0 O-C-N 123.805 0.691 . . . . 0.0 109.802 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -65.63 -18.34 58.71 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.333 2.022 . . . . 0.0 112.24 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.02 2.85 46.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.377 1.071 . . . . 0.0 111.714 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 19.4 tp -66.28 116.14 7.0 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.627 0.371 . . . . 0.0 110.15 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -145.02 117.87 8.74 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.438 ' HA2' HG12 ' A' ' 82' ' ' VAL . . . -93.45 103.48 3.04 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 175.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.44 98.14 10.01 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.5 tt -86.72 126.47 34.59 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.431 HD11 ' CD2' ' A' ' 79' ' ' HIS . 2.3 pp -114.32 -30.17 6.68 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.276 1.03 . . . . 0.0 110.438 -171.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.8 m -155.17 132.85 11.29 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.429 1.092 . . . . 0.0 109.055 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 0.8 OUTLIER -132.45 134.71 45.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.59 0.756 . . . . 0.0 109.288 167.181 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 77' ' ' ILE . 30.1 m -118.88 119.8 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.561 0.745 . . . . 0.0 109.807 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.449 HG13 HG22 ' A' ' 76' ' ' VAL . 17.3 tt -95.29 129.4 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-O 121.321 0.581 . . . . 0.0 109.504 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 p -141.01 96.41 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.515 1.126 . . . . 0.0 108.65 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.76 -128.08 31.67 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.337 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -83.43 3.47 31.83 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.698 0.799 . . . . 0.0 112.578 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.1 t -126.45 134.97 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.811 0.844 . . . . 0.0 109.765 -171.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.449 HG22 HG13 ' A' ' 71' ' ' ILE . 21.6 t -124.18 140.6 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 122.988 0.515 . . . . 0.0 109.627 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.509 HD13 ' HB ' ' A' ' 98' ' ' ILE . 16.2 mm -99.27 103.26 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 172.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -90.35 104.65 17.2 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.431 ' CD2' HD11 ' A' ' 67' ' ' LEU . 2.0 t60 -98.07 108.36 21.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -117.41 152.29 35.28 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.288 -1.324 . . . . 0.0 109.611 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.5 m -103.19 101.87 11.83 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 159.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.438 HG12 ' HA2' ' A' ' 64' ' ' GLY . 32.8 m -91.97 127.81 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.065 0.459 . . . . 0.0 110.367 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.3 m -75.71 120.49 21.17 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.149 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.577 HH21 HG11 ' A' ' 93' ' ' VAL . 61.3 mtm180 -125.05 -163.51 1.19 Allowed 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -127.8 109.24 11.43 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 118.284 0.493 . . . . 0.0 111.074 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.418 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 19.2 m-30 -108.34 144.6 29.81 Favored Pre-proline 0 N--CA 1.481 1.095 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.57 -7.52 20.98 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.791 2.328 . . . . 0.0 112.807 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -84.17 -20.72 31.92 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.065 0.946 . . . . 0.0 111.804 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.07 -125.15 1.09 Allowed Glycine 0 C--N 1.349 1.256 0 CA-C-O 119.549 -0.584 . . . . 0.0 111.962 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -59.61 -80.54 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.188 0.995 . . . . 0.0 111.931 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.418 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 118.52 24.12 3.24 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 116.308 -0.405 . . . . 0.0 113.048 -177.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.562 ' HG3' ' HB2' ' A' ' 117' ' ' ARG . 7.1 pt-20 -87.54 147.68 25.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.577 HG11 HH21 ' A' ' 84' ' ' ARG . 7.5 m -138.59 134.96 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 121.975 -0.453 . . . . 0.0 111.388 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.67 111.08 13.07 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.329 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.483 HG22 HG12 ' A' ' 113' ' ' ILE . 48.9 t -124.64 144.93 32.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 124.169 0.988 . . . . 0.0 108.95 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -106.5 107.3 18.24 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 170.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 56.5 m -93.12 104.34 16.55 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.593 HG23 ' HB2' ' A' ' 110' ' ' TRP . 5.5 tt -105.99 109.82 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.217 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -104.13 151.47 23.27 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.528 0.731 . . . . 0.0 110.549 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -121.43 114.33 21.12 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.144 0.978 . . . . 0.0 108.628 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.54 HG22 HG12 ' A' ' 106' ' ' ILE . 45.1 t -101.74 115.21 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.077 0.951 . . . . 0.0 109.2 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 41.7 tt0 -116.75 128.77 55.62 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.151 0.981 . . . . 0.0 109.006 176.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 62.25 32.37 17.18 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.951 0.901 . . . . 0.0 111.462 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.42 11.67 84.13 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 114.595 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -133.02 136.73 46.18 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.485 1.114 . . . . 0.0 108.679 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.54 HG12 HG22 ' A' ' 101' ' ' VAL . 60.0 mt -66.63 100.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -78.05 -28.07 48.86 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.227 0.611 . . . . 0.0 110.967 -175.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -149.58 153.77 37.64 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.076 0.951 . . . . 0.0 108.592 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -148.67 134.54 18.99 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.593 ' HB2' HG23 ' A' ' 98' ' ' ILE . 1.7 m-90 -135.53 154.8 51.27 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -143.03 146.37 33.78 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 169.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.641 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 17.1 ptpt -129.34 124.52 34.49 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.916 0.886 . . . . 0.0 109.182 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.483 HG12 HG22 ' A' ' 95' ' ' VAL . 92.1 mt -88.19 119.19 35.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.26 -63.41 3.27 Favored Glycine 0 N--CA 1.465 0.624 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.684 -177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -157.16 166.4 16.72 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 122.768 0.427 . . . . 0.0 110.35 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.574 ' HA ' HG12 ' A' ' 93' ' ' VAL . 97.2 Cg_endo -75.67 132.69 14.81 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.653 2.235 . . . . 0.0 112.069 163.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.562 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 15.6 mmt180 -115.84 140.84 48.84 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.381 1.072 . . . . 0.0 108.567 175.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.2 mm -132.04 149.8 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.732 0.301 . . . . 0.0 110.466 179.253 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.582 ' HB2' HD13 ' A' ' 71' ' ' ILE . 3.3 p-10 . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 81.8 p -62.26 -43.98 97.58 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.977 0.511 . . . . 0.0 110.084 -177.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -64.37 -14.68 57.82 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.676 1.19 . . . . 0.0 112.679 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.54 HG23 ' HB ' ' A' ' 101' ' ' VAL . 44.0 mm -89.85 -34.21 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.864 0.866 . . . . 0.0 109.992 174.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -84.97 -10.09 57.4 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.256 0.622 . . . . 0.0 111.709 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 3' ' ' SER . 65.3 mt -65.93 -54.46 27.78 Favored Pre-proline 0 N--CA 1.481 1.123 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.092 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.502 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 13.0 Cg_endo -56.32 -46.73 28.4 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 121.752 1.635 . . . . 0.0 112.572 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.48 -45.89 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 124.048 0.939 . . . . 0.0 113.215 -173.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -41.33 65.78 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -176.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -66.6 -26.39 67.07 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.907 0.483 . . . . 0.0 111.329 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 8' ' ' PRO . 50.0 mt-30 -60.89 -46.53 90.25 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.168 0.292 . . . . 0.0 110.232 171.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.93 -51.97 67.41 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 123.516 0.51 . . . . 0.0 109.702 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -55.19 -34.39 63.84 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 124.684 1.24 . . . . 0.0 110.145 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -82.45 -27.65 31.77 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.776 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -71.01 -44.07 66.64 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.871 0.469 . . . . 0.0 110.298 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -79.39 -28.55 41.85 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.004 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.2 5.02 52.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.578 0.751 . . . . 0.0 112.24 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 64.79 13.26 8.33 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.035 1.334 . . . . 0.0 113.992 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.511 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 18.6 m-20 -76.91 95.13 4.04 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.297 0.57 . . . . 0.0 111.583 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.437 HG13 HG12 ' A' ' 54' ' ' ILE . 29.5 mm -64.33 -25.49 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.144 0.578 . . . . 0.0 110.365 167.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -50.44 -50.55 51.84 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.99 0.916 . . . . 0.0 111.194 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -82.68 -37.72 24.41 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.181 0.592 . . . . 0.0 110.762 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -66.83 -6.63 16.96 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.215 0.606 . . . . 0.0 111.565 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.764 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -120.56 -30.63 4.48 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 171.325 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.44 -34.92 73.11 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.166 0.507 . . . . 0.0 112.303 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.502 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 99.4 m95 -88.54 4.0 48.33 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.867 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.445 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 16.2 m95 -102.97 157.31 17.07 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.64 0.776 . . . . 0.0 109.9 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -81.8 148.84 28.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.825 0.85 . . . . 0.0 109.404 171.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -66.45 -24.1 66.38 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.336 0.589 . . . . 0.0 111.031 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -86.51 -2.26 58.32 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.143 1.377 . . . . 0.0 111.724 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 42.3 t -59.89 132.89 55.33 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -167.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -88.12 154.7 20.25 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.453 0.701 . . . . 0.0 109.957 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -145.19 110.08 5.11 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.414 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 36.7 m-85 -111.1 155.19 23.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.951 0.9 . . . . 0.0 110.644 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.32 159.52 20.12 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.278 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.561 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 90.5 t80 -52.06 127.32 36.79 Favored Pre-proline 0 N--CA 1.486 1.342 0 C-N-CA 123.95 0.9 . . . . 0.0 111.149 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.8 -47.56 0.31 Allowed 'Cis proline' 0 C--N 1.387 2.556 0 CA-C-N 120.614 1.255 . . . . 0.0 113.681 -1.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.44 79.26 0.44 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.0 m -123.33 106.96 11.13 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.703 0.801 . . . . 0.0 109.282 -176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.2 tp -67.0 102.34 0.97 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.032 0.533 . . . . 0.0 110.198 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.6 mt -81.85 -36.67 28.0 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.973 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -145.57 116.56 7.81 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.372 -174.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.46 41.07 2.22 Favored Glycine 0 N--CA 1.474 1.181 0 C-N-CA 122.986 0.327 . . . . 0.0 113.398 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.5 p30 164.82 152.18 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 126.226 1.81 . . . . 0.0 108.852 -173.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -61.98 -26.78 68.42 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.965 0.906 . . . . 0.0 113.149 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -63.77 -38.32 90.66 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.44 0.296 . . . . 0.0 111.547 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.509 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 27.2 mt-10 -77.77 -31.22 51.83 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.997 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.7 mt -68.62 -41.36 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.759 0.824 . . . . 0.0 111.265 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.764 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 5.7 ptp180 -62.8 -45.9 90.47 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.069 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.403 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 96.5 t -54.8 -55.29 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.686 0.795 . . . . 0.0 110.29 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -52.07 -44.1 64.16 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.926 1.29 . . . . 0.0 111.963 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -78.35 -34.64 48.28 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.025 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.437 HG12 HG13 ' A' ' 21' ' ' ILE . 97.0 mt -60.77 -45.3 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-N 118.982 0.81 . . . . 0.0 109.472 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 51' ' ' VAL . 43.4 mt-10 -63.77 -32.84 74.47 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.355 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -88.22 -15.98 34.47 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -85.97 -4.53 59.19 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.107 0.563 . . . . 0.0 110.556 173.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.71 -20.21 63.54 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.265 0.626 . . . . 0.0 111.533 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 20.3 mm-40 -65.97 120.21 67.49 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.431 0.692 . . . . 0.0 110.314 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.14 -18.75 18.18 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.222 1.948 . . . . 0.0 112.249 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -81.62 -22.9 37.36 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.24 0.616 . . . . 0.0 110.775 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 30.8 tp -56.29 129.97 42.56 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.808 0.843 . . . . 0.0 112.024 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.442 ' CE2' ' HB2' ' A' ' 65' ' ' GLU . 46.2 t80 -151.24 144.35 24.65 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.595 0.758 . . . . 0.0 109.617 175.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.58 118.78 5.08 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.844 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.442 ' HB2' ' CE2' ' A' ' 63' ' ' TYR . 35.6 tt0 -126.32 99.77 6.0 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.8 tt -80.43 140.31 36.04 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.185 0.517 . . . . 0.0 110.169 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mt -109.46 -51.84 2.83 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.285 -173.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.0 m -147.99 139.5 23.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.909 -172.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 14.1 ptt180 -131.6 119.65 21.76 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.321 0.648 . . . . 0.0 109.693 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -115.84 127.16 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.034 0.934 . . . . 0.0 109.044 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.582 HD13 ' HB2' ' A' ' 2' ' ' ASN . 13.8 tt -114.96 132.98 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-O 121.386 0.613 . . . . 0.0 111.534 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.9 t -117.75 103.33 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 125.42 1.488 . . . . 0.0 107.851 172.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.6 -102.81 0.42 Allowed Glycine 0 N--CA 1.476 1.345 0 N-CA-C 113.994 0.357 . . . . 0.0 113.994 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.535 ' HA ' HG13 ' A' ' 5' ' ' ILE . 23.4 p-10 -111.67 21.19 16.36 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.121 0.568 . . . . 0.0 112.284 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.0 p -135.6 135.04 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.025 0.53 . . . . 0.0 110.012 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -117.75 137.43 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.265 0.626 . . . . 0.0 109.663 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.626 HD13 ' HB ' ' A' ' 98' ' ' ILE . 7.7 mm -98.95 102.68 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 165.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -102.54 105.69 16.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -98.4 107.02 19.38 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.205 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -103.87 172.77 6.62 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.547 1.139 . . . . 0.0 110.955 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.2 m -116.14 102.69 9.83 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 160.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.7 m -88.5 133.38 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.661 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.0 m -88.12 128.37 35.43 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -155.27 146.98 23.2 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -77.94 103.74 8.07 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -166.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -92.37 127.6 48.13 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 165.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -62.41 -15.97 48.71 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.465 2.777 . . . . 0.0 114.224 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -83.59 -32.12 25.95 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.405 0.282 . . . . 0.0 111.636 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.84 -136.35 2.1 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-O 119.456 -0.636 . . . . 0.0 111.65 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -72.54 -79.41 0.08 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 117.318 0.559 . . . . 0.0 110.468 171.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.1 30.43 2.3 Favored Glycine 0 C--N 1.346 1.091 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.713 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -88.82 98.48 11.74 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 122.456 1.122 . . . . 0.0 108.227 -174.495 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 117' ' ' ARG . 20.7 m -104.59 145.61 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.374 -0.829 . . . . 0.0 111.14 -165.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -78.11 132.4 37.68 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 176.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.589 HG22 HG12 ' A' ' 113' ' ' ILE . 46.8 t -136.27 124.39 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.01 100.53 11.12 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.6 m -94.08 122.79 36.96 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 110' ' ' TRP . 6.2 tt -123.87 115.38 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.925 0.89 . . . . 0.0 109.814 -173.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -116.86 127.22 54.07 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.849 0.859 . . . . 0.0 110.41 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -98.57 111.1 23.57 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.54 ' HB ' HG23 ' A' ' 5' ' ' ILE . 99.5 t -98.39 130.45 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.691 1.196 . . . . 0.0 109.977 -174.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -129.42 124.65 34.68 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.229 1.012 . . . . 0.0 109.298 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.6 m120 62.65 37.25 13.0 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.876 1.271 . . . . 0.0 112.45 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.11 5.25 65.29 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 113.884 0.314 . . . . 0.0 113.884 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.8 mmt85 -122.79 135.13 54.45 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.614 1.166 . . . . 0.0 108.285 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.451 HG12 HG22 ' A' ' 101' ' ' VAL . 77.8 mt -65.56 105.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -86.4 -23.35 26.14 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.764 0.426 . . . . 0.0 111.2 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -147.1 149.26 32.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.813 0.845 . . . . 0.0 109.711 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.92 137.4 24.9 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.744 0.818 . . . . 0.0 109.088 -176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.641 ' HB2' HG23 ' A' ' 98' ' ' ILE . 4.5 m-90 -139.0 152.71 47.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -142.3 137.1 30.35 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 169.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 51.6 mtmt -126.15 129.65 49.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.589 HG12 HG22 ' A' ' 95' ' ' VAL . 90.8 mt -88.35 131.94 34.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.93 -75.24 0.28 Allowed Glycine 0 CA--C 1.527 0.783 0 O-C-N 124.12 0.888 . . . . 0.0 112.354 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.91 166.44 16.43 Favored Pre-proline 0 CA--C 1.554 1.096 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.35 137.6 51.97 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.307 2.005 . . . . 0.0 112.289 173.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 19.8 mmt180 -135.35 138.89 43.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.258 1.023 . . . . 0.0 109.078 -174.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.9 mm -126.62 143.53 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.7 t . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.281 0.562 . . . . 0.0 110.679 176.718 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 121.598 0.713 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.2 m -63.31 -42.39 99.03 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.005 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -13.68 62.49 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.411 0.684 . . . . 0.0 112.374 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.504 HG23 ' HB ' ' A' ' 101' ' ' VAL . 26.9 mm -85.09 -32.05 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 122.94 0.496 . . . . 0.0 110.006 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.506 ' HG3' HD12 ' A' ' 71' ' ' ILE . 58.1 mt-10 -87.74 -10.02 52.32 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.2 mt -61.37 -50.24 84.11 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.256 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.465 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 18.4 Cg_endo -59.18 -50.95 7.46 Favored 'Trans proline' 0 C--N 1.389 2.697 0 CA-C-N 120.907 1.36 . . . . 0.0 111.285 172.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.501 HG21 HG21 ' A' ' 76' ' ' VAL . 63.4 t -50.55 -53.22 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 124.654 1.181 . . . . 0.0 113.029 -173.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 25.8 tp60 -61.77 -47.26 85.96 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.066 -177.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -71.18 -29.62 65.41 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.227 0.611 . . . . 0.0 111.824 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.447 ' HG2' ' HE1' ' A' ' 28' ' ' TRP . 44.8 mt-30 -62.4 -49.5 75.25 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.568 0.747 . . . . 0.0 109.775 176.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.486 HD22 HD13 ' A' ' 66' ' ' LEU . 31.9 tp -57.61 -52.06 66.97 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.47 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 13.4 mm-40 -58.38 -41.87 85.76 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.369 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -71.22 -28.28 64.09 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.25 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -68.43 -41.45 80.34 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.979 0.911 . . . . 0.0 110.54 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -83.61 -29.59 27.61 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.682 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.02 2.53 53.88 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.118 0.567 . . . . 0.0 112.462 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.51 HH21 ' HA ' ' A' ' 60' ' ' PRO . 37.7 mmt-85 69.77 8.11 6.56 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.118 1.367 . . . . 0.0 113.362 176.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.55 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 20.7 m-20 -77.27 94.57 4.17 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.219 0.533 . . . . 0.0 110.391 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.459 HG13 HG12 ' A' ' 54' ' ' ILE . 15.6 mm -67.81 -23.71 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 123.197 0.599 . . . . 0.0 109.705 167.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -54.56 -50.6 67.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.066 0.946 . . . . 0.0 112.196 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -82.5 -37.02 25.89 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.108 0.48 . . . . 0.0 110.496 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -65.92 -7.69 18.11 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.562 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.686 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -118.01 -30.88 5.23 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.957 -0.464 . . . . 0.0 112.22 172.464 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -30.96 69.48 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.05 0.54 . . . . 0.0 112.347 -175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 97.5 m95 -92.78 9.5 34.87 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.593 0.757 . . . . 0.0 112.693 -176.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.726 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 10.0 m95 -110.51 164.6 12.55 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.228 1.011 . . . . 0.0 108.906 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -82.78 153.78 25.07 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.836 0.454 . . . . 0.0 110.138 175.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.99 -27.67 68.99 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.976 0.511 . . . . 0.0 111.407 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -105.79 20.48 18.85 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.886 0.875 . . . . 0.0 110.697 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.726 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 44.0 t -57.7 113.1 1.68 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.867 0.365 . . . . 0.0 111.598 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -74.2 151.35 40.0 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 54.9 t80 -145.45 115.76 7.53 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -174.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.45 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 14.0 m-85 -115.06 156.38 25.27 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.949 1.3 . . . . 0.0 110.712 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -119.82 155.11 33.23 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.536 173.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.505 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 70.1 t80 -64.25 132.13 95.23 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.698 0.799 . . . . 0.0 111.477 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.81 -56.65 0.14 OUTLIER 'Cis proline' 0 C--N 1.386 2.505 0 CA-C-N 120.599 1.25 . . . . 0.0 113.958 -1.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.35 92.84 1.54 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.963 0.505 . . . . 0.0 109.665 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.0 m -135.72 109.16 7.88 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.595 0.758 . . . . 0.0 109.5 174.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.5 tt -69.11 103.11 1.8 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 36' ' ' ALA . 52.0 mt -78.58 -45.86 20.75 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.999 0.92 . . . . 0.0 109.951 178.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -135.1 124.96 25.51 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.475 -171.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.41 36.15 4.59 Favored Glycine 0 N--CA 1.475 1.297 0 O-C-N 123.076 0.235 . . . . 0.0 113.271 -174.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 167.93 158.63 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.503 1.521 . . . . 0.0 108.727 -171.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.491 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -57.95 -43.54 86.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.804 0.841 . . . . 0.0 112.532 -176.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.11 76.18 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.933 0.493 . . . . 0.0 112.091 -171.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -76.65 -31.46 57.35 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.831 0.452 . . . . 0.0 111.559 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.4 mt -65.1 -51.88 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.083 0.553 . . . . 0.0 110.271 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.686 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 21.2 ptt180 -64.63 -43.45 93.65 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.736 -172.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.518 ' HA ' HD12 ' A' ' 54' ' ' ILE . 30.2 m -66.29 -33.21 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 123.336 0.397 . . . . 0.0 111.696 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -71.75 -35.75 70.2 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.273 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -75.64 -29.37 59.13 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.439 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 51' ' ' VAL . 74.4 mt -55.32 -42.87 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 118.55 0.614 . . . . 0.0 109.973 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.98 -40.03 87.72 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.965 0.906 . . . . 0.0 111.328 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.0 tpp85 -73.44 -28.62 62.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.718 0.807 . . . . 0.0 111.095 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -82.1 -9.05 59.66 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.829 0.852 . . . . 0.0 110.991 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 7.8 mmpt? -76.85 -34.24 57.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.477 0.311 . . . . 0.0 111.382 176.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -83.99 118.25 70.82 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.51 ' HA ' HH21 ' A' ' 19' ' ' ARG . 89.7 Cg_endo -74.13 -9.15 21.78 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.433 2.755 . . . . 0.0 114.193 -166.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -77.87 -13.54 59.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.737 0.815 . . . . 0.0 111.097 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.3 tp -58.71 111.51 1.29 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.218 0.607 . . . . 0.0 110.603 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 91.3 t80 -149.91 115.4 5.51 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.09 101.96 2.06 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -84.49 101.51 12.12 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 78' ' ' ASP . 6.7 tt -84.79 128.31 34.55 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -176.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.475 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -116.84 -32.86 4.97 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.853 -167.624 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 99.0 m -147.9 138.56 23.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.087 0.955 . . . . 0.0 109.556 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -133.31 129.49 37.61 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 167.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.8 m -107.29 129.45 61.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 123.716 0.806 . . . . 0.0 109.593 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.506 HD12 ' HG3' ' A' ' 6' ' ' GLU . 10.5 tt -113.19 122.85 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.136 0.493 . . . . 0.0 110.145 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.28 94.13 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 56.66 -112.03 3.14 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 123.23 0.331 . . . . 0.0 113.664 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -99.15 15.82 24.76 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.452 0.701 . . . . 0.0 112.297 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.8 p -134.97 133.74 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.381 0.672 . . . . 0.0 109.19 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.501 HG21 HG21 ' A' ' 9' ' ' VAL . 64.4 t -123.01 136.03 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.98 0.512 . . . . 0.0 110.789 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.565 HG12 ' HB ' ' A' ' 98' ' ' ILE . 6.4 mt -103.11 119.9 52.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 163.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.615 ' HB2' HD11 ' A' ' 66' ' ' LEU . 6.9 p-10 -97.4 155.09 17.06 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 168.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -137.53 108.45 6.7 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.45 168.72 11.76 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.083 1.353 . . . . 0.0 109.715 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.2 m -115.65 105.58 12.92 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.107 168.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 63' ' ' TYR . 4.0 m -86.38 125.25 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.179 0.514 . . . . 0.0 110.944 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 62.8 m -72.35 117.63 14.24 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 170.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -125.46 120.92 32.31 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -74.39 89.29 2.1 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.194 0.521 . . . . 0.0 110.95 -172.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -82.66 144.95 49.71 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.515 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.84 -20.21 58.26 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 123.158 2.572 . . . . 0.0 113.88 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -82.25 -27.44 32.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.114 0.565 . . . . 0.0 112.521 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.52 -134.62 2.96 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.823 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -55.74 -71.23 0.09 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.165 0.986 . . . . 0.0 111.28 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.489 ' H ' HD13 ' A' ' 118' ' ' ILE . . . 94.21 32.34 7.49 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.397 0.436 . . . . 0.0 113.066 175.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -86.89 107.89 18.54 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.745 0.783 . . . . 0.0 108.996 -173.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 116' ' ' PRO . 5.3 m -105.77 143.85 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.413 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -91.54 142.12 27.99 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.426 HG22 HG12 ' A' ' 113' ' ' ILE . 19.0 t -130.44 149.52 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.78 101.74 8.56 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.7 m -98.14 108.03 20.64 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.662 HG23 ' HB2' ' A' ' 110' ' ' TRP . 12.1 tt -98.82 112.46 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.066 0.946 . . . . 0.0 109.04 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.42 ' HE1' HG22 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -128.45 138.54 52.36 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.166 0.508 . . . . 0.0 110.938 178.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -98.7 113.3 25.32 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.342 1.057 . . . . 0.0 109.445 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.504 ' HB ' HG23 ' A' ' 5' ' ' ILE . 92.2 t -88.82 116.1 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.017 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -124.44 128.61 49.28 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.153 0.981 . . . . 0.0 109.497 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.2 m120 59.18 31.04 20.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.784 1.234 . . . . 0.0 111.856 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.04 -20.1 30.93 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 115.568 -0.742 . . . . 0.0 113.738 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -107.07 140.46 39.85 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.319 1.048 . . . . 0.0 108.834 -172.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.408 HG12 HG22 ' A' ' 101' ' ' VAL . 64.1 mt -67.36 106.21 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.93 -34.07 44.87 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.281 0.633 . . . . 0.0 111.241 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -144.31 146.75 32.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.082 0.953 . . . . 0.0 108.685 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.9 137.9 35.21 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.674 0.789 . . . . 0.0 109.516 -177.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.662 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.5 m-90 -140.33 148.41 41.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -144.45 147.17 32.98 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.077 0.853 . . . . 0.0 111.097 174.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 21.5 ptmt -127.25 127.9 45.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.36 0.664 . . . . 0.0 109.494 172.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.426 HG12 HG22 ' A' ' 95' ' ' VAL . 80.0 mt -89.42 121.75 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.35 -94.72 0.02 OUTLIER Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.564 1.165 . . . . 0.0 114.497 -174.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -134.56 155.11 79.88 Favored Pre-proline 0 CA--C 1.547 0.827 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.707 ' HA ' HG12 ' A' ' 93' ' ' VAL . 41.4 Cg_endo -90.0 114.72 0.55 Allowed 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.908 2.405 . . . . 0.0 113.394 174.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -111.79 153.4 26.61 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.415 0.626 . . . . 0.0 111.114 -175.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.489 HD13 ' H ' ' A' ' 91' ' ' GLY . 35.2 mm -131.11 156.06 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 124.572 1.149 . . . . 0.0 108.181 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.7 t . . . . . 0 N--CA 1.486 1.354 0 C-N-CA 122.654 0.381 . . . . 0.0 110.573 173.702 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.2 m120 . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.493 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 13.1 m -61.7 -48.87 78.82 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.962 0.905 . . . . 0.0 110.719 -175.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -7.59 25.92 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.899 0.88 . . . . 0.0 113.026 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.4 mm -94.39 -31.34 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.639 0.775 . . . . 0.0 109.705 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.29 -32.85 32.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.274 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.2 mt -58.44 -47.64 98.41 Favored Pre-proline 0 CA--C 1.563 1.46 0 CA-C-O 118.405 -0.807 . . . . 0.0 112.185 -177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 10.1 Cg_endo -56.2 -63.07 0.19 Allowed 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 121.885 1.723 . . . . 0.0 112.379 172.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.41 -27.08 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -168.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.24 -55.39 6.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.449 0.7 . . . . 0.0 109.728 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -68.8 -29.82 68.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.983 0.513 . . . . 0.0 111.583 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -74.8 -36.85 62.48 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.827 0.851 . . . . 0.0 111.527 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.56 -48.77 80.31 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -57.87 -45.31 86.51 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 124.561 1.163 . . . . 0.0 109.315 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.78 -24.81 66.24 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.033 -1.44 . . . . 0.0 112.722 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -67.68 -40.61 84.39 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.579 0.352 . . . . 0.0 110.32 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -91.73 -25.73 18.93 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.429 0.692 . . . . 0.0 110.936 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.04 -6.38 59.47 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.493 0.717 . . . . 0.0 111.846 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 69.39 14.87 8.45 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.081 1.352 . . . . 0.0 112.929 171.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -83.81 95.3 8.41 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.488 HG13 HG12 ' A' ' 54' ' ' ILE . 20.7 mm -64.8 -29.77 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.427 0.691 . . . . 0.0 110.43 173.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -55.96 -47.04 78.34 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.902 0.481 . . . . 0.0 111.384 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.43 -32.89 28.78 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.306 0.642 . . . . 0.0 111.42 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -72.94 -8.82 57.39 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.104 0.562 . . . . 0.0 110.828 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.714 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 27.7 tpp -120.96 -15.76 8.21 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.909 0.484 . . . . 0.0 112.287 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.06 -50.46 61.46 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.492 0.717 . . . . 0.0 112.548 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 85.3 m95 -87.18 6.92 30.54 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.989 -168.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.66 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 12.9 m95 -93.96 149.81 20.9 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.415 0.686 . . . . 0.0 109.482 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.64 152.11 37.66 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.153 0.581 . . . . 0.0 109.976 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -64.16 -29.79 70.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.884 0.474 . . . . 0.0 111.249 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -96.91 20.36 11.23 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.816 0.846 . . . . 0.0 111.385 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.66 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 48.6 t -61.85 115.63 4.18 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -71.57 148.58 46.51 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.649 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 42.8 t80 -141.67 118.1 10.85 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -117.51 148.82 41.5 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.692 0.797 . . . . 0.0 110.081 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.525 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -103.12 153.48 20.27 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.601 171.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.546 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 90.4 t80 -56.59 128.94 75.77 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.87 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.46 -60.46 0.08 OUTLIER 'Cis proline' 0 C--N 1.384 2.43 0 CA-C-N 120.583 1.244 . . . . 0.0 113.488 0.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.35 74.06 0.68 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.652 0.781 . . . . 0.0 108.991 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 55.3 m -105.54 111.69 24.49 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.167 0.987 . . . . 0.0 109.016 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 tt -66.35 103.06 0.94 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 36' ' ' ALA . 78.7 mt -82.67 -43.47 16.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.656 0.783 . . . . 0.0 110.649 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -139.73 116.58 10.93 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.787 0.435 . . . . 0.0 111.083 -171.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.07 32.61 5.31 Favored Glycine 0 N--CA 1.482 1.708 0 C-N-CA 122.811 0.243 . . . . 0.0 113.064 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 47' ' ' ALA . 24.2 p-10 169.5 153.4 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.035 1.334 . . . . 0.0 109.645 -165.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.714 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -67.98 -24.61 65.16 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.079 0.952 . . . . 0.0 112.911 -176.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.423 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . . . -56.52 -47.61 78.99 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.504 0.721 . . . . 0.0 112.141 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.448 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 35.2 mt-10 -74.21 -31.33 62.59 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.494 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 46' ' ' ALA . 61.9 mt -64.81 -49.24 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.13 0.572 . . . . 0.0 111.188 -178.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.488 ' O ' HG13 ' A' ' 54' ' ' ILE . 6.9 ptm180 -62.78 -49.21 75.86 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 123.498 0.499 . . . . 0.0 110.724 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.406 ' HA ' HD12 ' A' ' 54' ' ' ILE . 76.3 t -63.47 -42.53 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.779 0.832 . . . . 0.0 111.399 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -68.36 -31.62 71.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.577 0.751 . . . . 0.0 110.879 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -77.91 -28.94 49.91 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.721 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.488 HG12 HG13 ' A' ' 21' ' ' ILE . 98.1 mt -57.88 -38.92 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 118.711 0.687 . . . . 0.0 109.729 174.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.38 -34.52 78.35 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.314 1.046 . . . . 0.0 111.38 175.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -78.66 -24.48 45.14 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.163 0.585 . . . . 0.0 110.916 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -83.53 -5.16 59.09 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.37 0.668 . . . . 0.0 110.631 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 70.4 mmtt -78.02 -9.99 59.39 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.096 0.558 . . . . 0.0 111.89 169.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 8.5 mm-40 -71.94 111.02 9.08 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 170.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.95 -28.14 74.97 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.297 1.998 . . . . 0.0 112.232 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -92.19 4.84 52.39 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.803 0.841 . . . . 0.0 112.048 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 28.4 tp -64.75 111.82 2.95 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-O 120.757 0.313 . . . . 0.0 110.213 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -148.07 116.15 6.47 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.98 101.14 2.71 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 174.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -81.51 99.95 9.07 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.2 tp -76.25 126.62 31.32 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.73 -33.99 5.94 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.956 0.902 . . . . 0.0 109.638 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 96.8 m -152.93 139.75 19.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.341 1.056 . . . . 0.0 108.99 -176.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -142.3 125.64 16.57 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 163.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.8 m -106.72 119.08 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.939 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.03 143.42 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 121.338 0.59 . . . . 0.0 110.033 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 p -148.32 97.49 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.263 1.425 . . . . 0.0 107.832 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.53 -116.2 7.27 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.673 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -101.89 18.7 19.91 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.072 0.549 . . . . 0.0 111.688 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.0 t -131.92 136.01 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.137 0.975 . . . . 0.0 109.5 -174.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -125.29 137.05 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 123.254 0.622 . . . . 0.0 110.012 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.688 HD13 ' HB ' ' A' ' 98' ' ' ILE . 2.5 mm -98.17 103.96 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 169.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.93 108.18 19.42 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -98.31 107.45 19.92 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 133.76 49.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.489 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.0 m -80.1 103.98 10.35 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 172.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -80.91 116.24 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.469 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.4 m -71.12 118.29 13.72 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.353 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 43.3 mmm-85 -119.02 -171.21 2.06 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -122.53 112.74 18.38 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.957 0.503 . . . . 0.0 109.763 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -113.44 137.35 22.08 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.032 0.933 . . . . 0.0 108.658 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -59.98 -18.94 53.05 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 123.218 2.612 . . . . 0.0 114.306 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -79.2 -25.94 42.65 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.044 0.538 . . . . 0.0 112.299 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.34 -117.39 0.58 Allowed Glycine 0 C--N 1.348 1.245 0 CA-C-O 119.683 -0.51 . . . . 0.0 112.914 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -68.83 -84.03 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.469 0.707 . . . . 0.0 111.88 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 116.93 26.69 2.95 Favored Glycine 0 C--N 1.343 0.947 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 -173.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.66 104.15 16.59 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.978 0.894 . . . . 0.0 108.591 -172.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 116' ' ' PRO . 21.7 m -103.7 136.59 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.509 -172.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -75.64 133.18 40.93 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.708 HG22 HG12 ' A' ' 113' ' ' ILE . 18.6 t -132.86 147.28 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.99 103.06 9.56 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 166.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 83.9 m -93.7 108.41 20.16 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.688 ' HB ' HD13 ' A' ' 77' ' ' ILE . 4.8 tt -102.11 111.94 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.631 1.172 . . . . 0.0 110.416 -173.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -103.43 129.95 50.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.902 0.881 . . . . 0.0 109.877 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 30.8 tt0 -100.22 111.92 24.22 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 168.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.61 HG22 HG12 ' A' ' 106' ' ' ILE . 48.7 t -94.59 113.79 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.488 1.115 . . . . 0.0 109.4 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -121.06 133.31 55.23 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.963 0.905 . . . . 0.0 109.185 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 62.63 30.42 16.95 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.244 1.017 . . . . 0.0 111.574 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.12 -7.09 79.56 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.268 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -130.75 147.5 52.42 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.943 0.897 . . . . 0.0 109.292 -173.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.61 HG12 HG22 ' A' ' 101' ' ' VAL . 45.7 mt -68.08 102.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 122.876 0.47 . . . . 0.0 110.677 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.16 -22.47 38.94 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.205 0.602 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 81.3 mttt -149.28 143.01 25.58 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.192 0.997 . . . . 0.0 108.781 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -146.67 134.23 20.94 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.501 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.1 m-90 -132.76 149.51 52.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -133.57 146.47 51.03 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 19.9 pttp -144.83 129.58 18.19 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.708 HG12 HG22 ' A' ' 95' ' ' VAL . 91.7 mt -89.84 120.53 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.03 -68.67 1.57 Allowed Glycine 0 C--N 1.344 1.024 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.354 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.96 163.61 23.57 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.54 ' HA ' HG12 ' A' ' 93' ' ' VAL . 83.5 Cg_endo -80.18 144.99 16.93 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 121.938 1.759 . . . . 0.0 111.9 165.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 47.4 mtm105 -132.81 142.81 49.17 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.495 0.664 . . . . 0.0 110.652 169.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.2 mm -128.28 124.84 63.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.678 1.191 . . . . 0.0 108.094 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.484 1.238 0 O-C-N 123.51 0.506 . . . . 0.0 109.909 179.377 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 39.5 p30 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 p -63.04 -43.57 98.31 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.132 0.973 . . . . 0.0 111.557 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.35 -2.31 18.75 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.599 0.76 . . . . 0.0 112.506 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.627 HG22 HG23 ' A' ' 76' ' ' VAL . 26.3 mm -94.81 -32.72 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.871 0.868 . . . . 0.0 109.264 174.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.95 -32.14 39.97 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.053 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 72.1 mt -57.97 -49.33 94.27 Favored Pre-proline 0 CA--C 1.564 1.484 0 CA-C-O 118.051 -0.976 . . . . 0.0 112.592 -177.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 9.3 Cg_endo -54.2 -61.79 0.38 Allowed 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 122.205 1.936 . . . . 0.0 111.648 175.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.491 HG11 ' HB ' ' A' ' 76' ' ' VAL . 16.7 m -64.12 -22.54 31.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.669 -171.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.55 ' HG2' HH22 ' A' ' 69' ' ' ARG . 0.9 OUTLIER -72.76 -55.62 6.46 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.552 0.741 . . . . 0.0 109.587 178.482 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 72.2 mmtt -70.28 -37.26 74.81 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.148 0.579 . . . . 0.0 110.972 -173.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -65.44 -39.31 91.91 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.052 0.941 . . . . 0.0 111.061 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.419 HD11 ' HB2' ' A' ' 66' ' ' LEU . 22.9 tp -57.89 -50.85 71.94 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.003 0.815 . . . . 0.0 110.09 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.44 -52.37 64.92 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.525 1.141 . . . . 0.0 109.444 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -60.92 -27.86 68.5 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.786 1.234 . . . . 0.0 112.182 -176.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -70.93 -39.73 72.51 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.757 0.823 . . . . 0.0 110.806 -177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -94.06 -17.71 22.57 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.987 0.515 . . . . 0.0 111.179 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.74 -3.58 54.55 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.349 0.66 . . . . 0.0 111.884 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 70.93 28.42 3.24 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.816 1.247 . . . . 0.0 112.39 174.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.46 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 17.6 m-20 -101.0 112.8 25.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.529 0.732 . . . . 0.0 110.067 174.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.0 mm -77.45 -31.46 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 122.719 0.408 . . . . 0.0 110.335 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -55.44 -48.38 74.54 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.848 0.459 . . . . 0.0 111.888 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.56 -29.64 33.37 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.638 0.375 . . . . 0.0 111.287 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -73.06 -8.17 54.53 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.136 0.574 . . . . 0.0 111.08 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.507 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 25.4 tpp -121.99 -15.55 7.77 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 173.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.46 -32.71 68.98 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -174.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.547 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 90.2 m95 -104.0 9.75 36.43 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.616 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 24.1 m95 -95.55 153.19 17.83 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.869 0.468 . . . . 0.0 110.102 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -80.0 151.18 30.13 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.341 0.656 . . . . 0.0 109.954 173.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -61.71 -31.11 71.24 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.449 0.699 . . . . 0.0 112.454 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -102.66 19.68 18.67 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.456 0.702 . . . . 0.0 111.303 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.616 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 46.1 t -60.49 119.25 7.67 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 121.074 0.464 . . . . 0.0 112.238 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.555 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 77.9 mm-40 -81.21 144.07 31.87 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.182 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -134.83 113.6 11.76 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.486 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 31.6 m-85 -115.88 155.11 28.53 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.922 0.889 . . . . 0.0 111.602 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.9 159.99 22.18 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.682 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 112' ' ' LYS . 18.3 p90 -55.27 136.41 68.71 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 123.993 0.917 . . . . 0.0 111.925 176.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -77.71 -40.27 1.16 Allowed 'Cis proline' 0 C--N 1.379 2.159 0 CA-C-N 119.854 0.984 . . . . 0.0 112.691 -7.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.71 66.66 0.21 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.832 0.853 . . . . 0.0 109.36 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 25.1 m -107.52 119.27 38.95 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.138 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tt -82.67 102.69 11.65 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.4 -45.18 16.47 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.836 0.454 . . . . 0.0 110.259 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -142.01 120.1 12.12 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -171.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.86 28.1 15.15 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.268 0.355 . . . . 0.0 113.898 -174.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.6 p30 176.18 157.77 0.26 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.254 1.422 . . . . 0.0 109.835 -174.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.507 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -60.48 -32.12 71.11 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.48 1.112 . . . . 0.0 113.378 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.485 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -60.55 -51.77 68.03 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.97 0.508 . . . . 0.0 111.124 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 33.9 mt-10 -69.27 -29.07 66.89 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.806 -175.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.1 mt -63.9 -52.11 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.329 0.652 . . . . 0.0 110.4 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.492 ' O ' HG13 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -67.19 -38.79 85.94 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.64 -175.556 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 47' ' ' ALA . 70.9 t -59.54 -49.37 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.481 0.712 . . . . 0.0 111.605 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -69.01 -29.41 67.59 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.765 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -77.87 -29.8 50.54 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 118.537 -0.745 . . . . 0.0 111.483 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 50' ' ' ARG . 76.2 mt -55.44 -46.78 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-N 118.645 0.657 . . . . 0.0 109.597 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -56.44 -42.44 78.11 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 124.413 1.071 . . . . 0.0 111.425 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.438 ' HG3' HD22 ' A' ' 62' ' ' LEU . 14.8 tpp180 -70.5 -31.5 68.62 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.414 0.686 . . . . 0.0 110.873 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -75.65 -14.31 60.36 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.534 0.734 . . . . 0.0 110.846 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 69.2 mmtt -91.6 -5.03 54.62 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.332 0.653 . . . . 0.0 111.565 170.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -105.49 122.1 43.91 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 122.985 0.514 . . . . 0.0 109.951 -175.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.54 -19.05 48.96 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.665 2.91 . . . . 0.0 115.165 -164.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -72.24 -24.42 61.37 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.629 0.372 . . . . 0.0 111.304 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.438 HD22 ' HG3' ' A' ' 56' ' ' ARG . 55.3 tp -56.19 120.66 7.9 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.661 0.784 . . . . 0.0 112.364 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -151.96 144.27 24.03 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.26 105.09 0.67 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -101.24 107.18 18.5 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.652 0.781 . . . . 0.0 109.525 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.419 ' HB2' HD11 ' A' ' 13' ' ' LEU . 14.3 tp -78.59 131.74 36.85 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 pp -111.98 -28.68 7.92 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.452 0.701 . . . . 0.0 110.206 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.9 m -157.47 143.69 17.76 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.288 1.035 . . . . 0.0 109.287 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.55 HH22 ' HG2' ' A' ' 10' ' ' GLN . 12.1 ptt180 -142.14 139.59 32.19 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.236 0.541 . . . . 0.0 110.315 162.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.11 143.7 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.843 1.257 . . . . 0.0 109.56 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.1 tt -115.85 134.07 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-O 121.309 0.576 . . . . 0.0 110.709 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -126.56 95.59 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 125.31 1.444 . . . . 0.0 107.81 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.2 -103.24 0.51 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 123.561 0.538 . . . . 0.0 113.369 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -106.46 18.18 22.31 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.529 0.732 . . . . 0.0 111.38 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.5 t -133.3 140.61 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.976 0.91 . . . . 0.0 109.071 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.627 HG23 HG22 ' A' ' 5' ' ' ILE . 57.1 t -125.86 137.82 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 118.516 0.598 . . . . 0.0 109.928 172.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.477 HG12 ' HB ' ' A' ' 98' ' ' ILE . 1.6 mt -99.86 110.0 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 167.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.45 ' HB2' ' SG ' ' A' ' 97' ' ' CYS . 1.3 m-20 -88.67 108.03 19.24 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 167.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.416 ' HE1' ' HB3' ' A' ' 94' ' ' ASP . 0.9 OUTLIER -98.5 108.71 21.46 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.318 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.99 163.67 21.82 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.516 1.127 . . . . 0.0 110.632 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.8 m -108.18 106.17 16.23 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.406 1.082 . . . . 0.0 108.582 165.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 m -90.52 134.05 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 122.481 0.313 . . . . 0.0 111.114 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 49.0 m -76.59 127.89 33.68 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.706 0.402 . . . . 0.0 109.994 175.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.4 mtm105 -126.72 161.48 28.04 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -90.17 99.31 12.35 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.825 0.345 . . . . 0.0 111.402 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -103.37 125.13 35.89 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.07 -16.17 53.42 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.087 2.525 . . . . 0.0 113.877 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -85.3 -9.03 58.18 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.912 0.485 . . . . 0.0 111.756 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.83 -127.14 1.18 Allowed Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.529 -0.595 . . . . 0.0 111.7 172.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -75.97 -83.34 0.07 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 117.282 0.541 . . . . 0.0 111.27 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.97 29.12 1.56 Allowed Glycine 0 C--N 1.354 1.542 0 N-CA-C 114.388 0.515 . . . . 0.0 114.388 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -89.82 99.28 12.32 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 122.136 0.969 . . . . 0.0 110.027 -172.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.9 m -102.75 137.5 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 121.616 -0.678 . . . . 0.0 111.444 -165.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB3' ' HE1' ' A' ' 79' ' ' HIS . 13.1 m-20 -79.31 115.01 18.7 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.686 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.526 HG22 HG12 ' A' ' 113' ' ' ILE . 35.2 t -119.17 156.17 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 125.12 1.368 . . . . 0.0 109.156 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.03 106.11 10.12 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 78' ' ' ASP . 20.5 p -97.23 109.06 21.89 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.541 HG23 ' HB2' ' A' ' 110' ' ' TRP . 7.1 tt -100.4 114.76 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.353 1.061 . . . . 0.0 109.622 -177.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -107.91 132.54 53.36 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.757 0.823 . . . . 0.0 109.71 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -98.4 112.83 24.71 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.546 HG22 HG12 ' A' ' 106' ' ' ILE . 42.1 t -95.08 113.85 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.192 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 41.7 tt0 -119.61 128.05 53.51 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.865 0.866 . . . . 0.0 109.511 175.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 64.37 31.35 12.81 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.391 1.077 . . . . 0.0 111.903 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.81 6.52 89.04 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.726 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -134.1 139.43 45.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.537 1.135 . . . . 0.0 108.957 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.546 HG12 HG22 ' A' ' 101' ' ' VAL . 45.9 mt -68.28 104.86 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 122.429 0.291 . . . . 0.0 110.316 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -78.33 -30.25 48.08 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.68 0.792 . . . . 0.0 111.175 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.555 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 97.9 mttt -149.48 152.18 35.19 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.877 0.871 . . . . 0.0 109.091 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -146.17 137.42 24.6 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.963 0.905 . . . . 0.0 108.824 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.541 ' HB2' HG23 ' A' ' 98' ' ' ILE . 4.0 m-90 -135.56 150.95 49.86 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -142.43 146.41 34.8 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 171.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 20.5 ptmt -131.19 125.36 32.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.537 176.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.526 HG12 HG22 ' A' ' 95' ' ' VAL . 87.2 mt -87.44 123.92 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.26 -65.94 2.97 Favored Glycine 0 CA--C 1.526 0.754 0 O-C-N 124.451 1.094 . . . . 0.0 113.187 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -159.5 167.63 13.81 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.19 138.31 33.08 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.558 2.172 . . . . 0.0 112.334 165.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 30.1 mmt180 -135.52 146.38 48.01 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.81 0.844 . . . . 0.0 111.213 -175.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.5 mm -136.83 132.65 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.855 1.262 . . . . 0.0 108.445 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.9 t . . . . . 0 N--CA 1.503 2.18 0 C-N-CA 123.734 0.813 . . . . 0.0 111.944 -178.709 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 121.822 0.82 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.5 m -75.78 -49.17 18.89 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.637 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -12.86 58.41 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.173 0.989 . . . . 0.0 113.387 -175.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.545 HG22 HG23 ' A' ' 76' ' ' VAL . 33.2 mm -87.1 -34.26 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.498 ' HG3' HD12 ' A' ' 71' ' ' ILE . 44.3 mt-10 -84.55 -22.33 30.15 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.5 -53.91 61.41 Favored Pre-proline 0 CA--C 1.568 1.639 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.662 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.528 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 33.6 Cg_endo -62.27 -49.56 5.97 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 122.156 1.904 . . . . 0.0 113.052 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 6' ' ' GLU . 15.6 m -66.95 -37.87 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -169.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -72.66 -43.67 62.85 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.423 0.689 . . . . 0.0 109.977 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -68.68 -29.72 68.24 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.326 0.651 . . . . 0.0 112.065 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -59.47 -48.03 83.23 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.904 0.752 . . . . 0.0 110.308 172.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.55 -51.75 68.51 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 124.012 0.82 . . . . 0.0 110.092 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.62 -27.1 66.02 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 124.029 0.831 . . . . 0.0 110.896 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . . . -83.08 -32.31 26.85 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.389 1.076 . . . . 0.0 112.285 175.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -72.02 -39.66 68.99 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.256 0.622 . . . . 0.0 110.534 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -87.67 1.07 54.73 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.887 0.875 . . . . 0.0 111.834 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.56 3.17 10.72 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.999 0.92 . . . . 0.0 111.171 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 70.28 9.53 7.02 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.127 1.371 . . . . 0.0 113.695 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.453 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 8.9 m-20 -81.13 116.86 21.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.14 0.495 . . . . 0.0 110.916 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.529 HG13 HG12 ' A' ' 54' ' ' ILE . 22.8 mm -82.58 -25.6 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.093 0.957 . . . . 0.0 110.073 171.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -54.74 -48.82 72.11 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.038 0.935 . . . . 0.0 112.097 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -79.4 -35.18 41.07 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.94 0.496 . . . . 0.0 110.623 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -69.93 -8.26 47.37 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.178 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.646 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 16.6 tpp -119.87 -28.64 5.15 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.447 0.699 . . . . 0.0 112.401 173.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.4 -47.42 75.9 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.036 0.534 . . . . 0.0 112.087 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 98.4 m95 -79.43 1.62 24.81 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -170.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.465 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 18.2 m95 -95.05 168.34 10.83 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.373 0.669 . . . . 0.0 110.045 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -87.1 148.35 25.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.54 0.736 . . . . 0.0 109.353 171.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.16 -25.79 67.96 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.316 0.646 . . . . 0.0 111.706 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -109.19 18.97 19.98 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.976 1.311 . . . . 0.0 111.381 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.465 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 53.7 t -60.84 133.93 56.58 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -173.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.55 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 36.6 mm-40 -95.44 105.46 17.43 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.567 0.747 . . . . 0.0 109.967 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.432 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 48.4 t80 -94.6 111.44 23.2 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.635 0.774 . . . . 0.0 110.246 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -105.16 139.89 39.14 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.287 1.035 . . . . 0.0 110.029 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.6 161.48 14.82 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.24 1.016 . . . . 0.0 110.345 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.41 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 71.3 t80 -50.26 127.58 22.74 Favored Pre-proline 0 CA--C 1.566 1.593 0 O-C-N 124.285 0.99 . . . . 0.0 112.039 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.23 -50.29 0.19 OUTLIER 'Cis proline' 0 C--N 1.386 2.519 0 CA-C-N 119.77 0.953 . . . . 0.0 113.513 -5.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.33 78.83 0.81 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.8 m -117.48 114.03 22.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.033 0.933 . . . . 0.0 109.237 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.74 101.48 0.81 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.8 mt -79.63 -36.36 38.02 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.275 0.63 . . . . 0.0 109.93 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.461 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -142.45 116.3 9.29 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.612 -170.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.0 33.21 4.77 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 123.374 0.421 . . . . 0.0 112.771 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.43 ' O ' HG13 ' A' ' 49' ' ' ILE . 8.9 p30 167.05 158.29 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.204 1.402 . . . . 0.0 109.816 -167.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.646 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -70.65 -25.2 62.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.245 1.018 . . . . 0.0 113.148 -175.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.4 98.27 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.861 0.465 . . . . 0.0 111.259 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.461 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 26.6 mt-10 -75.39 -32.36 60.75 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.611 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 46' ' ' ALA . 72.4 mt -65.44 -46.29 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.197 0.599 . . . . 0.0 110.945 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 54' ' ' ILE . 14.0 ptm180 -64.67 -51.43 62.56 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.686 0.616 . . . . 0.0 110.641 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.415 ' HA ' HD12 ' A' ' 54' ' ' ILE . 20.6 m -65.61 -35.23 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 122.97 0.508 . . . . 0.0 111.825 -175.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -71.41 -34.92 70.77 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.855 0.862 . . . . 0.0 110.476 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -75.08 -32.61 61.52 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.642 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.529 HG12 HG13 ' A' ' 21' ' ' ILE . 97.7 mt -58.15 -37.76 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.672 0.389 . . . . 0.0 110.026 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.12 -34.56 78.34 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.654 0.782 . . . . 0.0 111.6 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -75.2 -25.98 58.63 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.867 0.467 . . . . 0.0 110.157 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.549 ' HA ' HD22 ' A' ' 62' ' ' LEU . 2.8 m-85 -83.9 -4.42 58.68 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.59 0.756 . . . . 0.0 111.347 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HE2' HG22 ' A' ' 54' ' ' ILE . 74.5 mmtt -73.07 -25.84 61.05 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.717 0.407 . . . . 0.0 111.109 169.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 50.4 mm-40 -57.42 116.7 14.7 Favored Pre-proline 0 N--CA 1.481 1.113 0 C-N-CA 123.583 0.753 . . . . 0.0 110.748 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.23 -26.61 41.91 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.321 2.014 . . . . 0.0 112.609 -175.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.42 2.25 55.77 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.053 0.941 . . . . 0.0 111.484 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 57' ' ' PHE . 17.6 tp -62.23 114.02 3.21 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.932 0.493 . . . . 0.0 111.276 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -151.65 115.62 4.95 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.535 0.734 . . . . 0.0 109.084 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.12 104.59 3.11 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -91.68 101.82 14.45 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.7 tt -79.26 124.88 28.8 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.52 -32.79 5.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.736 -172.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.7 m -148.69 134.86 19.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.367 1.067 . . . . 0.0 108.558 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.409 HH12 ' HG2' ' A' ' 6' ' ' GLU . 52.3 ptt85 -137.76 133.31 33.94 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 166.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -121.56 128.09 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.511 1.124 . . . . 0.0 109.43 -172.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.498 HD12 ' HG3' ' A' ' 6' ' ' GLU . 11.9 tt -108.7 128.77 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 121.253 0.549 . . . . 0.0 110.657 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.1 p -123.89 94.46 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 173.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.27 -110.83 3.15 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.823 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -87.99 -1.1 57.78 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.609 1.163 . . . . 0.0 111.8 -172.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.3 t -128.77 140.18 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.074 0.95 . . . . 0.0 109.786 -172.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.545 HG23 HG22 ' A' ' 5' ' ' ILE . 33.2 t -125.29 134.65 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.349 0.66 . . . . 0.0 109.512 172.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.456 HG12 ' HB ' ' A' ' 98' ' ' ILE . 2.4 mt -99.58 107.04 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 165.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.75 109.32 20.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -98.74 109.69 22.41 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.25 159.24 36.73 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.467 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.2 m -107.43 110.05 21.91 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.121 172.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.0 t -81.77 103.25 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 123.293 0.637 . . . . 0.0 110.258 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.3 m -66.75 129.56 40.27 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.854 0.862 . . . . 0.0 110.205 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 91' ' ' GLY . 80.7 mtp180 -133.56 -162.53 1.25 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -130.21 83.5 2.13 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.917 0.389 . . . . 0.0 110.357 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -90.18 137.83 27.64 Favored Pre-proline 0 N--CA 1.475 0.8 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.3 8.15 1.56 Allowed 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.839 2.359 . . . . 0.0 113.046 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.91 -32.68 57.56 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.082 0.953 . . . . 0.0 109.314 169.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.09 -98.03 0.13 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.355 175.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -76.91 -82.41 0.08 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.786 0.834 . . . . 0.0 110.281 175.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 84' ' ' ARG . . . 117.43 28.59 2.31 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 121.312 -0.47 . . . . 0.0 113.877 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -88.1 140.95 28.97 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -174.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.585 HG12 ' HA ' ' A' ' 116' ' ' PRO . 29.1 m -127.43 129.27 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 122.04 -0.413 . . . . 0.0 110.817 -176.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -77.34 110.43 12.07 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.039 0.536 . . . . 0.0 109.703 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.459 HG22 HG12 ' A' ' 113' ' ' ILE . 33.8 t -114.15 156.55 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.607 1.163 . . . . 0.0 108.859 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.88 103.32 6.73 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 71.6 m -96.35 111.84 23.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.235 1.014 . . . . 0.0 109.959 -174.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.456 ' HB ' HG12 ' A' ' 77' ' ' ILE . 8.6 tt -103.42 110.96 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 124.602 1.161 . . . . 0.0 110.155 -175.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -105.69 133.64 50.1 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.167 0.587 . . . . 0.0 110.905 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -100.45 119.68 38.84 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.195 0.998 . . . . 0.0 108.474 169.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.5 t -110.28 115.25 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.014 0.926 . . . . 0.0 110.536 -173.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 11.4 tp10 -118.68 126.39 51.82 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.145 0.578 . . . . 0.0 109.806 177.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.3 m120 61.55 30.25 18.62 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.892 1.277 . . . . 0.0 112.174 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.45 0.03 86.03 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 116.379 -0.373 . . . . 0.0 113.774 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -117.38 138.41 51.82 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 67.1 mt -68.56 105.91 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -78.11 -32.13 50.36 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.056 0.542 . . . . 0.0 110.705 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.55 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 62.4 mtpt -150.2 134.23 16.98 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -130.4 132.28 45.68 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.425 ' HE1' ' HE2' ' A' ' 108' ' ' LYS . 0.7 OUTLIER -132.42 148.64 52.41 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -177.387 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -142.62 146.69 34.78 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.284 0.493 . . . . 0.0 110.03 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 25.1 pttm -121.19 127.68 51.73 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.459 HG12 HG22 ' A' ' 95' ' ' VAL . 88.3 mt -89.69 124.99 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.21 -73.88 0.52 Allowed Glycine 0 CA--C 1.526 0.765 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.914 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -160.69 170.3 8.71 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.134 0.574 . . . . 0.0 109.676 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.585 ' HA ' HG12 ' A' ' 93' ' ' VAL . 72.4 Cg_endo -73.84 123.74 8.68 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.215 1.943 . . . . 0.0 112.225 165.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.8 mmt85 -110.01 147.58 33.25 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.212 1.005 . . . . 0.0 109.243 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.9 mm -139.05 127.79 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.489 1.481 0 C-N-CA 123.711 0.805 . . . . 0.0 111.74 -175.877 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.6 m120 . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 121.552 0.691 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.417 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 33.8 p -67.74 -33.02 74.05 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.702 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.65 -20.32 63.27 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.49 1.116 . . . . 0.0 112.578 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 74' ' ' ASN . 30.0 mm -91.79 -28.98 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.946 0.898 . . . . 0.0 109.409 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -75.0 -27.39 60.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.965 174.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 3' ' ' SER . 83.7 mt -59.92 -55.21 47.83 Favored Pre-proline 0 CA--C 1.564 1.484 0 CA-C-O 117.884 -1.055 . . . . 0.0 112.032 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 19.3 Cg_endo -56.91 -55.59 2.55 Favored 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 122.111 1.874 . . . . 0.0 112.613 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.5 m -62.98 -35.36 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.489 -171.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -73.66 -52.2 14.12 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.163 0.585 . . . . 0.0 110.394 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -62.86 -28.29 69.93 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -75.42 -43.56 49.27 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.853 0.861 . . . . 0.0 111.422 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.14 -52.05 65.38 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.003 0.521 . . . . 0.0 110.331 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.71 -25.81 68.37 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.021 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 20' ' ' ASP . . . -80.76 -27.64 36.68 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.372 1.069 . . . . 0.0 112.177 172.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -66.91 -47.52 71.52 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.252 0.548 . . . . 0.0 109.885 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.62 -14.57 59.6 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.847 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.43 -2.77 41.45 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.449 0.699 . . . . 0.0 112.118 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 67.55 25.48 8.35 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.791 1.237 . . . . 0.0 112.835 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.497 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 11.0 m-20 -92.8 100.04 12.6 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.311 0.644 . . . . 0.0 110.011 173.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.429 HG13 HG12 ' A' ' 54' ' ' ILE . 12.6 mm -70.39 -31.17 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.001 0.52 . . . . 0.0 110.787 170.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -61.36 -45.11 95.77 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.014 0.525 . . . . 0.0 111.691 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.03 -30.82 44.39 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.134 0.574 . . . . 0.0 110.977 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -72.94 -5.94 41.93 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.855 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.751 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -112.75 -30.52 7.04 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.217 0.607 . . . . 0.0 112.215 172.3 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.75 -32.7 67.72 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -169.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.479 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.9 m95 -97.97 7.83 45.7 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -173.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.568 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 46.8 m95 -94.25 157.51 16.01 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.01 0.524 . . . . 0.0 110.288 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -76.76 148.49 36.66 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.322 169.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -67.83 -24.29 65.26 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.158 0.583 . . . . 0.0 111.32 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -106.18 18.33 22.18 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.312 1.045 . . . . 0.0 111.236 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.568 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 51.5 t -64.93 138.99 58.71 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -174.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -98.21 136.61 38.17 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.763 0.825 . . . . 0.0 108.847 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 56.4 t80 -130.92 110.98 11.66 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -109.64 151.81 26.38 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.602 0.761 . . . . 0.0 110.512 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.25 158.47 19.67 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.634 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.644 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 87.2 t80 -61.29 130.82 91.97 Favored Pre-proline 0 CA--C 1.558 1.276 0 O-C-N 123.899 0.749 . . . . 0.0 110.335 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.38 -57.25 0.14 OUTLIER 'Cis proline' 0 C--N 1.383 2.39 0 CA-C-N 120.138 1.085 . . . . 0.0 113.6 -1.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.26 81.53 1.42 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.7 m -129.19 108.21 10.17 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.497 0.719 . . . . 0.0 109.915 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.5 tp -65.78 102.57 0.77 Allowed 'General case' 0 CA--C 1.535 0.377 0 O-C-N 123.572 0.545 . . . . 0.0 109.824 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.9 mt -78.68 -25.74 44.87 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.531 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -157.3 117.05 3.41 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.85 35.34 4.59 Favored Glycine 0 C--N 1.346 1.119 0 C-N-CA 123.28 0.467 . . . . 0.0 112.926 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 p30 163.96 160.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 126.306 1.843 . . . . 0.0 108.426 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -69.55 -26.14 64.35 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -171.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.69 -41.65 99.22 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.331 0.586 . . . . 0.0 110.884 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -76.28 -29.19 57.31 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.922 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.0 mt -64.24 -50.96 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 122.916 0.486 . . . . 0.0 110.639 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.751 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 30.8 ptt180 -60.68 -51.59 68.75 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.904 0.752 . . . . 0.0 110.671 -176.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.454 ' HA ' HD12 ' A' ' 54' ' ' ILE . 35.5 m -63.97 -38.22 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -174.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -61.87 -38.08 86.96 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 123.815 0.697 . . . . 0.0 110.376 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -78.22 -34.32 49.37 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.121 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 50' ' ' ARG . 98.0 mt -56.46 -39.99 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.089 0.556 . . . . 0.0 110.182 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.87 -41.01 95.11 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.139 0.976 . . . . 0.0 111.576 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -73.9 -29.27 61.97 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.409 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -73.49 -4.66 35.15 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.002 0.521 . . . . 0.0 111.62 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -74.46 -36.22 63.33 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.962 0.505 . . . . 0.0 111.011 172.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.53 115.78 12.8 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 123.493 0.717 . . . . 0.0 110.919 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.89 -25.07 28.4 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.482 2.121 . . . . 0.0 112.49 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.78 -7.79 58.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.821 0.848 . . . . 0.0 111.69 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.55 120.56 12.56 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 122.477 0.311 . . . . 0.0 110.547 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -151.2 115.55 5.08 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 169.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.91 102.97 2.75 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -100.87 109.77 21.76 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 80' ' ' GLU . 13.8 tp -66.7 140.33 57.88 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.164 0.507 . . . . 0.0 110.089 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -107.0 -51.1 2.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.457 1.122 . . . . 0.0 107.989 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.9 m -154.54 141.07 18.85 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 113.024 -1.898 . . . . 0.0 109.032 -172.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 53.6 ptt85 -135.14 121.83 20.83 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 168.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.498 HG22 ' HB ' ' A' ' 77' ' ' ILE . 19.3 m -107.96 136.07 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.5 tt -120.71 129.83 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.274 0.559 . . . . 0.0 110.775 -175.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.95 99.35 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 C-N-CA 124.859 1.264 . . . . 0.0 108.393 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.79 -125.66 22.92 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.583 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.44 ' HA ' HG13 ' A' ' 5' ' ' ILE . 26.3 p-10 -91.48 17.98 7.9 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.307 0.643 . . . . 0.0 111.88 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.6 t -127.45 135.76 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.162 0.985 . . . . 0.0 109.8 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.2 t -125.37 139.66 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.006 0.522 . . . . 0.0 109.788 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.498 ' HB ' HG22 ' A' ' 70' ' ' VAL . 10.0 mm -98.81 104.33 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 167.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -94.87 105.16 17.07 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -100.19 105.81 17.44 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -121.28 171.16 8.93 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.156 1.382 . . . . 0.0 109.918 -178.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.4 m -118.09 106.23 12.66 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.924 0.89 . . . . 0.0 108.935 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.0 m -82.47 124.16 39.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-O 121.613 0.721 . . . . 0.0 109.194 170.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.9 m -83.09 119.42 24.48 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.681 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.637 HH21 ' HZ ' ' A' ' 86' ' ' PHE . 61.9 mtm180 -119.06 -160.89 0.82 Allowed 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -139.59 111.47 7.36 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.773 0.715 . . . . 0.0 110.32 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.637 ' HZ ' HH21 ' A' ' 84' ' ' ARG . 17.3 m-30 -109.28 151.49 42.09 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.745 0.818 . . . . 0.0 110.127 -178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.37 -28.82 88.58 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.649 2.232 . . . . 0.0 113.736 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -88.53 2.74 52.35 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.06 -146.56 16.09 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-O 119.479 -0.623 . . . . 0.0 113.235 173.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -39.07 -72.92 0.05 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.316 1.446 . . . . 0.0 113.059 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.424 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 103.62 25.7 7.17 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 113.897 0.319 . . . . 0.0 113.897 175.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -92.84 129.25 38.82 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.655 HG12 ' HA ' ' A' ' 116' ' ' PRO . 20.7 m -123.05 143.88 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.507 ' HB3' HH21 ' A' ' 117' ' ' ARG . 9.8 p-10 -85.89 122.95 30.67 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 174.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.447 HG22 HG12 ' A' ' 113' ' ' ILE . 44.2 t -113.68 142.33 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -106.12 97.65 7.43 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 94.1 m -93.49 108.28 19.99 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.357 0.663 . . . . 0.0 109.214 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.449 ' HB ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -97.78 115.75 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.897 0.879 . . . . 0.0 108.979 -178.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.402 ' CD1' HD13 ' A' ' 106' ' ' ILE . 64.0 m-85 -107.39 133.91 51.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.684 0.794 . . . . 0.0 109.711 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -103.31 113.37 26.81 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 168.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.628 HG22 HG12 ' A' ' 106' ' ' ILE . 96.9 t -100.0 135.29 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.204 1.001 . . . . 0.0 110.035 -176.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -133.27 119.2 19.49 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.959 0.904 . . . . 0.0 109.866 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.7 m120 61.12 30.54 19.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.927 1.291 . . . . 0.0 112.375 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.67 -6.64 83.13 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.009 -0.542 . . . . 0.0 113.858 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -113.86 133.51 55.38 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.628 HG12 HG22 ' A' ' 101' ' ' VAL . 57.5 mt -67.68 107.59 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.53 -32.1 47.84 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.495 0.718 . . . . 0.0 110.997 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -150.09 152.32 34.6 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.068 0.947 . . . . 0.0 108.821 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.66 135.49 12.73 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -136.75 151.79 49.61 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -139.57 144.79 37.96 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.249 0.547 . . . . 0.0 110.31 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.644 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 16.8 ttpt -117.03 125.6 51.59 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 172.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.447 HG12 HG22 ' A' ' 95' ' ' VAL . 62.0 mt -86.44 125.56 40.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.86 -132.21 1.47 Allowed Glycine 0 CA--C 1.52 0.4 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.938 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -83.5 134.26 45.5 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.591 0.756 . . . . 0.0 111.325 -169.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.655 ' HA ' HG12 ' A' ' 93' ' ' VAL . 77.5 Cg_endo -74.07 93.37 0.88 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 123.346 2.697 . . . . 0.0 111.435 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.507 HH21 ' HB3' ' A' ' 94' ' ' ASP . 49.5 mtm105 -100.45 141.48 33.24 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.532 0.682 . . . . 0.0 111.216 -169.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.3 mm -127.8 124.72 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.732 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 N--CA 1.481 1.107 0 C-N-CA 123.834 0.853 . . . . 0.0 110.258 177.199 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.421 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 13.8 m -65.68 -42.59 91.1 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.465 1.106 . . . . 0.0 111.348 -169.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.77 -19.17 64.78 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.038 0.935 . . . . 0.0 112.72 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 mm -96.1 -29.69 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.177 0.991 . . . . 0.0 109.617 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -71.53 -36.94 71.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.247 1.019 . . . . 0.0 111.212 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 91.4 mt -58.15 -52.76 72.18 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.061 -175.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 16.9 Cg_endo -57.19 -59.77 0.55 Allowed 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 121.6 1.533 . . . . 0.0 112.271 176.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.453 HG12 ' HD2' ' A' ' 99' ' ' TYR . 16.5 m -62.42 -29.81 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -169.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.461 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 26.2 tp60 -73.44 -55.61 6.13 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 122.852 0.461 . . . . 0.0 110.399 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.2 mmtt -63.68 -36.33 83.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 123.752 0.658 . . . . 0.0 111.002 -175.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.38 -46.0 90.59 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.136 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.44 -48.78 80.33 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 55.7 mm-40 -58.44 -33.72 70.02 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.508 1.13 . . . . 0.0 110.488 -176.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.71 -26.06 32.35 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.574 1.15 . . . . 0.0 112.417 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -69.7 -44.36 70.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.977 0.511 . . . . 0.0 109.945 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.87 -22.79 52.94 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.272 175.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.79 -0.78 57.81 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.28 0.632 . . . . 0.0 112.19 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 mmt85 68.96 7.72 6.39 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.009 1.324 . . . . 0.0 113.323 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.95 98.69 6.51 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.231 0.612 . . . . 0.0 110.228 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.447 HG13 HG12 ' A' ' 54' ' ' ILE . 12.5 mm -63.06 -36.02 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.02 0.528 . . . . 0.0 110.77 172.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -57.52 -49.17 77.21 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.505 0.722 . . . . 0.0 111.405 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.0 -30.79 27.87 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.136 0.575 . . . . 0.0 111.963 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -65.93 -20.68 66.3 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.11 0.256 . . . . 0.0 110.646 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 67.7 mmm -120.16 6.19 10.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.701 0.8 . . . . 0.0 112.107 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.84 -47.57 58.63 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.295 0.569 . . . . 0.0 110.426 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.412 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 92.0 m95 -86.95 9.3 19.85 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.349 -169.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.648 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 30.1 m95 -89.29 156.74 18.55 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 173.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -76.72 149.96 36.33 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 173.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.71 -27.4 68.3 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.74 0.416 . . . . 0.0 110.645 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.97 19.37 19.58 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.596 1.158 . . . . 0.0 111.017 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.648 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 52.1 t -63.5 123.57 19.11 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.058 0.456 . . . . 0.0 111.815 -174.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -85.73 140.44 30.5 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.417 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 63.0 t80 -132.87 110.08 10.06 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -172.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -111.03 155.91 22.06 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.364 1.065 . . . . 0.0 110.955 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.26 160.29 29.6 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.67 170.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -50.93 132.5 29.53 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 124.674 1.19 . . . . 0.0 112.156 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.85 -41.49 0.9 Allowed 'Cis proline' 0 C--N 1.379 2.145 0 CA-C-N 119.961 1.022 . . . . 0.0 113.801 -2.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.06 56.89 0.12 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.215 0.606 . . . . 0.0 110.894 -177.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 75.5 m -109.33 114.22 27.71 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.67 0.788 . . . . 0.0 110.218 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.4 tt -76.5 109.48 10.27 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.17 -44.54 14.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.224 0.61 . . . . 0.0 109.664 174.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -132.13 122.34 25.2 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.742 -171.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.21 46.74 1.13 Allowed Glycine 0 N--CA 1.478 1.448 0 C-N-CA 122.612 0.148 . . . . 0.0 112.793 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.435 ' O ' HG13 ' A' ' 49' ' ' ILE . 9.5 p30 162.34 152.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 126.341 1.856 . . . . 0.0 108.319 -171.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -63.44 -25.38 68.24 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.765 0.826 . . . . 0.0 113.194 -174.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -64.07 -44.27 92.92 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.942 0.497 . . . . 0.0 111.331 -177.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.432 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 33.0 mt-10 -75.68 -33.53 60.39 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 45' ' ' ASN . 53.2 mt -65.77 -42.81 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.098 0.559 . . . . 0.0 110.598 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.463 ' O ' HG13 ' A' ' 54' ' ' ILE . 14.0 ptm180 -66.44 -42.8 87.11 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.952 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 47' ' ' ALA . 97.8 t -61.04 -44.56 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 123.787 0.68 . . . . 0.0 110.572 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -63.59 -34.7 78.4 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.19 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -77.2 -35.55 55.64 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.038 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.48 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 78.9 mt -55.5 -44.22 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 123.195 0.598 . . . . 0.0 110.124 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -54.98 -43.15 73.26 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 124.377 1.048 . . . . 0.0 111.203 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.3 tpp85 -72.68 -30.7 64.47 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.619 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -78.22 -6.63 55.47 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.71 0.404 . . . . 0.0 111.596 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 69.4 mmtt -87.11 -12.63 46.52 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.229 0.612 . . . . 0.0 111.645 171.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.71 114.73 18.96 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.733 0.813 . . . . 0.0 108.886 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.62 -27.21 38.92 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.632 2.221 . . . . 0.0 113.157 -170.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -89.16 -6.54 56.87 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.625 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.4 tp -56.99 121.95 11.17 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.48 0.488 . . . . 0.0 111.571 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -149.31 119.47 7.24 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.495 ' HA2' HG12 ' A' ' 82' ' ' VAL . . . -88.8 104.93 3.13 Favored Glycine 0 C--N 1.34 0.778 0 O-C-N 123.524 0.515 . . . . 0.0 112.197 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -102.43 101.93 12.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 tt -83.74 131.24 34.93 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.432 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -115.65 -30.73 6.07 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.175 0.99 . . . . 0.0 111.136 -173.866 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.6 m -149.35 130.68 14.67 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.4 0.68 . . . . 0.0 109.344 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -137.82 117.58 13.16 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.43 115.69 47.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.778 0.831 . . . . 0.0 109.573 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.5 tt -106.51 123.9 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 122.935 0.494 . . . . 0.0 109.983 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 t -118.75 95.73 3.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.1 -95.33 0.2 Allowed Glycine 0 CA--C 1.531 1.077 0 O-C-N 123.661 0.601 . . . . 0.0 113.78 176.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -108.39 4.23 24.17 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.456 1.102 . . . . 0.0 111.495 -171.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.93 138.53 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.511 1.124 . . . . 0.0 109.631 -173.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.01 127.62 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.497 0.719 . . . . 0.0 109.388 173.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.477 HG12 ' HB ' ' A' ' 98' ' ' ILE . 4.0 mt -99.03 106.54 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 163.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -89.99 132.5 35.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 172.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -128.58 110.54 12.35 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.24 171.08 8.55 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.366 1.466 . . . . 0.0 109.282 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.426 HG22 ' HB2' ' A' ' 92' ' ' GLU . 97.1 m -125.9 102.64 7.37 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 164.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.495 HG12 ' HA2' ' A' ' 64' ' ' GLY . 15.0 m -84.22 124.37 39.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.843 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.48 HG23 ' HD2' ' A' ' 90' ' ' LYS . 88.2 m -66.4 123.9 21.26 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.958 170.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -129.81 -170.61 2.34 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -126.06 97.29 5.04 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 118.974 0.806 . . . . 0.0 111.018 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -100.92 140.32 21.23 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.093 0.957 . . . . 0.0 108.952 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -64.69 -17.74 60.47 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.687 2.258 . . . . 0.0 113.637 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -83.59 -9.24 59.05 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.925 0.49 . . . . 0.0 112.093 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.66 -120.49 0.94 Allowed Glycine 0 C--N 1.349 1.295 0 CA-C-O 120.041 -0.31 . . . . 0.0 112.495 172.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.48 ' HD2' HG23 ' A' ' 83' ' ' THR . 16.0 tppt? -66.76 -83.28 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.841 0.856 . . . . 0.0 111.317 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 119.44 27.06 2.26 Favored Glycine 0 C--N 1.346 1.086 0 O-C-N 123.094 0.246 . . . . 0.0 112.558 -174.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.426 ' HB2' HG22 ' A' ' 81' ' ' THR . 9.7 pt-20 -89.45 108.62 19.75 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.566 0.698 . . . . 0.0 109.441 -172.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.594 HG12 ' HA ' ' A' ' 116' ' ' PRO . 4.8 m -112.64 142.32 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 122.858 0.463 . . . . 0.0 109.849 -175.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -96.77 144.37 26.82 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.564 HG22 HG12 ' A' ' 113' ' ' ILE . 15.3 t -136.82 136.63 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.608 0.763 . . . . 0.0 109.17 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.32 98.83 9.44 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 170.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 63.1 m -98.22 112.69 24.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.598 0.759 . . . . 0.0 109.641 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.536 HG23 ' HB2' ' A' ' 110' ' ' TRP . 6.3 tt -97.56 110.8 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 123.58 0.752 . . . . 0.0 109.989 177.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.453 ' HD2' HG12 ' A' ' 9' ' ' VAL . 14.6 m-85 -98.32 154.83 17.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.456 0.702 . . . . 0.0 109.843 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -132.88 119.41 20.17 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.18 0.992 . . . . 0.0 108.452 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 56.6 t -94.54 140.03 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.909 0.883 . . . . 0.0 110.254 -174.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 24.3 tt0 -138.98 123.03 17.91 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.82 31.1 16.6 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.537 0.735 . . . . 0.0 110.934 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.49 -5.73 83.91 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.929 -0.578 . . . . 0.0 114.161 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -125.39 134.6 52.09 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.779 0.831 . . . . 0.0 109.748 -175.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 64.2 mt -63.66 103.61 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 122.854 0.462 . . . . 0.0 110.397 -178.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -81.28 -24.84 36.98 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.168 0.587 . . . . 0.0 111.559 -176.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -149.25 139.81 22.54 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.572 0.749 . . . . 0.0 109.405 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.88 138.25 33.79 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.08 0.952 . . . . 0.0 108.786 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.536 ' HB2' HG23 ' A' ' 98' ' ' ILE . 3.2 m-90 -136.84 142.8 42.86 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -142.64 147.1 35.2 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 119.181 0.901 . . . . 0.0 111.233 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -131.91 130.35 41.47 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.852 0.861 . . . . 0.0 108.839 173.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.564 HG12 HG22 ' A' ' 95' ' ' VAL . 95.9 mt -87.85 127.17 41.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.86 -80.22 0.12 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 114.923 -1.035 . . . . 0.0 113.355 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -158.55 163.67 23.58 Favored Pre-proline 0 C--O 1.243 0.745 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.594 ' HA ' HG12 ' A' ' 93' ' ' VAL . 97.8 Cg_endo -81.35 141.5 12.73 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.061 1.841 . . . . 0.0 112.495 166.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -132.67 157.63 44.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.893 0.877 . . . . 0.0 110.335 174.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.454 HG23 ' H ' ' A' ' 90' ' ' LYS . 45.9 mm -133.43 144.47 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.891 1.276 . . . . 0.0 107.825 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.0 t . . . . . 0 N--CA 1.491 1.619 0 C-N-CA 122.948 0.499 . . . . 0.0 110.915 179.149 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.9 m -52.4 -53.17 48.46 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.254 1.422 . . . . 0.0 113.89 -163.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.96 -11.88 59.66 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.416 ' HB ' HD11 ' A' ' 71' ' ' ILE . 13.3 mm -98.38 -30.51 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.978 0.911 . . . . 0.0 109.984 175.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.12 -35.9 71.92 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.137 0.975 . . . . 0.0 110.632 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -65.71 -46.71 67.13 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.219 1.407 . . . . 0.0 112.579 -168.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 11.6 Cg_endo -55.13 -57.81 1.49 Allowed 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 121.561 1.507 . . . . 0.0 111.425 171.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.502 HG21 HG21 ' A' ' 76' ' ' VAL . 73.6 t -59.63 -33.37 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.506 1.122 . . . . 0.0 112.407 -173.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.569 ' HA ' HH12 ' A' ' 69' ' ' ARG . 0.9 OUTLIER -69.43 -56.07 8.49 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.532 0.733 . . . . 0.0 110.306 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -66.34 -35.4 80.25 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.414 0.686 . . . . 0.0 111.423 -174.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.04 -39.29 93.13 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.615 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.688 ' HB2' HH22 ' A' ' 69' ' ' ARG . 58.1 tp -59.02 -52.55 65.28 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.671 0.607 . . . . 0.0 110.666 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -54.97 -46.92 75.11 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.969 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.54 -30.69 71.47 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.336 1.054 . . . . 0.0 112.307 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -68.74 -48.54 63.51 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.154 0.582 . . . . 0.0 110.467 -175.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -82.21 -19.79 39.04 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.098 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.01 -3.56 58.89 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.408 0.683 . . . . 0.0 112.124 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 68.2 21.24 8.62 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.773 1.229 . . . . 0.0 112.171 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -90.05 123.21 33.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.934 0.894 . . . . 0.0 110.506 174.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.5 mm -87.15 -28.32 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.47 0.708 . . . . 0.0 110.736 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.44 -47.29 86.04 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.325 0.65 . . . . 0.0 111.981 -170.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.64 -32.24 41.62 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.072 0.549 . . . . 0.0 110.66 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -73.27 -7.18 50.44 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.088 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.728 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 1.1 tpt -116.94 -33.95 4.58 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.303 0.641 . . . . 0.0 111.864 176.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.09 -48.53 78.36 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.338 0.655 . . . . 0.0 112.066 -172.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 99.1 m95 -76.43 -0.67 23.71 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.236 -173.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.654 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 14.8 m95 -91.99 149.4 21.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 173.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 107' ' ' ALA . . . -75.42 155.15 36.64 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.975 0.51 . . . . 0.0 110.651 176.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.75 -24.55 66.98 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.451 0.701 . . . . 0.0 111.384 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -104.56 19.19 20.81 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 124.366 1.066 . . . . 0.0 110.465 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.654 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 49.0 t -60.52 114.86 3.19 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -173.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -92.49 102.87 15.32 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.887 0.875 . . . . 0.0 110.099 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.46 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 78.4 t80 -97.08 111.28 23.58 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 125.265 1.426 . . . . 0.0 110.242 -173.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.497 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 45.5 m-85 -111.08 155.59 22.58 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.53 1.132 . . . . 0.0 110.55 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.69 157.05 23.67 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.242 170.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -55.81 134.3 72.71 Favored Pre-proline 0 CA--C 1.564 1.497 0 C-N-CA 124.374 1.07 . . . . 0.0 112.251 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.33 -40.83 1.11 Allowed 'Cis proline' 0 C--N 1.381 2.289 0 CA-C-N 120.146 1.088 . . . . 0.0 113.011 -8.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.16 92.62 0.75 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.983 0.913 . . . . 0.0 108.945 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.417 ' O ' HD22 ' A' ' 42' ' ' LEU . 90.5 m -139.0 117.38 11.98 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.729 0.812 . . . . 0.0 108.863 176.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 tt -81.93 103.14 11.37 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -176.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.417 HD22 ' O ' ' A' ' 40' ' ' THR . 2.4 mm? -89.73 -29.42 18.73 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.509 0.323 . . . . 0.0 110.785 177.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -146.83 116.34 7.09 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -175.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.96 36.26 4.22 Favored Glycine 0 N--CA 1.478 1.478 0 C-N-CA 123.19 0.424 . . . . 0.0 113.396 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 p30 168.94 163.28 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.473 1.509 . . . . 0.0 109.438 -172.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -64.0 -35.42 80.66 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.945 0.898 . . . . 0.0 112.602 -177.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.86 -45.61 91.89 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.164 0.586 . . . . 0.0 111.717 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -71.67 -31.82 67.22 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.709 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.3 mt -66.04 -38.73 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.55 0.74 . . . . 0.0 110.097 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.728 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 75.3 ttt180 -62.27 -57.05 12.82 Favored 'General case' 0 C--N 1.348 0.53 0 O-C-N 123.994 0.809 . . . . 0.0 110.091 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.2 t -55.34 -48.41 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 125.043 1.464 . . . . 0.0 110.843 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.1 ttt-85 -61.33 -37.74 84.38 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.325 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -78.75 -28.37 44.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 118.889 -0.577 . . . . 0.0 112.136 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 50' ' ' ARG . 97.2 mt -61.64 -44.43 98.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 118.879 0.763 . . . . 0.0 109.06 174.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -65.33 -34.33 78.08 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.978 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -71.16 -30.33 66.32 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.2 0.6 . . . . 0.0 110.961 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -79.55 -5.7 55.47 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.127 0.571 . . . . 0.0 111.304 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -82.53 -8.57 59.61 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.875 0.47 . . . . 0.0 111.577 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 24.0 mm-40 -70.1 118.64 65.62 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.81 -22.25 27.52 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.32 2.013 . . . . 0.0 112.76 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.07 -6.97 49.99 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.727 0.811 . . . . 0.0 111.731 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 21.7 tp -58.43 111.89 1.39 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.222 0.464 . . . . 0.0 111.282 -175.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -148.23 117.01 6.68 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.99 126.71 8.19 Favored Glycine 0 C--O 1.24 0.482 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 171.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -119.46 100.9 7.58 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.8 tt -91.29 117.87 30.01 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.454 HD22 ' H ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.45 -47.01 5.56 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.378 1.071 . . . . 0.0 109.559 175.059 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.3 m -121.69 139.42 53.59 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.601 0.76 . . . . 0.0 111.672 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.688 HH22 ' HB2' ' A' ' 13' ' ' LEU . 2.2 ptp180 -144.07 125.17 14.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.455 0.702 . . . . 0.0 109.322 159.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.4 m -110.71 152.4 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.999 0.919 . . . . 0.0 108.88 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.416 HD11 ' HB ' ' A' ' 5' ' ' ILE . 19.7 tt -138.53 144.97 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 122.604 0.361 . . . . 0.0 110.812 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 75' ' ' VAL . 2.1 p -149.46 101.67 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 124.431 1.093 . . . . 0.0 109.075 -177.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.2 -123.35 20.78 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.488 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -98.76 19.32 15.05 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.831 0.453 . . . . 0.0 111.749 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 72' ' ' VAL . 3.0 p -135.28 139.32 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.102 0.561 . . . . 0.0 110.785 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.502 HG21 HG21 ' A' ' 9' ' ' VAL . 15.8 t -124.86 141.86 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.047 0.939 . . . . 0.0 110.165 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.51 HD13 ' HB ' ' A' ' 98' ' ' ILE . 8.4 mm -107.28 104.4 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 165.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -100.95 114.17 27.81 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -106.11 112.07 24.96 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.875 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -108.42 166.69 10.58 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.22 171.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.5 m -99.98 100.87 11.82 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 152.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.0 m -86.82 138.59 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 37.6 m -95.99 120.11 35.68 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.055 0.455 . . . . 0.0 110.664 -173.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -111.46 -162.8 0.81 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 175.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 66.2 t30 -132.57 110.1 10.22 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.226 -0.296 . . . . 0.0 110.474 172.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -104.96 143.3 26.42 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 124.425 1.09 . . . . 0.0 108.741 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.05 -9.9 26.49 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.663 2.242 . . . . 0.0 113.706 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -85.48 -13.09 50.21 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.782 0.433 . . . . 0.0 112.085 175.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.68 -129.86 1.56 Allowed Glycine 0 C--N 1.349 1.262 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.981 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 15.8 tppt? -75.25 -72.32 0.31 Allowed 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.196 0.598 . . . . 0.0 110.428 174.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.92 26.94 3.13 Favored Glycine 0 C--N 1.341 0.836 0 O-C-N 123.277 0.361 . . . . 0.0 113.723 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 117' ' ' ARG . 4.8 pm0 -90.29 122.37 33.14 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -174.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 116' ' ' PRO . 34.1 m -123.57 143.63 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.448 0.699 . . . . 0.0 110.619 -169.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -79.34 108.4 12.83 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.139 0.575 . . . . 0.0 109.657 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.495 HG22 HG12 ' A' ' 113' ' ' ILE . 59.8 t -123.41 138.81 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.84 0.856 . . . . 0.0 110.078 -176.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.34 117.91 30.81 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.528 0.731 . . . . 0.0 109.399 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 64.2 m -94.27 123.29 37.58 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.61 HG23 ' HB2' ' A' ' 110' ' ' TRP . 10.3 tt -104.78 105.23 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.369 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.416 ' HD2' HG22 ' A' ' 9' ' ' VAL . 22.9 m-85 -99.53 127.88 45.62 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.613 0.765 . . . . 0.0 109.996 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -100.42 113.26 25.88 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 168.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.55 HG22 HG12 ' A' ' 106' ' ' ILE . 60.8 t -97.28 126.05 50.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 125.123 1.369 . . . . 0.0 110.508 -175.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -133.15 139.28 46.99 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.108 0.963 . . . . 0.0 109.635 174.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.8 m120 63.21 29.46 15.97 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.736 1.214 . . . . 0.0 111.644 -173.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.51 8.42 62.87 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.893 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -128.46 145.24 51.16 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.759 1.224 . . . . 0.0 108.4 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.55 HG12 HG22 ' A' ' 101' ' ' VAL . 57.5 mt -69.78 100.53 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 118.435 0.562 . . . . 0.0 109.832 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . . . -87.61 -15.31 37.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.723 0.409 . . . . 0.0 111.626 -177.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -148.33 129.73 14.79 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.4 132.93 48.51 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.61 ' HB2' HG23 ' A' ' 98' ' ' ILE . 1.6 m-90 -133.98 152.59 51.91 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -143.72 148.55 35.87 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 118.805 0.73 . . . . 0.0 111.251 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.7 129.72 51.53 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.422 1.089 . . . . 0.0 109.546 176.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.495 HG12 HG22 ' A' ' 95' ' ' VAL . 75.2 mt -90.23 127.76 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 171.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.53 -74.11 0.93 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.24 -176.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.96 167.41 13.23 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.099 0.56 . . . . 0.0 109.49 -175.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.658 ' HA ' HG12 ' A' ' 93' ' ' VAL . 56.8 Cg_endo -84.21 137.79 7.39 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.428 2.086 . . . . 0.0 113.001 168.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 29.3 mmt180 -131.22 149.64 52.49 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.974 0.91 . . . . 0.0 109.126 173.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.6 mm -131.58 131.55 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.033 0.933 . . . . 0.0 108.608 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.4 t . . . . . 0 N--CA 1.49 1.567 0 C-N-CA 123.218 0.607 . . . . 0.0 111.64 -177.456 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 . . . . . 0 N--CA 1.5 2.03 0 CA-C-O 121.054 0.454 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 14.4 m -75.75 -20.31 58.39 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.235 1.014 . . . . 0.0 112.483 -167.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -72.76 -19.77 61.31 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.527 0.331 . . . . 0.0 111.358 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.51 ' HB ' HD11 ' A' ' 71' ' ' ILE . 37.5 mm -88.88 -27.41 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 173.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.656 ' HG2' HH12 ' A' ' 69' ' ' ARG . 40.2 mt-10 -78.45 -19.79 52.4 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.663 173.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 3' ' ' SER . 77.6 mt -61.5 -50.75 81.38 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-O 118.736 -0.649 . . . . 0.0 111.729 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 19.6 Cg_endo -59.09 -55.33 1.98 Allowed 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 121.745 1.63 . . . . 0.0 111.709 173.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.1 t -54.4 -47.97 69.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 125.681 1.592 . . . . 0.0 113.576 -172.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -62.22 -47.4 84.59 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.859 0.864 . . . . 0.0 110.212 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -68.63 -35.18 76.95 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.632 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.29 -51.79 67.41 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.475 0.71 . . . . 0.0 111.033 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.66 -49.37 78.0 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.963 0.789 . . . . 0.0 109.494 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -60.11 -35.0 74.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 123.972 0.795 . . . . 0.0 111.03 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -74.17 -28.0 61.09 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.058 0.943 . . . . 0.0 111.395 175.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -70.36 -42.59 71.63 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.369 0.668 . . . . 0.0 110.238 -174.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -82.04 -28.33 32.54 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.433 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.92 11.38 27.48 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 63.74 20.69 12.35 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.351 1.06 . . . . 0.0 112.412 172.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.484 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 4.5 t70 -91.38 100.62 13.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.54 0.736 . . . . 0.0 109.406 -178.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.492 HG13 HG12 ' A' ' 54' ' ' ILE . 10.4 mm -74.47 -28.8 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.255 0.222 . . . . 0.0 110.974 173.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -62.72 -45.42 92.84 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.501 0.721 . . . . 0.0 110.891 -172.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.89 -36.05 31.76 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.787 0.835 . . . . 0.0 110.569 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -64.94 -8.8 17.17 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.25 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.753 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -112.27 -31.48 6.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.538 0.735 . . . . 0.0 111.855 174.033 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.07 -28.77 66.79 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -170.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 96.7 m95 -96.82 13.85 27.22 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.81 0.844 . . . . 0.0 112.782 -175.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.409 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 13.3 m95 -112.83 147.54 36.74 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.834 0.853 . . . . 0.0 109.011 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -72.48 152.86 41.67 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.402 0.681 . . . . 0.0 110.517 175.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.67 -27.72 69.43 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.264 0.625 . . . . 0.0 111.642 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -101.45 12.26 37.65 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.153 0.981 . . . . 0.0 111.345 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.409 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 53.4 t -59.69 125.89 25.42 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -169.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -81.08 150.41 28.8 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.593 0.757 . . . . 0.0 109.562 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.416 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 59.6 t80 -146.73 112.88 5.83 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.344 0.658 . . . . 0.0 109.309 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.412 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 34.1 m-85 -114.26 150.77 33.88 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.003 0.921 . . . . 0.0 111.331 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.525 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -99.03 159.44 14.97 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 113.942 -1.481 . . . . 0.0 108.294 165.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -58.65 136.83 86.44 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-O 119.116 -0.468 . . . . 0.0 110.269 173.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.83 -55.97 0.14 OUTLIER 'Cis proline' 0 C--N 1.381 2.263 0 CA-C-N 120.406 1.181 . . . . 0.0 112.556 -7.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -148.2 58.92 1.1 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.708 0.766 . . . . 0.0 109.865 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.4 m -95.65 104.0 15.9 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.407 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.64 104.29 1.58 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 36' ' ' ALA . 56.9 mt -82.1 -45.68 14.88 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.153 177.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -143.46 117.1 9.21 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.992 -172.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.77 37.05 3.89 Favored Glycine 0 N--CA 1.478 1.465 0 C-N-CA 122.874 0.273 . . . . 0.0 113.536 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.3 p30 168.74 156.26 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.786 1.634 . . . . 0.0 109.013 -171.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -58.97 -36.11 74.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.806 0.842 . . . . 0.0 112.82 -174.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.17 94.68 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.073 0.549 . . . . 0.0 112.082 -173.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.447 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 29.1 mt-10 -76.24 -32.54 58.95 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.969 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 78.5 mt -63.54 -42.83 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.396 0.679 . . . . 0.0 109.97 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.753 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 74.6 ttt180 -56.03 -58.51 7.61 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.913 1.285 . . . . 0.0 110.861 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.32 -35.55 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.876 -168.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -72.0 -34.11 68.61 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.857 0.463 . . . . 0.0 110.334 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -74.57 -27.07 60.34 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.742 -0.646 . . . . 0.0 111.548 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.492 HG12 HG13 ' A' ' 21' ' ' ILE . 85.1 mt -56.99 -42.72 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 118.453 0.57 . . . . 0.0 109.837 173.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -61.09 -37.24 82.02 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.009 0.818 . . . . 0.0 111.151 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -64.97 -39.15 93.05 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.571 0.749 . . . . 0.0 110.064 174.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -81.3 1.85 30.71 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.1 0.96 . . . . 0.0 112.17 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 9.8 mmpt? -95.97 -16.04 21.95 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.805 0.442 . . . . 0.0 111.177 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -70.54 122.64 87.19 Favored Pre-proline 0 N--CA 1.482 1.138 0 CA-C-O 119.023 -0.513 . . . . 0.0 109.965 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.22 -26.02 72.3 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.59 2.194 . . . . 0.0 112.374 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -86.12 -5.82 59.13 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.871 0.868 . . . . 0.0 112.137 -177.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.4 tp -57.87 114.39 2.29 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 120.969 0.414 . . . . 0.0 110.575 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -147.5 117.03 7.02 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 169.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.96 102.29 1.74 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -97.07 102.86 14.73 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' A' ' 69' ' ' ARG . 8.2 tt -74.59 115.61 14.34 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 171.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.504 ' H ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -101.45 -29.86 11.76 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.52 0.728 . . . . 0.0 110.695 -177.087 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.2 m -150.19 133.15 16.1 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.865 0.866 . . . . 0.0 110.008 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.656 HH12 ' HG2' ' A' ' 6' ' ' GLU . 52.5 ptt85 -139.56 139.69 36.91 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.139 0.576 . . . . 0.0 109.637 170.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.9 m -121.95 125.64 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.951 0.901 . . . . 0.0 109.455 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.51 HD11 ' HB ' ' A' ' 5' ' ' ILE . 14.0 tt -108.21 135.87 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 121.005 0.431 . . . . 0.0 110.713 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 p -142.68 96.24 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 124.778 1.231 . . . . 0.0 108.557 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.44 -124.69 22.41 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.616 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -88.25 7.51 31.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.17 0.588 . . . . 0.0 112.559 -175.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.16 142.86 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 122.989 0.516 . . . . 0.0 110.952 -175.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.13 141.88 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.796 0.839 . . . . 0.0 109.745 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.611 HD13 ' HB ' ' A' ' 98' ' ' ILE . 5.2 mm -99.25 105.88 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 168.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -99.34 105.43 17.41 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.498 0.719 . . . . 0.0 109.668 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -98.83 104.47 16.52 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -102.09 164.1 11.88 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.421 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.6 m -105.68 101.88 11.37 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 158.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.0 t -85.87 103.43 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.883 1.273 . . . . 0.0 110.028 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 48.3 m -71.12 127.16 31.64 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.624 0.77 . . . . 0.0 111.276 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -117.25 -161.37 0.81 Allowed 'General case' 0 C--O 1.247 0.931 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -131.65 103.82 6.59 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 172.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -108.37 134.96 20.03 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 123.861 0.864 . . . . 0.0 109.528 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.74 -10.98 24.41 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.426 2.751 . . . . 0.0 114.359 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -79.61 -28.31 40.98 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.94 0.496 . . . . 0.0 111.337 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.28 -115.63 0.49 Allowed Glycine 0 C--N 1.35 1.328 0 C-N-CA 121.497 -0.383 . . . . 0.0 112.873 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -70.02 -80.81 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.12 0.968 . . . . 0.0 111.437 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 116.15 26.45 3.22 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 116.437 -0.347 . . . . 0.0 113.221 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 9.3 pt-20 -89.0 114.54 25.73 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.416 0.627 . . . . 0.0 109.872 -172.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.657 HG12 ' HA ' ' A' ' 116' ' ' PRO . 33.6 m -111.0 126.15 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.183 0.593 . . . . 0.0 109.637 -173.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.19 109.28 13.37 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.1 t -113.06 131.8 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.321 0.648 . . . . 0.0 110.248 -172.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.1 99.87 12.38 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.756 0.822 . . . . 0.0 109.323 173.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 56.9 m -94.47 108.2 20.14 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.433 1.093 . . . . 0.0 108.436 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.611 ' HB ' HD13 ' A' ' 77' ' ' ILE . 5.1 tt -106.37 115.21 47.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.937 0.895 . . . . 0.0 110.205 -174.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -112.47 133.79 54.35 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.33 0.652 . . . . 0.0 110.025 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -106.96 112.88 26.04 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.766 0.826 . . . . 0.0 108.803 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 50.1 t -85.18 140.12 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.137 1.375 . . . . 0.0 110.332 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -141.31 105.64 4.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.287 1.035 . . . . 0.0 108.866 -173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.9 m120 62.4 31.67 17.13 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.651 1.18 . . . . 0.0 112.11 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.86 -7.58 67.69 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.78 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -131.72 133.37 44.75 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.725 0.81 . . . . 0.0 109.653 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 67.1 mt -67.57 112.11 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.507 0.723 . . . . 0.0 110.191 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.25 -10.98 26.67 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -150.28 131.13 14.18 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.58 139.78 31.48 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.629 0.772 . . . . 0.0 109.232 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.421 ' HB2' HG23 ' A' ' 98' ' ' ILE . 3.1 m-90 -138.29 156.99 47.12 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -143.5 147.09 33.98 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.028 0.442 . . . . 0.0 110.149 171.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -129.02 122.51 30.19 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.245 1.018 . . . . 0.0 108.363 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.7 mt -87.69 130.38 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.35 -129.87 0.56 Allowed Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.469 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -90.18 161.11 38.59 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.657 ' HA ' HG12 ' A' ' 93' ' ' VAL . 76.2 Cg_endo -83.96 114.79 1.98 Allowed 'Trans proline' 0 CA--C 1.551 1.357 0 C-N-CA 122.234 1.956 . . . . 0.0 112.136 167.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.426 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 34.6 mtm180 -107.0 148.42 28.71 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 121.852 0.834 . . . . 0.0 110.759 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.3 mm -128.65 147.09 33.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.486 1.34 0 C-N-CA 123.553 0.741 . . . . 0.0 112.488 -177.227 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.5 p30 . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.447 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 22.2 t -68.73 -45.78 70.61 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 123.963 0.905 . . . . 0.0 110.902 -175.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -60.63 -17.33 46.41 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.886 0.875 . . . . 0.0 112.909 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.445 HG23 ' HB ' ' A' ' 101' ' ' VAL . 28.1 mm -87.29 -34.6 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.239 0.616 . . . . 0.0 109.574 178.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.91 -17.78 32.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 118.652 -0.69 . . . . 0.0 112.053 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.2 mt -62.7 -50.36 78.32 Favored Pre-proline 0 N--CA 1.488 1.465 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.635 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.64 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 14.1 Cg_endo -57.25 -51.92 7.59 Favored 'Trans proline' 0 C--N 1.388 2.642 0 C-N-CA 122.089 1.86 . . . . 0.0 112.047 172.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.96 -31.31 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 C-N-CA 124.55 1.14 . . . . 0.0 112.733 -172.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.61 -47.86 44.42 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.82 0.848 . . . . 0.0 109.519 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.1 mmtt -70.62 -25.56 63.09 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.947 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -61.1 -46.77 89.26 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.654 0.597 . . . . 0.0 110.39 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.39 -50.45 71.56 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.144 0.903 . . . . 0.0 109.54 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -57.57 -45.78 84.77 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 124.656 1.222 . . . . 0.0 109.524 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -68.82 -26.62 65.26 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.932 -1.485 . . . . 0.0 112.161 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -73.39 -38.71 65.54 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.022 0.529 . . . . 0.0 109.667 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -91.08 -29.9 17.06 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.563 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.69 0.29 57.45 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.361 0.664 . . . . 0.0 111.989 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.9 mmt-85 65.96 24.26 11.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.523 1.129 . . . . 0.0 113.121 172.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 48.1 m-20 -87.97 95.26 10.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.954 0.406 . . . . 0.0 110.724 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.52 HG13 HG12 ' A' ' 54' ' ' ILE . 8.3 mm -64.05 -30.44 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.568 0.747 . . . . 0.0 111.314 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.87 -45.63 92.93 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.313 0.383 . . . . 0.0 111.116 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.82 -35.99 62.43 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.259 0.624 . . . . 0.0 110.711 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -71.73 -4.4 27.36 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.845 0.858 . . . . 0.0 111.052 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.754 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -120.95 -23.2 5.94 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 172.198 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.74 -35.79 75.28 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.672 0.789 . . . . 0.0 112.82 -173.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.64 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 97.2 m95 -89.89 -7.69 53.6 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.625 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 14.6 m95 -91.91 143.75 26.17 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.288 0.635 . . . . 0.0 110.049 -173.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.72 152.31 45.5 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.216 0.607 . . . . 0.0 110.066 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -68.82 -24.2 64.36 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 120.932 0.396 . . . . 0.0 110.689 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.59 19.32 16.01 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.727 1.211 . . . . 0.0 110.69 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.625 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 42.7 t -65.04 122.49 17.15 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 122.073 -0.392 . . . . 0.0 111.628 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -87.39 154.61 20.53 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.745 0.818 . . . . 0.0 109.331 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 48.2 t80 -145.06 114.28 7.03 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.416 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 17.3 m-85 -109.23 153.91 23.16 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.51 0.724 . . . . 0.0 110.288 176.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.406 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -112.84 151.28 30.58 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.066 173.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.617 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 84.7 t80 -57.64 128.84 80.47 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 123.656 0.782 . . . . 0.0 111.581 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.92 -50.32 0.19 OUTLIER 'Cis proline' 0 C--N 1.389 2.666 0 CA-C-N 120.464 1.201 . . . . 0.0 114.046 0.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.41 91.63 0.93 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.958 0.903 . . . . 0.0 108.757 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.3 m -136.7 107.84 6.78 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.5 103.97 1.8 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.271 0.628 . . . . 0.0 109.695 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.406 HD11 ' HB2' ' A' ' 36' ' ' ALA . 49.5 mt -80.63 -36.55 32.45 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.948 0.899 . . . . 0.0 110.71 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -140.09 121.18 14.72 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.154 0.582 . . . . 0.0 111.436 -171.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -107.62 40.01 2.68 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 123.401 0.524 . . . . 0.0 113.042 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.9 p30 165.64 164.67 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 126.023 1.729 . . . . 0.0 108.963 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.15 -37.86 88.73 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.777 0.831 . . . . 0.0 112.556 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.46 -43.26 99.18 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.294 0.638 . . . . 0.0 112.337 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -73.08 -30.0 63.35 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.711 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.435 HG21 ' CZ3' ' A' ' 28' ' ' TRP . 85.9 mt -66.58 -46.15 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.517 0.727 . . . . 0.0 109.871 173.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.754 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 36.8 ttt180 -56.28 -56.4 21.46 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.837 -176.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.444 ' HA ' HD12 ' A' ' 54' ' ' ILE . 29.4 m -63.48 -37.31 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 124.543 1.152 . . . . 0.0 113.147 -172.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -71.37 -34.51 70.5 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.028 0.442 . . . . 0.0 110.753 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -76.5 -26.96 55.84 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 118.965 -0.541 . . . . 0.0 111.2 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.52 HG12 HG13 ' A' ' 21' ' ' ILE . 85.6 mt -59.66 -47.82 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 172.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.03 -42.25 89.76 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.998 0.919 . . . . 0.0 111.179 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -66.44 -32.71 74.26 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.104 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -82.04 -13.31 57.53 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.259 0.624 . . . . 0.0 111.356 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 67.4 mmtt -73.13 -28.82 62.47 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.737 0.415 . . . . 0.0 110.486 170.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.53 115.38 21.56 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.987 0.915 . . . . 0.0 109.991 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.1 -22.76 18.96 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.578 2.185 . . . . 0.0 112.693 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.85 -12.09 59.48 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.786 0.834 . . . . 0.0 111.508 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.7 tp -60.02 117.17 4.77 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 123.515 0.509 . . . . 0.0 109.975 175.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -149.87 117.11 6.03 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.7 103.08 2.91 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -94.47 102.06 13.99 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 tt -82.83 125.39 31.27 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.49 ' H ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -116.57 -29.98 5.97 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.01 0.924 . . . . 0.0 111.077 178.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 92.2 m -144.96 133.59 22.12 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.428 0.691 . . . . 0.0 109.991 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.5 ' NH2' HG11 ' A' ' 76' ' ' VAL . 7.4 ptm180 -142.87 138.35 30.2 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.929 0.492 . . . . 0.0 110.429 171.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.466 HG22 ' HB ' ' A' ' 77' ' ' ILE . 15.0 m -128.67 158.35 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 124.517 1.127 . . . . 0.0 108.761 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -129.75 142.53 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-O 121.025 0.44 . . . . 0.0 110.085 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.483 HG13 HG13 ' A' ' 75' ' ' VAL . 2.2 p -137.1 95.85 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 124.509 1.124 . . . . 0.0 108.945 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.71 -120.14 8.73 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.024 -0.535 . . . . 0.0 113.154 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -97.47 15.0 24.46 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.108 0.563 . . . . 0.0 112.063 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.483 HG13 HG13 ' A' ' 72' ' ' VAL . 4.4 p -135.88 135.5 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.526 0.73 . . . . 0.0 110.255 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.5 HG11 ' NH2' ' A' ' 69' ' ' ARG . 5.1 t -114.05 141.92 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.354 0.662 . . . . 0.0 110.245 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.469 HD13 ' HB ' ' A' ' 98' ' ' ILE . 17.7 mm -99.67 114.73 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.929 1.292 . . . . 0.0 107.896 168.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -112.21 106.03 14.51 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -97.62 107.17 19.61 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -112.78 144.58 42.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.168 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.1 m -91.55 102.08 14.73 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 162.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.8 m -92.83 133.36 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.104 0.478 . . . . 0.0 110.791 -176.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 73.0 m -81.31 120.73 25.3 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.771 -177.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.617 HH21 HG11 ' A' ' 93' ' ' VAL . 72.9 mtm180 -118.84 -162.86 0.92 Allowed 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.693 1.197 . . . . 0.0 107.911 170.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -125.09 108.54 11.9 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 118.477 0.58 . . . . 0.0 110.994 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.411 ' CG ' ' HA2' ' A' ' 91' ' ' GLY . 11.7 m-30 -109.95 145.03 31.21 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 123.794 0.838 . . . . 0.0 109.824 176.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.94 -19.03 67.94 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 123.369 2.713 . . . . 0.0 114.164 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -79.57 -20.04 47.97 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.29 -111.36 0.46 Allowed Glycine 0 C--N 1.348 1.242 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.726 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -62.37 -82.32 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.957 0.903 . . . . 0.0 111.693 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.411 ' HA2' ' CG ' ' A' ' 86' ' ' PHE . . . 117.14 26.1 3.06 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.994 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -87.22 138.83 31.15 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.617 HG11 HH21 ' A' ' 84' ' ' ARG . 13.9 m -137.12 140.95 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 121.988 -0.445 . . . . 0.0 111.316 -173.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -75.6 112.79 12.31 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 174.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.408 HG22 HG12 ' A' ' 113' ' ' ILE . 61.3 t -129.24 133.6 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.079 0.952 . . . . 0.0 108.499 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.77 111.13 23.47 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.4 m -94.08 107.49 19.41 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' A' ' 110' ' ' TRP . 5.4 tt -112.87 107.94 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 124.35 1.06 . . . . 0.0 109.82 -169.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -109.93 127.91 55.05 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.815 0.846 . . . . 0.0 110.408 -174.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 33.6 tt0 -99.26 112.81 24.89 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 173.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.466 HG22 HG12 ' A' ' 106' ' ' ILE . 60.7 t -96.98 113.14 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.322 1.049 . . . . 0.0 109.492 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 35.0 tt0 -113.54 126.88 55.79 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.835 0.854 . . . . 0.0 108.94 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 63.09 33.67 14.39 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.262 1.025 . . . . 0.0 112.096 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.86 7.2 88.7 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.807 -0.633 . . . . 0.0 114.336 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -133.84 143.76 48.53 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.161 0.984 . . . . 0.0 108.852 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 8' ' ' PRO . 55.2 mt -67.95 102.7 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.407 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -84.06 -23.02 31.03 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.165 0.586 . . . . 0.0 111.02 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 79.5 mttt -149.28 146.47 27.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.01 0.924 . . . . 0.0 109.061 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -142.81 133.07 24.66 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.627 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.0 m-90 -135.68 159.49 41.48 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -142.78 145.6 33.42 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 169.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.617 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 14.4 ptmm? -126.86 123.52 37.48 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.408 HG12 HG22 ' A' ' 95' ' ' VAL . 95.1 mt -89.33 116.16 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.4 -71.8 1.03 Allowed Glycine 0 CA--C 1.523 0.561 0 CA-C-N 114.24 -1.345 . . . . 0.0 113.592 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -157.01 162.86 26.84 Favored Pre-proline 0 CA--C 1.548 0.904 0 CA-C-N 116.825 0.313 . . . . 0.0 110.723 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.584 ' HA ' HG12 ' A' ' 93' ' ' VAL . 92.7 Cg_endo -77.37 137.01 16.36 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.598 2.199 . . . . 0.0 113.596 171.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -129.26 153.56 47.67 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.438 1.095 . . . . 0.0 109.98 176.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.4 mm -138.98 151.51 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.487 1.388 0 C-N-CA 122.999 0.52 . . . . 0.0 111.259 178.456 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 CA--C 1.553 1.077 0 CA-C-O 121.021 0.439 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.4 m -71.8 -35.07 69.85 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.405 0.682 . . . . 0.0 112.693 -169.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -14.36 62.02 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.649 0.38 . . . . 0.0 111.718 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.486 ' HB ' HD11 ' A' ' 71' ' ' ILE . 27.2 mm -90.68 -28.45 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.866 0.867 . . . . 0.0 110.111 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.28 -32.08 71.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.676 0.79 . . . . 0.0 111.615 173.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.6 mt -61.94 -52.1 70.46 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-O 118.675 -0.678 . . . . 0.0 112.358 -175.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 23.0 Cg_endo -60.35 -51.1 5.8 Favored 'Trans proline' 0 C--N 1.396 3.063 0 C-N-CA 122.493 2.129 . . . . 0.0 113.739 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.5 m -67.81 -32.72 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 122.699 0.4 . . . . 0.0 112.025 -170.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -73.38 -50.68 20.61 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.255 0.622 . . . . 0.0 111.076 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -70.96 -30.64 66.98 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.558 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -69.6 -39.6 77.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.142 0.577 . . . . 0.0 109.477 177.775 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -58.87 -52.28 66.41 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.219 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.44 -29.57 64.28 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.824 0.702 . . . . 0.0 111.202 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 20' ' ' ASP . . . -79.47 -31.57 42.44 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.997 0.919 . . . . 0.0 111.881 176.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -62.94 -51.29 67.48 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.173 0.589 . . . . 0.0 111.271 -173.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -75.96 -20.94 57.52 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.691 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.9 1.23 54.57 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.515 0.726 . . . . 0.0 112.401 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 62.86 22.79 13.63 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.656 1.182 . . . . 0.0 111.936 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.433 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 5.8 t70 -89.86 131.74 35.63 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.433 ' HA ' ' HB3' ' A' ' 24' ' ' PHE . 14.9 mm -104.12 -27.46 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.292 0.637 . . . . 0.0 110.816 174.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.27 -48.36 81.78 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.85 0.46 . . . . 0.0 111.58 -176.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.46 -33.76 36.44 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.749 0.82 . . . . 0.0 110.637 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.433 ' HB3' ' HA ' ' A' ' 21' ' ' ILE . 49.8 t80 -59.87 -24.7 64.46 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.39 175.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 79.6 mmm -120.44 0.6 10.57 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.09 -41.16 77.86 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.367 0.603 . . . . 0.0 111.608 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 89.9 m95 -83.42 -0.02 48.15 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.654 -173.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.558 ' HE1' ' HG3' ' A' ' 12' ' ' GLN . 21.7 m95 -91.24 143.17 26.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.225 0.61 . . . . 0.0 110.352 -175.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.55 48.12 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.9 173.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.56 -28.64 70.01 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 120.84 0.353 . . . . 0.0 111.588 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -97.4 19.08 13.85 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.205 1.002 . . . . 0.0 110.973 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.476 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 48.6 t -62.62 123.52 18.58 Favored 'General case' 0 C--N 1.357 0.909 0 O-C-N 121.913 -0.492 . . . . 0.0 111.987 -174.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -89.72 151.4 21.86 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.294 1.038 . . . . 0.0 109.31 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -139.34 119.25 13.36 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.419 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 61.9 m-85 -122.34 154.8 37.16 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.13 0.972 . . . . 0.0 111.197 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.409 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -128.75 160.12 33.53 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.769 1.228 . . . . 0.0 109.625 177.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -63.18 139.71 97.58 Favored Pre-proline 0 CA--C 1.561 1.385 0 C-N-CA 124.114 0.966 . . . . 0.0 111.538 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.89 -44.59 0.51 Allowed 'Cis proline' 0 C--N 1.381 2.287 0 CA-C-N 120.152 1.09 . . . . 0.0 113.183 -9.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.53 79.58 0.5 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.132 0.573 . . . . 0.0 110.382 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.9 m -123.44 125.22 44.55 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.688 0.795 . . . . 0.0 109.588 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 tt -84.33 110.95 18.99 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.409 HD21 ' HB2' ' A' ' 36' ' ' ALA . 1.4 mm? -85.55 -51.1 6.72 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.27 0.628 . . . . 0.0 109.363 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -140.13 120.73 14.23 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.219 -168.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.28 37.42 3.83 Favored Glycine 0 N--CA 1.477 1.372 0 O-C-N 123.135 0.272 . . . . 0.0 113.539 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.5 p30 175.45 155.22 0.17 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.02 1.728 . . . . 0.0 108.722 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.12 -25.89 68.3 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.806 0.843 . . . . 0.0 113.162 -172.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.93 -47.25 81.26 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.928 0.491 . . . . 0.0 110.78 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.492 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.7 mt-10 -70.83 -37.97 73.22 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.771 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.5 mt -61.68 -43.25 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.262 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.491 ' O ' HG13 ' A' ' 54' ' ' ILE . 69.4 ttt-85 -60.17 -56.25 23.94 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.272 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.8 t -53.8 -49.06 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 124.546 1.154 . . . . 0.0 111.98 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -61.14 -36.26 79.29 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.183 0.593 . . . . 0.0 111.383 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -75.97 -32.7 59.62 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.748 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 50' ' ' ARG . 64.4 mt -64.64 -42.67 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -62.98 -31.25 72.32 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.096 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -85.33 -11.18 55.23 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.324 0.65 . . . . 0.0 111.525 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.472 ' HA ' HD22 ' A' ' 62' ' ' LEU . 3.3 m-85 -89.99 -0.7 57.73 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.471 0.709 . . . . 0.0 110.876 172.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.445 ' HE2' HG22 ' A' ' 54' ' ' ILE . 72.6 mmtt -82.56 -4.13 57.12 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.28 0.632 . . . . 0.0 112.091 173.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.724 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 22.5 mm-40 -67.66 120.13 71.13 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -65.62 -24.33 55.74 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.058 1.838 . . . . 0.0 112.693 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -111.54 21.76 15.81 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.596 0.758 . . . . 0.0 111.611 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.724 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 39.4 tp -67.2 111.62 4.04 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 120.795 0.331 . . . . 0.0 110.235 175.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -138.11 136.41 36.7 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.514 0.726 . . . . 0.0 109.301 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.32 128.06 8.93 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.329 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -127.74 99.91 5.74 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 tt -81.35 134.75 35.62 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-O 121.452 0.644 . . . . 0.0 110.354 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mt -107.05 -50.7 3.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.161 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.2 m -152.48 125.89 8.76 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.243 -1.799 . . . . 0.0 109.136 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -118.18 132.92 56.29 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 167.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.3 m -118.8 122.52 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.006 0.923 . . . . 0.0 109.285 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.486 HD11 ' HB ' ' A' ' 5' ' ' ILE . 17.4 tt -105.74 136.77 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 122.782 0.433 . . . . 0.0 110.796 -175.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.426 HG13 HG13 ' A' ' 75' ' ' VAL . 2.1 p -146.38 112.87 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.419 1.087 . . . . 0.0 109.488 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.83 -104.73 1.06 Allowed Glycine 0 C--N 1.346 1.098 0 CA-C-N 116.384 -0.371 . . . . 0.0 112.743 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.483 ' HA ' HG13 ' A' ' 5' ' ' ILE . 7.2 p30 -122.55 15.61 10.34 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.096 0.559 . . . . 0.0 111.074 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.426 HG13 HG13 ' A' ' 72' ' ' VAL . 3.0 p -135.37 132.64 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.766 0.826 . . . . 0.0 110.173 -173.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.03 141.22 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.65 0.78 . . . . 0.0 110.239 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.567 HG12 ' HB ' ' A' ' 98' ' ' ILE . 3.1 mt -100.58 103.93 15.49 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 165.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -93.38 106.22 18.21 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -100.09 109.35 21.64 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.691 -176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.15 171.14 7.61 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.103 0.961 . . . . 0.0 111.057 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.0 m -109.13 102.23 11.21 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 161.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -81.98 108.91 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.659 1.184 . . . . 0.0 110.029 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 75.7 m -68.59 119.02 12.36 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 122.952 0.501 . . . . 0.0 110.502 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -117.06 -169.13 1.59 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.396 1.078 . . . . 0.0 109.787 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -118.34 102.91 9.31 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.63 0.772 . . . . 0.0 110.448 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.404 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 21.3 m-30 -112.07 134.07 21.52 Favored Pre-proline 0 N--CA 1.474 0.728 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 171.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.74 -12.4 32.84 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.827 2.351 . . . . 0.0 113.409 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -83.1 -10.86 58.45 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.657 0.383 . . . . 0.0 111.902 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.86 -125.75 1.09 Allowed Glycine 0 C--N 1.349 1.269 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.691 172.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -71.01 -80.1 0.06 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.84 0.856 . . . . 0.0 110.704 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.404 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 120.33 27.15 2.06 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 113.455 0.142 . . . . 0.0 113.455 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 1.5 pm0 -88.95 112.28 23.14 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.762 0.791 . . . . 0.0 109.501 -171.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 116' ' ' PRO . 30.2 m -106.43 141.12 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.594 0.757 . . . . 0.0 110.313 -172.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -83.62 124.1 30.47 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.0 127.65 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.051 0.541 . . . . 0.0 109.649 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.47 102.59 14.41 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.627 0.771 . . . . 0.0 109.235 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.4 m -98.31 118.28 34.6 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.567 ' HB ' HG12 ' A' ' 77' ' ' ILE . 11.3 tt -111.75 105.77 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 C-N-CA 123.94 0.896 . . . . 0.0 110.81 -177.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -99.29 129.07 45.48 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.098 0.959 . . . . 0.0 110.457 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 34.8 tt0 -97.72 114.44 26.44 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.237 0.541 . . . . 0.0 109.68 170.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.474 HG22 HG12 ' A' ' 106' ' ' ILE . 61.7 t -99.86 111.65 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 124.562 1.145 . . . . 0.0 110.133 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 34.5 tt0 -112.18 132.97 54.59 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.253 1.021 . . . . 0.0 109.942 174.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 63.46 30.34 15.33 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.604 1.161 . . . . 0.0 111.46 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.99 14.0 75.98 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.051 -0.522 . . . . 0.0 113.458 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -129.79 134.66 47.71 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.803 1.241 . . . . 0.0 108.96 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.474 HG12 HG22 ' A' ' 101' ' ' VAL . 70.6 mt -63.95 99.39 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -82.7 -24.31 33.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.423 0.689 . . . . 0.0 110.912 -177.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 74.2 mttt -147.88 148.47 30.88 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.378 1.071 . . . . 0.0 108.216 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.78 132.19 20.79 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 172.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.545 ' HB2' HG23 ' A' ' 98' ' ' ILE . 1.5 m-90 -128.62 146.76 50.76 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -177.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -142.47 146.88 35.23 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.381 0.991 . . . . 0.0 110.97 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -129.91 122.14 28.02 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.073 0.949 . . . . 0.0 108.663 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.35 128.96 41.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.47 -121.24 0.55 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.099 -0.955 . . . . 0.0 113.448 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -97.91 141.09 22.42 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.22 1.008 . . . . 0.0 110.459 -172.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.621 ' HA ' HG12 ' A' ' 93' ' ' VAL . 55.9 Cg_endo -71.51 115.86 4.46 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.006 2.471 . . . . 0.0 110.492 170.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -121.22 153.87 37.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.273 0.629 . . . . 0.0 111.377 -174.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.5 mm -129.77 132.84 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.806 1.242 . . . . 0.0 108.966 174.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.6 t . . . . . 0 N--CA 1.492 1.629 0 C-N-CA 123.999 0.92 . . . . 0.0 112.197 179.439 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.5 ' HB2' HD11 ' A' ' 71' ' ' ILE . 16.3 m120 . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 121.326 0.584 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.439 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 66.6 m -69.36 -41.02 77.13 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.8 0.84 . . . . 0.0 111.736 -176.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -11.73 58.23 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.04 0.536 . . . . 0.0 112.208 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.456 HG22 HG23 ' A' ' 76' ' ' VAL . 37.8 mm -91.09 -33.11 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.57 0.748 . . . . 0.0 109.918 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -79.9 -17.59 52.72 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 119.099 -0.477 . . . . 0.0 112.225 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 3' ' ' SER . 93.5 mt -62.74 -52.1 67.0 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.963 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 24.4 Cg_endo -60.76 -47.37 13.48 Favored 'Trans proline' 0 C--N 1.395 2.988 0 C-N-CA 121.797 1.664 . . . . 0.0 111.887 173.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.5 t -59.02 -43.73 89.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 124.226 1.011 . . . . 0.0 112.285 -173.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.697 ' HG2' HH12 ' A' ' 69' ' ' ARG . 6.7 mm100 -68.47 -49.36 60.33 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.082 0.553 . . . . 0.0 111.767 175.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -63.81 -27.71 69.37 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -175.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -69.0 -47.32 65.82 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 123.489 0.493 . . . . 0.0 109.768 174.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' A' ' 66' ' ' LEU . 2.7 tt -57.1 -54.16 49.92 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.782 1.301 . . . . 0.0 109.442 -177.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 16.0 mm-40 -61.17 -37.8 84.19 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.859 -176.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -71.07 -27.4 63.6 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.55 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.428 ' CZ ' HD11 ' A' ' 62' ' ' LEU . 84.8 t80 -73.08 -38.57 66.37 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.006 0.922 . . . . 0.0 110.522 -175.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -88.42 -28.3 21.0 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.983 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.84 0.84 57.47 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.366 0.666 . . . . 0.0 112.265 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 64.7 mmt-85 71.33 12.6 6.68 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.058 1.343 . . . . 0.0 113.619 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.536 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 10.2 m-20 -74.37 95.12 2.64 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.824 0.449 . . . . 0.0 110.917 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.2 mm -66.22 -26.19 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 122.942 0.497 . . . . 0.0 110.574 169.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -60.14 -48.78 80.27 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.164 0.586 . . . . 0.0 111.142 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.62 -30.31 36.76 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.18 0.592 . . . . 0.0 110.767 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -72.56 -6.78 46.39 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.224 0.61 . . . . 0.0 110.967 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.744 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -119.26 -27.25 5.68 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 173.747 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.94 -30.09 70.01 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -172.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.581 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.3 m95 -95.37 -0.12 52.95 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.355 0.662 . . . . 0.0 112.575 -175.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.59 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 13.3 m95 -97.55 148.66 23.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.435 0.694 . . . . 0.0 109.219 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.68 154.74 29.88 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.42 0.688 . . . . 0.0 109.402 172.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -69.84 -23.66 63.33 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.81 0.444 . . . . 0.0 111.468 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -95.59 17.99 13.73 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.079 0.952 . . . . 0.0 111.073 177.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.59 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 45.4 t -64.21 123.24 18.58 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.006 0.431 . . . . 0.0 111.95 -174.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.41 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . 35.4 mm-40 -96.17 103.74 15.66 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.06 0.944 . . . . 0.0 109.743 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.535 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 55.2 t80 -96.37 111.86 23.8 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.001 0.92 . . . . 0.0 110.276 -177.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.41 ' HE1' ' HB3' ' A' ' 33' ' ' GLN . 80.5 m-85 -116.05 155.16 28.62 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.719 0.808 . . . . 0.0 110.498 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.91 160.67 17.19 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.691 1.196 . . . . 0.0 108.332 167.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -52.04 133.19 40.14 Favored Pre-proline 0 CA--C 1.568 1.635 0 C-N-CA 123.599 0.759 . . . . 0.0 112.431 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.48 -40.95 1.02 Allowed 'Cis proline' 0 C--N 1.384 2.398 0 C-N-CA 124.759 -0.934 . . . . 0.0 112.963 -7.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.83 56.86 0.2 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.631 0.772 . . . . 0.0 109.861 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.2 m -92.9 114.4 26.95 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.134 0.973 . . . . 0.0 109.484 176.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.7 tp -78.16 103.82 8.34 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.447 0.567 . . . . 0.0 109.595 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.04 -37.89 33.06 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -146.38 117.17 7.65 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.14 -172.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.24 45.23 1.39 Allowed Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.989 -0.339 . . . . 0.0 112.322 -176.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 161.35 161.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 126.233 1.813 . . . . 0.0 109.066 -171.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.463 ' HA ' HD12 ' A' ' 49' ' ' ILE . . . -64.75 -35.52 81.34 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.857 0.863 . . . . 0.0 113.049 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.65 -46.91 87.61 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.041 0.536 . . . . 0.0 112.092 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.407 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.6 mt-10 -72.45 -29.41 63.65 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.823 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.463 HD12 ' HA ' ' A' ' 46' ' ' ALA . 94.6 mt -63.97 -49.19 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.788 0.835 . . . . 0.0 110.264 175.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.744 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 77.4 ttt180 -55.76 -56.63 18.21 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.152 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.465 ' HA ' HD12 ' A' ' 54' ' ' ILE . 26.8 m -65.21 -35.99 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 124.433 1.083 . . . . 0.0 112.698 -173.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -69.06 -34.95 75.98 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.195 0.598 . . . . 0.0 110.423 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -78.42 -28.49 46.79 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 118.455 -0.784 . . . . 0.0 111.785 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 51' ' ' VAL . 94.2 mt -57.34 -41.19 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-N 118.593 0.633 . . . . 0.0 109.514 173.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.16 -37.72 86.29 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.349 1.06 . . . . 0.0 111.735 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -79.43 -25.98 41.92 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.387 0.675 . . . . 0.0 111.014 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -79.8 -15.97 56.41 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.818 0.447 . . . . 0.0 110.649 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -62.61 -28.47 69.91 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.941 0.497 . . . . 0.0 110.823 168.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -66.26 118.61 54.75 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.617 0.767 . . . . 0.0 110.581 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.29 -29.2 17.41 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.541 2.161 . . . . 0.0 111.704 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.14 -18.02 63.21 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.322 1.049 . . . . 0.0 111.504 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 16' ' ' TYR . 46.1 tp -59.17 123.57 17.11 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.595 0.758 . . . . 0.0 111.511 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.477 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 69.9 t80 -152.21 125.49 8.72 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.49 109.22 3.39 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -118.4 110.93 18.05 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.316 0.647 . . . . 0.0 109.731 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HB2' HD11 ' A' ' 13' ' ' LEU . 17.4 tp -76.91 146.53 37.55 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.428 0.455 . . . . 0.0 111.155 -177.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mt -112.69 -51.45 2.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.815 0.846 . . . . 0.0 109.346 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.7 m -157.45 153.11 26.61 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.758 -1.564 . . . . 0.0 108.922 -170.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.697 HH12 ' HG2' ' A' ' 10' ' ' GLN . 4.3 ptp180 -142.27 139.2 31.84 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.921 0.488 . . . . 0.0 109.901 169.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.49 HG22 ' HB ' ' A' ' 77' ' ' ILE . 17.8 m -112.42 111.28 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 122.159 0.98 . . . . 0.0 108.592 173.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.5 HD11 ' HB2' ' A' ' 2' ' ' ASN . 11.7 tt -99.93 139.13 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.038 -177.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 75' ' ' VAL . 2.5 p -145.9 99.45 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.801 1.24 . . . . 0.0 108.666 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.12 -120.82 21.2 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.986 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -86.44 2.44 47.72 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.496 0.718 . . . . 0.0 112.777 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -129.19 132.46 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.309 0.643 . . . . 0.0 110.716 -173.055 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.456 HG23 HG22 ' A' ' 5' ' ' ILE . 59.2 t -116.0 138.85 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.925 0.89 . . . . 0.0 109.074 174.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.653 HD13 ' HB ' ' A' ' 98' ' ' ILE . 9.6 mm -97.11 103.15 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 164.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -95.68 104.19 16.1 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -177.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -99.92 107.96 20.08 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.581 0.705 . . . . 0.0 109.846 -173.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.32 168.5 12.41 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.132 -177.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 m -117.47 104.27 10.92 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 168.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.0 m -91.22 125.17 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.274 0.559 . . . . 0.0 111.463 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 63' ' ' TYR . 34.9 m -76.86 133.66 39.25 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.073 176.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -133.12 -160.72 1.07 Allowed 'General case' 0 C--O 1.247 0.944 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -128.89 105.52 8.28 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.446 0.566 . . . . 0.0 110.193 174.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -106.32 135.03 19.53 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.88 -21.12 71.63 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.921 2.414 . . . . 0.0 113.446 -174.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -74.64 -25.81 59.46 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.01 0.524 . . . . 0.0 111.693 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.14 -120.08 0.6 Allowed Glycine 0 C--N 1.352 1.463 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.709 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -72.53 -81.0 0.06 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.605 0.762 . . . . 0.0 111.3 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.19 27.24 2.07 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 113.722 0.249 . . . . 0.0 113.722 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -90.7 133.39 35.18 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.696 HG12 ' HA ' ' A' ' 116' ' ' PRO . 35.9 m -130.66 134.62 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 122.464 0.306 . . . . 0.0 110.79 -172.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.23 117.0 17.47 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.596 HG22 HG12 ' A' ' 113' ' ' ILE . 16.7 t -123.74 158.88 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.649 1.18 . . . . 0.0 108.768 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -118.16 99.93 7.19 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 169.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 93.5 m -95.05 107.52 19.57 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.653 ' HB ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -96.17 138.12 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.988 0.915 . . . . 0.0 109.412 -177.628 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -127.42 119.98 27.38 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.619 0.768 . . . . 0.0 108.993 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 43.2 tt0 -97.14 112.48 24.25 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 48.7 t -95.5 139.54 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.166 1.386 . . . . 0.0 109.778 -175.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -129.79 100.44 5.49 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.553 1.141 . . . . 0.0 108.416 -175.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.3 m120 59.79 32.7 21.48 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.82 1.248 . . . . 0.0 112.117 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.24 -7.62 54.57 Favored Glycine 0 N--CA 1.475 1.244 0 N-CA-C 114.317 0.487 . . . . 0.0 114.317 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.9 mmt-85 -127.53 133.24 49.82 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.446 0.623 . . . . 0.0 109.821 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 8' ' ' PRO . 68.2 mt -70.02 106.27 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.189 0.996 . . . . 0.0 110.447 -173.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -82.69 -18.88 39.37 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.981 0.512 . . . . 0.0 111.671 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 75.1 mttt -151.99 134.14 15.09 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -139.52 129.02 24.31 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 172.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.42 ' CE3' HD12 ' A' ' 98' ' ' ILE . 1.5 m0 -130.52 159.06 38.23 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -176.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -142.79 146.38 34.18 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -137.29 127.41 26.08 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.596 HG12 HG22 ' A' ' 95' ' ' VAL . 89.3 mt -88.75 125.75 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.55 -60.53 8.6 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 114.869 -1.06 . . . . 0.0 113.09 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -160.56 168.32 12.05 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.457 0.703 . . . . 0.0 109.819 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.696 ' HA ' HG12 ' A' ' 93' ' ' VAL . 65.7 Cg_endo -85.76 130.98 3.79 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.718 2.279 . . . . 0.0 112.188 163.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -127.53 157.96 38.71 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.916 0.487 . . . . 0.0 110.693 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.4 mm -133.67 127.37 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.1 t . . . . . 0 N--CA 1.491 1.62 0 C-N-CA 123.876 0.87 . . . . 0.0 111.094 178.723 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.61 ' HB3' HD13 ' A' ' 71' ' ' ILE . 81.8 m-20 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.469 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 23.4 m -66.47 -40.71 89.49 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.76 0.824 . . . . 0.0 111.261 -174.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -14.23 62.85 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 122.98 0.512 . . . . 0.0 111.697 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.501 HG22 HG23 ' A' ' 76' ' ' VAL . 22.8 mm -95.08 -29.49 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.811 0.844 . . . . 0.0 109.832 175.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -84.25 -20.94 31.38 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.077 0.951 . . . . 0.0 112.167 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 3' ' ' SER . 68.4 mt -67.23 -48.99 46.3 Favored Pre-proline 0 N--CA 1.486 1.338 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.092 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 10.8 Cg_endo -54.47 -52.9 7.12 Favored 'Trans proline' 0 C--N 1.391 2.771 0 C-N-CA 121.708 1.605 . . . . 0.0 111.291 172.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 76' ' ' VAL . 83.8 t -57.98 -43.2 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.323 1.049 . . . . 0.0 112.81 -176.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -64.98 -54.93 22.72 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.352 0.661 . . . . 0.0 110.201 -176.348 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -71.91 -35.14 69.61 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.873 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.483 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 1.0 OUTLIER -72.73 -30.42 64.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.76 0.824 . . . . 0.0 110.946 -176.433 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.515 HD22 HD13 ' A' ' 66' ' ' LEU . 59.4 tp -62.36 -52.13 64.84 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.18 0.592 . . . . 0.0 109.657 173.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 14.7 mm-40 -53.34 -45.81 69.24 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.05 175.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -64.92 -30.26 71.25 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.349 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -69.02 -46.38 68.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.139 0.575 . . . . 0.0 110.578 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -84.24 -24.18 30.11 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.956 0.502 . . . . 0.0 111.525 -177.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.09 2.06 55.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.259 0.624 . . . . 0.0 112.141 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.7 mmt-85 68.53 15.02 9.15 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.894 1.278 . . . . 0.0 112.948 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.46 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 10.0 m-20 -77.13 96.53 4.5 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.868 0.467 . . . . 0.0 110.738 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.8 mm -64.34 -33.55 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.553 0.741 . . . . 0.0 111.122 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.13 -48.62 79.65 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.144 0.578 . . . . 0.0 111.664 -175.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.73 -29.8 40.68 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.197 0.599 . . . . 0.0 110.737 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -69.29 -13.05 62.18 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.817 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.627 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 3.8 mmt -116.6 -15.61 10.81 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.61 0.764 . . . . 0.0 112.344 175.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.04 99.79 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.639 0.776 . . . . 0.0 112.295 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.598 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 86.3 m95 -92.95 0.97 57.52 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.379 -172.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.483 ' HE1' ' HG3' ' A' ' 12' ' ' GLN . 17.8 m95 -96.67 148.8 22.49 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.56 0.744 . . . . 0.0 109.992 -177.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.9 149.41 39.48 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.78 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.27 -20.75 64.81 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.462 0.305 . . . . 0.0 111.755 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -104.86 18.71 21.83 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.819 0.847 . . . . 0.0 111.799 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 43.0 t -62.6 127.08 29.62 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -172.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.552 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 57.7 mm-40 -96.16 104.57 16.53 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.839 0.856 . . . . 0.0 109.922 -176.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -98.18 115.33 28.1 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 124.463 1.105 . . . . 0.0 109.938 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.467 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 80.7 m-85 -114.62 154.63 28.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.954 0.902 . . . . 0.0 110.936 177.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.21 155.92 19.4 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.791 167.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.532 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 71.6 t80 -62.0 133.24 93.91 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 123.275 0.63 . . . . 0.0 110.978 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.54 -45.26 0.43 Allowed 'Cis proline' 0 C--N 1.383 2.36 0 CA-C-N 120.235 1.12 . . . . 0.0 113.95 -4.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.76 67.33 0.44 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.35 0.595 . . . . 0.0 110.285 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 33.9 m -105.98 115.77 30.79 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.1 tp -75.26 103.87 5.6 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.79 -36.48 50.32 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.473 0.709 . . . . 0.0 109.542 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -157.74 122.27 4.3 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.4 -176.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.75 26.0 24.09 Favored Glycine 0 N--CA 1.477 1.383 0 O-C-N 123.224 0.328 . . . . 0.0 113.897 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.0 p30 178.93 156.73 0.49 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.164 1.385 . . . . 0.0 109.628 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.02 -34.01 71.39 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.23 1.012 . . . . 0.0 113.143 -172.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.57 -44.27 97.34 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.783 0.433 . . . . 0.0 111.148 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 38.1 mt-10 -75.67 -30.06 59.28 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.661 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.42 ' HB ' ' HE1' ' A' ' 25' ' ' MET . 79.8 mt -63.33 -40.82 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 123.134 0.574 . . . . 0.0 109.492 176.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.627 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 39.8 ttt180 -55.6 -56.1 24.25 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.41 175.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.06 -43.97 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 124.487 1.117 . . . . 0.0 111.183 -173.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.468 ' HE ' ' HA ' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -60.65 -42.6 97.3 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.844 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -78.97 -26.8 43.45 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-O 118.452 -0.785 . . . . 0.0 112.347 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.425 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 66.2 mt -57.34 -43.38 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.113 0.869 . . . . 0.0 108.971 173.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -62.32 -34.7 77.13 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.097 0.959 . . . . 0.0 111.368 177.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -77.71 -25.14 49.14 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 123.413 0.685 . . . . 0.0 111.036 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -84.12 -14.25 50.82 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.36 0.664 . . . . 0.0 110.491 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 10.4 mmpt? -69.14 -21.15 64.03 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.226 0.61 . . . . 0.0 110.583 171.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.84 114.27 12.94 Favored Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 124.152 0.981 . . . . 0.0 109.739 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.73 -22.1 24.32 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.483 2.122 . . . . 0.0 111.953 177.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.57 6.9 47.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.215 1.006 . . . . 0.0 111.634 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 tp -66.97 112.29 4.26 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-O 120.978 0.418 . . . . 0.0 109.938 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -144.2 115.89 8.2 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.29 100.74 2.13 Favored Glycine 0 C--N 1.342 0.861 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 174.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -88.0 101.5 13.83 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.515 HD13 HD22 ' A' ' 13' ' ' LEU . 8.5 tt -75.32 115.95 15.52 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.508 ' H ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -105.34 -33.46 8.18 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.914 -175.503 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.426 ' N ' HD22 ' A' ' 67' ' ' LEU . 52.0 m -139.78 138.52 35.93 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.302 0.641 . . . . 0.0 109.796 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -142.91 133.81 25.52 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.759 0.823 . . . . 0.0 109.556 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 77' ' ' ILE . 20.1 m -126.63 155.7 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.253 1.021 . . . . 0.0 108.658 173.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.61 HD13 ' HB3' ' A' ' 2' ' ' ASN . 15.1 tt -137.75 140.32 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.107 0.48 . . . . 0.0 111.081 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 p -144.48 107.24 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 125.144 1.377 . . . . 0.0 108.443 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.55 -119.25 14.7 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.839 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 17.0 p-10 -99.72 18.77 17.33 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.039 0.536 . . . . 0.0 111.407 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.2 t -126.73 136.75 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.45 1.1 . . . . 0.0 110.097 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.501 HG23 HG22 ' A' ' 5' ' ' ILE . 62.3 t -123.7 137.3 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.437 0.695 . . . . 0.0 109.646 173.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.536 ' HB ' HG22 ' A' ' 70' ' ' VAL . 7.8 mm -98.01 103.75 15.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 165.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -101.18 105.39 16.52 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.503 ' HE1' ' HB2' ' A' ' 94' ' ' ASP . 40.5 t-80 -99.79 113.71 26.4 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.0 -176.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.97 154.14 45.92 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.894 1.277 . . . . 0.0 110.564 -176.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.415 HG22 ' HB2' ' A' ' 92' ' ' GLU . 39.0 m -100.46 111.69 23.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.699 0.799 . . . . 0.0 109.556 172.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.99 115.54 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.503 1.121 . . . . 0.0 110.038 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.8 m -77.81 121.52 24.19 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 122.813 0.445 . . . . 0.0 110.695 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -122.9 -177.05 3.55 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.395 1.078 . . . . 0.0 108.289 172.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -115.73 103.68 10.92 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.929 0.491 . . . . 0.0 110.112 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -109.48 138.62 20.61 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 123.539 0.736 . . . . 0.0 109.133 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.65 -17.66 60.9 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.306 2.671 . . . . 0.0 114.274 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -82.87 -10.89 58.61 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 122.861 0.465 . . . . 0.0 112.138 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.48 -123.84 1.06 Allowed Glycine 0 C--N 1.346 1.123 0 CA-C-O 119.852 -0.415 . . . . 0.0 112.517 171.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -66.66 -76.63 0.08 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.9 0.88 . . . . 0.0 110.505 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.23 27.06 4.07 Favored Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.699 -0.228 . . . . 0.0 113.085 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.415 ' HB2' HG22 ' A' ' 81' ' ' THR . 9.8 pt-20 -91.12 115.96 28.43 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -175.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.645 HG12 ' HA ' ' A' ' 116' ' ' PRO . 11.5 m -104.07 134.48 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -175.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.503 ' HB2' ' HE1' ' A' ' 79' ' ' HIS . 2.4 p-10 -81.74 143.85 31.54 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.588 HG22 HG12 ' A' ' 113' ' ' ILE . 39.5 t -141.45 143.63 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -105.93 107.5 18.53 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 164.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 5.9 t -94.19 138.07 32.65 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.464 ' HB ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -131.17 121.31 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.586 0.754 . . . . 0.0 109.625 -175.6 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -108.9 139.06 44.26 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.228 0.611 . . . . 0.0 109.647 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -104.51 111.22 23.81 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 165.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.452 HG22 HG12 ' A' ' 106' ' ' ILE . 61.7 t -96.13 110.67 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.351 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 35.3 tt0 -111.04 128.45 55.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.679 0.792 . . . . 0.0 109.155 176.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 62.83 30.44 16.63 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.89 0.876 . . . . 0.0 111.661 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.37 9.9 86.63 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.898 -0.592 . . . . 0.0 113.76 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 63.5 mmt-85 -129.03 135.14 48.53 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.158 0.983 . . . . 0.0 109.211 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.452 HG12 HG22 ' A' ' 101' ' ' VAL . 79.2 mt -63.55 100.7 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -76.59 -31.98 57.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.49 -173.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.552 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 98.7 mttt -153.85 153.8 32.77 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.628 1.171 . . . . 0.0 108.566 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.79 135.31 20.77 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.467 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 5.4 m-90 -134.25 153.92 51.58 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -142.61 147.3 35.6 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 118.646 0.657 . . . . 0.0 110.605 173.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 17.6 ptpt -131.74 123.87 28.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.327 1.051 . . . . 0.0 109.227 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.588 HG12 HG22 ' A' ' 95' ' ' VAL . 96.9 mt -89.13 127.39 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -176.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.36 -81.12 0.09 OUTLIER Glycine 0 CA--C 1.532 1.148 0 O-C-N 123.957 0.786 . . . . 0.0 112.866 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.435 ' HB2' ' HD2' ' A' ' 116' ' ' PRO . 0.4 OUTLIER -160.18 171.58 7.02 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.398 0.679 . . . . 0.0 109.312 167.156 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.645 ' HA ' HG12 ' A' ' 93' ' ' VAL . 36.3 Cg_endo -63.49 131.43 31.75 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.037 1.825 . . . . 0.0 112.738 167.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -118.55 139.55 51.29 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.336 0.655 . . . . 0.0 109.939 173.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.8 mm -122.04 135.07 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.479 1.005 0 O-C-N 123.539 0.524 . . . . 0.0 110.673 -177.092 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.467 ' HB2' HD11 ' A' ' 71' ' ' ILE . 14.0 m120 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.53 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 15.0 m -57.34 -49.51 75.91 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.223 -174.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -57.16 -17.57 11.6 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.997 0.919 . . . . 0.0 113.125 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.433 HG13 ' HA ' ' A' ' 74' ' ' ASN . 22.8 mm -96.13 -34.4 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.953 0.901 . . . . 0.0 110.231 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -83.74 -24.85 30.97 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.661 0.784 . . . . 0.0 112.421 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 3' ' ' SER . 54.8 mt -66.58 -53.37 29.63 Favored Pre-proline 0 CA--C 1.561 1.388 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.291 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.632 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 9.5 Cg_endo -52.64 -50.63 13.4 Favored 'Trans proline' 0 C--N 1.399 3.214 0 C-N-CA 122.545 2.164 . . . . 0.0 112.219 175.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.488 HG11 HG11 ' A' ' 76' ' ' VAL . 7.7 t -54.79 -48.51 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 125.068 1.347 . . . . 0.0 113.27 -177.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -44.77 69.42 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.491 0.316 . . . . 0.0 111.262 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.7 mmtt -65.64 -35.55 81.12 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.746 0.419 . . . . 0.0 110.895 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -59.4 -49.79 76.46 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.946 0.779 . . . . 0.0 110.788 175.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.0 tp -55.89 -51.71 66.64 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.268 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -56.85 -46.95 81.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.536 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -67.31 -26.36 66.48 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.337 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -71.91 -48.52 44.92 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.097 0.559 . . . . 0.0 110.576 -173.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.06 -29.07 35.09 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.672 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.87 -3.42 58.91 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.401 0.68 . . . . 0.0 111.636 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 71.95 12.63 6.07 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.38 1.472 . . . . 0.0 113.065 172.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.487 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 5.9 m-20 -73.15 96.6 2.25 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.265 0.626 . . . . 0.0 111.11 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.5 mm -66.26 -29.75 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.452 0.701 . . . . 0.0 111.687 175.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.04 -48.56 81.17 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.023 0.529 . . . . 0.0 112.113 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.45 -30.1 33.57 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.866 0.466 . . . . 0.0 110.899 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -73.25 -7.86 53.31 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.924 177.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.801 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -114.22 -30.55 6.59 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.16 0.584 . . . . 0.0 112.197 173.168 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.66 -33.32 60.55 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -170.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.632 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.8 m95 -99.78 14.2 31.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.906 0.882 . . . . 0.0 112.651 -170.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.55 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 29.6 m95 -105.51 155.84 18.79 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.828 0.851 . . . . 0.0 109.949 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -85.36 148.32 26.08 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.478 0.711 . . . . 0.0 109.752 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -58.14 -30.94 66.74 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.894 0.878 . . . . 0.0 111.955 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -103.05 19.29 19.79 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.025 0.93 . . . . 0.0 111.737 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.55 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 53.7 t -64.05 132.23 49.94 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.483 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 36.3 mm-40 -101.44 105.25 16.25 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.64 0.776 . . . . 0.0 110.245 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -96.56 112.52 24.23 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.936 0.894 . . . . 0.0 110.26 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.471 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 89.2 m-85 -110.3 153.48 24.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.236 1.015 . . . . 0.0 111.378 178.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.556 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -102.08 150.95 22.73 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 113.996 -1.457 . . . . 0.0 107.717 165.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 16.4 p90 -50.48 128.63 25.18 Favored Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 124.748 1.219 . . . . 0.0 114.1 -176.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 83.4 Cg_endo -79.3 -36.7 2.15 Favored 'Cis proline' 0 C--N 1.385 2.482 0 C-N-CA 124.817 -0.91 . . . . 0.0 113.06 -9.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.13 81.64 0.99 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.51 0.724 . . . . 0.0 109.811 -174.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 40.6 m -121.74 100.1 6.82 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.2 tp -71.34 100.83 2.23 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -173.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 36' ' ' ALA . 1.1 mm? -77.27 -45.26 26.92 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.45 115.85 15.29 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.958 -172.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.6 45.94 1.39 Allowed Glycine 0 C--N 1.346 1.085 0 CA-C-O 119.838 -0.423 . . . . 0.0 112.91 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.3 p30 160.36 160.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 126.495 1.918 . . . . 0.0 108.771 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -66.94 -31.61 72.3 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.888 0.875 . . . . 0.0 113.158 -172.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.75 -43.81 98.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.131 0.572 . . . . 0.0 111.171 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -75.24 -30.69 60.6 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.985 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.2 mt -63.2 -45.11 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.523 0.729 . . . . 0.0 110.143 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.801 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 21.9 ttt180 -59.46 -55.44 34.6 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.653 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.477 ' HA ' HD12 ' A' ' 54' ' ' ILE . 34.3 m -66.34 -34.43 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 124.515 1.135 . . . . 0.0 112.822 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -71.24 -32.94 69.35 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.964 0.411 . . . . 0.0 110.456 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -75.03 -33.73 61.8 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.45 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 51' ' ' VAL . 39.6 mt -55.87 -39.62 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.782 0.833 . . . . 0.0 110.228 173.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 51' ' ' VAL . 34.6 mm-40 -59.06 -46.92 87.03 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.467 0.707 . . . . 0.0 111.118 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 -66.15 -30.21 70.64 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.535 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -81.29 -11.1 59.45 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 123.932 0.893 . . . . 0.0 111.651 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 72.2 mmtt -71.67 -22.3 61.68 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.788 0.435 . . . . 0.0 111.39 170.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -81.11 115.7 57.83 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.687 0.795 . . . . 0.0 110.392 -176.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.46 -30.05 79.64 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.238 2.625 . . . . 0.0 113.757 -174.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -86.75 3.73 43.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.268 0.627 . . . . 0.0 112.561 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.9 tp -67.28 118.05 10.13 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.706 0.289 . . . . 0.0 110.805 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -150.51 119.11 6.5 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 167.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.22 103.96 3.09 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 174.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -89.38 106.55 18.52 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.0 tt -80.88 128.57 33.82 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.41 HD22 ' H ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -115.08 -34.96 4.87 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.733 0.813 . . . . 0.0 111.137 178.611 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.41 ' H ' HD22 ' A' ' 67' ' ' LEU . 38.1 m -132.25 139.0 48.11 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.579 0.752 . . . . 0.0 109.67 178.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.01 139.12 37.76 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 167.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.51 144.93 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.248 1.019 . . . . 0.0 109.347 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.467 HD11 ' HB2' ' A' ' 2' ' ' ASN . 15.1 tt -122.76 141.43 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-O 121.338 0.59 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 p -143.5 98.01 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 125.239 1.415 . . . . 0.0 108.105 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.92 -120.57 19.12 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.185 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.433 ' HA ' HG13 ' A' ' 5' ' ' ILE . 7.8 p30 -93.69 13.4 22.34 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.477 0.711 . . . . 0.0 111.913 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.2 t -130.29 136.14 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.25 1.02 . . . . 0.0 109.664 -174.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.488 HG11 HG11 ' A' ' 9' ' ' VAL . 87.0 t -125.16 135.82 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.774 0.83 . . . . 0.0 109.796 176.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.537 HG12 ' HB ' ' A' ' 98' ' ' ILE . 2.2 mt -100.13 108.01 22.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 168.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -88.07 109.16 19.65 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 168.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -99.15 110.51 23.07 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 122.041 0.924 . . . . 0.0 108.788 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.47 165.45 18.42 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.868 -1.515 . . . . 0.0 109.533 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.7 m -114.65 103.2 10.76 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 167.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.9 m -85.44 130.55 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 120.928 0.394 . . . . 0.0 110.391 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.6 m -79.05 118.96 21.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.295 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -111.81 -166.93 1.12 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 168.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -124.23 108.18 11.99 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 121.823 -0.548 . . . . 0.0 110.323 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -106.31 144.47 29.04 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 123.544 0.738 . . . . 0.0 109.059 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.84 -12.31 32.49 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.724 2.283 . . . . 0.0 112.907 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -87.61 -2.78 58.85 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.669 0.787 . . . . 0.0 112.225 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.92 -119.55 0.9 Allowed Glycine 0 C--N 1.348 1.225 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.769 170.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -65.31 -79.08 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.867 0.867 . . . . 0.0 110.536 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 117.57 22.79 3.93 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.323 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' A' ' 117' ' ' ARG . 13.8 pt-20 -90.29 141.9 28.25 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -176.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.634 HG12 ' HA ' ' A' ' 116' ' ' PRO . 22.4 m -132.97 138.64 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.156 0.435 . . . . 0.0 111.247 -171.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -75.65 109.33 9.13 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.47 HG22 HG12 ' A' ' 113' ' ' ILE . 21.4 t -114.7 155.66 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.14 105.75 9.78 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 82.5 m -94.96 107.46 19.49 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.646 HG23 ' HB2' ' A' ' 110' ' ' TRP . 7.3 tt -105.25 106.55 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.634 -173.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -99.9 137.27 38.58 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.662 0.785 . . . . 0.0 110.645 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -100.47 114.41 27.98 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.292 1.037 . . . . 0.0 109.166 168.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.539 HG22 HG12 ' A' ' 106' ' ' ILE . 46.4 t -102.31 117.66 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 123.319 0.648 . . . . 0.0 109.548 175.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 19.7 tt0 -128.54 138.71 52.38 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.832 1.253 . . . . 0.0 109.138 175.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 63.43 30.9 15.31 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.897 0.879 . . . . 0.0 111.32 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.28 7.59 82.53 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.401 -0.818 . . . . 0.0 114.058 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 57.3 mmt-85 -137.56 153.77 49.91 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.635 1.174 . . . . 0.0 108.902 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.539 HG12 HG22 ' A' ' 101' ' ' VAL . 65.3 mt -73.45 105.74 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -79.53 -28.99 41.3 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.444 0.697 . . . . 0.0 111.353 -178.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.483 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 91.3 mttt -150.25 152.6 34.8 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.85 134.41 22.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 174.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.646 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.6 m-90 -126.08 152.99 45.1 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -142.65 147.06 35.13 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 172.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -134.85 117.68 16.16 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.082 0.553 . . . . 0.0 110.294 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.47 HG12 HG22 ' A' ' 95' ' ' VAL . 95.6 mt -89.02 110.82 21.92 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.2 -93.27 0.06 OUTLIER Glycine 0 CA--C 1.533 1.196 0 CA-C-N 114.289 -1.323 . . . . 0.0 114.327 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -126.79 140.33 37.3 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 123.455 0.702 . . . . 0.0 111.268 -169.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.634 ' HA ' HG12 ' A' ' 93' ' ' VAL . 48.0 Cg_endo -67.79 125.5 13.28 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.241 2.628 . . . . 0.0 111.947 173.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.426 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 36.1 mmt180 -111.46 124.47 52.34 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.41 1.084 . . . . 0.0 109.312 178.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.1 mm -124.05 124.86 69.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.1 t . . . . . 0 N--CA 1.481 1.098 0 O-C-N 124.005 0.816 . . . . 0.0 111.281 -173.599 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 CA--C 1.56 1.359 0 CA-C-O 121.39 0.614 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.405 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 36.1 p -72.94 -35.06 66.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.663 0.785 . . . . 0.0 111.547 -175.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.09 -5.1 32.9 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.895 0.478 . . . . 0.0 111.9 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.571 HG22 HG23 ' A' ' 76' ' ' VAL . 22.9 mm -94.29 -30.47 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.968 0.907 . . . . 0.0 109.701 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -72.74 -34.19 66.88 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.7 0.8 . . . . 0.0 111.636 174.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 3' ' ' SER . 93.8 mt -61.69 -50.58 81.37 Favored Pre-proline 0 CA--C 1.558 1.283 0 CA-C-O 118.089 -0.958 . . . . 0.0 112.46 -172.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.571 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 12.7 Cg_endo -54.84 -56.49 2.37 Favored 'Trans proline' 0 C--N 1.398 3.155 0 C-N-CA 122.123 1.882 . . . . 0.0 111.072 177.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 76' ' ' VAL . 98.8 t -53.45 -44.56 56.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.303 1.441 . . . . 0.0 112.411 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -62.63 -51.47 67.17 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.946 -178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -68.86 -34.39 75.37 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.18 0.592 . . . . 0.0 111.436 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -65.03 -43.41 92.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.973 0.909 . . . . 0.0 111.254 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.8 -52.06 67.1 Favored 'General case' 0 C--O 1.242 0.688 0 O-C-N 123.716 0.635 . . . . 0.0 109.398 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -54.13 -45.93 72.05 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 124.789 1.306 . . . . 0.0 109.258 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -68.64 -27.01 65.62 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.804 -1.544 . . . . 0.0 112.52 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -71.97 -41.01 68.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.532 0.333 . . . . 0.0 110.32 -174.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -90.76 -28.99 17.9 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.227 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.6 -2.18 57.05 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.244 0.618 . . . . 0.0 111.655 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 68.27 24.03 7.57 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.075 1.35 . . . . 0.0 112.958 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.528 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 21.6 m-20 -88.06 95.61 10.21 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.187 0.595 . . . . 0.0 109.765 175.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.432 HG13 HG12 ' A' ' 54' ' ' ILE . 13.2 mm -65.78 -28.34 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.697 0.399 . . . . 0.0 110.921 174.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.08 -48.15 81.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.194 0.597 . . . . 0.0 111.674 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.67 -30.87 36.49 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.83 0.452 . . . . 0.0 110.841 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -72.86 -7.57 51.49 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.248 0.619 . . . . 0.0 110.881 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.747 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -113.59 -29.64 7.09 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.395 0.678 . . . . 0.0 112.318 174.471 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.16 -34.91 70.82 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.873 0.869 . . . . 0.0 113.186 -169.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.571 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 96.1 m95 -93.75 8.29 41.62 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.722 0.809 . . . . 0.0 112.901 -173.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.76 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 21.8 m95 -102.84 158.81 16.01 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.667 0.787 . . . . 0.0 109.375 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -86.65 162.24 18.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.106 0.562 . . . . 0.0 110.408 177.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.57 -34.22 75.44 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.139 0.576 . . . . 0.0 111.347 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -98.06 15.74 23.27 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.619 0.768 . . . . 0.0 110.534 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.76 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 43.2 t -59.93 117.47 5.09 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-O 121.137 0.494 . . . . 0.0 111.745 -173.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.571 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 57.1 mm-40 -83.78 154.27 23.64 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.701 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.41 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 57.2 t80 -144.81 111.69 5.85 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -175.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.502 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 85.3 m-85 -118.12 146.59 44.03 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.973 0.909 . . . . 0.0 110.697 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.525 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -95.69 157.43 15.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.154 -1.384 . . . . 0.0 108.202 170.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.439 ' HB3' ' HA ' ' A' ' 112' ' ' LYS . 30.9 p90 -55.6 130.19 70.77 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 123.658 0.783 . . . . 0.0 112.248 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.87 -42.42 0.78 Allowed 'Cis proline' 0 C--N 1.385 2.472 0 CA-C-N 119.923 1.008 . . . . 0.0 113.09 -4.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.09 65.15 0.16 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.697 0.799 . . . . 0.0 109.613 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.9 m -105.79 118.38 36.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.938 0.895 . . . . 0.0 109.49 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.83 110.83 8.43 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.672 0.789 . . . . 0.0 110.971 -169.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.525 HD21 ' HB2' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -88.37 -51.63 5.63 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 170.691 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -137.24 116.63 12.75 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.233 -168.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.73 22.32 40.96 Favored Glycine 0 N--CA 1.478 1.486 0 N-CA-C 114.553 0.581 . . . . 0.0 114.553 -173.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -177.89 163.6 1.81 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.235 1.414 . . . . 0.0 109.479 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -59.67 -36.65 76.86 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.938 0.895 . . . . 0.0 112.695 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.11 -44.35 97.49 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.034 0.534 . . . . 0.0 111.802 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -72.85 -36.01 67.34 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.484 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.41 -42.62 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.264 0.626 . . . . 0.0 110.019 174.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.747 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 79.2 ttt180 -62.49 -58.16 8.61 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.547 -175.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.1 m -69.86 -35.0 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 124.248 0.967 . . . . 0.0 112.879 -170.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -67.43 -36.39 81.13 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.642 0.377 . . . . 0.0 110.163 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -77.14 -30.09 54.92 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.357 176.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 50' ' ' ARG . 91.6 mt -57.82 -42.58 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 118.84 0.745 . . . . 0.0 109.922 174.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.0 -32.8 73.44 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.576 0.75 . . . . 0.0 111.616 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -74.85 -28.8 60.82 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.939 0.495 . . . . 0.0 110.706 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -81.15 -3.71 52.99 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.217 0.607 . . . . 0.0 110.995 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -77.03 -29.34 55.26 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.007 0.523 . . . . 0.0 110.802 169.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -59.93 118.79 35.53 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 123.91 0.884 . . . . 0.0 110.753 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -64.39 -35.72 48.52 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.828 2.352 . . . . 0.0 113.118 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -93.14 8.4 40.26 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.966 0.506 . . . . 0.0 112.154 -173.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.4 tp -67.85 113.87 5.95 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -148.31 116.34 6.43 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.73 104.88 3.13 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 174.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -97.61 105.18 17.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 80' ' ' GLU . 8.1 tt -78.94 127.45 32.02 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.023 0.44 . . . . 0.0 110.095 -177.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.425 HD22 ' H ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -96.18 -48.11 5.78 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.202 1.001 . . . . 0.0 108.737 -176.64 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 92.4 m -143.93 134.22 24.49 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.633 -170.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 10.8 ptt180 -131.44 129.27 41.0 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 166.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.7 HG22 ' HB ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -107.24 156.26 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.115 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.411 HD11 ' HB ' ' A' ' 5' ' ' ILE . 18.7 tt -134.7 137.67 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.127 0.489 . . . . 0.0 110.754 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 p -147.16 102.36 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.527 1.131 . . . . 0.0 108.636 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.8 -115.94 8.09 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.497 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -99.55 12.35 36.71 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.089 0.556 . . . . 0.0 111.728 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.92 139.35 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.899 0.879 . . . . 0.0 110.09 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.571 HG23 HG22 ' A' ' 5' ' ' ILE . 53.2 t -126.13 140.11 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.525 0.73 . . . . 0.0 109.77 174.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.7 ' HB ' HG22 ' A' ' 70' ' ' VAL . 24.4 mm -98.22 101.69 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 165.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -95.31 104.48 16.37 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -100.48 109.0 21.11 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.722 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -120.34 165.63 14.62 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.678 1.191 . . . . 0.0 110.412 -179.553 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.9 m -116.24 105.54 12.67 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.314 1.046 . . . . 0.0 109.083 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.2 125.69 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.291 0.567 . . . . 0.0 111.079 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.5 m -74.63 132.07 41.43 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.365 1.066 . . . . 0.0 110.178 175.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -130.31 -168.24 1.94 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.204 1.002 . . . . 0.0 109.282 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -128.43 100.29 5.73 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.657 0.783 . . . . 0.0 109.413 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -108.84 149.65 39.82 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.389 0.676 . . . . 0.0 110.398 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.86 -27.07 51.56 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.784 2.323 . . . . 0.0 113.234 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -86.84 -9.43 55.8 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.02 -140.25 6.31 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 120.094 -0.281 . . . . 0.0 112.728 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -66.07 -81.08 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.691 0.797 . . . . 0.0 111.548 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.45 28.21 1.66 Allowed Glycine 0 C--N 1.347 1.187 0 C-N-CA 121.341 -0.457 . . . . 0.0 113.77 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 117' ' ' ARG . 0.3 OUTLIER -88.81 100.2 12.97 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 122.368 1.08 . . . . 0.0 108.234 -174.452 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 116' ' ' PRO . 3.9 m -105.18 143.41 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.719 -169.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.41 141.26 34.1 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.533 HG22 HG12 ' A' ' 113' ' ' ILE . 35.5 t -138.06 142.04 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -109.92 105.24 14.34 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 170.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 74.9 m -92.74 136.7 33.0 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.56 ' HB ' HD13 ' A' ' 77' ' ' ILE . 7.3 tt -122.11 111.72 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 124.374 1.069 . . . . 0.0 109.768 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.433 ' HD2' HG22 ' A' ' 9' ' ' VAL . 12.7 m-85 -99.85 142.85 30.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.871 0.469 . . . . 0.0 109.844 176.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -111.64 113.92 26.63 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.0 t -97.73 141.79 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 124.646 1.179 . . . . 0.0 110.265 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -141.63 105.6 4.76 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.917 1.287 . . . . 0.0 108.206 -172.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 20.4 m120 61.49 30.96 19.04 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.539 1.136 . . . . 0.0 111.837 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.0 4.68 78.15 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.335 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -126.5 132.56 51.37 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.649 0.78 . . . . 0.0 109.697 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 62.9 mt -68.47 112.57 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 122.986 0.514 . . . . 0.0 110.088 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -76.91 -37.79 54.74 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.361 0.664 . . . . 0.0 110.434 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.571 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 98.0 mttt -151.59 150.16 29.98 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.81 0.844 . . . . 0.0 109.279 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.0 135.35 32.62 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.502 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 3.1 m-90 -132.66 156.03 47.7 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -145.39 148.6 33.53 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.538 0.608 . . . . 0.0 110.959 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 8.4 ptpp? -126.5 129.98 49.72 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.162 0.985 . . . . 0.0 108.825 172.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.533 HG12 HG22 ' A' ' 95' ' ' VAL . 95.8 mt -90.85 129.65 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.54 -80.18 0.12 Allowed Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.64 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.25 161.12 30.14 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.486 ' HA ' HG12 ' A' ' 93' ' ' VAL . 72.4 Cg_endo -72.52 121.0 7.06 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.481 2.121 . . . . 0.0 112.262 170.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 78.0 mtt-85 -122.56 153.48 39.2 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.52 0.728 . . . . 0.0 110.661 -177.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.1 mm -136.51 139.58 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.6 1.16 . . . . 0.0 109.648 -176.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.7 t . . . . . 0 N--CA 1.49 1.563 0 C-N-CA 123.656 0.782 . . . . 0.0 111.021 174.78 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.3 p -64.63 -37.64 88.26 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.879 0.472 . . . . 0.0 110.039 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.04 -23.1 61.7 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.127 1.371 . . . . 0.0 112.977 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.537 HG23 ' HB ' ' A' ' 101' ' ' VAL . 29.1 mm -93.18 -29.27 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.386 1.074 . . . . 0.0 109.771 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -77.94 -24.16 48.29 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.704 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.451 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 88.2 mt -61.71 -57.67 23.12 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-O 118.136 -0.935 . . . . 0.0 112.012 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.578 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 14.1 Cg_endo -54.37 -50.11 14.61 Favored 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 122.766 2.31 . . . . 0.0 112.706 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.6 m -65.65 -32.4 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.901 -174.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.18 -50.63 31.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.583 0.753 . . . . 0.0 110.336 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.1 mmtt -66.84 -30.62 70.84 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.018 -176.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.17 -49.2 78.77 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 124.039 0.837 . . . . 0.0 111.288 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.75 -48.33 79.94 Favored 'General case' 0 C--O 1.246 0.897 0 O-C-N 123.774 0.671 . . . . 0.0 110.069 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -58.27 -42.61 86.87 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 124.904 1.377 . . . . 0.0 109.055 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -72.91 -25.78 61.17 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.753 -1.567 . . . . 0.0 112.796 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -68.14 -44.43 76.05 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.06 0.457 . . . . 0.0 110.324 -173.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -85.49 -29.58 24.16 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.644 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.87 -4.19 57.8 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.35 0.66 . . . . 0.0 111.497 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.42 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 23.6 mmt85 69.99 23.6 5.38 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.225 1.41 . . . . 0.0 112.796 171.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 19.7 m-20 -91.24 94.61 9.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.05 0.54 . . . . 0.0 110.541 177.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.475 HG13 HG12 ' A' ' 54' ' ' ILE . 20.2 mm -66.37 -28.7 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 123.514 0.726 . . . . 0.0 111.208 173.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -58.76 -47.15 85.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.945 0.498 . . . . 0.0 111.351 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.04 -33.97 33.16 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.421 0.689 . . . . 0.0 111.052 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -68.18 -8.88 42.63 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.777 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.709 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 24.9 tpp -120.53 -22.26 6.48 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 174.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.08 -28.79 69.86 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -175.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.578 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 96.1 m95 -94.17 9.63 37.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.786 0.834 . . . . 0.0 112.539 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -102.77 153.09 20.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.662 0.785 . . . . 0.0 110.002 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.47 140.43 44.59 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 168.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -67.81 -11.69 59.04 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.306 0.642 . . . . 0.0 112.37 -174.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -116.18 21.08 13.94 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.077 0.951 . . . . 0.0 111.232 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.7 t -59.76 147.55 37.55 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.45 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 33.8 mm-40 -107.21 105.42 15.39 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.171 0.988 . . . . 0.0 110.043 -175.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -102.55 112.63 25.46 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.587 0.755 . . . . 0.0 110.521 -173.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.421 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 13.9 m-85 -106.51 152.69 23.34 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.874 0.87 . . . . 0.0 110.322 175.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.64 161.95 18.4 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.355 1.062 . . . . 0.0 109.776 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.502 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 68.3 t80 -57.06 125.56 70.58 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 123.696 0.798 . . . . 0.0 110.26 174.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.24 -56.75 0.14 OUTLIER 'Cis proline' 0 C--N 1.386 2.545 0 CA-C-N 120.59 1.246 . . . . 0.0 113.898 2.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.9 57.72 0.37 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.558 0.743 . . . . 0.0 109.51 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.9 m -98.84 113.68 25.92 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.091 0.957 . . . . 0.0 110.533 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.47 102.46 0.7 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.9 mt -78.37 -42.26 30.91 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.621 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -140.19 115.55 9.95 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.001 -169.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.7 46.13 1.66 Allowed Glycine 0 C--N 1.344 1.006 0 O-C-N 123.386 0.429 . . . . 0.0 112.284 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 p30 163.26 153.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 126.491 1.916 . . . . 0.0 108.561 -172.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.709 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -68.56 -23.66 64.53 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.876 0.87 . . . . 0.0 113.328 -174.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.5 -48.76 80.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.753 0.421 . . . . 0.0 111.239 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.494 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 27.3 mt-10 -70.67 -30.17 66.69 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.652 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.513 HD12 ' HA ' ' A' ' 46' ' ' ALA . 63.9 mt -64.66 -52.43 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.487 0.715 . . . . 0.0 110.679 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.497 ' O ' HG13 ' A' ' 54' ' ' ILE . 6.4 ptp180 -64.2 -43.12 96.03 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.443 -175.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.9 t -67.91 -39.33 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.13 0.972 . . . . 0.0 111.743 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -71.33 -29.74 65.37 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.627 0.371 . . . . 0.0 110.851 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -73.61 -30.57 63.06 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 119.114 -0.469 . . . . 0.0 111.346 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 50' ' ' ARG . 77.6 mt -58.59 -38.75 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -57.2 -41.91 80.27 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.916 0.76 . . . . 0.0 111.717 174.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -73.59 -31.03 63.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.119 0.568 . . . . 0.0 110.722 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.42 ' CD2' ' HA ' ' A' ' 19' ' ' ARG . 2.6 m-30 -78.42 3.21 16.4 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.35 0.66 . . . . 0.0 111.478 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.417 ' HE2' HG22 ' A' ' 54' ' ' ILE . 73.4 mmtt -81.67 -18.38 44.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.312 0.645 . . . . 0.0 112.183 171.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.65 121.03 79.51 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-O 119.205 -0.426 . . . . 0.0 110.188 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.95 -20.05 34.42 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.357 2.038 . . . . 0.0 111.687 177.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -84.87 -13.36 51.16 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.885 0.874 . . . . 0.0 111.676 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 83' ' ' THR . 30.2 tp -62.85 112.56 2.6 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -173.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -145.5 118.03 8.56 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.18 105.54 3.31 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -96.3 105.73 17.84 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 tt -85.88 119.83 26.62 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.465 ' H ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -107.44 -31.43 8.16 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.706 0.802 . . . . 0.0 111.231 -174.737 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.418 ' N ' HD22 ' A' ' 67' ' ' LEU . 84.7 m -142.87 132.38 23.66 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.923 0.889 . . . . 0.0 109.805 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -135.67 135.07 39.82 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 164.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.494 HG22 ' HB ' ' A' ' 77' ' ' ILE . 20.4 m -122.56 142.41 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.5 tt -124.84 138.47 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 121.229 0.538 . . . . 0.0 111.219 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -139.76 99.41 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 125.284 1.434 . . . . 0.0 107.999 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.29 -126.79 23.15 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.718 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.423 ' HA ' HG13 ' A' ' 5' ' ' ILE . 21.1 p-10 -94.78 24.27 4.84 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.228 0.611 . . . . 0.0 111.411 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.2 t -131.43 130.75 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.404 1.082 . . . . 0.0 109.433 -174.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.9 t -120.93 142.53 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 122.982 0.513 . . . . 0.0 110.043 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.673 HD13 ' HB ' ' A' ' 98' ' ' ILE . 5.3 mm -98.28 107.69 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 165.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -91.57 109.38 20.68 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 167.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -100.72 108.51 20.38 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 175.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.53 129.35 42.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.757 1.223 . . . . 0.0 109.734 -174.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.5 m -83.91 103.02 12.83 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 172.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.6 m -89.33 137.71 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 29.2 m -95.58 135.45 37.23 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.195 0.598 . . . . 0.0 109.688 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -131.45 -166.11 1.66 Allowed 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -125.45 99.57 6.09 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 122.122 -0.361 . . . . 0.0 110.061 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.434 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 20.7 m-30 -99.53 135.74 20.54 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 172.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.03 -12.5 35.68 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.997 2.465 . . . . 0.0 113.812 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -83.98 -11.2 57.17 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA3' HG23 ' A' ' 118' ' ' ILE . . . 173.09 -119.3 0.75 Allowed Glycine 0 C--N 1.35 1.34 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.346 171.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -71.4 -80.61 0.06 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.215 0.606 . . . . 0.0 110.998 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.434 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 123.22 27.0 1.57 Allowed Glycine 0 C--N 1.344 0.978 0 N-CA-C 114.032 0.373 . . . . 0.0 114.032 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -89.53 141.12 28.87 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' A' ' 116' ' ' PRO . 30.4 m -133.49 133.37 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.199 0.599 . . . . 0.0 109.557 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.51 109.24 15.79 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.481 HG22 HG12 ' A' ' 113' ' ' ILE . 39.0 t -112.43 156.65 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -175.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -128.69 101.93 6.35 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 111' ' ' PHE . 76.2 m -92.08 105.7 17.88 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.673 ' HB ' HD13 ' A' ' 77' ' ' ILE . 8.5 tt -92.2 112.19 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.044 0.938 . . . . 0.0 109.58 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -99.94 148.84 24.05 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.571 0.748 . . . . 0.0 110.127 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -118.69 111.85 19.04 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.552 HG22 HG12 ' A' ' 106' ' ' ILE . 53.6 t -98.31 112.18 29.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.012 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -117.18 130.9 56.9 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 62.7 32.1 16.34 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.581 0.752 . . . . 0.0 111.386 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.63 -5.88 82.19 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 115.657 -0.702 . . . . 0.0 114.58 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 63.5 mmt-85 -132.22 147.44 52.41 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.6 0.76 . . . . 0.0 109.281 -175.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.552 HG12 HG22 ' A' ' 101' ' ' VAL . 66.4 mt -68.94 100.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.395 0.678 . . . . 0.0 110.256 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.68 -25.71 35.31 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.563 0.745 . . . . 0.0 111.312 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 96.8 mttt -145.58 150.03 35.63 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.788 0.835 . . . . 0.0 108.751 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.36 135.11 14.51 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.507 0.723 . . . . 0.0 109.408 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.421 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 2.5 m-90 -133.06 130.63 39.62 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.476 ' HB2' ' SG ' ' A' ' 97' ' ' CYS . 11.8 p90 -119.66 138.95 52.94 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.252 0.933 . . . . 0.0 109.583 175.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -127.36 119.9 27.29 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.371 0.668 . . . . 0.0 109.213 -178.878 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.481 HG12 HG22 ' A' ' 95' ' ' VAL . 88.7 mt -88.75 130.1 38.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.04 -78.8 0.17 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.153 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -158.38 163.26 24.96 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.632 ' HA ' HG12 ' A' ' 93' ' ' VAL . 74.5 Cg_endo -71.04 114.74 4.0 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.28 1.987 . . . . 0.0 112.189 170.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -107.05 150.68 26.27 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.887 0.875 . . . . 0.0 108.973 176.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.406 HG23 ' HA3' ' A' ' 89' ' ' GLY . 32.2 mm -138.11 121.35 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.875 0.87 . . . . 0.0 108.98 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.488 1.427 0 C-N-CA 123.024 0.53 . . . . 0.0 110.752 177.831 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -109.54 44.94 1.12 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 50.7 p -65.98 -43.62 87.28 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.407 -1.269 . . . . 0.0 111.749 -172.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.21 -6.82 31.46 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.622 0.769 . . . . 0.0 112.722 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.453 ' HB ' HD11 ' A' ' 71' ' ' ILE . 14.4 mm -95.78 -29.64 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.649 0.78 . . . . 0.0 109.016 174.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -77.73 -33.01 53.15 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.701 0.801 . . . . 0.0 111.492 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 3' ' ' SER . 93.0 mt -58.91 -49.54 92.81 Favored Pre-proline 0 N--CA 1.489 1.492 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.384 -176.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.6 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 11.9 Cg_endo -56.29 -60.92 0.39 Allowed 'Trans proline' 0 C--N 1.392 2.816 0 C-N-CA 122.245 1.964 . . . . 0.0 112.303 175.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.49 HG21 HG11 ' A' ' 76' ' ' VAL . 22.6 m -64.27 -29.54 47.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.848 -167.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -68.72 -55.18 12.19 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.564 0.745 . . . . 0.0 109.88 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -62.97 -35.08 78.96 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.892 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -74.79 -42.52 57.97 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.6 0.76 . . . . 0.0 111.438 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.459 HD21 ' HB2' ' A' ' 66' ' ' LEU . 22.9 tp -60.76 -46.79 89.11 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.851 0.46 . . . . 0.0 110.401 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.22 -49.94 74.43 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.94 173.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.85 -25.91 68.38 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.267 1.027 . . . . 0.0 112.3 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -63.75 -44.1 94.51 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.595 0.758 . . . . 0.0 110.71 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -91.25 -28.24 17.92 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.814 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.85 -10.23 59.74 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.831 0.852 . . . . 0.0 112.111 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 69.11 44.68 0.97 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.876 1.27 . . . . 0.0 112.095 173.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -115.77 93.81 4.42 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.261 0.624 . . . . 0.0 109.566 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.531 HG13 HG12 ' A' ' 54' ' ' ILE . 12.8 mm -71.62 -29.63 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 122.864 0.466 . . . . 0.0 111.35 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.78 -45.12 93.27 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.458 0.303 . . . . 0.0 111.4 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.43 -32.36 42.79 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.991 0.516 . . . . 0.0 110.94 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.488 ' HB3' ' HA ' ' A' ' 21' ' ' ILE . 50.8 t80 -70.05 -10.33 58.34 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.888 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.659 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -111.53 -29.74 7.64 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.453 0.701 . . . . 0.0 111.24 174.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.04 -54.25 32.31 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.808 0.843 . . . . 0.0 112.241 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.6 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 95.5 m95 -78.39 4.64 12.49 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.467 -1.242 . . . . 0.0 113.452 -169.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.711 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 28.3 m95 -93.29 162.37 14.03 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.54 0.736 . . . . 0.0 109.521 174.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -79.67 152.16 30.11 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.793 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.41 -27.24 66.91 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 120.782 0.325 . . . . 0.0 111.3 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.32 18.86 21.39 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.633 0.773 . . . . 0.0 110.791 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.711 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 53.2 t -60.72 133.8 56.45 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.069 0.548 . . . . 0.0 112.12 -174.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -88.08 148.96 24.23 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 56.6 t80 -140.53 112.85 7.87 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.432 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 27.0 m-85 -108.25 154.88 21.14 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.037 0.935 . . . . 0.0 110.83 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -113.39 155.31 25.46 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.872 1.269 . . . . 0.0 109.341 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.718 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 69.3 t80 -53.54 125.49 44.96 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.398 1.079 . . . . 0.0 111.971 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -76.85 -58.4 0.14 OUTLIER 'Cis proline' 0 C--N 1.383 2.362 0 CA-C-N 120.344 1.159 . . . . 0.0 113.986 -4.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -145.3 78.85 1.56 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.473 0.709 . . . . 0.0 109.819 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 94.5 m -125.95 106.05 9.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.473 0.709 . . . . 0.0 109.709 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.5 tp -66.12 102.41 0.82 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.549 0.74 . . . . 0.0 110.937 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 36' ' ' ALA . 41.2 mt -79.79 -35.86 37.92 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.384 0.673 . . . . 0.0 110.553 175.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -142.49 121.32 12.71 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.436 -171.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.91 35.38 4.9 Favored Glycine 0 C--N 1.347 1.176 0 C-N-CA 123.239 0.447 . . . . 0.0 112.754 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 p30 168.45 161.31 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.65 1.58 . . . . 0.0 109.79 -172.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -64.96 -36.93 85.96 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.407 1.083 . . . . 0.0 112.918 -173.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.28 82.86 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.124 0.569 . . . . 0.0 111.84 -173.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.403 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 27.4 mt-10 -77.02 -33.29 57.44 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.988 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.8 mt -61.64 -50.44 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.676 0.79 . . . . 0.0 110.756 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.659 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 21.3 ptt180 -61.91 -49.93 74.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 118.841 -0.599 . . . . 0.0 110.525 -177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.5 t -59.29 -42.82 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.531 0.732 . . . . 0.0 110.668 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.454 ' HE ' ' HA ' ' A' ' 52' ' ' ARG . 2.1 tpm_? -55.17 -43.72 74.54 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.024 0.827 . . . . 0.0 110.704 176.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -78.24 -29.78 48.34 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.387 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.531 HG12 HG13 ' A' ' 21' ' ' ILE . 95.7 mt -61.42 -38.47 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 118.414 0.552 . . . . 0.0 109.673 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -58.88 -40.17 83.59 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.653 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -70.47 -32.95 70.69 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.074 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -74.66 -8.66 57.08 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.811 0.844 . . . . 0.0 111.832 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.462 ' HE2' HG22 ' A' ' 54' ' ' ILE . 72.6 mmtt -71.12 -27.27 63.46 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.775 0.43 . . . . 0.0 111.542 174.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.44 117.05 43.25 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.97 -22.08 42.51 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.302 2.002 . . . . 0.0 110.885 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -85.84 -5.54 59.23 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.618 1.567 . . . . 0.0 112.603 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.79 120.9 12.17 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.418 0.287 . . . . 0.0 110.314 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -150.93 117.67 5.8 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.3 102.64 2.95 Favored Glycine 0 C--N 1.344 1.002 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -95.3 103.07 14.92 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.459 ' HB2' HD21 ' A' ' 13' ' ' LEU . 8.7 tp -68.02 139.88 56.32 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.134 0.492 . . . . 0.0 110.81 -177.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mt -107.39 -53.01 2.68 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.463 1.105 . . . . 0.0 108.392 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.8 m -148.11 144.69 27.99 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 113.613 -1.631 . . . . 0.0 109.739 -172.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 25.2 ptt180 -140.7 128.55 21.81 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.115 0.966 . . . . 0.0 108.739 173.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.522 HG22 ' HB ' ' A' ' 77' ' ' ILE . 33.1 m -123.83 152.08 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.453 HD11 ' HB ' ' A' ' 5' ' ' ILE . 11.2 tt -133.35 118.72 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.25 0.548 . . . . 0.0 110.401 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.6 t -112.18 95.27 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.368 1.067 . . . . 0.0 108.429 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.92 -111.1 3.8 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 116.027 -0.533 . . . . 0.0 113.433 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -93.44 12.43 25.0 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.769 0.828 . . . . 0.0 111.615 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.1 t -125.72 134.25 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.74 0.816 . . . . 0.0 109.52 -171.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 9' ' ' VAL . 24.5 t -125.69 135.17 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 122.807 0.443 . . . . 0.0 110.355 175.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.62 HD13 ' HB ' ' A' ' 98' ' ' ILE . 9.0 mm -99.81 105.06 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.092 1.357 . . . . 0.0 108.006 169.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.01 105.87 17.86 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 167.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.44 ' HE1' ' HB3' ' A' ' 94' ' ' ASP . 1.8 t60 -100.21 106.78 18.49 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.95 169.18 12.95 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.942 1.297 . . . . 0.0 110.18 -176.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.6 m -116.71 110.16 18.09 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.2 t -81.29 103.41 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.362 0.665 . . . . 0.0 110.123 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 88.0 m -66.24 118.81 10.48 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -123.98 -169.29 1.93 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.572 1.149 . . . . 0.0 108.031 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -118.1 109.37 16.33 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.39 0.676 . . . . 0.0 109.424 169.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -103.81 147.02 33.62 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 123.655 0.782 . . . . 0.0 110.015 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.02 -9.86 27.54 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.876 2.384 . . . . 0.0 114.216 -175.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -92.35 -15.14 27.7 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.419 0.287 . . . . 0.0 111.66 173.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.05 -121.66 1.03 Allowed Glycine 0 C--N 1.355 1.626 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.956 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -53.79 -84.57 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.503 1.121 . . . . 0.0 111.994 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.58 28.54 2.72 Favored Glycine 0 C--N 1.349 1.276 0 C-N-CA 121.686 -0.292 . . . . 0.0 113.575 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -89.77 119.57 30.27 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -173.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 116' ' ' PRO . 33.4 m -116.49 123.16 71.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 CA-C-O 121.114 0.483 . . . . 0.0 110.045 -175.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.44 ' HB3' ' HE1' ' A' ' 79' ' ' HIS . 2.8 m-20 -84.19 108.0 16.83 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 113' ' ' ILE . 24.0 t -113.14 149.42 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.788 1.235 . . . . 0.0 109.432 -174.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -112.84 103.19 11.18 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 167.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 76.7 m -93.76 109.05 20.74 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.62 ' HB ' HD13 ' A' ' 77' ' ' ILE . 4.9 tt -99.3 134.6 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.244 1.018 . . . . 0.0 109.739 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -123.22 155.6 36.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.773 0.829 . . . . 0.0 109.866 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -129.07 119.42 24.17 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.892 1.277 . . . . 0.0 107.645 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.534 HG22 HG12 ' A' ' 106' ' ' ILE . 97.1 t -107.46 117.62 53.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.226 1.01 . . . . 0.0 109.695 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 43.0 tt0 -126.95 133.26 50.66 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.92 0.888 . . . . 0.0 109.23 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.0 m120 61.54 28.62 17.84 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.027 1.331 . . . . 0.0 111.798 -175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.05 -7.56 80.0 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -121.27 149.29 43.1 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 101' ' ' VAL . 47.7 mt -66.41 109.77 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -75.78 -38.41 58.31 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.865 0.866 . . . . 0.0 110.608 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -149.12 146.7 27.82 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.191 0.996 . . . . 0.0 109.059 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -145.84 139.68 26.52 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.154 0.582 . . . . 0.0 109.504 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.432 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 2.0 m-90 -131.78 155.8 47.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -142.24 145.02 33.62 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 171.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.718 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 59.9 pttt -129.06 124.27 34.42 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.627 0.771 . . . . 0.0 109.066 175.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.461 HG12 HG22 ' A' ' 95' ' ' VAL . 96.5 mt -88.63 123.94 41.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.9 -66.84 2.24 Favored Glycine 0 C--O 1.242 0.607 0 O-C-N 124.39 1.056 . . . . 0.0 112.876 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -158.55 163.77 23.27 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.084 0.554 . . . . 0.0 109.653 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.627 ' HA ' HG12 ' A' ' 93' ' ' VAL . 88.7 Cg_endo -82.23 137.29 9.39 Favored 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.561 2.174 . . . . 0.0 112.475 163.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -132.82 158.74 41.73 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.74 0.781 . . . . 0.0 111.934 175.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.423 HG22 ' H ' ' A' ' 120' ' ' SER . 41.3 mm -138.54 139.63 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.235 1.414 . . . . 0.0 108.375 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.5 t -60.08 -39.01 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 124.001 0.921 . . . . 0.0 111.827 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.423 ' H ' HG22 ' A' ' 118' ' ' ILE . 32.4 t -66.32 -23.73 66.42 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.169 0.588 . . . . 0.0 112.127 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -108.58 7.29 26.61 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.698 0.799 . . . . 0.0 111.287 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -131.23 148.95 52.75 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.066 0.946 . . . . 0.0 109.463 -175.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 CA--C 1.558 1.253 0 C-N-CA 122.852 0.461 . . . . 0.0 109.758 173.407 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttp . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.55 ' HB2' HD11 ' A' ' 71' ' ' ILE . 11.1 m120 -83.38 72.64 10.21 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.596 0.758 . . . . 0.0 109.248 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.477 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 45.7 m -67.42 -33.22 74.71 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.547 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.29 -11.27 30.16 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.618 0.767 . . . . 0.0 112.408 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.559 HG22 HG23 ' A' ' 76' ' ' VAL . 16.3 mm -98.06 -32.55 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.742 0.817 . . . . 0.0 109.824 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -69.18 -33.81 73.94 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.66 0.784 . . . . 0.0 112.099 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.9 mt -66.83 -50.33 44.33 Favored Pre-proline 0 N--CA 1.486 1.331 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.182 -173.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 12.2 Cg_endo -54.83 -52.23 8.5 Favored 'Trans proline' 0 C--N 1.398 3.132 0 C-N-CA 122.136 1.891 . . . . 0.0 111.525 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.471 HG11 HG11 ' A' ' 76' ' ' VAL . 72.4 t -58.08 -43.64 85.66 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 C-N-CA 124.774 1.23 . . . . 0.0 112.496 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 24.4 tp60 -66.13 -55.87 14.25 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.409 0.684 . . . . 0.0 111.472 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.425 ' HG3' ' CZ2' ' A' ' 27' ' ' TRP . 73.4 mmtt -65.33 -38.34 89.85 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.325 0.65 . . . . 0.0 110.817 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -62.89 -39.49 94.65 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.523 1.129 . . . . 0.0 111.343 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' A' ' 16' ' ' TYR . 5.0 tt -59.81 -52.81 63.88 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 20.5 mm-40 -61.57 -32.03 72.09 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.806 -174.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.57 -27.64 55.93 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.588 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.4 ' HB3' ' O ' ' A' ' 13' ' ' LEU . 68.0 t80 -63.66 -47.36 81.6 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.218 1.007 . . . . 0.0 110.812 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -84.76 -23.49 29.2 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.17 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.64 -6.8 58.76 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.153 0.581 . . . . 0.0 112.337 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 71.8 12.59 6.22 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.268 1.427 . . . . 0.0 113.042 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -76.28 94.46 3.57 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.476 HG13 HG12 ' A' ' 54' ' ' ILE . 12.5 mm -66.95 -28.54 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.728 0.811 . . . . 0.0 110.883 173.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -58.62 -46.63 86.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.851 0.46 . . . . 0.0 111.1 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.6 -30.88 41.64 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.365 0.666 . . . . 0.0 110.972 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -72.87 -7.66 51.94 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.49 0.716 . . . . 0.0 110.514 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.732 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -116.35 -25.31 7.56 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.409 0.684 . . . . 0.0 112.034 175.053 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.6 -40.53 79.28 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.835 0.854 . . . . 0.0 113.123 -171.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 90.5 m95 -89.69 1.7 55.71 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.404 -173.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.567 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 14.2 m95 -99.05 138.6 35.92 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.576 0.75 . . . . 0.0 109.141 -177.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -71.46 160.66 32.35 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.443 0.697 . . . . 0.0 111.174 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -61.25 -39.82 91.74 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.398 0.679 . . . . 0.0 111.546 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -99.12 19.98 14.25 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.463 1.105 . . . . 0.0 110.856 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.567 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 50.1 t -58.03 115.12 2.68 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.224 0.609 . . . . 0.0 111.714 -176.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -75.68 153.2 37.3 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 59.8 t80 -142.07 118.67 11.0 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -115.82 153.1 32.08 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.476 1.11 . . . . 0.0 109.673 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.39 161.23 23.84 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.232 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -57.99 128.97 81.96 Favored Pre-proline 0 CA--C 1.562 1.404 0 O-C-N 124.327 1.017 . . . . 0.0 110.77 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -75.9 -51.16 0.16 OUTLIER 'Cis proline' 0 C--N 1.384 2.44 0 CA-C-N 120.185 1.102 . . . . 0.0 114.03 -0.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.0 86.4 0.62 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.2 m -141.88 117.7 10.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.38 0.672 . . . . 0.0 109.977 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 tt -68.84 106.76 2.81 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.258 1.023 . . . . 0.0 109.899 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.3 mt -82.29 -42.52 18.72 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.397 0.679 . . . . 0.0 111.345 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -141.47 117.22 10.39 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.872 0.469 . . . . 0.0 111.113 -170.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.27 42.72 1.9 Allowed Glycine 0 N--CA 1.478 1.441 0 O-C-N 123.117 0.26 . . . . 0.0 113.014 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 p30 167.69 156.51 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.649 1.579 . . . . 0.0 108.934 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -63.61 -32.88 74.48 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.782 0.833 . . . . 0.0 112.776 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.79 90.99 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.156 0.582 . . . . 0.0 112.221 -173.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 30.2 mt-10 -74.16 -34.86 63.96 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.617 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.8 mt -58.59 -45.41 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.049 0.94 . . . . 0.0 110.432 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.732 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 21.6 ttt180 -54.33 -56.71 15.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.43 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.7 t -54.77 -49.47 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 124.708 1.255 . . . . 0.0 111.568 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -62.18 -36.97 83.51 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.345 -174.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -77.55 -34.57 53.75 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 118.894 -0.574 . . . . 0.0 111.842 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 50' ' ' ARG . 77.5 mt -56.42 -40.32 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.053 0.454 . . . . 0.0 109.867 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -57.26 -43.0 82.62 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.506 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -76.25 -22.33 55.28 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 120.801 0.334 . . . . 0.0 111.282 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.473 ' HA ' HD22 ' A' ' 62' ' ' LEU . 3.5 m-30 -79.76 -0.5 34.62 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.527 0.731 . . . . 0.0 112.032 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -73.55 -30.63 63.19 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.097 0.559 . . . . 0.0 111.28 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -63.08 121.04 66.65 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.278 0.631 . . . . 0.0 110.883 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.75 -23.67 26.01 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.263 1.976 . . . . 0.0 110.773 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.34 -10.53 59.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.015 1.326 . . . . 0.0 111.477 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 57' ' ' PHE . 42.7 tp -59.29 112.63 1.81 Allowed 'General case' 0 C--N 1.36 1.024 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -148.76 130.37 14.95 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.259 1.023 . . . . 0.0 108.332 -175.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.16 127.15 8.24 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -122.56 102.99 8.4 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.62 HD12 ' HG2' ' A' ' 80' ' ' GLU . 6.3 tp -69.72 138.11 52.6 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.403 0.62 . . . . 0.0 111.208 -175.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mt -105.88 -50.85 3.09 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.822 1.249 . . . . 0.0 108.253 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.7 m -150.11 141.44 23.25 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 113.24 -1.8 . . . . 0.0 109.844 -173.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -131.38 130.43 42.6 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 165.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.59 127.6 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.884 1.274 . . . . 0.0 110.273 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.55 HD11 ' HB2' ' A' ' 2' ' ' ASN . 15.7 tt -102.89 120.67 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.145 0.578 . . . . 0.0 109.7 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.43 94.54 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 124.194 0.998 . . . . 0.0 108.486 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.37 -118.02 11.91 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 123.323 0.389 . . . . 0.0 112.669 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.5 ' HA ' HG13 ' A' ' 5' ' ' ILE . 10.9 p30 -95.04 7.99 44.36 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.325 0.65 . . . . 0.0 111.689 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.6 t -116.31 141.54 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.59 1.156 . . . . 0.0 108.581 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.559 HG23 HG22 ' A' ' 5' ' ' ILE . 70.0 t -126.29 133.5 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.004 0.522 . . . . 0.0 109.615 170.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.466 HG12 ' HB ' ' A' ' 98' ' ' ILE . 5.2 mt -100.65 114.84 40.79 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 164.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -96.65 150.84 20.22 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 166.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -138.09 106.34 5.77 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.62 ' HG2' HD12 ' A' ' 66' ' ' LEU . 6.6 mt-10 -115.75 158.98 22.02 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.344 0.658 . . . . 0.0 109.558 176.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 92' ' ' GLU . 56.9 m -97.05 103.14 15.04 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 163.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.53 125.2 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.452 0.644 . . . . 0.0 111.319 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.9 m -76.28 122.92 25.11 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.121 0.969 . . . . 0.0 111.708 -175.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.2 mmt-85 -119.97 -168.29 1.58 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.623 1.169 . . . . 0.0 109.189 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -123.81 104.99 9.29 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.275 1.03 . . . . 0.0 109.539 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.435 ' HE2' ' HB3' ' A' ' 116' ' ' PRO . 12.6 m-30 -112.4 149.46 41.09 Favored Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 123.558 0.743 . . . . 0.0 111.054 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.61 -18.84 64.05 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.952 2.435 . . . . 0.0 113.608 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -87.0 -4.38 59.17 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.44 -122.68 1.48 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.931 -0.372 . . . . 0.0 112.466 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.414 ' H ' HG23 ' A' ' 118' ' ' ILE . 16.2 tppt? -60.43 -82.14 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.983 0.913 . . . . 0.0 111.5 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.415 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 115.41 26.92 3.27 Favored Glycine 0 C--N 1.343 0.952 0 O-C-N 122.953 0.158 . . . . 0.0 113.205 -175.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.458 ' HB2' HG22 ' A' ' 81' ' ' THR . 16.9 pt-20 -89.21 104.7 17.22 Favored 'General case' 0 C--O 1.207 -1.138 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -174.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 116' ' ' PRO . 20.3 m -105.16 131.12 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 121.33 -0.856 . . . . 0.0 109.973 -171.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -78.33 127.91 32.91 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.518 HG22 HG12 ' A' ' 113' ' ' ILE . 43.1 t -131.57 126.25 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.09 99.41 12.43 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 172.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.6 m -94.81 108.51 20.53 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.152 0.981 . . . . 0.0 108.843 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.611 HG23 ' HB2' ' A' ' 110' ' ' TRP . 11.1 tt -105.86 107.23 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 C-N-CA 124.403 1.081 . . . . 0.0 110.735 -172.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -104.14 131.17 51.7 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.35 1.06 . . . . 0.0 110.024 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -97.82 112.03 24.09 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 168.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.52 HG22 HG12 ' A' ' 106' ' ' ILE . 75.2 t -99.62 125.1 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.077 0.951 . . . . 0.0 109.15 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -125.81 127.94 46.9 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.476 0.71 . . . . 0.0 109.981 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.6 m120 61.48 30.43 18.82 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.45 1.5 . . . . 0.0 112.116 -176.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.54 1.95 90.56 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 113.781 0.272 . . . . 0.0 113.781 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -124.79 136.0 53.46 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.047 0.939 . . . . 0.0 109.007 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.52 HG12 HG22 ' A' ' 101' ' ' VAL . 68.8 mt -62.43 102.86 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.252 1.021 . . . . 0.0 109.811 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -78.47 -29.89 47.09 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.291 0.636 . . . . 0.0 110.765 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -148.57 143.26 26.49 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -137.05 131.03 32.22 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.611 ' HB2' HG23 ' A' ' 98' ' ' ILE . 0.9 OUTLIER -135.37 152.86 51.84 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -176.319 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -143.0 144.85 32.46 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -130.82 123.7 29.69 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.518 HG12 HG22 ' A' ' 95' ' ' VAL . 96.7 mt -88.22 127.48 41.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.93 -78.82 0.16 Allowed Glycine 0 N--CA 1.468 0.826 0 O-C-N 124.331 1.019 . . . . 0.0 112.667 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -158.83 164.58 20.65 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.712 ' HA ' HG12 ' A' ' 93' ' ' VAL . 72.3 Cg_endo -72.2 117.69 5.26 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.433 2.089 . . . . 0.0 112.581 169.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.422 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 15.6 mmt180 -102.11 144.11 31.09 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.439 HG22 ' H ' ' A' ' 120' ' ' SER . 49.4 mm -122.83 152.37 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 173.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.0 t -59.43 -26.8 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 122.646 0.378 . . . . 0.0 111.402 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.439 ' H ' HG22 ' A' ' 118' ' ' ILE . 83.3 p -64.17 -41.13 97.26 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.399 0.68 . . . . 0.0 110.725 173.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -96.92 3.0 52.31 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.438 1.095 . . . . 0.0 111.888 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -132.06 -166.81 1.78 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--O 1.249 1.073 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 171.763 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -155.28 -2.32 0.15 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.365 0.666 . . . . 0.0 111.438 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.44 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 78.7 p -63.78 -37.79 88.69 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.463 ' HG3' HG12 ' A' ' 5' ' ' ILE . 9.5 pt-20 -55.8 -28.28 55.41 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.72 1.208 . . . . 0.0 112.716 174.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.575 HG13 ' HA ' ' A' ' 74' ' ' ASN . 32.8 mm -89.83 -27.88 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.492 1.117 . . . . 0.0 109.826 -177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.39 -24.04 60.25 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.117 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 3' ' ' SER . 79.5 mt -63.6 -50.65 71.34 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.725 -175.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.465 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 11.6 Cg_endo -55.96 -60.4 0.52 Allowed 'Trans proline' 0 C--N 1.394 2.932 0 C-N-CA 121.866 1.711 . . . . 0.0 111.984 172.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.3 t -51.07 -48.95 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 C-N-CA 124.509 1.123 . . . . 0.0 113.347 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.6 OUTLIER -63.09 -52.21 63.56 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.173 0.989 . . . . 0.0 110.937 -176.664 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -63.54 -37.17 86.29 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.029 0.532 . . . . 0.0 111.282 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -68.26 -38.1 81.42 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.116 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' A' ' 66' ' ' LEU . 50.8 tp -62.53 -50.86 69.69 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.524 0.73 . . . . 0.0 110.872 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 4.0 mm-40 -55.42 -47.23 76.27 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.31 1.007 . . . . 0.0 109.477 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 20' ' ' ASP . . . -66.22 -28.79 69.01 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.229 -1.35 . . . . 0.0 112.329 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -67.45 -48.26 67.76 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.176 0.59 . . . . 0.0 110.488 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -83.71 -14.67 51.11 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.251 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.96 0.4 55.95 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.425 0.69 . . . . 0.0 111.992 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 62.71 26.0 15.4 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.463 1.105 . . . . 0.0 111.851 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.402 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 13.1 t70 -96.48 110.57 22.92 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.793 1.237 . . . . 0.0 109.31 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.408 HG13 HG12 ' A' ' 54' ' ' ILE . 23.4 mm -76.84 -32.89 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.1 0.56 . . . . 0.0 110.999 173.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 24.8 t70 -58.19 -49.06 78.38 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.745 0.653 . . . . 0.0 112.161 -168.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.81 -35.63 22.2 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.177 0.991 . . . . 0.0 111.392 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -63.01 -14.18 44.67 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.293 0.371 . . . . 0.0 112.0 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 68.2 mmm -120.66 -14.4 8.6 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -60.79 -36.51 79.19 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.552 0.691 . . . . 0.0 112.304 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 91.8 m95 -93.57 14.03 20.13 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.718 -170.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.614 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 19.3 m95 -99.12 152.45 19.85 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.778 0.831 . . . . 0.0 109.267 174.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -78.92 154.54 29.58 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.262 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.44 -32.04 72.84 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.118 0.567 . . . . 0.0 111.184 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -99.42 17.9 19.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.889 0.875 . . . . 0.0 111.337 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.614 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 46.9 t -64.54 117.92 8.06 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 123.209 0.318 . . . . 0.0 111.549 -174.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -77.68 154.09 32.47 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -139.39 110.44 6.87 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.475 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 96.4 m-85 -113.37 138.33 50.22 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.818 0.847 . . . . 0.0 110.572 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.537 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -92.21 154.95 18.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.459 166.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -50.04 130.03 22.73 Favored Pre-proline 0 CA--C 1.567 1.617 0 C-N-CA 124.268 1.027 . . . . 0.0 112.508 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.43 -36.34 2.15 Favored 'Cis proline' 0 C--N 1.383 2.371 0 CA-C-N 119.967 1.024 . . . . 0.0 112.134 -4.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . . . -159.62 94.57 1.16 Allowed 'General case' 0 C--N 1.345 0.41 0 C-N-CA 124.821 1.248 . . . . 0.0 107.748 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 7.2 m -130.18 102.4 6.21 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.5 tp -73.1 100.89 3.15 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 117.961 0.346 . . . . 0.0 110.447 -175.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -83.36 -34.31 25.63 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.044 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -146.37 116.91 7.54 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.81 -173.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -107.53 46.66 1.14 Allowed Glycine 0 C--N 1.347 1.147 0 C-N-CA 123.032 0.349 . . . . 0.0 113.034 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.425 ' O ' HG13 ' A' ' 49' ' ' ILE . 9.6 p30 162.08 154.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 126.149 1.78 . . . . 0.0 109.227 -171.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -63.5 -26.28 68.64 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -175.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -62.22 -51.4 67.93 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.803 0.441 . . . . 0.0 110.98 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.443 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.0 mt-10 -68.41 -33.43 74.21 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.108 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 45' ' ' ASN . 54.2 mt -69.2 -43.14 81.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 122.962 0.505 . . . . 0.0 110.264 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.487 ' O ' HG13 ' A' ' 54' ' ' ILE . 32.0 ptt180 -69.87 -45.18 68.28 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.605 -173.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.8 m -68.95 -35.03 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 122.859 0.463 . . . . 0.0 111.894 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -71.41 -40.1 70.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.297 0.639 . . . . 0.0 110.357 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -64.61 -33.33 75.68 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.57 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 50' ' ' ARG . 97.0 mt -58.16 -47.07 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 122.557 0.343 . . . . 0.0 110.184 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.21 -33.3 75.09 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.455 0.702 . . . . 0.0 111.498 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -66.79 -35.04 79.15 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.174 0.59 . . . . 0.0 110.956 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -78.75 -2.45 39.47 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.21 0.604 . . . . 0.0 112.02 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -84.58 -19.71 32.63 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.948 0.499 . . . . 0.0 110.756 171.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.11 113.55 8.17 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 123.694 0.798 . . . . 0.0 109.813 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -61.35 -32.23 89.37 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 123.107 2.538 . . . . 0.0 113.547 -169.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.22 -0.6 56.79 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.723 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.6 tp -62.82 118.9 8.37 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.202 0.455 . . . . 0.0 111.359 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.456 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 76.3 t80 -151.02 127.56 10.77 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.84 104.2 2.53 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -97.83 100.89 12.27 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.168 0.587 . . . . 0.0 109.51 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HB2' HD11 ' A' ' 13' ' ' LEU . 7.7 tt -79.53 129.7 34.71 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.458 HD11 ' CD2' ' A' ' 79' ' ' HIS . 1.7 pp -115.9 -29.8 6.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.468 -175.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.5 m -150.69 143.79 24.77 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.957 0.903 . . . . 0.0 109.559 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -143.61 136.92 27.93 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.56 0.744 . . . . 0.0 109.326 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.78 130.88 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' A' ' 5' ' ' ILE . 9.5 tt -121.98 136.51 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.031 0.532 . . . . 0.0 110.258 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 p -143.35 110.05 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 124.678 1.191 . . . . 0.0 109.186 -176.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.78 -119.71 9.26 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.202 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.575 ' HA ' HG13 ' A' ' 5' ' ' ILE . 27.0 p-10 -108.63 19.86 19.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.275 0.63 . . . . 0.0 111.077 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -127.48 133.63 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.09 0.956 . . . . 0.0 109.251 -175.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 15.1 t -122.57 138.97 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.175 0.59 . . . . 0.0 110.255 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.639 HD13 ' HB ' ' A' ' 98' ' ' ILE . 6.7 mm -104.96 111.9 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.061 1.344 . . . . 0.0 107.708 167.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -106.35 116.06 31.28 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.458 ' CD2' HD11 ' A' ' 67' ' ' LEU . 1.5 t60 -99.83 109.01 21.43 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.36 140.05 52.06 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.947 1.299 . . . . 0.0 110.624 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.1 m -86.1 106.5 17.28 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.82 0.848 . . . . 0.0 109.131 169.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.4 t -82.79 104.08 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.754 0.822 . . . . 0.0 110.441 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.47 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 25.3 m -68.06 127.99 34.89 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.089 0.556 . . . . 0.0 110.425 170.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -139.07 -170.24 2.83 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.801 0.84 . . . . 0.0 109.097 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -119.3 100.55 7.38 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.877 0.471 . . . . 0.0 110.648 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.404 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 13.4 m-30 -100.22 142.6 24.92 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 123.714 0.806 . . . . 0.0 109.65 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.04 -23.03 66.79 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.983 2.455 . . . . 0.0 114.026 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -86.54 -4.91 59.24 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.22 -134.24 3.41 Favored Glycine 0 N--CA 1.474 1.174 0 CA-C-O 119.566 -0.574 . . . . 0.0 111.83 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.411 ' CG ' ' HG3' ' A' ' 92' ' ' GLU . 3.0 tppp? -53.15 -87.24 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.659 0.784 . . . . 0.0 112.804 172.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.404 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 124.37 26.69 1.44 Allowed Glycine 0 C--N 1.347 1.155 0 N-CA-C 113.761 0.265 . . . . 0.0 113.761 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.47 ' HG2' ' HA ' ' A' ' 83' ' ' THR . 46.8 mt-10 -89.61 115.51 27.06 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 117.099 0.45 . . . . 0.0 109.943 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.554 HG12 ' HA ' ' A' ' 116' ' ' PRO . 17.2 m -108.96 130.12 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.432 0.693 . . . . 0.0 109.613 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.435 ' HB3' ' HE1' ' A' ' 79' ' ' HIS . 1.3 m-20 -85.45 108.81 18.06 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.408 HG22 HG12 ' A' ' 113' ' ' ILE . 34.6 t -113.18 162.55 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.108 1.363 . . . . 0.0 108.995 -171.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.18 102.71 6.35 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.573 1.149 . . . . 0.0 108.029 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 80.6 m -93.1 107.92 19.62 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.712 HG23 ' HB2' ' A' ' 110' ' ' TRP . 5.7 tt -102.59 111.05 31.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.148 -176.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -100.46 153.85 19.02 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.618 0.767 . . . . 0.0 110.601 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -126.66 117.45 22.77 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.263 1.425 . . . . 0.0 107.47 171.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.484 HG22 HG12 ' A' ' 106' ' ' ILE . 86.2 t -109.02 124.31 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.266 1.026 . . . . 0.0 110.254 -173.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 10.6 tp10 -131.57 135.5 47.05 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.032 0.933 . . . . 0.0 109.406 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.0 m120 62.5 30.02 17.13 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.726 1.211 . . . . 0.0 112.488 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.47 7.82 79.43 Favored Glycine 0 N--CA 1.478 1.499 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.843 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -127.26 148.12 50.22 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.994 1.318 . . . . 0.0 108.149 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.484 HG12 HG22 ' A' ' 101' ' ' VAL . 53.0 mt -69.29 113.72 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -78.03 -36.66 48.33 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.703 0.801 . . . . 0.0 111.105 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.584 ' HE2' ' HE1' ' A' ' 110' ' ' TRP . 61.4 mtpt -150.59 132.49 15.12 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.055 0.942 . . . . 0.0 108.66 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -124.69 132.58 53.38 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.712 ' HB2' HG23 ' A' ' 98' ' ' ILE . 1.6 m-90 -130.77 152.45 50.1 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -176.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -144.25 147.02 33.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.797 0.332 . . . . 0.0 110.201 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -128.95 117.92 21.77 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.965 0.906 . . . . 0.0 109.064 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.408 HG12 HG22 ' A' ' 95' ' ' VAL . 94.5 mt -86.79 132.72 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.74 -83.12 0.09 OUTLIER Glycine 0 CA--C 1.526 0.778 0 O-C-N 123.708 0.63 . . . . 0.0 112.05 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.15 166.29 16.84 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.498 0.719 . . . . 0.0 109.463 175.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.554 ' HA ' HG12 ' A' ' 93' ' ' VAL . 51.5 Cg_endo -65.85 110.42 1.69 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.532 2.155 . . . . 0.0 113.111 168.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -109.6 149.83 29.09 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.83 0.852 . . . . 0.0 110.232 173.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 50.4 mm -124.68 154.93 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.4 t -70.98 -47.17 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.0 t -68.26 -16.3 63.91 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.344 0.658 . . . . 0.0 111.773 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.439 ' HB3' ' O ' ' A' ' 118' ' ' ILE . 34.4 tt0 -59.41 -41.63 89.92 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.901 0.88 . . . . 0.0 110.324 170.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.85 80.33 2.31 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 172.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 C--O 1.254 1.304 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.8 -178.168 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.1 m120 57.93 53.75 6.64 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.677 1.191 . . . . 0.0 112.219 167.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 m -66.31 -39.05 89.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.711 0.804 . . . . 0.0 111.345 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.18 -12.37 60.82 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.112 0.565 . . . . 0.0 111.808 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.9 mm -98.02 -39.15 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.927 0.891 . . . . 0.0 109.391 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -58.91 -44.58 91.28 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.54 1.136 . . . . 0.0 112.338 177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.53 -57.11 24.2 Favored Pre-proline 0 CA--C 1.561 1.391 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.883 -171.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.575 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 21.1 Cg_endo -58.27 -48.76 14.47 Favored 'Trans proline' 0 C--N 1.395 3.022 0 C-N-CA 122.401 2.067 . . . . 0.0 112.28 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.2 t -59.27 -44.06 91.26 Favored 'Isoleucine or valine' 0 C--O 1.247 0.956 0 C-N-CA 124.91 1.284 . . . . 0.0 112.605 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -46.07 67.06 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -63.35 -27.74 69.52 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.786 0.834 . . . . 0.0 111.919 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -63.2 -46.18 88.24 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.684 0.615 . . . . 0.0 110.221 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.16 -53.76 52.95 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.153 0.908 . . . . 0.0 109.218 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -52.17 -36.37 51.5 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 124.653 1.221 . . . . 0.0 111.089 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -81.75 -27.96 33.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.651 1.18 . . . . 0.0 112.195 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -69.66 -48.41 59.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.721 0.409 . . . . 0.0 110.267 -172.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -76.07 -28.97 57.8 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.932 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.46 1.16 56.92 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.55 0.74 . . . . 0.0 112.051 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 67.64 18.79 9.87 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.577 1.151 . . . . 0.0 112.797 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.48 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 67.9 m-20 -88.59 95.3 10.19 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.964 0.506 . . . . 0.0 110.467 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.404 ' HA ' ' HB3' ' A' ' 24' ' ' PHE . 23.9 mm -67.77 -26.87 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 123.024 0.53 . . . . 0.0 110.648 172.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -52.44 -48.38 65.84 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.485 0.714 . . . . 0.0 111.59 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.37 -35.0 31.34 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.883 0.473 . . . . 0.0 110.952 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.404 ' HB3' ' HA ' ' A' ' 21' ' ' ILE . 16.2 t80 -71.07 -5.84 34.52 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.617 0.767 . . . . 0.0 111.279 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.57 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 19.6 tpp -121.03 -25.62 5.3 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.173 0.589 . . . . 0.0 112.456 172.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.13 -44.22 74.84 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.1 m95 -82.71 -3.79 56.94 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -172.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -91.36 149.16 21.85 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.387 0.675 . . . . 0.0 109.8 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -74.05 152.26 40.01 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.349 0.66 . . . . 0.0 110.033 176.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.94 -23.93 65.13 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.112 0.482 . . . . 0.0 110.929 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -102.26 18.61 20.52 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.68 1.192 . . . . 0.0 111.114 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 42.1 t -64.57 122.98 18.07 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.931 0.396 . . . . 0.0 111.916 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -83.11 154.38 24.38 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.493 0.717 . . . . 0.0 109.481 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 33.9 t80 -145.68 120.69 10.05 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.407 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 43.3 m-85 -121.18 153.92 36.92 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.279 1.032 . . . . 0.0 110.484 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -120.44 159.83 24.34 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.385 1.074 . . . . 0.0 110.702 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.641 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 82.9 t80 -62.37 130.71 93.44 Favored Pre-proline 0 CA--C 1.56 1.36 0 O-C-N 124.18 0.925 . . . . 0.0 110.383 174.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.67 -47.43 0.31 Allowed 'Cis proline' 0 C--N 1.386 2.506 0 CA-C-N 120.697 1.285 . . . . 0.0 113.447 -1.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.68 93.35 0.82 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 98.3 m -141.33 115.79 9.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.155 0.582 . . . . 0.0 109.6 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 tt -70.8 101.71 2.17 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 36' ' ' ALA . 94.7 mt -80.64 -37.84 30.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.554 0.741 . . . . 0.0 110.868 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -148.23 121.24 8.82 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.421 0.451 . . . . 0.0 111.185 -171.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.4 39.55 2.81 Favored Glycine 0 C--N 1.35 1.327 0 C-N-CA 123.116 0.389 . . . . 0.0 113.26 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 166.06 165.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 125.847 1.659 . . . . 0.0 109.155 -171.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.57 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -66.54 -36.81 83.59 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.749 0.82 . . . . 0.0 112.748 -175.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.11 -46.87 84.82 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.15 0.58 . . . . 0.0 111.743 -174.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.1 mt-10 -72.85 -29.99 63.65 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.487 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.1 mt -67.43 -44.41 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.007 0.523 . . . . 0.0 109.704 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.43 ' O ' HG13 ' A' ' 54' ' ' ILE . 76.6 ttt180 -59.83 -56.1 26.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.552 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.5 m -61.58 -41.59 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 124.429 1.081 . . . . 0.0 112.563 -173.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -72.17 -29.15 63.73 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.145 0.578 . . . . 0.0 110.96 -176.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -77.94 -30.83 50.63 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 118.929 -0.558 . . . . 0.0 111.2 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 50' ' ' ARG . 99.0 mt -59.69 -41.28 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.9 -38.36 88.08 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.919 0.888 . . . . 0.0 111.414 175.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -78.84 -23.33 45.09 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.141 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -84.12 0.62 47.76 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.295 0.638 . . . . 0.0 110.931 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -79.76 -20.36 46.49 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.064 0.545 . . . . 0.0 111.673 170.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 7.3 mm-40 -64.45 112.86 8.67 Favored Pre-proline 0 CA--C 1.547 0.846 0 O-C-N 123.805 0.691 . . . . 0.0 109.802 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -65.63 -18.34 58.71 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.333 2.022 . . . . 0.0 112.24 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.02 2.85 46.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.377 1.071 . . . . 0.0 111.714 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 19.4 tp -66.28 116.14 7.0 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.627 0.371 . . . . 0.0 110.15 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -145.02 117.87 8.74 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.438 ' HA2' HG12 ' A' ' 82' ' ' VAL . . . -93.45 103.48 3.04 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 175.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.44 98.14 10.01 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.5 tt -86.72 126.47 34.59 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.431 HD11 ' CD2' ' A' ' 79' ' ' HIS . 2.3 pp -114.32 -30.17 6.68 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.276 1.03 . . . . 0.0 110.438 -171.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.8 m -155.17 132.85 11.29 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.429 1.092 . . . . 0.0 109.055 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 0.8 OUTLIER -132.45 134.71 45.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.59 0.756 . . . . 0.0 109.288 167.181 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 77' ' ' ILE . 30.1 m -118.88 119.8 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.561 0.745 . . . . 0.0 109.807 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.449 HG13 HG22 ' A' ' 76' ' ' VAL . 17.3 tt -95.29 129.4 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-O 121.321 0.581 . . . . 0.0 109.504 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 p -141.01 96.41 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.515 1.126 . . . . 0.0 108.65 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.76 -128.08 31.67 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.337 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -83.43 3.47 31.83 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.698 0.799 . . . . 0.0 112.578 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.1 t -126.45 134.97 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.811 0.844 . . . . 0.0 109.765 -171.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.449 HG22 HG13 ' A' ' 71' ' ' ILE . 21.6 t -124.18 140.6 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 122.988 0.515 . . . . 0.0 109.627 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.509 HD13 ' HB ' ' A' ' 98' ' ' ILE . 16.2 mm -99.27 103.26 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 172.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -90.35 104.65 17.2 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.431 ' CD2' HD11 ' A' ' 67' ' ' LEU . 2.0 t60 -98.07 108.36 21.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -117.41 152.29 35.28 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.288 -1.324 . . . . 0.0 109.611 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.5 m -103.19 101.87 11.83 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 159.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.438 HG12 ' HA2' ' A' ' 64' ' ' GLY . 32.8 m -91.97 127.81 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.065 0.459 . . . . 0.0 110.367 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.3 m -75.71 120.49 21.17 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.149 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.577 HH21 HG11 ' A' ' 93' ' ' VAL . 61.3 mtm180 -125.05 -163.51 1.19 Allowed 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -127.8 109.24 11.43 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 118.284 0.493 . . . . 0.0 111.074 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.418 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 19.2 m-30 -108.34 144.6 29.81 Favored Pre-proline 0 N--CA 1.481 1.095 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.57 -7.52 20.98 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.791 2.328 . . . . 0.0 112.807 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -84.17 -20.72 31.92 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.065 0.946 . . . . 0.0 111.804 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.07 -125.15 1.09 Allowed Glycine 0 C--N 1.349 1.256 0 CA-C-O 119.549 -0.584 . . . . 0.0 111.962 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -59.61 -80.54 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.188 0.995 . . . . 0.0 111.931 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.418 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 118.52 24.12 3.24 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 116.308 -0.405 . . . . 0.0 113.048 -177.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.562 ' HG3' ' HB2' ' A' ' 117' ' ' ARG . 7.1 pt-20 -87.54 147.68 25.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.577 HG11 HH21 ' A' ' 84' ' ' ARG . 7.5 m -138.59 134.96 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 121.975 -0.453 . . . . 0.0 111.388 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.67 111.08 13.07 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.329 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.483 HG22 HG12 ' A' ' 113' ' ' ILE . 48.9 t -124.64 144.93 32.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 124.169 0.988 . . . . 0.0 108.95 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -106.5 107.3 18.24 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 170.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 56.5 m -93.12 104.34 16.55 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.593 HG23 ' HB2' ' A' ' 110' ' ' TRP . 5.5 tt -105.99 109.82 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.217 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -104.13 151.47 23.27 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.528 0.731 . . . . 0.0 110.549 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -121.43 114.33 21.12 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.144 0.978 . . . . 0.0 108.628 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.54 HG22 HG12 ' A' ' 106' ' ' ILE . 45.1 t -101.74 115.21 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.077 0.951 . . . . 0.0 109.2 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 41.7 tt0 -116.75 128.77 55.62 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.151 0.981 . . . . 0.0 109.006 176.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 62.25 32.37 17.18 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.951 0.901 . . . . 0.0 111.462 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.42 11.67 84.13 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 114.595 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -133.02 136.73 46.18 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.485 1.114 . . . . 0.0 108.679 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.54 HG12 HG22 ' A' ' 101' ' ' VAL . 60.0 mt -66.63 100.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -78.05 -28.07 48.86 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.227 0.611 . . . . 0.0 110.967 -175.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -149.58 153.77 37.64 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.076 0.951 . . . . 0.0 108.592 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -148.67 134.54 18.99 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.593 ' HB2' HG23 ' A' ' 98' ' ' ILE . 1.7 m-90 -135.53 154.8 51.27 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -143.03 146.37 33.78 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 169.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.641 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 17.1 ptpt -129.34 124.52 34.49 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.916 0.886 . . . . 0.0 109.182 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.483 HG12 HG22 ' A' ' 95' ' ' VAL . 92.1 mt -88.19 119.19 35.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.26 -63.41 3.27 Favored Glycine 0 N--CA 1.465 0.624 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.684 -177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -157.16 166.4 16.72 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 122.768 0.427 . . . . 0.0 110.35 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.574 ' HA ' HG12 ' A' ' 93' ' ' VAL . 97.2 Cg_endo -75.67 132.69 14.81 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.653 2.235 . . . . 0.0 112.069 163.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.562 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 15.6 mmt180 -115.84 140.84 48.84 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.381 1.072 . . . . 0.0 108.567 175.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.469 ' HB ' ' HB2' ' A' ' 121' ' ' GLN . 42.2 mm -132.04 149.8 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.3 t -60.91 -42.98 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 120.732 0.301 . . . . 0.0 110.466 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.406 ' H ' HG22 ' A' ' 118' ' ' ILE . 47.6 t -76.7 -62.75 1.53 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.334 0.653 . . . . 0.0 109.793 175.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.469 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 44.6 mt-30 -80.87 81.16 7.19 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -118.75 113.81 21.72 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.821 0.848 . . . . 0.0 109.604 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.1 t . . . . . 0 CA--C 1.553 1.06 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.627 174.691 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 121.201 0.524 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.582 ' HB2' HD13 ' A' ' 71' ' ' ILE . 3.3 p-10 -172.51 -23.14 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.376 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 81.8 p -62.26 -43.98 97.58 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.977 0.511 . . . . 0.0 110.084 -177.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -64.37 -14.68 57.82 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.676 1.19 . . . . 0.0 112.679 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.54 HG23 ' HB ' ' A' ' 101' ' ' VAL . 44.0 mm -89.85 -34.21 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.864 0.866 . . . . 0.0 109.992 174.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -84.97 -10.09 57.4 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.256 0.622 . . . . 0.0 111.709 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 3' ' ' SER . 65.3 mt -65.93 -54.46 27.78 Favored Pre-proline 0 N--CA 1.481 1.123 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.092 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.502 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 13.0 Cg_endo -56.32 -46.73 28.4 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 121.752 1.635 . . . . 0.0 112.572 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.48 -45.89 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 124.048 0.939 . . . . 0.0 113.215 -173.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -41.33 65.78 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -176.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -66.6 -26.39 67.07 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.907 0.483 . . . . 0.0 111.329 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 8' ' ' PRO . 50.0 mt-30 -60.89 -46.53 90.25 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.168 0.292 . . . . 0.0 110.232 171.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.93 -51.97 67.41 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 123.516 0.51 . . . . 0.0 109.702 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -55.19 -34.39 63.84 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 124.684 1.24 . . . . 0.0 110.145 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -82.45 -27.65 31.77 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.776 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -71.01 -44.07 66.64 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.871 0.469 . . . . 0.0 110.298 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -79.39 -28.55 41.85 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.004 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.2 5.02 52.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.578 0.751 . . . . 0.0 112.24 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 64.79 13.26 8.33 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.035 1.334 . . . . 0.0 113.992 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.511 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 18.6 m-20 -76.91 95.13 4.04 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.297 0.57 . . . . 0.0 111.583 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.437 HG13 HG12 ' A' ' 54' ' ' ILE . 29.5 mm -64.33 -25.49 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.144 0.578 . . . . 0.0 110.365 167.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -50.44 -50.55 51.84 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.99 0.916 . . . . 0.0 111.194 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -82.68 -37.72 24.41 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.181 0.592 . . . . 0.0 110.762 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -66.83 -6.63 16.96 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.215 0.606 . . . . 0.0 111.565 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.764 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -120.56 -30.63 4.48 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 171.325 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.44 -34.92 73.11 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.166 0.507 . . . . 0.0 112.303 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.502 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 99.4 m95 -88.54 4.0 48.33 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.867 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.445 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 16.2 m95 -102.97 157.31 17.07 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.64 0.776 . . . . 0.0 109.9 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -81.8 148.84 28.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.825 0.85 . . . . 0.0 109.404 171.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -66.45 -24.1 66.38 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.336 0.589 . . . . 0.0 111.031 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -86.51 -2.26 58.32 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.143 1.377 . . . . 0.0 111.724 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 42.3 t -59.89 132.89 55.33 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -167.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -88.12 154.7 20.25 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.453 0.701 . . . . 0.0 109.957 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -145.19 110.08 5.11 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.414 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 36.7 m-85 -111.1 155.19 23.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.951 0.9 . . . . 0.0 110.644 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.32 159.52 20.12 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.278 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.561 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 90.5 t80 -52.06 127.32 36.79 Favored Pre-proline 0 N--CA 1.486 1.342 0 C-N-CA 123.95 0.9 . . . . 0.0 111.149 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.8 -47.56 0.31 Allowed 'Cis proline' 0 C--N 1.387 2.556 0 CA-C-N 120.614 1.255 . . . . 0.0 113.681 -1.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.44 79.26 0.44 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.0 m -123.33 106.96 11.13 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.703 0.801 . . . . 0.0 109.282 -176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.2 tp -67.0 102.34 0.97 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.032 0.533 . . . . 0.0 110.198 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.6 mt -81.85 -36.67 28.0 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.973 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -145.57 116.56 7.81 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.372 -174.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.46 41.07 2.22 Favored Glycine 0 N--CA 1.474 1.181 0 C-N-CA 122.986 0.327 . . . . 0.0 113.398 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.5 p30 164.82 152.18 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 126.226 1.81 . . . . 0.0 108.852 -173.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -61.98 -26.78 68.42 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.965 0.906 . . . . 0.0 113.149 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -63.77 -38.32 90.66 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.44 0.296 . . . . 0.0 111.547 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.509 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 27.2 mt-10 -77.77 -31.22 51.83 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.997 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.7 mt -68.62 -41.36 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.759 0.824 . . . . 0.0 111.265 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.764 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 5.7 ptp180 -62.8 -45.9 90.47 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.069 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.403 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 96.5 t -54.8 -55.29 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.686 0.795 . . . . 0.0 110.29 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -52.07 -44.1 64.16 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.926 1.29 . . . . 0.0 111.963 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -78.35 -34.64 48.28 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.025 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.437 HG12 HG13 ' A' ' 21' ' ' ILE . 97.0 mt -60.77 -45.3 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-N 118.982 0.81 . . . . 0.0 109.472 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 51' ' ' VAL . 43.4 mt-10 -63.77 -32.84 74.47 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.355 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -88.22 -15.98 34.47 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -85.97 -4.53 59.19 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.107 0.563 . . . . 0.0 110.556 173.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.71 -20.21 63.54 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.265 0.626 . . . . 0.0 111.533 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 20.3 mm-40 -65.97 120.21 67.49 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.431 0.692 . . . . 0.0 110.314 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.14 -18.75 18.18 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.222 1.948 . . . . 0.0 112.249 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -81.62 -22.9 37.36 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.24 0.616 . . . . 0.0 110.775 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 30.8 tp -56.29 129.97 42.56 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.808 0.843 . . . . 0.0 112.024 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.442 ' CE2' ' HB2' ' A' ' 65' ' ' GLU . 46.2 t80 -151.24 144.35 24.65 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.595 0.758 . . . . 0.0 109.617 175.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.58 118.78 5.08 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.844 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.442 ' HB2' ' CE2' ' A' ' 63' ' ' TYR . 35.6 tt0 -126.32 99.77 6.0 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.8 tt -80.43 140.31 36.04 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.185 0.517 . . . . 0.0 110.169 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mt -109.46 -51.84 2.83 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.285 -173.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.0 m -147.99 139.5 23.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.909 -172.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 14.1 ptt180 -131.6 119.65 21.76 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.321 0.648 . . . . 0.0 109.693 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -115.84 127.16 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.034 0.934 . . . . 0.0 109.044 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.582 HD13 ' HB2' ' A' ' 2' ' ' ASN . 13.8 tt -114.96 132.98 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-O 121.386 0.613 . . . . 0.0 111.534 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.9 t -117.75 103.33 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 125.42 1.488 . . . . 0.0 107.851 172.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.6 -102.81 0.42 Allowed Glycine 0 N--CA 1.476 1.345 0 N-CA-C 113.994 0.357 . . . . 0.0 113.994 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.535 ' HA ' HG13 ' A' ' 5' ' ' ILE . 23.4 p-10 -111.67 21.19 16.36 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.121 0.568 . . . . 0.0 112.284 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.0 p -135.6 135.04 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.025 0.53 . . . . 0.0 110.012 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -117.75 137.43 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.265 0.626 . . . . 0.0 109.663 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.626 HD13 ' HB ' ' A' ' 98' ' ' ILE . 7.7 mm -98.95 102.68 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 165.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -102.54 105.69 16.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -98.4 107.02 19.38 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.205 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -103.87 172.77 6.62 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.547 1.139 . . . . 0.0 110.955 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.2 m -116.14 102.69 9.83 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 160.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.7 m -88.5 133.38 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.661 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.0 m -88.12 128.37 35.43 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -155.27 146.98 23.2 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -77.94 103.74 8.07 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -166.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -92.37 127.6 48.13 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 165.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -62.41 -15.97 48.71 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.465 2.777 . . . . 0.0 114.224 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -83.59 -32.12 25.95 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.405 0.282 . . . . 0.0 111.636 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.84 -136.35 2.1 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-O 119.456 -0.636 . . . . 0.0 111.65 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -72.54 -79.41 0.08 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 117.318 0.559 . . . . 0.0 110.468 171.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.1 30.43 2.3 Favored Glycine 0 C--N 1.346 1.091 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.713 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -88.82 98.48 11.74 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 122.456 1.122 . . . . 0.0 108.227 -174.495 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 117' ' ' ARG . 20.7 m -104.59 145.61 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.374 -0.829 . . . . 0.0 111.14 -165.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -78.11 132.4 37.68 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 176.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.589 HG22 HG12 ' A' ' 113' ' ' ILE . 46.8 t -136.27 124.39 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.01 100.53 11.12 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.6 m -94.08 122.79 36.96 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 110' ' ' TRP . 6.2 tt -123.87 115.38 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.925 0.89 . . . . 0.0 109.814 -173.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -116.86 127.22 54.07 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.849 0.859 . . . . 0.0 110.41 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -98.57 111.1 23.57 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.54 ' HB ' HG23 ' A' ' 5' ' ' ILE . 99.5 t -98.39 130.45 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.691 1.196 . . . . 0.0 109.977 -174.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -129.42 124.65 34.68 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.229 1.012 . . . . 0.0 109.298 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.6 m120 62.65 37.25 13.0 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.876 1.271 . . . . 0.0 112.45 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.11 5.25 65.29 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 113.884 0.314 . . . . 0.0 113.884 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.8 mmt85 -122.79 135.13 54.45 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.614 1.166 . . . . 0.0 108.285 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.451 HG12 HG22 ' A' ' 101' ' ' VAL . 77.8 mt -65.56 105.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -86.4 -23.35 26.14 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.764 0.426 . . . . 0.0 111.2 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -147.1 149.26 32.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.813 0.845 . . . . 0.0 109.711 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.92 137.4 24.9 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.744 0.818 . . . . 0.0 109.088 -176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.641 ' HB2' HG23 ' A' ' 98' ' ' ILE . 4.5 m-90 -139.0 152.71 47.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -142.3 137.1 30.35 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 169.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 51.6 mtmt -126.15 129.65 49.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.589 HG12 HG22 ' A' ' 95' ' ' VAL . 90.8 mt -88.35 131.94 34.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.93 -75.24 0.28 Allowed Glycine 0 CA--C 1.527 0.783 0 O-C-N 124.12 0.888 . . . . 0.0 112.354 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.91 166.44 16.43 Favored Pre-proline 0 CA--C 1.554 1.096 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.35 137.6 51.97 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.307 2.005 . . . . 0.0 112.289 173.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 19.8 mmt180 -135.35 138.89 43.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.258 1.023 . . . . 0.0 109.078 -174.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.609 ' HB ' ' HB2' ' A' ' 121' ' ' GLN . 46.9 mm -126.62 143.53 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.7 t -57.18 -44.2 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.281 0.562 . . . . 0.0 110.679 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.508 ' H ' HG22 ' A' ' 118' ' ' ILE . 20.0 m -88.01 10.09 20.19 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.236 1.014 . . . . 0.0 112.931 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.609 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 35.2 tt0 -65.73 -40.26 91.97 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.243 0.617 . . . . 0.0 109.908 176.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -106.41 154.49 20.74 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.309 1.044 . . . . 0.0 109.337 171.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.251 1.153 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.807 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ppp? . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 112.027 0.381 . . . . 0.0 112.027 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -117.05 36.77 4.08 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.691 0.797 . . . . 0.0 109.698 176.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.2 m -63.31 -42.39 99.03 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.005 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -13.68 62.49 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.411 0.684 . . . . 0.0 112.374 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.504 HG23 ' HB ' ' A' ' 101' ' ' VAL . 26.9 mm -85.09 -32.05 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 122.94 0.496 . . . . 0.0 110.006 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.506 ' HG3' HD12 ' A' ' 71' ' ' ILE . 58.1 mt-10 -87.74 -10.02 52.32 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.2 mt -61.37 -50.24 84.11 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.256 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.465 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 18.4 Cg_endo -59.18 -50.95 7.46 Favored 'Trans proline' 0 C--N 1.389 2.697 0 CA-C-N 120.907 1.36 . . . . 0.0 111.285 172.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.501 HG21 HG21 ' A' ' 76' ' ' VAL . 63.4 t -50.55 -53.22 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 124.654 1.181 . . . . 0.0 113.029 -173.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 25.8 tp60 -61.77 -47.26 85.96 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.066 -177.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -71.18 -29.62 65.41 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.227 0.611 . . . . 0.0 111.824 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.447 ' HG2' ' HE1' ' A' ' 28' ' ' TRP . 44.8 mt-30 -62.4 -49.5 75.25 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.568 0.747 . . . . 0.0 109.775 176.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.486 HD22 HD13 ' A' ' 66' ' ' LEU . 31.9 tp -57.61 -52.06 66.97 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.47 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 13.4 mm-40 -58.38 -41.87 85.76 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.369 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -71.22 -28.28 64.09 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.25 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -68.43 -41.45 80.34 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.979 0.911 . . . . 0.0 110.54 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -83.61 -29.59 27.61 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.682 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.02 2.53 53.88 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.118 0.567 . . . . 0.0 112.462 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.51 HH21 ' HA ' ' A' ' 60' ' ' PRO . 37.7 mmt-85 69.77 8.11 6.56 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.118 1.367 . . . . 0.0 113.362 176.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.55 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 20.7 m-20 -77.27 94.57 4.17 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.219 0.533 . . . . 0.0 110.391 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.459 HG13 HG12 ' A' ' 54' ' ' ILE . 15.6 mm -67.81 -23.71 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 123.197 0.599 . . . . 0.0 109.705 167.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -54.56 -50.6 67.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.066 0.946 . . . . 0.0 112.196 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -82.5 -37.02 25.89 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.108 0.48 . . . . 0.0 110.496 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -65.92 -7.69 18.11 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.562 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.686 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -118.01 -30.88 5.23 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.957 -0.464 . . . . 0.0 112.22 172.464 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -30.96 69.48 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.05 0.54 . . . . 0.0 112.347 -175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 97.5 m95 -92.78 9.5 34.87 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.593 0.757 . . . . 0.0 112.693 -176.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.726 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 10.0 m95 -110.51 164.6 12.55 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.228 1.011 . . . . 0.0 108.906 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -82.78 153.78 25.07 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.836 0.454 . . . . 0.0 110.138 175.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.99 -27.67 68.99 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.976 0.511 . . . . 0.0 111.407 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -105.79 20.48 18.85 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.886 0.875 . . . . 0.0 110.697 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.726 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 44.0 t -57.7 113.1 1.68 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.867 0.365 . . . . 0.0 111.598 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -74.2 151.35 40.0 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 54.9 t80 -145.45 115.76 7.53 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -174.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.45 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 14.0 m-85 -115.06 156.38 25.27 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.949 1.3 . . . . 0.0 110.712 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -119.82 155.11 33.23 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.536 173.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.505 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 70.1 t80 -64.25 132.13 95.23 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.698 0.799 . . . . 0.0 111.477 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.81 -56.65 0.14 OUTLIER 'Cis proline' 0 C--N 1.386 2.505 0 CA-C-N 120.599 1.25 . . . . 0.0 113.958 -1.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.35 92.84 1.54 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.963 0.505 . . . . 0.0 109.665 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.0 m -135.72 109.16 7.88 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.595 0.758 . . . . 0.0 109.5 174.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.5 tt -69.11 103.11 1.8 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 36' ' ' ALA . 52.0 mt -78.58 -45.86 20.75 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.999 0.92 . . . . 0.0 109.951 178.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -135.1 124.96 25.51 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.475 -171.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.41 36.15 4.59 Favored Glycine 0 N--CA 1.475 1.297 0 O-C-N 123.076 0.235 . . . . 0.0 113.271 -174.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 167.93 158.63 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.503 1.521 . . . . 0.0 108.727 -171.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.491 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -57.95 -43.54 86.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.804 0.841 . . . . 0.0 112.532 -176.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.11 76.18 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.933 0.493 . . . . 0.0 112.091 -171.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -76.65 -31.46 57.35 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.831 0.452 . . . . 0.0 111.559 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.4 mt -65.1 -51.88 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.083 0.553 . . . . 0.0 110.271 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.686 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 21.2 ptt180 -64.63 -43.45 93.65 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.736 -172.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.518 ' HA ' HD12 ' A' ' 54' ' ' ILE . 30.2 m -66.29 -33.21 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 123.336 0.397 . . . . 0.0 111.696 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -71.75 -35.75 70.2 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.273 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -75.64 -29.37 59.13 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.439 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 51' ' ' VAL . 74.4 mt -55.32 -42.87 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 118.55 0.614 . . . . 0.0 109.973 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.98 -40.03 87.72 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.965 0.906 . . . . 0.0 111.328 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.0 tpp85 -73.44 -28.62 62.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.718 0.807 . . . . 0.0 111.095 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -82.1 -9.05 59.66 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.829 0.852 . . . . 0.0 110.991 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 7.8 mmpt? -76.85 -34.24 57.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.477 0.311 . . . . 0.0 111.382 176.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -83.99 118.25 70.82 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.51 ' HA ' HH21 ' A' ' 19' ' ' ARG . 89.7 Cg_endo -74.13 -9.15 21.78 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.433 2.755 . . . . 0.0 114.193 -166.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -77.87 -13.54 59.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.737 0.815 . . . . 0.0 111.097 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.3 tp -58.71 111.51 1.29 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.218 0.607 . . . . 0.0 110.603 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 91.3 t80 -149.91 115.4 5.51 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.09 101.96 2.06 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -84.49 101.51 12.12 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 78' ' ' ASP . 6.7 tt -84.79 128.31 34.55 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -176.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.475 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -116.84 -32.86 4.97 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.853 -167.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 99.0 m -147.9 138.56 23.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.087 0.955 . . . . 0.0 109.556 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -133.31 129.49 37.61 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 167.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.8 m -107.29 129.45 61.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 123.716 0.806 . . . . 0.0 109.593 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.506 HD12 ' HG3' ' A' ' 6' ' ' GLU . 10.5 tt -113.19 122.85 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.136 0.493 . . . . 0.0 110.145 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.28 94.13 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 56.66 -112.03 3.14 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 123.23 0.331 . . . . 0.0 113.664 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -99.15 15.82 24.76 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.452 0.701 . . . . 0.0 112.297 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.8 p -134.97 133.74 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.381 0.672 . . . . 0.0 109.19 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.501 HG21 HG21 ' A' ' 9' ' ' VAL . 64.4 t -123.01 136.03 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.98 0.512 . . . . 0.0 110.789 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.565 HG12 ' HB ' ' A' ' 98' ' ' ILE . 6.4 mt -103.11 119.9 52.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 163.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.615 ' HB2' HD11 ' A' ' 66' ' ' LEU . 6.9 p-10 -97.4 155.09 17.06 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 168.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -137.53 108.45 6.7 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.45 168.72 11.76 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.083 1.353 . . . . 0.0 109.715 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.2 m -115.65 105.58 12.92 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.107 168.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 63' ' ' TYR . 4.0 m -86.38 125.25 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.179 0.514 . . . . 0.0 110.944 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 62.8 m -72.35 117.63 14.24 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 170.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -125.46 120.92 32.31 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -74.39 89.29 2.1 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.194 0.521 . . . . 0.0 110.95 -172.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -82.66 144.95 49.71 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.515 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.84 -20.21 58.26 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 123.158 2.572 . . . . 0.0 113.88 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -82.25 -27.44 32.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.114 0.565 . . . . 0.0 112.521 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.52 -134.62 2.96 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.823 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -55.74 -71.23 0.09 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.165 0.986 . . . . 0.0 111.28 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.489 ' H ' HD13 ' A' ' 118' ' ' ILE . . . 94.21 32.34 7.49 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.397 0.436 . . . . 0.0 113.066 175.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -86.89 107.89 18.54 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.745 0.783 . . . . 0.0 108.996 -173.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 116' ' ' PRO . 5.3 m -105.77 143.85 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.413 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -91.54 142.12 27.99 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.426 HG22 HG12 ' A' ' 113' ' ' ILE . 19.0 t -130.44 149.52 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.78 101.74 8.56 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.7 m -98.14 108.03 20.64 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.662 HG23 ' HB2' ' A' ' 110' ' ' TRP . 12.1 tt -98.82 112.46 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.066 0.946 . . . . 0.0 109.04 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.42 ' HE1' HG22 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -128.45 138.54 52.36 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.166 0.508 . . . . 0.0 110.938 178.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -98.7 113.3 25.32 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.342 1.057 . . . . 0.0 109.445 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.504 ' HB ' HG23 ' A' ' 5' ' ' ILE . 92.2 t -88.82 116.1 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.017 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -124.44 128.61 49.28 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.153 0.981 . . . . 0.0 109.497 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.2 m120 59.18 31.04 20.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.784 1.234 . . . . 0.0 111.856 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.04 -20.1 30.93 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 115.568 -0.742 . . . . 0.0 113.738 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -107.07 140.46 39.85 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.319 1.048 . . . . 0.0 108.834 -172.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.408 HG12 HG22 ' A' ' 101' ' ' VAL . 64.1 mt -67.36 106.21 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.93 -34.07 44.87 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.281 0.633 . . . . 0.0 111.241 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -144.31 146.75 32.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.082 0.953 . . . . 0.0 108.685 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.9 137.9 35.21 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.674 0.789 . . . . 0.0 109.516 -177.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.662 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.5 m-90 -140.33 148.41 41.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -144.45 147.17 32.98 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.077 0.853 . . . . 0.0 111.097 174.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 21.5 ptmt -127.25 127.9 45.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.36 0.664 . . . . 0.0 109.494 172.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.426 HG12 HG22 ' A' ' 95' ' ' VAL . 80.0 mt -89.42 121.75 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.35 -94.72 0.02 OUTLIER Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.564 1.165 . . . . 0.0 114.497 -174.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -134.56 155.11 79.88 Favored Pre-proline 0 CA--C 1.547 0.827 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.707 ' HA ' HG12 ' A' ' 93' ' ' VAL . 41.4 Cg_endo -90.0 114.72 0.55 Allowed 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.908 2.405 . . . . 0.0 113.394 174.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -111.79 153.4 26.61 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.415 0.626 . . . . 0.0 111.114 -175.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 121' ' ' GLN . 35.2 mm -131.11 156.06 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 124.572 1.149 . . . . 0.0 108.181 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.31 -43.97 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 122.654 0.381 . . . . 0.0 110.573 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.508 ' H ' HG22 ' A' ' 118' ' ' ILE . 32.8 t -72.46 -7.91 52.31 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.364 0.666 . . . . 0.0 112.102 177.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.54 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 36.5 tt0 -68.29 -34.03 75.43 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.682 0.793 . . . . 0.0 110.327 172.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.0 pttt -107.83 -172.18 2.02 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.19 0.996 . . . . 0.0 109.222 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.251 1.161 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.891 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -134.38 25.31 3.8 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.175 0.99 . . . . 0.0 109.06 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.493 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 13.1 m -61.7 -48.87 78.82 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.962 0.905 . . . . 0.0 110.719 -175.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -7.59 25.92 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.899 0.88 . . . . 0.0 113.026 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.4 mm -94.39 -31.34 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.639 0.775 . . . . 0.0 109.705 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.29 -32.85 32.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.274 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.2 mt -58.44 -47.64 98.41 Favored Pre-proline 0 CA--C 1.563 1.46 0 CA-C-O 118.405 -0.807 . . . . 0.0 112.185 -177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 10.1 Cg_endo -56.2 -63.07 0.19 Allowed 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 121.885 1.723 . . . . 0.0 112.379 172.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.41 -27.08 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -168.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.24 -55.39 6.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.449 0.7 . . . . 0.0 109.728 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -68.8 -29.82 68.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.983 0.513 . . . . 0.0 111.583 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -74.8 -36.85 62.48 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.827 0.851 . . . . 0.0 111.527 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.56 -48.77 80.31 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -57.87 -45.31 86.51 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 124.561 1.163 . . . . 0.0 109.315 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.78 -24.81 66.24 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.033 -1.44 . . . . 0.0 112.722 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -67.68 -40.61 84.39 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.579 0.352 . . . . 0.0 110.32 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -91.73 -25.73 18.93 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.429 0.692 . . . . 0.0 110.936 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.04 -6.38 59.47 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.493 0.717 . . . . 0.0 111.846 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 69.39 14.87 8.45 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.081 1.352 . . . . 0.0 112.929 171.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -83.81 95.3 8.41 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.488 HG13 HG12 ' A' ' 54' ' ' ILE . 20.7 mm -64.8 -29.77 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.427 0.691 . . . . 0.0 110.43 173.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -55.96 -47.04 78.34 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.902 0.481 . . . . 0.0 111.384 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.43 -32.89 28.78 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.306 0.642 . . . . 0.0 111.42 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -72.94 -8.82 57.39 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.104 0.562 . . . . 0.0 110.828 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.714 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 27.7 tpp -120.96 -15.76 8.21 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.909 0.484 . . . . 0.0 112.287 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.06 -50.46 61.46 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.492 0.717 . . . . 0.0 112.548 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 85.3 m95 -87.18 6.92 30.54 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.989 -168.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.66 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 12.9 m95 -93.96 149.81 20.9 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.415 0.686 . . . . 0.0 109.482 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.64 152.11 37.66 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.153 0.581 . . . . 0.0 109.976 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -64.16 -29.79 70.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.884 0.474 . . . . 0.0 111.249 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -96.91 20.36 11.23 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.816 0.846 . . . . 0.0 111.385 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.66 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 48.6 t -61.85 115.63 4.18 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -71.57 148.58 46.51 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.649 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 42.8 t80 -141.67 118.1 10.85 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -117.51 148.82 41.5 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.692 0.797 . . . . 0.0 110.081 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.525 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -103.12 153.48 20.27 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.601 171.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.546 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 90.4 t80 -56.59 128.94 75.77 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.87 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.46 -60.46 0.08 OUTLIER 'Cis proline' 0 C--N 1.384 2.43 0 CA-C-N 120.583 1.244 . . . . 0.0 113.488 0.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.35 74.06 0.68 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.652 0.781 . . . . 0.0 108.991 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 55.3 m -105.54 111.69 24.49 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.167 0.987 . . . . 0.0 109.016 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 tt -66.35 103.06 0.94 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 36' ' ' ALA . 78.7 mt -82.67 -43.47 16.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.656 0.783 . . . . 0.0 110.649 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -139.73 116.58 10.93 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.787 0.435 . . . . 0.0 111.083 -171.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.07 32.61 5.31 Favored Glycine 0 N--CA 1.482 1.708 0 C-N-CA 122.811 0.243 . . . . 0.0 113.064 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 47' ' ' ALA . 24.2 p-10 169.5 153.4 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.035 1.334 . . . . 0.0 109.645 -165.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.714 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -67.98 -24.61 65.16 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.079 0.952 . . . . 0.0 112.911 -176.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.423 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . . . -56.52 -47.61 78.99 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.504 0.721 . . . . 0.0 112.141 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.448 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 35.2 mt-10 -74.21 -31.33 62.59 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.494 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 46' ' ' ALA . 61.9 mt -64.81 -49.24 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.13 0.572 . . . . 0.0 111.188 -178.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.488 ' O ' HG13 ' A' ' 54' ' ' ILE . 6.9 ptm180 -62.78 -49.21 75.86 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 123.498 0.499 . . . . 0.0 110.724 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.406 ' HA ' HD12 ' A' ' 54' ' ' ILE . 76.3 t -63.47 -42.53 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.779 0.832 . . . . 0.0 111.399 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -68.36 -31.62 71.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.577 0.751 . . . . 0.0 110.879 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -77.91 -28.94 49.91 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.721 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.488 HG12 HG13 ' A' ' 21' ' ' ILE . 98.1 mt -57.88 -38.92 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 118.711 0.687 . . . . 0.0 109.729 174.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.38 -34.52 78.35 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.314 1.046 . . . . 0.0 111.38 175.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -78.66 -24.48 45.14 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.163 0.585 . . . . 0.0 110.916 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -83.53 -5.16 59.09 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.37 0.668 . . . . 0.0 110.631 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 70.4 mmtt -78.02 -9.99 59.39 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.096 0.558 . . . . 0.0 111.89 169.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 8.5 mm-40 -71.94 111.02 9.08 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 170.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.95 -28.14 74.97 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.297 1.998 . . . . 0.0 112.232 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -92.19 4.84 52.39 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.803 0.841 . . . . 0.0 112.048 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 28.4 tp -64.75 111.82 2.95 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-O 120.757 0.313 . . . . 0.0 110.213 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -148.07 116.15 6.47 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.98 101.14 2.71 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 174.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -81.51 99.95 9.07 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.2 tp -76.25 126.62 31.32 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.73 -33.99 5.94 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.956 0.902 . . . . 0.0 109.638 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 96.8 m -152.93 139.75 19.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.341 1.056 . . . . 0.0 108.99 -176.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -142.3 125.64 16.57 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 163.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.8 m -106.72 119.08 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.939 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.03 143.42 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 121.338 0.59 . . . . 0.0 110.033 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 p -148.32 97.49 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.263 1.425 . . . . 0.0 107.832 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.53 -116.2 7.27 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.673 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -101.89 18.7 19.91 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.072 0.549 . . . . 0.0 111.688 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.0 t -131.92 136.01 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.137 0.975 . . . . 0.0 109.5 -174.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -125.29 137.05 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 123.254 0.622 . . . . 0.0 110.012 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.688 HD13 ' HB ' ' A' ' 98' ' ' ILE . 2.5 mm -98.17 103.96 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 169.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.93 108.18 19.42 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -98.31 107.45 19.92 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 133.76 49.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.489 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.0 m -80.1 103.98 10.35 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 172.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -80.91 116.24 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.469 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.4 m -71.12 118.29 13.72 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.353 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 43.3 mmm-85 -119.02 -171.21 2.06 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -122.53 112.74 18.38 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.957 0.503 . . . . 0.0 109.763 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -113.44 137.35 22.08 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.032 0.933 . . . . 0.0 108.658 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -59.98 -18.94 53.05 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 123.218 2.612 . . . . 0.0 114.306 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -79.2 -25.94 42.65 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.044 0.538 . . . . 0.0 112.299 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.34 -117.39 0.58 Allowed Glycine 0 C--N 1.348 1.245 0 CA-C-O 119.683 -0.51 . . . . 0.0 112.914 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -68.83 -84.03 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.469 0.707 . . . . 0.0 111.88 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 116.93 26.69 2.95 Favored Glycine 0 C--N 1.343 0.947 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 -173.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.66 104.15 16.59 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.978 0.894 . . . . 0.0 108.591 -172.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 116' ' ' PRO . 21.7 m -103.7 136.59 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.509 -172.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -75.64 133.18 40.93 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.708 HG22 HG12 ' A' ' 113' ' ' ILE . 18.6 t -132.86 147.28 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.99 103.06 9.56 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 166.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 83.9 m -93.7 108.41 20.16 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.688 ' HB ' HD13 ' A' ' 77' ' ' ILE . 4.8 tt -102.11 111.94 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.631 1.172 . . . . 0.0 110.416 -173.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -103.43 129.95 50.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.902 0.881 . . . . 0.0 109.877 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 30.8 tt0 -100.22 111.92 24.22 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 168.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.61 HG22 HG12 ' A' ' 106' ' ' ILE . 48.7 t -94.59 113.79 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.488 1.115 . . . . 0.0 109.4 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -121.06 133.31 55.23 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.963 0.905 . . . . 0.0 109.185 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 62.63 30.42 16.95 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.244 1.017 . . . . 0.0 111.574 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.12 -7.09 79.56 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.268 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -130.75 147.5 52.42 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.943 0.897 . . . . 0.0 109.292 -173.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.61 HG12 HG22 ' A' ' 101' ' ' VAL . 45.7 mt -68.08 102.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 122.876 0.47 . . . . 0.0 110.677 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.16 -22.47 38.94 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.205 0.602 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 81.3 mttt -149.28 143.01 25.58 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.192 0.997 . . . . 0.0 108.781 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -146.67 134.23 20.94 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.501 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.1 m-90 -132.76 149.51 52.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -133.57 146.47 51.03 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 19.9 pttp -144.83 129.58 18.19 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.708 HG12 HG22 ' A' ' 95' ' ' VAL . 91.7 mt -89.84 120.53 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.03 -68.67 1.57 Allowed Glycine 0 C--N 1.344 1.024 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.354 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.96 163.61 23.57 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.54 ' HA ' HG12 ' A' ' 93' ' ' VAL . 83.5 Cg_endo -80.18 144.99 16.93 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 121.938 1.759 . . . . 0.0 111.9 165.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 47.4 mtm105 -132.81 142.81 49.17 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.495 0.664 . . . . 0.0 110.652 169.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.2 mm -128.28 124.84 63.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.678 1.191 . . . . 0.0 108.094 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.95 -33.83 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 123.51 0.506 . . . . 0.0 109.909 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.6 m -73.9 -19.19 60.78 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.377 1.071 . . . . 0.0 112.488 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -72.33 -23.15 61.11 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.599 0.76 . . . . 0.0 110.195 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -109.27 134.86 51.24 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.616 1.166 . . . . 0.0 108.556 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.254 1.303 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.511 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 39.5 p30 177.98 -19.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.861 1.664 . . . . 0.0 109.55 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 p -63.04 -43.57 98.31 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.132 0.973 . . . . 0.0 111.557 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.35 -2.31 18.75 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.599 0.76 . . . . 0.0 112.506 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.627 HG22 HG23 ' A' ' 76' ' ' VAL . 26.3 mm -94.81 -32.72 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.871 0.868 . . . . 0.0 109.264 174.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.95 -32.14 39.97 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.053 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 72.1 mt -57.97 -49.33 94.27 Favored Pre-proline 0 CA--C 1.564 1.484 0 CA-C-O 118.051 -0.976 . . . . 0.0 112.592 -177.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 9.3 Cg_endo -54.2 -61.79 0.38 Allowed 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 122.205 1.936 . . . . 0.0 111.648 175.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.491 HG11 ' HB ' ' A' ' 76' ' ' VAL . 16.7 m -64.12 -22.54 31.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.669 -171.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.55 ' HG2' HH22 ' A' ' 69' ' ' ARG . 0.9 OUTLIER -72.76 -55.62 6.46 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.552 0.741 . . . . 0.0 109.587 178.482 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 72.2 mmtt -70.28 -37.26 74.81 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.148 0.579 . . . . 0.0 110.972 -173.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -65.44 -39.31 91.91 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.052 0.941 . . . . 0.0 111.061 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.419 HD11 ' HB2' ' A' ' 66' ' ' LEU . 22.9 tp -57.89 -50.85 71.94 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.003 0.815 . . . . 0.0 110.09 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.44 -52.37 64.92 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.525 1.141 . . . . 0.0 109.444 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -60.92 -27.86 68.5 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.786 1.234 . . . . 0.0 112.182 -176.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -70.93 -39.73 72.51 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.757 0.823 . . . . 0.0 110.806 -177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -94.06 -17.71 22.57 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.987 0.515 . . . . 0.0 111.179 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.74 -3.58 54.55 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.349 0.66 . . . . 0.0 111.884 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 70.93 28.42 3.24 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.816 1.247 . . . . 0.0 112.39 174.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.46 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 17.6 m-20 -101.0 112.8 25.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.529 0.732 . . . . 0.0 110.067 174.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.0 mm -77.45 -31.46 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 122.719 0.408 . . . . 0.0 110.335 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -55.44 -48.38 74.54 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.848 0.459 . . . . 0.0 111.888 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.56 -29.64 33.37 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.638 0.375 . . . . 0.0 111.287 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -73.06 -8.17 54.53 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.136 0.574 . . . . 0.0 111.08 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.507 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 25.4 tpp -121.99 -15.55 7.77 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 173.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.46 -32.71 68.98 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -174.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.547 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 90.2 m95 -104.0 9.75 36.43 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.616 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 24.1 m95 -95.55 153.19 17.83 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.869 0.468 . . . . 0.0 110.102 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -80.0 151.18 30.13 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.341 0.656 . . . . 0.0 109.954 173.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -61.71 -31.11 71.24 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.449 0.699 . . . . 0.0 112.454 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -102.66 19.68 18.67 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.456 0.702 . . . . 0.0 111.303 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.616 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 46.1 t -60.49 119.25 7.67 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 121.074 0.464 . . . . 0.0 112.238 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.555 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 77.9 mm-40 -81.21 144.07 31.87 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.182 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -134.83 113.6 11.76 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.486 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 31.6 m-85 -115.88 155.11 28.53 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.922 0.889 . . . . 0.0 111.602 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.9 159.99 22.18 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.682 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 112' ' ' LYS . 18.3 p90 -55.27 136.41 68.71 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 123.993 0.917 . . . . 0.0 111.925 176.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -77.71 -40.27 1.16 Allowed 'Cis proline' 0 C--N 1.379 2.159 0 CA-C-N 119.854 0.984 . . . . 0.0 112.691 -7.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.71 66.66 0.21 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.832 0.853 . . . . 0.0 109.36 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 25.1 m -107.52 119.27 38.95 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.138 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tt -82.67 102.69 11.65 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.4 -45.18 16.47 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.836 0.454 . . . . 0.0 110.259 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -142.01 120.1 12.12 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -171.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.86 28.1 15.15 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.268 0.355 . . . . 0.0 113.898 -174.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.6 p30 176.18 157.77 0.26 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.254 1.422 . . . . 0.0 109.835 -174.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.507 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -60.48 -32.12 71.11 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.48 1.112 . . . . 0.0 113.378 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.485 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -60.55 -51.77 68.03 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.97 0.508 . . . . 0.0 111.124 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 33.9 mt-10 -69.27 -29.07 66.89 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.806 -175.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.1 mt -63.9 -52.11 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.329 0.652 . . . . 0.0 110.4 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.492 ' O ' HG13 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -67.19 -38.79 85.94 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.64 -175.556 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 47' ' ' ALA . 70.9 t -59.54 -49.37 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.481 0.712 . . . . 0.0 111.605 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -69.01 -29.41 67.59 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.765 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -77.87 -29.8 50.54 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 118.537 -0.745 . . . . 0.0 111.483 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 50' ' ' ARG . 76.2 mt -55.44 -46.78 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-N 118.645 0.657 . . . . 0.0 109.597 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -56.44 -42.44 78.11 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 124.413 1.071 . . . . 0.0 111.425 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.438 ' HG3' HD22 ' A' ' 62' ' ' LEU . 14.8 tpp180 -70.5 -31.5 68.62 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.414 0.686 . . . . 0.0 110.873 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -75.65 -14.31 60.36 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.534 0.734 . . . . 0.0 110.846 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 69.2 mmtt -91.6 -5.03 54.62 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.332 0.653 . . . . 0.0 111.565 170.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -105.49 122.1 43.91 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 122.985 0.514 . . . . 0.0 109.951 -175.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.54 -19.05 48.96 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.665 2.91 . . . . 0.0 115.165 -164.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -72.24 -24.42 61.37 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.629 0.372 . . . . 0.0 111.304 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.438 HD22 ' HG3' ' A' ' 56' ' ' ARG . 55.3 tp -56.19 120.66 7.9 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.661 0.784 . . . . 0.0 112.364 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -151.96 144.27 24.03 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.26 105.09 0.67 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -101.24 107.18 18.5 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.652 0.781 . . . . 0.0 109.525 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.419 ' HB2' HD11 ' A' ' 13' ' ' LEU . 14.3 tp -78.59 131.74 36.85 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 pp -111.98 -28.68 7.92 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.452 0.701 . . . . 0.0 110.206 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.9 m -157.47 143.69 17.76 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.288 1.035 . . . . 0.0 109.287 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.55 HH22 ' HG2' ' A' ' 10' ' ' GLN . 12.1 ptt180 -142.14 139.59 32.19 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.236 0.541 . . . . 0.0 110.315 162.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.11 143.7 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.843 1.257 . . . . 0.0 109.56 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.1 tt -115.85 134.07 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-O 121.309 0.576 . . . . 0.0 110.709 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -126.56 95.59 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 125.31 1.444 . . . . 0.0 107.81 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.2 -103.24 0.51 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 123.561 0.538 . . . . 0.0 113.369 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -106.46 18.18 22.31 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.529 0.732 . . . . 0.0 111.38 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.5 t -133.3 140.61 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.976 0.91 . . . . 0.0 109.071 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.627 HG23 HG22 ' A' ' 5' ' ' ILE . 57.1 t -125.86 137.82 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 118.516 0.598 . . . . 0.0 109.928 172.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.477 HG12 ' HB ' ' A' ' 98' ' ' ILE . 1.6 mt -99.86 110.0 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 167.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.45 ' HB2' ' SG ' ' A' ' 97' ' ' CYS . 1.3 m-20 -88.67 108.03 19.24 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 167.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.416 ' HE1' ' HB3' ' A' ' 94' ' ' ASP . 0.9 OUTLIER -98.5 108.71 21.46 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.318 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.99 163.67 21.82 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.516 1.127 . . . . 0.0 110.632 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.8 m -108.18 106.17 16.23 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.406 1.082 . . . . 0.0 108.582 165.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 m -90.52 134.05 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 122.481 0.313 . . . . 0.0 111.114 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 49.0 m -76.59 127.89 33.68 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.706 0.402 . . . . 0.0 109.994 175.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.4 mtm105 -126.72 161.48 28.04 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -90.17 99.31 12.35 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.825 0.345 . . . . 0.0 111.402 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -103.37 125.13 35.89 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.07 -16.17 53.42 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.087 2.525 . . . . 0.0 113.877 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -85.3 -9.03 58.18 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.912 0.485 . . . . 0.0 111.756 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.83 -127.14 1.18 Allowed Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.529 -0.595 . . . . 0.0 111.7 172.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -75.97 -83.34 0.07 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 117.282 0.541 . . . . 0.0 111.27 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.97 29.12 1.56 Allowed Glycine 0 C--N 1.354 1.542 0 N-CA-C 114.388 0.515 . . . . 0.0 114.388 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -89.82 99.28 12.32 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 122.136 0.969 . . . . 0.0 110.027 -172.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.9 m -102.75 137.5 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 121.616 -0.678 . . . . 0.0 111.444 -165.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB3' ' HE1' ' A' ' 79' ' ' HIS . 13.1 m-20 -79.31 115.01 18.7 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.686 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.526 HG22 HG12 ' A' ' 113' ' ' ILE . 35.2 t -119.17 156.17 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 125.12 1.368 . . . . 0.0 109.156 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.03 106.11 10.12 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 78' ' ' ASP . 20.5 p -97.23 109.06 21.89 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.541 HG23 ' HB2' ' A' ' 110' ' ' TRP . 7.1 tt -100.4 114.76 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.353 1.061 . . . . 0.0 109.622 -177.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -107.91 132.54 53.36 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.757 0.823 . . . . 0.0 109.71 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -98.4 112.83 24.71 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.546 HG22 HG12 ' A' ' 106' ' ' ILE . 42.1 t -95.08 113.85 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.192 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 41.7 tt0 -119.61 128.05 53.51 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.865 0.866 . . . . 0.0 109.511 175.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 64.37 31.35 12.81 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.391 1.077 . . . . 0.0 111.903 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.81 6.52 89.04 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.726 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -134.1 139.43 45.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.537 1.135 . . . . 0.0 108.957 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.546 HG12 HG22 ' A' ' 101' ' ' VAL . 45.9 mt -68.28 104.86 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 122.429 0.291 . . . . 0.0 110.316 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -78.33 -30.25 48.08 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.68 0.792 . . . . 0.0 111.175 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.555 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 97.9 mttt -149.48 152.18 35.19 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.877 0.871 . . . . 0.0 109.091 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -146.17 137.42 24.6 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.963 0.905 . . . . 0.0 108.824 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.541 ' HB2' HG23 ' A' ' 98' ' ' ILE . 4.0 m-90 -135.56 150.95 49.86 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -142.43 146.41 34.8 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 171.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 20.5 ptmt -131.19 125.36 32.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.537 176.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.526 HG12 HG22 ' A' ' 95' ' ' VAL . 87.2 mt -87.44 123.92 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.26 -65.94 2.97 Favored Glycine 0 CA--C 1.526 0.754 0 O-C-N 124.451 1.094 . . . . 0.0 113.187 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -159.5 167.63 13.81 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.19 138.31 33.08 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.558 2.172 . . . . 0.0 112.334 165.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 30.1 mmt180 -135.52 146.38 48.01 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.81 0.844 . . . . 0.0 111.213 -175.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.5 mm -136.83 132.65 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.855 1.262 . . . . 0.0 108.445 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.9 t -53.13 -44.4 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 123.734 0.813 . . . . 0.0 111.944 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.3 t -61.46 -23.33 65.79 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.701 0.801 . . . . 0.0 111.763 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -115.76 4.37 13.99 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.096 0.958 . . . . 0.0 111.336 -176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -107.83 158.72 17.09 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.324 0.65 . . . . 0.0 110.598 -175.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.95 0.9 . . . . 0.0 108.76 -179.843 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtm . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.595 0.236 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -124.19 78.19 1.62 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.822 0.82 . . . . 0.0 110.292 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.5 m -75.78 -49.17 18.89 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.637 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -12.86 58.41 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.173 0.989 . . . . 0.0 113.387 -175.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.545 HG22 HG23 ' A' ' 76' ' ' VAL . 33.2 mm -87.1 -34.26 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.498 ' HG3' HD12 ' A' ' 71' ' ' ILE . 44.3 mt-10 -84.55 -22.33 30.15 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.5 -53.91 61.41 Favored Pre-proline 0 CA--C 1.568 1.639 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.662 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.528 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 33.6 Cg_endo -62.27 -49.56 5.97 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 122.156 1.904 . . . . 0.0 113.052 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 6' ' ' GLU . 15.6 m -66.95 -37.87 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -169.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -72.66 -43.67 62.85 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.423 0.689 . . . . 0.0 109.977 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -68.68 -29.72 68.24 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.326 0.651 . . . . 0.0 112.065 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -59.47 -48.03 83.23 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.904 0.752 . . . . 0.0 110.308 172.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.55 -51.75 68.51 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 124.012 0.82 . . . . 0.0 110.092 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.62 -27.1 66.02 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 124.029 0.831 . . . . 0.0 110.896 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . . . -83.08 -32.31 26.85 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.389 1.076 . . . . 0.0 112.285 175.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -72.02 -39.66 68.99 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.256 0.622 . . . . 0.0 110.534 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -87.67 1.07 54.73 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.887 0.875 . . . . 0.0 111.834 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.56 3.17 10.72 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.999 0.92 . . . . 0.0 111.171 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 70.28 9.53 7.02 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.127 1.371 . . . . 0.0 113.695 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.453 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 8.9 m-20 -81.13 116.86 21.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.14 0.495 . . . . 0.0 110.916 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.529 HG13 HG12 ' A' ' 54' ' ' ILE . 22.8 mm -82.58 -25.6 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.093 0.957 . . . . 0.0 110.073 171.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -54.74 -48.82 72.11 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.038 0.935 . . . . 0.0 112.097 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -79.4 -35.18 41.07 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.94 0.496 . . . . 0.0 110.623 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -69.93 -8.26 47.37 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.178 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.646 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 16.6 tpp -119.87 -28.64 5.15 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.447 0.699 . . . . 0.0 112.401 173.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.4 -47.42 75.9 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.036 0.534 . . . . 0.0 112.087 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 98.4 m95 -79.43 1.62 24.81 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -170.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.465 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 18.2 m95 -95.05 168.34 10.83 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.373 0.669 . . . . 0.0 110.045 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -87.1 148.35 25.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.54 0.736 . . . . 0.0 109.353 171.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.16 -25.79 67.96 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.316 0.646 . . . . 0.0 111.706 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -109.19 18.97 19.98 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.976 1.311 . . . . 0.0 111.381 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.465 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 53.7 t -60.84 133.93 56.58 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -173.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.55 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 36.6 mm-40 -95.44 105.46 17.43 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.567 0.747 . . . . 0.0 109.967 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.432 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 48.4 t80 -94.6 111.44 23.2 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.635 0.774 . . . . 0.0 110.246 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -105.16 139.89 39.14 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.287 1.035 . . . . 0.0 110.029 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.6 161.48 14.82 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.24 1.016 . . . . 0.0 110.345 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.41 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 71.3 t80 -50.26 127.58 22.74 Favored Pre-proline 0 CA--C 1.566 1.593 0 O-C-N 124.285 0.99 . . . . 0.0 112.039 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.23 -50.29 0.19 OUTLIER 'Cis proline' 0 C--N 1.386 2.519 0 CA-C-N 119.77 0.953 . . . . 0.0 113.513 -5.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.33 78.83 0.81 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.8 m -117.48 114.03 22.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.033 0.933 . . . . 0.0 109.237 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.74 101.48 0.81 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.8 mt -79.63 -36.36 38.02 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.275 0.63 . . . . 0.0 109.93 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.461 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -142.45 116.3 9.29 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.612 -170.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.0 33.21 4.77 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 123.374 0.421 . . . . 0.0 112.771 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.43 ' O ' HG13 ' A' ' 49' ' ' ILE . 8.9 p30 167.05 158.29 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.204 1.402 . . . . 0.0 109.816 -167.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.646 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -70.65 -25.2 62.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.245 1.018 . . . . 0.0 113.148 -175.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.4 98.27 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.861 0.465 . . . . 0.0 111.259 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.461 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 26.6 mt-10 -75.39 -32.36 60.75 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.611 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 46' ' ' ALA . 72.4 mt -65.44 -46.29 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.197 0.599 . . . . 0.0 110.945 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 54' ' ' ILE . 14.0 ptm180 -64.67 -51.43 62.56 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.686 0.616 . . . . 0.0 110.641 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.415 ' HA ' HD12 ' A' ' 54' ' ' ILE . 20.6 m -65.61 -35.23 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 122.97 0.508 . . . . 0.0 111.825 -175.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -71.41 -34.92 70.77 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.855 0.862 . . . . 0.0 110.476 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -75.08 -32.61 61.52 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.642 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.529 HG12 HG13 ' A' ' 21' ' ' ILE . 97.7 mt -58.15 -37.76 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.672 0.389 . . . . 0.0 110.026 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.12 -34.56 78.34 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.654 0.782 . . . . 0.0 111.6 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -75.2 -25.98 58.63 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.867 0.467 . . . . 0.0 110.157 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.549 ' HA ' HD22 ' A' ' 62' ' ' LEU . 2.8 m-85 -83.9 -4.42 58.68 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.59 0.756 . . . . 0.0 111.347 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HE2' HG22 ' A' ' 54' ' ' ILE . 74.5 mmtt -73.07 -25.84 61.05 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.717 0.407 . . . . 0.0 111.109 169.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 50.4 mm-40 -57.42 116.7 14.7 Favored Pre-proline 0 N--CA 1.481 1.113 0 C-N-CA 123.583 0.753 . . . . 0.0 110.748 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.23 -26.61 41.91 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.321 2.014 . . . . 0.0 112.609 -175.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.42 2.25 55.77 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.053 0.941 . . . . 0.0 111.484 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 57' ' ' PHE . 17.6 tp -62.23 114.02 3.21 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.932 0.493 . . . . 0.0 111.276 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -151.65 115.62 4.95 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.535 0.734 . . . . 0.0 109.084 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.12 104.59 3.11 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -91.68 101.82 14.45 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.7 tt -79.26 124.88 28.8 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.52 -32.79 5.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.736 -172.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.7 m -148.69 134.86 19.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.367 1.067 . . . . 0.0 108.558 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.409 HH12 ' HG2' ' A' ' 6' ' ' GLU . 52.3 ptt85 -137.76 133.31 33.94 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 166.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -121.56 128.09 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.511 1.124 . . . . 0.0 109.43 -172.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.498 HD12 ' HG3' ' A' ' 6' ' ' GLU . 11.9 tt -108.7 128.77 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 121.253 0.549 . . . . 0.0 110.657 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.1 p -123.89 94.46 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 173.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.27 -110.83 3.15 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.823 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -87.99 -1.1 57.78 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.609 1.163 . . . . 0.0 111.8 -172.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.3 t -128.77 140.18 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.074 0.95 . . . . 0.0 109.786 -172.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.545 HG23 HG22 ' A' ' 5' ' ' ILE . 33.2 t -125.29 134.65 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.349 0.66 . . . . 0.0 109.512 172.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.456 HG12 ' HB ' ' A' ' 98' ' ' ILE . 2.4 mt -99.58 107.04 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 165.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.75 109.32 20.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -98.74 109.69 22.41 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.25 159.24 36.73 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.467 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.2 m -107.43 110.05 21.91 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.121 172.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.0 t -81.77 103.25 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 123.293 0.637 . . . . 0.0 110.258 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.3 m -66.75 129.56 40.27 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.854 0.862 . . . . 0.0 110.205 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 91' ' ' GLY . 80.7 mtp180 -133.56 -162.53 1.25 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -130.21 83.5 2.13 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.917 0.389 . . . . 0.0 110.357 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -90.18 137.83 27.64 Favored Pre-proline 0 N--CA 1.475 0.8 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.3 8.15 1.56 Allowed 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.839 2.359 . . . . 0.0 113.046 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.91 -32.68 57.56 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.082 0.953 . . . . 0.0 109.314 169.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.09 -98.03 0.13 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.355 175.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -76.91 -82.41 0.08 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.786 0.834 . . . . 0.0 110.281 175.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 84' ' ' ARG . . . 117.43 28.59 2.31 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 121.312 -0.47 . . . . 0.0 113.877 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -88.1 140.95 28.97 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -174.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.585 HG12 ' HA ' ' A' ' 116' ' ' PRO . 29.1 m -127.43 129.27 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 122.04 -0.413 . . . . 0.0 110.817 -176.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -77.34 110.43 12.07 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.039 0.536 . . . . 0.0 109.703 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.459 HG22 HG12 ' A' ' 113' ' ' ILE . 33.8 t -114.15 156.55 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.607 1.163 . . . . 0.0 108.859 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.88 103.32 6.73 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 71.6 m -96.35 111.84 23.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.235 1.014 . . . . 0.0 109.959 -174.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.456 ' HB ' HG12 ' A' ' 77' ' ' ILE . 8.6 tt -103.42 110.96 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 124.602 1.161 . . . . 0.0 110.155 -175.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -105.69 133.64 50.1 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.167 0.587 . . . . 0.0 110.905 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -100.45 119.68 38.84 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.195 0.998 . . . . 0.0 108.474 169.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.5 t -110.28 115.25 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.014 0.926 . . . . 0.0 110.536 -173.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 11.4 tp10 -118.68 126.39 51.82 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.145 0.578 . . . . 0.0 109.806 177.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.3 m120 61.55 30.25 18.62 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.892 1.277 . . . . 0.0 112.174 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.45 0.03 86.03 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 116.379 -0.373 . . . . 0.0 113.774 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -117.38 138.41 51.82 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 67.1 mt -68.56 105.91 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -78.11 -32.13 50.36 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.056 0.542 . . . . 0.0 110.705 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.55 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 62.4 mtpt -150.2 134.23 16.98 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -130.4 132.28 45.68 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.425 ' HE1' ' HE2' ' A' ' 108' ' ' LYS . 0.7 OUTLIER -132.42 148.64 52.41 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -177.387 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -142.62 146.69 34.78 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.284 0.493 . . . . 0.0 110.03 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 25.1 pttm -121.19 127.68 51.73 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.459 HG12 HG22 ' A' ' 95' ' ' VAL . 88.3 mt -89.69 124.99 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.21 -73.88 0.52 Allowed Glycine 0 CA--C 1.526 0.765 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.914 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -160.69 170.3 8.71 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.134 0.574 . . . . 0.0 109.676 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.585 ' HA ' HG12 ' A' ' 93' ' ' VAL . 72.4 Cg_endo -73.84 123.74 8.68 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.215 1.943 . . . . 0.0 112.225 165.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.8 mmt85 -110.01 147.58 33.25 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.212 1.005 . . . . 0.0 109.243 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.9 mm -139.05 127.79 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.51 -30.57 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.711 0.805 . . . . 0.0 111.74 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -68.42 -31.51 70.9 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.038 0.535 . . . . 0.0 110.654 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -82.04 -37.03 27.1 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.154 0.982 . . . . 0.0 110.765 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -98.16 103.37 15.31 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.593 0.757 . . . . 0.0 109.0 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 C--O 1.255 1.36 0 C-N-CA 123.498 0.719 . . . . 0.0 109.482 -177.921 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.445 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -110.06 49.37 0.85 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.552 0.691 . . . . 0.0 110.722 -175.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.417 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 33.8 p -67.74 -33.02 74.05 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.702 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.65 -20.32 63.27 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.49 1.116 . . . . 0.0 112.578 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 74' ' ' ASN . 30.0 mm -91.79 -28.98 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.946 0.898 . . . . 0.0 109.409 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -75.0 -27.39 60.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.965 174.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 3' ' ' SER . 83.7 mt -59.92 -55.21 47.83 Favored Pre-proline 0 CA--C 1.564 1.484 0 CA-C-O 117.884 -1.055 . . . . 0.0 112.032 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 19.3 Cg_endo -56.91 -55.59 2.55 Favored 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 122.111 1.874 . . . . 0.0 112.613 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.5 m -62.98 -35.36 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.489 -171.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -73.66 -52.2 14.12 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.163 0.585 . . . . 0.0 110.394 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -62.86 -28.29 69.93 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -75.42 -43.56 49.27 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.853 0.861 . . . . 0.0 111.422 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.14 -52.05 65.38 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.003 0.521 . . . . 0.0 110.331 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.71 -25.81 68.37 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.021 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 20' ' ' ASP . . . -80.76 -27.64 36.68 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.372 1.069 . . . . 0.0 112.177 172.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -66.91 -47.52 71.52 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.252 0.548 . . . . 0.0 109.885 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.62 -14.57 59.6 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.847 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.43 -2.77 41.45 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.449 0.699 . . . . 0.0 112.118 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 67.55 25.48 8.35 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.791 1.237 . . . . 0.0 112.835 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.497 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 11.0 m-20 -92.8 100.04 12.6 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.311 0.644 . . . . 0.0 110.011 173.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.429 HG13 HG12 ' A' ' 54' ' ' ILE . 12.6 mm -70.39 -31.17 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.001 0.52 . . . . 0.0 110.787 170.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -61.36 -45.11 95.77 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.014 0.525 . . . . 0.0 111.691 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.03 -30.82 44.39 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.134 0.574 . . . . 0.0 110.977 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -72.94 -5.94 41.93 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.855 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.751 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -112.75 -30.52 7.04 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.217 0.607 . . . . 0.0 112.215 172.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.75 -32.7 67.72 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -169.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.479 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.9 m95 -97.97 7.83 45.7 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -173.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.568 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 46.8 m95 -94.25 157.51 16.01 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.01 0.524 . . . . 0.0 110.288 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -76.76 148.49 36.66 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.322 169.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -67.83 -24.29 65.26 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.158 0.583 . . . . 0.0 111.32 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -106.18 18.33 22.18 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.312 1.045 . . . . 0.0 111.236 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.568 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 51.5 t -64.93 138.99 58.71 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -174.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -98.21 136.61 38.17 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.763 0.825 . . . . 0.0 108.847 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 56.4 t80 -130.92 110.98 11.66 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -109.64 151.81 26.38 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.602 0.761 . . . . 0.0 110.512 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.25 158.47 19.67 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.634 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.644 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 87.2 t80 -61.29 130.82 91.97 Favored Pre-proline 0 CA--C 1.558 1.276 0 O-C-N 123.899 0.749 . . . . 0.0 110.335 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.38 -57.25 0.14 OUTLIER 'Cis proline' 0 C--N 1.383 2.39 0 CA-C-N 120.138 1.085 . . . . 0.0 113.6 -1.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.26 81.53 1.42 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.7 m -129.19 108.21 10.17 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.497 0.719 . . . . 0.0 109.915 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.5 tp -65.78 102.57 0.77 Allowed 'General case' 0 CA--C 1.535 0.377 0 O-C-N 123.572 0.545 . . . . 0.0 109.824 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.9 mt -78.68 -25.74 44.87 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.531 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -157.3 117.05 3.41 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.85 35.34 4.59 Favored Glycine 0 C--N 1.346 1.119 0 C-N-CA 123.28 0.467 . . . . 0.0 112.926 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 p30 163.96 160.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 126.306 1.843 . . . . 0.0 108.426 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -69.55 -26.14 64.35 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -171.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.69 -41.65 99.22 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.331 0.586 . . . . 0.0 110.884 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -76.28 -29.19 57.31 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.922 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.0 mt -64.24 -50.96 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 122.916 0.486 . . . . 0.0 110.639 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.751 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 30.8 ptt180 -60.68 -51.59 68.75 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.904 0.752 . . . . 0.0 110.671 -176.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.454 ' HA ' HD12 ' A' ' 54' ' ' ILE . 35.5 m -63.97 -38.22 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -174.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -61.87 -38.08 86.96 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 123.815 0.697 . . . . 0.0 110.376 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -78.22 -34.32 49.37 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.121 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 50' ' ' ARG . 98.0 mt -56.46 -39.99 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.089 0.556 . . . . 0.0 110.182 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.87 -41.01 95.11 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.139 0.976 . . . . 0.0 111.576 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -73.9 -29.27 61.97 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.409 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -73.49 -4.66 35.15 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.002 0.521 . . . . 0.0 111.62 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -74.46 -36.22 63.33 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.962 0.505 . . . . 0.0 111.011 172.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.53 115.78 12.8 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 123.493 0.717 . . . . 0.0 110.919 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.89 -25.07 28.4 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.482 2.121 . . . . 0.0 112.49 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.78 -7.79 58.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.821 0.848 . . . . 0.0 111.69 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.55 120.56 12.56 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 122.477 0.311 . . . . 0.0 110.547 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -151.2 115.55 5.08 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 169.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.91 102.97 2.75 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -100.87 109.77 21.76 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 80' ' ' GLU . 13.8 tp -66.7 140.33 57.88 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.164 0.507 . . . . 0.0 110.089 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -107.0 -51.1 2.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.457 1.122 . . . . 0.0 107.989 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.9 m -154.54 141.07 18.85 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 113.024 -1.898 . . . . 0.0 109.032 -172.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 53.6 ptt85 -135.14 121.83 20.83 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 168.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.498 HG22 ' HB ' ' A' ' 77' ' ' ILE . 19.3 m -107.96 136.07 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.5 tt -120.71 129.83 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.274 0.559 . . . . 0.0 110.775 -175.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.95 99.35 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 C-N-CA 124.859 1.264 . . . . 0.0 108.393 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.79 -125.66 22.92 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.583 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.44 ' HA ' HG13 ' A' ' 5' ' ' ILE . 26.3 p-10 -91.48 17.98 7.9 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.307 0.643 . . . . 0.0 111.88 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.6 t -127.45 135.76 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.162 0.985 . . . . 0.0 109.8 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.2 t -125.37 139.66 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.006 0.522 . . . . 0.0 109.788 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.498 ' HB ' HG22 ' A' ' 70' ' ' VAL . 10.0 mm -98.81 104.33 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 167.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -94.87 105.16 17.07 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -100.19 105.81 17.44 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -121.28 171.16 8.93 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.156 1.382 . . . . 0.0 109.918 -178.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.4 m -118.09 106.23 12.66 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.924 0.89 . . . . 0.0 108.935 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.0 m -82.47 124.16 39.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-O 121.613 0.721 . . . . 0.0 109.194 170.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.9 m -83.09 119.42 24.48 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.681 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.637 HH21 ' HZ ' ' A' ' 86' ' ' PHE . 61.9 mtm180 -119.06 -160.89 0.82 Allowed 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -139.59 111.47 7.36 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.773 0.715 . . . . 0.0 110.32 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.637 ' HZ ' HH21 ' A' ' 84' ' ' ARG . 17.3 m-30 -109.28 151.49 42.09 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.745 0.818 . . . . 0.0 110.127 -178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.37 -28.82 88.58 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.649 2.232 . . . . 0.0 113.736 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -88.53 2.74 52.35 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.06 -146.56 16.09 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-O 119.479 -0.623 . . . . 0.0 113.235 173.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -39.07 -72.92 0.05 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.316 1.446 . . . . 0.0 113.059 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.424 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 103.62 25.7 7.17 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 113.897 0.319 . . . . 0.0 113.897 175.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -92.84 129.25 38.82 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.655 HG12 ' HA ' ' A' ' 116' ' ' PRO . 20.7 m -123.05 143.88 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.507 ' HB3' HH21 ' A' ' 117' ' ' ARG . 9.8 p-10 -85.89 122.95 30.67 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 174.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.447 HG22 HG12 ' A' ' 113' ' ' ILE . 44.2 t -113.68 142.33 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -106.12 97.65 7.43 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 94.1 m -93.49 108.28 19.99 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.357 0.663 . . . . 0.0 109.214 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.449 ' HB ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -97.78 115.75 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.897 0.879 . . . . 0.0 108.979 -178.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.402 ' CD1' HD13 ' A' ' 106' ' ' ILE . 64.0 m-85 -107.39 133.91 51.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.684 0.794 . . . . 0.0 109.711 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -103.31 113.37 26.81 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 168.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.628 HG22 HG12 ' A' ' 106' ' ' ILE . 96.9 t -100.0 135.29 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.204 1.001 . . . . 0.0 110.035 -176.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -133.27 119.2 19.49 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.959 0.904 . . . . 0.0 109.866 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.7 m120 61.12 30.54 19.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.927 1.291 . . . . 0.0 112.375 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.67 -6.64 83.13 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.009 -0.542 . . . . 0.0 113.858 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -113.86 133.51 55.38 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.628 HG12 HG22 ' A' ' 101' ' ' VAL . 57.5 mt -67.68 107.59 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.53 -32.1 47.84 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.495 0.718 . . . . 0.0 110.997 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -150.09 152.32 34.6 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.068 0.947 . . . . 0.0 108.821 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.66 135.49 12.73 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -136.75 151.79 49.61 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -139.57 144.79 37.96 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.249 0.547 . . . . 0.0 110.31 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.644 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 16.8 ttpt -117.03 125.6 51.59 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 172.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.447 HG12 HG22 ' A' ' 95' ' ' VAL . 62.0 mt -86.44 125.56 40.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.86 -132.21 1.47 Allowed Glycine 0 CA--C 1.52 0.4 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.938 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -83.5 134.26 45.5 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.591 0.756 . . . . 0.0 111.325 -169.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.655 ' HA ' HG12 ' A' ' 93' ' ' VAL . 77.5 Cg_endo -74.07 93.37 0.88 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 123.346 2.697 . . . . 0.0 111.435 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.507 HH21 ' HB3' ' A' ' 94' ' ' ASP . 49.5 mtm105 -100.45 141.48 33.24 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.532 0.682 . . . . 0.0 111.216 -169.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.3 mm -127.8 124.72 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.732 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.62 -23.06 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.834 0.853 . . . . 0.0 110.258 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.6 m -78.41 18.64 0.53 Allowed 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.841 1.257 . . . . 0.0 112.949 -174.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -97.75 156.71 16.44 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.538 0.735 . . . . 0.0 110.731 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -138.45 152.13 48.05 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.528 0.731 . . . . 0.0 110.288 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.252 1.215 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.68 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 ttm . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.9 m120 61.28 15.87 6.84 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.093 1.357 . . . . 0.0 111.514 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.421 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 13.8 m -65.68 -42.59 91.1 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.465 1.106 . . . . 0.0 111.348 -169.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.77 -19.17 64.78 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.038 0.935 . . . . 0.0 112.72 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 mm -96.1 -29.69 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.177 0.991 . . . . 0.0 109.617 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -71.53 -36.94 71.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.247 1.019 . . . . 0.0 111.212 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 91.4 mt -58.15 -52.76 72.18 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.061 -175.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 16.9 Cg_endo -57.19 -59.77 0.55 Allowed 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 121.6 1.533 . . . . 0.0 112.271 176.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.453 HG12 ' HD2' ' A' ' 99' ' ' TYR . 16.5 m -62.42 -29.81 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -169.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.461 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 26.2 tp60 -73.44 -55.61 6.13 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 122.852 0.461 . . . . 0.0 110.399 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.2 mmtt -63.68 -36.33 83.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 123.752 0.658 . . . . 0.0 111.002 -175.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.38 -46.0 90.59 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.136 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.44 -48.78 80.33 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 55.7 mm-40 -58.44 -33.72 70.02 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.508 1.13 . . . . 0.0 110.488 -176.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.71 -26.06 32.35 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.574 1.15 . . . . 0.0 112.417 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -69.7 -44.36 70.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.977 0.511 . . . . 0.0 109.945 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.87 -22.79 52.94 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.272 175.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.79 -0.78 57.81 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.28 0.632 . . . . 0.0 112.19 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 mmt85 68.96 7.72 6.39 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.009 1.324 . . . . 0.0 113.323 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.95 98.69 6.51 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.231 0.612 . . . . 0.0 110.228 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.447 HG13 HG12 ' A' ' 54' ' ' ILE . 12.5 mm -63.06 -36.02 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.02 0.528 . . . . 0.0 110.77 172.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -57.52 -49.17 77.21 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.505 0.722 . . . . 0.0 111.405 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.0 -30.79 27.87 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.136 0.575 . . . . 0.0 111.963 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -65.93 -20.68 66.3 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.11 0.256 . . . . 0.0 110.646 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 67.7 mmm -120.16 6.19 10.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.701 0.8 . . . . 0.0 112.107 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.84 -47.57 58.63 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.295 0.569 . . . . 0.0 110.426 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.412 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 92.0 m95 -86.95 9.3 19.85 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.349 -169.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.648 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 30.1 m95 -89.29 156.74 18.55 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 173.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -76.72 149.96 36.33 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 173.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.71 -27.4 68.3 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.74 0.416 . . . . 0.0 110.645 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.97 19.37 19.58 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.596 1.158 . . . . 0.0 111.017 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.648 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 52.1 t -63.5 123.57 19.11 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.058 0.456 . . . . 0.0 111.815 -174.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -85.73 140.44 30.5 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.417 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 63.0 t80 -132.87 110.08 10.06 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -172.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -111.03 155.91 22.06 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.364 1.065 . . . . 0.0 110.955 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.26 160.29 29.6 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.67 170.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -50.93 132.5 29.53 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 124.674 1.19 . . . . 0.0 112.156 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.85 -41.49 0.9 Allowed 'Cis proline' 0 C--N 1.379 2.145 0 CA-C-N 119.961 1.022 . . . . 0.0 113.801 -2.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.06 56.89 0.12 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.215 0.606 . . . . 0.0 110.894 -177.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 75.5 m -109.33 114.22 27.71 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.67 0.788 . . . . 0.0 110.218 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.4 tt -76.5 109.48 10.27 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.17 -44.54 14.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.224 0.61 . . . . 0.0 109.664 174.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -132.13 122.34 25.2 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.742 -171.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.21 46.74 1.13 Allowed Glycine 0 N--CA 1.478 1.448 0 C-N-CA 122.612 0.148 . . . . 0.0 112.793 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.435 ' O ' HG13 ' A' ' 49' ' ' ILE . 9.5 p30 162.34 152.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 126.341 1.856 . . . . 0.0 108.319 -171.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -63.44 -25.38 68.24 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.765 0.826 . . . . 0.0 113.194 -174.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -64.07 -44.27 92.92 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.942 0.497 . . . . 0.0 111.331 -177.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.432 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 33.0 mt-10 -75.68 -33.53 60.39 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 45' ' ' ASN . 53.2 mt -65.77 -42.81 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.098 0.559 . . . . 0.0 110.598 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.463 ' O ' HG13 ' A' ' 54' ' ' ILE . 14.0 ptm180 -66.44 -42.8 87.11 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.952 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 47' ' ' ALA . 97.8 t -61.04 -44.56 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 123.787 0.68 . . . . 0.0 110.572 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -63.59 -34.7 78.4 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.19 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -77.2 -35.55 55.64 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.038 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.48 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 78.9 mt -55.5 -44.22 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 123.195 0.598 . . . . 0.0 110.124 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -54.98 -43.15 73.26 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 124.377 1.048 . . . . 0.0 111.203 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.3 tpp85 -72.68 -30.7 64.47 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.619 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -78.22 -6.63 55.47 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.71 0.404 . . . . 0.0 111.596 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 69.4 mmtt -87.11 -12.63 46.52 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.229 0.612 . . . . 0.0 111.645 171.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.71 114.73 18.96 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.733 0.813 . . . . 0.0 108.886 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.62 -27.21 38.92 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.632 2.221 . . . . 0.0 113.157 -170.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -89.16 -6.54 56.87 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.625 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.4 tp -56.99 121.95 11.17 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.48 0.488 . . . . 0.0 111.571 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -149.31 119.47 7.24 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.495 ' HA2' HG12 ' A' ' 82' ' ' VAL . . . -88.8 104.93 3.13 Favored Glycine 0 C--N 1.34 0.778 0 O-C-N 123.524 0.515 . . . . 0.0 112.197 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -102.43 101.93 12.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 tt -83.74 131.24 34.93 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.432 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -115.65 -30.73 6.07 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.175 0.99 . . . . 0.0 111.136 -173.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.6 m -149.35 130.68 14.67 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.4 0.68 . . . . 0.0 109.344 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -137.82 117.58 13.16 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.43 115.69 47.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.778 0.831 . . . . 0.0 109.573 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.5 tt -106.51 123.9 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 122.935 0.494 . . . . 0.0 109.983 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 t -118.75 95.73 3.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.1 -95.33 0.2 Allowed Glycine 0 CA--C 1.531 1.077 0 O-C-N 123.661 0.601 . . . . 0.0 113.78 176.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -108.39 4.23 24.17 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.456 1.102 . . . . 0.0 111.495 -171.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.93 138.53 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.511 1.124 . . . . 0.0 109.631 -173.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.01 127.62 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.497 0.719 . . . . 0.0 109.388 173.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.477 HG12 ' HB ' ' A' ' 98' ' ' ILE . 4.0 mt -99.03 106.54 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 163.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -89.99 132.5 35.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 172.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -128.58 110.54 12.35 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.24 171.08 8.55 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.366 1.466 . . . . 0.0 109.282 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.426 HG22 ' HB2' ' A' ' 92' ' ' GLU . 97.1 m -125.9 102.64 7.37 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 164.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.495 HG12 ' HA2' ' A' ' 64' ' ' GLY . 15.0 m -84.22 124.37 39.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.843 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.48 HG23 ' HD2' ' A' ' 90' ' ' LYS . 88.2 m -66.4 123.9 21.26 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.958 170.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -129.81 -170.61 2.34 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -126.06 97.29 5.04 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 118.974 0.806 . . . . 0.0 111.018 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -100.92 140.32 21.23 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.093 0.957 . . . . 0.0 108.952 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -64.69 -17.74 60.47 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.687 2.258 . . . . 0.0 113.637 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -83.59 -9.24 59.05 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.925 0.49 . . . . 0.0 112.093 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.66 -120.49 0.94 Allowed Glycine 0 C--N 1.349 1.295 0 CA-C-O 120.041 -0.31 . . . . 0.0 112.495 172.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.48 ' HD2' HG23 ' A' ' 83' ' ' THR . 16.0 tppt? -66.76 -83.28 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.841 0.856 . . . . 0.0 111.317 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 119.44 27.06 2.26 Favored Glycine 0 C--N 1.346 1.086 0 O-C-N 123.094 0.246 . . . . 0.0 112.558 -174.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.426 ' HB2' HG22 ' A' ' 81' ' ' THR . 9.7 pt-20 -89.45 108.62 19.75 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.566 0.698 . . . . 0.0 109.441 -172.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.594 HG12 ' HA ' ' A' ' 116' ' ' PRO . 4.8 m -112.64 142.32 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 122.858 0.463 . . . . 0.0 109.849 -175.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -96.77 144.37 26.82 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.564 HG22 HG12 ' A' ' 113' ' ' ILE . 15.3 t -136.82 136.63 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.608 0.763 . . . . 0.0 109.17 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.32 98.83 9.44 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 170.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 63.1 m -98.22 112.69 24.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.598 0.759 . . . . 0.0 109.641 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.536 HG23 ' HB2' ' A' ' 110' ' ' TRP . 6.3 tt -97.56 110.8 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 123.58 0.752 . . . . 0.0 109.989 177.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.453 ' HD2' HG12 ' A' ' 9' ' ' VAL . 14.6 m-85 -98.32 154.83 17.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.456 0.702 . . . . 0.0 109.843 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -132.88 119.41 20.17 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.18 0.992 . . . . 0.0 108.452 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 56.6 t -94.54 140.03 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.909 0.883 . . . . 0.0 110.254 -174.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 24.3 tt0 -138.98 123.03 17.91 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.82 31.1 16.6 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.537 0.735 . . . . 0.0 110.934 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.49 -5.73 83.91 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.929 -0.578 . . . . 0.0 114.161 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -125.39 134.6 52.09 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.779 0.831 . . . . 0.0 109.748 -175.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 64.2 mt -63.66 103.61 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 122.854 0.462 . . . . 0.0 110.397 -178.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -81.28 -24.84 36.98 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.168 0.587 . . . . 0.0 111.559 -176.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -149.25 139.81 22.54 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.572 0.749 . . . . 0.0 109.405 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.88 138.25 33.79 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.08 0.952 . . . . 0.0 108.786 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.536 ' HB2' HG23 ' A' ' 98' ' ' ILE . 3.2 m-90 -136.84 142.8 42.86 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -142.64 147.1 35.2 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 119.181 0.901 . . . . 0.0 111.233 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -131.91 130.35 41.47 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.852 0.861 . . . . 0.0 108.839 173.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.564 HG12 HG22 ' A' ' 95' ' ' VAL . 95.9 mt -87.85 127.17 41.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.86 -80.22 0.12 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 114.923 -1.035 . . . . 0.0 113.355 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -158.55 163.67 23.58 Favored Pre-proline 0 C--O 1.243 0.745 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.594 ' HA ' HG12 ' A' ' 93' ' ' VAL . 97.8 Cg_endo -81.35 141.5 12.73 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.061 1.841 . . . . 0.0 112.495 166.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -132.67 157.63 44.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.893 0.877 . . . . 0.0 110.335 174.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.454 HG23 ' H ' ' A' ' 90' ' ' LYS . 45.9 mm -133.43 144.47 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.891 1.276 . . . . 0.0 107.825 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.0 t -64.98 -43.04 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 122.948 0.499 . . . . 0.0 110.915 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.0 t -64.13 -30.15 71.23 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.484 0.713 . . . . 0.0 110.847 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -71.13 83.27 0.71 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.58 0.752 . . . . 0.0 109.051 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -166.9 139.59 3.57 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.604 -170.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 C--O 1.253 1.265 0 C-N-CA 123.84 0.856 . . . . 0.0 109.693 176.721 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.3 mtm . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -144.04 25.72 1.56 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.514 1.126 . . . . 0.0 108.054 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.9 m -52.4 -53.17 48.46 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.254 1.422 . . . . 0.0 113.89 -163.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.96 -11.88 59.66 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.416 ' HB ' HD11 ' A' ' 71' ' ' ILE . 13.3 mm -98.38 -30.51 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.978 0.911 . . . . 0.0 109.984 175.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.12 -35.9 71.92 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.137 0.975 . . . . 0.0 110.632 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -65.71 -46.71 67.13 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.219 1.407 . . . . 0.0 112.579 -168.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 11.6 Cg_endo -55.13 -57.81 1.49 Allowed 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 121.561 1.507 . . . . 0.0 111.425 171.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.502 HG21 HG21 ' A' ' 76' ' ' VAL . 73.6 t -59.63 -33.37 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.506 1.122 . . . . 0.0 112.407 -173.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.569 ' HA ' HH12 ' A' ' 69' ' ' ARG . 0.9 OUTLIER -69.43 -56.07 8.49 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.532 0.733 . . . . 0.0 110.306 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -66.34 -35.4 80.25 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.414 0.686 . . . . 0.0 111.423 -174.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.04 -39.29 93.13 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.615 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.688 ' HB2' HH22 ' A' ' 69' ' ' ARG . 58.1 tp -59.02 -52.55 65.28 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.671 0.607 . . . . 0.0 110.666 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -54.97 -46.92 75.11 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.969 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.54 -30.69 71.47 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.336 1.054 . . . . 0.0 112.307 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -68.74 -48.54 63.51 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.154 0.582 . . . . 0.0 110.467 -175.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -82.21 -19.79 39.04 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.098 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.01 -3.56 58.89 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.408 0.683 . . . . 0.0 112.124 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 68.2 21.24 8.62 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.773 1.229 . . . . 0.0 112.171 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -90.05 123.21 33.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.934 0.894 . . . . 0.0 110.506 174.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.5 mm -87.15 -28.32 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.47 0.708 . . . . 0.0 110.736 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.44 -47.29 86.04 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.325 0.65 . . . . 0.0 111.981 -170.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.64 -32.24 41.62 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.072 0.549 . . . . 0.0 110.66 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -73.27 -7.18 50.44 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.088 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.728 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 1.1 tpt -116.94 -33.95 4.58 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.303 0.641 . . . . 0.0 111.864 176.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.09 -48.53 78.36 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.338 0.655 . . . . 0.0 112.066 -172.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 99.1 m95 -76.43 -0.67 23.71 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.236 -173.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.654 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 14.8 m95 -91.99 149.4 21.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 173.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 107' ' ' ALA . . . -75.42 155.15 36.64 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.975 0.51 . . . . 0.0 110.651 176.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.75 -24.55 66.98 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.451 0.701 . . . . 0.0 111.384 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -104.56 19.19 20.81 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 124.366 1.066 . . . . 0.0 110.465 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.654 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 49.0 t -60.52 114.86 3.19 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -173.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -92.49 102.87 15.32 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.887 0.875 . . . . 0.0 110.099 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.46 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 78.4 t80 -97.08 111.28 23.58 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 125.265 1.426 . . . . 0.0 110.242 -173.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.497 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 45.5 m-85 -111.08 155.59 22.58 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.53 1.132 . . . . 0.0 110.55 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.69 157.05 23.67 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.242 170.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -55.81 134.3 72.71 Favored Pre-proline 0 CA--C 1.564 1.497 0 C-N-CA 124.374 1.07 . . . . 0.0 112.251 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.33 -40.83 1.11 Allowed 'Cis proline' 0 C--N 1.381 2.289 0 CA-C-N 120.146 1.088 . . . . 0.0 113.011 -8.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.16 92.62 0.75 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.983 0.913 . . . . 0.0 108.945 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.417 ' O ' HD22 ' A' ' 42' ' ' LEU . 90.5 m -139.0 117.38 11.98 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.729 0.812 . . . . 0.0 108.863 176.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 tt -81.93 103.14 11.37 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -176.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.417 HD22 ' O ' ' A' ' 40' ' ' THR . 2.4 mm? -89.73 -29.42 18.73 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.509 0.323 . . . . 0.0 110.785 177.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -146.83 116.34 7.09 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -175.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.96 36.26 4.22 Favored Glycine 0 N--CA 1.478 1.478 0 C-N-CA 123.19 0.424 . . . . 0.0 113.396 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 p30 168.94 163.28 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.473 1.509 . . . . 0.0 109.438 -172.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -64.0 -35.42 80.66 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.945 0.898 . . . . 0.0 112.602 -177.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.86 -45.61 91.89 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.164 0.586 . . . . 0.0 111.717 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -71.67 -31.82 67.22 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.709 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.3 mt -66.04 -38.73 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.55 0.74 . . . . 0.0 110.097 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.728 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 75.3 ttt180 -62.27 -57.05 12.82 Favored 'General case' 0 C--N 1.348 0.53 0 O-C-N 123.994 0.809 . . . . 0.0 110.091 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.2 t -55.34 -48.41 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 125.043 1.464 . . . . 0.0 110.843 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.1 ttt-85 -61.33 -37.74 84.38 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.325 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -78.75 -28.37 44.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 118.889 -0.577 . . . . 0.0 112.136 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 50' ' ' ARG . 97.2 mt -61.64 -44.43 98.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 118.879 0.763 . . . . 0.0 109.06 174.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -65.33 -34.33 78.08 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.978 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -71.16 -30.33 66.32 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.2 0.6 . . . . 0.0 110.961 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -79.55 -5.7 55.47 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.127 0.571 . . . . 0.0 111.304 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -82.53 -8.57 59.61 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.875 0.47 . . . . 0.0 111.577 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 24.0 mm-40 -70.1 118.64 65.62 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.81 -22.25 27.52 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.32 2.013 . . . . 0.0 112.76 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.07 -6.97 49.99 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.727 0.811 . . . . 0.0 111.731 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 21.7 tp -58.43 111.89 1.39 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.222 0.464 . . . . 0.0 111.282 -175.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -148.23 117.01 6.68 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.99 126.71 8.19 Favored Glycine 0 C--O 1.24 0.482 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 171.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -119.46 100.9 7.58 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.8 tt -91.29 117.87 30.01 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.454 HD22 ' H ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.45 -47.01 5.56 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.378 1.071 . . . . 0.0 109.559 175.059 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.3 m -121.69 139.42 53.59 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.601 0.76 . . . . 0.0 111.672 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.688 HH22 ' HB2' ' A' ' 13' ' ' LEU . 2.2 ptp180 -144.07 125.17 14.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.455 0.702 . . . . 0.0 109.322 159.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.4 m -110.71 152.4 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.999 0.919 . . . . 0.0 108.88 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.416 HD11 ' HB ' ' A' ' 5' ' ' ILE . 19.7 tt -138.53 144.97 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 122.604 0.361 . . . . 0.0 110.812 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 75' ' ' VAL . 2.1 p -149.46 101.67 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 124.431 1.093 . . . . 0.0 109.075 -177.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.2 -123.35 20.78 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.488 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -98.76 19.32 15.05 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.831 0.453 . . . . 0.0 111.749 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 72' ' ' VAL . 3.0 p -135.28 139.32 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.102 0.561 . . . . 0.0 110.785 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.502 HG21 HG21 ' A' ' 9' ' ' VAL . 15.8 t -124.86 141.86 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.047 0.939 . . . . 0.0 110.165 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.51 HD13 ' HB ' ' A' ' 98' ' ' ILE . 8.4 mm -107.28 104.4 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 165.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -100.95 114.17 27.81 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -106.11 112.07 24.96 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.875 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -108.42 166.69 10.58 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.22 171.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.5 m -99.98 100.87 11.82 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 152.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.0 m -86.82 138.59 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 37.6 m -95.99 120.11 35.68 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.055 0.455 . . . . 0.0 110.664 -173.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -111.46 -162.8 0.81 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 175.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 66.2 t30 -132.57 110.1 10.22 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.226 -0.296 . . . . 0.0 110.474 172.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -104.96 143.3 26.42 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 124.425 1.09 . . . . 0.0 108.741 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.05 -9.9 26.49 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.663 2.242 . . . . 0.0 113.706 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -85.48 -13.09 50.21 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.782 0.433 . . . . 0.0 112.085 175.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.68 -129.86 1.56 Allowed Glycine 0 C--N 1.349 1.262 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.981 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 15.8 tppt? -75.25 -72.32 0.31 Allowed 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.196 0.598 . . . . 0.0 110.428 174.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.92 26.94 3.13 Favored Glycine 0 C--N 1.341 0.836 0 O-C-N 123.277 0.361 . . . . 0.0 113.723 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 117' ' ' ARG . 4.8 pm0 -90.29 122.37 33.14 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -174.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 116' ' ' PRO . 34.1 m -123.57 143.63 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.448 0.699 . . . . 0.0 110.619 -169.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -79.34 108.4 12.83 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.139 0.575 . . . . 0.0 109.657 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.495 HG22 HG12 ' A' ' 113' ' ' ILE . 59.8 t -123.41 138.81 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.84 0.856 . . . . 0.0 110.078 -176.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.34 117.91 30.81 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.528 0.731 . . . . 0.0 109.399 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 64.2 m -94.27 123.29 37.58 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.61 HG23 ' HB2' ' A' ' 110' ' ' TRP . 10.3 tt -104.78 105.23 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.369 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.416 ' HD2' HG22 ' A' ' 9' ' ' VAL . 22.9 m-85 -99.53 127.88 45.62 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.613 0.765 . . . . 0.0 109.996 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -100.42 113.26 25.88 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 168.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.55 HG22 HG12 ' A' ' 106' ' ' ILE . 60.8 t -97.28 126.05 50.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 125.123 1.369 . . . . 0.0 110.508 -175.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -133.15 139.28 46.99 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.108 0.963 . . . . 0.0 109.635 174.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.8 m120 63.21 29.46 15.97 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.736 1.214 . . . . 0.0 111.644 -173.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.51 8.42 62.87 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.893 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -128.46 145.24 51.16 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.759 1.224 . . . . 0.0 108.4 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.55 HG12 HG22 ' A' ' 101' ' ' VAL . 57.5 mt -69.78 100.53 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 118.435 0.562 . . . . 0.0 109.832 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . . . -87.61 -15.31 37.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.723 0.409 . . . . 0.0 111.626 -177.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -148.33 129.73 14.79 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.4 132.93 48.51 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.61 ' HB2' HG23 ' A' ' 98' ' ' ILE . 1.6 m-90 -133.98 152.59 51.91 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -143.72 148.55 35.87 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 118.805 0.73 . . . . 0.0 111.251 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.7 129.72 51.53 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.422 1.089 . . . . 0.0 109.546 176.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.495 HG12 HG22 ' A' ' 95' ' ' VAL . 75.2 mt -90.23 127.76 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 171.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.53 -74.11 0.93 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.24 -176.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.96 167.41 13.23 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.099 0.56 . . . . 0.0 109.49 -175.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.658 ' HA ' HG12 ' A' ' 93' ' ' VAL . 56.8 Cg_endo -84.21 137.79 7.39 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.428 2.086 . . . . 0.0 113.001 168.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 29.3 mmt180 -131.22 149.64 52.49 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.974 0.91 . . . . 0.0 109.126 173.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.6 mm -131.58 131.55 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.033 0.933 . . . . 0.0 108.608 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.67 -37.85 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 C-N-CA 123.218 0.607 . . . . 0.0 111.64 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.1 m -76.04 -18.81 59.08 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.167 0.587 . . . . 0.0 111.466 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.69 98.82 0.55 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.594 0.758 . . . . 0.0 109.107 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.48 113.12 5.36 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.859 0.463 . . . . 0.0 109.848 -175.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 C--O 1.255 1.389 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.776 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 tmm? . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 60.56 14.24 4.76 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 124.433 1.093 . . . . 0.0 111.894 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 14.4 m -75.75 -20.31 58.39 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.235 1.014 . . . . 0.0 112.483 -167.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -72.76 -19.77 61.31 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.527 0.331 . . . . 0.0 111.358 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.51 ' HB ' HD11 ' A' ' 71' ' ' ILE . 37.5 mm -88.88 -27.41 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 173.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.656 ' HG2' HH12 ' A' ' 69' ' ' ARG . 40.2 mt-10 -78.45 -19.79 52.4 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.663 173.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 3' ' ' SER . 77.6 mt -61.5 -50.75 81.38 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-O 118.736 -0.649 . . . . 0.0 111.729 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 19.6 Cg_endo -59.09 -55.33 1.98 Allowed 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 121.745 1.63 . . . . 0.0 111.709 173.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.1 t -54.4 -47.97 69.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 125.681 1.592 . . . . 0.0 113.576 -172.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -62.22 -47.4 84.59 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.859 0.864 . . . . 0.0 110.212 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -68.63 -35.18 76.95 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.632 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.29 -51.79 67.41 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.475 0.71 . . . . 0.0 111.033 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.66 -49.37 78.0 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.963 0.789 . . . . 0.0 109.494 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -60.11 -35.0 74.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 123.972 0.795 . . . . 0.0 111.03 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -74.17 -28.0 61.09 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.058 0.943 . . . . 0.0 111.395 175.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -70.36 -42.59 71.63 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.369 0.668 . . . . 0.0 110.238 -174.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -82.04 -28.33 32.54 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.433 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.92 11.38 27.48 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 63.74 20.69 12.35 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.351 1.06 . . . . 0.0 112.412 172.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.484 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 4.5 t70 -91.38 100.62 13.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.54 0.736 . . . . 0.0 109.406 -178.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.492 HG13 HG12 ' A' ' 54' ' ' ILE . 10.4 mm -74.47 -28.8 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.255 0.222 . . . . 0.0 110.974 173.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -62.72 -45.42 92.84 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.501 0.721 . . . . 0.0 110.891 -172.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.89 -36.05 31.76 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.787 0.835 . . . . 0.0 110.569 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -64.94 -8.8 17.17 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.25 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.753 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -112.27 -31.48 6.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.538 0.735 . . . . 0.0 111.855 174.033 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.07 -28.77 66.79 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -170.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 96.7 m95 -96.82 13.85 27.22 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.81 0.844 . . . . 0.0 112.782 -175.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.409 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 13.3 m95 -112.83 147.54 36.74 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.834 0.853 . . . . 0.0 109.011 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -72.48 152.86 41.67 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.402 0.681 . . . . 0.0 110.517 175.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.67 -27.72 69.43 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.264 0.625 . . . . 0.0 111.642 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -101.45 12.26 37.65 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.153 0.981 . . . . 0.0 111.345 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.409 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 53.4 t -59.69 125.89 25.42 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -169.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -81.08 150.41 28.8 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.593 0.757 . . . . 0.0 109.562 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.416 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 59.6 t80 -146.73 112.88 5.83 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.344 0.658 . . . . 0.0 109.309 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.412 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 34.1 m-85 -114.26 150.77 33.88 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.003 0.921 . . . . 0.0 111.331 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.525 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -99.03 159.44 14.97 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 113.942 -1.481 . . . . 0.0 108.294 165.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -58.65 136.83 86.44 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-O 119.116 -0.468 . . . . 0.0 110.269 173.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.83 -55.97 0.14 OUTLIER 'Cis proline' 0 C--N 1.381 2.263 0 CA-C-N 120.406 1.181 . . . . 0.0 112.556 -7.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -148.2 58.92 1.1 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.708 0.766 . . . . 0.0 109.865 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.4 m -95.65 104.0 15.9 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.407 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.64 104.29 1.58 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 36' ' ' ALA . 56.9 mt -82.1 -45.68 14.88 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.153 177.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -143.46 117.1 9.21 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.992 -172.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.77 37.05 3.89 Favored Glycine 0 N--CA 1.478 1.465 0 C-N-CA 122.874 0.273 . . . . 0.0 113.536 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.3 p30 168.74 156.26 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.786 1.634 . . . . 0.0 109.013 -171.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -58.97 -36.11 74.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.806 0.842 . . . . 0.0 112.82 -174.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.17 94.68 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.073 0.549 . . . . 0.0 112.082 -173.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.447 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 29.1 mt-10 -76.24 -32.54 58.95 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.969 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 78.5 mt -63.54 -42.83 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.396 0.679 . . . . 0.0 109.97 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.753 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 74.6 ttt180 -56.03 -58.51 7.61 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.913 1.285 . . . . 0.0 110.861 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.32 -35.55 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.876 -168.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -72.0 -34.11 68.61 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.857 0.463 . . . . 0.0 110.334 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -74.57 -27.07 60.34 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.742 -0.646 . . . . 0.0 111.548 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.492 HG12 HG13 ' A' ' 21' ' ' ILE . 85.1 mt -56.99 -42.72 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 118.453 0.57 . . . . 0.0 109.837 173.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -61.09 -37.24 82.02 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.009 0.818 . . . . 0.0 111.151 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -64.97 -39.15 93.05 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.571 0.749 . . . . 0.0 110.064 174.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -81.3 1.85 30.71 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.1 0.96 . . . . 0.0 112.17 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 9.8 mmpt? -95.97 -16.04 21.95 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.805 0.442 . . . . 0.0 111.177 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -70.54 122.64 87.19 Favored Pre-proline 0 N--CA 1.482 1.138 0 CA-C-O 119.023 -0.513 . . . . 0.0 109.965 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.22 -26.02 72.3 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.59 2.194 . . . . 0.0 112.374 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -86.12 -5.82 59.13 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.871 0.868 . . . . 0.0 112.137 -177.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.4 tp -57.87 114.39 2.29 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 120.969 0.414 . . . . 0.0 110.575 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -147.5 117.03 7.02 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 169.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.96 102.29 1.74 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -97.07 102.86 14.73 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' A' ' 69' ' ' ARG . 8.2 tt -74.59 115.61 14.34 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 171.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.504 ' H ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -101.45 -29.86 11.76 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.52 0.728 . . . . 0.0 110.695 -177.087 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.2 m -150.19 133.15 16.1 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.865 0.866 . . . . 0.0 110.008 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.656 HH12 ' HG2' ' A' ' 6' ' ' GLU . 52.5 ptt85 -139.56 139.69 36.91 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.139 0.576 . . . . 0.0 109.637 170.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.9 m -121.95 125.64 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.951 0.901 . . . . 0.0 109.455 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.51 HD11 ' HB ' ' A' ' 5' ' ' ILE . 14.0 tt -108.21 135.87 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 121.005 0.431 . . . . 0.0 110.713 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 p -142.68 96.24 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 124.778 1.231 . . . . 0.0 108.557 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.44 -124.69 22.41 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.616 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -88.25 7.51 31.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.17 0.588 . . . . 0.0 112.559 -175.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.16 142.86 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 122.989 0.516 . . . . 0.0 110.952 -175.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.13 141.88 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.796 0.839 . . . . 0.0 109.745 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.611 HD13 ' HB ' ' A' ' 98' ' ' ILE . 5.2 mm -99.25 105.88 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 168.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -99.34 105.43 17.41 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.498 0.719 . . . . 0.0 109.668 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -98.83 104.47 16.52 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -102.09 164.1 11.88 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.421 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.6 m -105.68 101.88 11.37 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 158.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.0 t -85.87 103.43 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.883 1.273 . . . . 0.0 110.028 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 48.3 m -71.12 127.16 31.64 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.624 0.77 . . . . 0.0 111.276 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -117.25 -161.37 0.81 Allowed 'General case' 0 C--O 1.247 0.931 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -131.65 103.82 6.59 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 172.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -108.37 134.96 20.03 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 123.861 0.864 . . . . 0.0 109.528 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.74 -10.98 24.41 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.426 2.751 . . . . 0.0 114.359 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -79.61 -28.31 40.98 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.94 0.496 . . . . 0.0 111.337 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.28 -115.63 0.49 Allowed Glycine 0 C--N 1.35 1.328 0 C-N-CA 121.497 -0.383 . . . . 0.0 112.873 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -70.02 -80.81 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.12 0.968 . . . . 0.0 111.437 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 116.15 26.45 3.22 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 116.437 -0.347 . . . . 0.0 113.221 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 9.3 pt-20 -89.0 114.54 25.73 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.416 0.627 . . . . 0.0 109.872 -172.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.657 HG12 ' HA ' ' A' ' 116' ' ' PRO . 33.6 m -111.0 126.15 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.183 0.593 . . . . 0.0 109.637 -173.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.19 109.28 13.37 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.1 t -113.06 131.8 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.321 0.648 . . . . 0.0 110.248 -172.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.1 99.87 12.38 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.756 0.822 . . . . 0.0 109.323 173.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 56.9 m -94.47 108.2 20.14 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.433 1.093 . . . . 0.0 108.436 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.611 ' HB ' HD13 ' A' ' 77' ' ' ILE . 5.1 tt -106.37 115.21 47.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.937 0.895 . . . . 0.0 110.205 -174.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -112.47 133.79 54.35 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.33 0.652 . . . . 0.0 110.025 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -106.96 112.88 26.04 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.766 0.826 . . . . 0.0 108.803 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 50.1 t -85.18 140.12 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.137 1.375 . . . . 0.0 110.332 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -141.31 105.64 4.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.287 1.035 . . . . 0.0 108.866 -173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.9 m120 62.4 31.67 17.13 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.651 1.18 . . . . 0.0 112.11 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.86 -7.58 67.69 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.78 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -131.72 133.37 44.75 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.725 0.81 . . . . 0.0 109.653 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 67.1 mt -67.57 112.11 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.507 0.723 . . . . 0.0 110.191 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.25 -10.98 26.67 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -150.28 131.13 14.18 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.58 139.78 31.48 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.629 0.772 . . . . 0.0 109.232 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.421 ' HB2' HG23 ' A' ' 98' ' ' ILE . 3.1 m-90 -138.29 156.99 47.12 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -143.5 147.09 33.98 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.028 0.442 . . . . 0.0 110.149 171.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -129.02 122.51 30.19 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.245 1.018 . . . . 0.0 108.363 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.7 mt -87.69 130.38 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.35 -129.87 0.56 Allowed Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.469 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -90.18 161.11 38.59 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.657 ' HA ' HG12 ' A' ' 93' ' ' VAL . 76.2 Cg_endo -83.96 114.79 1.98 Allowed 'Trans proline' 0 CA--C 1.551 1.357 0 C-N-CA 122.234 1.956 . . . . 0.0 112.136 167.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.426 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 34.6 mtm180 -107.0 148.42 28.71 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 121.852 0.834 . . . . 0.0 110.759 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 120' ' ' SER . 47.3 mm -128.65 147.09 33.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.7 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 58.5 t -55.07 -29.34 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.553 0.741 . . . . 0.0 112.488 -177.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.43 ' H ' HG22 ' A' ' 118' ' ' ILE . 80.4 p -73.09 -45.33 57.78 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.789 0.835 . . . . 0.0 112.335 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -104.3 -4.37 23.04 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -168.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.7 ' HE3' ' HA ' ' A' ' 119' ' ' VAL . 19.1 ptpt -61.36 149.07 39.36 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -173.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.2 p . . . . . 0 CA--C 1.559 1.291 0 C-N-CA 123.714 0.806 . . . . 0.0 109.966 -177.944 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 121.255 0.55 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -132.18 21.62 4.45 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.113 0.965 . . . . 0.0 109.54 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.447 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 22.2 t -68.73 -45.78 70.61 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 123.963 0.905 . . . . 0.0 110.902 -175.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -60.63 -17.33 46.41 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.886 0.875 . . . . 0.0 112.909 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.445 HG23 ' HB ' ' A' ' 101' ' ' VAL . 28.1 mm -87.29 -34.6 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.239 0.616 . . . . 0.0 109.574 178.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.91 -17.78 32.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 118.652 -0.69 . . . . 0.0 112.053 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.2 mt -62.7 -50.36 78.32 Favored Pre-proline 0 N--CA 1.488 1.465 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.635 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.64 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 14.1 Cg_endo -57.25 -51.92 7.59 Favored 'Trans proline' 0 C--N 1.388 2.642 0 C-N-CA 122.089 1.86 . . . . 0.0 112.047 172.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.96 -31.31 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 C-N-CA 124.55 1.14 . . . . 0.0 112.733 -172.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.61 -47.86 44.42 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.82 0.848 . . . . 0.0 109.519 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.1 mmtt -70.62 -25.56 63.09 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.947 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -61.1 -46.77 89.26 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.654 0.597 . . . . 0.0 110.39 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.39 -50.45 71.56 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.144 0.903 . . . . 0.0 109.54 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -57.57 -45.78 84.77 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 124.656 1.222 . . . . 0.0 109.524 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -68.82 -26.62 65.26 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.932 -1.485 . . . . 0.0 112.161 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -73.39 -38.71 65.54 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.022 0.529 . . . . 0.0 109.667 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -91.08 -29.9 17.06 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.563 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.69 0.29 57.45 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.361 0.664 . . . . 0.0 111.989 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.9 mmt-85 65.96 24.26 11.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.523 1.129 . . . . 0.0 113.121 172.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 48.1 m-20 -87.97 95.26 10.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.954 0.406 . . . . 0.0 110.724 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.52 HG13 HG12 ' A' ' 54' ' ' ILE . 8.3 mm -64.05 -30.44 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.568 0.747 . . . . 0.0 111.314 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.87 -45.63 92.93 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.313 0.383 . . . . 0.0 111.116 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.82 -35.99 62.43 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.259 0.624 . . . . 0.0 110.711 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -71.73 -4.4 27.36 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.845 0.858 . . . . 0.0 111.052 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.754 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -120.95 -23.2 5.94 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 172.198 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.74 -35.79 75.28 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.672 0.789 . . . . 0.0 112.82 -173.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.64 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 97.2 m95 -89.89 -7.69 53.6 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.625 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 14.6 m95 -91.91 143.75 26.17 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.288 0.635 . . . . 0.0 110.049 -173.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.72 152.31 45.5 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.216 0.607 . . . . 0.0 110.066 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -68.82 -24.2 64.36 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 120.932 0.396 . . . . 0.0 110.689 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.59 19.32 16.01 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.727 1.211 . . . . 0.0 110.69 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.625 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 42.7 t -65.04 122.49 17.15 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 122.073 -0.392 . . . . 0.0 111.628 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -87.39 154.61 20.53 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.745 0.818 . . . . 0.0 109.331 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 48.2 t80 -145.06 114.28 7.03 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.416 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 17.3 m-85 -109.23 153.91 23.16 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.51 0.724 . . . . 0.0 110.288 176.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.406 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -112.84 151.28 30.58 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.066 173.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.617 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 84.7 t80 -57.64 128.84 80.47 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 123.656 0.782 . . . . 0.0 111.581 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.92 -50.32 0.19 OUTLIER 'Cis proline' 0 C--N 1.389 2.666 0 CA-C-N 120.464 1.201 . . . . 0.0 114.046 0.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.41 91.63 0.93 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.958 0.903 . . . . 0.0 108.757 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.3 m -136.7 107.84 6.78 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.5 103.97 1.8 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.271 0.628 . . . . 0.0 109.695 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.406 HD11 ' HB2' ' A' ' 36' ' ' ALA . 49.5 mt -80.63 -36.55 32.45 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.948 0.899 . . . . 0.0 110.71 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -140.09 121.18 14.72 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.154 0.582 . . . . 0.0 111.436 -171.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -107.62 40.01 2.68 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 123.401 0.524 . . . . 0.0 113.042 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.9 p30 165.64 164.67 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 126.023 1.729 . . . . 0.0 108.963 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.15 -37.86 88.73 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.777 0.831 . . . . 0.0 112.556 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.46 -43.26 99.18 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.294 0.638 . . . . 0.0 112.337 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -73.08 -30.0 63.35 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.711 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.435 HG21 ' CZ3' ' A' ' 28' ' ' TRP . 85.9 mt -66.58 -46.15 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.517 0.727 . . . . 0.0 109.871 173.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.754 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 36.8 ttt180 -56.28 -56.4 21.46 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.837 -176.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.444 ' HA ' HD12 ' A' ' 54' ' ' ILE . 29.4 m -63.48 -37.31 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 124.543 1.152 . . . . 0.0 113.147 -172.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -71.37 -34.51 70.5 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.028 0.442 . . . . 0.0 110.753 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -76.5 -26.96 55.84 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 118.965 -0.541 . . . . 0.0 111.2 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.52 HG12 HG13 ' A' ' 21' ' ' ILE . 85.6 mt -59.66 -47.82 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 172.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.03 -42.25 89.76 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.998 0.919 . . . . 0.0 111.179 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -66.44 -32.71 74.26 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.104 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -82.04 -13.31 57.53 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.259 0.624 . . . . 0.0 111.356 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 67.4 mmtt -73.13 -28.82 62.47 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.737 0.415 . . . . 0.0 110.486 170.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.53 115.38 21.56 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.987 0.915 . . . . 0.0 109.991 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.1 -22.76 18.96 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.578 2.185 . . . . 0.0 112.693 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.85 -12.09 59.48 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.786 0.834 . . . . 0.0 111.508 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.7 tp -60.02 117.17 4.77 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 123.515 0.509 . . . . 0.0 109.975 175.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -149.87 117.11 6.03 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.7 103.08 2.91 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -94.47 102.06 13.99 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 tt -82.83 125.39 31.27 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.49 ' H ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -116.57 -29.98 5.97 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.01 0.924 . . . . 0.0 111.077 178.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 92.2 m -144.96 133.59 22.12 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.428 0.691 . . . . 0.0 109.991 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.5 ' NH2' HG11 ' A' ' 76' ' ' VAL . 7.4 ptm180 -142.87 138.35 30.2 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.929 0.492 . . . . 0.0 110.429 171.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.466 HG22 ' HB ' ' A' ' 77' ' ' ILE . 15.0 m -128.67 158.35 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 124.517 1.127 . . . . 0.0 108.761 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -129.75 142.53 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-O 121.025 0.44 . . . . 0.0 110.085 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.483 HG13 HG13 ' A' ' 75' ' ' VAL . 2.2 p -137.1 95.85 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 124.509 1.124 . . . . 0.0 108.945 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.71 -120.14 8.73 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.024 -0.535 . . . . 0.0 113.154 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -97.47 15.0 24.46 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.108 0.563 . . . . 0.0 112.063 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.483 HG13 HG13 ' A' ' 72' ' ' VAL . 4.4 p -135.88 135.5 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.526 0.73 . . . . 0.0 110.255 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.5 HG11 ' NH2' ' A' ' 69' ' ' ARG . 5.1 t -114.05 141.92 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.354 0.662 . . . . 0.0 110.245 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.469 HD13 ' HB ' ' A' ' 98' ' ' ILE . 17.7 mm -99.67 114.73 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.929 1.292 . . . . 0.0 107.896 168.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -112.21 106.03 14.51 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -97.62 107.17 19.61 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -112.78 144.58 42.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.168 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.1 m -91.55 102.08 14.73 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 162.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.8 m -92.83 133.36 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.104 0.478 . . . . 0.0 110.791 -176.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 73.0 m -81.31 120.73 25.3 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.771 -177.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.617 HH21 HG11 ' A' ' 93' ' ' VAL . 72.9 mtm180 -118.84 -162.86 0.92 Allowed 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.693 1.197 . . . . 0.0 107.911 170.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -125.09 108.54 11.9 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 118.477 0.58 . . . . 0.0 110.994 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.411 ' CG ' ' HA2' ' A' ' 91' ' ' GLY . 11.7 m-30 -109.95 145.03 31.21 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 123.794 0.838 . . . . 0.0 109.824 176.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.94 -19.03 67.94 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 123.369 2.713 . . . . 0.0 114.164 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -79.57 -20.04 47.97 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.29 -111.36 0.46 Allowed Glycine 0 C--N 1.348 1.242 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.726 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -62.37 -82.32 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.957 0.903 . . . . 0.0 111.693 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.411 ' HA2' ' CG ' ' A' ' 86' ' ' PHE . . . 117.14 26.1 3.06 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.994 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -87.22 138.83 31.15 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.617 HG11 HH21 ' A' ' 84' ' ' ARG . 13.9 m -137.12 140.95 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 121.988 -0.445 . . . . 0.0 111.316 -173.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -75.6 112.79 12.31 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 174.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.408 HG22 HG12 ' A' ' 113' ' ' ILE . 61.3 t -129.24 133.6 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.079 0.952 . . . . 0.0 108.499 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.77 111.13 23.47 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.4 m -94.08 107.49 19.41 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' A' ' 110' ' ' TRP . 5.4 tt -112.87 107.94 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 124.35 1.06 . . . . 0.0 109.82 -169.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -109.93 127.91 55.05 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.815 0.846 . . . . 0.0 110.408 -174.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 33.6 tt0 -99.26 112.81 24.89 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 173.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.466 HG22 HG12 ' A' ' 106' ' ' ILE . 60.7 t -96.98 113.14 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.322 1.049 . . . . 0.0 109.492 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 35.0 tt0 -113.54 126.88 55.79 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.835 0.854 . . . . 0.0 108.94 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 63.09 33.67 14.39 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.262 1.025 . . . . 0.0 112.096 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.86 7.2 88.7 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.807 -0.633 . . . . 0.0 114.336 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -133.84 143.76 48.53 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.161 0.984 . . . . 0.0 108.852 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 8' ' ' PRO . 55.2 mt -67.95 102.7 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.407 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -84.06 -23.02 31.03 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.165 0.586 . . . . 0.0 111.02 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 79.5 mttt -149.28 146.47 27.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.01 0.924 . . . . 0.0 109.061 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -142.81 133.07 24.66 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.627 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.0 m-90 -135.68 159.49 41.48 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -142.78 145.6 33.42 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 169.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.617 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 14.4 ptmm? -126.86 123.52 37.48 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.408 HG12 HG22 ' A' ' 95' ' ' VAL . 95.1 mt -89.33 116.16 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.4 -71.8 1.03 Allowed Glycine 0 CA--C 1.523 0.561 0 CA-C-N 114.24 -1.345 . . . . 0.0 113.592 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -157.01 162.86 26.84 Favored Pre-proline 0 CA--C 1.548 0.904 0 CA-C-N 116.825 0.313 . . . . 0.0 110.723 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.584 ' HA ' HG12 ' A' ' 93' ' ' VAL . 92.7 Cg_endo -77.37 137.01 16.36 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.598 2.199 . . . . 0.0 113.596 171.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.462 ' HA ' ' NE2' ' A' ' 121' ' ' GLN . 34.6 mmt180 -129.26 153.56 47.67 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.438 1.095 . . . . 0.0 109.98 176.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 120' ' ' SER . 30.4 mm -138.98 151.51 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.5 t -56.94 -45.98 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 122.999 0.52 . . . . 0.0 111.259 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.481 ' H ' HG22 ' A' ' 118' ' ' ILE . 22.7 t -78.62 -11.43 59.97 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.84 0.856 . . . . 0.0 112.763 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.462 ' NE2' ' HA ' ' A' ' 117' ' ' ARG . 31.4 tt0 -51.91 -53.22 43.53 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.699 0.8 . . . . 0.0 111.456 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -84.73 100.27 11.39 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 173.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.4 t . . . . . 0 C--O 1.255 1.372 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.56 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.733 0.301 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -102.68 27.12 7.22 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.584 0.753 . . . . 0.0 110.882 -170.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.4 m -71.8 -35.07 69.85 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.405 0.682 . . . . 0.0 112.693 -169.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -14.36 62.02 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.649 0.38 . . . . 0.0 111.718 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.486 ' HB ' HD11 ' A' ' 71' ' ' ILE . 27.2 mm -90.68 -28.45 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.866 0.867 . . . . 0.0 110.111 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.28 -32.08 71.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.676 0.79 . . . . 0.0 111.615 173.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.6 mt -61.94 -52.1 70.46 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-O 118.675 -0.678 . . . . 0.0 112.358 -175.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 23.0 Cg_endo -60.35 -51.1 5.8 Favored 'Trans proline' 0 C--N 1.396 3.063 0 C-N-CA 122.493 2.129 . . . . 0.0 113.739 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.5 m -67.81 -32.72 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 122.699 0.4 . . . . 0.0 112.025 -170.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -73.38 -50.68 20.61 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.255 0.622 . . . . 0.0 111.076 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -70.96 -30.64 66.98 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.558 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -69.6 -39.6 77.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.142 0.577 . . . . 0.0 109.477 177.775 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -58.87 -52.28 66.41 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.219 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.44 -29.57 64.28 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.824 0.702 . . . . 0.0 111.202 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 20' ' ' ASP . . . -79.47 -31.57 42.44 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.997 0.919 . . . . 0.0 111.881 176.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -62.94 -51.29 67.48 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.173 0.589 . . . . 0.0 111.271 -173.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -75.96 -20.94 57.52 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.691 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.9 1.23 54.57 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.515 0.726 . . . . 0.0 112.401 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 62.86 22.79 13.63 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.656 1.182 . . . . 0.0 111.936 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.433 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 5.8 t70 -89.86 131.74 35.63 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.433 ' HA ' ' HB3' ' A' ' 24' ' ' PHE . 14.9 mm -104.12 -27.46 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.292 0.637 . . . . 0.0 110.816 174.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.27 -48.36 81.78 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.85 0.46 . . . . 0.0 111.58 -176.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.46 -33.76 36.44 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.749 0.82 . . . . 0.0 110.637 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.433 ' HB3' ' HA ' ' A' ' 21' ' ' ILE . 49.8 t80 -59.87 -24.7 64.46 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.39 175.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 79.6 mmm -120.44 0.6 10.57 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.09 -41.16 77.86 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.367 0.603 . . . . 0.0 111.608 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 89.9 m95 -83.42 -0.02 48.15 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.654 -173.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.558 ' HE1' ' HG3' ' A' ' 12' ' ' GLN . 21.7 m95 -91.24 143.17 26.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.225 0.61 . . . . 0.0 110.352 -175.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.55 48.12 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.9 173.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.56 -28.64 70.01 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 120.84 0.353 . . . . 0.0 111.588 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -97.4 19.08 13.85 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.205 1.002 . . . . 0.0 110.973 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.476 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 48.6 t -62.62 123.52 18.58 Favored 'General case' 0 C--N 1.357 0.909 0 O-C-N 121.913 -0.492 . . . . 0.0 111.987 -174.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -89.72 151.4 21.86 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.294 1.038 . . . . 0.0 109.31 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -139.34 119.25 13.36 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.419 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 61.9 m-85 -122.34 154.8 37.16 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.13 0.972 . . . . 0.0 111.197 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -128.75 160.12 33.53 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.769 1.228 . . . . 0.0 109.625 177.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -63.18 139.71 97.58 Favored Pre-proline 0 CA--C 1.561 1.385 0 C-N-CA 124.114 0.966 . . . . 0.0 111.538 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.89 -44.59 0.51 Allowed 'Cis proline' 0 C--N 1.381 2.287 0 CA-C-N 120.152 1.09 . . . . 0.0 113.183 -9.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.53 79.58 0.5 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.132 0.573 . . . . 0.0 110.382 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.9 m -123.44 125.22 44.55 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.688 0.795 . . . . 0.0 109.588 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 tt -84.33 110.95 18.99 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.409 HD21 ' HB2' ' A' ' 36' ' ' ALA . 1.4 mm? -85.55 -51.1 6.72 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.27 0.628 . . . . 0.0 109.363 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -140.13 120.73 14.23 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.219 -168.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.28 37.42 3.83 Favored Glycine 0 N--CA 1.477 1.372 0 O-C-N 123.135 0.272 . . . . 0.0 113.539 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.5 p30 175.45 155.22 0.17 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.02 1.728 . . . . 0.0 108.722 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.12 -25.89 68.3 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.806 0.843 . . . . 0.0 113.162 -172.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.93 -47.25 81.26 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.928 0.491 . . . . 0.0 110.78 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.492 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.7 mt-10 -70.83 -37.97 73.22 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.771 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.5 mt -61.68 -43.25 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.262 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.491 ' O ' HG13 ' A' ' 54' ' ' ILE . 69.4 ttt-85 -60.17 -56.25 23.94 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.272 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.8 t -53.8 -49.06 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 124.546 1.154 . . . . 0.0 111.98 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -61.14 -36.26 79.29 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.183 0.593 . . . . 0.0 111.383 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -75.97 -32.7 59.62 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.748 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 50' ' ' ARG . 64.4 mt -64.64 -42.67 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -62.98 -31.25 72.32 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.096 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -85.33 -11.18 55.23 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.324 0.65 . . . . 0.0 111.525 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.472 ' HA ' HD22 ' A' ' 62' ' ' LEU . 3.3 m-85 -89.99 -0.7 57.73 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.471 0.709 . . . . 0.0 110.876 172.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.445 ' HE2' HG22 ' A' ' 54' ' ' ILE . 72.6 mmtt -82.56 -4.13 57.12 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.28 0.632 . . . . 0.0 112.091 173.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.724 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 22.5 mm-40 -67.66 120.13 71.13 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -65.62 -24.33 55.74 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.058 1.838 . . . . 0.0 112.693 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -111.54 21.76 15.81 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.596 0.758 . . . . 0.0 111.611 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.724 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 39.4 tp -67.2 111.62 4.04 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 120.795 0.331 . . . . 0.0 110.235 175.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -138.11 136.41 36.7 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.514 0.726 . . . . 0.0 109.301 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.32 128.06 8.93 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.329 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -127.74 99.91 5.74 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 tt -81.35 134.75 35.62 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-O 121.452 0.644 . . . . 0.0 110.354 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mt -107.05 -50.7 3.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.161 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.2 m -152.48 125.89 8.76 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.243 -1.799 . . . . 0.0 109.136 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -118.18 132.92 56.29 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 167.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.3 m -118.8 122.52 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.006 0.923 . . . . 0.0 109.285 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.486 HD11 ' HB ' ' A' ' 5' ' ' ILE . 17.4 tt -105.74 136.77 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 122.782 0.433 . . . . 0.0 110.796 -175.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.426 HG13 HG13 ' A' ' 75' ' ' VAL . 2.1 p -146.38 112.87 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.419 1.087 . . . . 0.0 109.488 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.83 -104.73 1.06 Allowed Glycine 0 C--N 1.346 1.098 0 CA-C-N 116.384 -0.371 . . . . 0.0 112.743 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.483 ' HA ' HG13 ' A' ' 5' ' ' ILE . 7.2 p30 -122.55 15.61 10.34 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.096 0.559 . . . . 0.0 111.074 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.426 HG13 HG13 ' A' ' 72' ' ' VAL . 3.0 p -135.37 132.64 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.766 0.826 . . . . 0.0 110.173 -173.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.03 141.22 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.65 0.78 . . . . 0.0 110.239 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.567 HG12 ' HB ' ' A' ' 98' ' ' ILE . 3.1 mt -100.58 103.93 15.49 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 165.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -93.38 106.22 18.21 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -100.09 109.35 21.64 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.691 -176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.15 171.14 7.61 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.103 0.961 . . . . 0.0 111.057 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.0 m -109.13 102.23 11.21 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 161.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -81.98 108.91 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.659 1.184 . . . . 0.0 110.029 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 75.7 m -68.59 119.02 12.36 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 122.952 0.501 . . . . 0.0 110.502 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -117.06 -169.13 1.59 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.396 1.078 . . . . 0.0 109.787 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -118.34 102.91 9.31 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.63 0.772 . . . . 0.0 110.448 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.404 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 21.3 m-30 -112.07 134.07 21.52 Favored Pre-proline 0 N--CA 1.474 0.728 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 171.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.74 -12.4 32.84 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.827 2.351 . . . . 0.0 113.409 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -83.1 -10.86 58.45 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.657 0.383 . . . . 0.0 111.902 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.86 -125.75 1.09 Allowed Glycine 0 C--N 1.349 1.269 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.691 172.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -71.01 -80.1 0.06 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.84 0.856 . . . . 0.0 110.704 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.404 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 120.33 27.15 2.06 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 113.455 0.142 . . . . 0.0 113.455 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 1.5 pm0 -88.95 112.28 23.14 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.762 0.791 . . . . 0.0 109.501 -171.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 116' ' ' PRO . 30.2 m -106.43 141.12 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.594 0.757 . . . . 0.0 110.313 -172.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -83.62 124.1 30.47 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.0 127.65 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.051 0.541 . . . . 0.0 109.649 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.47 102.59 14.41 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.627 0.771 . . . . 0.0 109.235 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.4 m -98.31 118.28 34.6 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.567 ' HB ' HG12 ' A' ' 77' ' ' ILE . 11.3 tt -111.75 105.77 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 C-N-CA 123.94 0.896 . . . . 0.0 110.81 -177.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -99.29 129.07 45.48 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.098 0.959 . . . . 0.0 110.457 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 34.8 tt0 -97.72 114.44 26.44 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.237 0.541 . . . . 0.0 109.68 170.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.474 HG22 HG12 ' A' ' 106' ' ' ILE . 61.7 t -99.86 111.65 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 124.562 1.145 . . . . 0.0 110.133 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 34.5 tt0 -112.18 132.97 54.59 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.253 1.021 . . . . 0.0 109.942 174.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 63.46 30.34 15.33 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.604 1.161 . . . . 0.0 111.46 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.99 14.0 75.98 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.051 -0.522 . . . . 0.0 113.458 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -129.79 134.66 47.71 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.803 1.241 . . . . 0.0 108.96 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.474 HG12 HG22 ' A' ' 101' ' ' VAL . 70.6 mt -63.95 99.39 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -82.7 -24.31 33.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.423 0.689 . . . . 0.0 110.912 -177.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 74.2 mttt -147.88 148.47 30.88 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.378 1.071 . . . . 0.0 108.216 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.78 132.19 20.79 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 172.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.545 ' HB2' HG23 ' A' ' 98' ' ' ILE . 1.5 m-90 -128.62 146.76 50.76 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -177.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -142.47 146.88 35.23 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.381 0.991 . . . . 0.0 110.97 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -129.91 122.14 28.02 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.073 0.949 . . . . 0.0 108.663 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.35 128.96 41.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.47 -121.24 0.55 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.099 -0.955 . . . . 0.0 113.448 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -97.91 141.09 22.42 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.22 1.008 . . . . 0.0 110.459 -172.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.621 ' HA ' HG12 ' A' ' 93' ' ' VAL . 55.9 Cg_endo -71.51 115.86 4.46 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.006 2.471 . . . . 0.0 110.492 170.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -121.22 153.87 37.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.273 0.629 . . . . 0.0 111.377 -174.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.437 HG22 ' H ' ' A' ' 120' ' ' SER . 48.5 mm -129.77 132.84 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.806 1.242 . . . . 0.0 108.966 174.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.6 t -55.1 -38.94 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.999 0.92 . . . . 0.0 112.197 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.437 ' H ' HG22 ' A' ' 118' ' ' ILE . 29.9 t -72.58 -32.16 65.79 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.161 0.584 . . . . 0.0 111.695 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -91.83 79.85 5.29 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.404 0.682 . . . . 0.0 110.115 -173.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -134.08 138.89 45.6 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.336 0.654 . . . . 0.0 110.37 -177.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 CA--C 1.557 1.221 0 C-N-CA 123.899 0.88 . . . . 0.0 109.29 -177.494 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.5 ' HB2' HD11 ' A' ' 71' ' ' ILE . 16.3 m120 -89.53 76.89 7.34 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.766 0.826 . . . . 0.0 110.145 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.439 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 66.6 m -69.36 -41.02 77.13 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.8 0.84 . . . . 0.0 111.736 -176.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -11.73 58.23 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.04 0.536 . . . . 0.0 112.208 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.456 HG22 HG23 ' A' ' 76' ' ' VAL . 37.8 mm -91.09 -33.11 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.57 0.748 . . . . 0.0 109.918 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -79.9 -17.59 52.72 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 119.099 -0.477 . . . . 0.0 112.225 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 3' ' ' SER . 93.5 mt -62.74 -52.1 67.0 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.963 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 24.4 Cg_endo -60.76 -47.37 13.48 Favored 'Trans proline' 0 C--N 1.395 2.988 0 C-N-CA 121.797 1.664 . . . . 0.0 111.887 173.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.5 t -59.02 -43.73 89.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 124.226 1.011 . . . . 0.0 112.285 -173.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.697 ' HG2' HH12 ' A' ' 69' ' ' ARG . 6.7 mm100 -68.47 -49.36 60.33 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.082 0.553 . . . . 0.0 111.767 175.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -63.81 -27.71 69.37 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -175.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -69.0 -47.32 65.82 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 123.489 0.493 . . . . 0.0 109.768 174.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' A' ' 66' ' ' LEU . 2.7 tt -57.1 -54.16 49.92 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.782 1.301 . . . . 0.0 109.442 -177.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 16.0 mm-40 -61.17 -37.8 84.19 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.859 -176.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -71.07 -27.4 63.6 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.55 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.428 ' CZ ' HD11 ' A' ' 62' ' ' LEU . 84.8 t80 -73.08 -38.57 66.37 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.006 0.922 . . . . 0.0 110.522 -175.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -88.42 -28.3 21.0 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.983 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.84 0.84 57.47 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.366 0.666 . . . . 0.0 112.265 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 64.7 mmt-85 71.33 12.6 6.68 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.058 1.343 . . . . 0.0 113.619 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.536 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 10.2 m-20 -74.37 95.12 2.64 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.824 0.449 . . . . 0.0 110.917 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.2 mm -66.22 -26.19 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 122.942 0.497 . . . . 0.0 110.574 169.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -60.14 -48.78 80.27 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.164 0.586 . . . . 0.0 111.142 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.62 -30.31 36.76 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.18 0.592 . . . . 0.0 110.767 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -72.56 -6.78 46.39 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.224 0.61 . . . . 0.0 110.967 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.744 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -119.26 -27.25 5.68 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 173.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.94 -30.09 70.01 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -172.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.581 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.3 m95 -95.37 -0.12 52.95 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.355 0.662 . . . . 0.0 112.575 -175.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.59 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 13.3 m95 -97.55 148.66 23.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.435 0.694 . . . . 0.0 109.219 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.68 154.74 29.88 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.42 0.688 . . . . 0.0 109.402 172.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -69.84 -23.66 63.33 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.81 0.444 . . . . 0.0 111.468 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -95.59 17.99 13.73 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.079 0.952 . . . . 0.0 111.073 177.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.59 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 45.4 t -64.21 123.24 18.58 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.006 0.431 . . . . 0.0 111.95 -174.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.41 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . 35.4 mm-40 -96.17 103.74 15.66 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.06 0.944 . . . . 0.0 109.743 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.535 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 55.2 t80 -96.37 111.86 23.8 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.001 0.92 . . . . 0.0 110.276 -177.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.41 ' HE1' ' HB3' ' A' ' 33' ' ' GLN . 80.5 m-85 -116.05 155.16 28.62 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.719 0.808 . . . . 0.0 110.498 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.91 160.67 17.19 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.691 1.196 . . . . 0.0 108.332 167.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -52.04 133.19 40.14 Favored Pre-proline 0 CA--C 1.568 1.635 0 C-N-CA 123.599 0.759 . . . . 0.0 112.431 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.48 -40.95 1.02 Allowed 'Cis proline' 0 C--N 1.384 2.398 0 C-N-CA 124.759 -0.934 . . . . 0.0 112.963 -7.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.83 56.86 0.2 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.631 0.772 . . . . 0.0 109.861 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.2 m -92.9 114.4 26.95 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.134 0.973 . . . . 0.0 109.484 176.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.7 tp -78.16 103.82 8.34 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.447 0.567 . . . . 0.0 109.595 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.04 -37.89 33.06 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -146.38 117.17 7.65 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.14 -172.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.24 45.23 1.39 Allowed Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.989 -0.339 . . . . 0.0 112.322 -176.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 161.35 161.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 126.233 1.813 . . . . 0.0 109.066 -171.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.463 ' HA ' HD12 ' A' ' 49' ' ' ILE . . . -64.75 -35.52 81.34 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.857 0.863 . . . . 0.0 113.049 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.65 -46.91 87.61 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.041 0.536 . . . . 0.0 112.092 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.407 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.6 mt-10 -72.45 -29.41 63.65 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.823 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.463 HD12 ' HA ' ' A' ' 46' ' ' ALA . 94.6 mt -63.97 -49.19 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.788 0.835 . . . . 0.0 110.264 175.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.744 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 77.4 ttt180 -55.76 -56.63 18.21 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.152 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.465 ' HA ' HD12 ' A' ' 54' ' ' ILE . 26.8 m -65.21 -35.99 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 124.433 1.083 . . . . 0.0 112.698 -173.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -69.06 -34.95 75.98 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.195 0.598 . . . . 0.0 110.423 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -78.42 -28.49 46.79 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 118.455 -0.784 . . . . 0.0 111.785 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 51' ' ' VAL . 94.2 mt -57.34 -41.19 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-N 118.593 0.633 . . . . 0.0 109.514 173.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.16 -37.72 86.29 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.349 1.06 . . . . 0.0 111.735 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -79.43 -25.98 41.92 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.387 0.675 . . . . 0.0 111.014 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -79.8 -15.97 56.41 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.818 0.447 . . . . 0.0 110.649 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -62.61 -28.47 69.91 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.941 0.497 . . . . 0.0 110.823 168.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -66.26 118.61 54.75 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.617 0.767 . . . . 0.0 110.581 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.29 -29.2 17.41 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.541 2.161 . . . . 0.0 111.704 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.14 -18.02 63.21 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.322 1.049 . . . . 0.0 111.504 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 16' ' ' TYR . 46.1 tp -59.17 123.57 17.11 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.595 0.758 . . . . 0.0 111.511 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.477 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 69.9 t80 -152.21 125.49 8.72 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.49 109.22 3.39 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -118.4 110.93 18.05 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.316 0.647 . . . . 0.0 109.731 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HB2' HD11 ' A' ' 13' ' ' LEU . 17.4 tp -76.91 146.53 37.55 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.428 0.455 . . . . 0.0 111.155 -177.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mt -112.69 -51.45 2.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.815 0.846 . . . . 0.0 109.346 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.7 m -157.45 153.11 26.61 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.758 -1.564 . . . . 0.0 108.922 -170.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.697 HH12 ' HG2' ' A' ' 10' ' ' GLN . 4.3 ptp180 -142.27 139.2 31.84 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.921 0.488 . . . . 0.0 109.901 169.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.49 HG22 ' HB ' ' A' ' 77' ' ' ILE . 17.8 m -112.42 111.28 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 122.159 0.98 . . . . 0.0 108.592 173.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.5 HD11 ' HB2' ' A' ' 2' ' ' ASN . 11.7 tt -99.93 139.13 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.038 -177.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 75' ' ' VAL . 2.5 p -145.9 99.45 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.801 1.24 . . . . 0.0 108.666 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.12 -120.82 21.2 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.986 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -86.44 2.44 47.72 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.496 0.718 . . . . 0.0 112.777 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -129.19 132.46 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.309 0.643 . . . . 0.0 110.716 -173.055 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.456 HG23 HG22 ' A' ' 5' ' ' ILE . 59.2 t -116.0 138.85 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.925 0.89 . . . . 0.0 109.074 174.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.653 HD13 ' HB ' ' A' ' 98' ' ' ILE . 9.6 mm -97.11 103.15 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 164.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -95.68 104.19 16.1 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -177.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -99.92 107.96 20.08 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.581 0.705 . . . . 0.0 109.846 -173.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.32 168.5 12.41 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.132 -177.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 m -117.47 104.27 10.92 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 168.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.0 m -91.22 125.17 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.274 0.559 . . . . 0.0 111.463 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 63' ' ' TYR . 34.9 m -76.86 133.66 39.25 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.073 176.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -133.12 -160.72 1.07 Allowed 'General case' 0 C--O 1.247 0.944 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -128.89 105.52 8.28 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.446 0.566 . . . . 0.0 110.193 174.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -106.32 135.03 19.53 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.88 -21.12 71.63 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.921 2.414 . . . . 0.0 113.446 -174.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -74.64 -25.81 59.46 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.01 0.524 . . . . 0.0 111.693 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.14 -120.08 0.6 Allowed Glycine 0 C--N 1.352 1.463 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.709 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -72.53 -81.0 0.06 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.605 0.762 . . . . 0.0 111.3 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.19 27.24 2.07 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 113.722 0.249 . . . . 0.0 113.722 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -90.7 133.39 35.18 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.696 HG12 ' HA ' ' A' ' 116' ' ' PRO . 35.9 m -130.66 134.62 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 122.464 0.306 . . . . 0.0 110.79 -172.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.23 117.0 17.47 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.596 HG22 HG12 ' A' ' 113' ' ' ILE . 16.7 t -123.74 158.88 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.649 1.18 . . . . 0.0 108.768 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -118.16 99.93 7.19 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 169.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 93.5 m -95.05 107.52 19.57 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.653 ' HB ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -96.17 138.12 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.988 0.915 . . . . 0.0 109.412 -177.628 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -127.42 119.98 27.38 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.619 0.768 . . . . 0.0 108.993 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 43.2 tt0 -97.14 112.48 24.25 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 48.7 t -95.5 139.54 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.166 1.386 . . . . 0.0 109.778 -175.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -129.79 100.44 5.49 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.553 1.141 . . . . 0.0 108.416 -175.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.3 m120 59.79 32.7 21.48 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.82 1.248 . . . . 0.0 112.117 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.24 -7.62 54.57 Favored Glycine 0 N--CA 1.475 1.244 0 N-CA-C 114.317 0.487 . . . . 0.0 114.317 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.9 mmt-85 -127.53 133.24 49.82 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.446 0.623 . . . . 0.0 109.821 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 8' ' ' PRO . 68.2 mt -70.02 106.27 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.189 0.996 . . . . 0.0 110.447 -173.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -82.69 -18.88 39.37 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.981 0.512 . . . . 0.0 111.671 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 75.1 mttt -151.99 134.14 15.09 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -139.52 129.02 24.31 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 172.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.42 ' CE3' HD12 ' A' ' 98' ' ' ILE . 1.5 m0 -130.52 159.06 38.23 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -176.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -142.79 146.38 34.18 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -137.29 127.41 26.08 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.596 HG12 HG22 ' A' ' 95' ' ' VAL . 89.3 mt -88.75 125.75 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.55 -60.53 8.6 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 114.869 -1.06 . . . . 0.0 113.09 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -160.56 168.32 12.05 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.457 0.703 . . . . 0.0 109.819 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.696 ' HA ' HG12 ' A' ' 93' ' ' VAL . 65.7 Cg_endo -85.76 130.98 3.79 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.718 2.279 . . . . 0.0 112.188 163.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -127.53 157.96 38.71 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.916 0.487 . . . . 0.0 110.693 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.4 mm -133.67 127.37 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.64 -41.52 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 123.876 0.87 . . . . 0.0 111.094 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.9 t -64.23 -21.13 66.47 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.785 0.834 . . . . 0.0 112.207 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -94.35 86.32 4.85 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.007 0.523 . . . . 0.0 109.867 177.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -81.94 90.37 6.45 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 C--O 1.255 1.346 0 C-N-CA 123.341 0.657 . . . . 0.0 109.718 -179.462 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.61 ' HB3' HD13 ' A' ' 71' ' ' ILE . 81.8 m-20 71.12 -12.86 0.55 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 168.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.469 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 23.4 m -66.47 -40.71 89.49 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.76 0.824 . . . . 0.0 111.261 -174.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -14.23 62.85 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 122.98 0.512 . . . . 0.0 111.697 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.501 HG22 HG23 ' A' ' 76' ' ' VAL . 22.8 mm -95.08 -29.49 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.811 0.844 . . . . 0.0 109.832 175.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -84.25 -20.94 31.38 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.077 0.951 . . . . 0.0 112.167 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 3' ' ' SER . 68.4 mt -67.23 -48.99 46.3 Favored Pre-proline 0 N--CA 1.486 1.338 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.092 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 10.8 Cg_endo -54.47 -52.9 7.12 Favored 'Trans proline' 0 C--N 1.391 2.771 0 C-N-CA 121.708 1.605 . . . . 0.0 111.291 172.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 76' ' ' VAL . 83.8 t -57.98 -43.2 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.323 1.049 . . . . 0.0 112.81 -176.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -64.98 -54.93 22.72 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.352 0.661 . . . . 0.0 110.201 -176.348 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -71.91 -35.14 69.61 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.873 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.483 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 1.0 OUTLIER -72.73 -30.42 64.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.76 0.824 . . . . 0.0 110.946 -176.433 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.515 HD22 HD13 ' A' ' 66' ' ' LEU . 59.4 tp -62.36 -52.13 64.84 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.18 0.592 . . . . 0.0 109.657 173.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 14.7 mm-40 -53.34 -45.81 69.24 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.05 175.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -64.92 -30.26 71.25 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.349 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -69.02 -46.38 68.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.139 0.575 . . . . 0.0 110.578 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -84.24 -24.18 30.11 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.956 0.502 . . . . 0.0 111.525 -177.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.09 2.06 55.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.259 0.624 . . . . 0.0 112.141 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.7 mmt-85 68.53 15.02 9.15 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.894 1.278 . . . . 0.0 112.948 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.46 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 10.0 m-20 -77.13 96.53 4.5 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.868 0.467 . . . . 0.0 110.738 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.8 mm -64.34 -33.55 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.553 0.741 . . . . 0.0 111.122 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.13 -48.62 79.65 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.144 0.578 . . . . 0.0 111.664 -175.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.73 -29.8 40.68 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.197 0.599 . . . . 0.0 110.737 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -69.29 -13.05 62.18 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.817 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.627 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 3.8 mmt -116.6 -15.61 10.81 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.61 0.764 . . . . 0.0 112.344 175.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.04 99.79 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.639 0.776 . . . . 0.0 112.295 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.598 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 86.3 m95 -92.95 0.97 57.52 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.379 -172.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.483 ' HE1' ' HG3' ' A' ' 12' ' ' GLN . 17.8 m95 -96.67 148.8 22.49 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.56 0.744 . . . . 0.0 109.992 -177.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.9 149.41 39.48 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.78 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.27 -20.75 64.81 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.462 0.305 . . . . 0.0 111.755 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -104.86 18.71 21.83 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.819 0.847 . . . . 0.0 111.799 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 43.0 t -62.6 127.08 29.62 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -172.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.552 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 57.7 mm-40 -96.16 104.57 16.53 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.839 0.856 . . . . 0.0 109.922 -176.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -98.18 115.33 28.1 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 124.463 1.105 . . . . 0.0 109.938 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.467 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 80.7 m-85 -114.62 154.63 28.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.954 0.902 . . . . 0.0 110.936 177.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.21 155.92 19.4 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.791 167.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.532 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 71.6 t80 -62.0 133.24 93.91 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 123.275 0.63 . . . . 0.0 110.978 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.54 -45.26 0.43 Allowed 'Cis proline' 0 C--N 1.383 2.36 0 CA-C-N 120.235 1.12 . . . . 0.0 113.95 -4.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.76 67.33 0.44 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.35 0.595 . . . . 0.0 110.285 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 33.9 m -105.98 115.77 30.79 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.1 tp -75.26 103.87 5.6 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.79 -36.48 50.32 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.473 0.709 . . . . 0.0 109.542 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -157.74 122.27 4.3 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.4 -176.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.75 26.0 24.09 Favored Glycine 0 N--CA 1.477 1.383 0 O-C-N 123.224 0.328 . . . . 0.0 113.897 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.0 p30 178.93 156.73 0.49 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.164 1.385 . . . . 0.0 109.628 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.02 -34.01 71.39 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.23 1.012 . . . . 0.0 113.143 -172.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.57 -44.27 97.34 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.783 0.433 . . . . 0.0 111.148 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 38.1 mt-10 -75.67 -30.06 59.28 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.661 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.42 ' HB ' ' HE1' ' A' ' 25' ' ' MET . 79.8 mt -63.33 -40.82 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 123.134 0.574 . . . . 0.0 109.492 176.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.627 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 39.8 ttt180 -55.6 -56.1 24.25 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.41 175.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.06 -43.97 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 124.487 1.117 . . . . 0.0 111.183 -173.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.468 ' HE ' ' HA ' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -60.65 -42.6 97.3 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.844 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -78.97 -26.8 43.45 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-O 118.452 -0.785 . . . . 0.0 112.347 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.425 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 66.2 mt -57.34 -43.38 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.113 0.869 . . . . 0.0 108.971 173.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -62.32 -34.7 77.13 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.097 0.959 . . . . 0.0 111.368 177.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -77.71 -25.14 49.14 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 123.413 0.685 . . . . 0.0 111.036 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -84.12 -14.25 50.82 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.36 0.664 . . . . 0.0 110.491 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 10.4 mmpt? -69.14 -21.15 64.03 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.226 0.61 . . . . 0.0 110.583 171.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.84 114.27 12.94 Favored Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 124.152 0.981 . . . . 0.0 109.739 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.73 -22.1 24.32 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.483 2.122 . . . . 0.0 111.953 177.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.57 6.9 47.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.215 1.006 . . . . 0.0 111.634 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 tp -66.97 112.29 4.26 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-O 120.978 0.418 . . . . 0.0 109.938 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -144.2 115.89 8.2 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.29 100.74 2.13 Favored Glycine 0 C--N 1.342 0.861 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 174.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -88.0 101.5 13.83 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.515 HD13 HD22 ' A' ' 13' ' ' LEU . 8.5 tt -75.32 115.95 15.52 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.508 ' H ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -105.34 -33.46 8.18 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.914 -175.503 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.426 ' N ' HD22 ' A' ' 67' ' ' LEU . 52.0 m -139.78 138.52 35.93 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.302 0.641 . . . . 0.0 109.796 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -142.91 133.81 25.52 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.759 0.823 . . . . 0.0 109.556 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 77' ' ' ILE . 20.1 m -126.63 155.7 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.253 1.021 . . . . 0.0 108.658 173.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.61 HD13 ' HB3' ' A' ' 2' ' ' ASN . 15.1 tt -137.75 140.32 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.107 0.48 . . . . 0.0 111.081 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 p -144.48 107.24 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 125.144 1.377 . . . . 0.0 108.443 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.55 -119.25 14.7 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.839 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 17.0 p-10 -99.72 18.77 17.33 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.039 0.536 . . . . 0.0 111.407 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.2 t -126.73 136.75 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.45 1.1 . . . . 0.0 110.097 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.501 HG23 HG22 ' A' ' 5' ' ' ILE . 62.3 t -123.7 137.3 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.437 0.695 . . . . 0.0 109.646 173.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.536 ' HB ' HG22 ' A' ' 70' ' ' VAL . 7.8 mm -98.01 103.75 15.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 165.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -101.18 105.39 16.52 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.503 ' HE1' ' HB2' ' A' ' 94' ' ' ASP . 40.5 t-80 -99.79 113.71 26.4 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.0 -176.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.97 154.14 45.92 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.894 1.277 . . . . 0.0 110.564 -176.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.415 HG22 ' HB2' ' A' ' 92' ' ' GLU . 39.0 m -100.46 111.69 23.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.699 0.799 . . . . 0.0 109.556 172.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.99 115.54 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.503 1.121 . . . . 0.0 110.038 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.8 m -77.81 121.52 24.19 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 122.813 0.445 . . . . 0.0 110.695 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -122.9 -177.05 3.55 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.395 1.078 . . . . 0.0 108.289 172.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -115.73 103.68 10.92 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.929 0.491 . . . . 0.0 110.112 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -109.48 138.62 20.61 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 123.539 0.736 . . . . 0.0 109.133 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.65 -17.66 60.9 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.306 2.671 . . . . 0.0 114.274 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -82.87 -10.89 58.61 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 122.861 0.465 . . . . 0.0 112.138 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.48 -123.84 1.06 Allowed Glycine 0 C--N 1.346 1.123 0 CA-C-O 119.852 -0.415 . . . . 0.0 112.517 171.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -66.66 -76.63 0.08 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.9 0.88 . . . . 0.0 110.505 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.23 27.06 4.07 Favored Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.699 -0.228 . . . . 0.0 113.085 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.415 ' HB2' HG22 ' A' ' 81' ' ' THR . 9.8 pt-20 -91.12 115.96 28.43 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -175.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.645 HG12 ' HA ' ' A' ' 116' ' ' PRO . 11.5 m -104.07 134.48 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -175.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.503 ' HB2' ' HE1' ' A' ' 79' ' ' HIS . 2.4 p-10 -81.74 143.85 31.54 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.588 HG22 HG12 ' A' ' 113' ' ' ILE . 39.5 t -141.45 143.63 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -105.93 107.5 18.53 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 164.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 5.9 t -94.19 138.07 32.65 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.464 ' HB ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -131.17 121.31 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.586 0.754 . . . . 0.0 109.625 -175.6 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -108.9 139.06 44.26 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.228 0.611 . . . . 0.0 109.647 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -104.51 111.22 23.81 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 165.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.452 HG22 HG12 ' A' ' 106' ' ' ILE . 61.7 t -96.13 110.67 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.351 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 35.3 tt0 -111.04 128.45 55.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.679 0.792 . . . . 0.0 109.155 176.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 62.83 30.44 16.63 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.89 0.876 . . . . 0.0 111.661 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.37 9.9 86.63 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.898 -0.592 . . . . 0.0 113.76 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 63.5 mmt-85 -129.03 135.14 48.53 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.158 0.983 . . . . 0.0 109.211 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.452 HG12 HG22 ' A' ' 101' ' ' VAL . 79.2 mt -63.55 100.7 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -76.59 -31.98 57.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.49 -173.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.552 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 98.7 mttt -153.85 153.8 32.77 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.628 1.171 . . . . 0.0 108.566 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.79 135.31 20.77 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.467 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 5.4 m-90 -134.25 153.92 51.58 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -142.61 147.3 35.6 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 118.646 0.657 . . . . 0.0 110.605 173.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 17.6 ptpt -131.74 123.87 28.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.327 1.051 . . . . 0.0 109.227 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.588 HG12 HG22 ' A' ' 95' ' ' VAL . 96.9 mt -89.13 127.39 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -176.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.36 -81.12 0.09 OUTLIER Glycine 0 CA--C 1.532 1.148 0 O-C-N 123.957 0.786 . . . . 0.0 112.866 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.435 ' HB2' ' HD2' ' A' ' 116' ' ' PRO . 0.4 OUTLIER -160.18 171.58 7.02 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.398 0.679 . . . . 0.0 109.312 167.156 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.645 ' HA ' HG12 ' A' ' 93' ' ' VAL . 36.3 Cg_endo -63.49 131.43 31.75 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.037 1.825 . . . . 0.0 112.738 167.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -118.55 139.55 51.29 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.336 0.655 . . . . 0.0 109.939 173.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.8 mm -122.04 135.07 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.6 t -67.9 -44.57 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 123.539 0.524 . . . . 0.0 110.673 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.0 p -77.63 4.76 10.61 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.743 0.817 . . . . 0.0 112.851 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -74.88 -13.32 60.54 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.768 0.827 . . . . 0.0 111.255 176.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -72.0 154.16 41.33 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.443 0.697 . . . . 0.0 111.0 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 C--O 1.251 1.15 0 C-N-CA 123.554 0.742 . . . . 0.0 109.291 -175.582 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.7 ttp . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.467 ' HB2' HD11 ' A' ' 71' ' ' ILE . 14.0 m120 -89.35 69.08 8.08 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.79 0.836 . . . . 0.0 108.897 -178.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.53 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 15.0 m -57.34 -49.51 75.91 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.223 -174.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -57.16 -17.57 11.6 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.997 0.919 . . . . 0.0 113.125 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.433 HG13 ' HA ' ' A' ' 74' ' ' ASN . 22.8 mm -96.13 -34.4 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.953 0.901 . . . . 0.0 110.231 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -83.74 -24.85 30.97 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.661 0.784 . . . . 0.0 112.421 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 3' ' ' SER . 54.8 mt -66.58 -53.37 29.63 Favored Pre-proline 0 CA--C 1.561 1.388 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.291 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.632 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 9.5 Cg_endo -52.64 -50.63 13.4 Favored 'Trans proline' 0 C--N 1.399 3.214 0 C-N-CA 122.545 2.164 . . . . 0.0 112.219 175.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.488 HG11 HG11 ' A' ' 76' ' ' VAL . 7.7 t -54.79 -48.51 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 125.068 1.347 . . . . 0.0 113.27 -177.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -44.77 69.42 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.491 0.316 . . . . 0.0 111.262 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.7 mmtt -65.64 -35.55 81.12 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.746 0.419 . . . . 0.0 110.895 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -59.4 -49.79 76.46 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.946 0.779 . . . . 0.0 110.788 175.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.0 tp -55.89 -51.71 66.64 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.268 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -56.85 -46.95 81.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.536 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -67.31 -26.36 66.48 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.337 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -71.91 -48.52 44.92 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.097 0.559 . . . . 0.0 110.576 -173.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.06 -29.07 35.09 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.672 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.87 -3.42 58.91 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.401 0.68 . . . . 0.0 111.636 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 71.95 12.63 6.07 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.38 1.472 . . . . 0.0 113.065 172.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.487 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 5.9 m-20 -73.15 96.6 2.25 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.265 0.626 . . . . 0.0 111.11 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.5 mm -66.26 -29.75 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.452 0.701 . . . . 0.0 111.687 175.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.04 -48.56 81.17 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.023 0.529 . . . . 0.0 112.113 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.45 -30.1 33.57 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.866 0.466 . . . . 0.0 110.899 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -73.25 -7.86 53.31 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.924 177.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.801 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -114.22 -30.55 6.59 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.16 0.584 . . . . 0.0 112.197 173.168 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.66 -33.32 60.55 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -170.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.632 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.8 m95 -99.78 14.2 31.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.906 0.882 . . . . 0.0 112.651 -170.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.55 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 29.6 m95 -105.51 155.84 18.79 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.828 0.851 . . . . 0.0 109.949 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -85.36 148.32 26.08 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.478 0.711 . . . . 0.0 109.752 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -58.14 -30.94 66.74 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.894 0.878 . . . . 0.0 111.955 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -103.05 19.29 19.79 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.025 0.93 . . . . 0.0 111.737 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.55 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 53.7 t -64.05 132.23 49.94 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.483 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 36.3 mm-40 -101.44 105.25 16.25 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.64 0.776 . . . . 0.0 110.245 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -96.56 112.52 24.23 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.936 0.894 . . . . 0.0 110.26 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.471 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 89.2 m-85 -110.3 153.48 24.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.236 1.015 . . . . 0.0 111.378 178.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.556 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -102.08 150.95 22.73 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 113.996 -1.457 . . . . 0.0 107.717 165.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 16.4 p90 -50.48 128.63 25.18 Favored Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 124.748 1.219 . . . . 0.0 114.1 -176.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 83.4 Cg_endo -79.3 -36.7 2.15 Favored 'Cis proline' 0 C--N 1.385 2.482 0 C-N-CA 124.817 -0.91 . . . . 0.0 113.06 -9.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.13 81.64 0.99 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.51 0.724 . . . . 0.0 109.811 -174.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 40.6 m -121.74 100.1 6.82 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.2 tp -71.34 100.83 2.23 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -173.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 36' ' ' ALA . 1.1 mm? -77.27 -45.26 26.92 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.45 115.85 15.29 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.958 -172.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.6 45.94 1.39 Allowed Glycine 0 C--N 1.346 1.085 0 CA-C-O 119.838 -0.423 . . . . 0.0 112.91 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.3 p30 160.36 160.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 126.495 1.918 . . . . 0.0 108.771 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -66.94 -31.61 72.3 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.888 0.875 . . . . 0.0 113.158 -172.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.75 -43.81 98.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.131 0.572 . . . . 0.0 111.171 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -75.24 -30.69 60.6 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.985 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.2 mt -63.2 -45.11 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.523 0.729 . . . . 0.0 110.143 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.801 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 21.9 ttt180 -59.46 -55.44 34.6 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.653 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.477 ' HA ' HD12 ' A' ' 54' ' ' ILE . 34.3 m -66.34 -34.43 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 124.515 1.135 . . . . 0.0 112.822 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -71.24 -32.94 69.35 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.964 0.411 . . . . 0.0 110.456 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -75.03 -33.73 61.8 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.45 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 51' ' ' VAL . 39.6 mt -55.87 -39.62 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.782 0.833 . . . . 0.0 110.228 173.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 51' ' ' VAL . 34.6 mm-40 -59.06 -46.92 87.03 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.467 0.707 . . . . 0.0 111.118 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 -66.15 -30.21 70.64 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.535 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -81.29 -11.1 59.45 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 123.932 0.893 . . . . 0.0 111.651 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 72.2 mmtt -71.67 -22.3 61.68 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.788 0.435 . . . . 0.0 111.39 170.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -81.11 115.7 57.83 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.687 0.795 . . . . 0.0 110.392 -176.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.46 -30.05 79.64 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.238 2.625 . . . . 0.0 113.757 -174.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -86.75 3.73 43.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.268 0.627 . . . . 0.0 112.561 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.9 tp -67.28 118.05 10.13 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.706 0.289 . . . . 0.0 110.805 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -150.51 119.11 6.5 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 167.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.22 103.96 3.09 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 174.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -89.38 106.55 18.52 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.0 tt -80.88 128.57 33.82 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.41 HD22 ' H ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -115.08 -34.96 4.87 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.733 0.813 . . . . 0.0 111.137 178.611 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.41 ' H ' HD22 ' A' ' 67' ' ' LEU . 38.1 m -132.25 139.0 48.11 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.579 0.752 . . . . 0.0 109.67 178.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.01 139.12 37.76 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 167.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.51 144.93 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.248 1.019 . . . . 0.0 109.347 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.467 HD11 ' HB2' ' A' ' 2' ' ' ASN . 15.1 tt -122.76 141.43 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-O 121.338 0.59 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 p -143.5 98.01 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 125.239 1.415 . . . . 0.0 108.105 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.92 -120.57 19.12 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.185 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.433 ' HA ' HG13 ' A' ' 5' ' ' ILE . 7.8 p30 -93.69 13.4 22.34 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.477 0.711 . . . . 0.0 111.913 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.2 t -130.29 136.14 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.25 1.02 . . . . 0.0 109.664 -174.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.488 HG11 HG11 ' A' ' 9' ' ' VAL . 87.0 t -125.16 135.82 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.774 0.83 . . . . 0.0 109.796 176.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.537 HG12 ' HB ' ' A' ' 98' ' ' ILE . 2.2 mt -100.13 108.01 22.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 168.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -88.07 109.16 19.65 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 168.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -99.15 110.51 23.07 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 122.041 0.924 . . . . 0.0 108.788 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.47 165.45 18.42 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.868 -1.515 . . . . 0.0 109.533 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.7 m -114.65 103.2 10.76 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 167.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.9 m -85.44 130.55 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 120.928 0.394 . . . . 0.0 110.391 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.6 m -79.05 118.96 21.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.295 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -111.81 -166.93 1.12 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 168.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -124.23 108.18 11.99 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 121.823 -0.548 . . . . 0.0 110.323 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -106.31 144.47 29.04 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 123.544 0.738 . . . . 0.0 109.059 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.84 -12.31 32.49 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.724 2.283 . . . . 0.0 112.907 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -87.61 -2.78 58.85 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.669 0.787 . . . . 0.0 112.225 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.92 -119.55 0.9 Allowed Glycine 0 C--N 1.348 1.225 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.769 170.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -65.31 -79.08 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.867 0.867 . . . . 0.0 110.536 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 117.57 22.79 3.93 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.323 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' A' ' 117' ' ' ARG . 13.8 pt-20 -90.29 141.9 28.25 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -176.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.634 HG12 ' HA ' ' A' ' 116' ' ' PRO . 22.4 m -132.97 138.64 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.156 0.435 . . . . 0.0 111.247 -171.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -75.65 109.33 9.13 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.47 HG22 HG12 ' A' ' 113' ' ' ILE . 21.4 t -114.7 155.66 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.14 105.75 9.78 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 82.5 m -94.96 107.46 19.49 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.646 HG23 ' HB2' ' A' ' 110' ' ' TRP . 7.3 tt -105.25 106.55 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.634 -173.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -99.9 137.27 38.58 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.662 0.785 . . . . 0.0 110.645 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -100.47 114.41 27.98 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.292 1.037 . . . . 0.0 109.166 168.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.539 HG22 HG12 ' A' ' 106' ' ' ILE . 46.4 t -102.31 117.66 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 123.319 0.648 . . . . 0.0 109.548 175.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 19.7 tt0 -128.54 138.71 52.38 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.832 1.253 . . . . 0.0 109.138 175.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 63.43 30.9 15.31 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.897 0.879 . . . . 0.0 111.32 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.28 7.59 82.53 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.401 -0.818 . . . . 0.0 114.058 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 57.3 mmt-85 -137.56 153.77 49.91 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.635 1.174 . . . . 0.0 108.902 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.539 HG12 HG22 ' A' ' 101' ' ' VAL . 65.3 mt -73.45 105.74 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -79.53 -28.99 41.3 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.444 0.697 . . . . 0.0 111.353 -178.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.483 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 91.3 mttt -150.25 152.6 34.8 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.85 134.41 22.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 174.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.646 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.6 m-90 -126.08 152.99 45.1 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -142.65 147.06 35.13 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 172.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -134.85 117.68 16.16 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.082 0.553 . . . . 0.0 110.294 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.47 HG12 HG22 ' A' ' 95' ' ' VAL . 95.6 mt -89.02 110.82 21.92 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.2 -93.27 0.06 OUTLIER Glycine 0 CA--C 1.533 1.196 0 CA-C-N 114.289 -1.323 . . . . 0.0 114.327 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -126.79 140.33 37.3 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 123.455 0.702 . . . . 0.0 111.268 -169.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.634 ' HA ' HG12 ' A' ' 93' ' ' VAL . 48.0 Cg_endo -67.79 125.5 13.28 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.241 2.628 . . . . 0.0 111.947 173.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.426 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 36.1 mmt180 -111.46 124.47 52.34 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.41 1.084 . . . . 0.0 109.312 178.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.1 mm -124.05 124.86 69.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.1 t -59.23 -42.66 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 124.005 0.816 . . . . 0.0 111.281 -173.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.3 t -82.32 -70.56 0.54 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.253 0.621 . . . . 0.0 110.085 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -75.33 90.83 2.65 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.82 0.848 . . . . 0.0 110.4 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -159.69 143.89 14.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.897 0.479 . . . . 0.0 109.984 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.3 t . . . . . 0 C--O 1.252 1.191 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.96 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mtp . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -82.44 43.1 0.79 Allowed 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.705 0.802 . . . . 0.0 111.742 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.405 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 36.1 p -72.94 -35.06 66.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.663 0.785 . . . . 0.0 111.547 -175.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.09 -5.1 32.9 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.895 0.478 . . . . 0.0 111.9 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.571 HG22 HG23 ' A' ' 76' ' ' VAL . 22.9 mm -94.29 -30.47 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.968 0.907 . . . . 0.0 109.701 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -72.74 -34.19 66.88 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.7 0.8 . . . . 0.0 111.636 174.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 3' ' ' SER . 93.8 mt -61.69 -50.58 81.37 Favored Pre-proline 0 CA--C 1.558 1.283 0 CA-C-O 118.089 -0.958 . . . . 0.0 112.46 -172.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.571 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 12.7 Cg_endo -54.84 -56.49 2.37 Favored 'Trans proline' 0 C--N 1.398 3.155 0 C-N-CA 122.123 1.882 . . . . 0.0 111.072 177.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 76' ' ' VAL . 98.8 t -53.45 -44.56 56.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.303 1.441 . . . . 0.0 112.411 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -62.63 -51.47 67.17 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.946 -178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -68.86 -34.39 75.37 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.18 0.592 . . . . 0.0 111.436 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -65.03 -43.41 92.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.973 0.909 . . . . 0.0 111.254 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.8 -52.06 67.1 Favored 'General case' 0 C--O 1.242 0.688 0 O-C-N 123.716 0.635 . . . . 0.0 109.398 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -54.13 -45.93 72.05 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 124.789 1.306 . . . . 0.0 109.258 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -68.64 -27.01 65.62 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.804 -1.544 . . . . 0.0 112.52 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -71.97 -41.01 68.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.532 0.333 . . . . 0.0 110.32 -174.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -90.76 -28.99 17.9 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.227 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.6 -2.18 57.05 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.244 0.618 . . . . 0.0 111.655 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 68.27 24.03 7.57 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.075 1.35 . . . . 0.0 112.958 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.528 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 21.6 m-20 -88.06 95.61 10.21 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.187 0.595 . . . . 0.0 109.765 175.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.432 HG13 HG12 ' A' ' 54' ' ' ILE . 13.2 mm -65.78 -28.34 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.697 0.399 . . . . 0.0 110.921 174.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.08 -48.15 81.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.194 0.597 . . . . 0.0 111.674 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.67 -30.87 36.49 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.83 0.452 . . . . 0.0 110.841 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -72.86 -7.57 51.49 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.248 0.619 . . . . 0.0 110.881 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.747 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -113.59 -29.64 7.09 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.395 0.678 . . . . 0.0 112.318 174.471 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.16 -34.91 70.82 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.873 0.869 . . . . 0.0 113.186 -169.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.571 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 96.1 m95 -93.75 8.29 41.62 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.722 0.809 . . . . 0.0 112.901 -173.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.76 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 21.8 m95 -102.84 158.81 16.01 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.667 0.787 . . . . 0.0 109.375 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -86.65 162.24 18.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.106 0.562 . . . . 0.0 110.408 177.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.57 -34.22 75.44 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.139 0.576 . . . . 0.0 111.347 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -98.06 15.74 23.27 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.619 0.768 . . . . 0.0 110.534 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.76 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 43.2 t -59.93 117.47 5.09 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-O 121.137 0.494 . . . . 0.0 111.745 -173.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.571 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 57.1 mm-40 -83.78 154.27 23.64 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.701 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.41 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 57.2 t80 -144.81 111.69 5.85 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -175.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.502 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 85.3 m-85 -118.12 146.59 44.03 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.973 0.909 . . . . 0.0 110.697 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.525 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -95.69 157.43 15.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.154 -1.384 . . . . 0.0 108.202 170.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.439 ' HB3' ' HA ' ' A' ' 112' ' ' LYS . 30.9 p90 -55.6 130.19 70.77 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 123.658 0.783 . . . . 0.0 112.248 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.87 -42.42 0.78 Allowed 'Cis proline' 0 C--N 1.385 2.472 0 CA-C-N 119.923 1.008 . . . . 0.0 113.09 -4.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.09 65.15 0.16 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.697 0.799 . . . . 0.0 109.613 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.9 m -105.79 118.38 36.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.938 0.895 . . . . 0.0 109.49 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.83 110.83 8.43 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.672 0.789 . . . . 0.0 110.971 -169.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.525 HD21 ' HB2' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -88.37 -51.63 5.63 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 170.691 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -137.24 116.63 12.75 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.233 -168.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.73 22.32 40.96 Favored Glycine 0 N--CA 1.478 1.486 0 N-CA-C 114.553 0.581 . . . . 0.0 114.553 -173.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -177.89 163.6 1.81 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.235 1.414 . . . . 0.0 109.479 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -59.67 -36.65 76.86 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.938 0.895 . . . . 0.0 112.695 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.11 -44.35 97.49 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.034 0.534 . . . . 0.0 111.802 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -72.85 -36.01 67.34 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.484 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.41 -42.62 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.264 0.626 . . . . 0.0 110.019 174.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.747 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 79.2 ttt180 -62.49 -58.16 8.61 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.547 -175.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.1 m -69.86 -35.0 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 124.248 0.967 . . . . 0.0 112.879 -170.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -67.43 -36.39 81.13 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.642 0.377 . . . . 0.0 110.163 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -77.14 -30.09 54.92 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.357 176.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 50' ' ' ARG . 91.6 mt -57.82 -42.58 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 118.84 0.745 . . . . 0.0 109.922 174.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.0 -32.8 73.44 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.576 0.75 . . . . 0.0 111.616 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -74.85 -28.8 60.82 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.939 0.495 . . . . 0.0 110.706 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -81.15 -3.71 52.99 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.217 0.607 . . . . 0.0 110.995 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -77.03 -29.34 55.26 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.007 0.523 . . . . 0.0 110.802 169.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -59.93 118.79 35.53 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 123.91 0.884 . . . . 0.0 110.753 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -64.39 -35.72 48.52 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.828 2.352 . . . . 0.0 113.118 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -93.14 8.4 40.26 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.966 0.506 . . . . 0.0 112.154 -173.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.4 tp -67.85 113.87 5.95 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -148.31 116.34 6.43 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.73 104.88 3.13 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 174.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -97.61 105.18 17.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 80' ' ' GLU . 8.1 tt -78.94 127.45 32.02 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.023 0.44 . . . . 0.0 110.095 -177.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.425 HD22 ' H ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -96.18 -48.11 5.78 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.202 1.001 . . . . 0.0 108.737 -176.64 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 92.4 m -143.93 134.22 24.49 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.633 -170.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 10.8 ptt180 -131.44 129.27 41.0 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 166.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.7 HG22 ' HB ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -107.24 156.26 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.115 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.411 HD11 ' HB ' ' A' ' 5' ' ' ILE . 18.7 tt -134.7 137.67 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.127 0.489 . . . . 0.0 110.754 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 p -147.16 102.36 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.527 1.131 . . . . 0.0 108.636 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.8 -115.94 8.09 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.497 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -99.55 12.35 36.71 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.089 0.556 . . . . 0.0 111.728 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.92 139.35 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.899 0.879 . . . . 0.0 110.09 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.571 HG23 HG22 ' A' ' 5' ' ' ILE . 53.2 t -126.13 140.11 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.525 0.73 . . . . 0.0 109.77 174.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.7 ' HB ' HG22 ' A' ' 70' ' ' VAL . 24.4 mm -98.22 101.69 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 165.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -95.31 104.48 16.37 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -100.48 109.0 21.11 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.722 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -120.34 165.63 14.62 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.678 1.191 . . . . 0.0 110.412 -179.553 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.9 m -116.24 105.54 12.67 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.314 1.046 . . . . 0.0 109.083 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.2 125.69 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.291 0.567 . . . . 0.0 111.079 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.5 m -74.63 132.07 41.43 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.365 1.066 . . . . 0.0 110.178 175.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -130.31 -168.24 1.94 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.204 1.002 . . . . 0.0 109.282 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -128.43 100.29 5.73 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.657 0.783 . . . . 0.0 109.413 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -108.84 149.65 39.82 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.389 0.676 . . . . 0.0 110.398 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.86 -27.07 51.56 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.784 2.323 . . . . 0.0 113.234 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -86.84 -9.43 55.8 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.02 -140.25 6.31 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 120.094 -0.281 . . . . 0.0 112.728 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -66.07 -81.08 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.691 0.797 . . . . 0.0 111.548 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.45 28.21 1.66 Allowed Glycine 0 C--N 1.347 1.187 0 C-N-CA 121.341 -0.457 . . . . 0.0 113.77 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 117' ' ' ARG . 0.3 OUTLIER -88.81 100.2 12.97 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 122.368 1.08 . . . . 0.0 108.234 -174.452 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 116' ' ' PRO . 3.9 m -105.18 143.41 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.719 -169.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.41 141.26 34.1 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.533 HG22 HG12 ' A' ' 113' ' ' ILE . 35.5 t -138.06 142.04 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -109.92 105.24 14.34 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 170.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 74.9 m -92.74 136.7 33.0 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.56 ' HB ' HD13 ' A' ' 77' ' ' ILE . 7.3 tt -122.11 111.72 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 124.374 1.069 . . . . 0.0 109.768 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.433 ' HD2' HG22 ' A' ' 9' ' ' VAL . 12.7 m-85 -99.85 142.85 30.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.871 0.469 . . . . 0.0 109.844 176.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -111.64 113.92 26.63 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.0 t -97.73 141.79 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 124.646 1.179 . . . . 0.0 110.265 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -141.63 105.6 4.76 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.917 1.287 . . . . 0.0 108.206 -172.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 20.4 m120 61.49 30.96 19.04 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.539 1.136 . . . . 0.0 111.837 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.0 4.68 78.15 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.335 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -126.5 132.56 51.37 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.649 0.78 . . . . 0.0 109.697 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 62.9 mt -68.47 112.57 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 122.986 0.514 . . . . 0.0 110.088 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -76.91 -37.79 54.74 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.361 0.664 . . . . 0.0 110.434 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.571 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 98.0 mttt -151.59 150.16 29.98 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.81 0.844 . . . . 0.0 109.279 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.0 135.35 32.62 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.502 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 3.1 m-90 -132.66 156.03 47.7 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -145.39 148.6 33.53 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.538 0.608 . . . . 0.0 110.959 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 8.4 ptpp? -126.5 129.98 49.72 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.162 0.985 . . . . 0.0 108.825 172.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.533 HG12 HG22 ' A' ' 95' ' ' VAL . 95.8 mt -90.85 129.65 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.54 -80.18 0.12 Allowed Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.64 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.25 161.12 30.14 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.486 ' HA ' HG12 ' A' ' 93' ' ' VAL . 72.4 Cg_endo -72.52 121.0 7.06 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.481 2.121 . . . . 0.0 112.262 170.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 78.0 mtt-85 -122.56 153.48 39.2 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.52 0.728 . . . . 0.0 110.661 -177.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 120' ' ' SER . 40.1 mm -136.51 139.58 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.6 1.16 . . . . 0.0 109.648 -176.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.7 t -65.18 -41.89 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 123.656 0.782 . . . . 0.0 111.021 174.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 118' ' ' ILE . 45.5 t -63.32 -24.77 68.0 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.719 0.808 . . . . 0.0 112.073 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 61.1 mm-40 -104.06 20.02 19.01 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.973 0.509 . . . . 0.0 110.554 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -142.78 152.68 42.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.1 0.96 . . . . 0.0 110.01 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.4 p . . . . . 0 CA--C 1.561 1.386 0 C-N-CA 123.111 0.565 . . . . 0.0 109.623 172.073 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.484 1.246 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -155.18 24.7 0.42 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.586 0.354 . . . . 0.0 111.627 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.3 p -64.63 -37.64 88.26 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.879 0.472 . . . . 0.0 110.039 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.04 -23.1 61.7 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.127 1.371 . . . . 0.0 112.977 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.537 HG23 ' HB ' ' A' ' 101' ' ' VAL . 29.1 mm -93.18 -29.27 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.386 1.074 . . . . 0.0 109.771 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -77.94 -24.16 48.29 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.704 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.451 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 88.2 mt -61.71 -57.67 23.12 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-O 118.136 -0.935 . . . . 0.0 112.012 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.578 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 14.1 Cg_endo -54.37 -50.11 14.61 Favored 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 122.766 2.31 . . . . 0.0 112.706 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.6 m -65.65 -32.4 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.901 -174.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.18 -50.63 31.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.583 0.753 . . . . 0.0 110.336 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.1 mmtt -66.84 -30.62 70.84 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.018 -176.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.17 -49.2 78.77 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 124.039 0.837 . . . . 0.0 111.288 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.75 -48.33 79.94 Favored 'General case' 0 C--O 1.246 0.897 0 O-C-N 123.774 0.671 . . . . 0.0 110.069 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -58.27 -42.61 86.87 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 124.904 1.377 . . . . 0.0 109.055 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -72.91 -25.78 61.17 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.753 -1.567 . . . . 0.0 112.796 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -68.14 -44.43 76.05 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.06 0.457 . . . . 0.0 110.324 -173.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -85.49 -29.58 24.16 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.644 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.87 -4.19 57.8 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.35 0.66 . . . . 0.0 111.497 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.42 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 23.6 mmt85 69.99 23.6 5.38 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.225 1.41 . . . . 0.0 112.796 171.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 19.7 m-20 -91.24 94.61 9.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.05 0.54 . . . . 0.0 110.541 177.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.475 HG13 HG12 ' A' ' 54' ' ' ILE . 20.2 mm -66.37 -28.7 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 123.514 0.726 . . . . 0.0 111.208 173.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -58.76 -47.15 85.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.945 0.498 . . . . 0.0 111.351 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.04 -33.97 33.16 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.421 0.689 . . . . 0.0 111.052 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -68.18 -8.88 42.63 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.777 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.709 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 24.9 tpp -120.53 -22.26 6.48 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 174.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.08 -28.79 69.86 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -175.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.578 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 96.1 m95 -94.17 9.63 37.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.786 0.834 . . . . 0.0 112.539 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -102.77 153.09 20.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.662 0.785 . . . . 0.0 110.002 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.47 140.43 44.59 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 168.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -67.81 -11.69 59.04 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.306 0.642 . . . . 0.0 112.37 -174.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -116.18 21.08 13.94 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.077 0.951 . . . . 0.0 111.232 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.7 t -59.76 147.55 37.55 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.45 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 33.8 mm-40 -107.21 105.42 15.39 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.171 0.988 . . . . 0.0 110.043 -175.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -102.55 112.63 25.46 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.587 0.755 . . . . 0.0 110.521 -173.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.421 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 13.9 m-85 -106.51 152.69 23.34 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.874 0.87 . . . . 0.0 110.322 175.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.64 161.95 18.4 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.355 1.062 . . . . 0.0 109.776 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.502 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 68.3 t80 -57.06 125.56 70.58 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 123.696 0.798 . . . . 0.0 110.26 174.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.24 -56.75 0.14 OUTLIER 'Cis proline' 0 C--N 1.386 2.545 0 CA-C-N 120.59 1.246 . . . . 0.0 113.898 2.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.9 57.72 0.37 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.558 0.743 . . . . 0.0 109.51 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.9 m -98.84 113.68 25.92 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.091 0.957 . . . . 0.0 110.533 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.47 102.46 0.7 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.9 mt -78.37 -42.26 30.91 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.621 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -140.19 115.55 9.95 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.001 -169.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.7 46.13 1.66 Allowed Glycine 0 C--N 1.344 1.006 0 O-C-N 123.386 0.429 . . . . 0.0 112.284 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 p30 163.26 153.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 126.491 1.916 . . . . 0.0 108.561 -172.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.709 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -68.56 -23.66 64.53 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.876 0.87 . . . . 0.0 113.328 -174.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.5 -48.76 80.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.753 0.421 . . . . 0.0 111.239 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.494 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 27.3 mt-10 -70.67 -30.17 66.69 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.652 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.513 HD12 ' HA ' ' A' ' 46' ' ' ALA . 63.9 mt -64.66 -52.43 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.487 0.715 . . . . 0.0 110.679 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.497 ' O ' HG13 ' A' ' 54' ' ' ILE . 6.4 ptp180 -64.2 -43.12 96.03 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.443 -175.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.9 t -67.91 -39.33 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.13 0.972 . . . . 0.0 111.743 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -71.33 -29.74 65.37 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.627 0.371 . . . . 0.0 110.851 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -73.61 -30.57 63.06 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 119.114 -0.469 . . . . 0.0 111.346 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 50' ' ' ARG . 77.6 mt -58.59 -38.75 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -57.2 -41.91 80.27 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.916 0.76 . . . . 0.0 111.717 174.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -73.59 -31.03 63.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.119 0.568 . . . . 0.0 110.722 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.42 ' CD2' ' HA ' ' A' ' 19' ' ' ARG . 2.6 m-30 -78.42 3.21 16.4 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.35 0.66 . . . . 0.0 111.478 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.417 ' HE2' HG22 ' A' ' 54' ' ' ILE . 73.4 mmtt -81.67 -18.38 44.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.312 0.645 . . . . 0.0 112.183 171.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.65 121.03 79.51 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-O 119.205 -0.426 . . . . 0.0 110.188 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.95 -20.05 34.42 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.357 2.038 . . . . 0.0 111.687 177.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -84.87 -13.36 51.16 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.885 0.874 . . . . 0.0 111.676 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 83' ' ' THR . 30.2 tp -62.85 112.56 2.6 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -173.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -145.5 118.03 8.56 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.18 105.54 3.31 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -96.3 105.73 17.84 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 tt -85.88 119.83 26.62 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.465 ' H ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -107.44 -31.43 8.16 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.706 0.802 . . . . 0.0 111.231 -174.737 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.418 ' N ' HD22 ' A' ' 67' ' ' LEU . 84.7 m -142.87 132.38 23.66 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.923 0.889 . . . . 0.0 109.805 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -135.67 135.07 39.82 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 164.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.494 HG22 ' HB ' ' A' ' 77' ' ' ILE . 20.4 m -122.56 142.41 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.5 tt -124.84 138.47 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 121.229 0.538 . . . . 0.0 111.219 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -139.76 99.41 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 125.284 1.434 . . . . 0.0 107.999 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.29 -126.79 23.15 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.718 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.423 ' HA ' HG13 ' A' ' 5' ' ' ILE . 21.1 p-10 -94.78 24.27 4.84 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.228 0.611 . . . . 0.0 111.411 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.2 t -131.43 130.75 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.404 1.082 . . . . 0.0 109.433 -174.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.9 t -120.93 142.53 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 122.982 0.513 . . . . 0.0 110.043 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.673 HD13 ' HB ' ' A' ' 98' ' ' ILE . 5.3 mm -98.28 107.69 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 165.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -91.57 109.38 20.68 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 167.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -100.72 108.51 20.38 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 175.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.53 129.35 42.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.757 1.223 . . . . 0.0 109.734 -174.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.5 m -83.91 103.02 12.83 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 172.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.6 m -89.33 137.71 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 29.2 m -95.58 135.45 37.23 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.195 0.598 . . . . 0.0 109.688 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -131.45 -166.11 1.66 Allowed 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -125.45 99.57 6.09 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 122.122 -0.361 . . . . 0.0 110.061 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.434 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 20.7 m-30 -99.53 135.74 20.54 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 172.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.03 -12.5 35.68 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.997 2.465 . . . . 0.0 113.812 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -83.98 -11.2 57.17 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA3' HG23 ' A' ' 118' ' ' ILE . . . 173.09 -119.3 0.75 Allowed Glycine 0 C--N 1.35 1.34 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.346 171.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -71.4 -80.61 0.06 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.215 0.606 . . . . 0.0 110.998 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.434 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 123.22 27.0 1.57 Allowed Glycine 0 C--N 1.344 0.978 0 N-CA-C 114.032 0.373 . . . . 0.0 114.032 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -89.53 141.12 28.87 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' A' ' 116' ' ' PRO . 30.4 m -133.49 133.37 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.199 0.599 . . . . 0.0 109.557 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.51 109.24 15.79 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.481 HG22 HG12 ' A' ' 113' ' ' ILE . 39.0 t -112.43 156.65 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -175.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -128.69 101.93 6.35 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 111' ' ' PHE . 76.2 m -92.08 105.7 17.88 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.673 ' HB ' HD13 ' A' ' 77' ' ' ILE . 8.5 tt -92.2 112.19 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.044 0.938 . . . . 0.0 109.58 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -99.94 148.84 24.05 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.571 0.748 . . . . 0.0 110.127 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -118.69 111.85 19.04 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.552 HG22 HG12 ' A' ' 106' ' ' ILE . 53.6 t -98.31 112.18 29.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.012 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -117.18 130.9 56.9 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 62.7 32.1 16.34 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.581 0.752 . . . . 0.0 111.386 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.63 -5.88 82.19 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 115.657 -0.702 . . . . 0.0 114.58 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 63.5 mmt-85 -132.22 147.44 52.41 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.6 0.76 . . . . 0.0 109.281 -175.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.552 HG12 HG22 ' A' ' 101' ' ' VAL . 66.4 mt -68.94 100.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.395 0.678 . . . . 0.0 110.256 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.68 -25.71 35.31 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.563 0.745 . . . . 0.0 111.312 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 96.8 mttt -145.58 150.03 35.63 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.788 0.835 . . . . 0.0 108.751 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.36 135.11 14.51 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.507 0.723 . . . . 0.0 109.408 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.421 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 2.5 m-90 -133.06 130.63 39.62 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.476 ' HB2' ' SG ' ' A' ' 97' ' ' CYS . 11.8 p90 -119.66 138.95 52.94 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.252 0.933 . . . . 0.0 109.583 175.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -127.36 119.9 27.29 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.371 0.668 . . . . 0.0 109.213 -178.878 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.481 HG12 HG22 ' A' ' 95' ' ' VAL . 88.7 mt -88.75 130.1 38.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.04 -78.8 0.17 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.153 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -158.38 163.26 24.96 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.632 ' HA ' HG12 ' A' ' 93' ' ' VAL . 74.5 Cg_endo -71.04 114.74 4.0 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.28 1.987 . . . . 0.0 112.189 170.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -107.05 150.68 26.27 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.887 0.875 . . . . 0.0 108.973 176.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 121' ' ' GLN . 32.2 mm -138.11 121.35 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.875 0.87 . . . . 0.0 108.98 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.77 -40.96 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.024 0.53 . . . . 0.0 110.752 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.2 m -58.26 -66.38 0.49 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.85 0.86 . . . . 0.0 110.99 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.512 ' H ' HG22 ' A' ' 118' ' ' ILE . 64.6 tt0 -87.66 94.82 9.85 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.848 0.859 . . . . 0.0 109.397 175.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -147.1 120.78 9.18 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.8 t . . . . . 0 C--O 1.252 1.21 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -177.559 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 50.7 p -65.98 -43.62 87.28 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.407 -1.269 . . . . 0.0 111.749 -172.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.21 -6.82 31.46 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.622 0.769 . . . . 0.0 112.722 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.453 ' HB ' HD11 ' A' ' 71' ' ' ILE . 14.4 mm -95.78 -29.64 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.649 0.78 . . . . 0.0 109.016 174.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -77.73 -33.01 53.15 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.701 0.801 . . . . 0.0 111.492 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 3' ' ' SER . 93.0 mt -58.91 -49.54 92.81 Favored Pre-proline 0 N--CA 1.489 1.492 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.384 -176.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.6 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 11.9 Cg_endo -56.29 -60.92 0.39 Allowed 'Trans proline' 0 C--N 1.392 2.816 0 C-N-CA 122.245 1.964 . . . . 0.0 112.303 175.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.49 HG21 HG11 ' A' ' 76' ' ' VAL . 22.6 m -64.27 -29.54 47.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.848 -167.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -68.72 -55.18 12.19 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.564 0.745 . . . . 0.0 109.88 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -62.97 -35.08 78.96 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.892 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -74.79 -42.52 57.97 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.6 0.76 . . . . 0.0 111.438 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.459 HD21 ' HB2' ' A' ' 66' ' ' LEU . 22.9 tp -60.76 -46.79 89.11 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.851 0.46 . . . . 0.0 110.401 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.22 -49.94 74.43 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.94 173.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.85 -25.91 68.38 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.267 1.027 . . . . 0.0 112.3 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -63.75 -44.1 94.51 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.595 0.758 . . . . 0.0 110.71 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -91.25 -28.24 17.92 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.814 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.85 -10.23 59.74 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.831 0.852 . . . . 0.0 112.111 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 69.11 44.68 0.97 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.876 1.27 . . . . 0.0 112.095 173.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -115.77 93.81 4.42 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.261 0.624 . . . . 0.0 109.566 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.531 HG13 HG12 ' A' ' 54' ' ' ILE . 12.8 mm -71.62 -29.63 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 122.864 0.466 . . . . 0.0 111.35 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.78 -45.12 93.27 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.458 0.303 . . . . 0.0 111.4 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.43 -32.36 42.79 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.991 0.516 . . . . 0.0 110.94 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.488 ' HB3' ' HA ' ' A' ' 21' ' ' ILE . 50.8 t80 -70.05 -10.33 58.34 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.888 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.659 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -111.53 -29.74 7.64 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.453 0.701 . . . . 0.0 111.24 174.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.04 -54.25 32.31 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.808 0.843 . . . . 0.0 112.241 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.6 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 95.5 m95 -78.39 4.64 12.49 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.467 -1.242 . . . . 0.0 113.452 -169.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.711 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 28.3 m95 -93.29 162.37 14.03 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.54 0.736 . . . . 0.0 109.521 174.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -79.67 152.16 30.11 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.793 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.41 -27.24 66.91 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 120.782 0.325 . . . . 0.0 111.3 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.32 18.86 21.39 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.633 0.773 . . . . 0.0 110.791 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.711 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 53.2 t -60.72 133.8 56.45 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.069 0.548 . . . . 0.0 112.12 -174.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -88.08 148.96 24.23 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 56.6 t80 -140.53 112.85 7.87 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.432 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 27.0 m-85 -108.25 154.88 21.14 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.037 0.935 . . . . 0.0 110.83 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -113.39 155.31 25.46 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.872 1.269 . . . . 0.0 109.341 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.718 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 69.3 t80 -53.54 125.49 44.96 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.398 1.079 . . . . 0.0 111.971 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -76.85 -58.4 0.14 OUTLIER 'Cis proline' 0 C--N 1.383 2.362 0 CA-C-N 120.344 1.159 . . . . 0.0 113.986 -4.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -145.3 78.85 1.56 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.473 0.709 . . . . 0.0 109.819 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 94.5 m -125.95 106.05 9.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.473 0.709 . . . . 0.0 109.709 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.5 tp -66.12 102.41 0.82 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.549 0.74 . . . . 0.0 110.937 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 36' ' ' ALA . 41.2 mt -79.79 -35.86 37.92 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.384 0.673 . . . . 0.0 110.553 175.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -142.49 121.32 12.71 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.436 -171.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.91 35.38 4.9 Favored Glycine 0 C--N 1.347 1.176 0 C-N-CA 123.239 0.447 . . . . 0.0 112.754 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 p30 168.45 161.31 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.65 1.58 . . . . 0.0 109.79 -172.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -64.96 -36.93 85.96 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.407 1.083 . . . . 0.0 112.918 -173.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.28 82.86 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.124 0.569 . . . . 0.0 111.84 -173.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.403 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 27.4 mt-10 -77.02 -33.29 57.44 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.988 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.8 mt -61.64 -50.44 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.676 0.79 . . . . 0.0 110.756 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.659 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 21.3 ptt180 -61.91 -49.93 74.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 118.841 -0.599 . . . . 0.0 110.525 -177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.5 t -59.29 -42.82 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.531 0.732 . . . . 0.0 110.668 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.454 ' HA ' ' HE ' ' A' ' 52' ' ' ARG . 2.1 tpm_? -55.17 -43.72 74.54 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.024 0.827 . . . . 0.0 110.704 176.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -78.24 -29.78 48.34 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.387 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.531 HG12 HG13 ' A' ' 21' ' ' ILE . 95.7 mt -61.42 -38.47 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 118.414 0.552 . . . . 0.0 109.673 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -58.88 -40.17 83.59 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.653 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -70.47 -32.95 70.69 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.074 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -74.66 -8.66 57.08 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.811 0.844 . . . . 0.0 111.832 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.462 ' HE2' HG22 ' A' ' 54' ' ' ILE . 72.6 mmtt -71.12 -27.27 63.46 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.775 0.43 . . . . 0.0 111.542 174.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.44 117.05 43.25 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.97 -22.08 42.51 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.302 2.002 . . . . 0.0 110.885 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -85.84 -5.54 59.23 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.618 1.567 . . . . 0.0 112.603 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.79 120.9 12.17 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.418 0.287 . . . . 0.0 110.314 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -150.93 117.67 5.8 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.3 102.64 2.95 Favored Glycine 0 C--N 1.344 1.002 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -95.3 103.07 14.92 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.459 ' HB2' HD21 ' A' ' 13' ' ' LEU . 8.7 tp -68.02 139.88 56.32 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.134 0.492 . . . . 0.0 110.81 -177.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mt -107.39 -53.01 2.68 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.463 1.105 . . . . 0.0 108.392 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.8 m -148.11 144.69 27.99 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 113.613 -1.631 . . . . 0.0 109.739 -172.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 25.2 ptt180 -140.7 128.55 21.81 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.115 0.966 . . . . 0.0 108.739 173.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.522 HG22 ' HB ' ' A' ' 77' ' ' ILE . 33.1 m -123.83 152.08 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.453 HD11 ' HB ' ' A' ' 5' ' ' ILE . 11.2 tt -133.35 118.72 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.25 0.548 . . . . 0.0 110.401 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.6 t -112.18 95.27 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.368 1.067 . . . . 0.0 108.429 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.92 -111.1 3.8 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 116.027 -0.533 . . . . 0.0 113.433 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -93.44 12.43 25.0 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.769 0.828 . . . . 0.0 111.615 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.1 t -125.72 134.25 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.74 0.816 . . . . 0.0 109.52 -171.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 9' ' ' VAL . 24.5 t -125.69 135.17 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 122.807 0.443 . . . . 0.0 110.355 175.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.62 HD13 ' HB ' ' A' ' 98' ' ' ILE . 9.0 mm -99.81 105.06 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.092 1.357 . . . . 0.0 108.006 169.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.01 105.87 17.86 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 167.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.44 ' HE1' ' HB3' ' A' ' 94' ' ' ASP . 1.8 t60 -100.21 106.78 18.49 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.95 169.18 12.95 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.942 1.297 . . . . 0.0 110.18 -176.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.6 m -116.71 110.16 18.09 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.2 t -81.29 103.41 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.362 0.665 . . . . 0.0 110.123 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 88.0 m -66.24 118.81 10.48 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -123.98 -169.29 1.93 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.572 1.149 . . . . 0.0 108.031 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.1 109.37 16.33 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.39 0.676 . . . . 0.0 109.424 169.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -103.81 147.02 33.62 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 123.655 0.782 . . . . 0.0 110.015 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.02 -9.86 27.54 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.876 2.384 . . . . 0.0 114.216 -175.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -92.35 -15.14 27.7 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.419 0.287 . . . . 0.0 111.66 173.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.05 -121.66 1.03 Allowed Glycine 0 C--N 1.355 1.626 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.956 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -53.79 -84.57 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.503 1.121 . . . . 0.0 111.994 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.58 28.54 2.72 Favored Glycine 0 C--N 1.349 1.276 0 C-N-CA 121.686 -0.292 . . . . 0.0 113.575 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -89.77 119.57 30.27 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -173.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 116' ' ' PRO . 33.4 m -116.49 123.16 71.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 CA-C-O 121.114 0.483 . . . . 0.0 110.045 -175.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.44 ' HB3' ' HE1' ' A' ' 79' ' ' HIS . 2.8 m-20 -84.19 108.0 16.83 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 113' ' ' ILE . 24.0 t -113.14 149.42 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.788 1.235 . . . . 0.0 109.432 -174.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -112.84 103.19 11.18 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 167.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 76.7 m -93.76 109.05 20.74 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.62 ' HB ' HD13 ' A' ' 77' ' ' ILE . 4.9 tt -99.3 134.6 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.244 1.018 . . . . 0.0 109.739 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -123.22 155.6 36.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.773 0.829 . . . . 0.0 109.866 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -129.07 119.42 24.17 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.892 1.277 . . . . 0.0 107.645 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.534 HG22 HG12 ' A' ' 106' ' ' ILE . 97.1 t -107.46 117.62 53.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.226 1.01 . . . . 0.0 109.695 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.527 ' HG2' ' ND2' ' A' ' 103' ' ' ASN . 43.0 tt0 -126.95 133.26 50.66 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.92 0.888 . . . . 0.0 109.23 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.527 ' ND2' ' HG2' ' A' ' 102' ' ' GLU . 48.1 m-80 61.54 28.62 17.84 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.027 1.331 . . . . 0.0 111.798 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.05 -7.56 80.0 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -121.27 149.29 43.1 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 101' ' ' VAL . 47.7 mt -66.41 109.77 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -75.78 -38.41 58.31 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.865 0.866 . . . . 0.0 110.608 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -149.12 146.7 27.82 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.191 0.996 . . . . 0.0 109.059 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -145.84 139.68 26.52 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.154 0.582 . . . . 0.0 109.504 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.432 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 2.0 m-90 -131.78 155.8 47.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -142.24 145.02 33.62 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 171.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.718 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 59.9 pttt -129.06 124.27 34.42 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.627 0.771 . . . . 0.0 109.066 175.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.461 HG12 HG22 ' A' ' 95' ' ' VAL . 96.5 mt -88.63 123.94 41.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.9 -66.84 2.24 Favored Glycine 0 C--O 1.242 0.607 0 O-C-N 124.39 1.056 . . . . 0.0 112.876 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -158.55 163.77 23.27 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.084 0.554 . . . . 0.0 109.653 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.627 ' HA ' HG12 ' A' ' 93' ' ' VAL . 88.7 Cg_endo -82.23 137.29 9.39 Favored 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.561 2.174 . . . . 0.0 112.475 163.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -132.82 158.74 41.73 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.74 0.781 . . . . 0.0 111.934 175.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.3 mm -138.54 139.63 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.235 1.414 . . . . 0.0 108.375 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.493 1.709 0 C-N-CA 124.001 0.921 . . . . 0.0 111.827 -179.384 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.55 ' HB2' HD11 ' A' ' 71' ' ' ILE . 11.1 m120 . . . . . 0 N--CA 1.474 0.752 0 CA-C-O 121.617 0.722 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.477 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 45.7 m -67.42 -33.22 74.71 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.547 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.29 -11.27 30.16 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.618 0.767 . . . . 0.0 112.408 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.559 HG22 HG23 ' A' ' 76' ' ' VAL . 16.3 mm -98.06 -32.55 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.742 0.817 . . . . 0.0 109.824 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -69.18 -33.81 73.94 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.66 0.784 . . . . 0.0 112.099 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.9 mt -66.83 -50.33 44.33 Favored Pre-proline 0 N--CA 1.486 1.331 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.182 -173.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 12.2 Cg_endo -54.83 -52.23 8.5 Favored 'Trans proline' 0 C--N 1.398 3.132 0 C-N-CA 122.136 1.891 . . . . 0.0 111.525 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.471 HG11 HG11 ' A' ' 76' ' ' VAL . 72.4 t -58.08 -43.64 85.66 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 C-N-CA 124.774 1.23 . . . . 0.0 112.496 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 24.4 tp60 -66.13 -55.87 14.25 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.409 0.684 . . . . 0.0 111.472 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.425 ' HG3' ' CZ2' ' A' ' 27' ' ' TRP . 73.4 mmtt -65.33 -38.34 89.85 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.325 0.65 . . . . 0.0 110.817 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -62.89 -39.49 94.65 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.523 1.129 . . . . 0.0 111.343 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' A' ' 16' ' ' TYR . 5.0 tt -59.81 -52.81 63.88 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 20.5 mm-40 -61.57 -32.03 72.09 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.806 -174.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.57 -27.64 55.93 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.588 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.4 ' HB3' ' O ' ' A' ' 13' ' ' LEU . 68.0 t80 -63.66 -47.36 81.6 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.218 1.007 . . . . 0.0 110.812 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -84.76 -23.49 29.2 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.17 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.64 -6.8 58.76 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.153 0.581 . . . . 0.0 112.337 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 71.8 12.59 6.22 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.268 1.427 . . . . 0.0 113.042 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -76.28 94.46 3.57 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.476 HG13 HG12 ' A' ' 54' ' ' ILE . 12.5 mm -66.95 -28.54 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.728 0.811 . . . . 0.0 110.883 173.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -58.62 -46.63 86.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.851 0.46 . . . . 0.0 111.1 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.6 -30.88 41.64 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.365 0.666 . . . . 0.0 110.972 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -72.87 -7.66 51.94 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.49 0.716 . . . . 0.0 110.514 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.732 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -116.35 -25.31 7.56 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.409 0.684 . . . . 0.0 112.034 175.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.6 -40.53 79.28 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.835 0.854 . . . . 0.0 113.123 -171.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 90.5 m95 -89.69 1.7 55.71 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.404 -173.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.567 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 14.2 m95 -99.05 138.6 35.92 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.576 0.75 . . . . 0.0 109.141 -177.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -71.46 160.66 32.35 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.443 0.697 . . . . 0.0 111.174 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -61.25 -39.82 91.74 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.398 0.679 . . . . 0.0 111.546 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -99.12 19.98 14.25 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.463 1.105 . . . . 0.0 110.856 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.567 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 50.1 t -58.03 115.12 2.68 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.224 0.609 . . . . 0.0 111.714 -176.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -75.68 153.2 37.3 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 59.8 t80 -142.07 118.67 11.0 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -115.82 153.1 32.08 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.476 1.11 . . . . 0.0 109.673 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.39 161.23 23.84 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.232 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -57.99 128.97 81.96 Favored Pre-proline 0 CA--C 1.562 1.404 0 O-C-N 124.327 1.017 . . . . 0.0 110.77 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -75.9 -51.16 0.16 OUTLIER 'Cis proline' 0 C--N 1.384 2.44 0 CA-C-N 120.185 1.102 . . . . 0.0 114.03 -0.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.0 86.4 0.62 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.2 m -141.88 117.7 10.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.38 0.672 . . . . 0.0 109.977 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 tt -68.84 106.76 2.81 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.258 1.023 . . . . 0.0 109.899 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.3 mt -82.29 -42.52 18.72 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.397 0.679 . . . . 0.0 111.345 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -141.47 117.22 10.39 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.872 0.469 . . . . 0.0 111.113 -170.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.27 42.72 1.9 Allowed Glycine 0 N--CA 1.478 1.441 0 O-C-N 123.117 0.26 . . . . 0.0 113.014 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 p30 167.69 156.51 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.649 1.579 . . . . 0.0 108.934 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -63.61 -32.88 74.48 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.782 0.833 . . . . 0.0 112.776 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.79 90.99 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.156 0.582 . . . . 0.0 112.221 -173.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.501 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 30.2 mt-10 -74.16 -34.86 63.96 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.617 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.8 mt -58.59 -45.41 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.049 0.94 . . . . 0.0 110.432 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.732 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 21.6 ttt180 -54.33 -56.71 15.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.43 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.7 t -54.77 -49.47 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 124.708 1.255 . . . . 0.0 111.568 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -62.18 -36.97 83.51 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.345 -174.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -77.55 -34.57 53.75 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 118.894 -0.574 . . . . 0.0 111.842 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 50' ' ' ARG . 77.5 mt -56.42 -40.32 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.053 0.454 . . . . 0.0 109.867 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -57.26 -43.0 82.62 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.506 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -76.25 -22.33 55.28 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 120.801 0.334 . . . . 0.0 111.282 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.473 ' HA ' HD22 ' A' ' 62' ' ' LEU . 3.5 m-30 -79.76 -0.5 34.62 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.527 0.731 . . . . 0.0 112.032 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -73.55 -30.63 63.19 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.097 0.559 . . . . 0.0 111.28 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -63.08 121.04 66.65 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.278 0.631 . . . . 0.0 110.883 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.75 -23.67 26.01 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.263 1.976 . . . . 0.0 110.773 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.34 -10.53 59.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.015 1.326 . . . . 0.0 111.477 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 57' ' ' PHE . 42.7 tp -59.29 112.63 1.81 Allowed 'General case' 0 C--N 1.36 1.024 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -148.76 130.37 14.95 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.259 1.023 . . . . 0.0 108.332 -175.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.16 127.15 8.24 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -122.56 102.99 8.4 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.62 HD12 ' HG2' ' A' ' 80' ' ' GLU . 6.3 tp -69.72 138.11 52.6 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.403 0.62 . . . . 0.0 111.208 -175.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mt -105.88 -50.85 3.09 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.822 1.249 . . . . 0.0 108.253 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.7 m -150.11 141.44 23.25 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 113.24 -1.8 . . . . 0.0 109.844 -173.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -131.38 130.43 42.6 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 165.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.59 127.6 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.884 1.274 . . . . 0.0 110.273 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.55 HD11 ' HB2' ' A' ' 2' ' ' ASN . 15.7 tt -102.89 120.67 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.145 0.578 . . . . 0.0 109.7 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.43 94.54 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 124.194 0.998 . . . . 0.0 108.486 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.37 -118.02 11.91 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 123.323 0.389 . . . . 0.0 112.669 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.5 ' HA ' HG13 ' A' ' 5' ' ' ILE . 2.5 p-10 -95.04 7.99 44.36 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.325 0.65 . . . . 0.0 111.689 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.6 t -116.31 141.54 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.59 1.156 . . . . 0.0 108.581 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.559 HG23 HG22 ' A' ' 5' ' ' ILE . 70.0 t -126.29 133.5 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.004 0.522 . . . . 0.0 109.615 170.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.466 HG12 ' HB ' ' A' ' 98' ' ' ILE . 5.2 mt -100.65 114.84 40.79 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 164.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -96.65 150.84 20.22 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 166.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -138.09 106.34 5.77 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.62 ' HG2' HD12 ' A' ' 66' ' ' LEU . 6.6 mt-10 -115.75 158.98 22.02 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.344 0.658 . . . . 0.0 109.558 176.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 92' ' ' GLU . 56.9 m -97.05 103.14 15.04 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 163.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.53 125.2 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.452 0.644 . . . . 0.0 111.319 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.9 m -76.28 122.92 25.11 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.121 0.969 . . . . 0.0 111.708 -175.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.2 mmt-85 -119.97 -168.29 1.58 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.623 1.169 . . . . 0.0 109.189 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.81 104.99 9.29 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.275 1.03 . . . . 0.0 109.539 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.435 ' HE2' ' HB3' ' A' ' 116' ' ' PRO . 12.6 m-30 -112.4 149.46 41.09 Favored Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 123.558 0.743 . . . . 0.0 111.054 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.61 -18.84 64.05 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.952 2.435 . . . . 0.0 113.608 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -87.0 -4.38 59.17 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.44 -122.68 1.48 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.931 -0.372 . . . . 0.0 112.466 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.414 ' H ' HG23 ' A' ' 118' ' ' ILE . 16.2 tppt? -60.43 -82.14 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.983 0.913 . . . . 0.0 111.5 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.415 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 115.41 26.92 3.27 Favored Glycine 0 C--N 1.343 0.952 0 O-C-N 122.953 0.158 . . . . 0.0 113.205 -175.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.458 ' HB2' HG22 ' A' ' 81' ' ' THR . 16.9 pt-20 -89.21 104.7 17.22 Favored 'General case' 0 C--O 1.207 -1.138 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -174.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 116' ' ' PRO . 20.3 m -105.16 131.12 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 121.33 -0.856 . . . . 0.0 109.973 -171.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -78.33 127.91 32.91 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.518 HG22 HG12 ' A' ' 113' ' ' ILE . 43.1 t -131.57 126.25 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.09 99.41 12.43 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 172.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.6 m -94.81 108.51 20.53 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.152 0.981 . . . . 0.0 108.843 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.611 HG23 ' HB2' ' A' ' 110' ' ' TRP . 11.1 tt -105.86 107.23 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 C-N-CA 124.403 1.081 . . . . 0.0 110.735 -172.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -104.14 131.17 51.7 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.35 1.06 . . . . 0.0 110.024 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -97.82 112.03 24.09 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 168.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.52 HG22 HG12 ' A' ' 106' ' ' ILE . 75.2 t -99.62 125.1 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.077 0.951 . . . . 0.0 109.15 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.528 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 11.4 tp10 -125.81 127.94 46.9 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.476 0.71 . . . . 0.0 109.981 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.528 ' ND2' ' HG3' ' A' ' 102' ' ' GLU . 43.5 m-80 61.48 30.43 18.82 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.45 1.5 . . . . 0.0 112.116 -176.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.54 1.95 90.56 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 113.781 0.272 . . . . 0.0 113.781 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -124.79 136.0 53.46 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.047 0.939 . . . . 0.0 109.007 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.52 HG12 HG22 ' A' ' 101' ' ' VAL . 68.8 mt -62.43 102.86 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.252 1.021 . . . . 0.0 109.811 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -78.47 -29.89 47.09 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.291 0.636 . . . . 0.0 110.765 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -148.57 143.26 26.49 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -137.05 131.03 32.22 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.611 ' HB2' HG23 ' A' ' 98' ' ' ILE . 0.9 OUTLIER -135.37 152.86 51.84 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -176.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -143.0 144.85 32.46 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -130.82 123.7 29.69 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.518 HG12 HG22 ' A' ' 95' ' ' VAL . 96.7 mt -88.22 127.48 41.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.93 -78.82 0.16 Allowed Glycine 0 N--CA 1.468 0.826 0 O-C-N 124.331 1.019 . . . . 0.0 112.667 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -158.83 164.58 20.65 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.712 ' HA ' HG12 ' A' ' 93' ' ' VAL . 72.3 Cg_endo -72.2 117.69 5.26 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.433 2.089 . . . . 0.0 112.581 169.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.422 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 15.6 mmt180 -102.11 144.11 31.09 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.414 HG23 ' H ' ' A' ' 90' ' ' LYS . 49.4 mm -122.83 152.37 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 173.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 N--CA 1.493 1.715 0 C-N-CA 122.646 0.378 . . . . 0.0 111.402 -178.741 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.436 HD22 HD13 ' A' ' 71' ' ' ILE . 3.5 p-10 . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 119.747 -0.168 . . . . 0.0 111.438 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.44 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 78.7 p -63.78 -37.79 88.69 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.463 ' HG3' HG12 ' A' ' 5' ' ' ILE . 9.5 pt-20 -55.8 -28.28 55.41 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.72 1.208 . . . . 0.0 112.716 174.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.575 HG13 ' HA ' ' A' ' 74' ' ' ASN . 32.8 mm -89.83 -27.88 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.492 1.117 . . . . 0.0 109.826 -177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.39 -24.04 60.25 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.117 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 3' ' ' SER . 79.5 mt -63.6 -50.65 71.34 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.725 -175.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.465 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 11.6 Cg_endo -55.96 -60.4 0.52 Allowed 'Trans proline' 0 C--N 1.394 2.932 0 C-N-CA 121.866 1.711 . . . . 0.0 111.984 172.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.3 t -51.07 -48.95 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 C-N-CA 124.509 1.123 . . . . 0.0 113.347 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -63.09 -52.21 63.56 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.173 0.989 . . . . 0.0 110.937 -176.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -63.54 -37.17 86.29 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.029 0.532 . . . . 0.0 111.282 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -68.26 -38.1 81.42 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.116 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' A' ' 66' ' ' LEU . 50.8 tp -62.53 -50.86 69.69 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.524 0.73 . . . . 0.0 110.872 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 4.0 mm-40 -55.42 -47.23 76.27 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.31 1.007 . . . . 0.0 109.477 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 20' ' ' ASP . . . -66.22 -28.79 69.01 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.229 -1.35 . . . . 0.0 112.329 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -67.45 -48.26 67.76 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.176 0.59 . . . . 0.0 110.488 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -83.71 -14.67 51.11 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.251 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.96 0.4 55.95 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.425 0.69 . . . . 0.0 111.992 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 62.71 26.0 15.4 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.463 1.105 . . . . 0.0 111.851 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.402 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 13.1 t70 -96.48 110.57 22.92 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.793 1.237 . . . . 0.0 109.31 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.408 HG13 HG12 ' A' ' 54' ' ' ILE . 23.4 mm -76.84 -32.89 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.1 0.56 . . . . 0.0 110.999 173.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 24.8 t70 -58.19 -49.06 78.38 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.745 0.653 . . . . 0.0 112.161 -168.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.81 -35.63 22.2 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.177 0.991 . . . . 0.0 111.392 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -63.01 -14.18 44.67 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.293 0.371 . . . . 0.0 112.0 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 68.2 mmm -120.66 -14.4 8.6 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -60.79 -36.51 79.19 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.552 0.691 . . . . 0.0 112.304 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 91.8 m95 -93.57 14.03 20.13 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.718 -170.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.614 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 19.3 m95 -99.12 152.45 19.85 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.778 0.831 . . . . 0.0 109.267 174.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -78.92 154.54 29.58 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.262 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.44 -32.04 72.84 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.118 0.567 . . . . 0.0 111.184 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -99.42 17.9 19.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.889 0.875 . . . . 0.0 111.337 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.614 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 46.9 t -64.54 117.92 8.06 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 123.209 0.318 . . . . 0.0 111.549 -174.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -77.68 154.09 32.47 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -139.39 110.44 6.87 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.475 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 96.4 m-85 -113.37 138.33 50.22 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.818 0.847 . . . . 0.0 110.572 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.537 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -92.21 154.95 18.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.459 166.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -50.04 130.03 22.73 Favored Pre-proline 0 CA--C 1.567 1.617 0 C-N-CA 124.268 1.027 . . . . 0.0 112.508 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.43 -36.34 2.15 Favored 'Cis proline' 0 C--N 1.383 2.371 0 CA-C-N 119.967 1.024 . . . . 0.0 112.134 -4.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . . . -159.62 94.57 1.16 Allowed 'General case' 0 C--N 1.345 0.41 0 C-N-CA 124.821 1.248 . . . . 0.0 107.748 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 7.2 m -130.18 102.4 6.21 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.5 tp -73.1 100.89 3.15 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 117.961 0.346 . . . . 0.0 110.447 -175.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -83.36 -34.31 25.63 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -146.37 116.91 7.54 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.81 -173.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -107.53 46.66 1.14 Allowed Glycine 0 C--N 1.347 1.147 0 C-N-CA 123.032 0.349 . . . . 0.0 113.034 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.425 ' O ' HG13 ' A' ' 49' ' ' ILE . 9.6 p30 162.08 154.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 126.149 1.78 . . . . 0.0 109.227 -171.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -63.5 -26.28 68.64 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -175.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -62.22 -51.4 67.93 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.803 0.441 . . . . 0.0 110.98 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.443 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.0 mt-10 -68.41 -33.43 74.21 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.108 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 45' ' ' ASN . 54.2 mt -69.2 -43.14 81.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 122.962 0.505 . . . . 0.0 110.264 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.487 ' O ' HG13 ' A' ' 54' ' ' ILE . 32.0 ptt180 -69.87 -45.18 68.28 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.605 -173.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.8 m -68.95 -35.03 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 122.859 0.463 . . . . 0.0 111.894 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -71.41 -40.1 70.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.297 0.639 . . . . 0.0 110.357 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -64.61 -33.33 75.68 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.57 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 50' ' ' ARG . 97.0 mt -58.16 -47.07 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 122.557 0.343 . . . . 0.0 110.184 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.21 -33.3 75.09 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.455 0.702 . . . . 0.0 111.498 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -66.79 -35.04 79.15 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.174 0.59 . . . . 0.0 110.956 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -78.75 -2.45 39.47 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.21 0.604 . . . . 0.0 112.02 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -84.58 -19.71 32.63 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.948 0.499 . . . . 0.0 110.756 171.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.11 113.55 8.17 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 123.694 0.798 . . . . 0.0 109.813 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -61.35 -32.23 89.37 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 123.107 2.538 . . . . 0.0 113.547 -169.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.22 -0.6 56.79 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.723 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.6 tp -62.82 118.9 8.37 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.202 0.455 . . . . 0.0 111.359 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.456 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 76.3 t80 -151.02 127.56 10.77 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.84 104.2 2.53 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -97.83 100.89 12.27 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.168 0.587 . . . . 0.0 109.51 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HB2' HD11 ' A' ' 13' ' ' LEU . 7.7 tt -79.53 129.7 34.71 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.458 HD11 ' CD2' ' A' ' 79' ' ' HIS . 1.7 pp -115.9 -29.8 6.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.468 -175.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.5 m -150.69 143.79 24.77 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.957 0.903 . . . . 0.0 109.559 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -143.61 136.92 27.93 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.56 0.744 . . . . 0.0 109.326 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.78 130.88 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' A' ' 5' ' ' ILE . 9.5 tt -121.98 136.51 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.031 0.532 . . . . 0.0 110.258 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 p -143.35 110.05 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 124.678 1.191 . . . . 0.0 109.186 -176.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.78 -119.71 9.26 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.202 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.575 ' HA ' HG13 ' A' ' 5' ' ' ILE . 27.0 p-10 -108.63 19.86 19.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.275 0.63 . . . . 0.0 111.077 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -127.48 133.63 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.09 0.956 . . . . 0.0 109.251 -175.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 15.1 t -122.57 138.97 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.175 0.59 . . . . 0.0 110.255 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.639 HD13 ' HB ' ' A' ' 98' ' ' ILE . 6.7 mm -104.96 111.9 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.061 1.344 . . . . 0.0 107.708 167.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -106.35 116.06 31.28 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.458 ' CD2' HD11 ' A' ' 67' ' ' LEU . 1.5 t60 -99.83 109.01 21.43 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.36 140.05 52.06 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.947 1.299 . . . . 0.0 110.624 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.1 m -86.1 106.5 17.28 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.82 0.848 . . . . 0.0 109.131 169.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.4 t -82.79 104.08 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.754 0.822 . . . . 0.0 110.441 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.47 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 25.3 m -68.06 127.99 34.89 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.089 0.556 . . . . 0.0 110.425 170.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -139.07 -170.24 2.83 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.801 0.84 . . . . 0.0 109.097 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -119.3 100.55 7.38 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.877 0.471 . . . . 0.0 110.648 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.404 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 13.4 m-30 -100.22 142.6 24.92 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 123.714 0.806 . . . . 0.0 109.65 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.04 -23.03 66.79 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.983 2.455 . . . . 0.0 114.026 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -86.54 -4.91 59.24 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.22 -134.24 3.41 Favored Glycine 0 N--CA 1.474 1.174 0 CA-C-O 119.566 -0.574 . . . . 0.0 111.83 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.411 ' CG ' ' HG3' ' A' ' 92' ' ' GLU . 3.0 tppp? -53.15 -87.24 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.659 0.784 . . . . 0.0 112.804 172.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.404 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 124.37 26.69 1.44 Allowed Glycine 0 C--N 1.347 1.155 0 N-CA-C 113.761 0.265 . . . . 0.0 113.761 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.47 ' HG2' ' HA ' ' A' ' 83' ' ' THR . 46.8 mt-10 -89.61 115.51 27.06 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 117.099 0.45 . . . . 0.0 109.943 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.554 HG12 ' HA ' ' A' ' 116' ' ' PRO . 17.2 m -108.96 130.12 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.432 0.693 . . . . 0.0 109.613 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.435 ' HB3' ' HE1' ' A' ' 79' ' ' HIS . 1.3 m-20 -85.45 108.81 18.06 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.408 HG22 HG12 ' A' ' 113' ' ' ILE . 34.6 t -113.18 162.55 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.108 1.363 . . . . 0.0 108.995 -171.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.18 102.71 6.35 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.573 1.149 . . . . 0.0 108.029 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 80.6 m -93.1 107.92 19.62 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.712 HG23 ' HB2' ' A' ' 110' ' ' TRP . 5.7 tt -102.59 111.05 31.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.148 -176.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -100.46 153.85 19.02 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.618 0.767 . . . . 0.0 110.601 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -126.66 117.45 22.77 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.263 1.425 . . . . 0.0 107.47 171.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.484 HG22 HG12 ' A' ' 106' ' ' ILE . 86.2 t -109.02 124.31 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.266 1.026 . . . . 0.0 110.254 -173.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 10.6 tp10 -131.57 135.5 47.05 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.032 0.933 . . . . 0.0 109.406 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.521 ' ND2' ' HG3' ' A' ' 102' ' ' GLU . 54.1 m-80 62.5 30.02 17.13 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.726 1.211 . . . . 0.0 112.488 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.47 7.82 79.43 Favored Glycine 0 N--CA 1.478 1.499 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.843 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -127.26 148.12 50.22 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.994 1.318 . . . . 0.0 108.149 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.484 HG12 HG22 ' A' ' 101' ' ' VAL . 53.0 mt -69.29 113.72 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -78.03 -36.66 48.33 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.703 0.801 . . . . 0.0 111.105 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.584 ' HE2' ' HE1' ' A' ' 110' ' ' TRP . 61.4 mtpt -150.59 132.49 15.12 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.055 0.942 . . . . 0.0 108.66 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -124.69 132.58 53.38 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.712 ' HB2' HG23 ' A' ' 98' ' ' ILE . 1.6 m-90 -130.77 152.45 50.1 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -176.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -144.25 147.02 33.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.797 0.332 . . . . 0.0 110.201 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -128.95 117.92 21.77 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.965 0.906 . . . . 0.0 109.064 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.408 HG12 HG22 ' A' ' 95' ' ' VAL . 94.5 mt -86.79 132.72 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.74 -83.12 0.09 OUTLIER Glycine 0 CA--C 1.526 0.778 0 O-C-N 123.708 0.63 . . . . 0.0 112.05 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.15 166.29 16.84 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.498 0.719 . . . . 0.0 109.463 175.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.554 ' HA ' HG12 ' A' ' 93' ' ' VAL . 51.5 Cg_endo -65.85 110.42 1.69 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.532 2.155 . . . . 0.0 113.111 168.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -109.6 149.83 29.09 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.83 0.852 . . . . 0.0 110.232 173.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.4 mm -124.68 154.93 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.4 t . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.516 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.1 m120 . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 121.299 0.571 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 m -66.31 -39.05 89.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.711 0.804 . . . . 0.0 111.345 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.18 -12.37 60.82 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.112 0.565 . . . . 0.0 111.808 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.9 mm -98.02 -39.15 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.927 0.891 . . . . 0.0 109.391 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -58.91 -44.58 91.28 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.54 1.136 . . . . 0.0 112.338 177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.53 -57.11 24.2 Favored Pre-proline 0 CA--C 1.561 1.391 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.883 -171.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.575 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 21.1 Cg_endo -58.27 -48.76 14.47 Favored 'Trans proline' 0 C--N 1.395 3.022 0 C-N-CA 122.401 2.067 . . . . 0.0 112.28 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.2 t -59.27 -44.06 91.26 Favored 'Isoleucine or valine' 0 C--O 1.247 0.956 0 C-N-CA 124.91 1.284 . . . . 0.0 112.605 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -46.07 67.06 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -63.35 -27.74 69.52 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.786 0.834 . . . . 0.0 111.919 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -63.2 -46.18 88.24 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.684 0.615 . . . . 0.0 110.221 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.16 -53.76 52.95 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.153 0.908 . . . . 0.0 109.218 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -52.17 -36.37 51.5 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 124.653 1.221 . . . . 0.0 111.089 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -81.75 -27.96 33.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.651 1.18 . . . . 0.0 112.195 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -69.66 -48.41 59.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.721 0.409 . . . . 0.0 110.267 -172.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -76.07 -28.97 57.8 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.932 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.46 1.16 56.92 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.55 0.74 . . . . 0.0 112.051 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 67.64 18.79 9.87 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.577 1.151 . . . . 0.0 112.797 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.48 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 67.9 m-20 -88.59 95.3 10.19 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.964 0.506 . . . . 0.0 110.467 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.404 ' HA ' ' HB3' ' A' ' 24' ' ' PHE . 23.9 mm -67.77 -26.87 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 123.024 0.53 . . . . 0.0 110.648 172.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -52.44 -48.38 65.84 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.485 0.714 . . . . 0.0 111.59 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.37 -35.0 31.34 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.883 0.473 . . . . 0.0 110.952 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.404 ' HB3' ' HA ' ' A' ' 21' ' ' ILE . 16.2 t80 -71.07 -5.84 34.52 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.617 0.767 . . . . 0.0 111.279 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.57 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 19.6 tpp -121.03 -25.62 5.3 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.173 0.589 . . . . 0.0 112.456 172.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.13 -44.22 74.84 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.1 m95 -82.71 -3.79 56.94 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -172.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -91.36 149.16 21.85 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.387 0.675 . . . . 0.0 109.8 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -74.05 152.26 40.01 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.349 0.66 . . . . 0.0 110.033 176.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.94 -23.93 65.13 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.112 0.482 . . . . 0.0 110.929 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -102.26 18.61 20.52 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.68 1.192 . . . . 0.0 111.114 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 42.1 t -64.57 122.98 18.07 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.931 0.396 . . . . 0.0 111.916 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -83.11 154.38 24.38 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.493 0.717 . . . . 0.0 109.481 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 33.9 t80 -145.68 120.69 10.05 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.407 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 43.3 m-85 -121.18 153.92 36.92 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.279 1.032 . . . . 0.0 110.484 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -120.44 159.83 24.34 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.385 1.074 . . . . 0.0 110.702 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.641 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 82.9 t80 -62.37 130.71 93.44 Favored Pre-proline 0 CA--C 1.56 1.36 0 O-C-N 124.18 0.925 . . . . 0.0 110.383 174.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.67 -47.43 0.31 Allowed 'Cis proline' 0 C--N 1.386 2.506 0 CA-C-N 120.697 1.285 . . . . 0.0 113.447 -1.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.68 93.35 0.82 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 98.3 m -141.33 115.79 9.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.155 0.582 . . . . 0.0 109.6 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 tt -70.8 101.71 2.17 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 36' ' ' ALA . 94.7 mt -80.64 -37.84 30.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.554 0.741 . . . . 0.0 110.868 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -148.23 121.24 8.82 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.421 0.451 . . . . 0.0 111.185 -171.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.4 39.55 2.81 Favored Glycine 0 C--N 1.35 1.327 0 C-N-CA 123.116 0.389 . . . . 0.0 113.26 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 166.06 165.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 125.847 1.659 . . . . 0.0 109.155 -171.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.57 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -66.54 -36.81 83.59 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.749 0.82 . . . . 0.0 112.748 -175.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.11 -46.87 84.82 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.15 0.58 . . . . 0.0 111.743 -174.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.1 mt-10 -72.85 -29.99 63.65 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.487 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.1 mt -67.43 -44.41 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.007 0.523 . . . . 0.0 109.704 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.43 ' O ' HG13 ' A' ' 54' ' ' ILE . 76.6 ttt180 -59.83 -56.1 26.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.552 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.5 m -61.58 -41.59 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 124.429 1.081 . . . . 0.0 112.563 -173.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -72.17 -29.15 63.73 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.145 0.578 . . . . 0.0 110.96 -176.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -77.94 -30.83 50.63 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 118.929 -0.558 . . . . 0.0 111.2 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 50' ' ' ARG . 99.0 mt -59.69 -41.28 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.9 -38.36 88.08 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.919 0.888 . . . . 0.0 111.414 175.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -78.84 -23.33 45.09 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.141 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -84.12 0.62 47.76 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.295 0.638 . . . . 0.0 110.931 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -79.76 -20.36 46.49 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.064 0.545 . . . . 0.0 111.673 170.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 7.3 mm-40 -64.45 112.86 8.67 Favored Pre-proline 0 CA--C 1.547 0.846 0 O-C-N 123.805 0.691 . . . . 0.0 109.802 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -65.63 -18.34 58.71 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.333 2.022 . . . . 0.0 112.24 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.02 2.85 46.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.377 1.071 . . . . 0.0 111.714 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 19.4 tp -66.28 116.14 7.0 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.627 0.371 . . . . 0.0 110.15 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -145.02 117.87 8.74 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.438 ' HA2' HG12 ' A' ' 82' ' ' VAL . . . -93.45 103.48 3.04 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 175.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.44 98.14 10.01 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.5 tt -86.72 126.47 34.59 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.431 HD11 ' CD2' ' A' ' 79' ' ' HIS . 2.3 pp -114.32 -30.17 6.68 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.276 1.03 . . . . 0.0 110.438 -171.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.8 m -155.17 132.85 11.29 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.429 1.092 . . . . 0.0 109.055 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 0.8 OUTLIER -132.45 134.71 45.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.59 0.756 . . . . 0.0 109.288 167.181 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 77' ' ' ILE . 30.1 m -118.88 119.8 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.561 0.745 . . . . 0.0 109.807 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.449 HG13 HG22 ' A' ' 76' ' ' VAL . 17.3 tt -95.29 129.4 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-O 121.321 0.581 . . . . 0.0 109.504 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 p -141.01 96.41 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.515 1.126 . . . . 0.0 108.65 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.76 -128.08 31.67 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.337 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -83.43 3.47 31.83 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.698 0.799 . . . . 0.0 112.578 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.1 t -126.45 134.97 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.811 0.844 . . . . 0.0 109.765 -171.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.449 HG22 HG13 ' A' ' 71' ' ' ILE . 21.6 t -124.18 140.6 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 122.988 0.515 . . . . 0.0 109.627 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.509 HD13 ' HB ' ' A' ' 98' ' ' ILE . 16.2 mm -99.27 103.26 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 172.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -90.35 104.65 17.2 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.431 ' CD2' HD11 ' A' ' 67' ' ' LEU . 2.0 t60 -98.07 108.36 21.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -117.41 152.29 35.28 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.288 -1.324 . . . . 0.0 109.611 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.5 m -103.19 101.87 11.83 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 159.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.438 HG12 ' HA2' ' A' ' 64' ' ' GLY . 32.8 m -91.97 127.81 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.065 0.459 . . . . 0.0 110.367 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.3 m -75.71 120.49 21.17 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.149 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.577 HH21 HG11 ' A' ' 93' ' ' VAL . 61.3 mtm180 -125.05 -163.51 1.19 Allowed 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -127.8 109.24 11.43 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 118.284 0.493 . . . . 0.0 111.074 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.418 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 19.2 m-30 -108.34 144.6 29.81 Favored Pre-proline 0 N--CA 1.481 1.095 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.57 -7.52 20.98 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.791 2.328 . . . . 0.0 112.807 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -84.17 -20.72 31.92 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.065 0.946 . . . . 0.0 111.804 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.07 -125.15 1.09 Allowed Glycine 0 C--N 1.349 1.256 0 CA-C-O 119.549 -0.584 . . . . 0.0 111.962 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -59.61 -80.54 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.188 0.995 . . . . 0.0 111.931 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.418 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 118.52 24.12 3.24 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 116.308 -0.405 . . . . 0.0 113.048 -177.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.562 ' HG3' ' HB2' ' A' ' 117' ' ' ARG . 7.1 pt-20 -87.54 147.68 25.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.577 HG11 HH21 ' A' ' 84' ' ' ARG . 7.5 m -138.59 134.96 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 121.975 -0.453 . . . . 0.0 111.388 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.67 111.08 13.07 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.329 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.483 HG22 HG12 ' A' ' 113' ' ' ILE . 48.9 t -124.64 144.93 32.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 124.169 0.988 . . . . 0.0 108.95 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -106.5 107.3 18.24 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 170.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 56.5 m -93.12 104.34 16.55 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.593 HG23 ' HB2' ' A' ' 110' ' ' TRP . 5.5 tt -105.99 109.82 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.217 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -104.13 151.47 23.27 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.528 0.731 . . . . 0.0 110.549 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -121.43 114.33 21.12 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.144 0.978 . . . . 0.0 108.628 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.54 HG22 HG12 ' A' ' 106' ' ' ILE . 45.1 t -101.74 115.21 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.077 0.951 . . . . 0.0 109.2 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 41.7 tt0 -116.75 128.77 55.62 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.151 0.981 . . . . 0.0 109.006 176.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 62.25 32.37 17.18 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.951 0.901 . . . . 0.0 111.462 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.42 11.67 84.13 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 114.595 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -133.02 136.73 46.18 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.485 1.114 . . . . 0.0 108.679 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.54 HG12 HG22 ' A' ' 101' ' ' VAL . 60.0 mt -66.63 100.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -78.05 -28.07 48.86 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.227 0.611 . . . . 0.0 110.967 -175.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -149.58 153.77 37.64 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.076 0.951 . . . . 0.0 108.592 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -148.67 134.54 18.99 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.593 ' HB2' HG23 ' A' ' 98' ' ' ILE . 1.7 m-90 -135.53 154.8 51.27 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -143.03 146.37 33.78 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 169.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.641 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 17.1 ptpt -129.34 124.52 34.49 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.916 0.886 . . . . 0.0 109.182 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.483 HG12 HG22 ' A' ' 95' ' ' VAL . 92.1 mt -88.19 119.19 35.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.26 -63.41 3.27 Favored Glycine 0 N--CA 1.465 0.624 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.684 -177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -157.16 166.4 16.72 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 122.768 0.427 . . . . 0.0 110.35 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.574 ' HA ' HG12 ' A' ' 93' ' ' VAL . 97.2 Cg_endo -75.67 132.69 14.81 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.653 2.235 . . . . 0.0 112.069 163.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.562 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 15.6 mmt180 -115.84 140.84 48.84 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.381 1.072 . . . . 0.0 108.567 175.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.2 mm -132.04 149.8 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.732 0.301 . . . . 0.0 110.466 179.253 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.582 ' HB2' HD13 ' A' ' 71' ' ' ILE . 3.3 p-10 . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 81.8 p -62.26 -43.98 97.58 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.977 0.511 . . . . 0.0 110.084 -177.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -64.37 -14.68 57.82 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.676 1.19 . . . . 0.0 112.679 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.54 HG23 ' HB ' ' A' ' 101' ' ' VAL . 44.0 mm -89.85 -34.21 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.864 0.866 . . . . 0.0 109.992 174.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -84.97 -10.09 57.4 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.256 0.622 . . . . 0.0 111.709 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 3' ' ' SER . 65.3 mt -65.93 -54.46 27.78 Favored Pre-proline 0 N--CA 1.481 1.123 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.092 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.502 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 13.0 Cg_endo -56.32 -46.73 28.4 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 121.752 1.635 . . . . 0.0 112.572 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.626 ' HA ' HE21 ' A' ' 12' ' ' GLN . 54.8 t -64.48 -45.89 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 124.048 0.939 . . . . 0.0 113.215 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -41.33 65.78 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -176.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -66.6 -26.39 67.07 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.907 0.483 . . . . 0.0 111.329 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.626 HE21 ' HA ' ' A' ' 9' ' ' VAL . 39.6 mt-30 -60.89 -46.53 90.25 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.168 0.292 . . . . 0.0 110.232 171.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.93 -51.97 67.41 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 123.516 0.51 . . . . 0.0 109.702 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -55.19 -34.39 63.84 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 124.684 1.24 . . . . 0.0 110.145 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -82.45 -27.65 31.77 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.776 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -71.01 -44.07 66.64 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.871 0.469 . . . . 0.0 110.298 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -79.39 -28.55 41.85 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.004 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.2 5.02 52.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.578 0.751 . . . . 0.0 112.24 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 64.79 13.26 8.33 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.035 1.334 . . . . 0.0 113.992 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.511 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 18.6 m-20 -76.91 95.13 4.04 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.297 0.57 . . . . 0.0 111.583 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.437 HG13 HG12 ' A' ' 54' ' ' ILE . 29.5 mm -64.33 -25.49 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.144 0.578 . . . . 0.0 110.365 167.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -50.44 -50.55 51.84 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.99 0.916 . . . . 0.0 111.194 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -82.68 -37.72 24.41 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.181 0.592 . . . . 0.0 110.762 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -66.83 -6.63 16.96 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.215 0.606 . . . . 0.0 111.565 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.764 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -120.56 -30.63 4.48 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 171.325 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.44 -34.92 73.11 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.166 0.507 . . . . 0.0 112.303 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.502 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 99.4 m95 -88.54 4.0 48.33 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.867 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.445 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 16.2 m95 -102.97 157.31 17.07 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.64 0.776 . . . . 0.0 109.9 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -81.8 148.84 28.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.825 0.85 . . . . 0.0 109.404 171.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -66.45 -24.1 66.38 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.336 0.589 . . . . 0.0 111.031 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -86.51 -2.26 58.32 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.143 1.377 . . . . 0.0 111.724 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 42.3 t -59.89 132.89 55.33 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -167.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -88.12 154.7 20.25 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.453 0.701 . . . . 0.0 109.957 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -145.19 110.08 5.11 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.414 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 36.7 m-85 -111.1 155.19 23.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.951 0.9 . . . . 0.0 110.644 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.32 159.52 20.12 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.278 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.561 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 90.5 t80 -52.06 127.32 36.79 Favored Pre-proline 0 N--CA 1.486 1.342 0 C-N-CA 123.95 0.9 . . . . 0.0 111.149 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.8 -47.56 0.31 Allowed 'Cis proline' 0 C--N 1.387 2.556 0 CA-C-N 120.614 1.255 . . . . 0.0 113.681 -1.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.44 79.26 0.44 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.0 m -123.33 106.96 11.13 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.703 0.801 . . . . 0.0 109.282 -176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.2 tp -67.0 102.34 0.97 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.032 0.533 . . . . 0.0 110.198 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.6 mt -81.85 -36.67 28.0 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.973 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -145.57 116.56 7.81 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.372 -174.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.46 41.07 2.22 Favored Glycine 0 N--CA 1.474 1.181 0 C-N-CA 122.986 0.327 . . . . 0.0 113.398 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.5 p30 164.82 152.18 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 126.226 1.81 . . . . 0.0 108.852 -173.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -61.98 -26.78 68.42 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.965 0.906 . . . . 0.0 113.149 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -63.77 -38.32 90.66 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.44 0.296 . . . . 0.0 111.547 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.509 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 27.2 mt-10 -77.77 -31.22 51.83 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.997 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.7 mt -68.62 -41.36 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.759 0.824 . . . . 0.0 111.265 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.764 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 5.7 ptp180 -62.8 -45.9 90.47 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.069 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.403 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 96.5 t -54.8 -55.29 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.686 0.795 . . . . 0.0 110.29 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -52.07 -44.1 64.16 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.926 1.29 . . . . 0.0 111.963 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -78.35 -34.64 48.28 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.025 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.437 HG12 HG13 ' A' ' 21' ' ' ILE . 97.0 mt -60.77 -45.3 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-N 118.982 0.81 . . . . 0.0 109.472 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 51' ' ' VAL . 43.4 mt-10 -63.77 -32.84 74.47 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.355 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -88.22 -15.98 34.47 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -85.97 -4.53 59.19 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.107 0.563 . . . . 0.0 110.556 173.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.71 -20.21 63.54 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.265 0.626 . . . . 0.0 111.533 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 20.3 mm-40 -65.97 120.21 67.49 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.431 0.692 . . . . 0.0 110.314 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.14 -18.75 18.18 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.222 1.948 . . . . 0.0 112.249 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -81.62 -22.9 37.36 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.24 0.616 . . . . 0.0 110.775 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 30.8 tp -56.29 129.97 42.56 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.808 0.843 . . . . 0.0 112.024 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.442 ' CE2' ' HB2' ' A' ' 65' ' ' GLU . 46.2 t80 -151.24 144.35 24.65 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.595 0.758 . . . . 0.0 109.617 175.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.58 118.78 5.08 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.844 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.442 ' HB2' ' CE2' ' A' ' 63' ' ' TYR . 35.6 tt0 -126.32 99.77 6.0 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.8 tt -80.43 140.31 36.04 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.185 0.517 . . . . 0.0 110.169 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mt -109.46 -51.84 2.83 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.285 -173.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.0 m -147.99 139.5 23.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.909 -172.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 14.1 ptt180 -131.6 119.65 21.76 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.321 0.648 . . . . 0.0 109.693 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -115.84 127.16 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.034 0.934 . . . . 0.0 109.044 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.582 HD13 ' HB2' ' A' ' 2' ' ' ASN . 13.8 tt -114.96 132.98 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-O 121.386 0.613 . . . . 0.0 111.534 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.9 t -117.75 103.33 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 125.42 1.488 . . . . 0.0 107.851 172.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.6 -102.81 0.42 Allowed Glycine 0 N--CA 1.476 1.345 0 N-CA-C 113.994 0.357 . . . . 0.0 113.994 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.535 ' HA ' HG13 ' A' ' 5' ' ' ILE . 23.4 p-10 -111.67 21.19 16.36 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.121 0.568 . . . . 0.0 112.284 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.0 p -135.6 135.04 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.025 0.53 . . . . 0.0 110.012 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -117.75 137.43 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.265 0.626 . . . . 0.0 109.663 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.626 HD13 ' HB ' ' A' ' 98' ' ' ILE . 7.7 mm -98.95 102.68 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 165.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -102.54 105.69 16.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -98.4 107.02 19.38 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.205 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -103.87 172.77 6.62 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.547 1.139 . . . . 0.0 110.955 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.2 m -116.14 102.69 9.83 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 160.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.7 m -88.5 133.38 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.661 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.0 m -88.12 128.37 35.43 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -155.27 146.98 23.2 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -77.94 103.74 8.07 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -166.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -92.37 127.6 48.13 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 165.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -62.41 -15.97 48.71 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.465 2.777 . . . . 0.0 114.224 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -83.59 -32.12 25.95 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.405 0.282 . . . . 0.0 111.636 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.84 -136.35 2.1 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-O 119.456 -0.636 . . . . 0.0 111.65 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -72.54 -79.41 0.08 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 117.318 0.559 . . . . 0.0 110.468 171.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.1 30.43 2.3 Favored Glycine 0 C--N 1.346 1.091 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.713 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -88.82 98.48 11.74 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 122.456 1.122 . . . . 0.0 108.227 -174.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 117' ' ' ARG . 20.7 m -104.59 145.61 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.374 -0.829 . . . . 0.0 111.14 -165.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -78.11 132.4 37.68 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 176.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.589 HG22 HG12 ' A' ' 113' ' ' ILE . 46.8 t -136.27 124.39 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.01 100.53 11.12 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.6 m -94.08 122.79 36.96 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 110' ' ' TRP . 6.2 tt -123.87 115.38 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.925 0.89 . . . . 0.0 109.814 -173.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -116.86 127.22 54.07 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.849 0.859 . . . . 0.0 110.41 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -98.57 111.1 23.57 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.54 ' HB ' HG23 ' A' ' 5' ' ' ILE . 99.5 t -98.39 130.45 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.691 1.196 . . . . 0.0 109.977 -174.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.474 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 10.8 tp10 -129.42 124.65 34.68 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.229 1.012 . . . . 0.0 109.298 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.474 ' ND2' ' HG3' ' A' ' 102' ' ' GLU . 52.9 m-80 62.65 37.25 13.0 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.876 1.271 . . . . 0.0 112.45 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.11 5.25 65.29 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 113.884 0.314 . . . . 0.0 113.884 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.8 mmt85 -122.79 135.13 54.45 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.614 1.166 . . . . 0.0 108.285 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.451 HG12 HG22 ' A' ' 101' ' ' VAL . 77.8 mt -65.56 105.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -86.4 -23.35 26.14 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.764 0.426 . . . . 0.0 111.2 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -147.1 149.26 32.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.813 0.845 . . . . 0.0 109.711 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.92 137.4 24.9 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.744 0.818 . . . . 0.0 109.088 -176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.641 ' HB2' HG23 ' A' ' 98' ' ' ILE . 4.5 m-90 -139.0 152.71 47.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -142.3 137.1 30.35 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 169.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 51.6 mtmt -126.15 129.65 49.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.589 HG12 HG22 ' A' ' 95' ' ' VAL . 90.8 mt -88.35 131.94 34.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.93 -75.24 0.28 Allowed Glycine 0 CA--C 1.527 0.783 0 O-C-N 124.12 0.888 . . . . 0.0 112.354 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.91 166.44 16.43 Favored Pre-proline 0 CA--C 1.554 1.096 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.35 137.6 51.97 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.307 2.005 . . . . 0.0 112.289 173.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 19.8 mmt180 -135.35 138.89 43.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.258 1.023 . . . . 0.0 109.078 -174.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.9 mm -126.62 143.53 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.7 t . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.281 0.562 . . . . 0.0 110.679 176.718 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 121.598 0.713 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.2 m -63.31 -42.39 99.03 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.005 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -13.68 62.49 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.411 0.684 . . . . 0.0 112.374 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.504 HG23 ' HB ' ' A' ' 101' ' ' VAL . 26.9 mm -85.09 -32.05 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 122.94 0.496 . . . . 0.0 110.006 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.506 ' HG3' HD12 ' A' ' 71' ' ' ILE . 58.1 mt-10 -87.74 -10.02 52.32 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.2 mt -61.37 -50.24 84.11 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.256 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.465 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 18.4 Cg_endo -59.18 -50.95 7.46 Favored 'Trans proline' 0 C--N 1.389 2.697 0 CA-C-N 120.907 1.36 . . . . 0.0 111.285 172.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.501 HG21 HG21 ' A' ' 76' ' ' VAL . 63.4 t -50.55 -53.22 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 124.654 1.181 . . . . 0.0 113.029 -173.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 25.8 tp60 -61.77 -47.26 85.96 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.066 -177.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -71.18 -29.62 65.41 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.227 0.611 . . . . 0.0 111.824 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.447 ' HG2' ' HE1' ' A' ' 28' ' ' TRP . 44.8 mt-30 -62.4 -49.5 75.25 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.568 0.747 . . . . 0.0 109.775 176.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.486 HD22 HD13 ' A' ' 66' ' ' LEU . 31.9 tp -57.61 -52.06 66.97 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.47 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 13.4 mm-40 -58.38 -41.87 85.76 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.369 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -71.22 -28.28 64.09 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.25 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -68.43 -41.45 80.34 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.979 0.911 . . . . 0.0 110.54 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -83.61 -29.59 27.61 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.682 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.02 2.53 53.88 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.118 0.567 . . . . 0.0 112.462 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.51 HH21 ' HA ' ' A' ' 60' ' ' PRO . 37.7 mmt-85 69.77 8.11 6.56 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.118 1.367 . . . . 0.0 113.362 176.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.55 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 20.7 m-20 -77.27 94.57 4.17 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.219 0.533 . . . . 0.0 110.391 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.459 HG13 HG12 ' A' ' 54' ' ' ILE . 15.6 mm -67.81 -23.71 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 123.197 0.599 . . . . 0.0 109.705 167.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -54.56 -50.6 67.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.066 0.946 . . . . 0.0 112.196 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -82.5 -37.02 25.89 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.108 0.48 . . . . 0.0 110.496 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -65.92 -7.69 18.11 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.562 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.686 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -118.01 -30.88 5.23 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.957 -0.464 . . . . 0.0 112.22 172.464 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -30.96 69.48 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.05 0.54 . . . . 0.0 112.347 -175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 97.5 m95 -92.78 9.5 34.87 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.593 0.757 . . . . 0.0 112.693 -176.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.726 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 10.0 m95 -110.51 164.6 12.55 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.228 1.011 . . . . 0.0 108.906 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -82.78 153.78 25.07 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.836 0.454 . . . . 0.0 110.138 175.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.99 -27.67 68.99 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.976 0.511 . . . . 0.0 111.407 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -105.79 20.48 18.85 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.886 0.875 . . . . 0.0 110.697 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.726 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 44.0 t -57.7 113.1 1.68 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.867 0.365 . . . . 0.0 111.598 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -74.2 151.35 40.0 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 54.9 t80 -145.45 115.76 7.53 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -174.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.45 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 14.0 m-85 -115.06 156.38 25.27 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.949 1.3 . . . . 0.0 110.712 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -119.82 155.11 33.23 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.536 173.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.505 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 70.1 t80 -64.25 132.13 95.23 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.698 0.799 . . . . 0.0 111.477 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.81 -56.65 0.14 OUTLIER 'Cis proline' 0 C--N 1.386 2.505 0 CA-C-N 120.599 1.25 . . . . 0.0 113.958 -1.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.35 92.84 1.54 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.963 0.505 . . . . 0.0 109.665 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.0 m -135.72 109.16 7.88 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.595 0.758 . . . . 0.0 109.5 174.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.5 tt -69.11 103.11 1.8 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 36' ' ' ALA . 52.0 mt -78.58 -45.86 20.75 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.999 0.92 . . . . 0.0 109.951 178.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -135.1 124.96 25.51 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.475 -171.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.41 36.15 4.59 Favored Glycine 0 N--CA 1.475 1.297 0 O-C-N 123.076 0.235 . . . . 0.0 113.271 -174.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 167.93 158.63 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.503 1.521 . . . . 0.0 108.727 -171.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.491 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -57.95 -43.54 86.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.804 0.841 . . . . 0.0 112.532 -176.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.11 76.18 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.933 0.493 . . . . 0.0 112.091 -171.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -76.65 -31.46 57.35 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.831 0.452 . . . . 0.0 111.559 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.4 mt -65.1 -51.88 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.083 0.553 . . . . 0.0 110.271 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.686 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 21.2 ptt180 -64.63 -43.45 93.65 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.736 -172.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.518 ' HA ' HD12 ' A' ' 54' ' ' ILE . 30.2 m -66.29 -33.21 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 123.336 0.397 . . . . 0.0 111.696 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -71.75 -35.75 70.2 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.273 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -75.64 -29.37 59.13 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.439 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 51' ' ' VAL . 74.4 mt -55.32 -42.87 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 118.55 0.614 . . . . 0.0 109.973 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.98 -40.03 87.72 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.965 0.906 . . . . 0.0 111.328 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.0 tpp85 -73.44 -28.62 62.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.718 0.807 . . . . 0.0 111.095 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -82.1 -9.05 59.66 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.829 0.852 . . . . 0.0 110.991 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 7.8 mmpt? -76.85 -34.24 57.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.477 0.311 . . . . 0.0 111.382 176.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -83.99 118.25 70.82 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.51 ' HA ' HH21 ' A' ' 19' ' ' ARG . 89.7 Cg_endo -74.13 -9.15 21.78 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.433 2.755 . . . . 0.0 114.193 -166.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' HB2' ' ND2' ' A' ' 85' ' ' ASN . 7.6 p-10 -77.87 -13.54 59.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.737 0.815 . . . . 0.0 111.097 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.3 tp -58.71 111.51 1.29 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.218 0.607 . . . . 0.0 110.603 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 91.3 t80 -149.91 115.4 5.51 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.09 101.96 2.06 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -84.49 101.51 12.12 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 78' ' ' ASP . 6.7 tt -84.79 128.31 34.55 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -176.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.475 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -116.84 -32.86 4.97 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.853 -167.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 99.0 m -147.9 138.56 23.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.087 0.955 . . . . 0.0 109.556 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -133.31 129.49 37.61 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 167.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.8 m -107.29 129.45 61.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 123.716 0.806 . . . . 0.0 109.593 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.506 HD12 ' HG3' ' A' ' 6' ' ' GLU . 10.5 tt -113.19 122.85 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.136 0.493 . . . . 0.0 110.145 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.28 94.13 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 56.66 -112.03 3.14 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 123.23 0.331 . . . . 0.0 113.664 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -99.15 15.82 24.76 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.452 0.701 . . . . 0.0 112.297 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.8 p -134.97 133.74 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.381 0.672 . . . . 0.0 109.19 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.501 HG21 HG21 ' A' ' 9' ' ' VAL . 64.4 t -123.01 136.03 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.98 0.512 . . . . 0.0 110.789 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.565 HG12 ' HB ' ' A' ' 98' ' ' ILE . 6.4 mt -103.11 119.9 52.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 163.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.615 ' HB2' HD11 ' A' ' 66' ' ' LEU . 6.9 p-10 -97.4 155.09 17.06 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 168.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -137.53 108.45 6.7 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.45 168.72 11.76 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.083 1.353 . . . . 0.0 109.715 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.2 m -115.65 105.58 12.92 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.107 168.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 63' ' ' TYR . 4.0 m -86.38 125.25 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.179 0.514 . . . . 0.0 110.944 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 62.8 m -72.35 117.63 14.24 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 170.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -125.46 120.92 32.31 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.401 ' ND2' ' HB2' ' A' ' 61' ' ' ASP . 0.9 OUTLIER -74.39 89.29 2.1 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.194 0.521 . . . . 0.0 110.95 -172.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -82.66 144.95 49.71 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.515 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.84 -20.21 58.26 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 123.158 2.572 . . . . 0.0 113.88 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -82.25 -27.44 32.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.114 0.565 . . . . 0.0 112.521 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.52 -134.62 2.96 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.823 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -55.74 -71.23 0.09 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.165 0.986 . . . . 0.0 111.28 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.489 ' H ' HD13 ' A' ' 118' ' ' ILE . . . 94.21 32.34 7.49 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.397 0.436 . . . . 0.0 113.066 175.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -86.89 107.89 18.54 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.745 0.783 . . . . 0.0 108.996 -173.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 116' ' ' PRO . 5.3 m -105.77 143.85 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.413 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -91.54 142.12 27.99 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.426 HG22 HG12 ' A' ' 113' ' ' ILE . 19.0 t -130.44 149.52 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.78 101.74 8.56 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.7 m -98.14 108.03 20.64 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.662 HG23 ' HB2' ' A' ' 110' ' ' TRP . 12.1 tt -98.82 112.46 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.066 0.946 . . . . 0.0 109.04 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.42 ' HE1' HG22 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -128.45 138.54 52.36 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.166 0.508 . . . . 0.0 110.938 178.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -98.7 113.3 25.32 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.342 1.057 . . . . 0.0 109.445 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.504 ' HB ' HG23 ' A' ' 5' ' ' ILE . 92.2 t -88.82 116.1 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.017 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.433 ' HG3' HD22 ' A' ' 103' ' ' ASN . 10.6 tp10 -124.44 128.61 49.28 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.153 0.981 . . . . 0.0 109.497 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.433 HD22 ' HG3' ' A' ' 102' ' ' GLU . 54.9 m-80 59.18 31.04 20.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.784 1.234 . . . . 0.0 111.856 -174.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.04 -20.1 30.93 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 115.568 -0.742 . . . . 0.0 113.738 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -107.07 140.46 39.85 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.319 1.048 . . . . 0.0 108.834 -172.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.408 HG12 HG22 ' A' ' 101' ' ' VAL . 64.1 mt -67.36 106.21 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.93 -34.07 44.87 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.281 0.633 . . . . 0.0 111.241 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -144.31 146.75 32.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.082 0.953 . . . . 0.0 108.685 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.9 137.9 35.21 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.674 0.789 . . . . 0.0 109.516 -177.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.662 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.5 m-90 -140.33 148.41 41.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -144.45 147.17 32.98 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.077 0.853 . . . . 0.0 111.097 174.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 21.5 ptmt -127.25 127.9 45.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.36 0.664 . . . . 0.0 109.494 172.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.426 HG12 HG22 ' A' ' 95' ' ' VAL . 80.0 mt -89.42 121.75 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.35 -94.72 0.02 OUTLIER Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.564 1.165 . . . . 0.0 114.497 -174.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -134.56 155.11 79.88 Favored Pre-proline 0 CA--C 1.547 0.827 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.707 ' HA ' HG12 ' A' ' 93' ' ' VAL . 41.4 Cg_endo -90.0 114.72 0.55 Allowed 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.908 2.405 . . . . 0.0 113.394 174.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -111.79 153.4 26.61 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.415 0.626 . . . . 0.0 111.114 -175.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.489 HD13 ' H ' ' A' ' 91' ' ' GLY . 35.2 mm -131.11 156.06 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 124.572 1.149 . . . . 0.0 108.181 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.7 t . . . . . 0 N--CA 1.486 1.354 0 C-N-CA 122.654 0.381 . . . . 0.0 110.573 173.702 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.2 m120 . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.493 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 13.1 m -61.7 -48.87 78.82 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.962 0.905 . . . . 0.0 110.719 -175.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -7.59 25.92 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.899 0.88 . . . . 0.0 113.026 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.4 mm -94.39 -31.34 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.639 0.775 . . . . 0.0 109.705 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.29 -32.85 32.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.274 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.2 mt -58.44 -47.64 98.41 Favored Pre-proline 0 CA--C 1.563 1.46 0 CA-C-O 118.405 -0.807 . . . . 0.0 112.185 -177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 10.1 Cg_endo -56.2 -63.07 0.19 Allowed 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 121.885 1.723 . . . . 0.0 112.379 172.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.41 -27.08 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -168.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.24 -55.39 6.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.449 0.7 . . . . 0.0 109.728 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -68.8 -29.82 68.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.983 0.513 . . . . 0.0 111.583 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -74.8 -36.85 62.48 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.827 0.851 . . . . 0.0 111.527 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.56 -48.77 80.31 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -57.87 -45.31 86.51 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 124.561 1.163 . . . . 0.0 109.315 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.78 -24.81 66.24 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.033 -1.44 . . . . 0.0 112.722 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -67.68 -40.61 84.39 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.579 0.352 . . . . 0.0 110.32 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -91.73 -25.73 18.93 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.429 0.692 . . . . 0.0 110.936 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.04 -6.38 59.47 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.493 0.717 . . . . 0.0 111.846 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 69.39 14.87 8.45 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.081 1.352 . . . . 0.0 112.929 171.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -83.81 95.3 8.41 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.488 HG13 HG12 ' A' ' 54' ' ' ILE . 20.7 mm -64.8 -29.77 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.427 0.691 . . . . 0.0 110.43 173.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -55.96 -47.04 78.34 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.902 0.481 . . . . 0.0 111.384 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.43 -32.89 28.78 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.306 0.642 . . . . 0.0 111.42 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -72.94 -8.82 57.39 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.104 0.562 . . . . 0.0 110.828 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.714 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 27.7 tpp -120.96 -15.76 8.21 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.909 0.484 . . . . 0.0 112.287 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.06 -50.46 61.46 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.492 0.717 . . . . 0.0 112.548 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 85.3 m95 -87.18 6.92 30.54 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.989 -168.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.66 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 12.9 m95 -93.96 149.81 20.9 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.415 0.686 . . . . 0.0 109.482 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.64 152.11 37.66 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.153 0.581 . . . . 0.0 109.976 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -64.16 -29.79 70.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.884 0.474 . . . . 0.0 111.249 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -96.91 20.36 11.23 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.816 0.846 . . . . 0.0 111.385 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.66 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 48.6 t -61.85 115.63 4.18 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -71.57 148.58 46.51 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.649 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 42.8 t80 -141.67 118.1 10.85 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -117.51 148.82 41.5 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.692 0.797 . . . . 0.0 110.081 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.525 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -103.12 153.48 20.27 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.601 171.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.546 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 90.4 t80 -56.59 128.94 75.77 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.87 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.46 -60.46 0.08 OUTLIER 'Cis proline' 0 C--N 1.384 2.43 0 CA-C-N 120.583 1.244 . . . . 0.0 113.488 0.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.35 74.06 0.68 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.652 0.781 . . . . 0.0 108.991 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 55.3 m -105.54 111.69 24.49 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.167 0.987 . . . . 0.0 109.016 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 tt -66.35 103.06 0.94 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 36' ' ' ALA . 78.7 mt -82.67 -43.47 16.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.656 0.783 . . . . 0.0 110.649 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -139.73 116.58 10.93 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.787 0.435 . . . . 0.0 111.083 -171.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.07 32.61 5.31 Favored Glycine 0 N--CA 1.482 1.708 0 C-N-CA 122.811 0.243 . . . . 0.0 113.064 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.479 HD21 ' HG3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER 169.5 153.4 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.035 1.334 . . . . 0.0 109.645 -165.322 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.714 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -67.98 -24.61 65.16 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.079 0.952 . . . . 0.0 112.911 -176.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.52 -47.61 78.99 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.504 0.721 . . . . 0.0 112.141 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.479 ' HG3' HD21 ' A' ' 45' ' ' ASN . 35.2 mt-10 -74.21 -31.33 62.59 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.494 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 46' ' ' ALA . 61.9 mt -64.81 -49.24 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.13 0.572 . . . . 0.0 111.188 -178.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.488 ' O ' HG13 ' A' ' 54' ' ' ILE . 6.9 ptm180 -62.78 -49.21 75.86 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 123.498 0.499 . . . . 0.0 110.724 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.406 ' HA ' HD12 ' A' ' 54' ' ' ILE . 76.3 t -63.47 -42.53 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.779 0.832 . . . . 0.0 111.399 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -68.36 -31.62 71.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.577 0.751 . . . . 0.0 110.879 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -77.91 -28.94 49.91 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.721 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 50' ' ' ARG . 98.1 mt -57.88 -38.92 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 118.711 0.687 . . . . 0.0 109.729 174.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.38 -34.52 78.35 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.314 1.046 . . . . 0.0 111.38 175.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -78.66 -24.48 45.14 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.163 0.585 . . . . 0.0 110.916 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -83.53 -5.16 59.09 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.37 0.668 . . . . 0.0 110.631 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 70.4 mmtt -78.02 -9.99 59.39 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.096 0.558 . . . . 0.0 111.89 169.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 8.5 mm-40 -71.94 111.02 9.08 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 170.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.95 -28.14 74.97 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.297 1.998 . . . . 0.0 112.232 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -92.19 4.84 52.39 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.803 0.841 . . . . 0.0 112.048 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 28.4 tp -64.75 111.82 2.95 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-O 120.757 0.313 . . . . 0.0 110.213 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -148.07 116.15 6.47 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.98 101.14 2.71 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 174.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -81.51 99.95 9.07 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.2 tp -76.25 126.62 31.32 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.73 -33.99 5.94 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.956 0.902 . . . . 0.0 109.638 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 96.8 m -152.93 139.75 19.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.341 1.056 . . . . 0.0 108.99 -176.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -142.3 125.64 16.57 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 163.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.8 m -106.72 119.08 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.939 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.03 143.42 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 121.338 0.59 . . . . 0.0 110.033 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 p -148.32 97.49 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.263 1.425 . . . . 0.0 107.832 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.53 -116.2 7.27 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.673 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -101.89 18.7 19.91 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.072 0.549 . . . . 0.0 111.688 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.0 t -131.92 136.01 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.137 0.975 . . . . 0.0 109.5 -174.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -125.29 137.05 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 123.254 0.622 . . . . 0.0 110.012 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.688 HD13 ' HB ' ' A' ' 98' ' ' ILE . 2.5 mm -98.17 103.96 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 169.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.93 108.18 19.42 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -98.31 107.45 19.92 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 133.76 49.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.489 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.0 m -80.1 103.98 10.35 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 172.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -80.91 116.24 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.469 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.4 m -71.12 118.29 13.72 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.353 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 43.3 mmm-85 -119.02 -171.21 2.06 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -122.53 112.74 18.38 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.957 0.503 . . . . 0.0 109.763 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -113.44 137.35 22.08 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.032 0.933 . . . . 0.0 108.658 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -59.98 -18.94 53.05 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 123.218 2.612 . . . . 0.0 114.306 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -79.2 -25.94 42.65 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.044 0.538 . . . . 0.0 112.299 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.34 -117.39 0.58 Allowed Glycine 0 C--N 1.348 1.245 0 CA-C-O 119.683 -0.51 . . . . 0.0 112.914 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -68.83 -84.03 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.469 0.707 . . . . 0.0 111.88 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 116.93 26.69 2.95 Favored Glycine 0 C--N 1.343 0.947 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 -173.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.66 104.15 16.59 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.978 0.894 . . . . 0.0 108.591 -172.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 116' ' ' PRO . 21.7 m -103.7 136.59 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.509 -172.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -75.64 133.18 40.93 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.708 HG22 HG12 ' A' ' 113' ' ' ILE . 18.6 t -132.86 147.28 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.99 103.06 9.56 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 166.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 83.9 m -93.7 108.41 20.16 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.688 ' HB ' HD13 ' A' ' 77' ' ' ILE . 4.8 tt -102.11 111.94 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.631 1.172 . . . . 0.0 110.416 -173.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -103.43 129.95 50.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.902 0.881 . . . . 0.0 109.877 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 30.8 tt0 -100.22 111.92 24.22 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 168.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.61 HG22 HG12 ' A' ' 106' ' ' ILE . 48.7 t -94.59 113.79 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.488 1.115 . . . . 0.0 109.4 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -121.06 133.31 55.23 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.963 0.905 . . . . 0.0 109.185 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 62.63 30.42 16.95 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.244 1.017 . . . . 0.0 111.574 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.12 -7.09 79.56 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.268 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -130.75 147.5 52.42 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.943 0.897 . . . . 0.0 109.292 -173.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.61 HG12 HG22 ' A' ' 101' ' ' VAL . 45.7 mt -68.08 102.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 122.876 0.47 . . . . 0.0 110.677 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.16 -22.47 38.94 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.205 0.602 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 81.3 mttt -149.28 143.01 25.58 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.192 0.997 . . . . 0.0 108.781 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -146.67 134.23 20.94 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.501 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.1 m-90 -132.76 149.51 52.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -133.57 146.47 51.03 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 19.9 pttp -144.83 129.58 18.19 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.708 HG12 HG22 ' A' ' 95' ' ' VAL . 91.7 mt -89.84 120.53 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.03 -68.67 1.57 Allowed Glycine 0 C--N 1.344 1.024 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.354 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.96 163.61 23.57 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.54 ' HA ' HG12 ' A' ' 93' ' ' VAL . 83.5 Cg_endo -80.18 144.99 16.93 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 121.938 1.759 . . . . 0.0 111.9 165.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 47.4 mtm105 -132.81 142.81 49.17 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.495 0.664 . . . . 0.0 110.652 169.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.2 mm -128.28 124.84 63.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.678 1.191 . . . . 0.0 108.094 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.484 1.238 0 O-C-N 123.51 0.506 . . . . 0.0 109.909 179.377 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 39.5 p30 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 p -63.04 -43.57 98.31 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.132 0.973 . . . . 0.0 111.557 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.35 -2.31 18.75 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.599 0.76 . . . . 0.0 112.506 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.627 HG22 HG23 ' A' ' 76' ' ' VAL . 26.3 mm -94.81 -32.72 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.871 0.868 . . . . 0.0 109.264 174.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.95 -32.14 39.97 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.053 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 72.1 mt -57.97 -49.33 94.27 Favored Pre-proline 0 CA--C 1.564 1.484 0 CA-C-O 118.051 -0.976 . . . . 0.0 112.592 -177.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 9.3 Cg_endo -54.2 -61.79 0.38 Allowed 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 122.205 1.936 . . . . 0.0 111.648 175.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.491 HG11 ' HB ' ' A' ' 76' ' ' VAL . 16.7 m -64.12 -22.54 31.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.669 -171.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.55 ' HG2' HH22 ' A' ' 69' ' ' ARG . 0.9 OUTLIER -72.76 -55.62 6.46 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.552 0.741 . . . . 0.0 109.587 178.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 72.2 mmtt -70.28 -37.26 74.81 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.148 0.579 . . . . 0.0 110.972 -173.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -65.44 -39.31 91.91 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.052 0.941 . . . . 0.0 111.061 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.419 HD11 ' HB2' ' A' ' 66' ' ' LEU . 22.9 tp -57.89 -50.85 71.94 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.003 0.815 . . . . 0.0 110.09 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.44 -52.37 64.92 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.525 1.141 . . . . 0.0 109.444 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -60.92 -27.86 68.5 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.786 1.234 . . . . 0.0 112.182 -176.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -70.93 -39.73 72.51 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.757 0.823 . . . . 0.0 110.806 -177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -94.06 -17.71 22.57 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.987 0.515 . . . . 0.0 111.179 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.74 -3.58 54.55 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.349 0.66 . . . . 0.0 111.884 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 70.93 28.42 3.24 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.816 1.247 . . . . 0.0 112.39 174.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.46 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 17.6 m-20 -101.0 112.8 25.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.529 0.732 . . . . 0.0 110.067 174.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.0 mm -77.45 -31.46 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 122.719 0.408 . . . . 0.0 110.335 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -55.44 -48.38 74.54 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.848 0.459 . . . . 0.0 111.888 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.56 -29.64 33.37 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.638 0.375 . . . . 0.0 111.287 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -73.06 -8.17 54.53 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.136 0.574 . . . . 0.0 111.08 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.507 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 25.4 tpp -121.99 -15.55 7.77 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 173.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.46 -32.71 68.98 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -174.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.547 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 90.2 m95 -104.0 9.75 36.43 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.616 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 24.1 m95 -95.55 153.19 17.83 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.869 0.468 . . . . 0.0 110.102 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -80.0 151.18 30.13 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.341 0.656 . . . . 0.0 109.954 173.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -61.71 -31.11 71.24 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.449 0.699 . . . . 0.0 112.454 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -102.66 19.68 18.67 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.456 0.702 . . . . 0.0 111.303 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.616 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 46.1 t -60.49 119.25 7.67 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 121.074 0.464 . . . . 0.0 112.238 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.555 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 77.9 mm-40 -81.21 144.07 31.87 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.182 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -134.83 113.6 11.76 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.486 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 31.6 m-85 -115.88 155.11 28.53 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.922 0.889 . . . . 0.0 111.602 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.9 159.99 22.18 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.682 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 112' ' ' LYS . 18.3 p90 -55.27 136.41 68.71 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 123.993 0.917 . . . . 0.0 111.925 176.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -77.71 -40.27 1.16 Allowed 'Cis proline' 0 C--N 1.379 2.159 0 CA-C-N 119.854 0.984 . . . . 0.0 112.691 -7.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.71 66.66 0.21 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.832 0.853 . . . . 0.0 109.36 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 25.1 m -107.52 119.27 38.95 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.138 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tt -82.67 102.69 11.65 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.4 -45.18 16.47 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.836 0.454 . . . . 0.0 110.259 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -142.01 120.1 12.12 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -171.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.86 28.1 15.15 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.268 0.355 . . . . 0.0 113.898 -174.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.6 p30 176.18 157.77 0.26 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.254 1.422 . . . . 0.0 109.835 -174.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.507 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -60.48 -32.12 71.11 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.48 1.112 . . . . 0.0 113.378 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.485 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -60.55 -51.77 68.03 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.97 0.508 . . . . 0.0 111.124 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 33.9 mt-10 -69.27 -29.07 66.89 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.806 -175.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.1 mt -63.9 -52.11 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.329 0.652 . . . . 0.0 110.4 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.492 ' O ' HG13 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -67.19 -38.79 85.94 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.64 -175.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 47' ' ' ALA . 70.9 t -59.54 -49.37 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.481 0.712 . . . . 0.0 111.605 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -69.01 -29.41 67.59 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.765 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -77.87 -29.8 50.54 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 118.537 -0.745 . . . . 0.0 111.483 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 50' ' ' ARG . 76.2 mt -55.44 -46.78 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-N 118.645 0.657 . . . . 0.0 109.597 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -56.44 -42.44 78.11 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 124.413 1.071 . . . . 0.0 111.425 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.438 ' HG3' HD22 ' A' ' 62' ' ' LEU . 14.8 tpp180 -70.5 -31.5 68.62 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.414 0.686 . . . . 0.0 110.873 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -75.65 -14.31 60.36 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.534 0.734 . . . . 0.0 110.846 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 69.2 mmtt -91.6 -5.03 54.62 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.332 0.653 . . . . 0.0 111.565 170.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -105.49 122.1 43.91 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 122.985 0.514 . . . . 0.0 109.951 -175.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.54 -19.05 48.96 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.665 2.91 . . . . 0.0 115.165 -164.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -72.24 -24.42 61.37 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.629 0.372 . . . . 0.0 111.304 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.438 HD22 ' HG3' ' A' ' 56' ' ' ARG . 55.3 tp -56.19 120.66 7.9 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.661 0.784 . . . . 0.0 112.364 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -151.96 144.27 24.03 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.26 105.09 0.67 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -101.24 107.18 18.5 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.652 0.781 . . . . 0.0 109.525 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.419 ' HB2' HD11 ' A' ' 13' ' ' LEU . 14.3 tp -78.59 131.74 36.85 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 pp -111.98 -28.68 7.92 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.452 0.701 . . . . 0.0 110.206 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.9 m -157.47 143.69 17.76 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.288 1.035 . . . . 0.0 109.287 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.55 HH22 ' HG2' ' A' ' 10' ' ' GLN . 12.1 ptt180 -142.14 139.59 32.19 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.236 0.541 . . . . 0.0 110.315 162.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.11 143.7 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.843 1.257 . . . . 0.0 109.56 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.1 tt -115.85 134.07 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-O 121.309 0.576 . . . . 0.0 110.709 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -126.56 95.59 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 125.31 1.444 . . . . 0.0 107.81 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.2 -103.24 0.51 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 123.561 0.538 . . . . 0.0 113.369 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -106.46 18.18 22.31 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.529 0.732 . . . . 0.0 111.38 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.5 t -133.3 140.61 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.976 0.91 . . . . 0.0 109.071 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.627 HG23 HG22 ' A' ' 5' ' ' ILE . 57.1 t -125.86 137.82 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 118.516 0.598 . . . . 0.0 109.928 172.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.477 HG12 ' HB ' ' A' ' 98' ' ' ILE . 1.6 mt -99.86 110.0 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 167.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.45 ' HB2' ' SG ' ' A' ' 97' ' ' CYS . 1.3 m-20 -88.67 108.03 19.24 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 167.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.416 ' HE1' ' HB3' ' A' ' 94' ' ' ASP . 0.9 OUTLIER -98.5 108.71 21.46 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.318 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.99 163.67 21.82 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.516 1.127 . . . . 0.0 110.632 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.8 m -108.18 106.17 16.23 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.406 1.082 . . . . 0.0 108.582 165.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 m -90.52 134.05 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 122.481 0.313 . . . . 0.0 111.114 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 49.0 m -76.59 127.89 33.68 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.706 0.402 . . . . 0.0 109.994 175.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.4 mtm105 -126.72 161.48 28.04 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -90.17 99.31 12.35 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.825 0.345 . . . . 0.0 111.402 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -103.37 125.13 35.89 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.07 -16.17 53.42 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.087 2.525 . . . . 0.0 113.877 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -85.3 -9.03 58.18 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.912 0.485 . . . . 0.0 111.756 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.83 -127.14 1.18 Allowed Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.529 -0.595 . . . . 0.0 111.7 172.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -75.97 -83.34 0.07 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 117.282 0.541 . . . . 0.0 111.27 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.97 29.12 1.56 Allowed Glycine 0 C--N 1.354 1.542 0 N-CA-C 114.388 0.515 . . . . 0.0 114.388 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -89.82 99.28 12.32 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 122.136 0.969 . . . . 0.0 110.027 -172.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.9 m -102.75 137.5 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 121.616 -0.678 . . . . 0.0 111.444 -165.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB3' ' HE1' ' A' ' 79' ' ' HIS . 13.1 m-20 -79.31 115.01 18.7 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.686 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.526 HG22 HG12 ' A' ' 113' ' ' ILE . 35.2 t -119.17 156.17 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 125.12 1.368 . . . . 0.0 109.156 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.03 106.11 10.12 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 78' ' ' ASP . 20.5 p -97.23 109.06 21.89 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.541 HG23 ' HB2' ' A' ' 110' ' ' TRP . 7.1 tt -100.4 114.76 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.353 1.061 . . . . 0.0 109.622 -177.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -107.91 132.54 53.36 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.757 0.823 . . . . 0.0 109.71 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -98.4 112.83 24.71 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.546 HG22 HG12 ' A' ' 106' ' ' ILE . 42.1 t -95.08 113.85 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.192 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 41.7 tt0 -119.61 128.05 53.51 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.865 0.866 . . . . 0.0 109.511 175.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 64.37 31.35 12.81 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.391 1.077 . . . . 0.0 111.903 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.81 6.52 89.04 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.726 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -134.1 139.43 45.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.537 1.135 . . . . 0.0 108.957 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.546 HG12 HG22 ' A' ' 101' ' ' VAL . 45.9 mt -68.28 104.86 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 122.429 0.291 . . . . 0.0 110.316 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -78.33 -30.25 48.08 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.68 0.792 . . . . 0.0 111.175 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.555 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 97.9 mttt -149.48 152.18 35.19 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.877 0.871 . . . . 0.0 109.091 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -146.17 137.42 24.6 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.963 0.905 . . . . 0.0 108.824 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.541 ' HB2' HG23 ' A' ' 98' ' ' ILE . 4.0 m-90 -135.56 150.95 49.86 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -142.43 146.41 34.8 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 171.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 20.5 ptmt -131.19 125.36 32.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.537 176.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.526 HG12 HG22 ' A' ' 95' ' ' VAL . 87.2 mt -87.44 123.92 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.26 -65.94 2.97 Favored Glycine 0 CA--C 1.526 0.754 0 O-C-N 124.451 1.094 . . . . 0.0 113.187 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -159.5 167.63 13.81 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.19 138.31 33.08 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.558 2.172 . . . . 0.0 112.334 165.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 30.1 mmt180 -135.52 146.38 48.01 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.81 0.844 . . . . 0.0 111.213 -175.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.5 mm -136.83 132.65 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.855 1.262 . . . . 0.0 108.445 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.9 t . . . . . 0 N--CA 1.503 2.18 0 C-N-CA 123.734 0.813 . . . . 0.0 111.944 -178.709 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 121.822 0.82 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.5 m -75.78 -49.17 18.89 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.637 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -12.86 58.41 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.173 0.989 . . . . 0.0 113.387 -175.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.545 HG22 HG23 ' A' ' 76' ' ' VAL . 33.2 mm -87.1 -34.26 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.498 ' HG3' HD12 ' A' ' 71' ' ' ILE . 44.3 mt-10 -84.55 -22.33 30.15 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.5 -53.91 61.41 Favored Pre-proline 0 CA--C 1.568 1.639 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.662 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.528 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 33.6 Cg_endo -62.27 -49.56 5.97 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 122.156 1.904 . . . . 0.0 113.052 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.669 ' HA ' HE21 ' A' ' 12' ' ' GLN . 15.6 m -66.95 -37.87 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -169.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -43.67 62.85 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.423 0.689 . . . . 0.0 109.977 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -68.68 -29.72 68.24 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.326 0.651 . . . . 0.0 112.065 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.669 HE21 ' HA ' ' A' ' 9' ' ' VAL . 44.9 mt-30 -59.47 -48.03 83.23 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.904 0.752 . . . . 0.0 110.308 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.55 -51.75 68.51 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 124.012 0.82 . . . . 0.0 110.092 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.62 -27.1 66.02 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 124.029 0.831 . . . . 0.0 110.896 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . . . -83.08 -32.31 26.85 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.389 1.076 . . . . 0.0 112.285 175.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -72.02 -39.66 68.99 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.256 0.622 . . . . 0.0 110.534 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.67 1.07 54.73 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.887 0.875 . . . . 0.0 111.834 177.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.56 3.17 10.72 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.999 0.92 . . . . 0.0 111.171 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 70.28 9.53 7.02 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.127 1.371 . . . . 0.0 113.695 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.453 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 8.9 m-20 -81.13 116.86 21.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.14 0.495 . . . . 0.0 110.916 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.529 HG13 HG12 ' A' ' 54' ' ' ILE . 22.8 mm -82.58 -25.6 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.093 0.957 . . . . 0.0 110.073 171.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -54.74 -48.82 72.11 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.038 0.935 . . . . 0.0 112.097 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -79.4 -35.18 41.07 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.94 0.496 . . . . 0.0 110.623 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -69.93 -8.26 47.37 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.178 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.646 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 16.6 tpp -119.87 -28.64 5.15 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.447 0.699 . . . . 0.0 112.401 173.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.4 -47.42 75.9 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.036 0.534 . . . . 0.0 112.087 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 98.4 m95 -79.43 1.62 24.81 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -170.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.465 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 18.2 m95 -95.05 168.34 10.83 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.373 0.669 . . . . 0.0 110.045 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -87.1 148.35 25.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.54 0.736 . . . . 0.0 109.353 171.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.16 -25.79 67.96 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.316 0.646 . . . . 0.0 111.706 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -109.19 18.97 19.98 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.976 1.311 . . . . 0.0 111.381 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.465 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 53.7 t -60.84 133.93 56.58 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -173.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.55 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 36.6 mm-40 -95.44 105.46 17.43 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.567 0.747 . . . . 0.0 109.967 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.432 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 48.4 t80 -94.6 111.44 23.2 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.635 0.774 . . . . 0.0 110.246 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -105.16 139.89 39.14 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.287 1.035 . . . . 0.0 110.029 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.6 161.48 14.82 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.24 1.016 . . . . 0.0 110.345 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.41 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 71.3 t80 -50.26 127.58 22.74 Favored Pre-proline 0 CA--C 1.566 1.593 0 O-C-N 124.285 0.99 . . . . 0.0 112.039 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.23 -50.29 0.19 OUTLIER 'Cis proline' 0 C--N 1.386 2.519 0 CA-C-N 119.77 0.953 . . . . 0.0 113.513 -5.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.33 78.83 0.81 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.8 m -117.48 114.03 22.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.033 0.933 . . . . 0.0 109.237 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.74 101.48 0.81 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.8 mt -79.63 -36.36 38.02 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.275 0.63 . . . . 0.0 109.93 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.461 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -142.45 116.3 9.29 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.612 -170.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.0 33.21 4.77 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 123.374 0.421 . . . . 0.0 112.771 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.43 ' O ' HG13 ' A' ' 49' ' ' ILE . 8.9 p30 167.05 158.29 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.204 1.402 . . . . 0.0 109.816 -167.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.646 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -70.65 -25.2 62.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.245 1.018 . . . . 0.0 113.148 -175.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.4 98.27 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.861 0.465 . . . . 0.0 111.259 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.461 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 26.6 mt-10 -75.39 -32.36 60.75 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.611 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 46' ' ' ALA . 72.4 mt -65.44 -46.29 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.197 0.599 . . . . 0.0 110.945 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 54' ' ' ILE . 14.0 ptm180 -64.67 -51.43 62.56 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.686 0.616 . . . . 0.0 110.641 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.415 ' HA ' HD12 ' A' ' 54' ' ' ILE . 20.6 m -65.61 -35.23 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 122.97 0.508 . . . . 0.0 111.825 -175.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -71.41 -34.92 70.77 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.855 0.862 . . . . 0.0 110.476 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -75.08 -32.61 61.52 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.642 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.529 HG12 HG13 ' A' ' 21' ' ' ILE . 97.7 mt -58.15 -37.76 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.672 0.389 . . . . 0.0 110.026 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.12 -34.56 78.34 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.654 0.782 . . . . 0.0 111.6 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -75.2 -25.98 58.63 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.867 0.467 . . . . 0.0 110.157 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.549 ' HA ' HD22 ' A' ' 62' ' ' LEU . 2.8 m-85 -83.9 -4.42 58.68 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.59 0.756 . . . . 0.0 111.347 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HE2' HG22 ' A' ' 54' ' ' ILE . 74.5 mmtt -73.07 -25.84 61.05 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.717 0.407 . . . . 0.0 111.109 169.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 50.4 mm-40 -57.42 116.7 14.7 Favored Pre-proline 0 N--CA 1.481 1.113 0 C-N-CA 123.583 0.753 . . . . 0.0 110.748 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.23 -26.61 41.91 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.321 2.014 . . . . 0.0 112.609 -175.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.42 2.25 55.77 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.053 0.941 . . . . 0.0 111.484 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 57' ' ' PHE . 17.6 tp -62.23 114.02 3.21 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.932 0.493 . . . . 0.0 111.276 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -151.65 115.62 4.95 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.535 0.734 . . . . 0.0 109.084 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.12 104.59 3.11 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -91.68 101.82 14.45 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.7 tt -79.26 124.88 28.8 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.52 -32.79 5.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.736 -172.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.7 m -148.69 134.86 19.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.367 1.067 . . . . 0.0 108.558 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.409 HH12 ' HG2' ' A' ' 6' ' ' GLU . 52.3 ptt85 -137.76 133.31 33.94 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 166.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -121.56 128.09 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.511 1.124 . . . . 0.0 109.43 -172.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.498 HD12 ' HG3' ' A' ' 6' ' ' GLU . 11.9 tt -108.7 128.77 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 121.253 0.549 . . . . 0.0 110.657 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.1 p -123.89 94.46 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 173.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.27 -110.83 3.15 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.823 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -87.99 -1.1 57.78 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.609 1.163 . . . . 0.0 111.8 -172.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.3 t -128.77 140.18 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.074 0.95 . . . . 0.0 109.786 -172.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.545 HG23 HG22 ' A' ' 5' ' ' ILE . 33.2 t -125.29 134.65 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.349 0.66 . . . . 0.0 109.512 172.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.456 HG12 ' HB ' ' A' ' 98' ' ' ILE . 2.4 mt -99.58 107.04 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 165.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.75 109.32 20.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -98.74 109.69 22.41 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.25 159.24 36.73 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.467 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.2 m -107.43 110.05 21.91 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.121 172.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.0 t -81.77 103.25 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 123.293 0.637 . . . . 0.0 110.258 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.3 m -66.75 129.56 40.27 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.854 0.862 . . . . 0.0 110.205 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 91' ' ' GLY . 80.7 mtp180 -133.56 -162.53 1.25 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -130.21 83.5 2.13 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.917 0.389 . . . . 0.0 110.357 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -90.18 137.83 27.64 Favored Pre-proline 0 N--CA 1.475 0.8 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.3 8.15 1.56 Allowed 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.839 2.359 . . . . 0.0 113.046 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.91 -32.68 57.56 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.082 0.953 . . . . 0.0 109.314 169.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.09 -98.03 0.13 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.355 175.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -76.91 -82.41 0.08 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.786 0.834 . . . . 0.0 110.281 175.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 84' ' ' ARG . . . 117.43 28.59 2.31 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 121.312 -0.47 . . . . 0.0 113.877 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -88.1 140.95 28.97 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -174.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.585 HG12 ' HA ' ' A' ' 116' ' ' PRO . 29.1 m -127.43 129.27 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 122.04 -0.413 . . . . 0.0 110.817 -176.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -77.34 110.43 12.07 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.039 0.536 . . . . 0.0 109.703 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.459 HG22 HG12 ' A' ' 113' ' ' ILE . 33.8 t -114.15 156.55 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.607 1.163 . . . . 0.0 108.859 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.88 103.32 6.73 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 71.6 m -96.35 111.84 23.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.235 1.014 . . . . 0.0 109.959 -174.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.456 ' HB ' HG12 ' A' ' 77' ' ' ILE . 8.6 tt -103.42 110.96 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 124.602 1.161 . . . . 0.0 110.155 -175.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -105.69 133.64 50.1 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.167 0.587 . . . . 0.0 110.905 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -100.45 119.68 38.84 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.195 0.998 . . . . 0.0 108.474 169.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.5 t -110.28 115.25 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.014 0.926 . . . . 0.0 110.536 -173.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.482 ' HG3' HD22 ' A' ' 103' ' ' ASN . 11.4 tp10 -118.68 126.39 51.82 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.145 0.578 . . . . 0.0 109.806 177.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.482 HD22 ' HG3' ' A' ' 102' ' ' GLU . 54.9 m-80 61.55 30.25 18.62 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.892 1.277 . . . . 0.0 112.174 -177.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.45 0.03 86.03 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 116.379 -0.373 . . . . 0.0 113.774 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -117.38 138.41 51.82 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 67.1 mt -68.56 105.91 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -78.11 -32.13 50.36 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.056 0.542 . . . . 0.0 110.705 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.55 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 62.4 mtpt -150.2 134.23 16.98 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -130.4 132.28 45.68 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.425 ' HE1' ' HE2' ' A' ' 108' ' ' LYS . 0.7 OUTLIER -132.42 148.64 52.41 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -177.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -142.62 146.69 34.78 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.284 0.493 . . . . 0.0 110.03 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 25.1 pttm -121.19 127.68 51.73 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.459 HG12 HG22 ' A' ' 95' ' ' VAL . 88.3 mt -89.69 124.99 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.21 -73.88 0.52 Allowed Glycine 0 CA--C 1.526 0.765 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.914 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -160.69 170.3 8.71 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.134 0.574 . . . . 0.0 109.676 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.585 ' HA ' HG12 ' A' ' 93' ' ' VAL . 72.4 Cg_endo -73.84 123.74 8.68 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.215 1.943 . . . . 0.0 112.225 165.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.8 mmt85 -110.01 147.58 33.25 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.212 1.005 . . . . 0.0 109.243 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.9 mm -139.05 127.79 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.489 1.481 0 C-N-CA 123.711 0.805 . . . . 0.0 111.74 -175.877 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.6 m120 . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 121.552 0.691 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.417 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 33.8 p -67.74 -33.02 74.05 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.702 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.65 -20.32 63.27 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.49 1.116 . . . . 0.0 112.578 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 74' ' ' ASN . 30.0 mm -91.79 -28.98 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.946 0.898 . . . . 0.0 109.409 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -75.0 -27.39 60.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.965 174.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 3' ' ' SER . 83.7 mt -59.92 -55.21 47.83 Favored Pre-proline 0 CA--C 1.564 1.484 0 CA-C-O 117.884 -1.055 . . . . 0.0 112.032 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 19.3 Cg_endo -56.91 -55.59 2.55 Favored 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 122.111 1.874 . . . . 0.0 112.613 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.5 m -62.98 -35.36 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.489 -171.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -73.66 -52.2 14.12 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.163 0.585 . . . . 0.0 110.394 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -62.86 -28.29 69.93 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -75.42 -43.56 49.27 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.853 0.861 . . . . 0.0 111.422 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.14 -52.05 65.38 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.003 0.521 . . . . 0.0 110.331 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.71 -25.81 68.37 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.021 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 20' ' ' ASP . . . -80.76 -27.64 36.68 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.372 1.069 . . . . 0.0 112.177 172.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -66.91 -47.52 71.52 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.252 0.548 . . . . 0.0 109.885 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.62 -14.57 59.6 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.847 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.43 -2.77 41.45 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.449 0.699 . . . . 0.0 112.118 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 67.55 25.48 8.35 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.791 1.237 . . . . 0.0 112.835 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.497 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 11.0 m-20 -92.8 100.04 12.6 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.311 0.644 . . . . 0.0 110.011 173.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.429 HG13 HG12 ' A' ' 54' ' ' ILE . 12.6 mm -70.39 -31.17 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.001 0.52 . . . . 0.0 110.787 170.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -61.36 -45.11 95.77 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.014 0.525 . . . . 0.0 111.691 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.03 -30.82 44.39 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.134 0.574 . . . . 0.0 110.977 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -72.94 -5.94 41.93 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.855 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.751 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -112.75 -30.52 7.04 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.217 0.607 . . . . 0.0 112.215 172.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.75 -32.7 67.72 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -169.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.479 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.9 m95 -97.97 7.83 45.7 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -173.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.568 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 46.8 m95 -94.25 157.51 16.01 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.01 0.524 . . . . 0.0 110.288 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -76.76 148.49 36.66 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.322 169.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -67.83 -24.29 65.26 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.158 0.583 . . . . 0.0 111.32 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -106.18 18.33 22.18 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.312 1.045 . . . . 0.0 111.236 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.568 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 51.5 t -64.93 138.99 58.71 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -174.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -98.21 136.61 38.17 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.763 0.825 . . . . 0.0 108.847 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 56.4 t80 -130.92 110.98 11.66 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -109.64 151.81 26.38 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.602 0.761 . . . . 0.0 110.512 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.25 158.47 19.67 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.634 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.644 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 87.2 t80 -61.29 130.82 91.97 Favored Pre-proline 0 CA--C 1.558 1.276 0 O-C-N 123.899 0.749 . . . . 0.0 110.335 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.38 -57.25 0.14 OUTLIER 'Cis proline' 0 C--N 1.383 2.39 0 CA-C-N 120.138 1.085 . . . . 0.0 113.6 -1.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.26 81.53 1.42 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.7 m -129.19 108.21 10.17 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.497 0.719 . . . . 0.0 109.915 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.5 tp -65.78 102.57 0.77 Allowed 'General case' 0 CA--C 1.535 0.377 0 O-C-N 123.572 0.545 . . . . 0.0 109.824 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.9 mt -78.68 -25.74 44.87 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.531 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -157.3 117.05 3.41 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.85 35.34 4.59 Favored Glycine 0 C--N 1.346 1.119 0 C-N-CA 123.28 0.467 . . . . 0.0 112.926 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 p30 163.96 160.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 126.306 1.843 . . . . 0.0 108.426 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -69.55 -26.14 64.35 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -171.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.69 -41.65 99.22 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.331 0.586 . . . . 0.0 110.884 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -76.28 -29.19 57.31 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.922 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.0 mt -64.24 -50.96 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 122.916 0.486 . . . . 0.0 110.639 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.751 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 30.8 ptt180 -60.68 -51.59 68.75 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.904 0.752 . . . . 0.0 110.671 -176.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.454 ' HA ' HD12 ' A' ' 54' ' ' ILE . 35.5 m -63.97 -38.22 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -174.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -61.87 -38.08 86.96 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 123.815 0.697 . . . . 0.0 110.376 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -78.22 -34.32 49.37 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.121 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 50' ' ' ARG . 98.0 mt -56.46 -39.99 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.089 0.556 . . . . 0.0 110.182 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.87 -41.01 95.11 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.139 0.976 . . . . 0.0 111.576 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -73.9 -29.27 61.97 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.409 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -73.49 -4.66 35.15 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.002 0.521 . . . . 0.0 111.62 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -74.46 -36.22 63.33 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.962 0.505 . . . . 0.0 111.011 172.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.53 115.78 12.8 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 123.493 0.717 . . . . 0.0 110.919 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.89 -25.07 28.4 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.482 2.121 . . . . 0.0 112.49 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.78 -7.79 58.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.821 0.848 . . . . 0.0 111.69 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.55 120.56 12.56 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 122.477 0.311 . . . . 0.0 110.547 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -151.2 115.55 5.08 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 169.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.91 102.97 2.75 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -100.87 109.77 21.76 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 80' ' ' GLU . 13.8 tp -66.7 140.33 57.88 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.164 0.507 . . . . 0.0 110.089 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -107.0 -51.1 2.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.457 1.122 . . . . 0.0 107.989 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.9 m -154.54 141.07 18.85 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 113.024 -1.898 . . . . 0.0 109.032 -172.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 53.6 ptt85 -135.14 121.83 20.83 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 168.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.498 HG22 ' HB ' ' A' ' 77' ' ' ILE . 19.3 m -107.96 136.07 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.5 tt -120.71 129.83 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.274 0.559 . . . . 0.0 110.775 -175.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.95 99.35 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 C-N-CA 124.859 1.264 . . . . 0.0 108.393 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.79 -125.66 22.92 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.583 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.44 ' HA ' HG13 ' A' ' 5' ' ' ILE . 26.3 p-10 -91.48 17.98 7.9 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.307 0.643 . . . . 0.0 111.88 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.6 t -127.45 135.76 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.162 0.985 . . . . 0.0 109.8 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.2 t -125.37 139.66 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.006 0.522 . . . . 0.0 109.788 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.498 ' HB ' HG22 ' A' ' 70' ' ' VAL . 10.0 mm -98.81 104.33 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 167.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -94.87 105.16 17.07 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -100.19 105.81 17.44 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -121.28 171.16 8.93 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.156 1.382 . . . . 0.0 109.918 -178.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.4 m -118.09 106.23 12.66 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.924 0.89 . . . . 0.0 108.935 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.0 m -82.47 124.16 39.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-O 121.613 0.721 . . . . 0.0 109.194 170.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.9 m -83.09 119.42 24.48 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.681 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.637 HH21 ' HZ ' ' A' ' 86' ' ' PHE . 61.9 mtm180 -119.06 -160.89 0.82 Allowed 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -139.59 111.47 7.36 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.773 0.715 . . . . 0.0 110.32 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.637 ' HZ ' HH21 ' A' ' 84' ' ' ARG . 17.3 m-30 -109.28 151.49 42.09 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.745 0.818 . . . . 0.0 110.127 -178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.37 -28.82 88.58 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.649 2.232 . . . . 0.0 113.736 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -88.53 2.74 52.35 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.06 -146.56 16.09 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-O 119.479 -0.623 . . . . 0.0 113.235 173.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -39.07 -72.92 0.05 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.316 1.446 . . . . 0.0 113.059 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.424 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 103.62 25.7 7.17 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 113.897 0.319 . . . . 0.0 113.897 175.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -92.84 129.25 38.82 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.655 HG12 ' HA ' ' A' ' 116' ' ' PRO . 20.7 m -123.05 143.88 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.507 ' HB3' HH21 ' A' ' 117' ' ' ARG . 9.8 p-10 -85.89 122.95 30.67 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 174.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.447 HG22 HG12 ' A' ' 113' ' ' ILE . 44.2 t -113.68 142.33 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -106.12 97.65 7.43 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 94.1 m -93.49 108.28 19.99 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.357 0.663 . . . . 0.0 109.214 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.449 ' HB ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -97.78 115.75 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.897 0.879 . . . . 0.0 108.979 -178.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.402 ' CD1' HD13 ' A' ' 106' ' ' ILE . 64.0 m-85 -107.39 133.91 51.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.684 0.794 . . . . 0.0 109.711 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -103.31 113.37 26.81 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 168.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.628 HG22 HG12 ' A' ' 106' ' ' ILE . 96.9 t -100.0 135.29 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.204 1.001 . . . . 0.0 110.035 -176.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.46 ' HG3' HD22 ' A' ' 103' ' ' ASN . 9.9 tp10 -133.27 119.2 19.49 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.959 0.904 . . . . 0.0 109.866 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.46 HD22 ' HG3' ' A' ' 102' ' ' GLU . 57.2 m-80 61.12 30.54 19.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.927 1.291 . . . . 0.0 112.375 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.67 -6.64 83.13 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.009 -0.542 . . . . 0.0 113.858 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -113.86 133.51 55.38 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.628 HG12 HG22 ' A' ' 101' ' ' VAL . 57.5 mt -67.68 107.59 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.53 -32.1 47.84 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.495 0.718 . . . . 0.0 110.997 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -150.09 152.32 34.6 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.068 0.947 . . . . 0.0 108.821 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.66 135.49 12.73 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -136.75 151.79 49.61 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -139.57 144.79 37.96 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.249 0.547 . . . . 0.0 110.31 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.644 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 16.8 ttpt -117.03 125.6 51.59 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 172.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.447 HG12 HG22 ' A' ' 95' ' ' VAL . 62.0 mt -86.44 125.56 40.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.86 -132.21 1.47 Allowed Glycine 0 CA--C 1.52 0.4 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.938 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -83.5 134.26 45.5 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.591 0.756 . . . . 0.0 111.325 -169.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.655 ' HA ' HG12 ' A' ' 93' ' ' VAL . 77.5 Cg_endo -74.07 93.37 0.88 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 123.346 2.697 . . . . 0.0 111.435 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.507 HH21 ' HB3' ' A' ' 94' ' ' ASP . 49.5 mtm105 -100.45 141.48 33.24 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.532 0.682 . . . . 0.0 111.216 -169.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.3 mm -127.8 124.72 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.732 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 N--CA 1.481 1.107 0 C-N-CA 123.834 0.853 . . . . 0.0 110.258 177.199 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.421 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 13.8 m -65.68 -42.59 91.1 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.465 1.106 . . . . 0.0 111.348 -169.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.77 -19.17 64.78 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.038 0.935 . . . . 0.0 112.72 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 mm -96.1 -29.69 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.177 0.991 . . . . 0.0 109.617 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -71.53 -36.94 71.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.247 1.019 . . . . 0.0 111.212 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 91.4 mt -58.15 -52.76 72.18 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.061 -175.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 16.9 Cg_endo -57.19 -59.77 0.55 Allowed 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 121.6 1.533 . . . . 0.0 112.271 176.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.453 HG12 ' HD2' ' A' ' 99' ' ' TYR . 16.5 m -62.42 -29.81 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -169.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.461 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 26.2 tp60 -73.44 -55.61 6.13 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 122.852 0.461 . . . . 0.0 110.399 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.2 mmtt -63.68 -36.33 83.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 123.752 0.658 . . . . 0.0 111.002 -175.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.38 -46.0 90.59 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.136 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.44 -48.78 80.33 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 55.7 mm-40 -58.44 -33.72 70.02 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.508 1.13 . . . . 0.0 110.488 -176.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.71 -26.06 32.35 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.574 1.15 . . . . 0.0 112.417 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -69.7 -44.36 70.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.977 0.511 . . . . 0.0 109.945 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.87 -22.79 52.94 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.272 175.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.79 -0.78 57.81 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.28 0.632 . . . . 0.0 112.19 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 mmt85 68.96 7.72 6.39 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.009 1.324 . . . . 0.0 113.323 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.95 98.69 6.51 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.231 0.612 . . . . 0.0 110.228 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.447 HG13 HG12 ' A' ' 54' ' ' ILE . 12.5 mm -63.06 -36.02 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.02 0.528 . . . . 0.0 110.77 172.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -57.52 -49.17 77.21 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.505 0.722 . . . . 0.0 111.405 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.0 -30.79 27.87 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.136 0.575 . . . . 0.0 111.963 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -65.93 -20.68 66.3 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.11 0.256 . . . . 0.0 110.646 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 67.7 mmm -120.16 6.19 10.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.701 0.8 . . . . 0.0 112.107 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.84 -47.57 58.63 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.295 0.569 . . . . 0.0 110.426 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.412 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 92.0 m95 -86.95 9.3 19.85 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.349 -169.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.648 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 30.1 m95 -89.29 156.74 18.55 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 173.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -76.72 149.96 36.33 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 173.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.71 -27.4 68.3 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.74 0.416 . . . . 0.0 110.645 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.97 19.37 19.58 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.596 1.158 . . . . 0.0 111.017 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.648 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 52.1 t -63.5 123.57 19.11 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.058 0.456 . . . . 0.0 111.815 -174.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -85.73 140.44 30.5 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.417 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 63.0 t80 -132.87 110.08 10.06 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -172.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -111.03 155.91 22.06 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.364 1.065 . . . . 0.0 110.955 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.26 160.29 29.6 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.67 170.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -50.93 132.5 29.53 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 124.674 1.19 . . . . 0.0 112.156 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.85 -41.49 0.9 Allowed 'Cis proline' 0 C--N 1.379 2.145 0 CA-C-N 119.961 1.022 . . . . 0.0 113.801 -2.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.06 56.89 0.12 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.215 0.606 . . . . 0.0 110.894 -177.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 75.5 m -109.33 114.22 27.71 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.67 0.788 . . . . 0.0 110.218 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.4 tt -76.5 109.48 10.27 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.17 -44.54 14.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.224 0.61 . . . . 0.0 109.664 174.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -132.13 122.34 25.2 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.742 -171.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.21 46.74 1.13 Allowed Glycine 0 N--CA 1.478 1.448 0 C-N-CA 122.612 0.148 . . . . 0.0 112.793 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.435 ' O ' HG13 ' A' ' 49' ' ' ILE . 9.5 p30 162.34 152.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 126.341 1.856 . . . . 0.0 108.319 -171.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -63.44 -25.38 68.24 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.765 0.826 . . . . 0.0 113.194 -174.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -64.07 -44.27 92.92 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.942 0.497 . . . . 0.0 111.331 -177.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.432 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 33.0 mt-10 -75.68 -33.53 60.39 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 45' ' ' ASN . 53.2 mt -65.77 -42.81 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.098 0.559 . . . . 0.0 110.598 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.463 ' O ' HG13 ' A' ' 54' ' ' ILE . 14.0 ptm180 -66.44 -42.8 87.11 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.952 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 47' ' ' ALA . 97.8 t -61.04 -44.56 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 123.787 0.68 . . . . 0.0 110.572 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -63.59 -34.7 78.4 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.19 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -77.2 -35.55 55.64 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.038 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.48 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 78.9 mt -55.5 -44.22 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 123.195 0.598 . . . . 0.0 110.124 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -54.98 -43.15 73.26 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 124.377 1.048 . . . . 0.0 111.203 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.3 tpp85 -72.68 -30.7 64.47 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.619 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -78.22 -6.63 55.47 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.71 0.404 . . . . 0.0 111.596 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 69.4 mmtt -87.11 -12.63 46.52 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.229 0.612 . . . . 0.0 111.645 171.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.71 114.73 18.96 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.733 0.813 . . . . 0.0 108.886 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.62 -27.21 38.92 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.632 2.221 . . . . 0.0 113.157 -170.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -89.16 -6.54 56.87 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.625 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.4 tp -56.99 121.95 11.17 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.48 0.488 . . . . 0.0 111.571 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -149.31 119.47 7.24 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.495 ' HA2' HG12 ' A' ' 82' ' ' VAL . . . -88.8 104.93 3.13 Favored Glycine 0 C--N 1.34 0.778 0 O-C-N 123.524 0.515 . . . . 0.0 112.197 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -102.43 101.93 12.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 tt -83.74 131.24 34.93 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.432 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -115.65 -30.73 6.07 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.175 0.99 . . . . 0.0 111.136 -173.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.6 m -149.35 130.68 14.67 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.4 0.68 . . . . 0.0 109.344 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -137.82 117.58 13.16 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.43 115.69 47.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.778 0.831 . . . . 0.0 109.573 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.5 tt -106.51 123.9 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 122.935 0.494 . . . . 0.0 109.983 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 t -118.75 95.73 3.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.1 -95.33 0.2 Allowed Glycine 0 CA--C 1.531 1.077 0 O-C-N 123.661 0.601 . . . . 0.0 113.78 176.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -108.39 4.23 24.17 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.456 1.102 . . . . 0.0 111.495 -171.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.93 138.53 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.511 1.124 . . . . 0.0 109.631 -173.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.01 127.62 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.497 0.719 . . . . 0.0 109.388 173.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.477 HG12 ' HB ' ' A' ' 98' ' ' ILE . 4.0 mt -99.03 106.54 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 163.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -89.99 132.5 35.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 172.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -128.58 110.54 12.35 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.24 171.08 8.55 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.366 1.466 . . . . 0.0 109.282 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.426 HG22 ' HB2' ' A' ' 92' ' ' GLU . 97.1 m -125.9 102.64 7.37 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 164.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.495 HG12 ' HA2' ' A' ' 64' ' ' GLY . 15.0 m -84.22 124.37 39.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.843 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.48 HG23 ' HD2' ' A' ' 90' ' ' LYS . 88.2 m -66.4 123.9 21.26 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.958 170.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -129.81 -170.61 2.34 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -126.06 97.29 5.04 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 118.974 0.806 . . . . 0.0 111.018 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -100.92 140.32 21.23 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.093 0.957 . . . . 0.0 108.952 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -64.69 -17.74 60.47 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.687 2.258 . . . . 0.0 113.637 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -83.59 -9.24 59.05 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.925 0.49 . . . . 0.0 112.093 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.66 -120.49 0.94 Allowed Glycine 0 C--N 1.349 1.295 0 CA-C-O 120.041 -0.31 . . . . 0.0 112.495 172.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.48 ' HD2' HG23 ' A' ' 83' ' ' THR . 16.0 tppt? -66.76 -83.28 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.841 0.856 . . . . 0.0 111.317 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 119.44 27.06 2.26 Favored Glycine 0 C--N 1.346 1.086 0 O-C-N 123.094 0.246 . . . . 0.0 112.558 -174.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.426 ' HB2' HG22 ' A' ' 81' ' ' THR . 9.7 pt-20 -89.45 108.62 19.75 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.566 0.698 . . . . 0.0 109.441 -172.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.594 HG12 ' HA ' ' A' ' 116' ' ' PRO . 4.8 m -112.64 142.32 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 122.858 0.463 . . . . 0.0 109.849 -175.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -96.77 144.37 26.82 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.564 HG22 HG12 ' A' ' 113' ' ' ILE . 15.3 t -136.82 136.63 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.608 0.763 . . . . 0.0 109.17 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.32 98.83 9.44 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 170.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 63.1 m -98.22 112.69 24.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.598 0.759 . . . . 0.0 109.641 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.536 HG23 ' HB2' ' A' ' 110' ' ' TRP . 6.3 tt -97.56 110.8 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 123.58 0.752 . . . . 0.0 109.989 177.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.453 ' HD2' HG12 ' A' ' 9' ' ' VAL . 14.6 m-85 -98.32 154.83 17.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.456 0.702 . . . . 0.0 109.843 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -132.88 119.41 20.17 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.18 0.992 . . . . 0.0 108.452 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 56.6 t -94.54 140.03 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.909 0.883 . . . . 0.0 110.254 -174.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 24.3 tt0 -138.98 123.03 17.91 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.82 31.1 16.6 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.537 0.735 . . . . 0.0 110.934 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.49 -5.73 83.91 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.929 -0.578 . . . . 0.0 114.161 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -125.39 134.6 52.09 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.779 0.831 . . . . 0.0 109.748 -175.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 64.2 mt -63.66 103.61 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 122.854 0.462 . . . . 0.0 110.397 -178.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -81.28 -24.84 36.98 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.168 0.587 . . . . 0.0 111.559 -176.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -149.25 139.81 22.54 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.572 0.749 . . . . 0.0 109.405 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.88 138.25 33.79 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.08 0.952 . . . . 0.0 108.786 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.536 ' HB2' HG23 ' A' ' 98' ' ' ILE . 3.2 m-90 -136.84 142.8 42.86 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -142.64 147.1 35.2 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 119.181 0.901 . . . . 0.0 111.233 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -131.91 130.35 41.47 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.852 0.861 . . . . 0.0 108.839 173.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.564 HG12 HG22 ' A' ' 95' ' ' VAL . 95.9 mt -87.85 127.17 41.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.86 -80.22 0.12 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 114.923 -1.035 . . . . 0.0 113.355 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -158.55 163.67 23.58 Favored Pre-proline 0 C--O 1.243 0.745 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.594 ' HA ' HG12 ' A' ' 93' ' ' VAL . 97.8 Cg_endo -81.35 141.5 12.73 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.061 1.841 . . . . 0.0 112.495 166.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -132.67 157.63 44.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.893 0.877 . . . . 0.0 110.335 174.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.454 HG23 ' H ' ' A' ' 90' ' ' LYS . 45.9 mm -133.43 144.47 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.891 1.276 . . . . 0.0 107.825 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.0 t . . . . . 0 N--CA 1.491 1.619 0 C-N-CA 122.948 0.499 . . . . 0.0 110.915 179.149 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.9 m -52.4 -53.17 48.46 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.254 1.422 . . . . 0.0 113.89 -163.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.96 -11.88 59.66 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.416 ' HB ' HD11 ' A' ' 71' ' ' ILE . 13.3 mm -98.38 -30.51 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.978 0.911 . . . . 0.0 109.984 175.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.12 -35.9 71.92 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.137 0.975 . . . . 0.0 110.632 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -65.71 -46.71 67.13 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.219 1.407 . . . . 0.0 112.579 -168.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 11.6 Cg_endo -55.13 -57.81 1.49 Allowed 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 121.561 1.507 . . . . 0.0 111.425 171.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.502 HG21 HG21 ' A' ' 76' ' ' VAL . 73.6 t -59.63 -33.37 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.506 1.122 . . . . 0.0 112.407 -173.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.569 ' HA ' HH12 ' A' ' 69' ' ' ARG . 0.9 OUTLIER -69.43 -56.07 8.49 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.532 0.733 . . . . 0.0 110.306 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -66.34 -35.4 80.25 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.414 0.686 . . . . 0.0 111.423 -174.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.04 -39.29 93.13 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.615 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.688 ' HB2' HH22 ' A' ' 69' ' ' ARG . 58.1 tp -59.02 -52.55 65.28 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.671 0.607 . . . . 0.0 110.666 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -54.97 -46.92 75.11 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.969 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.54 -30.69 71.47 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.336 1.054 . . . . 0.0 112.307 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -68.74 -48.54 63.51 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.154 0.582 . . . . 0.0 110.467 -175.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -82.21 -19.79 39.04 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.098 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.01 -3.56 58.89 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.408 0.683 . . . . 0.0 112.124 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 68.2 21.24 8.62 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.773 1.229 . . . . 0.0 112.171 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -90.05 123.21 33.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.934 0.894 . . . . 0.0 110.506 174.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.5 mm -87.15 -28.32 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.47 0.708 . . . . 0.0 110.736 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.44 -47.29 86.04 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.325 0.65 . . . . 0.0 111.981 -170.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.64 -32.24 41.62 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.072 0.549 . . . . 0.0 110.66 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -73.27 -7.18 50.44 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.088 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.728 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 1.1 tpt -116.94 -33.95 4.58 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.303 0.641 . . . . 0.0 111.864 176.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.09 -48.53 78.36 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.338 0.655 . . . . 0.0 112.066 -172.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 99.1 m95 -76.43 -0.67 23.71 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.236 -173.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.654 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 14.8 m95 -91.99 149.4 21.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 173.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 107' ' ' ALA . . . -75.42 155.15 36.64 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.975 0.51 . . . . 0.0 110.651 176.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.75 -24.55 66.98 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.451 0.701 . . . . 0.0 111.384 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -104.56 19.19 20.81 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 124.366 1.066 . . . . 0.0 110.465 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.654 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 49.0 t -60.52 114.86 3.19 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -173.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -92.49 102.87 15.32 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.887 0.875 . . . . 0.0 110.099 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.46 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 78.4 t80 -97.08 111.28 23.58 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 125.265 1.426 . . . . 0.0 110.242 -173.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.497 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 45.5 m-85 -111.08 155.59 22.58 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.53 1.132 . . . . 0.0 110.55 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.69 157.05 23.67 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.242 170.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -55.81 134.3 72.71 Favored Pre-proline 0 CA--C 1.564 1.497 0 C-N-CA 124.374 1.07 . . . . 0.0 112.251 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.33 -40.83 1.11 Allowed 'Cis proline' 0 C--N 1.381 2.289 0 CA-C-N 120.146 1.088 . . . . 0.0 113.011 -8.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.16 92.62 0.75 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.983 0.913 . . . . 0.0 108.945 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.417 ' O ' HD22 ' A' ' 42' ' ' LEU . 90.5 m -139.0 117.38 11.98 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.729 0.812 . . . . 0.0 108.863 176.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 tt -81.93 103.14 11.37 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -176.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.417 HD22 ' O ' ' A' ' 40' ' ' THR . 2.4 mm? -89.73 -29.42 18.73 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.509 0.323 . . . . 0.0 110.785 177.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -146.83 116.34 7.09 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -175.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.96 36.26 4.22 Favored Glycine 0 N--CA 1.478 1.478 0 C-N-CA 123.19 0.424 . . . . 0.0 113.396 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 p30 168.94 163.28 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.473 1.509 . . . . 0.0 109.438 -172.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -64.0 -35.42 80.66 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.945 0.898 . . . . 0.0 112.602 -177.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.86 -45.61 91.89 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.164 0.586 . . . . 0.0 111.717 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -71.67 -31.82 67.22 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.709 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.3 mt -66.04 -38.73 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.55 0.74 . . . . 0.0 110.097 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.728 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 75.3 ttt180 -62.27 -57.05 12.82 Favored 'General case' 0 C--N 1.348 0.53 0 O-C-N 123.994 0.809 . . . . 0.0 110.091 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.2 t -55.34 -48.41 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 125.043 1.464 . . . . 0.0 110.843 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.1 ttt-85 -61.33 -37.74 84.38 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.325 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -78.75 -28.37 44.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 118.889 -0.577 . . . . 0.0 112.136 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 50' ' ' ARG . 97.2 mt -61.64 -44.43 98.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 118.879 0.763 . . . . 0.0 109.06 174.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -65.33 -34.33 78.08 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.978 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -71.16 -30.33 66.32 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.2 0.6 . . . . 0.0 110.961 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -79.55 -5.7 55.47 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.127 0.571 . . . . 0.0 111.304 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -82.53 -8.57 59.61 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.875 0.47 . . . . 0.0 111.577 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 24.0 mm-40 -70.1 118.64 65.62 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.81 -22.25 27.52 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.32 2.013 . . . . 0.0 112.76 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.07 -6.97 49.99 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.727 0.811 . . . . 0.0 111.731 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 21.7 tp -58.43 111.89 1.39 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.222 0.464 . . . . 0.0 111.282 -175.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -148.23 117.01 6.68 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.99 126.71 8.19 Favored Glycine 0 C--O 1.24 0.482 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 171.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -119.46 100.9 7.58 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.8 tt -91.29 117.87 30.01 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.454 HD22 ' H ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.45 -47.01 5.56 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.378 1.071 . . . . 0.0 109.559 175.059 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.3 m -121.69 139.42 53.59 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.601 0.76 . . . . 0.0 111.672 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.688 HH22 ' HB2' ' A' ' 13' ' ' LEU . 2.2 ptp180 -144.07 125.17 14.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.455 0.702 . . . . 0.0 109.322 159.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.4 m -110.71 152.4 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.999 0.919 . . . . 0.0 108.88 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.416 HD11 ' HB ' ' A' ' 5' ' ' ILE . 19.7 tt -138.53 144.97 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 122.604 0.361 . . . . 0.0 110.812 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 75' ' ' VAL . 2.1 p -149.46 101.67 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 124.431 1.093 . . . . 0.0 109.075 -177.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.2 -123.35 20.78 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.488 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -98.76 19.32 15.05 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.831 0.453 . . . . 0.0 111.749 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 72' ' ' VAL . 3.0 p -135.28 139.32 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.102 0.561 . . . . 0.0 110.785 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.502 HG21 HG21 ' A' ' 9' ' ' VAL . 15.8 t -124.86 141.86 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.047 0.939 . . . . 0.0 110.165 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.51 HD13 ' HB ' ' A' ' 98' ' ' ILE . 8.4 mm -107.28 104.4 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 165.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -100.95 114.17 27.81 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -106.11 112.07 24.96 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.875 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -108.42 166.69 10.58 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.22 171.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.5 m -99.98 100.87 11.82 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 152.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.0 m -86.82 138.59 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 37.6 m -95.99 120.11 35.68 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.055 0.455 . . . . 0.0 110.664 -173.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -111.46 -162.8 0.81 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 175.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 3.4 t-20 -132.57 110.1 10.22 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.226 -0.296 . . . . 0.0 110.474 172.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -104.96 143.3 26.42 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 124.425 1.09 . . . . 0.0 108.741 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.05 -9.9 26.49 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.663 2.242 . . . . 0.0 113.706 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -85.48 -13.09 50.21 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.782 0.433 . . . . 0.0 112.085 175.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.68 -129.86 1.56 Allowed Glycine 0 C--N 1.349 1.262 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.981 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 15.8 tppt? -75.25 -72.32 0.31 Allowed 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.196 0.598 . . . . 0.0 110.428 174.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.92 26.94 3.13 Favored Glycine 0 C--N 1.341 0.836 0 O-C-N 123.277 0.361 . . . . 0.0 113.723 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 117' ' ' ARG . 4.8 pm0 -90.29 122.37 33.14 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -174.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 116' ' ' PRO . 34.1 m -123.57 143.63 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.448 0.699 . . . . 0.0 110.619 -169.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -79.34 108.4 12.83 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.139 0.575 . . . . 0.0 109.657 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.495 HG22 HG12 ' A' ' 113' ' ' ILE . 59.8 t -123.41 138.81 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.84 0.856 . . . . 0.0 110.078 -176.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.34 117.91 30.81 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.528 0.731 . . . . 0.0 109.399 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 64.2 m -94.27 123.29 37.58 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.61 HG23 ' HB2' ' A' ' 110' ' ' TRP . 10.3 tt -104.78 105.23 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.369 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.416 ' HD2' HG22 ' A' ' 9' ' ' VAL . 22.9 m-85 -99.53 127.88 45.62 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.613 0.765 . . . . 0.0 109.996 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -100.42 113.26 25.88 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 168.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.55 HG22 HG12 ' A' ' 106' ' ' ILE . 60.8 t -97.28 126.05 50.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 125.123 1.369 . . . . 0.0 110.508 -175.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.461 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 8.5 tp10 -133.15 139.28 46.99 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.108 0.963 . . . . 0.0 109.635 174.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.461 ' ND2' ' HG3' ' A' ' 102' ' ' GLU . 37.0 m-80 63.21 29.46 15.97 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.736 1.214 . . . . 0.0 111.644 -173.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.51 8.42 62.87 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.893 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -128.46 145.24 51.16 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.759 1.224 . . . . 0.0 108.4 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.55 HG12 HG22 ' A' ' 101' ' ' VAL . 57.5 mt -69.78 100.53 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 118.435 0.562 . . . . 0.0 109.832 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . . . -87.61 -15.31 37.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.723 0.409 . . . . 0.0 111.626 -177.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -148.33 129.73 14.79 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.4 132.93 48.51 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.61 ' HB2' HG23 ' A' ' 98' ' ' ILE . 1.6 m-90 -133.98 152.59 51.91 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -143.72 148.55 35.87 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 118.805 0.73 . . . . 0.0 111.251 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.7 129.72 51.53 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.422 1.089 . . . . 0.0 109.546 176.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.495 HG12 HG22 ' A' ' 95' ' ' VAL . 75.2 mt -90.23 127.76 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 171.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.53 -74.11 0.93 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.24 -176.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.96 167.41 13.23 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.099 0.56 . . . . 0.0 109.49 -175.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.658 ' HA ' HG12 ' A' ' 93' ' ' VAL . 56.8 Cg_endo -84.21 137.79 7.39 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.428 2.086 . . . . 0.0 113.001 168.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 29.3 mmt180 -131.22 149.64 52.49 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.974 0.91 . . . . 0.0 109.126 173.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.6 mm -131.58 131.55 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.033 0.933 . . . . 0.0 108.608 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.4 t . . . . . 0 N--CA 1.49 1.567 0 C-N-CA 123.218 0.607 . . . . 0.0 111.64 -177.456 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 . . . . . 0 N--CA 1.5 2.03 0 CA-C-O 121.054 0.454 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 14.4 m -75.75 -20.31 58.39 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.235 1.014 . . . . 0.0 112.483 -167.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -72.76 -19.77 61.31 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.527 0.331 . . . . 0.0 111.358 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.51 ' HB ' HD11 ' A' ' 71' ' ' ILE . 37.5 mm -88.88 -27.41 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 173.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.656 ' HG2' HH12 ' A' ' 69' ' ' ARG . 40.2 mt-10 -78.45 -19.79 52.4 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.663 173.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 3' ' ' SER . 77.6 mt -61.5 -50.75 81.38 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-O 118.736 -0.649 . . . . 0.0 111.729 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 19.6 Cg_endo -59.09 -55.33 1.98 Allowed 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 121.745 1.63 . . . . 0.0 111.709 173.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.1 t -54.4 -47.97 69.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 125.681 1.592 . . . . 0.0 113.576 -172.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -62.22 -47.4 84.59 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.859 0.864 . . . . 0.0 110.212 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -68.63 -35.18 76.95 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.632 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.29 -51.79 67.41 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.475 0.71 . . . . 0.0 111.033 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.66 -49.37 78.0 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.963 0.789 . . . . 0.0 109.494 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.418 ' HA ' HD21 ' A' ' 17' ' ' ASN . 22.3 mm-40 -60.11 -35.0 74.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 123.972 0.795 . . . . 0.0 111.03 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -74.17 -28.0 61.09 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.058 0.943 . . . . 0.0 111.395 175.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -70.36 -42.59 71.63 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.369 0.668 . . . . 0.0 110.238 -174.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.418 HD21 ' HA ' ' A' ' 14' ' ' GLU . 9.2 p30 -82.04 -28.33 32.54 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.433 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.92 11.38 27.48 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 63.74 20.69 12.35 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.351 1.06 . . . . 0.0 112.412 172.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.484 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 4.5 t70 -91.38 100.62 13.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.54 0.736 . . . . 0.0 109.406 -178.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.492 HG13 HG12 ' A' ' 54' ' ' ILE . 10.4 mm -74.47 -28.8 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.255 0.222 . . . . 0.0 110.974 173.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -62.72 -45.42 92.84 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.501 0.721 . . . . 0.0 110.891 -172.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.89 -36.05 31.76 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.787 0.835 . . . . 0.0 110.569 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -64.94 -8.8 17.17 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.25 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.753 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -112.27 -31.48 6.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.538 0.735 . . . . 0.0 111.855 174.033 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.07 -28.77 66.79 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -170.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 96.7 m95 -96.82 13.85 27.22 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.81 0.844 . . . . 0.0 112.782 -175.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.409 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 13.3 m95 -112.83 147.54 36.74 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.834 0.853 . . . . 0.0 109.011 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -72.48 152.86 41.67 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.402 0.681 . . . . 0.0 110.517 175.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.67 -27.72 69.43 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.264 0.625 . . . . 0.0 111.642 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -101.45 12.26 37.65 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.153 0.981 . . . . 0.0 111.345 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.409 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 53.4 t -59.69 125.89 25.42 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -169.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -81.08 150.41 28.8 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.593 0.757 . . . . 0.0 109.562 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.416 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 59.6 t80 -146.73 112.88 5.83 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.344 0.658 . . . . 0.0 109.309 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.412 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 34.1 m-85 -114.26 150.77 33.88 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.003 0.921 . . . . 0.0 111.331 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.525 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -99.03 159.44 14.97 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 113.942 -1.481 . . . . 0.0 108.294 165.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -58.65 136.83 86.44 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-O 119.116 -0.468 . . . . 0.0 110.269 173.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.83 -55.97 0.14 OUTLIER 'Cis proline' 0 C--N 1.381 2.263 0 CA-C-N 120.406 1.181 . . . . 0.0 112.556 -7.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -148.2 58.92 1.1 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.708 0.766 . . . . 0.0 109.865 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.4 m -95.65 104.0 15.9 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.407 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.64 104.29 1.58 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 36' ' ' ALA . 56.9 mt -82.1 -45.68 14.88 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.153 177.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -143.46 117.1 9.21 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.992 -172.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.77 37.05 3.89 Favored Glycine 0 N--CA 1.478 1.465 0 C-N-CA 122.874 0.273 . . . . 0.0 113.536 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.3 p30 168.74 156.26 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.786 1.634 . . . . 0.0 109.013 -171.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -58.97 -36.11 74.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.806 0.842 . . . . 0.0 112.82 -174.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.17 94.68 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.073 0.549 . . . . 0.0 112.082 -173.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.447 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 29.1 mt-10 -76.24 -32.54 58.95 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.969 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 78.5 mt -63.54 -42.83 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.396 0.679 . . . . 0.0 109.97 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.753 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 74.6 ttt180 -56.03 -58.51 7.61 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.913 1.285 . . . . 0.0 110.861 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.32 -35.55 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.876 -168.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -72.0 -34.11 68.61 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.857 0.463 . . . . 0.0 110.334 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -74.57 -27.07 60.34 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.742 -0.646 . . . . 0.0 111.548 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.492 HG12 HG13 ' A' ' 21' ' ' ILE . 85.1 mt -56.99 -42.72 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 118.453 0.57 . . . . 0.0 109.837 173.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -61.09 -37.24 82.02 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.009 0.818 . . . . 0.0 111.151 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -64.97 -39.15 93.05 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.571 0.749 . . . . 0.0 110.064 174.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -81.3 1.85 30.71 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.1 0.96 . . . . 0.0 112.17 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 9.8 mmpt? -95.97 -16.04 21.95 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.805 0.442 . . . . 0.0 111.177 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -70.54 122.64 87.19 Favored Pre-proline 0 N--CA 1.482 1.138 0 CA-C-O 119.023 -0.513 . . . . 0.0 109.965 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.22 -26.02 72.3 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.59 2.194 . . . . 0.0 112.374 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -86.12 -5.82 59.13 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.871 0.868 . . . . 0.0 112.137 -177.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.4 tp -57.87 114.39 2.29 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 120.969 0.414 . . . . 0.0 110.575 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -147.5 117.03 7.02 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 169.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.96 102.29 1.74 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -97.07 102.86 14.73 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' A' ' 69' ' ' ARG . 8.2 tt -74.59 115.61 14.34 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 171.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.504 ' H ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -101.45 -29.86 11.76 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.52 0.728 . . . . 0.0 110.695 -177.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.2 m -150.19 133.15 16.1 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.865 0.866 . . . . 0.0 110.008 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.656 HH12 ' HG2' ' A' ' 6' ' ' GLU . 52.5 ptt85 -139.56 139.69 36.91 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.139 0.576 . . . . 0.0 109.637 170.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.9 m -121.95 125.64 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.951 0.901 . . . . 0.0 109.455 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.51 HD11 ' HB ' ' A' ' 5' ' ' ILE . 14.0 tt -108.21 135.87 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 121.005 0.431 . . . . 0.0 110.713 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 p -142.68 96.24 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 124.778 1.231 . . . . 0.0 108.557 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.44 -124.69 22.41 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.616 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -88.25 7.51 31.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.17 0.588 . . . . 0.0 112.559 -175.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.16 142.86 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 122.989 0.516 . . . . 0.0 110.952 -175.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.13 141.88 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.796 0.839 . . . . 0.0 109.745 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.611 HD13 ' HB ' ' A' ' 98' ' ' ILE . 5.2 mm -99.25 105.88 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 168.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -99.34 105.43 17.41 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.498 0.719 . . . . 0.0 109.668 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -98.83 104.47 16.52 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -102.09 164.1 11.88 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.421 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.6 m -105.68 101.88 11.37 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 158.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.0 t -85.87 103.43 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.883 1.273 . . . . 0.0 110.028 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 48.3 m -71.12 127.16 31.64 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.624 0.77 . . . . 0.0 111.276 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -117.25 -161.37 0.81 Allowed 'General case' 0 C--O 1.247 0.931 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -131.65 103.82 6.59 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 172.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -108.37 134.96 20.03 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 123.861 0.864 . . . . 0.0 109.528 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.74 -10.98 24.41 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.426 2.751 . . . . 0.0 114.359 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -79.61 -28.31 40.98 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.94 0.496 . . . . 0.0 111.337 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.28 -115.63 0.49 Allowed Glycine 0 C--N 1.35 1.328 0 C-N-CA 121.497 -0.383 . . . . 0.0 112.873 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -70.02 -80.81 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.12 0.968 . . . . 0.0 111.437 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 116.15 26.45 3.22 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 116.437 -0.347 . . . . 0.0 113.221 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 9.3 pt-20 -89.0 114.54 25.73 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.416 0.627 . . . . 0.0 109.872 -172.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.657 HG12 ' HA ' ' A' ' 116' ' ' PRO . 33.6 m -111.0 126.15 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.183 0.593 . . . . 0.0 109.637 -173.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.19 109.28 13.37 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.1 t -113.06 131.8 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.321 0.648 . . . . 0.0 110.248 -172.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.1 99.87 12.38 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.756 0.822 . . . . 0.0 109.323 173.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 56.9 m -94.47 108.2 20.14 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.433 1.093 . . . . 0.0 108.436 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.611 ' HB ' HD13 ' A' ' 77' ' ' ILE . 5.1 tt -106.37 115.21 47.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.937 0.895 . . . . 0.0 110.205 -174.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -112.47 133.79 54.35 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.33 0.652 . . . . 0.0 110.025 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -106.96 112.88 26.04 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.766 0.826 . . . . 0.0 108.803 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 50.1 t -85.18 140.12 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.137 1.375 . . . . 0.0 110.332 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.465 ' HG3' HD22 ' A' ' 103' ' ' ASN . 9.7 tp10 -141.31 105.64 4.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.287 1.035 . . . . 0.0 108.866 -173.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.465 HD22 ' HG3' ' A' ' 102' ' ' GLU . 33.4 m-80 62.4 31.67 17.13 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.651 1.18 . . . . 0.0 112.11 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.86 -7.58 67.69 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.78 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -131.72 133.37 44.75 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.725 0.81 . . . . 0.0 109.653 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 67.1 mt -67.57 112.11 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.507 0.723 . . . . 0.0 110.191 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.25 -10.98 26.67 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -150.28 131.13 14.18 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.58 139.78 31.48 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.629 0.772 . . . . 0.0 109.232 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.421 ' HB2' HG23 ' A' ' 98' ' ' ILE . 3.1 m-90 -138.29 156.99 47.12 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -143.5 147.09 33.98 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.028 0.442 . . . . 0.0 110.149 171.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -129.02 122.51 30.19 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.245 1.018 . . . . 0.0 108.363 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.7 mt -87.69 130.38 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.35 -129.87 0.56 Allowed Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.469 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -90.18 161.11 38.59 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.657 ' HA ' HG12 ' A' ' 93' ' ' VAL . 76.2 Cg_endo -83.96 114.79 1.98 Allowed 'Trans proline' 0 CA--C 1.551 1.357 0 C-N-CA 122.234 1.956 . . . . 0.0 112.136 167.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.426 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 34.6 mtm180 -107.0 148.42 28.71 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 121.852 0.834 . . . . 0.0 110.759 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.3 mm -128.65 147.09 33.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.486 1.34 0 C-N-CA 123.553 0.741 . . . . 0.0 112.488 -177.227 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.447 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 22.2 t -68.73 -45.78 70.61 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 123.963 0.905 . . . . 0.0 110.902 -175.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -60.63 -17.33 46.41 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.886 0.875 . . . . 0.0 112.909 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.445 HG23 ' HB ' ' A' ' 101' ' ' VAL . 28.1 mm -87.29 -34.6 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.239 0.616 . . . . 0.0 109.574 178.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.91 -17.78 32.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 118.652 -0.69 . . . . 0.0 112.053 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.2 mt -62.7 -50.36 78.32 Favored Pre-proline 0 N--CA 1.488 1.465 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.635 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.64 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 14.1 Cg_endo -57.25 -51.92 7.59 Favored 'Trans proline' 0 C--N 1.388 2.642 0 C-N-CA 122.089 1.86 . . . . 0.0 112.047 172.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.96 -31.31 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 C-N-CA 124.55 1.14 . . . . 0.0 112.733 -172.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.61 -47.86 44.42 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.82 0.848 . . . . 0.0 109.519 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.1 mmtt -70.62 -25.56 63.09 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.947 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -61.1 -46.77 89.26 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.654 0.597 . . . . 0.0 110.39 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.39 -50.45 71.56 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.144 0.903 . . . . 0.0 109.54 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -57.57 -45.78 84.77 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 124.656 1.222 . . . . 0.0 109.524 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -68.82 -26.62 65.26 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.932 -1.485 . . . . 0.0 112.161 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -73.39 -38.71 65.54 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.022 0.529 . . . . 0.0 109.667 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -91.08 -29.9 17.06 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.563 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.69 0.29 57.45 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.361 0.664 . . . . 0.0 111.989 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.9 mmt-85 65.96 24.26 11.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.523 1.129 . . . . 0.0 113.121 172.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 48.1 m-20 -87.97 95.26 10.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.954 0.406 . . . . 0.0 110.724 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.52 HG13 HG12 ' A' ' 54' ' ' ILE . 8.3 mm -64.05 -30.44 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.568 0.747 . . . . 0.0 111.314 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.87 -45.63 92.93 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.313 0.383 . . . . 0.0 111.116 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.82 -35.99 62.43 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.259 0.624 . . . . 0.0 110.711 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -71.73 -4.4 27.36 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.845 0.858 . . . . 0.0 111.052 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.754 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -120.95 -23.2 5.94 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 172.198 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.74 -35.79 75.28 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.672 0.789 . . . . 0.0 112.82 -173.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.64 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 97.2 m95 -89.89 -7.69 53.6 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.625 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 14.6 m95 -91.91 143.75 26.17 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.288 0.635 . . . . 0.0 110.049 -173.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.72 152.31 45.5 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.216 0.607 . . . . 0.0 110.066 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -68.82 -24.2 64.36 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 120.932 0.396 . . . . 0.0 110.689 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.59 19.32 16.01 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.727 1.211 . . . . 0.0 110.69 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.625 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 42.7 t -65.04 122.49 17.15 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 122.073 -0.392 . . . . 0.0 111.628 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -87.39 154.61 20.53 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.745 0.818 . . . . 0.0 109.331 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 48.2 t80 -145.06 114.28 7.03 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.416 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 17.3 m-85 -109.23 153.91 23.16 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.51 0.724 . . . . 0.0 110.288 176.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.406 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -112.84 151.28 30.58 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.066 173.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.617 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 84.7 t80 -57.64 128.84 80.47 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 123.656 0.782 . . . . 0.0 111.581 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.92 -50.32 0.19 OUTLIER 'Cis proline' 0 C--N 1.389 2.666 0 CA-C-N 120.464 1.201 . . . . 0.0 114.046 0.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.41 91.63 0.93 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.958 0.903 . . . . 0.0 108.757 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.3 m -136.7 107.84 6.78 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.5 103.97 1.8 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.271 0.628 . . . . 0.0 109.695 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.406 HD11 ' HB2' ' A' ' 36' ' ' ALA . 49.5 mt -80.63 -36.55 32.45 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.948 0.899 . . . . 0.0 110.71 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -140.09 121.18 14.72 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.154 0.582 . . . . 0.0 111.436 -171.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -107.62 40.01 2.68 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 123.401 0.524 . . . . 0.0 113.042 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.9 p30 165.64 164.67 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 126.023 1.729 . . . . 0.0 108.963 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.15 -37.86 88.73 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.777 0.831 . . . . 0.0 112.556 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.46 -43.26 99.18 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.294 0.638 . . . . 0.0 112.337 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -73.08 -30.0 63.35 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.711 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.435 HG21 ' CZ3' ' A' ' 28' ' ' TRP . 85.9 mt -66.58 -46.15 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.517 0.727 . . . . 0.0 109.871 173.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.754 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 36.8 ttt180 -56.28 -56.4 21.46 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.837 -176.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.444 ' HA ' HD12 ' A' ' 54' ' ' ILE . 29.4 m -63.48 -37.31 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 124.543 1.152 . . . . 0.0 113.147 -172.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -71.37 -34.51 70.5 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.028 0.442 . . . . 0.0 110.753 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -76.5 -26.96 55.84 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 118.965 -0.541 . . . . 0.0 111.2 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.52 HG12 HG13 ' A' ' 21' ' ' ILE . 85.6 mt -59.66 -47.82 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 172.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.03 -42.25 89.76 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.998 0.919 . . . . 0.0 111.179 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -66.44 -32.71 74.26 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.104 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -82.04 -13.31 57.53 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.259 0.624 . . . . 0.0 111.356 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 67.4 mmtt -73.13 -28.82 62.47 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.737 0.415 . . . . 0.0 110.486 170.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.53 115.38 21.56 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.987 0.915 . . . . 0.0 109.991 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.1 -22.76 18.96 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.578 2.185 . . . . 0.0 112.693 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.85 -12.09 59.48 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.786 0.834 . . . . 0.0 111.508 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.7 tp -60.02 117.17 4.77 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 123.515 0.509 . . . . 0.0 109.975 175.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -149.87 117.11 6.03 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.7 103.08 2.91 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -94.47 102.06 13.99 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 tt -82.83 125.39 31.27 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.49 ' H ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -116.57 -29.98 5.97 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.01 0.924 . . . . 0.0 111.077 178.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 92.2 m -144.96 133.59 22.12 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.428 0.691 . . . . 0.0 109.991 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.5 ' NH2' HG11 ' A' ' 76' ' ' VAL . 7.4 ptm180 -142.87 138.35 30.2 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.929 0.492 . . . . 0.0 110.429 171.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.466 HG22 ' HB ' ' A' ' 77' ' ' ILE . 15.0 m -128.67 158.35 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 124.517 1.127 . . . . 0.0 108.761 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -129.75 142.53 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-O 121.025 0.44 . . . . 0.0 110.085 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.483 HG13 HG13 ' A' ' 75' ' ' VAL . 2.2 p -137.1 95.85 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 124.509 1.124 . . . . 0.0 108.945 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.71 -120.14 8.73 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.024 -0.535 . . . . 0.0 113.154 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -97.47 15.0 24.46 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.108 0.563 . . . . 0.0 112.063 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.483 HG13 HG13 ' A' ' 72' ' ' VAL . 4.4 p -135.88 135.5 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.526 0.73 . . . . 0.0 110.255 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.5 HG11 ' NH2' ' A' ' 69' ' ' ARG . 5.1 t -114.05 141.92 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.354 0.662 . . . . 0.0 110.245 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.469 HD13 ' HB ' ' A' ' 98' ' ' ILE . 17.7 mm -99.67 114.73 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.929 1.292 . . . . 0.0 107.896 168.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -112.21 106.03 14.51 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -97.62 107.17 19.61 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -112.78 144.58 42.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.168 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.1 m -91.55 102.08 14.73 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 162.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.8 m -92.83 133.36 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.104 0.478 . . . . 0.0 110.791 -176.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 73.0 m -81.31 120.73 25.3 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.771 -177.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.617 HH21 HG11 ' A' ' 93' ' ' VAL . 72.9 mtm180 -118.84 -162.86 0.92 Allowed 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.693 1.197 . . . . 0.0 107.911 170.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -125.09 108.54 11.9 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 118.477 0.58 . . . . 0.0 110.994 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.411 ' CG ' ' HA2' ' A' ' 91' ' ' GLY . 11.7 m-30 -109.95 145.03 31.21 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 123.794 0.838 . . . . 0.0 109.824 176.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.94 -19.03 67.94 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 123.369 2.713 . . . . 0.0 114.164 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -79.57 -20.04 47.97 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.29 -111.36 0.46 Allowed Glycine 0 C--N 1.348 1.242 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.726 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -62.37 -82.32 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.957 0.903 . . . . 0.0 111.693 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.411 ' HA2' ' CG ' ' A' ' 86' ' ' PHE . . . 117.14 26.1 3.06 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.994 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -87.22 138.83 31.15 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.617 HG11 HH21 ' A' ' 84' ' ' ARG . 13.9 m -137.12 140.95 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 121.988 -0.445 . . . . 0.0 111.316 -173.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -75.6 112.79 12.31 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 174.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.408 HG22 HG12 ' A' ' 113' ' ' ILE . 61.3 t -129.24 133.6 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.079 0.952 . . . . 0.0 108.499 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.77 111.13 23.47 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.4 m -94.08 107.49 19.41 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' A' ' 110' ' ' TRP . 5.4 tt -112.87 107.94 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 124.35 1.06 . . . . 0.0 109.82 -169.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -109.93 127.91 55.05 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.815 0.846 . . . . 0.0 110.408 -174.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 33.6 tt0 -99.26 112.81 24.89 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 173.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.466 HG22 HG12 ' A' ' 106' ' ' ILE . 60.7 t -96.98 113.14 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.322 1.049 . . . . 0.0 109.492 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 35.0 tt0 -113.54 126.88 55.79 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.835 0.854 . . . . 0.0 108.94 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 63.09 33.67 14.39 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.262 1.025 . . . . 0.0 112.096 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.86 7.2 88.7 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.807 -0.633 . . . . 0.0 114.336 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -133.84 143.76 48.53 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.161 0.984 . . . . 0.0 108.852 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 8' ' ' PRO . 55.2 mt -67.95 102.7 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.407 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -84.06 -23.02 31.03 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.165 0.586 . . . . 0.0 111.02 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 79.5 mttt -149.28 146.47 27.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.01 0.924 . . . . 0.0 109.061 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -142.81 133.07 24.66 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.627 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.0 m-90 -135.68 159.49 41.48 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -142.78 145.6 33.42 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 169.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.617 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 14.4 ptmm? -126.86 123.52 37.48 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.408 HG12 HG22 ' A' ' 95' ' ' VAL . 95.1 mt -89.33 116.16 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.4 -71.8 1.03 Allowed Glycine 0 CA--C 1.523 0.561 0 CA-C-N 114.24 -1.345 . . . . 0.0 113.592 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -157.01 162.86 26.84 Favored Pre-proline 0 CA--C 1.548 0.904 0 CA-C-N 116.825 0.313 . . . . 0.0 110.723 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.584 ' HA ' HG12 ' A' ' 93' ' ' VAL . 92.7 Cg_endo -77.37 137.01 16.36 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.598 2.199 . . . . 0.0 113.596 171.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -129.26 153.56 47.67 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.438 1.095 . . . . 0.0 109.98 176.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.4 mm -138.98 151.51 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.487 1.388 0 C-N-CA 122.999 0.52 . . . . 0.0 111.259 178.456 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 . . . . . 0 CA--C 1.553 1.077 0 CA-C-O 121.021 0.439 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.4 m -71.8 -35.07 69.85 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.405 0.682 . . . . 0.0 112.693 -169.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -14.36 62.02 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.649 0.38 . . . . 0.0 111.718 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.486 ' HB ' HD11 ' A' ' 71' ' ' ILE . 27.2 mm -90.68 -28.45 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.866 0.867 . . . . 0.0 110.111 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.28 -32.08 71.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.676 0.79 . . . . 0.0 111.615 173.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.6 mt -61.94 -52.1 70.46 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-O 118.675 -0.678 . . . . 0.0 112.358 -175.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 23.0 Cg_endo -60.35 -51.1 5.8 Favored 'Trans proline' 0 C--N 1.396 3.063 0 C-N-CA 122.493 2.129 . . . . 0.0 113.739 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.5 m -67.81 -32.72 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 122.699 0.4 . . . . 0.0 112.025 -170.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -73.38 -50.68 20.61 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.255 0.622 . . . . 0.0 111.076 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -70.96 -30.64 66.98 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.558 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -69.6 -39.6 77.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.142 0.577 . . . . 0.0 109.477 177.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -58.87 -52.28 66.41 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.219 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.44 -29.57 64.28 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.824 0.702 . . . . 0.0 111.202 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 20' ' ' ASP . . . -79.47 -31.57 42.44 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.997 0.919 . . . . 0.0 111.881 176.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -62.94 -51.29 67.48 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.173 0.589 . . . . 0.0 111.271 -173.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -75.96 -20.94 57.52 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.691 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.9 1.23 54.57 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.515 0.726 . . . . 0.0 112.401 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 62.86 22.79 13.63 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.656 1.182 . . . . 0.0 111.936 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.433 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 5.8 t70 -89.86 131.74 35.63 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.433 ' HA ' ' HB3' ' A' ' 24' ' ' PHE . 14.9 mm -104.12 -27.46 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.292 0.637 . . . . 0.0 110.816 174.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.27 -48.36 81.78 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.85 0.46 . . . . 0.0 111.58 -176.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.46 -33.76 36.44 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.749 0.82 . . . . 0.0 110.637 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.433 ' HB3' ' HA ' ' A' ' 21' ' ' ILE . 49.8 t80 -59.87 -24.7 64.46 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.39 175.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 79.6 mmm -120.44 0.6 10.57 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.09 -41.16 77.86 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.367 0.603 . . . . 0.0 111.608 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 89.9 m95 -83.42 -0.02 48.15 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.654 -173.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.558 ' HE1' ' HG3' ' A' ' 12' ' ' GLN . 21.7 m95 -91.24 143.17 26.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.225 0.61 . . . . 0.0 110.352 -175.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.55 48.12 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.9 173.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.56 -28.64 70.01 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 120.84 0.353 . . . . 0.0 111.588 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -97.4 19.08 13.85 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.205 1.002 . . . . 0.0 110.973 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.476 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 48.6 t -62.62 123.52 18.58 Favored 'General case' 0 C--N 1.357 0.909 0 O-C-N 121.913 -0.492 . . . . 0.0 111.987 -174.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -89.72 151.4 21.86 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.294 1.038 . . . . 0.0 109.31 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -139.34 119.25 13.36 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.419 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 61.9 m-85 -122.34 154.8 37.16 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.13 0.972 . . . . 0.0 111.197 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.409 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -128.75 160.12 33.53 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.769 1.228 . . . . 0.0 109.625 177.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -63.18 139.71 97.58 Favored Pre-proline 0 CA--C 1.561 1.385 0 C-N-CA 124.114 0.966 . . . . 0.0 111.538 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.89 -44.59 0.51 Allowed 'Cis proline' 0 C--N 1.381 2.287 0 CA-C-N 120.152 1.09 . . . . 0.0 113.183 -9.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.53 79.58 0.5 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.132 0.573 . . . . 0.0 110.382 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.9 m -123.44 125.22 44.55 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.688 0.795 . . . . 0.0 109.588 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 tt -84.33 110.95 18.99 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.409 HD21 ' HB2' ' A' ' 36' ' ' ALA . 1.4 mm? -85.55 -51.1 6.72 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.27 0.628 . . . . 0.0 109.363 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -140.13 120.73 14.23 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.219 -168.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.28 37.42 3.83 Favored Glycine 0 N--CA 1.477 1.372 0 O-C-N 123.135 0.272 . . . . 0.0 113.539 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.5 p30 175.45 155.22 0.17 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.02 1.728 . . . . 0.0 108.722 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.12 -25.89 68.3 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.806 0.843 . . . . 0.0 113.162 -172.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.93 -47.25 81.26 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.928 0.491 . . . . 0.0 110.78 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.492 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.7 mt-10 -70.83 -37.97 73.22 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.771 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.5 mt -61.68 -43.25 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.262 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.491 ' O ' HG13 ' A' ' 54' ' ' ILE . 69.4 ttt-85 -60.17 -56.25 23.94 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.272 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.8 t -53.8 -49.06 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 124.546 1.154 . . . . 0.0 111.98 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -61.14 -36.26 79.29 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.183 0.593 . . . . 0.0 111.383 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -75.97 -32.7 59.62 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.748 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 50' ' ' ARG . 64.4 mt -64.64 -42.67 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -62.98 -31.25 72.32 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.096 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -85.33 -11.18 55.23 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.324 0.65 . . . . 0.0 111.525 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.472 ' HA ' HD22 ' A' ' 62' ' ' LEU . 3.3 m-85 -89.99 -0.7 57.73 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.471 0.709 . . . . 0.0 110.876 172.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.445 ' HE2' HG22 ' A' ' 54' ' ' ILE . 72.6 mmtt -82.56 -4.13 57.12 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.28 0.632 . . . . 0.0 112.091 173.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.724 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 22.5 mm-40 -67.66 120.13 71.13 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -65.62 -24.33 55.74 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.058 1.838 . . . . 0.0 112.693 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -111.54 21.76 15.81 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.596 0.758 . . . . 0.0 111.611 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.724 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 39.4 tp -67.2 111.62 4.04 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 120.795 0.331 . . . . 0.0 110.235 175.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -138.11 136.41 36.7 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.514 0.726 . . . . 0.0 109.301 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.32 128.06 8.93 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.329 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -127.74 99.91 5.74 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 tt -81.35 134.75 35.62 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-O 121.452 0.644 . . . . 0.0 110.354 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mt -107.05 -50.7 3.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.161 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.2 m -152.48 125.89 8.76 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.243 -1.799 . . . . 0.0 109.136 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -118.18 132.92 56.29 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 167.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.3 m -118.8 122.52 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.006 0.923 . . . . 0.0 109.285 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.486 HD11 ' HB ' ' A' ' 5' ' ' ILE . 17.4 tt -105.74 136.77 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 122.782 0.433 . . . . 0.0 110.796 -175.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.426 HG13 HG13 ' A' ' 75' ' ' VAL . 2.1 p -146.38 112.87 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.419 1.087 . . . . 0.0 109.488 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.83 -104.73 1.06 Allowed Glycine 0 C--N 1.346 1.098 0 CA-C-N 116.384 -0.371 . . . . 0.0 112.743 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.483 ' HA ' HG13 ' A' ' 5' ' ' ILE . 4.0 p-10 -122.55 15.61 10.34 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.096 0.559 . . . . 0.0 111.074 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.426 HG13 HG13 ' A' ' 72' ' ' VAL . 3.0 p -135.37 132.64 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.766 0.826 . . . . 0.0 110.173 -173.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.03 141.22 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.65 0.78 . . . . 0.0 110.239 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.567 HG12 ' HB ' ' A' ' 98' ' ' ILE . 3.1 mt -100.58 103.93 15.49 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 165.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -93.38 106.22 18.21 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -100.09 109.35 21.64 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.691 -176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.15 171.14 7.61 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.103 0.961 . . . . 0.0 111.057 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.0 m -109.13 102.23 11.21 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 161.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -81.98 108.91 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.659 1.184 . . . . 0.0 110.029 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 75.7 m -68.59 119.02 12.36 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 122.952 0.501 . . . . 0.0 110.502 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -117.06 -169.13 1.59 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.396 1.078 . . . . 0.0 109.787 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -118.34 102.91 9.31 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.63 0.772 . . . . 0.0 110.448 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.404 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 21.3 m-30 -112.07 134.07 21.52 Favored Pre-proline 0 N--CA 1.474 0.728 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 171.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.74 -12.4 32.84 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.827 2.351 . . . . 0.0 113.409 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -83.1 -10.86 58.45 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.657 0.383 . . . . 0.0 111.902 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.86 -125.75 1.09 Allowed Glycine 0 C--N 1.349 1.269 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.691 172.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -71.01 -80.1 0.06 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.84 0.856 . . . . 0.0 110.704 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.404 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 120.33 27.15 2.06 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 113.455 0.142 . . . . 0.0 113.455 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 1.5 pm0 -88.95 112.28 23.14 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.762 0.791 . . . . 0.0 109.501 -171.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 116' ' ' PRO . 30.2 m -106.43 141.12 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.594 0.757 . . . . 0.0 110.313 -172.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -83.62 124.1 30.47 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.0 127.65 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.051 0.541 . . . . 0.0 109.649 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.47 102.59 14.41 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.627 0.771 . . . . 0.0 109.235 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.4 m -98.31 118.28 34.6 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.567 ' HB ' HG12 ' A' ' 77' ' ' ILE . 11.3 tt -111.75 105.77 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 C-N-CA 123.94 0.896 . . . . 0.0 110.81 -177.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -99.29 129.07 45.48 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.098 0.959 . . . . 0.0 110.457 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 34.8 tt0 -97.72 114.44 26.44 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.237 0.541 . . . . 0.0 109.68 170.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.474 HG22 HG12 ' A' ' 106' ' ' ILE . 61.7 t -99.86 111.65 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 124.562 1.145 . . . . 0.0 110.133 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 34.5 tt0 -112.18 132.97 54.59 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.253 1.021 . . . . 0.0 109.942 174.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 63.46 30.34 15.33 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.604 1.161 . . . . 0.0 111.46 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.99 14.0 75.98 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.051 -0.522 . . . . 0.0 113.458 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -129.79 134.66 47.71 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.803 1.241 . . . . 0.0 108.96 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.474 HG12 HG22 ' A' ' 101' ' ' VAL . 70.6 mt -63.95 99.39 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -82.7 -24.31 33.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.423 0.689 . . . . 0.0 110.912 -177.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 74.2 mttt -147.88 148.47 30.88 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.378 1.071 . . . . 0.0 108.216 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.78 132.19 20.79 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 172.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.545 ' HB2' HG23 ' A' ' 98' ' ' ILE . 1.5 m-90 -128.62 146.76 50.76 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -177.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -142.47 146.88 35.23 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.381 0.991 . . . . 0.0 110.97 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -129.91 122.14 28.02 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.073 0.949 . . . . 0.0 108.663 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.35 128.96 41.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.47 -121.24 0.55 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.099 -0.955 . . . . 0.0 113.448 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -97.91 141.09 22.42 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.22 1.008 . . . . 0.0 110.459 -172.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.621 ' HA ' HG12 ' A' ' 93' ' ' VAL . 55.9 Cg_endo -71.51 115.86 4.46 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.006 2.471 . . . . 0.0 110.492 170.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -121.22 153.87 37.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.273 0.629 . . . . 0.0 111.377 -174.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.5 mm -129.77 132.84 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.806 1.242 . . . . 0.0 108.966 174.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.6 t . . . . . 0 N--CA 1.492 1.629 0 C-N-CA 123.999 0.92 . . . . 0.0 112.197 179.439 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.5 ' HB2' HD11 ' A' ' 71' ' ' ILE . 16.3 m120 . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 121.326 0.584 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.439 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 66.6 m -69.36 -41.02 77.13 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.8 0.84 . . . . 0.0 111.736 -176.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -11.73 58.23 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.04 0.536 . . . . 0.0 112.208 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.456 HG22 HG23 ' A' ' 76' ' ' VAL . 37.8 mm -91.09 -33.11 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.57 0.748 . . . . 0.0 109.918 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -79.9 -17.59 52.72 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 119.099 -0.477 . . . . 0.0 112.225 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 3' ' ' SER . 93.5 mt -62.74 -52.1 67.0 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.963 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 24.4 Cg_endo -60.76 -47.37 13.48 Favored 'Trans proline' 0 C--N 1.395 2.988 0 C-N-CA 121.797 1.664 . . . . 0.0 111.887 173.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.445 ' HA ' HE21 ' A' ' 12' ' ' GLN . 73.5 t -59.02 -43.73 89.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 124.226 1.011 . . . . 0.0 112.285 -173.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.697 ' HG2' HH12 ' A' ' 69' ' ' ARG . 6.7 mm100 -68.47 -49.36 60.33 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.082 0.553 . . . . 0.0 111.767 175.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -63.81 -27.71 69.37 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -175.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.445 HE21 ' HA ' ' A' ' 9' ' ' VAL . 46.7 mt-30 -69.0 -47.32 65.82 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 123.489 0.493 . . . . 0.0 109.768 174.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' A' ' 66' ' ' LEU . 2.7 tt -57.1 -54.16 49.92 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.782 1.301 . . . . 0.0 109.442 -177.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.443 ' HA ' HD21 ' A' ' 17' ' ' ASN . 16.0 mm-40 -61.17 -37.8 84.19 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.859 -176.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -71.07 -27.4 63.6 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.55 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.428 ' CZ ' HD11 ' A' ' 62' ' ' LEU . 84.8 t80 -73.08 -38.57 66.37 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.006 0.922 . . . . 0.0 110.522 -175.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.443 HD21 ' HA ' ' A' ' 14' ' ' GLU . 10.0 p30 -88.42 -28.3 21.0 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.983 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.84 0.84 57.47 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.366 0.666 . . . . 0.0 112.265 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 64.7 mmt-85 71.33 12.6 6.68 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.058 1.343 . . . . 0.0 113.619 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.536 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 10.2 m-20 -74.37 95.12 2.64 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.824 0.449 . . . . 0.0 110.917 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.2 mm -66.22 -26.19 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 122.942 0.497 . . . . 0.0 110.574 169.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -60.14 -48.78 80.27 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.164 0.586 . . . . 0.0 111.142 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.62 -30.31 36.76 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.18 0.592 . . . . 0.0 110.767 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -72.56 -6.78 46.39 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.224 0.61 . . . . 0.0 110.967 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.744 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -119.26 -27.25 5.68 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 173.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.94 -30.09 70.01 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -172.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.581 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.3 m95 -95.37 -0.12 52.95 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.355 0.662 . . . . 0.0 112.575 -175.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.59 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 13.3 m95 -97.55 148.66 23.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.435 0.694 . . . . 0.0 109.219 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.68 154.74 29.88 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.42 0.688 . . . . 0.0 109.402 172.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -69.84 -23.66 63.33 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.81 0.444 . . . . 0.0 111.468 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -95.59 17.99 13.73 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.079 0.952 . . . . 0.0 111.073 177.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.59 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 45.4 t -64.21 123.24 18.58 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.006 0.431 . . . . 0.0 111.95 -174.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.41 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . 35.4 mm-40 -96.17 103.74 15.66 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.06 0.944 . . . . 0.0 109.743 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.535 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 55.2 t80 -96.37 111.86 23.8 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.001 0.92 . . . . 0.0 110.276 -177.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.41 ' HE1' ' HB3' ' A' ' 33' ' ' GLN . 80.5 m-85 -116.05 155.16 28.62 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.719 0.808 . . . . 0.0 110.498 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.91 160.67 17.19 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.691 1.196 . . . . 0.0 108.332 167.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -52.04 133.19 40.14 Favored Pre-proline 0 CA--C 1.568 1.635 0 C-N-CA 123.599 0.759 . . . . 0.0 112.431 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.48 -40.95 1.02 Allowed 'Cis proline' 0 C--N 1.384 2.398 0 C-N-CA 124.759 -0.934 . . . . 0.0 112.963 -7.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.83 56.86 0.2 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.631 0.772 . . . . 0.0 109.861 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.2 m -92.9 114.4 26.95 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.134 0.973 . . . . 0.0 109.484 176.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.7 tp -78.16 103.82 8.34 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.447 0.567 . . . . 0.0 109.595 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.04 -37.89 33.06 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -146.38 117.17 7.65 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.14 -172.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.24 45.23 1.39 Allowed Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.989 -0.339 . . . . 0.0 112.322 -176.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 161.35 161.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 126.233 1.813 . . . . 0.0 109.066 -171.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.463 ' HA ' HD12 ' A' ' 49' ' ' ILE . . . -64.75 -35.52 81.34 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.857 0.863 . . . . 0.0 113.049 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.65 -46.91 87.61 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.041 0.536 . . . . 0.0 112.092 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.407 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.6 mt-10 -72.45 -29.41 63.65 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.823 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.463 HD12 ' HA ' ' A' ' 46' ' ' ALA . 94.6 mt -63.97 -49.19 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.788 0.835 . . . . 0.0 110.264 175.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.744 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 77.4 ttt180 -55.76 -56.63 18.21 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.152 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.465 ' HA ' HD12 ' A' ' 54' ' ' ILE . 26.8 m -65.21 -35.99 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 124.433 1.083 . . . . 0.0 112.698 -173.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -69.06 -34.95 75.98 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.195 0.598 . . . . 0.0 110.423 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -78.42 -28.49 46.79 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 118.455 -0.784 . . . . 0.0 111.785 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 51' ' ' VAL . 94.2 mt -57.34 -41.19 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-N 118.593 0.633 . . . . 0.0 109.514 173.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.16 -37.72 86.29 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.349 1.06 . . . . 0.0 111.735 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -79.43 -25.98 41.92 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.387 0.675 . . . . 0.0 111.014 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -79.8 -15.97 56.41 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.818 0.447 . . . . 0.0 110.649 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -62.61 -28.47 69.91 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.941 0.497 . . . . 0.0 110.823 168.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -66.26 118.61 54.75 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.617 0.767 . . . . 0.0 110.581 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.29 -29.2 17.41 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.541 2.161 . . . . 0.0 111.704 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.14 -18.02 63.21 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.322 1.049 . . . . 0.0 111.504 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 16' ' ' TYR . 46.1 tp -59.17 123.57 17.11 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.595 0.758 . . . . 0.0 111.511 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.477 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 69.9 t80 -152.21 125.49 8.72 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.49 109.22 3.39 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -118.4 110.93 18.05 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.316 0.647 . . . . 0.0 109.731 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HB2' HD11 ' A' ' 13' ' ' LEU . 17.4 tp -76.91 146.53 37.55 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.428 0.455 . . . . 0.0 111.155 -177.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mt -112.69 -51.45 2.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.815 0.846 . . . . 0.0 109.346 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.7 m -157.45 153.11 26.61 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.758 -1.564 . . . . 0.0 108.922 -170.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.697 HH12 ' HG2' ' A' ' 10' ' ' GLN . 4.3 ptp180 -142.27 139.2 31.84 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.921 0.488 . . . . 0.0 109.901 169.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.49 HG22 ' HB ' ' A' ' 77' ' ' ILE . 17.8 m -112.42 111.28 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 122.159 0.98 . . . . 0.0 108.592 173.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.5 HD11 ' HB2' ' A' ' 2' ' ' ASN . 11.7 tt -99.93 139.13 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.038 -177.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 75' ' ' VAL . 2.5 p -145.9 99.45 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.801 1.24 . . . . 0.0 108.666 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.12 -120.82 21.2 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.986 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -86.44 2.44 47.72 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.496 0.718 . . . . 0.0 112.777 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -129.19 132.46 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.309 0.643 . . . . 0.0 110.716 -173.055 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.456 HG23 HG22 ' A' ' 5' ' ' ILE . 59.2 t -116.0 138.85 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.925 0.89 . . . . 0.0 109.074 174.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.653 HD13 ' HB ' ' A' ' 98' ' ' ILE . 9.6 mm -97.11 103.15 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 164.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -95.68 104.19 16.1 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -177.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -99.92 107.96 20.08 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.581 0.705 . . . . 0.0 109.846 -173.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.32 168.5 12.41 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.132 -177.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 m -117.47 104.27 10.92 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 168.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.0 m -91.22 125.17 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.274 0.559 . . . . 0.0 111.463 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 63' ' ' TYR . 34.9 m -76.86 133.66 39.25 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.073 176.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -133.12 -160.72 1.07 Allowed 'General case' 0 C--O 1.247 0.944 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -128.89 105.52 8.28 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.446 0.566 . . . . 0.0 110.193 174.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -106.32 135.03 19.53 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.88 -21.12 71.63 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.921 2.414 . . . . 0.0 113.446 -174.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -74.64 -25.81 59.46 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.01 0.524 . . . . 0.0 111.693 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.14 -120.08 0.6 Allowed Glycine 0 C--N 1.352 1.463 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.709 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -72.53 -81.0 0.06 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.605 0.762 . . . . 0.0 111.3 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.19 27.24 2.07 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 113.722 0.249 . . . . 0.0 113.722 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -90.7 133.39 35.18 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.696 HG12 ' HA ' ' A' ' 116' ' ' PRO . 35.9 m -130.66 134.62 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 122.464 0.306 . . . . 0.0 110.79 -172.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.23 117.0 17.47 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.596 HG22 HG12 ' A' ' 113' ' ' ILE . 16.7 t -123.74 158.88 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.649 1.18 . . . . 0.0 108.768 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -118.16 99.93 7.19 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 169.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 93.5 m -95.05 107.52 19.57 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.653 ' HB ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -96.17 138.12 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.988 0.915 . . . . 0.0 109.412 -177.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -127.42 119.98 27.38 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.619 0.768 . . . . 0.0 108.993 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 43.2 tt0 -97.14 112.48 24.25 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 48.7 t -95.5 139.54 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.166 1.386 . . . . 0.0 109.778 -175.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.508 ' HG3' HD22 ' A' ' 103' ' ' ASN . 8.9 tp10 -129.79 100.44 5.49 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.553 1.141 . . . . 0.0 108.416 -175.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.508 HD22 ' HG3' ' A' ' 102' ' ' GLU . 24.7 m-80 59.79 32.7 21.48 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.82 1.248 . . . . 0.0 112.117 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.24 -7.62 54.57 Favored Glycine 0 N--CA 1.475 1.244 0 N-CA-C 114.317 0.487 . . . . 0.0 114.317 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.9 mmt-85 -127.53 133.24 49.82 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.446 0.623 . . . . 0.0 109.821 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 8' ' ' PRO . 68.2 mt -70.02 106.27 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.189 0.996 . . . . 0.0 110.447 -173.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -82.69 -18.88 39.37 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.981 0.512 . . . . 0.0 111.671 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 75.1 mttt -151.99 134.14 15.09 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -139.52 129.02 24.31 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 172.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.42 ' CE3' HD12 ' A' ' 98' ' ' ILE . 1.5 m0 -130.52 159.06 38.23 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -176.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -142.79 146.38 34.18 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -137.29 127.41 26.08 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.596 HG12 HG22 ' A' ' 95' ' ' VAL . 89.3 mt -88.75 125.75 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.55 -60.53 8.6 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 114.869 -1.06 . . . . 0.0 113.09 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -160.56 168.32 12.05 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.457 0.703 . . . . 0.0 109.819 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.696 ' HA ' HG12 ' A' ' 93' ' ' VAL . 65.7 Cg_endo -85.76 130.98 3.79 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.718 2.279 . . . . 0.0 112.188 163.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -127.53 157.96 38.71 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.916 0.487 . . . . 0.0 110.693 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.4 mm -133.67 127.37 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.1 t . . . . . 0 N--CA 1.491 1.62 0 C-N-CA 123.876 0.87 . . . . 0.0 111.094 178.723 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.61 ' HB3' HD13 ' A' ' 71' ' ' ILE . 81.8 m-20 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.469 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 23.4 m -66.47 -40.71 89.49 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.76 0.824 . . . . 0.0 111.261 -174.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -14.23 62.85 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 122.98 0.512 . . . . 0.0 111.697 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.501 HG22 HG23 ' A' ' 76' ' ' VAL . 22.8 mm -95.08 -29.49 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.811 0.844 . . . . 0.0 109.832 175.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -84.25 -20.94 31.38 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.077 0.951 . . . . 0.0 112.167 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 3' ' ' SER . 68.4 mt -67.23 -48.99 46.3 Favored Pre-proline 0 N--CA 1.486 1.338 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.092 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 10.8 Cg_endo -54.47 -52.9 7.12 Favored 'Trans proline' 0 C--N 1.391 2.771 0 C-N-CA 121.708 1.605 . . . . 0.0 111.291 172.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 76' ' ' VAL . 83.8 t -57.98 -43.2 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.323 1.049 . . . . 0.0 112.81 -176.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -64.98 -54.93 22.72 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.352 0.661 . . . . 0.0 110.201 -176.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -71.91 -35.14 69.61 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.873 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.483 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 1.0 OUTLIER -72.73 -30.42 64.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.76 0.824 . . . . 0.0 110.946 -176.433 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.515 HD22 HD13 ' A' ' 66' ' ' LEU . 59.4 tp -62.36 -52.13 64.84 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.18 0.592 . . . . 0.0 109.657 173.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 14.7 mm-40 -53.34 -45.81 69.24 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.05 175.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -64.92 -30.26 71.25 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.349 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -69.02 -46.38 68.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.139 0.575 . . . . 0.0 110.578 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -84.24 -24.18 30.11 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.956 0.502 . . . . 0.0 111.525 -177.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.09 2.06 55.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.259 0.624 . . . . 0.0 112.141 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.7 mmt-85 68.53 15.02 9.15 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.894 1.278 . . . . 0.0 112.948 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.46 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 10.0 m-20 -77.13 96.53 4.5 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.868 0.467 . . . . 0.0 110.738 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.8 mm -64.34 -33.55 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.553 0.741 . . . . 0.0 111.122 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.13 -48.62 79.65 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.144 0.578 . . . . 0.0 111.664 -175.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.73 -29.8 40.68 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.197 0.599 . . . . 0.0 110.737 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -69.29 -13.05 62.18 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.817 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.627 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 3.8 mmt -116.6 -15.61 10.81 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.61 0.764 . . . . 0.0 112.344 175.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.04 99.79 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.639 0.776 . . . . 0.0 112.295 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.598 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 86.3 m95 -92.95 0.97 57.52 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.379 -172.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.483 ' HE1' ' HG3' ' A' ' 12' ' ' GLN . 17.8 m95 -96.67 148.8 22.49 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.56 0.744 . . . . 0.0 109.992 -177.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.9 149.41 39.48 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.78 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.27 -20.75 64.81 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.462 0.305 . . . . 0.0 111.755 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -104.86 18.71 21.83 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.819 0.847 . . . . 0.0 111.799 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 43.0 t -62.6 127.08 29.62 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -172.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.552 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 57.7 mm-40 -96.16 104.57 16.53 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.839 0.856 . . . . 0.0 109.922 -176.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -98.18 115.33 28.1 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 124.463 1.105 . . . . 0.0 109.938 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.467 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 80.7 m-85 -114.62 154.63 28.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.954 0.902 . . . . 0.0 110.936 177.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.21 155.92 19.4 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.791 167.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.532 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 71.6 t80 -62.0 133.24 93.91 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 123.275 0.63 . . . . 0.0 110.978 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.54 -45.26 0.43 Allowed 'Cis proline' 0 C--N 1.383 2.36 0 CA-C-N 120.235 1.12 . . . . 0.0 113.95 -4.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.76 67.33 0.44 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.35 0.595 . . . . 0.0 110.285 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 33.9 m -105.98 115.77 30.79 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.1 tp -75.26 103.87 5.6 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.79 -36.48 50.32 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.473 0.709 . . . . 0.0 109.542 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -157.74 122.27 4.3 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.4 -176.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.75 26.0 24.09 Favored Glycine 0 N--CA 1.477 1.383 0 O-C-N 123.224 0.328 . . . . 0.0 113.897 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.0 p30 178.93 156.73 0.49 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.164 1.385 . . . . 0.0 109.628 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.02 -34.01 71.39 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.23 1.012 . . . . 0.0 113.143 -172.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.57 -44.27 97.34 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.783 0.433 . . . . 0.0 111.148 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 38.1 mt-10 -75.67 -30.06 59.28 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.661 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.42 ' HB ' ' HE1' ' A' ' 25' ' ' MET . 79.8 mt -63.33 -40.82 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 123.134 0.574 . . . . 0.0 109.492 176.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.627 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 39.8 ttt180 -55.6 -56.1 24.25 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.41 175.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.06 -43.97 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 124.487 1.117 . . . . 0.0 111.183 -173.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.468 ' HA ' ' HE ' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -60.65 -42.6 97.3 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.844 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -78.97 -26.8 43.45 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-O 118.452 -0.785 . . . . 0.0 112.347 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.425 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 66.2 mt -57.34 -43.38 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.113 0.869 . . . . 0.0 108.971 173.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -62.32 -34.7 77.13 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.097 0.959 . . . . 0.0 111.368 177.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -77.71 -25.14 49.14 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 123.413 0.685 . . . . 0.0 111.036 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -84.12 -14.25 50.82 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.36 0.664 . . . . 0.0 110.491 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 10.4 mmpt? -69.14 -21.15 64.03 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.226 0.61 . . . . 0.0 110.583 171.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.84 114.27 12.94 Favored Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 124.152 0.981 . . . . 0.0 109.739 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.73 -22.1 24.32 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.483 2.122 . . . . 0.0 111.953 177.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.57 6.9 47.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.215 1.006 . . . . 0.0 111.634 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 tp -66.97 112.29 4.26 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-O 120.978 0.418 . . . . 0.0 109.938 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -144.2 115.89 8.2 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.29 100.74 2.13 Favored Glycine 0 C--N 1.342 0.861 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 174.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -88.0 101.5 13.83 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.515 HD13 HD22 ' A' ' 13' ' ' LEU . 8.5 tt -75.32 115.95 15.52 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.508 ' H ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -105.34 -33.46 8.18 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.914 -175.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.426 ' N ' HD22 ' A' ' 67' ' ' LEU . 52.0 m -139.78 138.52 35.93 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.302 0.641 . . . . 0.0 109.796 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -142.91 133.81 25.52 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.759 0.823 . . . . 0.0 109.556 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 77' ' ' ILE . 20.1 m -126.63 155.7 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.253 1.021 . . . . 0.0 108.658 173.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.61 HD13 ' HB3' ' A' ' 2' ' ' ASN . 15.1 tt -137.75 140.32 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.107 0.48 . . . . 0.0 111.081 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 p -144.48 107.24 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 125.144 1.377 . . . . 0.0 108.443 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.55 -119.25 14.7 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.839 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 17.0 p-10 -99.72 18.77 17.33 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.039 0.536 . . . . 0.0 111.407 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.2 t -126.73 136.75 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.45 1.1 . . . . 0.0 110.097 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.501 HG23 HG22 ' A' ' 5' ' ' ILE . 62.3 t -123.7 137.3 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.437 0.695 . . . . 0.0 109.646 173.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.536 ' HB ' HG22 ' A' ' 70' ' ' VAL . 7.8 mm -98.01 103.75 15.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 165.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -101.18 105.39 16.52 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.503 ' HE1' ' HB2' ' A' ' 94' ' ' ASP . 40.5 t-80 -99.79 113.71 26.4 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.0 -176.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.97 154.14 45.92 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.894 1.277 . . . . 0.0 110.564 -176.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.415 HG22 ' HB2' ' A' ' 92' ' ' GLU . 39.0 m -100.46 111.69 23.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.699 0.799 . . . . 0.0 109.556 172.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.99 115.54 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.503 1.121 . . . . 0.0 110.038 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.8 m -77.81 121.52 24.19 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 122.813 0.445 . . . . 0.0 110.695 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -122.9 -177.05 3.55 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.395 1.078 . . . . 0.0 108.289 172.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -115.73 103.68 10.92 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.929 0.491 . . . . 0.0 110.112 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -109.48 138.62 20.61 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 123.539 0.736 . . . . 0.0 109.133 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.65 -17.66 60.9 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.306 2.671 . . . . 0.0 114.274 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -82.87 -10.89 58.61 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 122.861 0.465 . . . . 0.0 112.138 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.48 -123.84 1.06 Allowed Glycine 0 C--N 1.346 1.123 0 CA-C-O 119.852 -0.415 . . . . 0.0 112.517 171.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -66.66 -76.63 0.08 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.9 0.88 . . . . 0.0 110.505 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.23 27.06 4.07 Favored Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.699 -0.228 . . . . 0.0 113.085 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.415 ' HB2' HG22 ' A' ' 81' ' ' THR . 9.8 pt-20 -91.12 115.96 28.43 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -175.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.645 HG12 ' HA ' ' A' ' 116' ' ' PRO . 11.5 m -104.07 134.48 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -175.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.503 ' HB2' ' HE1' ' A' ' 79' ' ' HIS . 2.4 p-10 -81.74 143.85 31.54 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.588 HG22 HG12 ' A' ' 113' ' ' ILE . 39.5 t -141.45 143.63 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -105.93 107.5 18.53 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 164.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 5.9 t -94.19 138.07 32.65 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.464 ' HB ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -131.17 121.31 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.586 0.754 . . . . 0.0 109.625 -175.6 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -108.9 139.06 44.26 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.228 0.611 . . . . 0.0 109.647 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -104.51 111.22 23.81 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 165.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.452 HG22 HG12 ' A' ' 106' ' ' ILE . 61.7 t -96.13 110.67 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.351 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 35.3 tt0 -111.04 128.45 55.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.679 0.792 . . . . 0.0 109.155 176.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 62.83 30.44 16.63 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.89 0.876 . . . . 0.0 111.661 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.37 9.9 86.63 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.898 -0.592 . . . . 0.0 113.76 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 63.5 mmt-85 -129.03 135.14 48.53 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.158 0.983 . . . . 0.0 109.211 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.452 HG12 HG22 ' A' ' 101' ' ' VAL . 79.2 mt -63.55 100.7 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -76.59 -31.98 57.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.49 -173.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.552 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 98.7 mttt -153.85 153.8 32.77 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.628 1.171 . . . . 0.0 108.566 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.79 135.31 20.77 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.467 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 5.4 m-90 -134.25 153.92 51.58 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -142.61 147.3 35.6 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 118.646 0.657 . . . . 0.0 110.605 173.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 17.6 ptpt -131.74 123.87 28.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.327 1.051 . . . . 0.0 109.227 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.588 HG12 HG22 ' A' ' 95' ' ' VAL . 96.9 mt -89.13 127.39 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -176.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.36 -81.12 0.09 OUTLIER Glycine 0 CA--C 1.532 1.148 0 O-C-N 123.957 0.786 . . . . 0.0 112.866 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.435 ' HB2' ' HD2' ' A' ' 116' ' ' PRO . 0.4 OUTLIER -160.18 171.58 7.02 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.398 0.679 . . . . 0.0 109.312 167.156 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.645 ' HA ' HG12 ' A' ' 93' ' ' VAL . 36.3 Cg_endo -63.49 131.43 31.75 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.037 1.825 . . . . 0.0 112.738 167.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -118.55 139.55 51.29 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.336 0.655 . . . . 0.0 109.939 173.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.8 mm -122.04 135.07 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.479 1.005 0 O-C-N 123.539 0.524 . . . . 0.0 110.673 -177.092 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.467 ' HB2' HD11 ' A' ' 71' ' ' ILE . 14.0 m120 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.53 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 15.0 m -57.34 -49.51 75.91 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.223 -174.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -57.16 -17.57 11.6 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.997 0.919 . . . . 0.0 113.125 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.433 HG13 ' HA ' ' A' ' 74' ' ' ASN . 22.8 mm -96.13 -34.4 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.953 0.901 . . . . 0.0 110.231 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -83.74 -24.85 30.97 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.661 0.784 . . . . 0.0 112.421 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 3' ' ' SER . 54.8 mt -66.58 -53.37 29.63 Favored Pre-proline 0 CA--C 1.561 1.388 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.291 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.632 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 9.5 Cg_endo -52.64 -50.63 13.4 Favored 'Trans proline' 0 C--N 1.399 3.214 0 C-N-CA 122.545 2.164 . . . . 0.0 112.219 175.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.488 HG11 HG11 ' A' ' 76' ' ' VAL . 7.7 t -54.79 -48.51 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 125.068 1.347 . . . . 0.0 113.27 -177.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -44.77 69.42 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.491 0.316 . . . . 0.0 111.262 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.7 mmtt -65.64 -35.55 81.12 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.746 0.419 . . . . 0.0 110.895 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 9' ' ' VAL . 43.6 mt-30 -59.4 -49.79 76.46 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.946 0.779 . . . . 0.0 110.788 175.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.0 tp -55.89 -51.71 66.64 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.268 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -56.85 -46.95 81.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.536 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -67.31 -26.36 66.48 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.337 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -71.91 -48.52 44.92 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.097 0.559 . . . . 0.0 110.576 -173.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.06 -29.07 35.09 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.672 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.87 -3.42 58.91 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.401 0.68 . . . . 0.0 111.636 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 71.95 12.63 6.07 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.38 1.472 . . . . 0.0 113.065 172.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.487 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 5.9 m-20 -73.15 96.6 2.25 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.265 0.626 . . . . 0.0 111.11 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.5 mm -66.26 -29.75 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.452 0.701 . . . . 0.0 111.687 175.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.04 -48.56 81.17 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.023 0.529 . . . . 0.0 112.113 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.45 -30.1 33.57 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.866 0.466 . . . . 0.0 110.899 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -73.25 -7.86 53.31 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.924 177.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.801 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -114.22 -30.55 6.59 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.16 0.584 . . . . 0.0 112.197 173.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.66 -33.32 60.55 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -170.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.632 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.8 m95 -99.78 14.2 31.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.906 0.882 . . . . 0.0 112.651 -170.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.55 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 29.6 m95 -105.51 155.84 18.79 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.828 0.851 . . . . 0.0 109.949 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -85.36 148.32 26.08 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.478 0.711 . . . . 0.0 109.752 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -58.14 -30.94 66.74 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.894 0.878 . . . . 0.0 111.955 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -103.05 19.29 19.79 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.025 0.93 . . . . 0.0 111.737 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.55 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 53.7 t -64.05 132.23 49.94 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.483 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 36.3 mm-40 -101.44 105.25 16.25 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.64 0.776 . . . . 0.0 110.245 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -96.56 112.52 24.23 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.936 0.894 . . . . 0.0 110.26 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.471 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 89.2 m-85 -110.3 153.48 24.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.236 1.015 . . . . 0.0 111.378 178.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.556 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -102.08 150.95 22.73 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 113.996 -1.457 . . . . 0.0 107.717 165.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 16.4 p90 -50.48 128.63 25.18 Favored Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 124.748 1.219 . . . . 0.0 114.1 -176.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 83.4 Cg_endo -79.3 -36.7 2.15 Favored 'Cis proline' 0 C--N 1.385 2.482 0 C-N-CA 124.817 -0.91 . . . . 0.0 113.06 -9.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.13 81.64 0.99 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.51 0.724 . . . . 0.0 109.811 -174.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 40.6 m -121.74 100.1 6.82 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.2 tp -71.34 100.83 2.23 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -173.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 36' ' ' ALA . 1.1 mm? -77.27 -45.26 26.92 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.45 115.85 15.29 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.958 -172.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.6 45.94 1.39 Allowed Glycine 0 C--N 1.346 1.085 0 CA-C-O 119.838 -0.423 . . . . 0.0 112.91 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.3 p30 160.36 160.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 126.495 1.918 . . . . 0.0 108.771 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -66.94 -31.61 72.3 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.888 0.875 . . . . 0.0 113.158 -172.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.75 -43.81 98.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.131 0.572 . . . . 0.0 111.171 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -75.24 -30.69 60.6 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.985 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.2 mt -63.2 -45.11 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.523 0.729 . . . . 0.0 110.143 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.801 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 21.9 ttt180 -59.46 -55.44 34.6 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.653 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.477 ' HA ' HD12 ' A' ' 54' ' ' ILE . 34.3 m -66.34 -34.43 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 124.515 1.135 . . . . 0.0 112.822 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -71.24 -32.94 69.35 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.964 0.411 . . . . 0.0 110.456 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -75.03 -33.73 61.8 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.45 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 51' ' ' VAL . 39.6 mt -55.87 -39.62 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.782 0.833 . . . . 0.0 110.228 173.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 51' ' ' VAL . 34.6 mm-40 -59.06 -46.92 87.03 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.467 0.707 . . . . 0.0 111.118 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 -66.15 -30.21 70.64 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.535 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -81.29 -11.1 59.45 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 123.932 0.893 . . . . 0.0 111.651 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 72.2 mmtt -71.67 -22.3 61.68 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.788 0.435 . . . . 0.0 111.39 170.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -81.11 115.7 57.83 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.687 0.795 . . . . 0.0 110.392 -176.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.46 -30.05 79.64 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.238 2.625 . . . . 0.0 113.757 -174.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -86.75 3.73 43.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.268 0.627 . . . . 0.0 112.561 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.9 tp -67.28 118.05 10.13 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.706 0.289 . . . . 0.0 110.805 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -150.51 119.11 6.5 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 167.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.22 103.96 3.09 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 174.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -89.38 106.55 18.52 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.0 tt -80.88 128.57 33.82 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.41 HD22 ' H ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -115.08 -34.96 4.87 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.733 0.813 . . . . 0.0 111.137 178.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.41 ' H ' HD22 ' A' ' 67' ' ' LEU . 38.1 m -132.25 139.0 48.11 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.579 0.752 . . . . 0.0 109.67 178.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.01 139.12 37.76 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 167.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.51 144.93 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.248 1.019 . . . . 0.0 109.347 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.467 HD11 ' HB2' ' A' ' 2' ' ' ASN . 15.1 tt -122.76 141.43 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-O 121.338 0.59 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 p -143.5 98.01 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 125.239 1.415 . . . . 0.0 108.105 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.92 -120.57 19.12 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.185 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.433 ' HA ' HG13 ' A' ' 5' ' ' ILE . 3.3 p-10 -93.69 13.4 22.34 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.477 0.711 . . . . 0.0 111.913 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.2 t -130.29 136.14 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.25 1.02 . . . . 0.0 109.664 -174.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.488 HG11 HG11 ' A' ' 9' ' ' VAL . 87.0 t -125.16 135.82 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.774 0.83 . . . . 0.0 109.796 176.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.537 HG12 ' HB ' ' A' ' 98' ' ' ILE . 2.2 mt -100.13 108.01 22.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 168.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -88.07 109.16 19.65 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 168.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -99.15 110.51 23.07 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 122.041 0.924 . . . . 0.0 108.788 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.47 165.45 18.42 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.868 -1.515 . . . . 0.0 109.533 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.7 m -114.65 103.2 10.76 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 167.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.9 m -85.44 130.55 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 120.928 0.394 . . . . 0.0 110.391 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.6 m -79.05 118.96 21.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.295 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -111.81 -166.93 1.12 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 168.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -124.23 108.18 11.99 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 121.823 -0.548 . . . . 0.0 110.323 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -106.31 144.47 29.04 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 123.544 0.738 . . . . 0.0 109.059 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.84 -12.31 32.49 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.724 2.283 . . . . 0.0 112.907 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -87.61 -2.78 58.85 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.669 0.787 . . . . 0.0 112.225 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.92 -119.55 0.9 Allowed Glycine 0 C--N 1.348 1.225 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.769 170.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -65.31 -79.08 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.867 0.867 . . . . 0.0 110.536 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 117.57 22.79 3.93 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.323 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' A' ' 117' ' ' ARG . 13.8 pt-20 -90.29 141.9 28.25 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -176.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.634 HG12 ' HA ' ' A' ' 116' ' ' PRO . 22.4 m -132.97 138.64 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.156 0.435 . . . . 0.0 111.247 -171.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -75.65 109.33 9.13 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.47 HG22 HG12 ' A' ' 113' ' ' ILE . 21.4 t -114.7 155.66 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.14 105.75 9.78 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 82.5 m -94.96 107.46 19.49 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.646 HG23 ' HB2' ' A' ' 110' ' ' TRP . 7.3 tt -105.25 106.55 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.634 -173.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -99.9 137.27 38.58 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.662 0.785 . . . . 0.0 110.645 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -100.47 114.41 27.98 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.292 1.037 . . . . 0.0 109.166 168.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.539 HG22 HG12 ' A' ' 106' ' ' ILE . 46.4 t -102.31 117.66 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 123.319 0.648 . . . . 0.0 109.548 175.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 19.7 tt0 -128.54 138.71 52.38 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.832 1.253 . . . . 0.0 109.138 175.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 63.43 30.9 15.31 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.897 0.879 . . . . 0.0 111.32 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.28 7.59 82.53 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.401 -0.818 . . . . 0.0 114.058 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 57.3 mmt-85 -137.56 153.77 49.91 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.635 1.174 . . . . 0.0 108.902 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.539 HG12 HG22 ' A' ' 101' ' ' VAL . 65.3 mt -73.45 105.74 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -79.53 -28.99 41.3 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.444 0.697 . . . . 0.0 111.353 -178.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.483 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 91.3 mttt -150.25 152.6 34.8 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.85 134.41 22.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 174.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.646 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.6 m-90 -126.08 152.99 45.1 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -142.65 147.06 35.13 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 172.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -134.85 117.68 16.16 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.082 0.553 . . . . 0.0 110.294 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.47 HG12 HG22 ' A' ' 95' ' ' VAL . 95.6 mt -89.02 110.82 21.92 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.2 -93.27 0.06 OUTLIER Glycine 0 CA--C 1.533 1.196 0 CA-C-N 114.289 -1.323 . . . . 0.0 114.327 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -126.79 140.33 37.3 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 123.455 0.702 . . . . 0.0 111.268 -169.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.634 ' HA ' HG12 ' A' ' 93' ' ' VAL . 48.0 Cg_endo -67.79 125.5 13.28 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.241 2.628 . . . . 0.0 111.947 173.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.426 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 36.1 mmt180 -111.46 124.47 52.34 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.41 1.084 . . . . 0.0 109.312 178.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.1 mm -124.05 124.86 69.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.1 t . . . . . 0 N--CA 1.481 1.098 0 O-C-N 124.005 0.816 . . . . 0.0 111.281 -173.599 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 CA--C 1.56 1.359 0 CA-C-O 121.39 0.614 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.405 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 36.1 p -72.94 -35.06 66.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.663 0.785 . . . . 0.0 111.547 -175.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.09 -5.1 32.9 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.895 0.478 . . . . 0.0 111.9 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.571 HG22 HG23 ' A' ' 76' ' ' VAL . 22.9 mm -94.29 -30.47 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.968 0.907 . . . . 0.0 109.701 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -72.74 -34.19 66.88 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.7 0.8 . . . . 0.0 111.636 174.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 3' ' ' SER . 93.8 mt -61.69 -50.58 81.37 Favored Pre-proline 0 CA--C 1.558 1.283 0 CA-C-O 118.089 -0.958 . . . . 0.0 112.46 -172.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.571 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 12.7 Cg_endo -54.84 -56.49 2.37 Favored 'Trans proline' 0 C--N 1.398 3.155 0 C-N-CA 122.123 1.882 . . . . 0.0 111.072 177.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 76' ' ' VAL . 98.8 t -53.45 -44.56 56.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.303 1.441 . . . . 0.0 112.411 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -62.63 -51.47 67.17 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.946 -178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -68.86 -34.39 75.37 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.18 0.592 . . . . 0.0 111.436 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -65.03 -43.41 92.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.973 0.909 . . . . 0.0 111.254 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.8 -52.06 67.1 Favored 'General case' 0 C--O 1.242 0.688 0 O-C-N 123.716 0.635 . . . . 0.0 109.398 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -54.13 -45.93 72.05 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 124.789 1.306 . . . . 0.0 109.258 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -68.64 -27.01 65.62 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.804 -1.544 . . . . 0.0 112.52 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -71.97 -41.01 68.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.532 0.333 . . . . 0.0 110.32 -174.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -90.76 -28.99 17.9 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.227 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.6 -2.18 57.05 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.244 0.618 . . . . 0.0 111.655 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 68.27 24.03 7.57 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.075 1.35 . . . . 0.0 112.958 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.528 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 21.6 m-20 -88.06 95.61 10.21 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.187 0.595 . . . . 0.0 109.765 175.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.432 HG13 HG12 ' A' ' 54' ' ' ILE . 13.2 mm -65.78 -28.34 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.697 0.399 . . . . 0.0 110.921 174.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.08 -48.15 81.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.194 0.597 . . . . 0.0 111.674 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.67 -30.87 36.49 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.83 0.452 . . . . 0.0 110.841 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -72.86 -7.57 51.49 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.248 0.619 . . . . 0.0 110.881 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.747 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -113.59 -29.64 7.09 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.395 0.678 . . . . 0.0 112.318 174.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.16 -34.91 70.82 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.873 0.869 . . . . 0.0 113.186 -169.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.571 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 96.1 m95 -93.75 8.29 41.62 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.722 0.809 . . . . 0.0 112.901 -173.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.76 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 21.8 m95 -102.84 158.81 16.01 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.667 0.787 . . . . 0.0 109.375 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -86.65 162.24 18.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.106 0.562 . . . . 0.0 110.408 177.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.57 -34.22 75.44 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.139 0.576 . . . . 0.0 111.347 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -98.06 15.74 23.27 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.619 0.768 . . . . 0.0 110.534 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.76 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 43.2 t -59.93 117.47 5.09 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-O 121.137 0.494 . . . . 0.0 111.745 -173.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.571 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 57.1 mm-40 -83.78 154.27 23.64 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.701 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.41 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 57.2 t80 -144.81 111.69 5.85 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -175.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.502 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 85.3 m-85 -118.12 146.59 44.03 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.973 0.909 . . . . 0.0 110.697 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.525 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -95.69 157.43 15.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.154 -1.384 . . . . 0.0 108.202 170.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.439 ' HB3' ' HA ' ' A' ' 112' ' ' LYS . 30.9 p90 -55.6 130.19 70.77 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 123.658 0.783 . . . . 0.0 112.248 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.87 -42.42 0.78 Allowed 'Cis proline' 0 C--N 1.385 2.472 0 CA-C-N 119.923 1.008 . . . . 0.0 113.09 -4.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.09 65.15 0.16 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.697 0.799 . . . . 0.0 109.613 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.9 m -105.79 118.38 36.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.938 0.895 . . . . 0.0 109.49 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.83 110.83 8.43 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.672 0.789 . . . . 0.0 110.971 -169.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.525 HD21 ' HB2' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -88.37 -51.63 5.63 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 170.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -137.24 116.63 12.75 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.233 -168.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.73 22.32 40.96 Favored Glycine 0 N--CA 1.478 1.486 0 N-CA-C 114.553 0.581 . . . . 0.0 114.553 -173.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -177.89 163.6 1.81 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.235 1.414 . . . . 0.0 109.479 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -59.67 -36.65 76.86 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.938 0.895 . . . . 0.0 112.695 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.11 -44.35 97.49 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.034 0.534 . . . . 0.0 111.802 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -72.85 -36.01 67.34 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.484 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.41 -42.62 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.264 0.626 . . . . 0.0 110.019 174.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.747 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 79.2 ttt180 -62.49 -58.16 8.61 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.547 -175.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.1 m -69.86 -35.0 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 124.248 0.967 . . . . 0.0 112.879 -170.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -67.43 -36.39 81.13 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.642 0.377 . . . . 0.0 110.163 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -77.14 -30.09 54.92 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.357 176.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 50' ' ' ARG . 91.6 mt -57.82 -42.58 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 118.84 0.745 . . . . 0.0 109.922 174.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.0 -32.8 73.44 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.576 0.75 . . . . 0.0 111.616 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -74.85 -28.8 60.82 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.939 0.495 . . . . 0.0 110.706 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -81.15 -3.71 52.99 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.217 0.607 . . . . 0.0 110.995 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -77.03 -29.34 55.26 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.007 0.523 . . . . 0.0 110.802 169.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -59.93 118.79 35.53 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 123.91 0.884 . . . . 0.0 110.753 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -64.39 -35.72 48.52 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.828 2.352 . . . . 0.0 113.118 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -93.14 8.4 40.26 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.966 0.506 . . . . 0.0 112.154 -173.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.4 tp -67.85 113.87 5.95 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -148.31 116.34 6.43 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.73 104.88 3.13 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 174.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -97.61 105.18 17.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 80' ' ' GLU . 8.1 tt -78.94 127.45 32.02 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.023 0.44 . . . . 0.0 110.095 -177.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.425 HD22 ' H ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -96.18 -48.11 5.78 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.202 1.001 . . . . 0.0 108.737 -176.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 92.4 m -143.93 134.22 24.49 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.633 -170.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 10.8 ptt180 -131.44 129.27 41.0 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 166.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.7 HG22 ' HB ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -107.24 156.26 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.115 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.411 HD11 ' HB ' ' A' ' 5' ' ' ILE . 18.7 tt -134.7 137.67 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.127 0.489 . . . . 0.0 110.754 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 p -147.16 102.36 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.527 1.131 . . . . 0.0 108.636 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.8 -115.94 8.09 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.497 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -99.55 12.35 36.71 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.089 0.556 . . . . 0.0 111.728 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.92 139.35 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.899 0.879 . . . . 0.0 110.09 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.571 HG23 HG22 ' A' ' 5' ' ' ILE . 53.2 t -126.13 140.11 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.525 0.73 . . . . 0.0 109.77 174.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.7 ' HB ' HG22 ' A' ' 70' ' ' VAL . 24.4 mm -98.22 101.69 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 165.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -95.31 104.48 16.37 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -100.48 109.0 21.11 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.722 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -120.34 165.63 14.62 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.678 1.191 . . . . 0.0 110.412 -179.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.9 m -116.24 105.54 12.67 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.314 1.046 . . . . 0.0 109.083 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.2 125.69 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.291 0.567 . . . . 0.0 111.079 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.5 m -74.63 132.07 41.43 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.365 1.066 . . . . 0.0 110.178 175.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -130.31 -168.24 1.94 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.204 1.002 . . . . 0.0 109.282 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -128.43 100.29 5.73 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.657 0.783 . . . . 0.0 109.413 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -108.84 149.65 39.82 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.389 0.676 . . . . 0.0 110.398 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.86 -27.07 51.56 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.784 2.323 . . . . 0.0 113.234 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -86.84 -9.43 55.8 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.02 -140.25 6.31 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 120.094 -0.281 . . . . 0.0 112.728 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -66.07 -81.08 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.691 0.797 . . . . 0.0 111.548 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.45 28.21 1.66 Allowed Glycine 0 C--N 1.347 1.187 0 C-N-CA 121.341 -0.457 . . . . 0.0 113.77 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 117' ' ' ARG . 0.3 OUTLIER -88.81 100.2 12.97 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 122.368 1.08 . . . . 0.0 108.234 -174.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 116' ' ' PRO . 3.9 m -105.18 143.41 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.719 -169.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.41 141.26 34.1 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.533 HG22 HG12 ' A' ' 113' ' ' ILE . 35.5 t -138.06 142.04 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -109.92 105.24 14.34 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 170.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 74.9 m -92.74 136.7 33.0 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.56 ' HB ' HD13 ' A' ' 77' ' ' ILE . 7.3 tt -122.11 111.72 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 124.374 1.069 . . . . 0.0 109.768 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.433 ' HD2' HG22 ' A' ' 9' ' ' VAL . 12.7 m-85 -99.85 142.85 30.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.871 0.469 . . . . 0.0 109.844 176.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -111.64 113.92 26.63 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.0 t -97.73 141.79 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 124.646 1.179 . . . . 0.0 110.265 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.472 ' HG3' HD22 ' A' ' 103' ' ' ASN . 11.0 tp10 -141.63 105.6 4.76 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.917 1.287 . . . . 0.0 108.206 -172.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.472 HD22 ' HG3' ' A' ' 102' ' ' GLU . 37.9 m-80 61.49 30.96 19.04 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.539 1.136 . . . . 0.0 111.837 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.0 4.68 78.15 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.335 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -126.5 132.56 51.37 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.649 0.78 . . . . 0.0 109.697 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 62.9 mt -68.47 112.57 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 122.986 0.514 . . . . 0.0 110.088 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -76.91 -37.79 54.74 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.361 0.664 . . . . 0.0 110.434 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.571 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 98.0 mttt -151.59 150.16 29.98 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.81 0.844 . . . . 0.0 109.279 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.0 135.35 32.62 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.502 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 3.1 m-90 -132.66 156.03 47.7 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -145.39 148.6 33.53 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.538 0.608 . . . . 0.0 110.959 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 8.4 ptpp? -126.5 129.98 49.72 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.162 0.985 . . . . 0.0 108.825 172.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.533 HG12 HG22 ' A' ' 95' ' ' VAL . 95.8 mt -90.85 129.65 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.54 -80.18 0.12 Allowed Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.64 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.25 161.12 30.14 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.486 ' HA ' HG12 ' A' ' 93' ' ' VAL . 72.4 Cg_endo -72.52 121.0 7.06 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.481 2.121 . . . . 0.0 112.262 170.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 78.0 mtt-85 -122.56 153.48 39.2 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.52 0.728 . . . . 0.0 110.661 -177.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.1 mm -136.51 139.58 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.6 1.16 . . . . 0.0 109.648 -176.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.7 t . . . . . 0 N--CA 1.49 1.563 0 C-N-CA 123.656 0.782 . . . . 0.0 111.021 174.78 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.3 p -64.63 -37.64 88.26 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.879 0.472 . . . . 0.0 110.039 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.04 -23.1 61.7 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.127 1.371 . . . . 0.0 112.977 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.537 HG23 ' HB ' ' A' ' 101' ' ' VAL . 29.1 mm -93.18 -29.27 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.386 1.074 . . . . 0.0 109.771 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -77.94 -24.16 48.29 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.704 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.451 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 88.2 mt -61.71 -57.67 23.12 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-O 118.136 -0.935 . . . . 0.0 112.012 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.578 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 14.1 Cg_endo -54.37 -50.11 14.61 Favored 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 122.766 2.31 . . . . 0.0 112.706 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.609 ' HA ' HE21 ' A' ' 12' ' ' GLN . 15.6 m -65.65 -32.4 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.901 -174.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.18 -50.63 31.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.583 0.753 . . . . 0.0 110.336 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.1 mmtt -66.84 -30.62 70.84 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.018 -176.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.609 HE21 ' HA ' ' A' ' 9' ' ' VAL . 37.1 mt-30 -59.17 -49.2 78.77 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 124.039 0.837 . . . . 0.0 111.288 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.75 -48.33 79.94 Favored 'General case' 0 C--O 1.246 0.897 0 O-C-N 123.774 0.671 . . . . 0.0 110.069 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -58.27 -42.61 86.87 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 124.904 1.377 . . . . 0.0 109.055 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -72.91 -25.78 61.17 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.753 -1.567 . . . . 0.0 112.796 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -68.14 -44.43 76.05 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.06 0.457 . . . . 0.0 110.324 -173.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -85.49 -29.58 24.16 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.644 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.87 -4.19 57.8 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.35 0.66 . . . . 0.0 111.497 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.42 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 23.6 mmt85 69.99 23.6 5.38 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.225 1.41 . . . . 0.0 112.796 171.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 19.7 m-20 -91.24 94.61 9.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.05 0.54 . . . . 0.0 110.541 177.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.475 HG13 HG12 ' A' ' 54' ' ' ILE . 20.2 mm -66.37 -28.7 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 123.514 0.726 . . . . 0.0 111.208 173.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -58.76 -47.15 85.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.945 0.498 . . . . 0.0 111.351 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.04 -33.97 33.16 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.421 0.689 . . . . 0.0 111.052 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -68.18 -8.88 42.63 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.777 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.709 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 24.9 tpp -120.53 -22.26 6.48 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 174.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.08 -28.79 69.86 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -175.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.578 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 96.1 m95 -94.17 9.63 37.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.786 0.834 . . . . 0.0 112.539 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -102.77 153.09 20.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.662 0.785 . . . . 0.0 110.002 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.47 140.43 44.59 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 168.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -67.81 -11.69 59.04 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.306 0.642 . . . . 0.0 112.37 -174.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -116.18 21.08 13.94 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.077 0.951 . . . . 0.0 111.232 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.7 t -59.76 147.55 37.55 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.45 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 33.8 mm-40 -107.21 105.42 15.39 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.171 0.988 . . . . 0.0 110.043 -175.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -102.55 112.63 25.46 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.587 0.755 . . . . 0.0 110.521 -173.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.421 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 13.9 m-85 -106.51 152.69 23.34 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.874 0.87 . . . . 0.0 110.322 175.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.64 161.95 18.4 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.355 1.062 . . . . 0.0 109.776 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.502 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 68.3 t80 -57.06 125.56 70.58 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 123.696 0.798 . . . . 0.0 110.26 174.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.24 -56.75 0.14 OUTLIER 'Cis proline' 0 C--N 1.386 2.545 0 CA-C-N 120.59 1.246 . . . . 0.0 113.898 2.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.9 57.72 0.37 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.558 0.743 . . . . 0.0 109.51 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.9 m -98.84 113.68 25.92 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.091 0.957 . . . . 0.0 110.533 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.47 102.46 0.7 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.9 mt -78.37 -42.26 30.91 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.621 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -140.19 115.55 9.95 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.001 -169.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.7 46.13 1.66 Allowed Glycine 0 C--N 1.344 1.006 0 O-C-N 123.386 0.429 . . . . 0.0 112.284 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 p30 163.26 153.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 126.491 1.916 . . . . 0.0 108.561 -172.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.709 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -68.56 -23.66 64.53 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.876 0.87 . . . . 0.0 113.328 -174.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.5 -48.76 80.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.753 0.421 . . . . 0.0 111.239 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.494 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 27.3 mt-10 -70.67 -30.17 66.69 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.652 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.513 HD12 ' HA ' ' A' ' 46' ' ' ALA . 63.9 mt -64.66 -52.43 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.487 0.715 . . . . 0.0 110.679 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.497 ' O ' HG13 ' A' ' 54' ' ' ILE . 6.4 ptp180 -64.2 -43.12 96.03 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.443 -175.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.9 t -67.91 -39.33 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.13 0.972 . . . . 0.0 111.743 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -71.33 -29.74 65.37 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.627 0.371 . . . . 0.0 110.851 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -73.61 -30.57 63.06 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 119.114 -0.469 . . . . 0.0 111.346 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 50' ' ' ARG . 77.6 mt -58.59 -38.75 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -57.2 -41.91 80.27 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.916 0.76 . . . . 0.0 111.717 174.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -73.59 -31.03 63.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.119 0.568 . . . . 0.0 110.722 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.42 ' CD2' ' HA ' ' A' ' 19' ' ' ARG . 2.6 m-30 -78.42 3.21 16.4 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.35 0.66 . . . . 0.0 111.478 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.417 ' HE2' HG22 ' A' ' 54' ' ' ILE . 73.4 mmtt -81.67 -18.38 44.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.312 0.645 . . . . 0.0 112.183 171.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.65 121.03 79.51 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-O 119.205 -0.426 . . . . 0.0 110.188 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.95 -20.05 34.42 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.357 2.038 . . . . 0.0 111.687 177.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -84.87 -13.36 51.16 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.885 0.874 . . . . 0.0 111.676 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 83' ' ' THR . 30.2 tp -62.85 112.56 2.6 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -173.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -145.5 118.03 8.56 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.18 105.54 3.31 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -96.3 105.73 17.84 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 tt -85.88 119.83 26.62 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.465 ' H ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -107.44 -31.43 8.16 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.706 0.802 . . . . 0.0 111.231 -174.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.418 ' N ' HD22 ' A' ' 67' ' ' LEU . 84.7 m -142.87 132.38 23.66 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.923 0.889 . . . . 0.0 109.805 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -135.67 135.07 39.82 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 164.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.494 HG22 ' HB ' ' A' ' 77' ' ' ILE . 20.4 m -122.56 142.41 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.5 tt -124.84 138.47 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 121.229 0.538 . . . . 0.0 111.219 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -139.76 99.41 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 125.284 1.434 . . . . 0.0 107.999 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.29 -126.79 23.15 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.718 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.423 ' HA ' HG13 ' A' ' 5' ' ' ILE . 21.1 p-10 -94.78 24.27 4.84 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.228 0.611 . . . . 0.0 111.411 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.2 t -131.43 130.75 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.404 1.082 . . . . 0.0 109.433 -174.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.9 t -120.93 142.53 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 122.982 0.513 . . . . 0.0 110.043 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.673 HD13 ' HB ' ' A' ' 98' ' ' ILE . 5.3 mm -98.28 107.69 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 165.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -91.57 109.38 20.68 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 167.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -100.72 108.51 20.38 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 175.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.53 129.35 42.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.757 1.223 . . . . 0.0 109.734 -174.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.5 m -83.91 103.02 12.83 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 172.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.6 m -89.33 137.71 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 29.2 m -95.58 135.45 37.23 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.195 0.598 . . . . 0.0 109.688 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -131.45 -166.11 1.66 Allowed 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -125.45 99.57 6.09 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 122.122 -0.361 . . . . 0.0 110.061 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.434 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 20.7 m-30 -99.53 135.74 20.54 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 172.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.03 -12.5 35.68 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.997 2.465 . . . . 0.0 113.812 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -83.98 -11.2 57.17 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA3' HG23 ' A' ' 118' ' ' ILE . . . 173.09 -119.3 0.75 Allowed Glycine 0 C--N 1.35 1.34 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.346 171.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -71.4 -80.61 0.06 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.215 0.606 . . . . 0.0 110.998 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.434 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 123.22 27.0 1.57 Allowed Glycine 0 C--N 1.344 0.978 0 N-CA-C 114.032 0.373 . . . . 0.0 114.032 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -89.53 141.12 28.87 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' A' ' 116' ' ' PRO . 30.4 m -133.49 133.37 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.199 0.599 . . . . 0.0 109.557 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.51 109.24 15.79 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.481 HG22 HG12 ' A' ' 113' ' ' ILE . 39.0 t -112.43 156.65 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -175.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -128.69 101.93 6.35 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 111' ' ' PHE . 76.2 m -92.08 105.7 17.88 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.673 ' HB ' HD13 ' A' ' 77' ' ' ILE . 8.5 tt -92.2 112.19 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.044 0.938 . . . . 0.0 109.58 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -99.94 148.84 24.05 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.571 0.748 . . . . 0.0 110.127 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -118.69 111.85 19.04 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.552 HG22 HG12 ' A' ' 106' ' ' ILE . 53.6 t -98.31 112.18 29.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.012 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -117.18 130.9 56.9 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 62.7 32.1 16.34 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.581 0.752 . . . . 0.0 111.386 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.63 -5.88 82.19 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 115.657 -0.702 . . . . 0.0 114.58 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 63.5 mmt-85 -132.22 147.44 52.41 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.6 0.76 . . . . 0.0 109.281 -175.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.552 HG12 HG22 ' A' ' 101' ' ' VAL . 66.4 mt -68.94 100.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.395 0.678 . . . . 0.0 110.256 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.68 -25.71 35.31 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.563 0.745 . . . . 0.0 111.312 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 96.8 mttt -145.58 150.03 35.63 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.788 0.835 . . . . 0.0 108.751 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.36 135.11 14.51 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.507 0.723 . . . . 0.0 109.408 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.421 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 2.5 m-90 -133.06 130.63 39.62 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.476 ' HB2' ' SG ' ' A' ' 97' ' ' CYS . 11.8 p90 -119.66 138.95 52.94 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.252 0.933 . . . . 0.0 109.583 175.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -127.36 119.9 27.29 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.371 0.668 . . . . 0.0 109.213 -178.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.481 HG12 HG22 ' A' ' 95' ' ' VAL . 88.7 mt -88.75 130.1 38.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.04 -78.8 0.17 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.153 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -158.38 163.26 24.96 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.632 ' HA ' HG12 ' A' ' 93' ' ' VAL . 74.5 Cg_endo -71.04 114.74 4.0 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.28 1.987 . . . . 0.0 112.189 170.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -107.05 150.68 26.27 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.887 0.875 . . . . 0.0 108.973 176.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.406 HG23 ' HA3' ' A' ' 89' ' ' GLY . 32.2 mm -138.11 121.35 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.875 0.87 . . . . 0.0 108.98 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.488 1.427 0 C-N-CA 123.024 0.53 . . . . 0.0 110.752 177.831 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -109.54 44.94 1.12 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 50.7 p -65.98 -43.62 87.28 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.407 -1.269 . . . . 0.0 111.749 -172.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.21 -6.82 31.46 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.622 0.769 . . . . 0.0 112.722 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.453 ' HB ' HD11 ' A' ' 71' ' ' ILE . 14.4 mm -95.78 -29.64 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.649 0.78 . . . . 0.0 109.016 174.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -77.73 -33.01 53.15 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.701 0.801 . . . . 0.0 111.492 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 3' ' ' SER . 93.0 mt -58.91 -49.54 92.81 Favored Pre-proline 0 N--CA 1.489 1.492 0 CA-C-O 118.665 -0.683 . . . . 0.0 112.384 -176.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.6 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 11.9 Cg_endo -56.29 -60.92 0.39 Allowed 'Trans proline' 0 C--N 1.392 2.816 0 C-N-CA 122.245 1.964 . . . . 0.0 112.303 175.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.49 HG21 HG11 ' A' ' 76' ' ' VAL . 22.6 m -64.27 -29.54 47.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.848 -167.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -68.72 -55.18 12.19 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.564 0.745 . . . . 0.0 109.88 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -62.97 -35.08 78.96 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.892 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -74.79 -42.52 57.97 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.6 0.76 . . . . 0.0 111.438 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.459 HD21 ' HB2' ' A' ' 66' ' ' LEU . 22.9 tp -60.76 -46.79 89.11 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.851 0.46 . . . . 0.0 110.401 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.22 -49.94 74.43 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.94 173.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.85 -25.91 68.38 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.267 1.027 . . . . 0.0 112.3 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -63.75 -44.1 94.51 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.595 0.758 . . . . 0.0 110.71 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -91.25 -28.24 17.92 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.814 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.85 -10.23 59.74 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.831 0.852 . . . . 0.0 112.111 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 69.11 44.68 0.97 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.876 1.27 . . . . 0.0 112.095 173.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -115.77 93.81 4.42 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.261 0.624 . . . . 0.0 109.566 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.531 HG13 HG12 ' A' ' 54' ' ' ILE . 12.8 mm -71.62 -29.63 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 122.864 0.466 . . . . 0.0 111.35 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.78 -45.12 93.27 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.458 0.303 . . . . 0.0 111.4 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.43 -32.36 42.79 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.991 0.516 . . . . 0.0 110.94 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.488 ' HB3' ' HA ' ' A' ' 21' ' ' ILE . 50.8 t80 -70.05 -10.33 58.34 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.888 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.659 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -111.53 -29.74 7.64 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.453 0.701 . . . . 0.0 111.24 174.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.04 -54.25 32.31 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.808 0.843 . . . . 0.0 112.241 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.6 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 95.5 m95 -78.39 4.64 12.49 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.467 -1.242 . . . . 0.0 113.452 -169.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.711 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 28.3 m95 -93.29 162.37 14.03 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.54 0.736 . . . . 0.0 109.521 174.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -79.67 152.16 30.11 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.793 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.41 -27.24 66.91 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 120.782 0.325 . . . . 0.0 111.3 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.32 18.86 21.39 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.633 0.773 . . . . 0.0 110.791 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.711 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 53.2 t -60.72 133.8 56.45 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.069 0.548 . . . . 0.0 112.12 -174.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -88.08 148.96 24.23 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 56.6 t80 -140.53 112.85 7.87 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.432 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 27.0 m-85 -108.25 154.88 21.14 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.037 0.935 . . . . 0.0 110.83 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.442 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -113.39 155.31 25.46 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.872 1.269 . . . . 0.0 109.341 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.718 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 69.3 t80 -53.54 125.49 44.96 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.398 1.079 . . . . 0.0 111.971 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -76.85 -58.4 0.14 OUTLIER 'Cis proline' 0 C--N 1.383 2.362 0 CA-C-N 120.344 1.159 . . . . 0.0 113.986 -4.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -145.3 78.85 1.56 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.473 0.709 . . . . 0.0 109.819 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 94.5 m -125.95 106.05 9.36 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.473 0.709 . . . . 0.0 109.709 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.5 tp -66.12 102.41 0.82 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.549 0.74 . . . . 0.0 110.937 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 36' ' ' ALA . 41.2 mt -79.79 -35.86 37.92 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.384 0.673 . . . . 0.0 110.553 175.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -142.49 121.32 12.71 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.436 -171.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.91 35.38 4.9 Favored Glycine 0 C--N 1.347 1.176 0 C-N-CA 123.239 0.447 . . . . 0.0 112.754 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 p30 168.45 161.31 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.65 1.58 . . . . 0.0 109.79 -172.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -64.96 -36.93 85.96 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.407 1.083 . . . . 0.0 112.918 -173.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.28 82.86 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.124 0.569 . . . . 0.0 111.84 -173.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.403 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 27.4 mt-10 -77.02 -33.29 57.44 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.988 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.8 mt -61.64 -50.44 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.676 0.79 . . . . 0.0 110.756 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.659 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 21.3 ptt180 -61.91 -49.93 74.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 118.841 -0.599 . . . . 0.0 110.525 -177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.5 t -59.29 -42.82 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.531 0.732 . . . . 0.0 110.668 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.454 ' HA ' ' HE ' ' A' ' 52' ' ' ARG . 2.1 tpm_? -55.17 -43.72 74.54 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.024 0.827 . . . . 0.0 110.704 176.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -78.24 -29.78 48.34 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.387 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.531 HG12 HG13 ' A' ' 21' ' ' ILE . 95.7 mt -61.42 -38.47 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 118.414 0.552 . . . . 0.0 109.673 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -58.88 -40.17 83.59 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.653 173.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -70.47 -32.95 70.69 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.074 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -74.66 -8.66 57.08 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.811 0.844 . . . . 0.0 111.832 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.462 ' HE2' HG22 ' A' ' 54' ' ' ILE . 72.6 mmtt -71.12 -27.27 63.46 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.775 0.43 . . . . 0.0 111.542 174.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.44 117.05 43.25 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.97 -22.08 42.51 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.302 2.002 . . . . 0.0 110.885 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -85.84 -5.54 59.23 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.618 1.567 . . . . 0.0 112.603 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.79 120.9 12.17 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.418 0.287 . . . . 0.0 110.314 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -150.93 117.67 5.8 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.3 102.64 2.95 Favored Glycine 0 C--N 1.344 1.002 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -95.3 103.07 14.92 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.459 ' HB2' HD21 ' A' ' 13' ' ' LEU . 8.7 tp -68.02 139.88 56.32 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.134 0.492 . . . . 0.0 110.81 -177.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mt -107.39 -53.01 2.68 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.463 1.105 . . . . 0.0 108.392 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.8 m -148.11 144.69 27.99 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 113.613 -1.631 . . . . 0.0 109.739 -172.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 25.2 ptt180 -140.7 128.55 21.81 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.115 0.966 . . . . 0.0 108.739 173.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.522 HG22 ' HB ' ' A' ' 77' ' ' ILE . 33.1 m -123.83 152.08 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 176.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.453 HD11 ' HB ' ' A' ' 5' ' ' ILE . 11.2 tt -133.35 118.72 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.25 0.548 . . . . 0.0 110.401 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.6 t -112.18 95.27 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.368 1.067 . . . . 0.0 108.429 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.92 -111.1 3.8 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 116.027 -0.533 . . . . 0.0 113.433 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -93.44 12.43 25.0 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.769 0.828 . . . . 0.0 111.615 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.1 t -125.72 134.25 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.74 0.816 . . . . 0.0 109.52 -171.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 9' ' ' VAL . 24.5 t -125.69 135.17 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 122.807 0.443 . . . . 0.0 110.355 175.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.62 HD13 ' HB ' ' A' ' 98' ' ' ILE . 9.0 mm -99.81 105.06 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.092 1.357 . . . . 0.0 108.006 169.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.01 105.87 17.86 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 167.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.44 ' HE1' ' HB3' ' A' ' 94' ' ' ASP . 1.8 t60 -100.21 106.78 18.49 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.95 169.18 12.95 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.942 1.297 . . . . 0.0 110.18 -176.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.6 m -116.71 110.16 18.09 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.2 t -81.29 103.41 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.362 0.665 . . . . 0.0 110.123 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 88.0 m -66.24 118.81 10.48 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -123.98 -169.29 1.93 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.572 1.149 . . . . 0.0 108.031 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.1 109.37 16.33 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.39 0.676 . . . . 0.0 109.424 169.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -103.81 147.02 33.62 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 123.655 0.782 . . . . 0.0 110.015 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.02 -9.86 27.54 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.876 2.384 . . . . 0.0 114.216 -175.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -92.35 -15.14 27.7 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.419 0.287 . . . . 0.0 111.66 173.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.05 -121.66 1.03 Allowed Glycine 0 C--N 1.355 1.626 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.956 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -53.79 -84.57 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.503 1.121 . . . . 0.0 111.994 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.58 28.54 2.72 Favored Glycine 0 C--N 1.349 1.276 0 C-N-CA 121.686 -0.292 . . . . 0.0 113.575 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -89.77 119.57 30.27 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -173.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 116' ' ' PRO . 33.4 m -116.49 123.16 71.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 CA-C-O 121.114 0.483 . . . . 0.0 110.045 -175.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.44 ' HB3' ' HE1' ' A' ' 79' ' ' HIS . 2.8 m-20 -84.19 108.0 16.83 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 113' ' ' ILE . 24.0 t -113.14 149.42 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.788 1.235 . . . . 0.0 109.432 -174.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -112.84 103.19 11.18 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 167.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 76.7 m -93.76 109.05 20.74 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.62 ' HB ' HD13 ' A' ' 77' ' ' ILE . 4.9 tt -99.3 134.6 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.244 1.018 . . . . 0.0 109.739 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -123.22 155.6 36.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.773 0.829 . . . . 0.0 109.866 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -129.07 119.42 24.17 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.892 1.277 . . . . 0.0 107.645 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.534 HG22 HG12 ' A' ' 106' ' ' ILE . 97.1 t -107.46 117.62 53.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.226 1.01 . . . . 0.0 109.695 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.527 ' HG2' ' ND2' ' A' ' 103' ' ' ASN . 43.0 tt0 -126.95 133.26 50.66 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.92 0.888 . . . . 0.0 109.23 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.527 ' ND2' ' HG2' ' A' ' 102' ' ' GLU . 48.1 m-80 61.54 28.62 17.84 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.027 1.331 . . . . 0.0 111.798 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.05 -7.56 80.0 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -121.27 149.29 43.1 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 101' ' ' VAL . 47.7 mt -66.41 109.77 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -75.78 -38.41 58.31 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.865 0.866 . . . . 0.0 110.608 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -149.12 146.7 27.82 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.191 0.996 . . . . 0.0 109.059 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -145.84 139.68 26.52 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.154 0.582 . . . . 0.0 109.504 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.432 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 2.0 m-90 -131.78 155.8 47.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -142.24 145.02 33.62 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 171.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.718 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 59.9 pttt -129.06 124.27 34.42 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.627 0.771 . . . . 0.0 109.066 175.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.461 HG12 HG22 ' A' ' 95' ' ' VAL . 96.5 mt -88.63 123.94 41.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.9 -66.84 2.24 Favored Glycine 0 C--O 1.242 0.607 0 O-C-N 124.39 1.056 . . . . 0.0 112.876 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -158.55 163.77 23.27 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.084 0.554 . . . . 0.0 109.653 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.627 ' HA ' HG12 ' A' ' 93' ' ' VAL . 88.7 Cg_endo -82.23 137.29 9.39 Favored 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.561 2.174 . . . . 0.0 112.475 163.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -132.82 158.74 41.73 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.74 0.781 . . . . 0.0 111.934 175.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.423 HG22 ' H ' ' A' ' 120' ' ' SER . 41.3 mm -138.54 139.63 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.235 1.414 . . . . 0.0 108.375 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.5 t -60.08 -39.01 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 124.001 0.921 . . . . 0.0 111.827 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.423 ' H ' HG22 ' A' ' 118' ' ' ILE . 32.4 t -66.32 -23.73 66.42 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.169 0.588 . . . . 0.0 112.127 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -108.58 7.29 26.61 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.698 0.799 . . . . 0.0 111.287 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -131.23 148.95 52.75 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.066 0.946 . . . . 0.0 109.463 -175.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 CA--C 1.558 1.253 0 C-N-CA 122.852 0.461 . . . . 0.0 109.758 173.407 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttp . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.55 ' HB2' HD11 ' A' ' 71' ' ' ILE . 11.1 m120 -83.38 72.64 10.21 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.596 0.758 . . . . 0.0 109.248 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.477 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 45.7 m -67.42 -33.22 74.71 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.547 -175.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.29 -11.27 30.16 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.618 0.767 . . . . 0.0 112.408 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.559 HG22 HG23 ' A' ' 76' ' ' VAL . 16.3 mm -98.06 -32.55 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.742 0.817 . . . . 0.0 109.824 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -69.18 -33.81 73.94 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.66 0.784 . . . . 0.0 112.099 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.9 mt -66.83 -50.33 44.33 Favored Pre-proline 0 N--CA 1.486 1.331 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.182 -173.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 12.2 Cg_endo -54.83 -52.23 8.5 Favored 'Trans proline' 0 C--N 1.398 3.132 0 C-N-CA 122.136 1.891 . . . . 0.0 111.525 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.471 HG11 HG11 ' A' ' 76' ' ' VAL . 72.4 t -58.08 -43.64 85.66 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 C-N-CA 124.774 1.23 . . . . 0.0 112.496 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 24.4 tp60 -66.13 -55.87 14.25 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.409 0.684 . . . . 0.0 111.472 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.425 ' HG3' ' CZ2' ' A' ' 27' ' ' TRP . 73.4 mmtt -65.33 -38.34 89.85 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.325 0.65 . . . . 0.0 110.817 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -62.89 -39.49 94.65 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.523 1.129 . . . . 0.0 111.343 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' A' ' 16' ' ' TYR . 5.0 tt -59.81 -52.81 63.88 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 20.5 mm-40 -61.57 -32.03 72.09 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.806 -174.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.57 -27.64 55.93 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.588 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.4 ' HB3' ' O ' ' A' ' 13' ' ' LEU . 68.0 t80 -63.66 -47.36 81.6 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.218 1.007 . . . . 0.0 110.812 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -84.76 -23.49 29.2 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.17 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.64 -6.8 58.76 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.153 0.581 . . . . 0.0 112.337 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 71.8 12.59 6.22 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.268 1.427 . . . . 0.0 113.042 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -76.28 94.46 3.57 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.476 HG13 HG12 ' A' ' 54' ' ' ILE . 12.5 mm -66.95 -28.54 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.728 0.811 . . . . 0.0 110.883 173.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -58.62 -46.63 86.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.851 0.46 . . . . 0.0 111.1 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.6 -30.88 41.64 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.365 0.666 . . . . 0.0 110.972 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -72.87 -7.66 51.94 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.49 0.716 . . . . 0.0 110.514 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.732 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -116.35 -25.31 7.56 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.409 0.684 . . . . 0.0 112.034 175.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.6 -40.53 79.28 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.835 0.854 . . . . 0.0 113.123 -171.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 90.5 m95 -89.69 1.7 55.71 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.404 -173.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.567 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 14.2 m95 -99.05 138.6 35.92 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.576 0.75 . . . . 0.0 109.141 -177.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -71.46 160.66 32.35 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.443 0.697 . . . . 0.0 111.174 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -61.25 -39.82 91.74 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.398 0.679 . . . . 0.0 111.546 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -99.12 19.98 14.25 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.463 1.105 . . . . 0.0 110.856 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.567 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 50.1 t -58.03 115.12 2.68 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.224 0.609 . . . . 0.0 111.714 -176.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -75.68 153.2 37.3 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 59.8 t80 -142.07 118.67 11.0 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -115.82 153.1 32.08 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.476 1.11 . . . . 0.0 109.673 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.39 161.23 23.84 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.232 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -57.99 128.97 81.96 Favored Pre-proline 0 CA--C 1.562 1.404 0 O-C-N 124.327 1.017 . . . . 0.0 110.77 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -75.9 -51.16 0.16 OUTLIER 'Cis proline' 0 C--N 1.384 2.44 0 CA-C-N 120.185 1.102 . . . . 0.0 114.03 -0.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.0 86.4 0.62 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 90.2 m -141.88 117.7 10.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.38 0.672 . . . . 0.0 109.977 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 tt -68.84 106.76 2.81 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.258 1.023 . . . . 0.0 109.899 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.3 mt -82.29 -42.52 18.72 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.397 0.679 . . . . 0.0 111.345 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -141.47 117.22 10.39 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.872 0.469 . . . . 0.0 111.113 -170.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.27 42.72 1.9 Allowed Glycine 0 N--CA 1.478 1.441 0 O-C-N 123.117 0.26 . . . . 0.0 113.014 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 p30 167.69 156.51 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.649 1.579 . . . . 0.0 108.934 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -63.61 -32.88 74.48 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.782 0.833 . . . . 0.0 112.776 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.79 90.99 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.156 0.582 . . . . 0.0 112.221 -173.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 30.2 mt-10 -74.16 -34.86 63.96 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.617 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.8 mt -58.59 -45.41 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 124.049 0.94 . . . . 0.0 110.432 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.732 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 21.6 ttt180 -54.33 -56.71 15.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.43 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.7 t -54.77 -49.47 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 124.708 1.255 . . . . 0.0 111.568 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -62.18 -36.97 83.51 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.345 -174.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -77.55 -34.57 53.75 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 118.894 -0.574 . . . . 0.0 111.842 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 50' ' ' ARG . 77.5 mt -56.42 -40.32 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.053 0.454 . . . . 0.0 109.867 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -57.26 -43.0 82.62 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.506 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -76.25 -22.33 55.28 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 120.801 0.334 . . . . 0.0 111.282 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.473 ' HA ' HD22 ' A' ' 62' ' ' LEU . 3.5 m-30 -79.76 -0.5 34.62 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.527 0.731 . . . . 0.0 112.032 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -73.55 -30.63 63.19 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.097 0.559 . . . . 0.0 111.28 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -63.08 121.04 66.65 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.278 0.631 . . . . 0.0 110.883 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.75 -23.67 26.01 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.263 1.976 . . . . 0.0 110.773 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.34 -10.53 59.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.015 1.326 . . . . 0.0 111.477 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 57' ' ' PHE . 42.7 tp -59.29 112.63 1.81 Allowed 'General case' 0 C--N 1.36 1.024 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -148.76 130.37 14.95 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.259 1.023 . . . . 0.0 108.332 -175.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.16 127.15 8.24 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -122.56 102.99 8.4 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.62 HD12 ' HG2' ' A' ' 80' ' ' GLU . 6.3 tp -69.72 138.11 52.6 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.403 0.62 . . . . 0.0 111.208 -175.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mt -105.88 -50.85 3.09 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.822 1.249 . . . . 0.0 108.253 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.7 m -150.11 141.44 23.25 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 113.24 -1.8 . . . . 0.0 109.844 -173.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -131.38 130.43 42.6 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 165.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.59 127.6 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.884 1.274 . . . . 0.0 110.273 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.55 HD11 ' HB2' ' A' ' 2' ' ' ASN . 15.7 tt -102.89 120.67 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.145 0.578 . . . . 0.0 109.7 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.43 94.54 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 124.194 0.998 . . . . 0.0 108.486 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.37 -118.02 11.91 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 123.323 0.389 . . . . 0.0 112.669 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.5 ' HA ' HG13 ' A' ' 5' ' ' ILE . 2.5 p-10 -95.04 7.99 44.36 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.325 0.65 . . . . 0.0 111.689 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.6 t -116.31 141.54 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.59 1.156 . . . . 0.0 108.581 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.559 HG23 HG22 ' A' ' 5' ' ' ILE . 70.0 t -126.29 133.5 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.004 0.522 . . . . 0.0 109.615 170.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.466 HG12 ' HB ' ' A' ' 98' ' ' ILE . 5.2 mt -100.65 114.84 40.79 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 164.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -96.65 150.84 20.22 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 166.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -138.09 106.34 5.77 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.62 ' HG2' HD12 ' A' ' 66' ' ' LEU . 6.6 mt-10 -115.75 158.98 22.02 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.344 0.658 . . . . 0.0 109.558 176.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 92' ' ' GLU . 56.9 m -97.05 103.14 15.04 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 163.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.53 125.2 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.452 0.644 . . . . 0.0 111.319 -175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.9 m -76.28 122.92 25.11 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.121 0.969 . . . . 0.0 111.708 -175.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.2 mmt-85 -119.97 -168.29 1.58 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.623 1.169 . . . . 0.0 109.189 172.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.81 104.99 9.29 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.275 1.03 . . . . 0.0 109.539 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.435 ' HE2' ' HB3' ' A' ' 116' ' ' PRO . 12.6 m-30 -112.4 149.46 41.09 Favored Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 123.558 0.743 . . . . 0.0 111.054 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.61 -18.84 64.05 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.952 2.435 . . . . 0.0 113.608 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -87.0 -4.38 59.17 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.44 -122.68 1.48 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.931 -0.372 . . . . 0.0 112.466 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.414 ' H ' HG23 ' A' ' 118' ' ' ILE . 16.2 tppt? -60.43 -82.14 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.983 0.913 . . . . 0.0 111.5 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.415 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 115.41 26.92 3.27 Favored Glycine 0 C--N 1.343 0.952 0 O-C-N 122.953 0.158 . . . . 0.0 113.205 -175.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.458 ' HB2' HG22 ' A' ' 81' ' ' THR . 16.9 pt-20 -89.21 104.7 17.22 Favored 'General case' 0 C--O 1.207 -1.138 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -174.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 116' ' ' PRO . 20.3 m -105.16 131.12 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 121.33 -0.856 . . . . 0.0 109.973 -171.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -78.33 127.91 32.91 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.518 HG22 HG12 ' A' ' 113' ' ' ILE . 43.1 t -131.57 126.25 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.09 99.41 12.43 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 172.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.6 m -94.81 108.51 20.53 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.152 0.981 . . . . 0.0 108.843 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.611 HG23 ' HB2' ' A' ' 110' ' ' TRP . 11.1 tt -105.86 107.23 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 C-N-CA 124.403 1.081 . . . . 0.0 110.735 -172.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -104.14 131.17 51.7 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.35 1.06 . . . . 0.0 110.024 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -97.82 112.03 24.09 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 168.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.52 HG22 HG12 ' A' ' 106' ' ' ILE . 75.2 t -99.62 125.1 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.077 0.951 . . . . 0.0 109.15 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.528 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 11.4 tp10 -125.81 127.94 46.9 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.476 0.71 . . . . 0.0 109.981 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.528 ' ND2' ' HG3' ' A' ' 102' ' ' GLU . 43.5 m-80 61.48 30.43 18.82 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.45 1.5 . . . . 0.0 112.116 -176.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.54 1.95 90.56 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 113.781 0.272 . . . . 0.0 113.781 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -124.79 136.0 53.46 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.047 0.939 . . . . 0.0 109.007 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.52 HG12 HG22 ' A' ' 101' ' ' VAL . 68.8 mt -62.43 102.86 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.252 1.021 . . . . 0.0 109.811 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -78.47 -29.89 47.09 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.291 0.636 . . . . 0.0 110.765 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -148.57 143.26 26.49 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -137.05 131.03 32.22 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.611 ' HB2' HG23 ' A' ' 98' ' ' ILE . 0.9 OUTLIER -135.37 152.86 51.84 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -176.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -143.0 144.85 32.46 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -130.82 123.7 29.69 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.518 HG12 HG22 ' A' ' 95' ' ' VAL . 96.7 mt -88.22 127.48 41.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.93 -78.82 0.16 Allowed Glycine 0 N--CA 1.468 0.826 0 O-C-N 124.331 1.019 . . . . 0.0 112.667 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -158.83 164.58 20.65 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.712 ' HA ' HG12 ' A' ' 93' ' ' VAL . 72.3 Cg_endo -72.2 117.69 5.26 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.433 2.089 . . . . 0.0 112.581 169.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.422 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 15.6 mmt180 -102.11 144.11 31.09 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.439 HG22 ' H ' ' A' ' 120' ' ' SER . 49.4 mm -122.83 152.37 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 173.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.0 t -59.43 -26.8 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 122.646 0.378 . . . . 0.0 111.402 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.439 ' H ' HG22 ' A' ' 118' ' ' ILE . 83.3 p -64.17 -41.13 97.26 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.399 0.68 . . . . 0.0 110.725 173.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -96.92 3.0 52.31 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.438 1.095 . . . . 0.0 111.888 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -132.06 -166.81 1.78 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--O 1.249 1.073 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 171.763 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.436 HD22 HD13 ' A' ' 71' ' ' ILE . 3.5 p-10 -155.28 -2.32 0.15 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.365 0.666 . . . . 0.0 111.438 -178.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.44 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 78.7 p -63.78 -37.79 88.69 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.463 ' HG3' HG12 ' A' ' 5' ' ' ILE . 9.5 pt-20 -55.8 -28.28 55.41 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.72 1.208 . . . . 0.0 112.716 174.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.575 HG13 ' HA ' ' A' ' 74' ' ' ASN . 32.8 mm -89.83 -27.88 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.492 1.117 . . . . 0.0 109.826 -177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.39 -24.04 60.25 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.117 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 3' ' ' SER . 79.5 mt -63.6 -50.65 71.34 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.725 -175.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.465 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 11.6 Cg_endo -55.96 -60.4 0.52 Allowed 'Trans proline' 0 C--N 1.394 2.932 0 C-N-CA 121.866 1.711 . . . . 0.0 111.984 172.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.3 t -51.07 -48.95 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 C-N-CA 124.509 1.123 . . . . 0.0 113.347 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -63.09 -52.21 63.56 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.173 0.989 . . . . 0.0 110.937 -176.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -63.54 -37.17 86.29 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.029 0.532 . . . . 0.0 111.282 -177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -68.26 -38.1 81.42 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.116 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' A' ' 66' ' ' LEU . 50.8 tp -62.53 -50.86 69.69 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.524 0.73 . . . . 0.0 110.872 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 4.0 mm-40 -55.42 -47.23 76.27 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.31 1.007 . . . . 0.0 109.477 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 20' ' ' ASP . . . -66.22 -28.79 69.01 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.229 -1.35 . . . . 0.0 112.329 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -67.45 -48.26 67.76 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.176 0.59 . . . . 0.0 110.488 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -83.71 -14.67 51.11 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.251 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.96 0.4 55.95 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.425 0.69 . . . . 0.0 111.992 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 62.71 26.0 15.4 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.463 1.105 . . . . 0.0 111.851 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.402 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 13.1 t70 -96.48 110.57 22.92 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.793 1.237 . . . . 0.0 109.31 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.408 HG13 HG12 ' A' ' 54' ' ' ILE . 23.4 mm -76.84 -32.89 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.1 0.56 . . . . 0.0 110.999 173.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 24.8 t70 -58.19 -49.06 78.38 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.745 0.653 . . . . 0.0 112.161 -168.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -84.81 -35.63 22.2 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.177 0.991 . . . . 0.0 111.392 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -63.01 -14.18 44.67 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.293 0.371 . . . . 0.0 112.0 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 68.2 mmm -120.66 -14.4 8.6 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -60.79 -36.51 79.19 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.552 0.691 . . . . 0.0 112.304 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 91.8 m95 -93.57 14.03 20.13 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.718 -170.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.614 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 19.3 m95 -99.12 152.45 19.85 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.778 0.831 . . . . 0.0 109.267 174.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -78.92 154.54 29.58 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.262 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.44 -32.04 72.84 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.118 0.567 . . . . 0.0 111.184 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -99.42 17.9 19.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.889 0.875 . . . . 0.0 111.337 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.614 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 46.9 t -64.54 117.92 8.06 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 123.209 0.318 . . . . 0.0 111.549 -174.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -77.68 154.09 32.47 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -139.39 110.44 6.87 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.475 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 96.4 m-85 -113.37 138.33 50.22 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.818 0.847 . . . . 0.0 110.572 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.537 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -92.21 154.95 18.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.459 166.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -50.04 130.03 22.73 Favored Pre-proline 0 CA--C 1.567 1.617 0 C-N-CA 124.268 1.027 . . . . 0.0 112.508 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.43 -36.34 2.15 Favored 'Cis proline' 0 C--N 1.383 2.371 0 CA-C-N 119.967 1.024 . . . . 0.0 112.134 -4.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . . . -159.62 94.57 1.16 Allowed 'General case' 0 C--N 1.345 0.41 0 C-N-CA 124.821 1.248 . . . . 0.0 107.748 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 7.2 m -130.18 102.4 6.21 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.5 tp -73.1 100.89 3.15 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 117.961 0.346 . . . . 0.0 110.447 -175.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -83.36 -34.31 25.63 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -146.37 116.91 7.54 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.81 -173.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -107.53 46.66 1.14 Allowed Glycine 0 C--N 1.347 1.147 0 C-N-CA 123.032 0.349 . . . . 0.0 113.034 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.425 ' O ' HG13 ' A' ' 49' ' ' ILE . 9.6 p30 162.08 154.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 126.149 1.78 . . . . 0.0 109.227 -171.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -63.5 -26.28 68.64 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -175.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -62.22 -51.4 67.93 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.803 0.441 . . . . 0.0 110.98 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.443 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.0 mt-10 -68.41 -33.43 74.21 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.108 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 45' ' ' ASN . 54.2 mt -69.2 -43.14 81.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 122.962 0.505 . . . . 0.0 110.264 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.487 ' O ' HG13 ' A' ' 54' ' ' ILE . 32.0 ptt180 -69.87 -45.18 68.28 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.605 -173.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.8 m -68.95 -35.03 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 122.859 0.463 . . . . 0.0 111.894 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -71.41 -40.1 70.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.297 0.639 . . . . 0.0 110.357 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -64.61 -33.33 75.68 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.57 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 50' ' ' ARG . 97.0 mt -58.16 -47.07 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 122.557 0.343 . . . . 0.0 110.184 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.21 -33.3 75.09 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.455 0.702 . . . . 0.0 111.498 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -66.79 -35.04 79.15 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.174 0.59 . . . . 0.0 110.956 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -78.75 -2.45 39.47 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.21 0.604 . . . . 0.0 112.02 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -84.58 -19.71 32.63 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.948 0.499 . . . . 0.0 110.756 171.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.11 113.55 8.17 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 123.694 0.798 . . . . 0.0 109.813 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -61.35 -32.23 89.37 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 123.107 2.538 . . . . 0.0 113.547 -169.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.22 -0.6 56.79 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.723 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.6 tp -62.82 118.9 8.37 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.202 0.455 . . . . 0.0 111.359 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.456 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 76.3 t80 -151.02 127.56 10.77 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.84 104.2 2.53 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -97.83 100.89 12.27 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.168 0.587 . . . . 0.0 109.51 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' HB2' HD11 ' A' ' 13' ' ' LEU . 7.7 tt -79.53 129.7 34.71 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.458 HD11 ' CD2' ' A' ' 79' ' ' HIS . 1.7 pp -115.9 -29.8 6.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.468 -175.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.5 m -150.69 143.79 24.77 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.957 0.903 . . . . 0.0 109.559 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -143.61 136.92 27.93 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.56 0.744 . . . . 0.0 109.326 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.78 130.88 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' A' ' 5' ' ' ILE . 9.5 tt -121.98 136.51 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.031 0.532 . . . . 0.0 110.258 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 p -143.35 110.05 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 C-N-CA 124.678 1.191 . . . . 0.0 109.186 -176.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.78 -119.71 9.26 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.202 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.575 ' HA ' HG13 ' A' ' 5' ' ' ILE . 27.0 p-10 -108.63 19.86 19.22 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.275 0.63 . . . . 0.0 111.077 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -127.48 133.63 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.09 0.956 . . . . 0.0 109.251 -175.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 15.1 t -122.57 138.97 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.175 0.59 . . . . 0.0 110.255 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.639 HD13 ' HB ' ' A' ' 98' ' ' ILE . 6.7 mm -104.96 111.9 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.061 1.344 . . . . 0.0 107.708 167.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -106.35 116.06 31.28 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.458 ' CD2' HD11 ' A' ' 67' ' ' LEU . 1.5 t60 -99.83 109.01 21.43 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.36 140.05 52.06 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.947 1.299 . . . . 0.0 110.624 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.1 m -86.1 106.5 17.28 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.82 0.848 . . . . 0.0 109.131 169.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.4 t -82.79 104.08 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.754 0.822 . . . . 0.0 110.441 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.47 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 25.3 m -68.06 127.99 34.89 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.089 0.556 . . . . 0.0 110.425 170.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -139.07 -170.24 2.83 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.801 0.84 . . . . 0.0 109.097 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -119.3 100.55 7.38 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.877 0.471 . . . . 0.0 110.648 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.404 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 13.4 m-30 -100.22 142.6 24.92 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 123.714 0.806 . . . . 0.0 109.65 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.04 -23.03 66.79 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.983 2.455 . . . . 0.0 114.026 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -86.54 -4.91 59.24 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.22 -134.24 3.41 Favored Glycine 0 N--CA 1.474 1.174 0 CA-C-O 119.566 -0.574 . . . . 0.0 111.83 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.411 ' CG ' ' HG3' ' A' ' 92' ' ' GLU . 3.0 tppp? -53.15 -87.24 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.659 0.784 . . . . 0.0 112.804 172.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.404 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 124.37 26.69 1.44 Allowed Glycine 0 C--N 1.347 1.155 0 N-CA-C 113.761 0.265 . . . . 0.0 113.761 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.47 ' HG2' ' HA ' ' A' ' 83' ' ' THR . 46.8 mt-10 -89.61 115.51 27.06 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 117.099 0.45 . . . . 0.0 109.943 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.554 HG12 ' HA ' ' A' ' 116' ' ' PRO . 17.2 m -108.96 130.12 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.432 0.693 . . . . 0.0 109.613 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.435 ' HB3' ' HE1' ' A' ' 79' ' ' HIS . 1.3 m-20 -85.45 108.81 18.06 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.408 HG22 HG12 ' A' ' 113' ' ' ILE . 34.6 t -113.18 162.55 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 125.108 1.363 . . . . 0.0 108.995 -171.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.18 102.71 6.35 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.573 1.149 . . . . 0.0 108.029 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 80.6 m -93.1 107.92 19.62 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.712 HG23 ' HB2' ' A' ' 110' ' ' TRP . 5.7 tt -102.59 111.05 31.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.148 -176.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -100.46 153.85 19.02 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.618 0.767 . . . . 0.0 110.601 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -126.66 117.45 22.77 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.263 1.425 . . . . 0.0 107.47 171.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.484 HG22 HG12 ' A' ' 106' ' ' ILE . 86.2 t -109.02 124.31 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.266 1.026 . . . . 0.0 110.254 -173.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 10.6 tp10 -131.57 135.5 47.05 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.032 0.933 . . . . 0.0 109.406 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.521 ' ND2' ' HG3' ' A' ' 102' ' ' GLU . 54.1 m-80 62.5 30.02 17.13 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.726 1.211 . . . . 0.0 112.488 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.47 7.82 79.43 Favored Glycine 0 N--CA 1.478 1.499 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.843 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -127.26 148.12 50.22 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.994 1.318 . . . . 0.0 108.149 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.484 HG12 HG22 ' A' ' 101' ' ' VAL . 53.0 mt -69.29 113.72 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -78.03 -36.66 48.33 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.703 0.801 . . . . 0.0 111.105 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.584 ' HE2' ' HE1' ' A' ' 110' ' ' TRP . 61.4 mtpt -150.59 132.49 15.12 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.055 0.942 . . . . 0.0 108.66 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -124.69 132.58 53.38 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.712 ' HB2' HG23 ' A' ' 98' ' ' ILE . 1.6 m-90 -130.77 152.45 50.1 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -176.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -144.25 147.02 33.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.797 0.332 . . . . 0.0 110.201 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -128.95 117.92 21.77 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.965 0.906 . . . . 0.0 109.064 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.408 HG12 HG22 ' A' ' 95' ' ' VAL . 94.5 mt -86.79 132.72 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.74 -83.12 0.09 OUTLIER Glycine 0 CA--C 1.526 0.778 0 O-C-N 123.708 0.63 . . . . 0.0 112.05 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.15 166.29 16.84 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.498 0.719 . . . . 0.0 109.463 175.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.554 ' HA ' HG12 ' A' ' 93' ' ' VAL . 51.5 Cg_endo -65.85 110.42 1.69 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.532 2.155 . . . . 0.0 113.111 168.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -109.6 149.83 29.09 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.83 0.852 . . . . 0.0 110.232 173.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 50.4 mm -124.68 154.93 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.4 t -70.98 -47.17 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.0 t -68.26 -16.3 63.91 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.344 0.658 . . . . 0.0 111.773 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.439 ' HB3' ' O ' ' A' ' 118' ' ' ILE . 34.4 tt0 -59.41 -41.63 89.92 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.901 0.88 . . . . 0.0 110.324 170.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.85 80.33 2.31 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 172.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 C--O 1.254 1.304 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.8 -178.168 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.1 m120 57.93 53.75 6.64 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.677 1.191 . . . . 0.0 112.219 167.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 m -66.31 -39.05 89.05 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.711 0.804 . . . . 0.0 111.345 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.18 -12.37 60.82 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.112 0.565 . . . . 0.0 111.808 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.9 mm -98.02 -39.15 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.927 0.891 . . . . 0.0 109.391 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -58.91 -44.58 91.28 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.54 1.136 . . . . 0.0 112.338 177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.53 -57.11 24.2 Favored Pre-proline 0 CA--C 1.561 1.391 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.883 -171.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.575 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 21.1 Cg_endo -58.27 -48.76 14.47 Favored 'Trans proline' 0 C--N 1.395 3.022 0 C-N-CA 122.401 2.067 . . . . 0.0 112.28 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.2 t -59.27 -44.06 91.26 Favored 'Isoleucine or valine' 0 C--O 1.247 0.956 0 C-N-CA 124.91 1.284 . . . . 0.0 112.605 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -46.07 67.06 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -63.35 -27.74 69.52 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.786 0.834 . . . . 0.0 111.919 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -63.2 -46.18 88.24 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.684 0.615 . . . . 0.0 110.221 175.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.16 -53.76 52.95 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.153 0.908 . . . . 0.0 109.218 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -52.17 -36.37 51.5 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 124.653 1.221 . . . . 0.0 111.089 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -81.75 -27.96 33.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.651 1.18 . . . . 0.0 112.195 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -69.66 -48.41 59.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.721 0.409 . . . . 0.0 110.267 -172.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -76.07 -28.97 57.8 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.932 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.46 1.16 56.92 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.55 0.74 . . . . 0.0 112.051 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 67.64 18.79 9.87 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.577 1.151 . . . . 0.0 112.797 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.48 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 67.9 m-20 -88.59 95.3 10.19 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.964 0.506 . . . . 0.0 110.467 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.404 ' HA ' ' HB3' ' A' ' 24' ' ' PHE . 23.9 mm -67.77 -26.87 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 123.024 0.53 . . . . 0.0 110.648 172.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -52.44 -48.38 65.84 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.485 0.714 . . . . 0.0 111.59 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.37 -35.0 31.34 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.883 0.473 . . . . 0.0 110.952 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.404 ' HB3' ' HA ' ' A' ' 21' ' ' ILE . 16.2 t80 -71.07 -5.84 34.52 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.617 0.767 . . . . 0.0 111.279 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.57 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 19.6 tpp -121.03 -25.62 5.3 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.173 0.589 . . . . 0.0 112.456 172.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.13 -44.22 74.84 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.1 m95 -82.71 -3.79 56.94 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -172.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -91.36 149.16 21.85 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.387 0.675 . . . . 0.0 109.8 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -74.05 152.26 40.01 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.349 0.66 . . . . 0.0 110.033 176.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.94 -23.93 65.13 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.112 0.482 . . . . 0.0 110.929 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -102.26 18.61 20.52 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.68 1.192 . . . . 0.0 111.114 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 42.1 t -64.57 122.98 18.07 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.931 0.396 . . . . 0.0 111.916 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -83.11 154.38 24.38 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.493 0.717 . . . . 0.0 109.481 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 33.9 t80 -145.68 120.69 10.05 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.407 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 43.3 m-85 -121.18 153.92 36.92 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.279 1.032 . . . . 0.0 110.484 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -120.44 159.83 24.34 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.385 1.074 . . . . 0.0 110.702 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.641 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 82.9 t80 -62.37 130.71 93.44 Favored Pre-proline 0 CA--C 1.56 1.36 0 O-C-N 124.18 0.925 . . . . 0.0 110.383 174.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.67 -47.43 0.31 Allowed 'Cis proline' 0 C--N 1.386 2.506 0 CA-C-N 120.697 1.285 . . . . 0.0 113.447 -1.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.68 93.35 0.82 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 98.3 m -141.33 115.79 9.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.155 0.582 . . . . 0.0 109.6 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 tt -70.8 101.71 2.17 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 36' ' ' ALA . 94.7 mt -80.64 -37.84 30.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.554 0.741 . . . . 0.0 110.868 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -148.23 121.24 8.82 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.421 0.451 . . . . 0.0 111.185 -171.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.4 39.55 2.81 Favored Glycine 0 C--N 1.35 1.327 0 C-N-CA 123.116 0.389 . . . . 0.0 113.26 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 166.06 165.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 125.847 1.659 . . . . 0.0 109.155 -171.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.57 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -66.54 -36.81 83.59 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.749 0.82 . . . . 0.0 112.748 -175.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.11 -46.87 84.82 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.15 0.58 . . . . 0.0 111.743 -174.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.1 mt-10 -72.85 -29.99 63.65 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.487 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.1 mt -67.43 -44.41 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.007 0.523 . . . . 0.0 109.704 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.43 ' O ' HG13 ' A' ' 54' ' ' ILE . 76.6 ttt180 -59.83 -56.1 26.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.552 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.5 m -61.58 -41.59 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 124.429 1.081 . . . . 0.0 112.563 -173.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -72.17 -29.15 63.73 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.145 0.578 . . . . 0.0 110.96 -176.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -77.94 -30.83 50.63 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 118.929 -0.558 . . . . 0.0 111.2 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 50' ' ' ARG . 99.0 mt -59.69 -41.28 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -61.9 -38.36 88.08 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.919 0.888 . . . . 0.0 111.414 175.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -78.84 -23.33 45.09 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.141 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -84.12 0.62 47.76 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.295 0.638 . . . . 0.0 110.931 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -79.76 -20.36 46.49 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.064 0.545 . . . . 0.0 111.673 170.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 7.3 mm-40 -64.45 112.86 8.67 Favored Pre-proline 0 CA--C 1.547 0.846 0 O-C-N 123.805 0.691 . . . . 0.0 109.802 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -65.63 -18.34 58.71 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.333 2.022 . . . . 0.0 112.24 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.02 2.85 46.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.377 1.071 . . . . 0.0 111.714 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 19.4 tp -66.28 116.14 7.0 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.627 0.371 . . . . 0.0 110.15 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -145.02 117.87 8.74 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.438 ' HA2' HG12 ' A' ' 82' ' ' VAL . . . -93.45 103.48 3.04 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 175.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.44 98.14 10.01 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.5 tt -86.72 126.47 34.59 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.431 HD11 ' CD2' ' A' ' 79' ' ' HIS . 2.3 pp -114.32 -30.17 6.68 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.276 1.03 . . . . 0.0 110.438 -171.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.8 m -155.17 132.85 11.29 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.429 1.092 . . . . 0.0 109.055 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 0.8 OUTLIER -132.45 134.71 45.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.59 0.756 . . . . 0.0 109.288 167.181 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 77' ' ' ILE . 30.1 m -118.88 119.8 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.561 0.745 . . . . 0.0 109.807 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.449 HG13 HG22 ' A' ' 76' ' ' VAL . 17.3 tt -95.29 129.4 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-O 121.321 0.581 . . . . 0.0 109.504 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 p -141.01 96.41 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.515 1.126 . . . . 0.0 108.65 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.76 -128.08 31.67 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.337 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -83.43 3.47 31.83 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.698 0.799 . . . . 0.0 112.578 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.1 t -126.45 134.97 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.811 0.844 . . . . 0.0 109.765 -171.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.449 HG22 HG13 ' A' ' 71' ' ' ILE . 21.6 t -124.18 140.6 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 122.988 0.515 . . . . 0.0 109.627 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.509 HD13 ' HB ' ' A' ' 98' ' ' ILE . 16.2 mm -99.27 103.26 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 172.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -90.35 104.65 17.2 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.431 ' CD2' HD11 ' A' ' 67' ' ' LEU . 2.0 t60 -98.07 108.36 21.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -117.41 152.29 35.28 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.288 -1.324 . . . . 0.0 109.611 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.5 m -103.19 101.87 11.83 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 159.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.438 HG12 ' HA2' ' A' ' 64' ' ' GLY . 32.8 m -91.97 127.81 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.065 0.459 . . . . 0.0 110.367 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.3 m -75.71 120.49 21.17 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.149 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.577 HH21 HG11 ' A' ' 93' ' ' VAL . 61.3 mtm180 -125.05 -163.51 1.19 Allowed 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -127.8 109.24 11.43 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 118.284 0.493 . . . . 0.0 111.074 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.418 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 19.2 m-30 -108.34 144.6 29.81 Favored Pre-proline 0 N--CA 1.481 1.095 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.57 -7.52 20.98 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.791 2.328 . . . . 0.0 112.807 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -84.17 -20.72 31.92 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.065 0.946 . . . . 0.0 111.804 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.07 -125.15 1.09 Allowed Glycine 0 C--N 1.349 1.256 0 CA-C-O 119.549 -0.584 . . . . 0.0 111.962 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -59.61 -80.54 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.188 0.995 . . . . 0.0 111.931 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.418 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 118.52 24.12 3.24 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 116.308 -0.405 . . . . 0.0 113.048 -177.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.562 ' HG3' ' HB2' ' A' ' 117' ' ' ARG . 7.1 pt-20 -87.54 147.68 25.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.577 HG11 HH21 ' A' ' 84' ' ' ARG . 7.5 m -138.59 134.96 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 121.975 -0.453 . . . . 0.0 111.388 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.67 111.08 13.07 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.329 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.483 HG22 HG12 ' A' ' 113' ' ' ILE . 48.9 t -124.64 144.93 32.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 124.169 0.988 . . . . 0.0 108.95 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -106.5 107.3 18.24 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 170.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 56.5 m -93.12 104.34 16.55 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.593 HG23 ' HB2' ' A' ' 110' ' ' TRP . 5.5 tt -105.99 109.82 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.217 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -104.13 151.47 23.27 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.528 0.731 . . . . 0.0 110.549 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -121.43 114.33 21.12 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.144 0.978 . . . . 0.0 108.628 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.54 HG22 HG12 ' A' ' 106' ' ' ILE . 45.1 t -101.74 115.21 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.077 0.951 . . . . 0.0 109.2 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 41.7 tt0 -116.75 128.77 55.62 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.151 0.981 . . . . 0.0 109.006 176.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 62.25 32.37 17.18 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.951 0.901 . . . . 0.0 111.462 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.42 11.67 84.13 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 114.595 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -133.02 136.73 46.18 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.485 1.114 . . . . 0.0 108.679 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.54 HG12 HG22 ' A' ' 101' ' ' VAL . 60.0 mt -66.63 100.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -78.05 -28.07 48.86 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.227 0.611 . . . . 0.0 110.967 -175.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -149.58 153.77 37.64 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.076 0.951 . . . . 0.0 108.592 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -148.67 134.54 18.99 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.593 ' HB2' HG23 ' A' ' 98' ' ' ILE . 1.7 m-90 -135.53 154.8 51.27 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -143.03 146.37 33.78 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 169.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.641 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 17.1 ptpt -129.34 124.52 34.49 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.916 0.886 . . . . 0.0 109.182 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.483 HG12 HG22 ' A' ' 95' ' ' VAL . 92.1 mt -88.19 119.19 35.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.26 -63.41 3.27 Favored Glycine 0 N--CA 1.465 0.624 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.684 -177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -157.16 166.4 16.72 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 122.768 0.427 . . . . 0.0 110.35 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.574 ' HA ' HG12 ' A' ' 93' ' ' VAL . 97.2 Cg_endo -75.67 132.69 14.81 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.653 2.235 . . . . 0.0 112.069 163.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.562 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 15.6 mmt180 -115.84 140.84 48.84 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.381 1.072 . . . . 0.0 108.567 175.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.469 ' HB ' ' HB2' ' A' ' 121' ' ' GLN . 42.2 mm -132.04 149.8 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.3 t -60.91 -42.98 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 120.732 0.301 . . . . 0.0 110.466 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.406 ' H ' HG22 ' A' ' 118' ' ' ILE . 47.6 t -76.7 -62.75 1.53 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.334 0.653 . . . . 0.0 109.793 175.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.469 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 41.5 mt-30 -80.87 81.16 7.19 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -118.75 113.81 21.72 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.821 0.848 . . . . 0.0 109.604 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.1 t . . . . . 0 CA--C 1.553 1.06 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.627 174.691 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 121.201 0.524 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.582 ' HB2' HD13 ' A' ' 71' ' ' ILE . 3.3 p-10 -172.51 -23.14 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.376 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 81.8 p -62.26 -43.98 97.58 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.977 0.511 . . . . 0.0 110.084 -177.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -64.37 -14.68 57.82 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.676 1.19 . . . . 0.0 112.679 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.54 HG23 ' HB ' ' A' ' 101' ' ' VAL . 44.0 mm -89.85 -34.21 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.864 0.866 . . . . 0.0 109.992 174.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -84.97 -10.09 57.4 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.256 0.622 . . . . 0.0 111.709 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 3' ' ' SER . 65.3 mt -65.93 -54.46 27.78 Favored Pre-proline 0 N--CA 1.481 1.123 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.092 174.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.502 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 13.0 Cg_endo -56.32 -46.73 28.4 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 121.752 1.635 . . . . 0.0 112.572 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.626 ' HA ' HE21 ' A' ' 12' ' ' GLN . 54.8 t -64.48 -45.89 94.39 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 124.048 0.939 . . . . 0.0 113.215 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -41.33 65.78 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -176.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -66.6 -26.39 67.07 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.907 0.483 . . . . 0.0 111.329 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.626 HE21 ' HA ' ' A' ' 9' ' ' VAL . 39.6 mt-30 -60.89 -46.53 90.25 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.168 0.292 . . . . 0.0 110.232 171.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.93 -51.97 67.41 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 123.516 0.51 . . . . 0.0 109.702 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -55.19 -34.39 63.84 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 124.684 1.24 . . . . 0.0 110.145 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -82.45 -27.65 31.77 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.776 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -71.01 -44.07 66.64 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.871 0.469 . . . . 0.0 110.298 -171.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -79.39 -28.55 41.85 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.004 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.2 5.02 52.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.578 0.751 . . . . 0.0 112.24 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 64.79 13.26 8.33 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.035 1.334 . . . . 0.0 113.992 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.511 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 18.6 m-20 -76.91 95.13 4.04 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.297 0.57 . . . . 0.0 111.583 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.437 HG13 HG12 ' A' ' 54' ' ' ILE . 29.5 mm -64.33 -25.49 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.144 0.578 . . . . 0.0 110.365 167.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -50.44 -50.55 51.84 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.99 0.916 . . . . 0.0 111.194 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -82.68 -37.72 24.41 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.181 0.592 . . . . 0.0 110.762 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -66.83 -6.63 16.96 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.215 0.606 . . . . 0.0 111.565 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.764 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -120.56 -30.63 4.48 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 171.325 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.44 -34.92 73.11 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.166 0.507 . . . . 0.0 112.303 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.502 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 99.4 m95 -88.54 4.0 48.33 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.867 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.445 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 16.2 m95 -102.97 157.31 17.07 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.64 0.776 . . . . 0.0 109.9 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -81.8 148.84 28.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.825 0.85 . . . . 0.0 109.404 171.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -66.45 -24.1 66.38 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.336 0.589 . . . . 0.0 111.031 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -86.51 -2.26 58.32 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.143 1.377 . . . . 0.0 111.724 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 42.3 t -59.89 132.89 55.33 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -167.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -88.12 154.7 20.25 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.453 0.701 . . . . 0.0 109.957 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -145.19 110.08 5.11 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.414 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 36.7 m-85 -111.1 155.19 23.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.951 0.9 . . . . 0.0 110.644 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.32 159.52 20.12 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.278 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.561 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 90.5 t80 -52.06 127.32 36.79 Favored Pre-proline 0 N--CA 1.486 1.342 0 C-N-CA 123.95 0.9 . . . . 0.0 111.149 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.8 -47.56 0.31 Allowed 'Cis proline' 0 C--N 1.387 2.556 0 CA-C-N 120.614 1.255 . . . . 0.0 113.681 -1.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.44 79.26 0.44 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.0 m -123.33 106.96 11.13 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.703 0.801 . . . . 0.0 109.282 -176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.2 tp -67.0 102.34 0.97 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.032 0.533 . . . . 0.0 110.198 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.6 mt -81.85 -36.67 28.0 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.973 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -145.57 116.56 7.81 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.372 -174.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.46 41.07 2.22 Favored Glycine 0 N--CA 1.474 1.181 0 C-N-CA 122.986 0.327 . . . . 0.0 113.398 -175.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.5 p30 164.82 152.18 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 126.226 1.81 . . . . 0.0 108.852 -173.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -61.98 -26.78 68.42 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.965 0.906 . . . . 0.0 113.149 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -63.77 -38.32 90.66 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.44 0.296 . . . . 0.0 111.547 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.509 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 27.2 mt-10 -77.77 -31.22 51.83 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.997 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.7 mt -68.62 -41.36 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.759 0.824 . . . . 0.0 111.265 -177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.764 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 5.7 ptp180 -62.8 -45.9 90.47 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.069 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.403 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 96.5 t -54.8 -55.29 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.686 0.795 . . . . 0.0 110.29 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -52.07 -44.1 64.16 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.926 1.29 . . . . 0.0 111.963 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -78.35 -34.64 48.28 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.025 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.437 HG12 HG13 ' A' ' 21' ' ' ILE . 97.0 mt -60.77 -45.3 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-N 118.982 0.81 . . . . 0.0 109.472 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 51' ' ' VAL . 43.4 mt-10 -63.77 -32.84 74.47 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.355 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -88.22 -15.98 34.47 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -85.97 -4.53 59.19 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.107 0.563 . . . . 0.0 110.556 173.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.71 -20.21 63.54 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.265 0.626 . . . . 0.0 111.533 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 20.3 mm-40 -65.97 120.21 67.49 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.431 0.692 . . . . 0.0 110.314 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.14 -18.75 18.18 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.222 1.948 . . . . 0.0 112.249 174.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -81.62 -22.9 37.36 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.24 0.616 . . . . 0.0 110.775 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 30.8 tp -56.29 129.97 42.56 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.808 0.843 . . . . 0.0 112.024 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.442 ' CE2' ' HB2' ' A' ' 65' ' ' GLU . 46.2 t80 -151.24 144.35 24.65 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.595 0.758 . . . . 0.0 109.617 175.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.58 118.78 5.08 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.844 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.442 ' HB2' ' CE2' ' A' ' 63' ' ' TYR . 35.6 tt0 -126.32 99.77 6.0 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.8 tt -80.43 140.31 36.04 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.185 0.517 . . . . 0.0 110.169 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mt -109.46 -51.84 2.83 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.285 -173.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.0 m -147.99 139.5 23.69 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.909 -172.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 14.1 ptt180 -131.6 119.65 21.76 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.321 0.648 . . . . 0.0 109.693 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -115.84 127.16 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.034 0.934 . . . . 0.0 109.044 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.582 HD13 ' HB2' ' A' ' 2' ' ' ASN . 13.8 tt -114.96 132.98 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-O 121.386 0.613 . . . . 0.0 111.534 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.9 t -117.75 103.33 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 125.42 1.488 . . . . 0.0 107.851 172.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.6 -102.81 0.42 Allowed Glycine 0 N--CA 1.476 1.345 0 N-CA-C 113.994 0.357 . . . . 0.0 113.994 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.535 ' HA ' HG13 ' A' ' 5' ' ' ILE . 23.4 p-10 -111.67 21.19 16.36 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.121 0.568 . . . . 0.0 112.284 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.0 p -135.6 135.04 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.025 0.53 . . . . 0.0 110.012 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -117.75 137.43 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.265 0.626 . . . . 0.0 109.663 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.626 HD13 ' HB ' ' A' ' 98' ' ' ILE . 7.7 mm -98.95 102.68 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 165.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -102.54 105.69 16.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -98.4 107.02 19.38 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.205 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -103.87 172.77 6.62 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.547 1.139 . . . . 0.0 110.955 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.2 m -116.14 102.69 9.83 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 160.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.7 m -88.5 133.38 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.661 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.0 m -88.12 128.37 35.43 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -155.27 146.98 23.2 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -77.94 103.74 8.07 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -166.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -92.37 127.6 48.13 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 165.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -62.41 -15.97 48.71 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.465 2.777 . . . . 0.0 114.224 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -83.59 -32.12 25.95 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.405 0.282 . . . . 0.0 111.636 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.84 -136.35 2.1 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-O 119.456 -0.636 . . . . 0.0 111.65 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -72.54 -79.41 0.08 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 117.318 0.559 . . . . 0.0 110.468 171.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.1 30.43 2.3 Favored Glycine 0 C--N 1.346 1.091 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.713 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 117' ' ' ARG . 0.1 OUTLIER -88.82 98.48 11.74 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-O 122.456 1.122 . . . . 0.0 108.227 -174.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 117' ' ' ARG . 20.7 m -104.59 145.61 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.374 -0.829 . . . . 0.0 111.14 -165.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -78.11 132.4 37.68 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 176.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.589 HG22 HG12 ' A' ' 113' ' ' ILE . 46.8 t -136.27 124.39 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.01 100.53 11.12 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.6 m -94.08 122.79 36.96 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 110' ' ' TRP . 6.2 tt -123.87 115.38 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.925 0.89 . . . . 0.0 109.814 -173.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -116.86 127.22 54.07 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.849 0.859 . . . . 0.0 110.41 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -98.57 111.1 23.57 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.54 ' HB ' HG23 ' A' ' 5' ' ' ILE . 99.5 t -98.39 130.45 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.691 1.196 . . . . 0.0 109.977 -174.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.474 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 10.8 tp10 -129.42 124.65 34.68 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.229 1.012 . . . . 0.0 109.298 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.474 ' ND2' ' HG3' ' A' ' 102' ' ' GLU . 52.9 m-80 62.65 37.25 13.0 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 124.876 1.271 . . . . 0.0 112.45 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.11 5.25 65.29 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 113.884 0.314 . . . . 0.0 113.884 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.8 mmt85 -122.79 135.13 54.45 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.614 1.166 . . . . 0.0 108.285 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.451 HG12 HG22 ' A' ' 101' ' ' VAL . 77.8 mt -65.56 105.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -86.4 -23.35 26.14 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.764 0.426 . . . . 0.0 111.2 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -147.1 149.26 32.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.813 0.845 . . . . 0.0 109.711 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.92 137.4 24.9 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.744 0.818 . . . . 0.0 109.088 -176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.641 ' HB2' HG23 ' A' ' 98' ' ' ILE . 4.5 m-90 -139.0 152.71 47.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -142.3 137.1 30.35 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 169.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 51.6 mtmt -126.15 129.65 49.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 173.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.589 HG12 HG22 ' A' ' 95' ' ' VAL . 90.8 mt -88.35 131.94 34.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.93 -75.24 0.28 Allowed Glycine 0 CA--C 1.527 0.783 0 O-C-N 124.12 0.888 . . . . 0.0 112.354 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.91 166.44 16.43 Favored Pre-proline 0 CA--C 1.554 1.096 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.35 137.6 51.97 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.307 2.005 . . . . 0.0 112.289 173.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 19.8 mmt180 -135.35 138.89 43.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.258 1.023 . . . . 0.0 109.078 -174.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.609 ' HB ' ' HB2' ' A' ' 121' ' ' GLN . 46.9 mm -126.62 143.53 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.7 t -57.18 -44.2 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.281 0.562 . . . . 0.0 110.679 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.508 ' H ' HG22 ' A' ' 118' ' ' ILE . 20.0 m -88.01 10.09 20.19 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.236 1.014 . . . . 0.0 112.931 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.609 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 35.2 tt0 -65.73 -40.26 91.97 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.243 0.617 . . . . 0.0 109.908 176.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -106.41 154.49 20.74 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.309 1.044 . . . . 0.0 109.337 171.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.251 1.153 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.807 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ppp? . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 112.027 0.381 . . . . 0.0 112.027 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -117.05 36.77 4.08 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.691 0.797 . . . . 0.0 109.698 176.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.2 m -63.31 -42.39 99.03 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.005 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -13.68 62.49 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.411 0.684 . . . . 0.0 112.374 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.504 HG23 ' HB ' ' A' ' 101' ' ' VAL . 26.9 mm -85.09 -32.05 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 122.94 0.496 . . . . 0.0 110.006 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.506 ' HG3' HD12 ' A' ' 71' ' ' ILE . 58.1 mt-10 -87.74 -10.02 52.32 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 176.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.2 mt -61.37 -50.24 84.11 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.256 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.465 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 18.4 Cg_endo -59.18 -50.95 7.46 Favored 'Trans proline' 0 C--N 1.389 2.697 0 CA-C-N 120.907 1.36 . . . . 0.0 111.285 172.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.501 HG21 HG21 ' A' ' 76' ' ' VAL . 63.4 t -50.55 -53.22 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 124.654 1.181 . . . . 0.0 113.029 -173.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 25.8 tp60 -61.77 -47.26 85.96 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.066 -177.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -71.18 -29.62 65.41 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.227 0.611 . . . . 0.0 111.824 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.447 ' HG2' ' HE1' ' A' ' 28' ' ' TRP . 44.8 mt-30 -62.4 -49.5 75.25 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.568 0.747 . . . . 0.0 109.775 176.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.486 HD22 HD13 ' A' ' 66' ' ' LEU . 31.9 tp -57.61 -52.06 66.97 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.47 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 13.4 mm-40 -58.38 -41.87 85.76 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.369 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -71.22 -28.28 64.09 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.25 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -68.43 -41.45 80.34 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.979 0.911 . . . . 0.0 110.54 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -83.61 -29.59 27.61 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.682 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.02 2.53 53.88 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.118 0.567 . . . . 0.0 112.462 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.51 HH21 ' HA ' ' A' ' 60' ' ' PRO . 37.7 mmt-85 69.77 8.11 6.56 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.118 1.367 . . . . 0.0 113.362 176.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.55 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 20.7 m-20 -77.27 94.57 4.17 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.219 0.533 . . . . 0.0 110.391 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.459 HG13 HG12 ' A' ' 54' ' ' ILE . 15.6 mm -67.81 -23.71 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 123.197 0.599 . . . . 0.0 109.705 167.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -54.56 -50.6 67.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.066 0.946 . . . . 0.0 112.196 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -82.5 -37.02 25.89 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.108 0.48 . . . . 0.0 110.496 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -65.92 -7.69 18.11 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.562 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.686 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -118.01 -30.88 5.23 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.957 -0.464 . . . . 0.0 112.22 172.464 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -30.96 69.48 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.05 0.54 . . . . 0.0 112.347 -175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 97.5 m95 -92.78 9.5 34.87 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.593 0.757 . . . . 0.0 112.693 -176.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.726 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 10.0 m95 -110.51 164.6 12.55 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.228 1.011 . . . . 0.0 108.906 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -82.78 153.78 25.07 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.836 0.454 . . . . 0.0 110.138 175.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.99 -27.67 68.99 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.976 0.511 . . . . 0.0 111.407 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -105.79 20.48 18.85 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.886 0.875 . . . . 0.0 110.697 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.726 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 44.0 t -57.7 113.1 1.68 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.867 0.365 . . . . 0.0 111.598 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -74.2 151.35 40.0 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 54.9 t80 -145.45 115.76 7.53 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -174.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.45 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 14.0 m-85 -115.06 156.38 25.27 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.949 1.3 . . . . 0.0 110.712 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -119.82 155.11 33.23 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.536 173.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.505 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 70.1 t80 -64.25 132.13 95.23 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.698 0.799 . . . . 0.0 111.477 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.81 -56.65 0.14 OUTLIER 'Cis proline' 0 C--N 1.386 2.505 0 CA-C-N 120.599 1.25 . . . . 0.0 113.958 -1.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.35 92.84 1.54 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.963 0.505 . . . . 0.0 109.665 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.0 m -135.72 109.16 7.88 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.595 0.758 . . . . 0.0 109.5 174.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.5 tt -69.11 103.11 1.8 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 36' ' ' ALA . 52.0 mt -78.58 -45.86 20.75 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.999 0.92 . . . . 0.0 109.951 178.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -135.1 124.96 25.51 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.475 -171.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.41 36.15 4.59 Favored Glycine 0 N--CA 1.475 1.297 0 O-C-N 123.076 0.235 . . . . 0.0 113.271 -174.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 167.93 158.63 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.503 1.521 . . . . 0.0 108.727 -171.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.491 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -57.95 -43.54 86.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.804 0.841 . . . . 0.0 112.532 -176.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.11 76.18 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.933 0.493 . . . . 0.0 112.091 -171.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -76.65 -31.46 57.35 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.831 0.452 . . . . 0.0 111.559 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.4 mt -65.1 -51.88 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.083 0.553 . . . . 0.0 110.271 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.686 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 21.2 ptt180 -64.63 -43.45 93.65 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.736 -172.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.518 ' HA ' HD12 ' A' ' 54' ' ' ILE . 30.2 m -66.29 -33.21 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 123.336 0.397 . . . . 0.0 111.696 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -71.75 -35.75 70.2 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.273 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -75.64 -29.37 59.13 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.439 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 51' ' ' VAL . 74.4 mt -55.32 -42.87 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 118.55 0.614 . . . . 0.0 109.973 177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.98 -40.03 87.72 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.965 0.906 . . . . 0.0 111.328 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.0 tpp85 -73.44 -28.62 62.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.718 0.807 . . . . 0.0 111.095 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -82.1 -9.05 59.66 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.829 0.852 . . . . 0.0 110.991 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 7.8 mmpt? -76.85 -34.24 57.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.477 0.311 . . . . 0.0 111.382 176.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -83.99 118.25 70.82 Favored Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.51 ' HA ' HH21 ' A' ' 19' ' ' ARG . 89.7 Cg_endo -74.13 -9.15 21.78 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.433 2.755 . . . . 0.0 114.193 -166.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' HB2' ' ND2' ' A' ' 85' ' ' ASN . 7.6 p-10 -77.87 -13.54 59.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.737 0.815 . . . . 0.0 111.097 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.3 tp -58.71 111.51 1.29 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.218 0.607 . . . . 0.0 110.603 175.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 91.3 t80 -149.91 115.4 5.51 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.09 101.96 2.06 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -84.49 101.51 12.12 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 78' ' ' ASP . 6.7 tt -84.79 128.31 34.55 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -176.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.475 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -116.84 -32.86 4.97 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.853 -167.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 99.0 m -147.9 138.56 23.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.087 0.955 . . . . 0.0 109.556 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -133.31 129.49 37.61 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 167.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.8 m -107.29 129.45 61.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 123.716 0.806 . . . . 0.0 109.593 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.506 HD12 ' HG3' ' A' ' 6' ' ' GLU . 10.5 tt -113.19 122.85 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.136 0.493 . . . . 0.0 110.145 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.28 94.13 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 56.66 -112.03 3.14 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 123.23 0.331 . . . . 0.0 113.664 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -99.15 15.82 24.76 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.452 0.701 . . . . 0.0 112.297 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.8 p -134.97 133.74 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.381 0.672 . . . . 0.0 109.19 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.501 HG21 HG21 ' A' ' 9' ' ' VAL . 64.4 t -123.01 136.03 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.98 0.512 . . . . 0.0 110.789 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.565 HG12 ' HB ' ' A' ' 98' ' ' ILE . 6.4 mt -103.11 119.9 52.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 163.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.615 ' HB2' HD11 ' A' ' 66' ' ' LEU . 6.9 p-10 -97.4 155.09 17.06 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 168.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -137.53 108.45 6.7 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.45 168.72 11.76 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.083 1.353 . . . . 0.0 109.715 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.2 m -115.65 105.58 12.92 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.107 168.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 63' ' ' TYR . 4.0 m -86.38 125.25 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.179 0.514 . . . . 0.0 110.944 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 62.8 m -72.35 117.63 14.24 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 170.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -125.46 120.92 32.31 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.401 ' ND2' ' HB2' ' A' ' 61' ' ' ASP . 0.9 OUTLIER -74.39 89.29 2.1 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.194 0.521 . . . . 0.0 110.95 -172.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -82.66 144.95 49.71 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.515 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.84 -20.21 58.26 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 123.158 2.572 . . . . 0.0 113.88 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -82.25 -27.44 32.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.114 0.565 . . . . 0.0 112.521 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.52 -134.62 2.96 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.823 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -55.74 -71.23 0.09 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.165 0.986 . . . . 0.0 111.28 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.489 ' H ' HD13 ' A' ' 118' ' ' ILE . . . 94.21 32.34 7.49 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.397 0.436 . . . . 0.0 113.066 175.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -86.89 107.89 18.54 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.745 0.783 . . . . 0.0 108.996 -173.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 116' ' ' PRO . 5.3 m -105.77 143.85 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.413 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -91.54 142.12 27.99 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.426 HG22 HG12 ' A' ' 113' ' ' ILE . 19.0 t -130.44 149.52 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.78 101.74 8.56 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.7 m -98.14 108.03 20.64 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.662 HG23 ' HB2' ' A' ' 110' ' ' TRP . 12.1 tt -98.82 112.46 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.066 0.946 . . . . 0.0 109.04 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.42 ' HE1' HG22 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -128.45 138.54 52.36 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.166 0.508 . . . . 0.0 110.938 178.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -98.7 113.3 25.32 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.342 1.057 . . . . 0.0 109.445 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.504 ' HB ' HG23 ' A' ' 5' ' ' ILE . 92.2 t -88.82 116.1 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.017 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.433 ' HG3' HD22 ' A' ' 103' ' ' ASN . 10.6 tp10 -124.44 128.61 49.28 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.153 0.981 . . . . 0.0 109.497 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.433 HD22 ' HG3' ' A' ' 102' ' ' GLU . 54.9 m-80 59.18 31.04 20.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.784 1.234 . . . . 0.0 111.856 -174.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.04 -20.1 30.93 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 115.568 -0.742 . . . . 0.0 113.738 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -107.07 140.46 39.85 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.319 1.048 . . . . 0.0 108.834 -172.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.408 HG12 HG22 ' A' ' 101' ' ' VAL . 64.1 mt -67.36 106.21 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.93 -34.07 44.87 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.281 0.633 . . . . 0.0 111.241 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -144.31 146.75 32.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.082 0.953 . . . . 0.0 108.685 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.9 137.9 35.21 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.674 0.789 . . . . 0.0 109.516 -177.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.662 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.5 m-90 -140.33 148.41 41.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -144.45 147.17 32.98 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.077 0.853 . . . . 0.0 111.097 174.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 21.5 ptmt -127.25 127.9 45.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.36 0.664 . . . . 0.0 109.494 172.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.426 HG12 HG22 ' A' ' 95' ' ' VAL . 80.0 mt -89.42 121.75 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.35 -94.72 0.02 OUTLIER Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.564 1.165 . . . . 0.0 114.497 -174.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -134.56 155.11 79.88 Favored Pre-proline 0 CA--C 1.547 0.827 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -177.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.707 ' HA ' HG12 ' A' ' 93' ' ' VAL . 41.4 Cg_endo -90.0 114.72 0.55 Allowed 'Trans proline' 0 C--N 1.364 1.38 0 C-N-CA 122.908 2.405 . . . . 0.0 113.394 174.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -111.79 153.4 26.61 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.415 0.626 . . . . 0.0 111.114 -175.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 121' ' ' GLN . 35.2 mm -131.11 156.06 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 124.572 1.149 . . . . 0.0 108.181 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.31 -43.97 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 122.654 0.381 . . . . 0.0 110.573 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.508 ' H ' HG22 ' A' ' 118' ' ' ILE . 32.8 t -72.46 -7.91 52.31 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.364 0.666 . . . . 0.0 112.102 177.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.54 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 36.5 tt0 -68.29 -34.03 75.43 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.682 0.793 . . . . 0.0 110.327 172.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.0 pttt -107.83 -172.18 2.02 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.19 0.996 . . . . 0.0 109.222 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.251 1.161 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 173.891 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -134.38 25.31 3.8 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.175 0.99 . . . . 0.0 109.06 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.493 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 13.1 m -61.7 -48.87 78.82 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.962 0.905 . . . . 0.0 110.719 -175.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -7.59 25.92 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.899 0.88 . . . . 0.0 113.026 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.4 mm -94.39 -31.34 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.639 0.775 . . . . 0.0 109.705 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -81.29 -32.85 32.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.274 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.2 mt -58.44 -47.64 98.41 Favored Pre-proline 0 CA--C 1.563 1.46 0 CA-C-O 118.405 -0.807 . . . . 0.0 112.185 -177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 10.1 Cg_endo -56.2 -63.07 0.19 Allowed 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 121.885 1.723 . . . . 0.0 112.379 172.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.41 -27.08 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -168.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.24 -55.39 6.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.449 0.7 . . . . 0.0 109.728 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -68.8 -29.82 68.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.983 0.513 . . . . 0.0 111.583 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -74.8 -36.85 62.48 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.827 0.851 . . . . 0.0 111.527 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.56 -48.77 80.31 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -57.87 -45.31 86.51 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 124.561 1.163 . . . . 0.0 109.315 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.78 -24.81 66.24 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.033 -1.44 . . . . 0.0 112.722 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -67.68 -40.61 84.39 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.579 0.352 . . . . 0.0 110.32 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -91.73 -25.73 18.93 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.429 0.692 . . . . 0.0 110.936 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.04 -6.38 59.47 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.493 0.717 . . . . 0.0 111.846 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 69.39 14.87 8.45 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.081 1.352 . . . . 0.0 112.929 171.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -83.81 95.3 8.41 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.488 HG13 HG12 ' A' ' 54' ' ' ILE . 20.7 mm -64.8 -29.77 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.427 0.691 . . . . 0.0 110.43 173.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -55.96 -47.04 78.34 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.902 0.481 . . . . 0.0 111.384 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.43 -32.89 28.78 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.306 0.642 . . . . 0.0 111.42 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -72.94 -8.82 57.39 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.104 0.562 . . . . 0.0 110.828 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.714 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 27.7 tpp -120.96 -15.76 8.21 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.909 0.484 . . . . 0.0 112.287 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.06 -50.46 61.46 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.492 0.717 . . . . 0.0 112.548 -174.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 85.3 m95 -87.18 6.92 30.54 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.989 -168.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.66 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 12.9 m95 -93.96 149.81 20.9 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.415 0.686 . . . . 0.0 109.482 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.64 152.11 37.66 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.153 0.581 . . . . 0.0 109.976 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -64.16 -29.79 70.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.884 0.474 . . . . 0.0 111.249 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -96.91 20.36 11.23 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.816 0.846 . . . . 0.0 111.385 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.66 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 48.6 t -61.85 115.63 4.18 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -71.57 148.58 46.51 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.649 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 42.8 t80 -141.67 118.1 10.85 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -117.51 148.82 41.5 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.692 0.797 . . . . 0.0 110.081 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.525 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -103.12 153.48 20.27 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.601 171.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.546 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 90.4 t80 -56.59 128.94 75.77 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.87 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.46 -60.46 0.08 OUTLIER 'Cis proline' 0 C--N 1.384 2.43 0 CA-C-N 120.583 1.244 . . . . 0.0 113.488 0.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.35 74.06 0.68 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.652 0.781 . . . . 0.0 108.991 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 55.3 m -105.54 111.69 24.49 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.167 0.987 . . . . 0.0 109.016 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 tt -66.35 103.06 0.94 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 36' ' ' ALA . 78.7 mt -82.67 -43.47 16.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.656 0.783 . . . . 0.0 110.649 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -139.73 116.58 10.93 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.787 0.435 . . . . 0.0 111.083 -171.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.07 32.61 5.31 Favored Glycine 0 N--CA 1.482 1.708 0 C-N-CA 122.811 0.243 . . . . 0.0 113.064 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.479 HD21 ' HG3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER 169.5 153.4 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.035 1.334 . . . . 0.0 109.645 -165.322 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.714 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -67.98 -24.61 65.16 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.079 0.952 . . . . 0.0 112.911 -176.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.52 -47.61 78.99 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.504 0.721 . . . . 0.0 112.141 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.479 ' HG3' HD21 ' A' ' 45' ' ' ASN . 35.2 mt-10 -74.21 -31.33 62.59 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.494 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 46' ' ' ALA . 61.9 mt -64.81 -49.24 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.13 0.572 . . . . 0.0 111.188 -178.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.488 ' O ' HG13 ' A' ' 54' ' ' ILE . 6.9 ptm180 -62.78 -49.21 75.86 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 123.498 0.499 . . . . 0.0 110.724 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.406 ' HA ' HD12 ' A' ' 54' ' ' ILE . 76.3 t -63.47 -42.53 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.779 0.832 . . . . 0.0 111.399 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -68.36 -31.62 71.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.577 0.751 . . . . 0.0 110.879 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -77.91 -28.94 49.91 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.721 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 50' ' ' ARG . 98.1 mt -57.88 -38.92 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 118.711 0.687 . . . . 0.0 109.729 174.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.38 -34.52 78.35 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.314 1.046 . . . . 0.0 111.38 175.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -78.66 -24.48 45.14 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.163 0.585 . . . . 0.0 110.916 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -83.53 -5.16 59.09 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.37 0.668 . . . . 0.0 110.631 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 70.4 mmtt -78.02 -9.99 59.39 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.096 0.558 . . . . 0.0 111.89 169.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 8.5 mm-40 -71.94 111.02 9.08 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 170.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.95 -28.14 74.97 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.297 1.998 . . . . 0.0 112.232 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -92.19 4.84 52.39 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.803 0.841 . . . . 0.0 112.048 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 28.4 tp -64.75 111.82 2.95 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-O 120.757 0.313 . . . . 0.0 110.213 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -148.07 116.15 6.47 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.98 101.14 2.71 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 174.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -81.51 99.95 9.07 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.2 tp -76.25 126.62 31.32 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.73 -33.99 5.94 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.956 0.902 . . . . 0.0 109.638 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 96.8 m -152.93 139.75 19.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.341 1.056 . . . . 0.0 108.99 -176.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -142.3 125.64 16.57 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 163.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.8 m -106.72 119.08 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.939 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.03 143.42 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 121.338 0.59 . . . . 0.0 110.033 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 p -148.32 97.49 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.263 1.425 . . . . 0.0 107.832 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.53 -116.2 7.27 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.673 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -101.89 18.7 19.91 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.072 0.549 . . . . 0.0 111.688 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.0 t -131.92 136.01 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.137 0.975 . . . . 0.0 109.5 -174.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -125.29 137.05 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 123.254 0.622 . . . . 0.0 110.012 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.688 HD13 ' HB ' ' A' ' 98' ' ' ILE . 2.5 mm -98.17 103.96 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 169.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.93 108.18 19.42 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -98.31 107.45 19.92 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 133.76 49.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.489 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.0 m -80.1 103.98 10.35 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 172.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -80.91 116.24 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.469 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.4 m -71.12 118.29 13.72 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.353 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 43.3 mmm-85 -119.02 -171.21 2.06 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -122.53 112.74 18.38 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.957 0.503 . . . . 0.0 109.763 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -113.44 137.35 22.08 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.032 0.933 . . . . 0.0 108.658 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -59.98 -18.94 53.05 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 123.218 2.612 . . . . 0.0 114.306 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -79.2 -25.94 42.65 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.044 0.538 . . . . 0.0 112.299 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.34 -117.39 0.58 Allowed Glycine 0 C--N 1.348 1.245 0 CA-C-O 119.683 -0.51 . . . . 0.0 112.914 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -68.83 -84.03 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.469 0.707 . . . . 0.0 111.88 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 116.93 26.69 2.95 Favored Glycine 0 C--N 1.343 0.947 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 -173.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.66 104.15 16.59 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.978 0.894 . . . . 0.0 108.591 -172.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 116' ' ' PRO . 21.7 m -103.7 136.59 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.509 -172.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -75.64 133.18 40.93 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.708 HG22 HG12 ' A' ' 113' ' ' ILE . 18.6 t -132.86 147.28 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.99 103.06 9.56 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 166.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 83.9 m -93.7 108.41 20.16 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.688 ' HB ' HD13 ' A' ' 77' ' ' ILE . 4.8 tt -102.11 111.94 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.631 1.172 . . . . 0.0 110.416 -173.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -103.43 129.95 50.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.902 0.881 . . . . 0.0 109.877 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 30.8 tt0 -100.22 111.92 24.22 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 168.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.61 HG22 HG12 ' A' ' 106' ' ' ILE . 48.7 t -94.59 113.79 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.488 1.115 . . . . 0.0 109.4 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -121.06 133.31 55.23 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.963 0.905 . . . . 0.0 109.185 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 62.63 30.42 16.95 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.244 1.017 . . . . 0.0 111.574 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.12 -7.09 79.56 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.268 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -130.75 147.5 52.42 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.943 0.897 . . . . 0.0 109.292 -173.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.61 HG12 HG22 ' A' ' 101' ' ' VAL . 45.7 mt -68.08 102.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 122.876 0.47 . . . . 0.0 110.677 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.16 -22.47 38.94 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.205 0.602 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 81.3 mttt -149.28 143.01 25.58 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.192 0.997 . . . . 0.0 108.781 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -146.67 134.23 20.94 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.501 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.1 m-90 -132.76 149.51 52.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -133.57 146.47 51.03 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 19.9 pttp -144.83 129.58 18.19 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.708 HG12 HG22 ' A' ' 95' ' ' VAL . 91.7 mt -89.84 120.53 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.03 -68.67 1.57 Allowed Glycine 0 C--N 1.344 1.024 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.354 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.96 163.61 23.57 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.54 ' HA ' HG12 ' A' ' 93' ' ' VAL . 83.5 Cg_endo -80.18 144.99 16.93 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 121.938 1.759 . . . . 0.0 111.9 165.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 47.4 mtm105 -132.81 142.81 49.17 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.495 0.664 . . . . 0.0 110.652 169.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.2 mm -128.28 124.84 63.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.678 1.191 . . . . 0.0 108.094 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.95 -33.83 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 123.51 0.506 . . . . 0.0 109.909 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.6 m -73.9 -19.19 60.78 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.377 1.071 . . . . 0.0 112.488 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -72.33 -23.15 61.11 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.599 0.76 . . . . 0.0 110.195 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -109.27 134.86 51.24 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.616 1.166 . . . . 0.0 108.556 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.254 1.303 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.511 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 39.5 p30 177.98 -19.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.861 1.664 . . . . 0.0 109.55 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 p -63.04 -43.57 98.31 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.132 0.973 . . . . 0.0 111.557 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.35 -2.31 18.75 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.599 0.76 . . . . 0.0 112.506 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.627 HG22 HG23 ' A' ' 76' ' ' VAL . 26.3 mm -94.81 -32.72 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.871 0.868 . . . . 0.0 109.264 174.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.95 -32.14 39.97 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.053 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.471 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 72.1 mt -57.97 -49.33 94.27 Favored Pre-proline 0 CA--C 1.564 1.484 0 CA-C-O 118.051 -0.976 . . . . 0.0 112.592 -177.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 9.3 Cg_endo -54.2 -61.79 0.38 Allowed 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 122.205 1.936 . . . . 0.0 111.648 175.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.491 HG11 ' HB ' ' A' ' 76' ' ' VAL . 16.7 m -64.12 -22.54 31.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.669 -171.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.55 ' HG2' HH22 ' A' ' 69' ' ' ARG . 0.9 OUTLIER -72.76 -55.62 6.46 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.552 0.741 . . . . 0.0 109.587 178.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 72.2 mmtt -70.28 -37.26 74.81 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.148 0.579 . . . . 0.0 110.972 -173.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -65.44 -39.31 91.91 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.052 0.941 . . . . 0.0 111.061 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.419 HD11 ' HB2' ' A' ' 66' ' ' LEU . 22.9 tp -57.89 -50.85 71.94 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.003 0.815 . . . . 0.0 110.09 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.44 -52.37 64.92 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.525 1.141 . . . . 0.0 109.444 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -60.92 -27.86 68.5 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.786 1.234 . . . . 0.0 112.182 -176.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -70.93 -39.73 72.51 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.757 0.823 . . . . 0.0 110.806 -177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -94.06 -17.71 22.57 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.987 0.515 . . . . 0.0 111.179 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.74 -3.58 54.55 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.349 0.66 . . . . 0.0 111.884 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 70.93 28.42 3.24 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.816 1.247 . . . . 0.0 112.39 174.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.46 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 17.6 m-20 -101.0 112.8 25.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.529 0.732 . . . . 0.0 110.067 174.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.0 mm -77.45 -31.46 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 122.719 0.408 . . . . 0.0 110.335 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -55.44 -48.38 74.54 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.848 0.459 . . . . 0.0 111.888 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.56 -29.64 33.37 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.638 0.375 . . . . 0.0 111.287 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -73.06 -8.17 54.53 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.136 0.574 . . . . 0.0 111.08 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.507 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 25.4 tpp -121.99 -15.55 7.77 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 173.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.46 -32.71 68.98 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -174.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.547 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 90.2 m95 -104.0 9.75 36.43 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.616 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 24.1 m95 -95.55 153.19 17.83 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.869 0.468 . . . . 0.0 110.102 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -80.0 151.18 30.13 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.341 0.656 . . . . 0.0 109.954 173.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -61.71 -31.11 71.24 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.449 0.699 . . . . 0.0 112.454 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -102.66 19.68 18.67 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.456 0.702 . . . . 0.0 111.303 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.616 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 46.1 t -60.49 119.25 7.67 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 121.074 0.464 . . . . 0.0 112.238 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.555 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 77.9 mm-40 -81.21 144.07 31.87 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.182 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -134.83 113.6 11.76 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.486 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 31.6 m-85 -115.88 155.11 28.53 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.922 0.889 . . . . 0.0 111.602 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.9 159.99 22.18 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.682 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 112' ' ' LYS . 18.3 p90 -55.27 136.41 68.71 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 123.993 0.917 . . . . 0.0 111.925 176.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -77.71 -40.27 1.16 Allowed 'Cis proline' 0 C--N 1.379 2.159 0 CA-C-N 119.854 0.984 . . . . 0.0 112.691 -7.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.71 66.66 0.21 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.832 0.853 . . . . 0.0 109.36 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 25.1 m -107.52 119.27 38.95 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.138 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tt -82.67 102.69 11.65 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.4 -45.18 16.47 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.836 0.454 . . . . 0.0 110.259 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -142.01 120.1 12.12 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -171.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.86 28.1 15.15 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.268 0.355 . . . . 0.0 113.898 -174.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.6 p30 176.18 157.77 0.26 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.254 1.422 . . . . 0.0 109.835 -174.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.507 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -60.48 -32.12 71.11 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.48 1.112 . . . . 0.0 113.378 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.485 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -60.55 -51.77 68.03 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.97 0.508 . . . . 0.0 111.124 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 33.9 mt-10 -69.27 -29.07 66.89 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.806 -175.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.1 mt -63.9 -52.11 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.329 0.652 . . . . 0.0 110.4 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.492 ' O ' HG13 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -67.19 -38.79 85.94 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.64 -175.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 47' ' ' ALA . 70.9 t -59.54 -49.37 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 123.481 0.712 . . . . 0.0 111.605 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -69.01 -29.41 67.59 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.765 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -77.87 -29.8 50.54 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 118.537 -0.745 . . . . 0.0 111.483 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 50' ' ' ARG . 76.2 mt -55.44 -46.78 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-N 118.645 0.657 . . . . 0.0 109.597 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -56.44 -42.44 78.11 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 124.413 1.071 . . . . 0.0 111.425 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.438 ' HG3' HD22 ' A' ' 62' ' ' LEU . 14.8 tpp180 -70.5 -31.5 68.62 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.414 0.686 . . . . 0.0 110.873 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -75.65 -14.31 60.36 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.534 0.734 . . . . 0.0 110.846 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 69.2 mmtt -91.6 -5.03 54.62 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.332 0.653 . . . . 0.0 111.565 170.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -105.49 122.1 43.91 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 122.985 0.514 . . . . 0.0 109.951 -175.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.54 -19.05 48.96 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.665 2.91 . . . . 0.0 115.165 -164.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -72.24 -24.42 61.37 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.629 0.372 . . . . 0.0 111.304 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.438 HD22 ' HG3' ' A' ' 56' ' ' ARG . 55.3 tp -56.19 120.66 7.9 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.661 0.784 . . . . 0.0 112.364 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -151.96 144.27 24.03 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.26 105.09 0.67 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -101.24 107.18 18.5 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.652 0.781 . . . . 0.0 109.525 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.419 ' HB2' HD11 ' A' ' 13' ' ' LEU . 14.3 tp -78.59 131.74 36.85 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 pp -111.98 -28.68 7.92 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.452 0.701 . . . . 0.0 110.206 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.9 m -157.47 143.69 17.76 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.288 1.035 . . . . 0.0 109.287 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.55 HH22 ' HG2' ' A' ' 10' ' ' GLN . 12.1 ptt180 -142.14 139.59 32.19 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.236 0.541 . . . . 0.0 110.315 162.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.11 143.7 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.843 1.257 . . . . 0.0 109.56 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.1 tt -115.85 134.07 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-O 121.309 0.576 . . . . 0.0 110.709 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -126.56 95.59 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 125.31 1.444 . . . . 0.0 107.81 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.2 -103.24 0.51 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 123.561 0.538 . . . . 0.0 113.369 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -106.46 18.18 22.31 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.529 0.732 . . . . 0.0 111.38 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.5 t -133.3 140.61 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.976 0.91 . . . . 0.0 109.071 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.627 HG23 HG22 ' A' ' 5' ' ' ILE . 57.1 t -125.86 137.82 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 118.516 0.598 . . . . 0.0 109.928 172.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.477 HG12 ' HB ' ' A' ' 98' ' ' ILE . 1.6 mt -99.86 110.0 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 167.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.45 ' HB2' ' SG ' ' A' ' 97' ' ' CYS . 1.3 m-20 -88.67 108.03 19.24 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 167.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.416 ' HE1' ' HB3' ' A' ' 94' ' ' ASP . 0.9 OUTLIER -98.5 108.71 21.46 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.318 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.99 163.67 21.82 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.516 1.127 . . . . 0.0 110.632 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.8 m -108.18 106.17 16.23 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.406 1.082 . . . . 0.0 108.582 165.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 m -90.52 134.05 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 122.481 0.313 . . . . 0.0 111.114 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 49.0 m -76.59 127.89 33.68 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.706 0.402 . . . . 0.0 109.994 175.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.4 mtm105 -126.72 161.48 28.04 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -90.17 99.31 12.35 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.825 0.345 . . . . 0.0 111.402 -177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -103.37 125.13 35.89 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.07 -16.17 53.42 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.087 2.525 . . . . 0.0 113.877 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -85.3 -9.03 58.18 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.912 0.485 . . . . 0.0 111.756 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.83 -127.14 1.18 Allowed Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.529 -0.595 . . . . 0.0 111.7 172.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -75.97 -83.34 0.07 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 117.282 0.541 . . . . 0.0 111.27 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.97 29.12 1.56 Allowed Glycine 0 C--N 1.354 1.542 0 N-CA-C 114.388 0.515 . . . . 0.0 114.388 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -89.82 99.28 12.32 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 122.136 0.969 . . . . 0.0 110.027 -172.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.9 m -102.75 137.5 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 121.616 -0.678 . . . . 0.0 111.444 -165.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.416 ' HB3' ' HE1' ' A' ' 79' ' ' HIS . 13.1 m-20 -79.31 115.01 18.7 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.686 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.526 HG22 HG12 ' A' ' 113' ' ' ILE . 35.2 t -119.17 156.17 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 125.12 1.368 . . . . 0.0 109.156 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.03 106.11 10.12 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 78' ' ' ASP . 20.5 p -97.23 109.06 21.89 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.541 HG23 ' HB2' ' A' ' 110' ' ' TRP . 7.1 tt -100.4 114.76 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.353 1.061 . . . . 0.0 109.622 -177.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -107.91 132.54 53.36 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.757 0.823 . . . . 0.0 109.71 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -98.4 112.83 24.71 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.546 HG22 HG12 ' A' ' 106' ' ' ILE . 42.1 t -95.08 113.85 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.192 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 41.7 tt0 -119.61 128.05 53.51 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.865 0.866 . . . . 0.0 109.511 175.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 64.37 31.35 12.81 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.391 1.077 . . . . 0.0 111.903 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.81 6.52 89.04 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.726 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -134.1 139.43 45.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.537 1.135 . . . . 0.0 108.957 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.546 HG12 HG22 ' A' ' 101' ' ' VAL . 45.9 mt -68.28 104.86 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 122.429 0.291 . . . . 0.0 110.316 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -78.33 -30.25 48.08 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.68 0.792 . . . . 0.0 111.175 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.555 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 97.9 mttt -149.48 152.18 35.19 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.877 0.871 . . . . 0.0 109.091 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -146.17 137.42 24.6 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.963 0.905 . . . . 0.0 108.824 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.541 ' HB2' HG23 ' A' ' 98' ' ' ILE . 4.0 m-90 -135.56 150.95 49.86 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -142.43 146.41 34.8 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 171.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 20.5 ptmt -131.19 125.36 32.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.537 176.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.526 HG12 HG22 ' A' ' 95' ' ' VAL . 87.2 mt -87.44 123.92 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.26 -65.94 2.97 Favored Glycine 0 CA--C 1.526 0.754 0 O-C-N 124.451 1.094 . . . . 0.0 113.187 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -159.5 167.63 13.81 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.19 138.31 33.08 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.558 2.172 . . . . 0.0 112.334 165.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 30.1 mmt180 -135.52 146.38 48.01 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.81 0.844 . . . . 0.0 111.213 -175.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.5 mm -136.83 132.65 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.855 1.262 . . . . 0.0 108.445 175.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.9 t -53.13 -44.4 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 123.734 0.813 . . . . 0.0 111.944 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.3 t -61.46 -23.33 65.79 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.701 0.801 . . . . 0.0 111.763 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -115.76 4.37 13.99 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.096 0.958 . . . . 0.0 111.336 -176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -107.83 158.72 17.09 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.324 0.65 . . . . 0.0 110.598 -175.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.95 0.9 . . . . 0.0 108.76 -179.843 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtm . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.595 0.236 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -124.19 78.19 1.62 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.822 0.82 . . . . 0.0 110.292 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.5 m -75.78 -49.17 18.89 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.637 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -12.86 58.41 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.173 0.989 . . . . 0.0 113.387 -175.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.545 HG22 HG23 ' A' ' 76' ' ' VAL . 33.2 mm -87.1 -34.26 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.498 ' HG3' HD12 ' A' ' 71' ' ' ILE . 44.3 mt-10 -84.55 -22.33 30.15 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.5 -53.91 61.41 Favored Pre-proline 0 CA--C 1.568 1.639 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.662 177.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.528 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 33.6 Cg_endo -62.27 -49.56 5.97 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 122.156 1.904 . . . . 0.0 113.052 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.669 ' HA ' HE21 ' A' ' 12' ' ' GLN . 15.6 m -66.95 -37.87 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -169.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -43.67 62.85 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.423 0.689 . . . . 0.0 109.977 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -68.68 -29.72 68.24 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.326 0.651 . . . . 0.0 112.065 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.669 HE21 ' HA ' ' A' ' 9' ' ' VAL . 44.9 mt-30 -59.47 -48.03 83.23 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.904 0.752 . . . . 0.0 110.308 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.55 -51.75 68.51 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 124.012 0.82 . . . . 0.0 110.092 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -59.62 -27.1 66.02 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 124.029 0.831 . . . . 0.0 110.896 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . . . -83.08 -32.31 26.85 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.389 1.076 . . . . 0.0 112.285 175.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -72.02 -39.66 68.99 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.256 0.622 . . . . 0.0 110.534 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.67 1.07 54.73 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.887 0.875 . . . . 0.0 111.834 177.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.56 3.17 10.72 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.999 0.92 . . . . 0.0 111.171 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 70.28 9.53 7.02 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.127 1.371 . . . . 0.0 113.695 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.453 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 8.9 m-20 -81.13 116.86 21.25 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.14 0.495 . . . . 0.0 110.916 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.529 HG13 HG12 ' A' ' 54' ' ' ILE . 22.8 mm -82.58 -25.6 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.093 0.957 . . . . 0.0 110.073 171.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -54.74 -48.82 72.11 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.038 0.935 . . . . 0.0 112.097 -176.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -79.4 -35.18 41.07 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.94 0.496 . . . . 0.0 110.623 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -69.93 -8.26 47.37 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.178 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.646 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 16.6 tpp -119.87 -28.64 5.15 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.447 0.699 . . . . 0.0 112.401 173.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.4 -47.42 75.9 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.036 0.534 . . . . 0.0 112.087 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 98.4 m95 -79.43 1.62 24.81 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -170.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.465 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 18.2 m95 -95.05 168.34 10.83 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.373 0.669 . . . . 0.0 110.045 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -87.1 148.35 25.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.54 0.736 . . . . 0.0 109.353 171.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.16 -25.79 67.96 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.316 0.646 . . . . 0.0 111.706 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -109.19 18.97 19.98 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.976 1.311 . . . . 0.0 111.381 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.465 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 53.7 t -60.84 133.93 56.58 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -173.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.55 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 36.6 mm-40 -95.44 105.46 17.43 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.567 0.747 . . . . 0.0 109.967 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.432 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 48.4 t80 -94.6 111.44 23.2 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.635 0.774 . . . . 0.0 110.246 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -105.16 139.89 39.14 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.287 1.035 . . . . 0.0 110.029 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.6 161.48 14.82 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.24 1.016 . . . . 0.0 110.345 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.41 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 71.3 t80 -50.26 127.58 22.74 Favored Pre-proline 0 CA--C 1.566 1.593 0 O-C-N 124.285 0.99 . . . . 0.0 112.039 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.23 -50.29 0.19 OUTLIER 'Cis proline' 0 C--N 1.386 2.519 0 CA-C-N 119.77 0.953 . . . . 0.0 113.513 -5.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.33 78.83 0.81 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.8 m -117.48 114.03 22.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.033 0.933 . . . . 0.0 109.237 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.74 101.48 0.81 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.8 mt -79.63 -36.36 38.02 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.275 0.63 . . . . 0.0 109.93 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.461 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -142.45 116.3 9.29 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.612 -170.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.0 33.21 4.77 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 123.374 0.421 . . . . 0.0 112.771 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.43 ' O ' HG13 ' A' ' 49' ' ' ILE . 8.9 p30 167.05 158.29 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.204 1.402 . . . . 0.0 109.816 -167.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.646 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -70.65 -25.2 62.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.245 1.018 . . . . 0.0 113.148 -175.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.4 98.27 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.861 0.465 . . . . 0.0 111.259 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.461 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 26.6 mt-10 -75.39 -32.36 60.75 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.611 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 46' ' ' ALA . 72.4 mt -65.44 -46.29 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.197 0.599 . . . . 0.0 110.945 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 54' ' ' ILE . 14.0 ptm180 -64.67 -51.43 62.56 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.686 0.616 . . . . 0.0 110.641 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.415 ' HA ' HD12 ' A' ' 54' ' ' ILE . 20.6 m -65.61 -35.23 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 122.97 0.508 . . . . 0.0 111.825 -175.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -71.41 -34.92 70.77 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.855 0.862 . . . . 0.0 110.476 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -75.08 -32.61 61.52 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.642 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.529 HG12 HG13 ' A' ' 21' ' ' ILE . 97.7 mt -58.15 -37.76 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.672 0.389 . . . . 0.0 110.026 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.12 -34.56 78.34 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.654 0.782 . . . . 0.0 111.6 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -75.2 -25.98 58.63 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.867 0.467 . . . . 0.0 110.157 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.549 ' HA ' HD22 ' A' ' 62' ' ' LEU . 2.8 m-85 -83.9 -4.42 58.68 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.59 0.756 . . . . 0.0 111.347 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HE2' HG22 ' A' ' 54' ' ' ILE . 74.5 mmtt -73.07 -25.84 61.05 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.717 0.407 . . . . 0.0 111.109 169.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 50.4 mm-40 -57.42 116.7 14.7 Favored Pre-proline 0 N--CA 1.481 1.113 0 C-N-CA 123.583 0.753 . . . . 0.0 110.748 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.23 -26.61 41.91 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.321 2.014 . . . . 0.0 112.609 -175.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.42 2.25 55.77 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.053 0.941 . . . . 0.0 111.484 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 57' ' ' PHE . 17.6 tp -62.23 114.02 3.21 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.932 0.493 . . . . 0.0 111.276 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -151.65 115.62 4.95 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.535 0.734 . . . . 0.0 109.084 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.12 104.59 3.11 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -91.68 101.82 14.45 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.7 tt -79.26 124.88 28.8 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.52 -32.79 5.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.736 -172.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.7 m -148.69 134.86 19.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.367 1.067 . . . . 0.0 108.558 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.409 HH12 ' HG2' ' A' ' 6' ' ' GLU . 52.3 ptt85 -137.76 133.31 33.94 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 166.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -121.56 128.09 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.511 1.124 . . . . 0.0 109.43 -172.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.498 HD12 ' HG3' ' A' ' 6' ' ' GLU . 11.9 tt -108.7 128.77 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 121.253 0.549 . . . . 0.0 110.657 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.1 p -123.89 94.46 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 173.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.27 -110.83 3.15 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.823 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -87.99 -1.1 57.78 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.609 1.163 . . . . 0.0 111.8 -172.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.3 t -128.77 140.18 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.074 0.95 . . . . 0.0 109.786 -172.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.545 HG23 HG22 ' A' ' 5' ' ' ILE . 33.2 t -125.29 134.65 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.349 0.66 . . . . 0.0 109.512 172.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.456 HG12 ' HB ' ' A' ' 98' ' ' ILE . 2.4 mt -99.58 107.04 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 165.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.75 109.32 20.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -98.74 109.69 22.41 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.25 159.24 36.73 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.467 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.2 m -107.43 110.05 21.91 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.121 172.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 91.0 t -81.77 103.25 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 123.293 0.637 . . . . 0.0 110.258 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.3 m -66.75 129.56 40.27 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.854 0.862 . . . . 0.0 110.205 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 91' ' ' GLY . 80.7 mtp180 -133.56 -162.53 1.25 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -130.21 83.5 2.13 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.917 0.389 . . . . 0.0 110.357 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -90.18 137.83 27.64 Favored Pre-proline 0 N--CA 1.475 0.8 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.3 8.15 1.56 Allowed 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.839 2.359 . . . . 0.0 113.046 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.91 -32.68 57.56 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.082 0.953 . . . . 0.0 109.314 169.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.09 -98.03 0.13 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.355 175.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -76.91 -82.41 0.08 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.786 0.834 . . . . 0.0 110.281 175.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 84' ' ' ARG . . . 117.43 28.59 2.31 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 121.312 -0.47 . . . . 0.0 113.877 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -88.1 140.95 28.97 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -174.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.585 HG12 ' HA ' ' A' ' 116' ' ' PRO . 29.1 m -127.43 129.27 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 122.04 -0.413 . . . . 0.0 110.817 -176.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -77.34 110.43 12.07 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.039 0.536 . . . . 0.0 109.703 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.459 HG22 HG12 ' A' ' 113' ' ' ILE . 33.8 t -114.15 156.55 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.607 1.163 . . . . 0.0 108.859 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.88 103.32 6.73 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 71.6 m -96.35 111.84 23.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.235 1.014 . . . . 0.0 109.959 -174.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.456 ' HB ' HG12 ' A' ' 77' ' ' ILE . 8.6 tt -103.42 110.96 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 124.602 1.161 . . . . 0.0 110.155 -175.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -105.69 133.64 50.1 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.167 0.587 . . . . 0.0 110.905 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -100.45 119.68 38.84 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.195 0.998 . . . . 0.0 108.474 169.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.5 t -110.28 115.25 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.014 0.926 . . . . 0.0 110.536 -173.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.482 ' HG3' HD22 ' A' ' 103' ' ' ASN . 11.4 tp10 -118.68 126.39 51.82 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.145 0.578 . . . . 0.0 109.806 177.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.482 HD22 ' HG3' ' A' ' 102' ' ' GLU . 54.9 m-80 61.55 30.25 18.62 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.892 1.277 . . . . 0.0 112.174 -177.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.45 0.03 86.03 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 116.379 -0.373 . . . . 0.0 113.774 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -117.38 138.41 51.82 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 67.1 mt -68.56 105.91 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -78.11 -32.13 50.36 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.056 0.542 . . . . 0.0 110.705 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.55 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 62.4 mtpt -150.2 134.23 16.98 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -130.4 132.28 45.68 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.425 ' HE1' ' HE2' ' A' ' 108' ' ' LYS . 0.7 OUTLIER -132.42 148.64 52.41 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -177.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -142.62 146.69 34.78 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.284 0.493 . . . . 0.0 110.03 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 25.1 pttm -121.19 127.68 51.73 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.459 HG12 HG22 ' A' ' 95' ' ' VAL . 88.3 mt -89.69 124.99 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.21 -73.88 0.52 Allowed Glycine 0 CA--C 1.526 0.765 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.914 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -160.69 170.3 8.71 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.134 0.574 . . . . 0.0 109.676 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.585 ' HA ' HG12 ' A' ' 93' ' ' VAL . 72.4 Cg_endo -73.84 123.74 8.68 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.215 1.943 . . . . 0.0 112.225 165.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.8 mmt85 -110.01 147.58 33.25 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.212 1.005 . . . . 0.0 109.243 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 35.9 mm -139.05 127.79 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.51 -30.57 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.711 0.805 . . . . 0.0 111.74 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -68.42 -31.51 70.9 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.038 0.535 . . . . 0.0 110.654 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -82.04 -37.03 27.1 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.154 0.982 . . . . 0.0 110.765 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -98.16 103.37 15.31 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.593 0.757 . . . . 0.0 109.0 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 C--O 1.255 1.36 0 C-N-CA 123.498 0.719 . . . . 0.0 109.482 -177.921 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.445 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -110.06 49.37 0.85 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.552 0.691 . . . . 0.0 110.722 -175.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.417 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 33.8 p -67.74 -33.02 74.05 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.702 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.65 -20.32 63.27 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.49 1.116 . . . . 0.0 112.578 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 74' ' ' ASN . 30.0 mm -91.79 -28.98 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.946 0.898 . . . . 0.0 109.409 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -75.0 -27.39 60.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.965 174.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 3' ' ' SER . 83.7 mt -59.92 -55.21 47.83 Favored Pre-proline 0 CA--C 1.564 1.484 0 CA-C-O 117.884 -1.055 . . . . 0.0 112.032 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 19.3 Cg_endo -56.91 -55.59 2.55 Favored 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 122.111 1.874 . . . . 0.0 112.613 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.5 m -62.98 -35.36 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.489 -171.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -73.66 -52.2 14.12 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.163 0.585 . . . . 0.0 110.394 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -62.86 -28.29 69.93 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -75.42 -43.56 49.27 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.853 0.861 . . . . 0.0 111.422 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.14 -52.05 65.38 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.003 0.521 . . . . 0.0 110.331 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.71 -25.81 68.37 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.021 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 20' ' ' ASP . . . -80.76 -27.64 36.68 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.372 1.069 . . . . 0.0 112.177 172.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -66.91 -47.52 71.52 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.252 0.548 . . . . 0.0 109.885 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.62 -14.57 59.6 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.847 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.43 -2.77 41.45 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.449 0.699 . . . . 0.0 112.118 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 67.55 25.48 8.35 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.791 1.237 . . . . 0.0 112.835 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.497 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 11.0 m-20 -92.8 100.04 12.6 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.311 0.644 . . . . 0.0 110.011 173.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.429 HG13 HG12 ' A' ' 54' ' ' ILE . 12.6 mm -70.39 -31.17 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.001 0.52 . . . . 0.0 110.787 170.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -61.36 -45.11 95.77 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.014 0.525 . . . . 0.0 111.691 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.03 -30.82 44.39 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.134 0.574 . . . . 0.0 110.977 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -72.94 -5.94 41.93 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.855 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.751 ' SD ' ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -112.75 -30.52 7.04 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.217 0.607 . . . . 0.0 112.215 172.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.75 -32.7 67.72 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -169.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.479 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.9 m95 -97.97 7.83 45.7 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -173.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.568 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 46.8 m95 -94.25 157.51 16.01 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.01 0.524 . . . . 0.0 110.288 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -76.76 148.49 36.66 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.322 169.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -67.83 -24.29 65.26 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.158 0.583 . . . . 0.0 111.32 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -106.18 18.33 22.18 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.312 1.045 . . . . 0.0 111.236 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.568 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 51.5 t -64.93 138.99 58.71 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -174.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -98.21 136.61 38.17 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.763 0.825 . . . . 0.0 108.847 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 56.4 t80 -130.92 110.98 11.66 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -109.64 151.81 26.38 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.602 0.761 . . . . 0.0 110.512 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.25 158.47 19.67 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.634 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.644 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 87.2 t80 -61.29 130.82 91.97 Favored Pre-proline 0 CA--C 1.558 1.276 0 O-C-N 123.899 0.749 . . . . 0.0 110.335 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.38 -57.25 0.14 OUTLIER 'Cis proline' 0 C--N 1.383 2.39 0 CA-C-N 120.138 1.085 . . . . 0.0 113.6 -1.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.26 81.53 1.42 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.7 m -129.19 108.21 10.17 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.497 0.719 . . . . 0.0 109.915 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.5 tp -65.78 102.57 0.77 Allowed 'General case' 0 CA--C 1.535 0.377 0 O-C-N 123.572 0.545 . . . . 0.0 109.824 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.9 mt -78.68 -25.74 44.87 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.531 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -157.3 117.05 3.41 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.85 35.34 4.59 Favored Glycine 0 C--N 1.346 1.119 0 C-N-CA 123.28 0.467 . . . . 0.0 112.926 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.2 p30 163.96 160.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 126.306 1.843 . . . . 0.0 108.426 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -69.55 -26.14 64.35 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -171.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.69 -41.65 99.22 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.331 0.586 . . . . 0.0 110.884 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -76.28 -29.19 57.31 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.922 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.0 mt -64.24 -50.96 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 122.916 0.486 . . . . 0.0 110.639 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.751 ' HB3' ' SD ' ' A' ' 25' ' ' MET . 30.8 ptt180 -60.68 -51.59 68.75 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.904 0.752 . . . . 0.0 110.671 -176.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.454 ' HA ' HD12 ' A' ' 54' ' ' ILE . 35.5 m -63.97 -38.22 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -174.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -61.87 -38.08 86.96 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 123.815 0.697 . . . . 0.0 110.376 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -78.22 -34.32 49.37 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.121 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 50' ' ' ARG . 98.0 mt -56.46 -39.99 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.089 0.556 . . . . 0.0 110.182 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.87 -41.01 95.11 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.139 0.976 . . . . 0.0 111.576 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -73.9 -29.27 61.97 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.409 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -73.49 -4.66 35.15 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.002 0.521 . . . . 0.0 111.62 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -74.46 -36.22 63.33 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.962 0.505 . . . . 0.0 111.011 172.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.53 115.78 12.8 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 123.493 0.717 . . . . 0.0 110.919 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.89 -25.07 28.4 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.482 2.121 . . . . 0.0 112.49 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.78 -7.79 58.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.821 0.848 . . . . 0.0 111.69 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.55 120.56 12.56 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 122.477 0.311 . . . . 0.0 110.547 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -151.2 115.55 5.08 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 169.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.91 102.97 2.75 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -100.87 109.77 21.76 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 80' ' ' GLU . 13.8 tp -66.7 140.33 57.88 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.164 0.507 . . . . 0.0 110.089 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -107.0 -51.1 2.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.457 1.122 . . . . 0.0 107.989 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.9 m -154.54 141.07 18.85 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 113.024 -1.898 . . . . 0.0 109.032 -172.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 53.6 ptt85 -135.14 121.83 20.83 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 168.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.498 HG22 ' HB ' ' A' ' 77' ' ' ILE . 19.3 m -107.96 136.07 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.5 tt -120.71 129.83 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.274 0.559 . . . . 0.0 110.775 -175.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -129.95 99.35 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 C-N-CA 124.859 1.264 . . . . 0.0 108.393 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.79 -125.66 22.92 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.583 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.44 ' HA ' HG13 ' A' ' 5' ' ' ILE . 26.3 p-10 -91.48 17.98 7.9 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.307 0.643 . . . . 0.0 111.88 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.6 t -127.45 135.76 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.162 0.985 . . . . 0.0 109.8 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.2 t -125.37 139.66 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.006 0.522 . . . . 0.0 109.788 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.498 ' HB ' HG22 ' A' ' 70' ' ' VAL . 10.0 mm -98.81 104.33 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 167.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -94.87 105.16 17.07 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -100.19 105.81 17.44 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -121.28 171.16 8.93 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.156 1.382 . . . . 0.0 109.918 -178.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.4 m -118.09 106.23 12.66 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.924 0.89 . . . . 0.0 108.935 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.0 m -82.47 124.16 39.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-O 121.613 0.721 . . . . 0.0 109.194 170.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.9 m -83.09 119.42 24.48 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.681 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.637 HH21 ' HZ ' ' A' ' 86' ' ' PHE . 61.9 mtm180 -119.06 -160.89 0.82 Allowed 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -139.59 111.47 7.36 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.773 0.715 . . . . 0.0 110.32 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.637 ' HZ ' HH21 ' A' ' 84' ' ' ARG . 17.3 m-30 -109.28 151.49 42.09 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.745 0.818 . . . . 0.0 110.127 -178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.37 -28.82 88.58 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.649 2.232 . . . . 0.0 113.736 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -88.53 2.74 52.35 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.06 -146.56 16.09 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-O 119.479 -0.623 . . . . 0.0 113.235 173.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -39.07 -72.92 0.05 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.316 1.446 . . . . 0.0 113.059 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.424 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 103.62 25.7 7.17 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 113.897 0.319 . . . . 0.0 113.897 175.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -92.84 129.25 38.82 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.655 HG12 ' HA ' ' A' ' 116' ' ' PRO . 20.7 m -123.05 143.88 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.507 ' HB3' HH21 ' A' ' 117' ' ' ARG . 9.8 p-10 -85.89 122.95 30.67 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 174.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.447 HG22 HG12 ' A' ' 113' ' ' ILE . 44.2 t -113.68 142.33 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -106.12 97.65 7.43 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 94.1 m -93.49 108.28 19.99 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.357 0.663 . . . . 0.0 109.214 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.449 ' HB ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -97.78 115.75 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.897 0.879 . . . . 0.0 108.979 -178.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.402 ' CD1' HD13 ' A' ' 106' ' ' ILE . 64.0 m-85 -107.39 133.91 51.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.684 0.794 . . . . 0.0 109.711 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -103.31 113.37 26.81 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 168.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.628 HG22 HG12 ' A' ' 106' ' ' ILE . 96.9 t -100.0 135.29 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.204 1.001 . . . . 0.0 110.035 -176.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.46 ' HG3' HD22 ' A' ' 103' ' ' ASN . 9.9 tp10 -133.27 119.2 19.49 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.959 0.904 . . . . 0.0 109.866 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.46 HD22 ' HG3' ' A' ' 102' ' ' GLU . 57.2 m-80 61.12 30.54 19.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.927 1.291 . . . . 0.0 112.375 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.67 -6.64 83.13 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.009 -0.542 . . . . 0.0 113.858 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 -113.86 133.51 55.38 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.628 HG12 HG22 ' A' ' 101' ' ' VAL . 57.5 mt -67.68 107.59 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.53 -32.1 47.84 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.495 0.718 . . . . 0.0 110.997 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -150.09 152.32 34.6 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.068 0.947 . . . . 0.0 108.821 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.66 135.49 12.73 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -136.75 151.79 49.61 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -139.57 144.79 37.96 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.249 0.547 . . . . 0.0 110.31 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.644 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 16.8 ttpt -117.03 125.6 51.59 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 172.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.447 HG12 HG22 ' A' ' 95' ' ' VAL . 62.0 mt -86.44 125.56 40.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.86 -132.21 1.47 Allowed Glycine 0 CA--C 1.52 0.4 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.938 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -83.5 134.26 45.5 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.591 0.756 . . . . 0.0 111.325 -169.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.655 ' HA ' HG12 ' A' ' 93' ' ' VAL . 77.5 Cg_endo -74.07 93.37 0.88 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 123.346 2.697 . . . . 0.0 111.435 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.507 HH21 ' HB3' ' A' ' 94' ' ' ASP . 49.5 mtm105 -100.45 141.48 33.24 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.532 0.682 . . . . 0.0 111.216 -169.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.3 mm -127.8 124.72 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.732 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.62 -23.06 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.834 0.853 . . . . 0.0 110.258 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.6 m -78.41 18.64 0.53 Allowed 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.841 1.257 . . . . 0.0 112.949 -174.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -97.75 156.71 16.44 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.538 0.735 . . . . 0.0 110.731 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -138.45 152.13 48.05 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.528 0.731 . . . . 0.0 110.288 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.252 1.215 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.68 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 ttm . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 61.28 15.87 6.84 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.093 1.357 . . . . 0.0 111.514 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.421 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 13.8 m -65.68 -42.59 91.1 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.465 1.106 . . . . 0.0 111.348 -169.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.77 -19.17 64.78 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.038 0.935 . . . . 0.0 112.72 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 mm -96.1 -29.69 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.177 0.991 . . . . 0.0 109.617 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -71.53 -36.94 71.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.247 1.019 . . . . 0.0 111.212 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 91.4 mt -58.15 -52.76 72.18 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.061 -175.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 16.9 Cg_endo -57.19 -59.77 0.55 Allowed 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 121.6 1.533 . . . . 0.0 112.271 176.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.453 HG12 ' HD2' ' A' ' 99' ' ' TYR . 16.5 m -62.42 -29.81 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -169.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.461 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 26.2 tp60 -73.44 -55.61 6.13 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 122.852 0.461 . . . . 0.0 110.399 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.2 mmtt -63.68 -36.33 83.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 123.752 0.658 . . . . 0.0 111.002 -175.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.38 -46.0 90.59 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.136 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.44 -48.78 80.33 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 55.7 mm-40 -58.44 -33.72 70.02 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.508 1.13 . . . . 0.0 110.488 -176.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.71 -26.06 32.35 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.574 1.15 . . . . 0.0 112.417 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -69.7 -44.36 70.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.977 0.511 . . . . 0.0 109.945 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.87 -22.79 52.94 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.272 175.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.79 -0.78 57.81 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.28 0.632 . . . . 0.0 112.19 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 mmt85 68.96 7.72 6.39 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.009 1.324 . . . . 0.0 113.323 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.95 98.69 6.51 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.231 0.612 . . . . 0.0 110.228 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.447 HG13 HG12 ' A' ' 54' ' ' ILE . 12.5 mm -63.06 -36.02 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.02 0.528 . . . . 0.0 110.77 172.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -57.52 -49.17 77.21 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.505 0.722 . . . . 0.0 111.405 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.0 -30.79 27.87 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.136 0.575 . . . . 0.0 111.963 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -65.93 -20.68 66.3 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.11 0.256 . . . . 0.0 110.646 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 67.7 mmm -120.16 6.19 10.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.701 0.8 . . . . 0.0 112.107 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.84 -47.57 58.63 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.295 0.569 . . . . 0.0 110.426 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.412 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 92.0 m95 -86.95 9.3 19.85 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.349 -169.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.648 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 30.1 m95 -89.29 156.74 18.55 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 173.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -76.72 149.96 36.33 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 173.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.71 -27.4 68.3 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.74 0.416 . . . . 0.0 110.645 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.97 19.37 19.58 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.596 1.158 . . . . 0.0 111.017 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.648 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 52.1 t -63.5 123.57 19.11 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.058 0.456 . . . . 0.0 111.815 -174.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -85.73 140.44 30.5 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.417 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 63.0 t80 -132.87 110.08 10.06 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -172.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -111.03 155.91 22.06 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.364 1.065 . . . . 0.0 110.955 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.26 160.29 29.6 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.67 170.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -50.93 132.5 29.53 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 124.674 1.19 . . . . 0.0 112.156 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.85 -41.49 0.9 Allowed 'Cis proline' 0 C--N 1.379 2.145 0 CA-C-N 119.961 1.022 . . . . 0.0 113.801 -2.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.06 56.89 0.12 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.215 0.606 . . . . 0.0 110.894 -177.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 75.5 m -109.33 114.22 27.71 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.67 0.788 . . . . 0.0 110.218 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.4 tt -76.5 109.48 10.27 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.17 -44.54 14.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.224 0.61 . . . . 0.0 109.664 174.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -132.13 122.34 25.2 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.742 -171.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.21 46.74 1.13 Allowed Glycine 0 N--CA 1.478 1.448 0 C-N-CA 122.612 0.148 . . . . 0.0 112.793 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.435 ' O ' HG13 ' A' ' 49' ' ' ILE . 9.5 p30 162.34 152.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 126.341 1.856 . . . . 0.0 108.319 -171.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -63.44 -25.38 68.24 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.765 0.826 . . . . 0.0 113.194 -174.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 51' ' ' VAL . . . -64.07 -44.27 92.92 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.942 0.497 . . . . 0.0 111.331 -177.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.432 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 33.0 mt-10 -75.68 -33.53 60.39 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 45' ' ' ASN . 53.2 mt -65.77 -42.81 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.098 0.559 . . . . 0.0 110.598 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.463 ' O ' HG13 ' A' ' 54' ' ' ILE . 14.0 ptm180 -66.44 -42.8 87.11 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.952 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 47' ' ' ALA . 97.8 t -61.04 -44.56 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 123.787 0.68 . . . . 0.0 110.572 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -63.59 -34.7 78.4 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.19 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -77.2 -35.55 55.64 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.038 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.48 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 78.9 mt -55.5 -44.22 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 123.195 0.598 . . . . 0.0 110.124 177.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -54.98 -43.15 73.26 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 124.377 1.048 . . . . 0.0 111.203 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.3 tpp85 -72.68 -30.7 64.47 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.619 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -78.22 -6.63 55.47 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.71 0.404 . . . . 0.0 111.596 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 69.4 mmtt -87.11 -12.63 46.52 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.229 0.612 . . . . 0.0 111.645 171.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.71 114.73 18.96 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.733 0.813 . . . . 0.0 108.886 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.62 -27.21 38.92 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.632 2.221 . . . . 0.0 113.157 -170.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -89.16 -6.54 56.87 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.625 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.4 tp -56.99 121.95 11.17 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.48 0.488 . . . . 0.0 111.571 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -149.31 119.47 7.24 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.495 ' HA2' HG12 ' A' ' 82' ' ' VAL . . . -88.8 104.93 3.13 Favored Glycine 0 C--N 1.34 0.778 0 O-C-N 123.524 0.515 . . . . 0.0 112.197 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -102.43 101.93 12.19 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 tt -83.74 131.24 34.93 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.432 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -115.65 -30.73 6.07 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.175 0.99 . . . . 0.0 111.136 -173.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 66.6 m -149.35 130.68 14.67 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.4 0.68 . . . . 0.0 109.344 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -137.82 117.58 13.16 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.43 115.69 47.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.778 0.831 . . . . 0.0 109.573 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.5 tt -106.51 123.9 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 122.935 0.494 . . . . 0.0 109.983 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 t -118.75 95.73 3.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.1 -95.33 0.2 Allowed Glycine 0 CA--C 1.531 1.077 0 O-C-N 123.661 0.601 . . . . 0.0 113.78 176.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -108.39 4.23 24.17 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 124.456 1.102 . . . . 0.0 111.495 -171.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.93 138.53 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.511 1.124 . . . . 0.0 109.631 -173.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.01 127.62 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.497 0.719 . . . . 0.0 109.388 173.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.477 HG12 ' HB ' ' A' ' 98' ' ' ILE . 4.0 mt -99.03 106.54 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 163.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -89.99 132.5 35.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 172.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -128.58 110.54 12.35 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.24 171.08 8.55 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.366 1.466 . . . . 0.0 109.282 -177.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.426 HG22 ' HB2' ' A' ' 92' ' ' GLU . 97.1 m -125.9 102.64 7.37 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 164.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.495 HG12 ' HA2' ' A' ' 64' ' ' GLY . 15.0 m -84.22 124.37 39.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.843 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.48 HG23 ' HD2' ' A' ' 90' ' ' LYS . 88.2 m -66.4 123.9 21.26 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.958 170.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -129.81 -170.61 2.34 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -126.06 97.29 5.04 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 118.974 0.806 . . . . 0.0 111.018 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -100.92 140.32 21.23 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.093 0.957 . . . . 0.0 108.952 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -64.69 -17.74 60.47 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.687 2.258 . . . . 0.0 113.637 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -83.59 -9.24 59.05 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.925 0.49 . . . . 0.0 112.093 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.66 -120.49 0.94 Allowed Glycine 0 C--N 1.349 1.295 0 CA-C-O 120.041 -0.31 . . . . 0.0 112.495 172.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.48 ' HD2' HG23 ' A' ' 83' ' ' THR . 16.0 tppt? -66.76 -83.28 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.841 0.856 . . . . 0.0 111.317 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 119.44 27.06 2.26 Favored Glycine 0 C--N 1.346 1.086 0 O-C-N 123.094 0.246 . . . . 0.0 112.558 -174.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.426 ' HB2' HG22 ' A' ' 81' ' ' THR . 9.7 pt-20 -89.45 108.62 19.75 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.566 0.698 . . . . 0.0 109.441 -172.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.594 HG12 ' HA ' ' A' ' 116' ' ' PRO . 4.8 m -112.64 142.32 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 122.858 0.463 . . . . 0.0 109.849 -175.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -96.77 144.37 26.82 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.564 HG22 HG12 ' A' ' 113' ' ' ILE . 15.3 t -136.82 136.63 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.608 0.763 . . . . 0.0 109.17 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -100.32 98.83 9.44 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 170.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 63.1 m -98.22 112.69 24.58 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.598 0.759 . . . . 0.0 109.641 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.536 HG23 ' HB2' ' A' ' 110' ' ' TRP . 6.3 tt -97.56 110.8 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 123.58 0.752 . . . . 0.0 109.989 177.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.453 ' HD2' HG12 ' A' ' 9' ' ' VAL . 14.6 m-85 -98.32 154.83 17.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.456 0.702 . . . . 0.0 109.843 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -132.88 119.41 20.17 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.18 0.992 . . . . 0.0 108.452 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 56.6 t -94.54 140.03 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.909 0.883 . . . . 0.0 110.254 -174.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 24.3 tt0 -138.98 123.03 17.91 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.82 31.1 16.6 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.537 0.735 . . . . 0.0 110.934 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.49 -5.73 83.91 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.929 -0.578 . . . . 0.0 114.161 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -125.39 134.6 52.09 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.779 0.831 . . . . 0.0 109.748 -175.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 64.2 mt -63.66 103.61 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 122.854 0.462 . . . . 0.0 110.397 -178.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -81.28 -24.84 36.98 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.168 0.587 . . . . 0.0 111.559 -176.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -149.25 139.81 22.54 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.572 0.749 . . . . 0.0 109.405 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.88 138.25 33.79 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.08 0.952 . . . . 0.0 108.786 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.536 ' HB2' HG23 ' A' ' 98' ' ' ILE . 3.2 m-90 -136.84 142.8 42.86 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -142.64 147.1 35.2 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 119.181 0.901 . . . . 0.0 111.233 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -131.91 130.35 41.47 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.852 0.861 . . . . 0.0 108.839 173.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.564 HG12 HG22 ' A' ' 95' ' ' VAL . 95.9 mt -87.85 127.17 41.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.86 -80.22 0.12 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 114.923 -1.035 . . . . 0.0 113.355 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -158.55 163.67 23.58 Favored Pre-proline 0 C--O 1.243 0.745 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.594 ' HA ' HG12 ' A' ' 93' ' ' VAL . 97.8 Cg_endo -81.35 141.5 12.73 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.061 1.841 . . . . 0.0 112.495 166.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -132.67 157.63 44.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.893 0.877 . . . . 0.0 110.335 174.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.454 HG23 ' H ' ' A' ' 90' ' ' LYS . 45.9 mm -133.43 144.47 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.891 1.276 . . . . 0.0 107.825 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.0 t -64.98 -43.04 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 122.948 0.499 . . . . 0.0 110.915 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.0 t -64.13 -30.15 71.23 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.484 0.713 . . . . 0.0 110.847 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -71.13 83.27 0.71 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.58 0.752 . . . . 0.0 109.051 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -166.9 139.59 3.57 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.604 -170.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 C--O 1.253 1.265 0 C-N-CA 123.84 0.856 . . . . 0.0 109.693 176.721 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.3 mtm . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -144.04 25.72 1.56 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.514 1.126 . . . . 0.0 108.054 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.9 m -52.4 -53.17 48.46 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.254 1.422 . . . . 0.0 113.89 -163.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.96 -11.88 59.66 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.416 ' HB ' HD11 ' A' ' 71' ' ' ILE . 13.3 mm -98.38 -30.51 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.978 0.911 . . . . 0.0 109.984 175.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.12 -35.9 71.92 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.137 0.975 . . . . 0.0 110.632 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -65.71 -46.71 67.13 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.219 1.407 . . . . 0.0 112.579 -168.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 11.6 Cg_endo -55.13 -57.81 1.49 Allowed 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 121.561 1.507 . . . . 0.0 111.425 171.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.502 HG21 HG21 ' A' ' 76' ' ' VAL . 73.6 t -59.63 -33.37 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.506 1.122 . . . . 0.0 112.407 -173.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.569 ' HA ' HH12 ' A' ' 69' ' ' ARG . 0.9 OUTLIER -69.43 -56.07 8.49 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.532 0.733 . . . . 0.0 110.306 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -66.34 -35.4 80.25 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.414 0.686 . . . . 0.0 111.423 -174.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.04 -39.29 93.13 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.615 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.688 ' HB2' HH22 ' A' ' 69' ' ' ARG . 58.1 tp -59.02 -52.55 65.28 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.671 0.607 . . . . 0.0 110.666 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -54.97 -46.92 75.11 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.155 -1.384 . . . . 0.0 109.969 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.54 -30.69 71.47 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.336 1.054 . . . . 0.0 112.307 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -68.74 -48.54 63.51 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.154 0.582 . . . . 0.0 110.467 -175.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -82.21 -19.79 39.04 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.098 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.01 -3.56 58.89 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.408 0.683 . . . . 0.0 112.124 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.8 mmt85 68.2 21.24 8.62 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.773 1.229 . . . . 0.0 112.171 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -90.05 123.21 33.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.934 0.894 . . . . 0.0 110.506 174.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.5 mm -87.15 -28.32 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.47 0.708 . . . . 0.0 110.736 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.44 -47.29 86.04 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.325 0.65 . . . . 0.0 111.981 -170.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.64 -32.24 41.62 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.072 0.549 . . . . 0.0 110.66 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -73.27 -7.18 50.44 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.088 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.728 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 1.1 tpt -116.94 -33.95 4.58 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.303 0.641 . . . . 0.0 111.864 176.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.09 -48.53 78.36 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.338 0.655 . . . . 0.0 112.066 -172.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 99.1 m95 -76.43 -0.67 23.71 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.236 -173.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.654 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 14.8 m95 -91.99 149.4 21.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 173.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 107' ' ' ALA . . . -75.42 155.15 36.64 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.975 0.51 . . . . 0.0 110.651 176.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.75 -24.55 66.98 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.451 0.701 . . . . 0.0 111.384 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -104.56 19.19 20.81 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 124.366 1.066 . . . . 0.0 110.465 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.654 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 49.0 t -60.52 114.86 3.19 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -173.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -92.49 102.87 15.32 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.887 0.875 . . . . 0.0 110.099 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.46 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 78.4 t80 -97.08 111.28 23.58 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 125.265 1.426 . . . . 0.0 110.242 -173.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.497 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 45.5 m-85 -111.08 155.59 22.58 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.53 1.132 . . . . 0.0 110.55 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.69 157.05 23.67 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.242 170.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -55.81 134.3 72.71 Favored Pre-proline 0 CA--C 1.564 1.497 0 C-N-CA 124.374 1.07 . . . . 0.0 112.251 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.33 -40.83 1.11 Allowed 'Cis proline' 0 C--N 1.381 2.289 0 CA-C-N 120.146 1.088 . . . . 0.0 113.011 -8.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.16 92.62 0.75 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.983 0.913 . . . . 0.0 108.945 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.417 ' O ' HD22 ' A' ' 42' ' ' LEU . 90.5 m -139.0 117.38 11.98 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.729 0.812 . . . . 0.0 108.863 176.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 tt -81.93 103.14 11.37 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -176.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.417 HD22 ' O ' ' A' ' 40' ' ' THR . 2.4 mm? -89.73 -29.42 18.73 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.509 0.323 . . . . 0.0 110.785 177.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -146.83 116.34 7.09 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -175.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.96 36.26 4.22 Favored Glycine 0 N--CA 1.478 1.478 0 C-N-CA 123.19 0.424 . . . . 0.0 113.396 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 p30 168.94 163.28 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.473 1.509 . . . . 0.0 109.438 -172.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -64.0 -35.42 80.66 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.945 0.898 . . . . 0.0 112.602 -177.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.86 -45.61 91.89 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.164 0.586 . . . . 0.0 111.717 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -71.67 -31.82 67.22 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.709 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.3 mt -66.04 -38.73 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.55 0.74 . . . . 0.0 110.097 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.728 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 75.3 ttt180 -62.27 -57.05 12.82 Favored 'General case' 0 C--N 1.348 0.53 0 O-C-N 123.994 0.809 . . . . 0.0 110.091 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.2 t -55.34 -48.41 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 125.043 1.464 . . . . 0.0 110.843 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.1 ttt-85 -61.33 -37.74 84.38 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.325 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -78.75 -28.37 44.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 118.889 -0.577 . . . . 0.0 112.136 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 50' ' ' ARG . 97.2 mt -61.64 -44.43 98.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 118.879 0.763 . . . . 0.0 109.06 174.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -65.33 -34.33 78.08 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.978 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -71.16 -30.33 66.32 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.2 0.6 . . . . 0.0 110.961 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -79.55 -5.7 55.47 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.127 0.571 . . . . 0.0 111.304 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -82.53 -8.57 59.61 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.875 0.47 . . . . 0.0 111.577 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 24.0 mm-40 -70.1 118.64 65.62 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.81 -22.25 27.52 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.32 2.013 . . . . 0.0 112.76 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.07 -6.97 49.99 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.727 0.811 . . . . 0.0 111.731 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 21.7 tp -58.43 111.89 1.39 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.222 0.464 . . . . 0.0 111.282 -175.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -148.23 117.01 6.68 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.99 126.71 8.19 Favored Glycine 0 C--O 1.24 0.482 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 171.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -119.46 100.9 7.58 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.8 tt -91.29 117.87 30.01 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.454 HD22 ' H ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.45 -47.01 5.56 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.378 1.071 . . . . 0.0 109.559 175.059 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.3 m -121.69 139.42 53.59 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.601 0.76 . . . . 0.0 111.672 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.688 HH22 ' HB2' ' A' ' 13' ' ' LEU . 2.2 ptp180 -144.07 125.17 14.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.455 0.702 . . . . 0.0 109.322 159.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.4 m -110.71 152.4 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.999 0.919 . . . . 0.0 108.88 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.416 HD11 ' HB ' ' A' ' 5' ' ' ILE . 19.7 tt -138.53 144.97 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 122.604 0.361 . . . . 0.0 110.812 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 75' ' ' VAL . 2.1 p -149.46 101.67 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 124.431 1.093 . . . . 0.0 109.075 -177.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.2 -123.35 20.78 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.488 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -98.76 19.32 15.05 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.831 0.453 . . . . 0.0 111.749 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 72' ' ' VAL . 3.0 p -135.28 139.32 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.102 0.561 . . . . 0.0 110.785 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.502 HG21 HG21 ' A' ' 9' ' ' VAL . 15.8 t -124.86 141.86 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.047 0.939 . . . . 0.0 110.165 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.51 HD13 ' HB ' ' A' ' 98' ' ' ILE . 8.4 mm -107.28 104.4 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 165.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -100.95 114.17 27.81 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -106.11 112.07 24.96 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.875 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -108.42 166.69 10.58 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.22 171.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.5 m -99.98 100.87 11.82 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 152.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.0 m -86.82 138.59 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 37.6 m -95.99 120.11 35.68 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.055 0.455 . . . . 0.0 110.664 -173.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -111.46 -162.8 0.81 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 175.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 3.4 t-20 -132.57 110.1 10.22 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.226 -0.296 . . . . 0.0 110.474 172.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -104.96 143.3 26.42 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 124.425 1.09 . . . . 0.0 108.741 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.05 -9.9 26.49 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.663 2.242 . . . . 0.0 113.706 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -85.48 -13.09 50.21 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.782 0.433 . . . . 0.0 112.085 175.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.68 -129.86 1.56 Allowed Glycine 0 C--N 1.349 1.262 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.981 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 85' ' ' ASN . 15.8 tppt? -75.25 -72.32 0.31 Allowed 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.196 0.598 . . . . 0.0 110.428 174.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 115.92 26.94 3.13 Favored Glycine 0 C--N 1.341 0.836 0 O-C-N 123.277 0.361 . . . . 0.0 113.723 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 117' ' ' ARG . 4.8 pm0 -90.29 122.37 33.14 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -174.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 116' ' ' PRO . 34.1 m -123.57 143.63 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.448 0.699 . . . . 0.0 110.619 -169.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -79.34 108.4 12.83 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.139 0.575 . . . . 0.0 109.657 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.495 HG22 HG12 ' A' ' 113' ' ' ILE . 59.8 t -123.41 138.81 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.84 0.856 . . . . 0.0 110.078 -176.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.34 117.91 30.81 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.528 0.731 . . . . 0.0 109.399 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 64.2 m -94.27 123.29 37.58 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.61 HG23 ' HB2' ' A' ' 110' ' ' TRP . 10.3 tt -104.78 105.23 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.369 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.416 ' HD2' HG22 ' A' ' 9' ' ' VAL . 22.9 m-85 -99.53 127.88 45.62 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.613 0.765 . . . . 0.0 109.996 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -100.42 113.26 25.88 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 168.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.55 HG22 HG12 ' A' ' 106' ' ' ILE . 60.8 t -97.28 126.05 50.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 125.123 1.369 . . . . 0.0 110.508 -175.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.461 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 8.5 tp10 -133.15 139.28 46.99 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.108 0.963 . . . . 0.0 109.635 174.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.461 ' ND2' ' HG3' ' A' ' 102' ' ' GLU . 37.0 m-80 63.21 29.46 15.97 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.736 1.214 . . . . 0.0 111.644 -173.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.51 8.42 62.87 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.893 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -128.46 145.24 51.16 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.759 1.224 . . . . 0.0 108.4 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.55 HG12 HG22 ' A' ' 101' ' ' VAL . 57.5 mt -69.78 100.53 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 118.435 0.562 . . . . 0.0 109.832 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . . . -87.61 -15.31 37.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.723 0.409 . . . . 0.0 111.626 -177.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -148.33 129.73 14.79 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.4 132.93 48.51 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.61 ' HB2' HG23 ' A' ' 98' ' ' ILE . 1.6 m-90 -133.98 152.59 51.91 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -143.72 148.55 35.87 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 118.805 0.73 . . . . 0.0 111.251 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.7 129.72 51.53 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.422 1.089 . . . . 0.0 109.546 176.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.495 HG12 HG22 ' A' ' 95' ' ' VAL . 75.2 mt -90.23 127.76 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 171.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.53 -74.11 0.93 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.329 -0.851 . . . . 0.0 113.24 -176.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.96 167.41 13.23 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 123.099 0.56 . . . . 0.0 109.49 -175.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.658 ' HA ' HG12 ' A' ' 93' ' ' VAL . 56.8 Cg_endo -84.21 137.79 7.39 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.428 2.086 . . . . 0.0 113.001 168.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 29.3 mmt180 -131.22 149.64 52.49 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.974 0.91 . . . . 0.0 109.126 173.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.6 mm -131.58 131.55 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.033 0.933 . . . . 0.0 108.608 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.4 t -64.67 -37.85 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 C-N-CA 123.218 0.607 . . . . 0.0 111.64 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 49.1 m -76.04 -18.81 59.08 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.167 0.587 . . . . 0.0 111.466 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.69 98.82 0.55 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.594 0.758 . . . . 0.0 109.107 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.48 113.12 5.36 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.859 0.463 . . . . 0.0 109.848 -175.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 C--O 1.255 1.389 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.776 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 tmm? . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 60.56 14.24 4.76 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 124.433 1.093 . . . . 0.0 111.894 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 14.4 m -75.75 -20.31 58.39 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.235 1.014 . . . . 0.0 112.483 -167.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -72.76 -19.77 61.31 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.527 0.331 . . . . 0.0 111.358 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.51 ' HB ' HD11 ' A' ' 71' ' ' ILE . 37.5 mm -88.88 -27.41 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 173.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.656 ' HG2' HH12 ' A' ' 69' ' ' ARG . 40.2 mt-10 -78.45 -19.79 52.4 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.663 173.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 3' ' ' SER . 77.6 mt -61.5 -50.75 81.38 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-O 118.736 -0.649 . . . . 0.0 111.729 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 19.6 Cg_endo -59.09 -55.33 1.98 Allowed 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 121.745 1.63 . . . . 0.0 111.709 173.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.1 t -54.4 -47.97 69.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 125.681 1.592 . . . . 0.0 113.576 -172.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -62.22 -47.4 84.59 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.859 0.864 . . . . 0.0 110.212 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -68.63 -35.18 76.95 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.632 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.29 -51.79 67.41 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.475 0.71 . . . . 0.0 111.033 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.66 -49.37 78.0 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.963 0.789 . . . . 0.0 109.494 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' HA ' HD21 ' A' ' 17' ' ' ASN . 22.3 mm-40 -60.11 -35.0 74.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 123.972 0.795 . . . . 0.0 111.03 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -74.17 -28.0 61.09 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.058 0.943 . . . . 0.0 111.395 175.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -70.36 -42.59 71.63 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.369 0.668 . . . . 0.0 110.238 -174.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.418 HD21 ' HA ' ' A' ' 14' ' ' GLU . 9.2 p30 -82.04 -28.33 32.54 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.433 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.92 11.38 27.48 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 63.74 20.69 12.35 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.351 1.06 . . . . 0.0 112.412 172.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.484 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 4.5 t70 -91.38 100.62 13.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.54 0.736 . . . . 0.0 109.406 -178.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.492 HG13 HG12 ' A' ' 54' ' ' ILE . 10.4 mm -74.47 -28.8 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.255 0.222 . . . . 0.0 110.974 173.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -62.72 -45.42 92.84 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.501 0.721 . . . . 0.0 110.891 -172.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.89 -36.05 31.76 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.787 0.835 . . . . 0.0 110.569 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -64.94 -8.8 17.17 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.25 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.753 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -112.27 -31.48 6.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.538 0.735 . . . . 0.0 111.855 174.033 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.07 -28.77 66.79 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -170.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 96.7 m95 -96.82 13.85 27.22 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.81 0.844 . . . . 0.0 112.782 -175.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.409 ' HE3' ' SG ' ' A' ' 32' ' ' CYS . 13.3 m95 -112.83 147.54 36.74 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.834 0.853 . . . . 0.0 109.011 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -72.48 152.86 41.67 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.402 0.681 . . . . 0.0 110.517 175.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.67 -27.72 69.43 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.264 0.625 . . . . 0.0 111.642 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -101.45 12.26 37.65 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 124.153 0.981 . . . . 0.0 111.345 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.409 ' SG ' ' HE3' ' A' ' 28' ' ' TRP . 53.4 t -59.69 125.89 25.42 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -169.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -81.08 150.41 28.8 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.593 0.757 . . . . 0.0 109.562 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.416 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 59.6 t80 -146.73 112.88 5.83 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.344 0.658 . . . . 0.0 109.309 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.412 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 34.1 m-85 -114.26 150.77 33.88 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.003 0.921 . . . . 0.0 111.331 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.525 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -99.03 159.44 14.97 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 113.942 -1.481 . . . . 0.0 108.294 165.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -58.65 136.83 86.44 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-O 119.116 -0.468 . . . . 0.0 110.269 173.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.83 -55.97 0.14 OUTLIER 'Cis proline' 0 C--N 1.381 2.263 0 CA-C-N 120.406 1.181 . . . . 0.0 112.556 -7.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -148.2 58.92 1.1 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.708 0.766 . . . . 0.0 109.865 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.4 m -95.65 104.0 15.9 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.407 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 tt -67.64 104.29 1.58 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 36' ' ' ALA . 56.9 mt -82.1 -45.68 14.88 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.153 177.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -143.46 117.1 9.21 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.992 -172.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.77 37.05 3.89 Favored Glycine 0 N--CA 1.478 1.465 0 C-N-CA 122.874 0.273 . . . . 0.0 113.536 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.3 p30 168.74 156.26 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.786 1.634 . . . . 0.0 109.013 -171.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -58.97 -36.11 74.31 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.806 0.842 . . . . 0.0 112.82 -174.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.17 94.68 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.073 0.549 . . . . 0.0 112.082 -173.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.447 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 29.1 mt-10 -76.24 -32.54 58.95 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.969 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 78.5 mt -63.54 -42.83 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.396 0.679 . . . . 0.0 109.97 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.753 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 74.6 ttt180 -56.03 -58.51 7.61 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.913 1.285 . . . . 0.0 110.861 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.32 -35.55 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.876 -168.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -72.0 -34.11 68.61 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.857 0.463 . . . . 0.0 110.334 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -74.57 -27.07 60.34 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.742 -0.646 . . . . 0.0 111.548 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.492 HG12 HG13 ' A' ' 21' ' ' ILE . 85.1 mt -56.99 -42.72 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 118.453 0.57 . . . . 0.0 109.837 173.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -61.09 -37.24 82.02 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.009 0.818 . . . . 0.0 111.151 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -64.97 -39.15 93.05 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.571 0.749 . . . . 0.0 110.064 174.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -81.3 1.85 30.71 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.1 0.96 . . . . 0.0 112.17 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 9.8 mmpt? -95.97 -16.04 21.95 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.805 0.442 . . . . 0.0 111.177 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -70.54 122.64 87.19 Favored Pre-proline 0 N--CA 1.482 1.138 0 CA-C-O 119.023 -0.513 . . . . 0.0 109.965 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.22 -26.02 72.3 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.59 2.194 . . . . 0.0 112.374 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -86.12 -5.82 59.13 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.871 0.868 . . . . 0.0 112.137 -177.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.4 tp -57.87 114.39 2.29 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 120.969 0.414 . . . . 0.0 110.575 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -147.5 117.03 7.02 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 169.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.96 102.29 1.74 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -97.07 102.86 14.73 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' A' ' 69' ' ' ARG . 8.2 tt -74.59 115.61 14.34 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 171.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.504 ' H ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -101.45 -29.86 11.76 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.52 0.728 . . . . 0.0 110.695 -177.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.2 m -150.19 133.15 16.1 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.865 0.866 . . . . 0.0 110.008 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.656 HH12 ' HG2' ' A' ' 6' ' ' GLU . 52.5 ptt85 -139.56 139.69 36.91 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.139 0.576 . . . . 0.0 109.637 170.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.9 m -121.95 125.64 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.951 0.901 . . . . 0.0 109.455 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.51 HD11 ' HB ' ' A' ' 5' ' ' ILE . 14.0 tt -108.21 135.87 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 121.005 0.431 . . . . 0.0 110.713 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 p -142.68 96.24 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 124.778 1.231 . . . . 0.0 108.557 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.44 -124.69 22.41 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.616 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -88.25 7.51 31.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.17 0.588 . . . . 0.0 112.559 -175.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.16 142.86 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 122.989 0.516 . . . . 0.0 110.952 -175.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.13 141.88 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.796 0.839 . . . . 0.0 109.745 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.611 HD13 ' HB ' ' A' ' 98' ' ' ILE . 5.2 mm -99.25 105.88 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 168.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -99.34 105.43 17.41 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.498 0.719 . . . . 0.0 109.668 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -98.83 104.47 16.52 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -102.09 164.1 11.88 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.421 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.6 m -105.68 101.88 11.37 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 158.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.0 t -85.87 103.43 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.883 1.273 . . . . 0.0 110.028 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 48.3 m -71.12 127.16 31.64 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.624 0.77 . . . . 0.0 111.276 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -117.25 -161.37 0.81 Allowed 'General case' 0 C--O 1.247 0.931 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -131.65 103.82 6.59 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 172.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -108.37 134.96 20.03 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 123.861 0.864 . . . . 0.0 109.528 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.74 -10.98 24.41 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.426 2.751 . . . . 0.0 114.359 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -79.61 -28.31 40.98 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.94 0.496 . . . . 0.0 111.337 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.28 -115.63 0.49 Allowed Glycine 0 C--N 1.35 1.328 0 C-N-CA 121.497 -0.383 . . . . 0.0 112.873 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -70.02 -80.81 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.12 0.968 . . . . 0.0 111.437 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 116.15 26.45 3.22 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 116.437 -0.347 . . . . 0.0 113.221 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 9.3 pt-20 -89.0 114.54 25.73 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.416 0.627 . . . . 0.0 109.872 -172.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.657 HG12 ' HA ' ' A' ' 116' ' ' PRO . 33.6 m -111.0 126.15 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.183 0.593 . . . . 0.0 109.637 -173.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.19 109.28 13.37 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.1 t -113.06 131.8 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.321 0.648 . . . . 0.0 110.248 -172.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.1 99.87 12.38 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.756 0.822 . . . . 0.0 109.323 173.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 56.9 m -94.47 108.2 20.14 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.433 1.093 . . . . 0.0 108.436 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.611 ' HB ' HD13 ' A' ' 77' ' ' ILE . 5.1 tt -106.37 115.21 47.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.937 0.895 . . . . 0.0 110.205 -174.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -112.47 133.79 54.35 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.33 0.652 . . . . 0.0 110.025 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -106.96 112.88 26.04 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.766 0.826 . . . . 0.0 108.803 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 50.1 t -85.18 140.12 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.137 1.375 . . . . 0.0 110.332 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.465 ' HG3' HD22 ' A' ' 103' ' ' ASN . 9.7 tp10 -141.31 105.64 4.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.287 1.035 . . . . 0.0 108.866 -173.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.465 HD22 ' HG3' ' A' ' 102' ' ' GLU . 33.4 m-80 62.4 31.67 17.13 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.651 1.18 . . . . 0.0 112.11 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.86 -7.58 67.69 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.78 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -131.72 133.37 44.75 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.725 0.81 . . . . 0.0 109.653 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 101' ' ' VAL . 67.1 mt -67.57 112.11 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.507 0.723 . . . . 0.0 110.191 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.25 -10.98 26.67 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -150.28 131.13 14.18 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.58 139.78 31.48 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.629 0.772 . . . . 0.0 109.232 -177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.421 ' HB2' HG23 ' A' ' 98' ' ' ILE . 3.1 m-90 -138.29 156.99 47.12 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -143.5 147.09 33.98 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.028 0.442 . . . . 0.0 110.149 171.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -129.02 122.51 30.19 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.245 1.018 . . . . 0.0 108.363 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.7 mt -87.69 130.38 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.35 -129.87 0.56 Allowed Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.469 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -90.18 161.11 38.59 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.657 ' HA ' HG12 ' A' ' 93' ' ' VAL . 76.2 Cg_endo -83.96 114.79 1.98 Allowed 'Trans proline' 0 CA--C 1.551 1.357 0 C-N-CA 122.234 1.956 . . . . 0.0 112.136 167.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.426 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 34.6 mtm180 -107.0 148.42 28.71 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 121.852 0.834 . . . . 0.0 110.759 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 120' ' ' SER . 47.3 mm -128.65 147.09 33.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.7 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 58.5 t -55.07 -29.34 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.553 0.741 . . . . 0.0 112.488 -177.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.43 ' H ' HG22 ' A' ' 118' ' ' ILE . 80.4 p -73.09 -45.33 57.78 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.789 0.835 . . . . 0.0 112.335 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -104.3 -4.37 23.04 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -168.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.7 ' HE3' ' HA ' ' A' ' 119' ' ' VAL . 19.1 ptpt -61.36 149.07 39.36 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -173.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.2 p . . . . . 0 CA--C 1.559 1.291 0 C-N-CA 123.714 0.806 . . . . 0.0 109.966 -177.944 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 121.255 0.55 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -132.18 21.62 4.45 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.113 0.965 . . . . 0.0 109.54 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.447 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 22.2 t -68.73 -45.78 70.61 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 123.963 0.905 . . . . 0.0 110.902 -175.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -60.63 -17.33 46.41 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.886 0.875 . . . . 0.0 112.909 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.445 HG23 ' HB ' ' A' ' 101' ' ' VAL . 28.1 mm -87.29 -34.6 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.239 0.616 . . . . 0.0 109.574 178.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.91 -17.78 32.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 118.652 -0.69 . . . . 0.0 112.053 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 3' ' ' SER . 90.2 mt -62.7 -50.36 78.32 Favored Pre-proline 0 N--CA 1.488 1.465 0 CA-C-O 118.687 -0.673 . . . . 0.0 110.635 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.64 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 14.1 Cg_endo -57.25 -51.92 7.59 Favored 'Trans proline' 0 C--N 1.388 2.642 0 C-N-CA 122.089 1.86 . . . . 0.0 112.047 172.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.96 -31.31 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 C-N-CA 124.55 1.14 . . . . 0.0 112.733 -172.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.61 -47.86 44.42 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.82 0.848 . . . . 0.0 109.519 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.1 mmtt -70.62 -25.56 63.09 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.947 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -61.1 -46.77 89.26 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.654 0.597 . . . . 0.0 110.39 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.39 -50.45 71.56 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.144 0.903 . . . . 0.0 109.54 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -57.57 -45.78 84.77 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 124.656 1.222 . . . . 0.0 109.524 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -68.82 -26.62 65.26 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.932 -1.485 . . . . 0.0 112.161 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -73.39 -38.71 65.54 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.022 0.529 . . . . 0.0 109.667 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -91.08 -29.9 17.06 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.563 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.69 0.29 57.45 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.361 0.664 . . . . 0.0 111.989 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.9 mmt-85 65.96 24.26 11.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.523 1.129 . . . . 0.0 113.121 172.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 48.1 m-20 -87.97 95.26 10.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.954 0.406 . . . . 0.0 110.724 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.52 HG13 HG12 ' A' ' 54' ' ' ILE . 8.3 mm -64.05 -30.44 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.568 0.747 . . . . 0.0 111.314 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.87 -45.63 92.93 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.313 0.383 . . . . 0.0 111.116 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.82 -35.99 62.43 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.259 0.624 . . . . 0.0 110.711 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -71.73 -4.4 27.36 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.845 0.858 . . . . 0.0 111.052 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.754 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -120.95 -23.2 5.94 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 172.198 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.74 -35.79 75.28 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.672 0.789 . . . . 0.0 112.82 -173.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.64 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 97.2 m95 -89.89 -7.69 53.6 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.625 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 14.6 m95 -91.91 143.75 26.17 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.288 0.635 . . . . 0.0 110.049 -173.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.72 152.31 45.5 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.216 0.607 . . . . 0.0 110.066 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -68.82 -24.2 64.36 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 120.932 0.396 . . . . 0.0 110.689 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.59 19.32 16.01 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.727 1.211 . . . . 0.0 110.69 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.625 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 42.7 t -65.04 122.49 17.15 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 122.073 -0.392 . . . . 0.0 111.628 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -87.39 154.61 20.53 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.745 0.818 . . . . 0.0 109.331 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 48.2 t80 -145.06 114.28 7.03 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.416 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 17.3 m-85 -109.23 153.91 23.16 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.51 0.724 . . . . 0.0 110.288 176.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.406 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -112.84 151.28 30.58 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.066 173.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.617 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 84.7 t80 -57.64 128.84 80.47 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 123.656 0.782 . . . . 0.0 111.581 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.92 -50.32 0.19 OUTLIER 'Cis proline' 0 C--N 1.389 2.666 0 CA-C-N 120.464 1.201 . . . . 0.0 114.046 0.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.41 91.63 0.93 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.958 0.903 . . . . 0.0 108.757 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.3 m -136.7 107.84 6.78 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.5 103.97 1.8 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.271 0.628 . . . . 0.0 109.695 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.406 HD11 ' HB2' ' A' ' 36' ' ' ALA . 49.5 mt -80.63 -36.55 32.45 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.948 0.899 . . . . 0.0 110.71 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -140.09 121.18 14.72 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.154 0.582 . . . . 0.0 111.436 -171.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -107.62 40.01 2.68 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 123.401 0.524 . . . . 0.0 113.042 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.9 p30 165.64 164.67 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 126.023 1.729 . . . . 0.0 108.963 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.15 -37.86 88.73 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.777 0.831 . . . . 0.0 112.556 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.46 -43.26 99.18 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.294 0.638 . . . . 0.0 112.337 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -73.08 -30.0 63.35 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.711 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.435 HG21 ' CZ3' ' A' ' 28' ' ' TRP . 85.9 mt -66.58 -46.15 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.517 0.727 . . . . 0.0 109.871 173.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.754 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 36.8 ttt180 -56.28 -56.4 21.46 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.837 -176.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.444 ' HA ' HD12 ' A' ' 54' ' ' ILE . 29.4 m -63.48 -37.31 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 124.543 1.152 . . . . 0.0 113.147 -172.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.1 ttt85 -71.37 -34.51 70.5 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.028 0.442 . . . . 0.0 110.753 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -76.5 -26.96 55.84 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 118.965 -0.541 . . . . 0.0 111.2 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.52 HG12 HG13 ' A' ' 21' ' ' ILE . 85.6 mt -59.66 -47.82 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 172.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.03 -42.25 89.76 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.998 0.919 . . . . 0.0 111.179 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -66.44 -32.71 74.26 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.104 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -82.04 -13.31 57.53 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.259 0.624 . . . . 0.0 111.356 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 67.4 mmtt -73.13 -28.82 62.47 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.737 0.415 . . . . 0.0 110.486 170.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.53 115.38 21.56 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.987 0.915 . . . . 0.0 109.991 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.1 -22.76 18.96 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.578 2.185 . . . . 0.0 112.693 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.85 -12.09 59.48 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.786 0.834 . . . . 0.0 111.508 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.7 tp -60.02 117.17 4.77 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 123.515 0.509 . . . . 0.0 109.975 175.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -149.87 117.11 6.03 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.7 103.08 2.91 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -94.47 102.06 13.99 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 tt -82.83 125.39 31.27 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.49 ' H ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -116.57 -29.98 5.97 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.01 0.924 . . . . 0.0 111.077 178.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 92.2 m -144.96 133.59 22.12 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.428 0.691 . . . . 0.0 109.991 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.5 ' NH2' HG11 ' A' ' 76' ' ' VAL . 7.4 ptm180 -142.87 138.35 30.2 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.929 0.492 . . . . 0.0 110.429 171.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.466 HG22 ' HB ' ' A' ' 77' ' ' ILE . 15.0 m -128.67 158.35 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 124.517 1.127 . . . . 0.0 108.761 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.3 tt -129.75 142.53 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-O 121.025 0.44 . . . . 0.0 110.085 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.483 HG13 HG13 ' A' ' 75' ' ' VAL . 2.2 p -137.1 95.85 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 124.509 1.124 . . . . 0.0 108.945 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.71 -120.14 8.73 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.024 -0.535 . . . . 0.0 113.154 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -97.47 15.0 24.46 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.108 0.563 . . . . 0.0 112.063 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.483 HG13 HG13 ' A' ' 72' ' ' VAL . 4.4 p -135.88 135.5 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.526 0.73 . . . . 0.0 110.255 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.5 HG11 ' NH2' ' A' ' 69' ' ' ARG . 5.1 t -114.05 141.92 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.354 0.662 . . . . 0.0 110.245 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.469 HD13 ' HB ' ' A' ' 98' ' ' ILE . 17.7 mm -99.67 114.73 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.929 1.292 . . . . 0.0 107.896 168.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -112.21 106.03 14.51 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -97.62 107.17 19.61 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -112.78 144.58 42.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.168 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.1 m -91.55 102.08 14.73 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 162.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.8 m -92.83 133.36 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.104 0.478 . . . . 0.0 110.791 -176.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 73.0 m -81.31 120.73 25.3 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.771 -177.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.617 HH21 HG11 ' A' ' 93' ' ' VAL . 72.9 mtm180 -118.84 -162.86 0.92 Allowed 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.693 1.197 . . . . 0.0 107.911 170.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -125.09 108.54 11.9 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 118.477 0.58 . . . . 0.0 110.994 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.411 ' CG ' ' HA2' ' A' ' 91' ' ' GLY . 11.7 m-30 -109.95 145.03 31.21 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 123.794 0.838 . . . . 0.0 109.824 176.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.94 -19.03 67.94 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 123.369 2.713 . . . . 0.0 114.164 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -79.57 -20.04 47.97 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.29 -111.36 0.46 Allowed Glycine 0 C--N 1.348 1.242 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.726 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -62.37 -82.32 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.957 0.903 . . . . 0.0 111.693 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.411 ' HA2' ' CG ' ' A' ' 86' ' ' PHE . . . 117.14 26.1 3.06 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.994 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -87.22 138.83 31.15 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.617 HG11 HH21 ' A' ' 84' ' ' ARG . 13.9 m -137.12 140.95 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 O-C-N 121.988 -0.445 . . . . 0.0 111.316 -173.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -75.6 112.79 12.31 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 174.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.408 HG22 HG12 ' A' ' 113' ' ' ILE . 61.3 t -129.24 133.6 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.079 0.952 . . . . 0.0 108.499 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -99.77 111.13 23.47 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.4 m -94.08 107.49 19.41 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' A' ' 110' ' ' TRP . 5.4 tt -112.87 107.94 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 124.35 1.06 . . . . 0.0 109.82 -169.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -109.93 127.91 55.05 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.815 0.846 . . . . 0.0 110.408 -174.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 33.6 tt0 -99.26 112.81 24.89 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 173.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.466 HG22 HG12 ' A' ' 106' ' ' ILE . 60.7 t -96.98 113.14 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.322 1.049 . . . . 0.0 109.492 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 35.0 tt0 -113.54 126.88 55.79 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.835 0.854 . . . . 0.0 108.94 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 63.09 33.67 14.39 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.262 1.025 . . . . 0.0 112.096 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.86 7.2 88.7 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.807 -0.633 . . . . 0.0 114.336 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -133.84 143.76 48.53 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.161 0.984 . . . . 0.0 108.852 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 8' ' ' PRO . 55.2 mt -67.95 102.7 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.407 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -84.06 -23.02 31.03 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.165 0.586 . . . . 0.0 111.02 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 79.5 mttt -149.28 146.47 27.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.01 0.924 . . . . 0.0 109.061 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -142.81 133.07 24.66 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.627 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.0 m-90 -135.68 159.49 41.48 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -142.78 145.6 33.42 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 169.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.617 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 14.4 ptmm? -126.86 123.52 37.48 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.408 HG12 HG22 ' A' ' 95' ' ' VAL . 95.1 mt -89.33 116.16 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.4 -71.8 1.03 Allowed Glycine 0 CA--C 1.523 0.561 0 CA-C-N 114.24 -1.345 . . . . 0.0 113.592 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -157.01 162.86 26.84 Favored Pre-proline 0 CA--C 1.548 0.904 0 CA-C-N 116.825 0.313 . . . . 0.0 110.723 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.584 ' HA ' HG12 ' A' ' 93' ' ' VAL . 92.7 Cg_endo -77.37 137.01 16.36 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.598 2.199 . . . . 0.0 113.596 171.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.462 ' HA ' ' NE2' ' A' ' 121' ' ' GLN . 34.6 mmt180 -129.26 153.56 47.67 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.438 1.095 . . . . 0.0 109.98 176.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 120' ' ' SER . 30.4 mm -138.98 151.51 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.5 t -56.94 -45.98 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 122.999 0.52 . . . . 0.0 111.259 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.481 ' H ' HG22 ' A' ' 118' ' ' ILE . 22.7 t -78.62 -11.43 59.97 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.84 0.856 . . . . 0.0 112.763 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.462 ' NE2' ' HA ' ' A' ' 117' ' ' ARG . 31.4 tt0 -51.91 -53.22 43.53 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.699 0.8 . . . . 0.0 111.456 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -84.73 100.27 11.39 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 173.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.4 t . . . . . 0 C--O 1.255 1.372 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.56 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.733 0.301 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -102.68 27.12 7.22 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.584 0.753 . . . . 0.0 110.882 -170.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.4 m -71.8 -35.07 69.85 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.405 0.682 . . . . 0.0 112.693 -169.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -14.36 62.02 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.649 0.38 . . . . 0.0 111.718 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.486 ' HB ' HD11 ' A' ' 71' ' ' ILE . 27.2 mm -90.68 -28.45 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.866 0.867 . . . . 0.0 110.111 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -69.28 -32.08 71.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.676 0.79 . . . . 0.0 111.615 173.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.6 mt -61.94 -52.1 70.46 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-O 118.675 -0.678 . . . . 0.0 112.358 -175.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 23.0 Cg_endo -60.35 -51.1 5.8 Favored 'Trans proline' 0 C--N 1.396 3.063 0 C-N-CA 122.493 2.129 . . . . 0.0 113.739 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.5 m -67.81 -32.72 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 122.699 0.4 . . . . 0.0 112.025 -170.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -73.38 -50.68 20.61 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.255 0.622 . . . . 0.0 111.076 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -70.96 -30.64 66.98 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.558 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -69.6 -39.6 77.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.142 0.577 . . . . 0.0 109.477 177.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -58.87 -52.28 66.41 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.219 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.44 -29.57 64.28 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.824 0.702 . . . . 0.0 111.202 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 20' ' ' ASP . . . -79.47 -31.57 42.44 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.997 0.919 . . . . 0.0 111.881 176.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -62.94 -51.29 67.48 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.173 0.589 . . . . 0.0 111.271 -173.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -75.96 -20.94 57.52 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.691 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.9 1.23 54.57 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.515 0.726 . . . . 0.0 112.401 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.8 mmt85 62.86 22.79 13.63 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.656 1.182 . . . . 0.0 111.936 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.433 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 5.8 t70 -89.86 131.74 35.63 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.433 ' HA ' ' HB3' ' A' ' 24' ' ' PHE . 14.9 mm -104.12 -27.46 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.292 0.637 . . . . 0.0 110.816 174.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.27 -48.36 81.78 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.85 0.46 . . . . 0.0 111.58 -176.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.46 -33.76 36.44 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.749 0.82 . . . . 0.0 110.637 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.433 ' HB3' ' HA ' ' A' ' 21' ' ' ILE . 49.8 t80 -59.87 -24.7 64.46 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.39 175.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 79.6 mmm -120.44 0.6 10.57 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.09 -41.16 77.86 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.367 0.603 . . . . 0.0 111.608 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 89.9 m95 -83.42 -0.02 48.15 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.654 -173.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.558 ' HE1' ' HG3' ' A' ' 12' ' ' GLN . 21.7 m95 -91.24 143.17 26.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.225 0.61 . . . . 0.0 110.352 -175.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.55 48.12 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.9 173.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.56 -28.64 70.01 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 120.84 0.353 . . . . 0.0 111.588 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -97.4 19.08 13.85 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.205 1.002 . . . . 0.0 110.973 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.476 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 48.6 t -62.62 123.52 18.58 Favored 'General case' 0 C--N 1.357 0.909 0 O-C-N 121.913 -0.492 . . . . 0.0 111.987 -174.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -89.72 151.4 21.86 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.294 1.038 . . . . 0.0 109.31 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -139.34 119.25 13.36 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.419 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 61.9 m-85 -122.34 154.8 37.16 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.13 0.972 . . . . 0.0 111.197 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -128.75 160.12 33.53 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.769 1.228 . . . . 0.0 109.625 177.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -63.18 139.71 97.58 Favored Pre-proline 0 CA--C 1.561 1.385 0 C-N-CA 124.114 0.966 . . . . 0.0 111.538 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.89 -44.59 0.51 Allowed 'Cis proline' 0 C--N 1.381 2.287 0 CA-C-N 120.152 1.09 . . . . 0.0 113.183 -9.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.53 79.58 0.5 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.132 0.573 . . . . 0.0 110.382 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.9 m -123.44 125.22 44.55 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.688 0.795 . . . . 0.0 109.588 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 tt -84.33 110.95 18.99 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.409 HD21 ' HB2' ' A' ' 36' ' ' ALA . 1.4 mm? -85.55 -51.1 6.72 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.27 0.628 . . . . 0.0 109.363 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -140.13 120.73 14.23 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.219 -168.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.28 37.42 3.83 Favored Glycine 0 N--CA 1.477 1.372 0 O-C-N 123.135 0.272 . . . . 0.0 113.539 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.5 p30 175.45 155.22 0.17 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.02 1.728 . . . . 0.0 108.722 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.12 -25.89 68.3 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.806 0.843 . . . . 0.0 113.162 -172.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.93 -47.25 81.26 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.928 0.491 . . . . 0.0 110.78 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.492 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.7 mt-10 -70.83 -37.97 73.22 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.771 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.5 mt -61.68 -43.25 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.262 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.491 ' O ' HG13 ' A' ' 54' ' ' ILE . 69.4 ttt-85 -60.17 -56.25 23.94 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.272 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.8 t -53.8 -49.06 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 124.546 1.154 . . . . 0.0 111.98 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -61.14 -36.26 79.29 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.183 0.593 . . . . 0.0 111.383 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -75.97 -32.7 59.62 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.748 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 50' ' ' ARG . 64.4 mt -64.64 -42.67 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -62.98 -31.25 72.32 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.096 174.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -85.33 -11.18 55.23 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.324 0.65 . . . . 0.0 111.525 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.472 ' HA ' HD22 ' A' ' 62' ' ' LEU . 3.3 m-85 -89.99 -0.7 57.73 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.471 0.709 . . . . 0.0 110.876 172.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.445 ' HE2' HG22 ' A' ' 54' ' ' ILE . 72.6 mmtt -82.56 -4.13 57.12 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.28 0.632 . . . . 0.0 112.091 173.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.724 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 22.5 mm-40 -67.66 120.13 71.13 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -65.62 -24.33 55.74 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.058 1.838 . . . . 0.0 112.693 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -111.54 21.76 15.81 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.596 0.758 . . . . 0.0 111.611 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.724 ' HB2' ' HB2' ' A' ' 59' ' ' GLU . 39.4 tp -67.2 111.62 4.04 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 120.795 0.331 . . . . 0.0 110.235 175.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -138.11 136.41 36.7 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.514 0.726 . . . . 0.0 109.301 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.32 128.06 8.93 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.329 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -127.74 99.91 5.74 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 tt -81.35 134.75 35.62 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-O 121.452 0.644 . . . . 0.0 110.354 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mt -107.05 -50.7 3.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.161 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.2 m -152.48 125.89 8.76 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.243 -1.799 . . . . 0.0 109.136 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -118.18 132.92 56.29 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 167.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.3 m -118.8 122.52 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.006 0.923 . . . . 0.0 109.285 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.486 HD11 ' HB ' ' A' ' 5' ' ' ILE . 17.4 tt -105.74 136.77 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 122.782 0.433 . . . . 0.0 110.796 -175.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.426 HG13 HG13 ' A' ' 75' ' ' VAL . 2.1 p -146.38 112.87 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.419 1.087 . . . . 0.0 109.488 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.83 -104.73 1.06 Allowed Glycine 0 C--N 1.346 1.098 0 CA-C-N 116.384 -0.371 . . . . 0.0 112.743 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.483 ' HA ' HG13 ' A' ' 5' ' ' ILE . 4.0 p-10 -122.55 15.61 10.34 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.096 0.559 . . . . 0.0 111.074 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.426 HG13 HG13 ' A' ' 72' ' ' VAL . 3.0 p -135.37 132.64 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.766 0.826 . . . . 0.0 110.173 -173.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.03 141.22 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.65 0.78 . . . . 0.0 110.239 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.567 HG12 ' HB ' ' A' ' 98' ' ' ILE . 3.1 mt -100.58 103.93 15.49 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 165.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -93.38 106.22 18.21 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -100.09 109.35 21.64 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.691 -176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.15 171.14 7.61 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.103 0.961 . . . . 0.0 111.057 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.0 m -109.13 102.23 11.21 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 161.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -81.98 108.91 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.659 1.184 . . . . 0.0 110.029 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 75.7 m -68.59 119.02 12.36 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 122.952 0.501 . . . . 0.0 110.502 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -117.06 -169.13 1.59 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.396 1.078 . . . . 0.0 109.787 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -118.34 102.91 9.31 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.63 0.772 . . . . 0.0 110.448 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.404 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 21.3 m-30 -112.07 134.07 21.52 Favored Pre-proline 0 N--CA 1.474 0.728 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 171.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.74 -12.4 32.84 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.827 2.351 . . . . 0.0 113.409 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -83.1 -10.86 58.45 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.657 0.383 . . . . 0.0 111.902 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.86 -125.75 1.09 Allowed Glycine 0 C--N 1.349 1.269 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.691 172.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -71.01 -80.1 0.06 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.84 0.856 . . . . 0.0 110.704 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.404 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 120.33 27.15 2.06 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 113.455 0.142 . . . . 0.0 113.455 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 1.5 pm0 -88.95 112.28 23.14 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.762 0.791 . . . . 0.0 109.501 -171.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 116' ' ' PRO . 30.2 m -106.43 141.12 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.594 0.757 . . . . 0.0 110.313 -172.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -83.62 124.1 30.47 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.9 t -126.0 127.65 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.051 0.541 . . . . 0.0 109.649 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -95.47 102.59 14.41 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.627 0.771 . . . . 0.0 109.235 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.4 m -98.31 118.28 34.6 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.567 ' HB ' HG12 ' A' ' 77' ' ' ILE . 11.3 tt -111.75 105.77 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 C-N-CA 123.94 0.896 . . . . 0.0 110.81 -177.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -99.29 129.07 45.48 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.098 0.959 . . . . 0.0 110.457 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 34.8 tt0 -97.72 114.44 26.44 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.237 0.541 . . . . 0.0 109.68 170.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.474 HG22 HG12 ' A' ' 106' ' ' ILE . 61.7 t -99.86 111.65 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 124.562 1.145 . . . . 0.0 110.133 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 34.5 tt0 -112.18 132.97 54.59 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.253 1.021 . . . . 0.0 109.942 174.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 63.46 30.34 15.33 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.604 1.161 . . . . 0.0 111.46 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.99 14.0 75.98 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.051 -0.522 . . . . 0.0 113.458 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -129.79 134.66 47.71 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.803 1.241 . . . . 0.0 108.96 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.474 HG12 HG22 ' A' ' 101' ' ' VAL . 70.6 mt -63.95 99.39 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -82.7 -24.31 33.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.423 0.689 . . . . 0.0 110.912 -177.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 74.2 mttt -147.88 148.47 30.88 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.378 1.071 . . . . 0.0 108.216 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.78 132.19 20.79 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 172.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.545 ' HB2' HG23 ' A' ' 98' ' ' ILE . 1.5 m-90 -128.62 146.76 50.76 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -177.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -142.47 146.88 35.23 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 119.381 0.991 . . . . 0.0 110.97 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -129.91 122.14 28.02 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.073 0.949 . . . . 0.0 108.663 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.35 128.96 41.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.47 -121.24 0.55 Allowed Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.099 -0.955 . . . . 0.0 113.448 -175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -97.91 141.09 22.42 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.22 1.008 . . . . 0.0 110.459 -172.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.621 ' HA ' HG12 ' A' ' 93' ' ' VAL . 55.9 Cg_endo -71.51 115.86 4.46 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.006 2.471 . . . . 0.0 110.492 170.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -121.22 153.87 37.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.273 0.629 . . . . 0.0 111.377 -174.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.437 HG22 ' H ' ' A' ' 120' ' ' SER . 48.5 mm -129.77 132.84 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.806 1.242 . . . . 0.0 108.966 174.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.6 t -55.1 -38.94 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.999 0.92 . . . . 0.0 112.197 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.437 ' H ' HG22 ' A' ' 118' ' ' ILE . 29.9 t -72.58 -32.16 65.79 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.161 0.584 . . . . 0.0 111.695 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -91.83 79.85 5.29 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.404 0.682 . . . . 0.0 110.115 -173.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -134.08 138.89 45.6 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.336 0.654 . . . . 0.0 110.37 -177.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 CA--C 1.557 1.221 0 C-N-CA 123.899 0.88 . . . . 0.0 109.29 -177.494 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.5 ' HB2' HD11 ' A' ' 71' ' ' ILE . 16.3 m120 -89.53 76.89 7.34 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.766 0.826 . . . . 0.0 110.145 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.439 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 66.6 m -69.36 -41.02 77.13 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.8 0.84 . . . . 0.0 111.736 -176.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -11.73 58.23 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.04 0.536 . . . . 0.0 112.208 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.456 HG22 HG23 ' A' ' 76' ' ' VAL . 37.8 mm -91.09 -33.11 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.57 0.748 . . . . 0.0 109.918 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -79.9 -17.59 52.72 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 119.099 -0.477 . . . . 0.0 112.225 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 3' ' ' SER . 93.5 mt -62.74 -52.1 67.0 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.963 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 24.4 Cg_endo -60.76 -47.37 13.48 Favored 'Trans proline' 0 C--N 1.395 2.988 0 C-N-CA 121.797 1.664 . . . . 0.0 111.887 173.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.445 ' HA ' HE21 ' A' ' 12' ' ' GLN . 73.5 t -59.02 -43.73 89.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 124.226 1.011 . . . . 0.0 112.285 -173.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.697 ' HG2' HH12 ' A' ' 69' ' ' ARG . 6.7 mm100 -68.47 -49.36 60.33 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.082 0.553 . . . . 0.0 111.767 175.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -63.81 -27.71 69.37 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -175.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.445 HE21 ' HA ' ' A' ' 9' ' ' VAL . 46.7 mt-30 -69.0 -47.32 65.82 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 123.489 0.493 . . . . 0.0 109.768 174.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' A' ' 66' ' ' LEU . 2.7 tt -57.1 -54.16 49.92 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.782 1.301 . . . . 0.0 109.442 -177.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.443 ' HA ' HD21 ' A' ' 17' ' ' ASN . 16.0 mm-40 -61.17 -37.8 84.19 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.859 -176.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -71.07 -27.4 63.6 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.55 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.428 ' CZ ' HD11 ' A' ' 62' ' ' LEU . 84.8 t80 -73.08 -38.57 66.37 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.006 0.922 . . . . 0.0 110.522 -175.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.443 HD21 ' HA ' ' A' ' 14' ' ' GLU . 10.0 p30 -88.42 -28.3 21.0 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.983 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.84 0.84 57.47 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.366 0.666 . . . . 0.0 112.265 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 64.7 mmt-85 71.33 12.6 6.68 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.058 1.343 . . . . 0.0 113.619 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.536 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 10.2 m-20 -74.37 95.12 2.64 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.824 0.449 . . . . 0.0 110.917 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.2 mm -66.22 -26.19 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 122.942 0.497 . . . . 0.0 110.574 169.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -60.14 -48.78 80.27 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.164 0.586 . . . . 0.0 111.142 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.62 -30.31 36.76 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.18 0.592 . . . . 0.0 110.767 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -72.56 -6.78 46.39 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.224 0.61 . . . . 0.0 110.967 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.744 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -119.26 -27.25 5.68 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 173.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.94 -30.09 70.01 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -172.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.581 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.3 m95 -95.37 -0.12 52.95 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.355 0.662 . . . . 0.0 112.575 -175.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.59 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 13.3 m95 -97.55 148.66 23.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.435 0.694 . . . . 0.0 109.219 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.68 154.74 29.88 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.42 0.688 . . . . 0.0 109.402 172.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -69.84 -23.66 63.33 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.81 0.444 . . . . 0.0 111.468 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -95.59 17.99 13.73 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.079 0.952 . . . . 0.0 111.073 177.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.59 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 45.4 t -64.21 123.24 18.58 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.006 0.431 . . . . 0.0 111.95 -174.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.41 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . 35.4 mm-40 -96.17 103.74 15.66 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.06 0.944 . . . . 0.0 109.743 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.535 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 55.2 t80 -96.37 111.86 23.8 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.001 0.92 . . . . 0.0 110.276 -177.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.41 ' HE1' ' HB3' ' A' ' 33' ' ' GLN . 80.5 m-85 -116.05 155.16 28.62 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.719 0.808 . . . . 0.0 110.498 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.91 160.67 17.19 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.691 1.196 . . . . 0.0 108.332 167.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -52.04 133.19 40.14 Favored Pre-proline 0 CA--C 1.568 1.635 0 C-N-CA 123.599 0.759 . . . . 0.0 112.431 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.48 -40.95 1.02 Allowed 'Cis proline' 0 C--N 1.384 2.398 0 C-N-CA 124.759 -0.934 . . . . 0.0 112.963 -7.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.83 56.86 0.2 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.631 0.772 . . . . 0.0 109.861 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.2 m -92.9 114.4 26.95 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.134 0.973 . . . . 0.0 109.484 176.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.7 tp -78.16 103.82 8.34 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.447 0.567 . . . . 0.0 109.595 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.04 -37.89 33.06 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -146.38 117.17 7.65 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.14 -172.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.24 45.23 1.39 Allowed Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.989 -0.339 . . . . 0.0 112.322 -176.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.3 p30 161.35 161.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 126.233 1.813 . . . . 0.0 109.066 -171.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.463 ' HA ' HD12 ' A' ' 49' ' ' ILE . . . -64.75 -35.52 81.34 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.857 0.863 . . . . 0.0 113.049 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.65 -46.91 87.61 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.041 0.536 . . . . 0.0 112.092 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.407 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 31.6 mt-10 -72.45 -29.41 63.65 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.823 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.463 HD12 ' HA ' ' A' ' 46' ' ' ALA . 94.6 mt -63.97 -49.19 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.788 0.835 . . . . 0.0 110.264 175.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.744 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 77.4 ttt180 -55.76 -56.63 18.21 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.152 -176.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.465 ' HA ' HD12 ' A' ' 54' ' ' ILE . 26.8 m -65.21 -35.99 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 124.433 1.083 . . . . 0.0 112.698 -173.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -69.06 -34.95 75.98 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.195 0.598 . . . . 0.0 110.423 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -78.42 -28.49 46.79 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 118.455 -0.784 . . . . 0.0 111.785 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 51' ' ' VAL . 94.2 mt -57.34 -41.19 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-N 118.593 0.633 . . . . 0.0 109.514 173.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.16 -37.72 86.29 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.349 1.06 . . . . 0.0 111.735 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -79.43 -25.98 41.92 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.387 0.675 . . . . 0.0 111.014 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -79.8 -15.97 56.41 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.818 0.447 . . . . 0.0 110.649 178.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -62.61 -28.47 69.91 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.941 0.497 . . . . 0.0 110.823 168.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -66.26 118.61 54.75 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.617 0.767 . . . . 0.0 110.581 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.29 -29.2 17.41 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.541 2.161 . . . . 0.0 111.704 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.14 -18.02 63.21 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.322 1.049 . . . . 0.0 111.504 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.428 HD11 ' CZ ' ' A' ' 16' ' ' TYR . 46.1 tp -59.17 123.57 17.11 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.595 0.758 . . . . 0.0 111.511 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.477 ' HB3' ' HB ' ' A' ' 83' ' ' THR . 69.9 t80 -152.21 125.49 8.72 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.49 109.22 3.39 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -118.4 110.93 18.05 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.316 0.647 . . . . 0.0 109.731 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HB2' HD11 ' A' ' 13' ' ' LEU . 17.4 tp -76.91 146.53 37.55 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 123.428 0.455 . . . . 0.0 111.155 -177.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mt -112.69 -51.45 2.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.815 0.846 . . . . 0.0 109.346 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.7 m -157.45 153.11 26.61 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.758 -1.564 . . . . 0.0 108.922 -170.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.697 HH12 ' HG2' ' A' ' 10' ' ' GLN . 4.3 ptp180 -142.27 139.2 31.84 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.921 0.488 . . . . 0.0 109.901 169.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.49 HG22 ' HB ' ' A' ' 77' ' ' ILE . 17.8 m -112.42 111.28 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 122.159 0.98 . . . . 0.0 108.592 173.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.5 HD11 ' HB2' ' A' ' 2' ' ' ASN . 11.7 tt -99.93 139.13 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.038 -177.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 75' ' ' VAL . 2.5 p -145.9 99.45 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.801 1.24 . . . . 0.0 108.666 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.12 -120.82 21.2 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.986 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -86.44 2.44 47.72 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.496 0.718 . . . . 0.0 112.777 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.459 HG13 HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -129.19 132.46 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.309 0.643 . . . . 0.0 110.716 -173.055 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.456 HG23 HG22 ' A' ' 5' ' ' ILE . 59.2 t -116.0 138.85 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.925 0.89 . . . . 0.0 109.074 174.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.653 HD13 ' HB ' ' A' ' 98' ' ' ILE . 9.6 mm -97.11 103.15 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 164.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -95.68 104.19 16.1 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -177.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -99.92 107.96 20.08 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.581 0.705 . . . . 0.0 109.846 -173.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.32 168.5 12.41 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.132 -177.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 m -117.47 104.27 10.92 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 168.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.0 m -91.22 125.17 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.274 0.559 . . . . 0.0 111.463 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 63' ' ' TYR . 34.9 m -76.86 133.66 39.25 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.073 176.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -133.12 -160.72 1.07 Allowed 'General case' 0 C--O 1.247 0.944 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -128.89 105.52 8.28 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.446 0.566 . . . . 0.0 110.193 174.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -106.32 135.03 19.53 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.88 -21.12 71.63 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.921 2.414 . . . . 0.0 113.446 -174.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -74.64 -25.81 59.46 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.01 0.524 . . . . 0.0 111.693 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.14 -120.08 0.6 Allowed Glycine 0 C--N 1.352 1.463 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.709 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -72.53 -81.0 0.06 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.605 0.762 . . . . 0.0 111.3 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 120.19 27.24 2.07 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 113.722 0.249 . . . . 0.0 113.722 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -90.7 133.39 35.18 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.696 HG12 ' HA ' ' A' ' 116' ' ' PRO . 35.9 m -130.66 134.62 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 122.464 0.306 . . . . 0.0 110.79 -172.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.23 117.0 17.47 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.596 HG22 HG12 ' A' ' 113' ' ' ILE . 16.7 t -123.74 158.88 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.649 1.18 . . . . 0.0 108.768 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -118.16 99.93 7.19 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 169.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 93.5 m -95.05 107.52 19.57 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.653 ' HB ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -96.17 138.12 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.988 0.915 . . . . 0.0 109.412 -177.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -127.42 119.98 27.38 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.619 0.768 . . . . 0.0 108.993 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 108' ' ' LYS . 43.2 tt0 -97.14 112.48 24.25 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 106' ' ' ILE . 48.7 t -95.5 139.54 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 125.166 1.386 . . . . 0.0 109.778 -175.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.508 ' HG3' HD22 ' A' ' 103' ' ' ASN . 8.9 tp10 -129.79 100.44 5.49 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.553 1.141 . . . . 0.0 108.416 -175.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.508 HD22 ' HG3' ' A' ' 102' ' ' GLU . 24.7 m-80 59.79 32.7 21.48 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.82 1.248 . . . . 0.0 112.117 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.24 -7.62 54.57 Favored Glycine 0 N--CA 1.475 1.244 0 N-CA-C 114.317 0.487 . . . . 0.0 114.317 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.9 mmt-85 -127.53 133.24 49.82 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.446 0.623 . . . . 0.0 109.821 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 8' ' ' PRO . 68.2 mt -70.02 106.27 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.189 0.996 . . . . 0.0 110.447 -173.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -82.69 -18.88 39.37 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.981 0.512 . . . . 0.0 111.671 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 75.1 mttt -151.99 134.14 15.09 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 34' ' ' TYR . . . -139.52 129.02 24.31 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 172.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.42 ' CE3' HD12 ' A' ' 98' ' ' ILE . 1.5 m0 -130.52 159.06 38.23 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -176.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -142.79 146.38 34.18 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -137.29 127.41 26.08 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.596 HG12 HG22 ' A' ' 95' ' ' VAL . 89.3 mt -88.75 125.75 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.55 -60.53 8.6 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 114.869 -1.06 . . . . 0.0 113.09 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -160.56 168.32 12.05 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.457 0.703 . . . . 0.0 109.819 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.696 ' HA ' HG12 ' A' ' 93' ' ' VAL . 65.7 Cg_endo -85.76 130.98 3.79 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.718 2.279 . . . . 0.0 112.188 163.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -127.53 157.96 38.71 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.916 0.487 . . . . 0.0 110.693 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.4 mm -133.67 127.37 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.64 -41.52 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 123.876 0.87 . . . . 0.0 111.094 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.9 t -64.23 -21.13 66.47 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.785 0.834 . . . . 0.0 112.207 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -94.35 86.32 4.85 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.007 0.523 . . . . 0.0 109.867 177.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -81.94 90.37 6.45 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 C--O 1.255 1.346 0 C-N-CA 123.341 0.657 . . . . 0.0 109.718 -179.462 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.61 ' HB3' HD13 ' A' ' 71' ' ' ILE . 81.8 m-20 71.12 -12.86 0.55 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 168.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.469 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 23.4 m -66.47 -40.71 89.49 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.76 0.824 . . . . 0.0 111.261 -174.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -14.23 62.85 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 122.98 0.512 . . . . 0.0 111.697 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.501 HG22 HG23 ' A' ' 76' ' ' VAL . 22.8 mm -95.08 -29.49 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.811 0.844 . . . . 0.0 109.832 175.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -84.25 -20.94 31.38 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.077 0.951 . . . . 0.0 112.167 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 3' ' ' SER . 68.4 mt -67.23 -48.99 46.3 Favored Pre-proline 0 N--CA 1.486 1.338 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.092 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 10.8 Cg_endo -54.47 -52.9 7.12 Favored 'Trans proline' 0 C--N 1.391 2.771 0 C-N-CA 121.708 1.605 . . . . 0.0 111.291 172.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 76' ' ' VAL . 83.8 t -57.98 -43.2 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.323 1.049 . . . . 0.0 112.81 -176.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -64.98 -54.93 22.72 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.352 0.661 . . . . 0.0 110.201 -176.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -71.91 -35.14 69.61 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.873 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.483 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 1.0 OUTLIER -72.73 -30.42 64.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.76 0.824 . . . . 0.0 110.946 -176.433 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.515 HD22 HD13 ' A' ' 66' ' ' LEU . 59.4 tp -62.36 -52.13 64.84 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.18 0.592 . . . . 0.0 109.657 173.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 10' ' ' GLN . 14.7 mm-40 -53.34 -45.81 69.24 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.05 175.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -64.92 -30.26 71.25 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.349 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -69.02 -46.38 68.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.139 0.575 . . . . 0.0 110.578 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -84.24 -24.18 30.11 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.956 0.502 . . . . 0.0 111.525 -177.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.09 2.06 55.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.259 0.624 . . . . 0.0 112.141 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.7 mmt-85 68.53 15.02 9.15 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.894 1.278 . . . . 0.0 112.948 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.46 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 10.0 m-20 -77.13 96.53 4.5 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.868 0.467 . . . . 0.0 110.738 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.8 mm -64.34 -33.55 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.553 0.741 . . . . 0.0 111.122 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.13 -48.62 79.65 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.144 0.578 . . . . 0.0 111.664 -175.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.73 -29.8 40.68 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.197 0.599 . . . . 0.0 110.737 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -69.29 -13.05 62.18 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.817 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.627 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 3.8 mmt -116.6 -15.61 10.81 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.61 0.764 . . . . 0.0 112.344 175.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.04 99.79 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.639 0.776 . . . . 0.0 112.295 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.598 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 86.3 m95 -92.95 0.97 57.52 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.379 -172.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.483 ' HE1' ' HG3' ' A' ' 12' ' ' GLN . 17.8 m95 -96.67 148.8 22.49 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.56 0.744 . . . . 0.0 109.992 -177.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.9 149.41 39.48 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.78 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.27 -20.75 64.81 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.462 0.305 . . . . 0.0 111.755 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -104.86 18.71 21.83 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.819 0.847 . . . . 0.0 111.799 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 107' ' ' ALA . 43.0 t -62.6 127.08 29.62 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -172.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.552 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 57.7 mm-40 -96.16 104.57 16.53 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.839 0.856 . . . . 0.0 109.922 -176.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -98.18 115.33 28.1 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 124.463 1.105 . . . . 0.0 109.938 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.467 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 80.7 m-85 -114.62 154.63 28.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.954 0.902 . . . . 0.0 110.936 177.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.21 155.92 19.4 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.791 167.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.532 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 71.6 t80 -62.0 133.24 93.91 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 123.275 0.63 . . . . 0.0 110.978 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.54 -45.26 0.43 Allowed 'Cis proline' 0 C--N 1.383 2.36 0 CA-C-N 120.235 1.12 . . . . 0.0 113.95 -4.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.76 67.33 0.44 Allowed 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.35 0.595 . . . . 0.0 110.285 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 33.9 m -105.98 115.77 30.79 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.1 tp -75.26 103.87 5.6 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.79 -36.48 50.32 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.473 0.709 . . . . 0.0 109.542 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -157.74 122.27 4.3 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.4 -176.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.75 26.0 24.09 Favored Glycine 0 N--CA 1.477 1.383 0 O-C-N 123.224 0.328 . . . . 0.0 113.897 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.0 p30 178.93 156.73 0.49 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.164 1.385 . . . . 0.0 109.628 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.02 -34.01 71.39 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.23 1.012 . . . . 0.0 113.143 -172.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.57 -44.27 97.34 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.783 0.433 . . . . 0.0 111.148 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 38.1 mt-10 -75.67 -30.06 59.28 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.661 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.42 ' HB ' ' HE1' ' A' ' 25' ' ' MET . 79.8 mt -63.33 -40.82 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 123.134 0.574 . . . . 0.0 109.492 176.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.627 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 39.8 ttt180 -55.6 -56.1 24.25 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.41 175.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 76.0 t -63.06 -43.97 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 124.487 1.117 . . . . 0.0 111.183 -173.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.468 ' HA ' ' HE ' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -60.65 -42.6 97.3 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.844 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -78.97 -26.8 43.45 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-O 118.452 -0.785 . . . . 0.0 112.347 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.425 ' O ' ' HG2' ' A' ' 58' ' ' LYS . 66.2 mt -57.34 -43.38 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.113 0.869 . . . . 0.0 108.971 173.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -62.32 -34.7 77.13 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.097 0.959 . . . . 0.0 111.368 177.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -77.71 -25.14 49.14 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 123.413 0.685 . . . . 0.0 111.036 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -84.12 -14.25 50.82 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.36 0.664 . . . . 0.0 110.491 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 10.4 mmpt? -69.14 -21.15 64.03 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.226 0.61 . . . . 0.0 110.583 171.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.84 114.27 12.94 Favored Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 124.152 0.981 . . . . 0.0 109.739 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.73 -22.1 24.32 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.483 2.122 . . . . 0.0 111.953 177.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.57 6.9 47.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.215 1.006 . . . . 0.0 111.634 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 tp -66.97 112.29 4.26 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-O 120.978 0.418 . . . . 0.0 109.938 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -144.2 115.89 8.2 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.29 100.74 2.13 Favored Glycine 0 C--N 1.342 0.861 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 174.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -88.0 101.5 13.83 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.515 HD13 HD22 ' A' ' 13' ' ' LEU . 8.5 tt -75.32 115.95 15.52 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.508 ' H ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -105.34 -33.46 8.18 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.914 -175.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.426 ' N ' HD22 ' A' ' 67' ' ' LEU . 52.0 m -139.78 138.52 35.93 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.302 0.641 . . . . 0.0 109.796 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -142.91 133.81 25.52 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.759 0.823 . . . . 0.0 109.556 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 77' ' ' ILE . 20.1 m -126.63 155.7 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.253 1.021 . . . . 0.0 108.658 173.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.61 HD13 ' HB3' ' A' ' 2' ' ' ASN . 15.1 tt -137.75 140.32 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.107 0.48 . . . . 0.0 111.081 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 p -144.48 107.24 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 125.144 1.377 . . . . 0.0 108.443 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.55 -119.25 14.7 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.839 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 101' ' ' VAL . 17.0 p-10 -99.72 18.77 17.33 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.039 0.536 . . . . 0.0 111.407 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.2 t -126.73 136.75 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.45 1.1 . . . . 0.0 110.097 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.501 HG23 HG22 ' A' ' 5' ' ' ILE . 62.3 t -123.7 137.3 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.437 0.695 . . . . 0.0 109.646 173.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.536 ' HB ' HG22 ' A' ' 70' ' ' VAL . 7.8 mm -98.01 103.75 15.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 165.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -101.18 105.39 16.52 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.503 ' HE1' ' HB2' ' A' ' 94' ' ' ASP . 40.5 t-80 -99.79 113.71 26.4 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.0 -176.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.97 154.14 45.92 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.894 1.277 . . . . 0.0 110.564 -176.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.415 HG22 ' HB2' ' A' ' 92' ' ' GLU . 39.0 m -100.46 111.69 23.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.699 0.799 . . . . 0.0 109.556 172.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.99 115.54 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.503 1.121 . . . . 0.0 110.038 177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.8 m -77.81 121.52 24.19 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 122.813 0.445 . . . . 0.0 110.695 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -122.9 -177.05 3.55 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.395 1.078 . . . . 0.0 108.289 172.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -115.73 103.68 10.92 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.929 0.491 . . . . 0.0 110.112 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -109.48 138.62 20.61 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 123.539 0.736 . . . . 0.0 109.133 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.65 -17.66 60.9 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.306 2.671 . . . . 0.0 114.274 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -82.87 -10.89 58.61 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 122.861 0.465 . . . . 0.0 112.138 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 171.48 -123.84 1.06 Allowed Glycine 0 C--N 1.346 1.123 0 CA-C-O 119.852 -0.415 . . . . 0.0 112.517 171.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -66.66 -76.63 0.08 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.9 0.88 . . . . 0.0 110.505 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.23 27.06 4.07 Favored Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.699 -0.228 . . . . 0.0 113.085 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.415 ' HB2' HG22 ' A' ' 81' ' ' THR . 9.8 pt-20 -91.12 115.96 28.43 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -175.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.645 HG12 ' HA ' ' A' ' 116' ' ' PRO . 11.5 m -104.07 134.48 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -175.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.503 ' HB2' ' HE1' ' A' ' 79' ' ' HIS . 2.4 p-10 -81.74 143.85 31.54 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.588 HG22 HG12 ' A' ' 113' ' ' ILE . 39.5 t -141.45 143.63 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -105.93 107.5 18.53 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 164.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 5.9 t -94.19 138.07 32.65 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.464 ' HB ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -131.17 121.31 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.586 0.754 . . . . 0.0 109.625 -175.6 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -108.9 139.06 44.26 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.228 0.611 . . . . 0.0 109.647 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -104.51 111.22 23.81 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 165.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.452 HG22 HG12 ' A' ' 106' ' ' ILE . 61.7 t -96.13 110.67 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.351 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 35.3 tt0 -111.04 128.45 55.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.679 0.792 . . . . 0.0 109.155 176.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 62.83 30.44 16.63 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.89 0.876 . . . . 0.0 111.661 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.37 9.9 86.63 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.898 -0.592 . . . . 0.0 113.76 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 63.5 mmt-85 -129.03 135.14 48.53 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.158 0.983 . . . . 0.0 109.211 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.452 HG12 HG22 ' A' ' 101' ' ' VAL . 79.2 mt -63.55 100.7 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -76.59 -31.98 57.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.49 -173.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.552 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 98.7 mttt -153.85 153.8 32.77 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.628 1.171 . . . . 0.0 108.566 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.79 135.31 20.77 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.467 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 5.4 m-90 -134.25 153.92 51.58 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -142.61 147.3 35.6 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 118.646 0.657 . . . . 0.0 110.605 173.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 17.6 ptpt -131.74 123.87 28.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.327 1.051 . . . . 0.0 109.227 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.588 HG12 HG22 ' A' ' 95' ' ' VAL . 96.9 mt -89.13 127.39 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -176.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.36 -81.12 0.09 OUTLIER Glycine 0 CA--C 1.532 1.148 0 O-C-N 123.957 0.786 . . . . 0.0 112.866 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.435 ' HB2' ' HD2' ' A' ' 116' ' ' PRO . 0.4 OUTLIER -160.18 171.58 7.02 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.398 0.679 . . . . 0.0 109.312 167.156 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.645 ' HA ' HG12 ' A' ' 93' ' ' VAL . 36.3 Cg_endo -63.49 131.43 31.75 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.037 1.825 . . . . 0.0 112.738 167.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -118.55 139.55 51.29 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.336 0.655 . . . . 0.0 109.939 173.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.8 mm -122.04 135.07 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.6 t -67.9 -44.57 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 123.539 0.524 . . . . 0.0 110.673 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.0 p -77.63 4.76 10.61 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.743 0.817 . . . . 0.0 112.851 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -74.88 -13.32 60.54 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.768 0.827 . . . . 0.0 111.255 176.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -72.0 154.16 41.33 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.443 0.697 . . . . 0.0 111.0 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 C--O 1.251 1.15 0 C-N-CA 123.554 0.742 . . . . 0.0 109.291 -175.582 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.7 ttp . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.467 ' HB2' HD11 ' A' ' 71' ' ' ILE . 14.0 m120 -89.35 69.08 8.08 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.79 0.836 . . . . 0.0 108.897 -178.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.53 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 15.0 m -57.34 -49.51 75.91 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.223 -174.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -57.16 -17.57 11.6 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.997 0.919 . . . . 0.0 113.125 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.433 HG13 ' HA ' ' A' ' 74' ' ' ASN . 22.8 mm -96.13 -34.4 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.953 0.901 . . . . 0.0 110.231 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -83.74 -24.85 30.97 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.661 0.784 . . . . 0.0 112.421 -174.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 3' ' ' SER . 54.8 mt -66.58 -53.37 29.63 Favored Pre-proline 0 CA--C 1.561 1.388 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.291 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.632 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 9.5 Cg_endo -52.64 -50.63 13.4 Favored 'Trans proline' 0 C--N 1.399 3.214 0 C-N-CA 122.545 2.164 . . . . 0.0 112.219 175.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.488 HG11 HG11 ' A' ' 76' ' ' VAL . 7.7 t -54.79 -48.51 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 125.068 1.347 . . . . 0.0 113.27 -177.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -44.77 69.42 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.491 0.316 . . . . 0.0 111.262 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.7 mmtt -65.64 -35.55 81.12 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.746 0.419 . . . . 0.0 110.895 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 9' ' ' VAL . 43.6 mt-30 -59.4 -49.79 76.46 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.946 0.779 . . . . 0.0 110.788 175.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.0 tp -55.89 -51.71 66.64 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.268 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -56.85 -46.95 81.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.536 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -67.31 -26.36 66.48 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.337 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -71.91 -48.52 44.92 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.097 0.559 . . . . 0.0 110.576 -173.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.06 -29.07 35.09 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.672 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.87 -3.42 58.91 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.401 0.68 . . . . 0.0 111.636 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 71.95 12.63 6.07 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.38 1.472 . . . . 0.0 113.065 172.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.487 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 5.9 m-20 -73.15 96.6 2.25 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.265 0.626 . . . . 0.0 111.11 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.5 mm -66.26 -29.75 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.452 0.701 . . . . 0.0 111.687 175.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.04 -48.56 81.17 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.023 0.529 . . . . 0.0 112.113 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.45 -30.1 33.57 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.866 0.466 . . . . 0.0 110.899 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -73.25 -7.86 53.31 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.924 177.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.801 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -114.22 -30.55 6.59 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.16 0.584 . . . . 0.0 112.197 173.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.66 -33.32 60.55 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -170.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.632 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 94.8 m95 -99.78 14.2 31.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.906 0.882 . . . . 0.0 112.651 -170.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.55 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 29.6 m95 -105.51 155.84 18.79 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.828 0.851 . . . . 0.0 109.949 178.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -85.36 148.32 26.08 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.478 0.711 . . . . 0.0 109.752 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -58.14 -30.94 66.74 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.894 0.878 . . . . 0.0 111.955 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -103.05 19.29 19.79 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.025 0.93 . . . . 0.0 111.737 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.55 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 53.7 t -64.05 132.23 49.94 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.483 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 36.3 mm-40 -101.44 105.25 16.25 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.64 0.776 . . . . 0.0 110.245 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -96.56 112.52 24.23 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.936 0.894 . . . . 0.0 110.26 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.471 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 89.2 m-85 -110.3 153.48 24.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.236 1.015 . . . . 0.0 111.378 178.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.556 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -102.08 150.95 22.73 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 113.996 -1.457 . . . . 0.0 107.717 165.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 16.4 p90 -50.48 128.63 25.18 Favored Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 124.748 1.219 . . . . 0.0 114.1 -176.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 83.4 Cg_endo -79.3 -36.7 2.15 Favored 'Cis proline' 0 C--N 1.385 2.482 0 C-N-CA 124.817 -0.91 . . . . 0.0 113.06 -9.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.13 81.64 0.99 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.51 0.724 . . . . 0.0 109.811 -174.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 40.6 m -121.74 100.1 6.82 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 175.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.2 tp -71.34 100.83 2.23 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -173.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 36' ' ' ALA . 1.1 mm? -77.27 -45.26 26.92 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.45 115.85 15.29 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.958 -172.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.6 45.94 1.39 Allowed Glycine 0 C--N 1.346 1.085 0 CA-C-O 119.838 -0.423 . . . . 0.0 112.91 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.3 p30 160.36 160.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 126.495 1.918 . . . . 0.0 108.771 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -66.94 -31.61 72.3 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.888 0.875 . . . . 0.0 113.158 -172.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.75 -43.81 98.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.131 0.572 . . . . 0.0 111.171 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -75.24 -30.69 60.6 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.985 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 80.2 mt -63.2 -45.11 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.523 0.729 . . . . 0.0 110.143 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.801 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 21.9 ttt180 -59.46 -55.44 34.6 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.653 -177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.477 ' HA ' HD12 ' A' ' 54' ' ' ILE . 34.3 m -66.34 -34.43 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 124.515 1.135 . . . . 0.0 112.822 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -71.24 -32.94 69.35 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.964 0.411 . . . . 0.0 110.456 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -75.03 -33.73 61.8 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.45 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 51' ' ' VAL . 39.6 mt -55.87 -39.62 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.782 0.833 . . . . 0.0 110.228 173.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 51' ' ' VAL . 34.6 mm-40 -59.06 -46.92 87.03 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.467 0.707 . . . . 0.0 111.118 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 -66.15 -30.21 70.64 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.535 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -81.29 -11.1 59.45 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 123.932 0.893 . . . . 0.0 111.651 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 72.2 mmtt -71.67 -22.3 61.68 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.788 0.435 . . . . 0.0 111.39 170.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -81.11 115.7 57.83 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.687 0.795 . . . . 0.0 110.392 -176.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.46 -30.05 79.64 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.238 2.625 . . . . 0.0 113.757 -174.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -86.75 3.73 43.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.268 0.627 . . . . 0.0 112.561 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.9 tp -67.28 118.05 10.13 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.706 0.289 . . . . 0.0 110.805 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -150.51 119.11 6.5 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 167.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.22 103.96 3.09 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 174.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -89.38 106.55 18.52 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.0 tt -80.88 128.57 33.82 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.41 HD22 ' H ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -115.08 -34.96 4.87 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.733 0.813 . . . . 0.0 111.137 178.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.41 ' H ' HD22 ' A' ' 67' ' ' LEU . 38.1 m -132.25 139.0 48.11 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.579 0.752 . . . . 0.0 109.67 178.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.01 139.12 37.76 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 167.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.51 144.93 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.248 1.019 . . . . 0.0 109.347 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.467 HD11 ' HB2' ' A' ' 2' ' ' ASN . 15.1 tt -122.76 141.43 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-O 121.338 0.59 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 p -143.5 98.01 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 125.239 1.415 . . . . 0.0 108.105 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.92 -120.57 19.12 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.185 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.433 ' HA ' HG13 ' A' ' 5' ' ' ILE . 3.3 p-10 -93.69 13.4 22.34 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.477 0.711 . . . . 0.0 111.913 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.2 t -130.29 136.14 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.25 1.02 . . . . 0.0 109.664 -174.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.488 HG11 HG11 ' A' ' 9' ' ' VAL . 87.0 t -125.16 135.82 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.774 0.83 . . . . 0.0 109.796 176.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.537 HG12 ' HB ' ' A' ' 98' ' ' ILE . 2.2 mt -100.13 108.01 22.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 168.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -88.07 109.16 19.65 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 168.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -99.15 110.51 23.07 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 122.041 0.924 . . . . 0.0 108.788 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.47 165.45 18.42 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.868 -1.515 . . . . 0.0 109.533 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.7 m -114.65 103.2 10.76 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 167.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.9 m -85.44 130.55 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 120.928 0.394 . . . . 0.0 110.391 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.6 m -79.05 118.96 21.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.295 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -111.81 -166.93 1.12 Allowed 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 168.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -124.23 108.18 11.99 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 121.823 -0.548 . . . . 0.0 110.323 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -106.31 144.47 29.04 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 123.544 0.738 . . . . 0.0 109.059 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.84 -12.31 32.49 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.724 2.283 . . . . 0.0 112.907 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -87.61 -2.78 58.85 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.669 0.787 . . . . 0.0 112.225 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.92 -119.55 0.9 Allowed Glycine 0 C--N 1.348 1.225 0 CA-C-O 119.824 -0.431 . . . . 0.0 112.769 170.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -65.31 -79.08 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.867 0.867 . . . . 0.0 110.536 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 117.57 22.79 3.93 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.323 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' A' ' 117' ' ' ARG . 13.8 pt-20 -90.29 141.9 28.25 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -176.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.634 HG12 ' HA ' ' A' ' 116' ' ' PRO . 22.4 m -132.97 138.64 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 118.156 0.435 . . . . 0.0 111.247 -171.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -75.65 109.33 9.13 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.47 HG22 HG12 ' A' ' 113' ' ' ILE . 21.4 t -114.7 155.66 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -124.14 105.75 9.78 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 82.5 m -94.96 107.46 19.49 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.646 HG23 ' HB2' ' A' ' 110' ' ' TRP . 7.3 tt -105.25 106.55 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.634 -173.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -99.9 137.27 38.58 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.662 0.785 . . . . 0.0 110.645 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -100.47 114.41 27.98 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.292 1.037 . . . . 0.0 109.166 168.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.539 HG22 HG12 ' A' ' 106' ' ' ILE . 46.4 t -102.31 117.66 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 123.319 0.648 . . . . 0.0 109.548 175.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 19.7 tt0 -128.54 138.71 52.38 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.832 1.253 . . . . 0.0 109.138 175.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 63.43 30.9 15.31 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.897 0.879 . . . . 0.0 111.32 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.28 7.59 82.53 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.401 -0.818 . . . . 0.0 114.058 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 57.3 mmt-85 -137.56 153.77 49.91 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.635 1.174 . . . . 0.0 108.902 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.539 HG12 HG22 ' A' ' 101' ' ' VAL . 65.3 mt -73.45 105.74 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . . . -79.53 -28.99 41.3 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.444 0.697 . . . . 0.0 111.353 -178.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.483 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 91.3 mttt -150.25 152.6 34.8 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.85 134.41 22.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 174.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.646 ' HB2' HG23 ' A' ' 98' ' ' ILE . 2.6 m-90 -126.08 152.99 45.1 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -142.65 147.06 35.13 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 172.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -134.85 117.68 16.16 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.082 0.553 . . . . 0.0 110.294 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.47 HG12 HG22 ' A' ' 95' ' ' VAL . 95.6 mt -89.02 110.82 21.92 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.2 -93.27 0.06 OUTLIER Glycine 0 CA--C 1.533 1.196 0 CA-C-N 114.289 -1.323 . . . . 0.0 114.327 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -126.79 140.33 37.3 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 123.455 0.702 . . . . 0.0 111.268 -169.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.634 ' HA ' HG12 ' A' ' 93' ' ' VAL . 48.0 Cg_endo -67.79 125.5 13.28 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.241 2.628 . . . . 0.0 111.947 173.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.426 ' HB2' ' HG3' ' A' ' 92' ' ' GLU . 36.1 mmt180 -111.46 124.47 52.34 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.41 1.084 . . . . 0.0 109.312 178.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.1 mm -124.05 124.86 69.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.1 t -59.23 -42.66 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 124.005 0.816 . . . . 0.0 111.281 -173.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.3 t -82.32 -70.56 0.54 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.253 0.621 . . . . 0.0 110.085 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -75.33 90.83 2.65 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.82 0.848 . . . . 0.0 110.4 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -159.69 143.89 14.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.897 0.479 . . . . 0.0 109.984 178.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.3 t . . . . . 0 C--O 1.252 1.191 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.96 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mtp . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -82.44 43.1 0.79 Allowed 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 123.705 0.802 . . . . 0.0 111.742 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.405 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 36.1 p -72.94 -35.06 66.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.663 0.785 . . . . 0.0 111.547 -175.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.09 -5.1 32.9 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.895 0.478 . . . . 0.0 111.9 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.571 HG22 HG23 ' A' ' 76' ' ' VAL . 22.9 mm -94.29 -30.47 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.968 0.907 . . . . 0.0 109.701 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -72.74 -34.19 66.88 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.7 0.8 . . . . 0.0 111.636 174.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 3' ' ' SER . 93.8 mt -61.69 -50.58 81.37 Favored Pre-proline 0 CA--C 1.558 1.283 0 CA-C-O 118.089 -0.958 . . . . 0.0 112.46 -172.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.571 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 12.7 Cg_endo -54.84 -56.49 2.37 Favored 'Trans proline' 0 C--N 1.398 3.155 0 C-N-CA 122.123 1.882 . . . . 0.0 111.072 177.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 76' ' ' VAL . 98.8 t -53.45 -44.56 56.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.303 1.441 . . . . 0.0 112.411 -176.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -62.63 -51.47 67.17 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.946 -178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -68.86 -34.39 75.37 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.18 0.592 . . . . 0.0 111.436 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -65.03 -43.41 92.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.973 0.909 . . . . 0.0 111.254 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.8 -52.06 67.1 Favored 'General case' 0 C--O 1.242 0.688 0 O-C-N 123.716 0.635 . . . . 0.0 109.398 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -54.13 -45.93 72.05 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 124.789 1.306 . . . . 0.0 109.258 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -68.64 -27.01 65.62 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.804 -1.544 . . . . 0.0 112.52 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -71.97 -41.01 68.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.532 0.333 . . . . 0.0 110.32 -174.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -90.76 -28.99 17.9 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.227 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.6 -2.18 57.05 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.244 0.618 . . . . 0.0 111.655 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 68.27 24.03 7.57 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.075 1.35 . . . . 0.0 112.958 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.528 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 21.6 m-20 -88.06 95.61 10.21 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.187 0.595 . . . . 0.0 109.765 175.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.432 HG13 HG12 ' A' ' 54' ' ' ILE . 13.2 mm -65.78 -28.34 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.697 0.399 . . . . 0.0 110.921 174.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.08 -48.15 81.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.194 0.597 . . . . 0.0 111.674 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.67 -30.87 36.49 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 122.83 0.452 . . . . 0.0 110.841 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -72.86 -7.57 51.49 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.248 0.619 . . . . 0.0 110.881 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.747 ' SD ' ' HB2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -113.59 -29.64 7.09 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.395 0.678 . . . . 0.0 112.318 174.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.16 -34.91 70.82 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.873 0.869 . . . . 0.0 113.186 -169.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.571 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 96.1 m95 -93.75 8.29 41.62 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.722 0.809 . . . . 0.0 112.901 -173.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.76 ' HE3' ' HG ' ' A' ' 32' ' ' CYS . 21.8 m95 -102.84 158.81 16.01 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.667 0.787 . . . . 0.0 109.375 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 46' ' ' ALA . . . -86.65 162.24 18.05 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.106 0.562 . . . . 0.0 110.408 177.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.57 -34.22 75.44 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.139 0.576 . . . . 0.0 111.347 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -98.06 15.74 23.27 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.619 0.768 . . . . 0.0 110.534 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.76 ' HG ' ' HE3' ' A' ' 28' ' ' TRP . 43.2 t -59.93 117.47 5.09 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-O 121.137 0.494 . . . . 0.0 111.745 -173.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.571 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 57.1 mm-40 -83.78 154.27 23.64 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.701 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.41 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 57.2 t80 -144.81 111.69 5.85 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -175.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.502 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 85.3 m-85 -118.12 146.59 44.03 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.973 0.909 . . . . 0.0 110.697 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.525 ' HB2' HD21 ' A' ' 42' ' ' LEU . . . -95.69 157.43 15.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.154 -1.384 . . . . 0.0 108.202 170.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.439 ' HB3' ' HA ' ' A' ' 112' ' ' LYS . 30.9 p90 -55.6 130.19 70.77 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 123.658 0.783 . . . . 0.0 112.248 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.87 -42.42 0.78 Allowed 'Cis proline' 0 C--N 1.385 2.472 0 CA-C-N 119.923 1.008 . . . . 0.0 113.09 -4.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.09 65.15 0.16 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.697 0.799 . . . . 0.0 109.613 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.9 m -105.79 118.38 36.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.938 0.895 . . . . 0.0 109.49 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.83 110.83 8.43 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.672 0.789 . . . . 0.0 110.971 -169.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.525 HD21 ' HB2' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -88.37 -51.63 5.63 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 170.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . . . -137.24 116.63 12.75 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.233 -168.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.73 22.32 40.96 Favored Glycine 0 N--CA 1.478 1.486 0 N-CA-C 114.553 0.581 . . . . 0.0 114.553 -173.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -177.89 163.6 1.81 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.235 1.414 . . . . 0.0 109.479 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . -59.67 -36.65 76.86 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.938 0.895 . . . . 0.0 112.695 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.11 -44.35 97.49 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.034 0.534 . . . . 0.0 111.802 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -72.85 -36.01 67.34 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.484 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.41 -42.62 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.264 0.626 . . . . 0.0 110.019 174.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.747 ' HB2' ' SD ' ' A' ' 25' ' ' MET . 79.2 ttt180 -62.49 -58.16 8.61 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.547 -175.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.1 m -69.86 -35.0 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 124.248 0.967 . . . . 0.0 112.879 -170.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -67.43 -36.39 81.13 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.642 0.377 . . . . 0.0 110.163 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -77.14 -30.09 54.92 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.357 176.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 50' ' ' ARG . 91.6 mt -57.82 -42.58 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 118.84 0.745 . . . . 0.0 109.922 174.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.0 -32.8 73.44 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.576 0.75 . . . . 0.0 111.616 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -74.85 -28.8 60.82 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.939 0.495 . . . . 0.0 110.706 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -81.15 -3.71 52.99 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.217 0.607 . . . . 0.0 110.995 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -77.03 -29.34 55.26 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.007 0.523 . . . . 0.0 110.802 169.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -59.93 118.79 35.53 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 123.91 0.884 . . . . 0.0 110.753 178.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -64.39 -35.72 48.52 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.828 2.352 . . . . 0.0 113.118 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -93.14 8.4 40.26 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.966 0.506 . . . . 0.0 112.154 -173.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.4 tp -67.85 113.87 5.95 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -148.31 116.34 6.43 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.73 104.88 3.13 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 174.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -97.61 105.18 17.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 80' ' ' GLU . 8.1 tt -78.94 127.45 32.02 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.023 0.44 . . . . 0.0 110.095 -177.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.425 HD22 ' H ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -96.18 -48.11 5.78 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.202 1.001 . . . . 0.0 108.737 -176.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 92.4 m -143.93 134.22 24.49 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.633 -170.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 10.8 ptt180 -131.44 129.27 41.0 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 166.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.7 HG22 ' HB ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -107.24 156.26 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.115 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.411 HD11 ' HB ' ' A' ' 5' ' ' ILE . 18.7 tt -134.7 137.67 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.127 0.489 . . . . 0.0 110.754 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 p -147.16 102.36 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 124.527 1.131 . . . . 0.0 108.636 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.8 -115.94 8.09 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.497 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -99.55 12.35 36.71 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.089 0.556 . . . . 0.0 111.728 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.92 139.35 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.899 0.879 . . . . 0.0 110.09 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.571 HG23 HG22 ' A' ' 5' ' ' ILE . 53.2 t -126.13 140.11 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.525 0.73 . . . . 0.0 109.77 174.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.7 ' HB ' HG22 ' A' ' 70' ' ' VAL . 24.4 mm -98.22 101.69 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 165.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -95.31 104.48 16.37 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -100.48 109.0 21.11 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.722 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -120.34 165.63 14.62 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.678 1.191 . . . . 0.0 110.412 -179.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.9 m -116.24 105.54 12.67 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.314 1.046 . . . . 0.0 109.083 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.2 125.69 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.291 0.567 . . . . 0.0 111.079 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.5 m -74.63 132.07 41.43 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.365 1.066 . . . . 0.0 110.178 175.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -130.31 -168.24 1.94 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.204 1.002 . . . . 0.0 109.282 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -128.43 100.29 5.73 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.657 0.783 . . . . 0.0 109.413 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -108.84 149.65 39.82 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.389 0.676 . . . . 0.0 110.398 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.86 -27.07 51.56 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.784 2.323 . . . . 0.0 113.234 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -86.84 -9.43 55.8 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.02 -140.25 6.31 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 120.094 -0.281 . . . . 0.0 112.728 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -66.07 -81.08 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.691 0.797 . . . . 0.0 111.548 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.45 28.21 1.66 Allowed Glycine 0 C--N 1.347 1.187 0 C-N-CA 121.341 -0.457 . . . . 0.0 113.77 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 117' ' ' ARG . 0.3 OUTLIER -88.81 100.2 12.97 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 122.368 1.08 . . . . 0.0 108.234 -174.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 116' ' ' PRO . 3.9 m -105.18 143.41 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.719 -169.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.41 141.26 34.1 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.533 HG22 HG12 ' A' ' 113' ' ' ILE . 35.5 t -138.06 142.04 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -109.92 105.24 14.34 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 170.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 74.9 m -92.74 136.7 33.0 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.56 ' HB ' HD13 ' A' ' 77' ' ' ILE . 7.3 tt -122.11 111.72 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 124.374 1.069 . . . . 0.0 109.768 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.433 ' HD2' HG22 ' A' ' 9' ' ' VAL . 12.7 m-85 -99.85 142.85 30.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.871 0.469 . . . . 0.0 109.844 176.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -111.64 113.92 26.63 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.0 t -97.73 141.79 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 124.646 1.179 . . . . 0.0 110.265 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.472 ' HG3' HD22 ' A' ' 103' ' ' ASN . 11.0 tp10 -141.63 105.6 4.76 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.917 1.287 . . . . 0.0 108.206 -172.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.472 HD22 ' HG3' ' A' ' 102' ' ' GLU . 37.9 m-80 61.49 30.96 19.04 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.539 1.136 . . . . 0.0 111.837 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.0 4.68 78.15 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 116.03 -0.532 . . . . 0.0 113.335 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -126.5 132.56 51.37 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.649 0.78 . . . . 0.0 109.697 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 62.9 mt -68.47 112.57 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 122.986 0.514 . . . . 0.0 110.088 -178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 32' ' ' CYS . . . -76.91 -37.79 54.74 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.361 0.664 . . . . 0.0 110.434 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.571 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 98.0 mttt -151.59 150.16 29.98 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.81 0.844 . . . . 0.0 109.279 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.0 135.35 32.62 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.502 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 3.1 m-90 -132.66 156.03 47.7 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -145.39 148.6 33.53 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.538 0.608 . . . . 0.0 110.959 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 8.4 ptpp? -126.5 129.98 49.72 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.162 0.985 . . . . 0.0 108.825 172.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.533 HG12 HG22 ' A' ' 95' ' ' VAL . 95.8 mt -90.85 129.65 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.54 -80.18 0.12 Allowed Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.64 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.25 161.12 30.14 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.486 ' HA ' HG12 ' A' ' 93' ' ' VAL . 72.4 Cg_endo -72.52 121.0 7.06 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.481 2.121 . . . . 0.0 112.262 170.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 92' ' ' GLU . 78.0 mtt-85 -122.56 153.48 39.2 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.52 0.728 . . . . 0.0 110.661 -177.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 120' ' ' SER . 40.1 mm -136.51 139.58 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.6 1.16 . . . . 0.0 109.648 -176.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.7 t -65.18 -41.89 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 123.656 0.782 . . . . 0.0 111.021 174.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 118' ' ' ILE . 45.5 t -63.32 -24.77 68.0 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.719 0.808 . . . . 0.0 112.073 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 61.1 mm-40 -104.06 20.02 19.01 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.973 0.509 . . . . 0.0 110.554 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -142.78 152.68 42.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.1 0.96 . . . . 0.0 110.01 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.4 p . . . . . 0 CA--C 1.561 1.386 0 C-N-CA 123.111 0.565 . . . . 0.0 109.623 172.073 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.484 1.246 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.18 24.7 0.42 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.586 0.354 . . . . 0.0 111.627 -175.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.3 p -64.63 -37.64 88.26 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.879 0.472 . . . . 0.0 110.039 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.04 -23.1 61.7 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.127 1.371 . . . . 0.0 112.977 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.537 HG23 ' HB ' ' A' ' 101' ' ' VAL . 29.1 mm -93.18 -29.27 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.386 1.074 . . . . 0.0 109.771 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -77.94 -24.16 48.29 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.704 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.451 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 88.2 mt -61.71 -57.67 23.12 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-O 118.136 -0.935 . . . . 0.0 112.012 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.578 ' HB3' ' HB3' ' A' ' 27' ' ' TRP . 14.1 Cg_endo -54.37 -50.11 14.61 Favored 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 122.766 2.31 . . . . 0.0 112.706 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.609 ' HA ' HE21 ' A' ' 12' ' ' GLN . 15.6 m -65.65 -32.4 58.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.901 -174.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.18 -50.63 31.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.583 0.753 . . . . 0.0 110.336 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 74.1 mmtt -66.84 -30.62 70.84 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.018 -176.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.609 HE21 ' HA ' ' A' ' 9' ' ' VAL . 37.1 mt-30 -59.17 -49.2 78.77 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 124.039 0.837 . . . . 0.0 111.288 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.75 -48.33 79.94 Favored 'General case' 0 C--O 1.246 0.897 0 O-C-N 123.774 0.671 . . . . 0.0 110.069 -175.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -58.27 -42.61 86.87 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 124.904 1.377 . . . . 0.0 109.055 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . -72.91 -25.78 61.17 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.753 -1.567 . . . . 0.0 112.796 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -68.14 -44.43 76.05 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.06 0.457 . . . . 0.0 110.324 -173.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -85.49 -29.58 24.16 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.644 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.87 -4.19 57.8 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.35 0.66 . . . . 0.0 111.497 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.42 ' HA ' ' CD2' ' A' ' 57' ' ' PHE . 23.6 mmt85 69.99 23.6 5.38 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.225 1.41 . . . . 0.0 112.796 171.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 19.7 m-20 -91.24 94.61 9.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.05 0.54 . . . . 0.0 110.541 177.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.475 HG13 HG12 ' A' ' 54' ' ' ILE . 20.2 mm -66.37 -28.7 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 123.514 0.726 . . . . 0.0 111.208 173.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -58.76 -47.15 85.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.945 0.498 . . . . 0.0 111.351 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.04 -33.97 33.16 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.421 0.689 . . . . 0.0 111.052 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -68.18 -8.88 42.63 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.777 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.709 ' SD ' ' HB1' ' A' ' 46' ' ' ALA . 24.9 tpp -120.53 -22.26 6.48 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 174.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.08 -28.79 69.86 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -175.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.578 ' HB3' ' HB3' ' A' ' 8' ' ' PRO . 96.1 m95 -94.17 9.63 37.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.786 0.834 . . . . 0.0 112.539 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -102.77 153.09 20.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.662 0.785 . . . . 0.0 110.002 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.47 140.43 44.59 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 168.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -67.81 -11.69 59.04 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.306 0.642 . . . . 0.0 112.37 -174.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -116.18 21.08 13.94 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.077 0.951 . . . . 0.0 111.232 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.7 t -59.76 147.55 37.55 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.45 ' HB2' ' HG2' ' A' ' 108' ' ' LYS . 33.8 mm-40 -107.21 105.42 15.39 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.171 0.988 . . . . 0.0 110.043 -175.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -102.55 112.63 25.46 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.587 0.755 . . . . 0.0 110.521 -173.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.421 ' HB2' ' HD1' ' A' ' 110' ' ' TRP . 13.9 m-85 -106.51 152.69 23.34 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.874 0.87 . . . . 0.0 110.322 175.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.64 161.95 18.4 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.355 1.062 . . . . 0.0 109.776 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.502 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 68.3 t80 -57.06 125.56 70.58 Favored Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 123.696 0.798 . . . . 0.0 110.26 174.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.24 -56.75 0.14 OUTLIER 'Cis proline' 0 C--N 1.386 2.545 0 CA-C-N 120.59 1.246 . . . . 0.0 113.898 2.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.9 57.72 0.37 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.558 0.743 . . . . 0.0 109.51 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.9 m -98.84 113.68 25.92 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.091 0.957 . . . . 0.0 110.533 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.47 102.46 0.7 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.9 mt -78.37 -42.26 30.91 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.621 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 48' ' ' GLU . . . -140.19 115.55 9.95 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.001 -169.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.7 46.13 1.66 Allowed Glycine 0 C--N 1.344 1.006 0 O-C-N 123.386 0.429 . . . . 0.0 112.284 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 p30 163.26 153.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 126.491 1.916 . . . . 0.0 108.561 -172.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.709 ' HB1' ' SD ' ' A' ' 25' ' ' MET . . . -68.56 -23.66 64.53 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.876 0.87 . . . . 0.0 113.328 -174.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.5 -48.76 80.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.753 0.421 . . . . 0.0 111.239 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.494 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 27.3 mt-10 -70.67 -30.17 66.69 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.652 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.513 HD12 ' HA ' ' A' ' 46' ' ' ALA . 63.9 mt -64.66 -52.43 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.487 0.715 . . . . 0.0 110.679 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.497 ' O ' HG13 ' A' ' 54' ' ' ILE . 6.4 ptp180 -64.2 -43.12 96.03 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.443 -175.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.9 t -67.91 -39.33 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.13 0.972 . . . . 0.0 111.743 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -71.33 -29.74 65.37 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.627 0.371 . . . . 0.0 110.851 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -73.61 -30.57 63.06 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 119.114 -0.469 . . . . 0.0 111.346 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 50' ' ' ARG . 77.6 mt -58.59 -38.75 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -57.2 -41.91 80.27 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.916 0.76 . . . . 0.0 111.717 174.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -73.59 -31.03 63.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.119 0.568 . . . . 0.0 110.722 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.42 ' CD2' ' HA ' ' A' ' 19' ' ' ARG . 2.6 m-30 -78.42 3.21 16.4 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.35 0.66 . . . . 0.0 111.478 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.417 ' HE2' HG22 ' A' ' 54' ' ' ILE . 73.4 mmtt -81.67 -18.38 44.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.312 0.645 . . . . 0.0 112.183 171.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.65 121.03 79.51 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-O 119.205 -0.426 . . . . 0.0 110.188 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.95 -20.05 34.42 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.357 2.038 . . . . 0.0 111.687 177.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -84.87 -13.36 51.16 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.885 0.874 . . . . 0.0 111.676 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 83' ' ' THR . 30.2 tp -62.85 112.56 2.6 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -173.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -145.5 118.03 8.56 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.18 105.54 3.31 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -96.3 105.73 17.84 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 tt -85.88 119.83 26.62 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.465 ' H ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -107.44 -31.43 8.16 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.706 0.802 . . . . 0.0 111.231 -174.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.418 ' N ' HD22 ' A' ' 67' ' ' LEU . 84.7 m -142.87 132.38 23.66 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.923 0.889 . . . . 0.0 109.805 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -135.67 135.07 39.82 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 164.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.494 HG22 ' HB ' ' A' ' 77' ' ' ILE . 20.4 m -122.56 142.41 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.5 tt -124.84 138.47 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 121.229 0.538 . . . . 0.0 111.219 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -139.76 99.41 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 125.284 1.434 . . . . 0.0 107.999 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.29 -126.79 23.15 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.718 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.423 ' HA ' HG13 ' A' ' 5' ' ' ILE . 21.1 p-10 -94.78 24.27 4.84 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.228 0.611 . . . . 0.0 111.411 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.2 t -131.43 130.75 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.404 1.082 . . . . 0.0 109.433 -174.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.9 t -120.93 142.53 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 122.982 0.513 . . . . 0.0 110.043 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.673 HD13 ' HB ' ' A' ' 98' ' ' ILE . 5.3 mm -98.28 107.69 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 165.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -91.57 109.38 20.68 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 167.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -100.72 108.51 20.38 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 175.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.53 129.35 42.73 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.757 1.223 . . . . 0.0 109.734 -174.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.5 m -83.91 103.02 12.83 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 172.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.6 m -89.33 137.71 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 62' ' ' LEU . 29.2 m -95.58 135.45 37.23 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.195 0.598 . . . . 0.0 109.688 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -131.45 -166.11 1.66 Allowed 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -125.45 99.57 6.09 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 122.122 -0.361 . . . . 0.0 110.061 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.434 ' CD2' ' HA2' ' A' ' 91' ' ' GLY . 20.7 m-30 -99.53 135.74 20.54 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 172.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.03 -12.5 35.68 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.997 2.465 . . . . 0.0 113.812 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -83.98 -11.2 57.17 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA3' HG23 ' A' ' 118' ' ' ILE . . . 173.09 -119.3 0.75 Allowed Glycine 0 C--N 1.35 1.34 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.346 171.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -71.4 -80.61 0.06 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.215 0.606 . . . . 0.0 110.998 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.434 ' HA2' ' CD2' ' A' ' 86' ' ' PHE . . . 123.22 27.0 1.57 Allowed Glycine 0 C--N 1.344 0.978 0 N-CA-C 114.032 0.373 . . . . 0.0 114.032 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -89.53 141.12 28.87 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' A' ' 116' ' ' PRO . 30.4 m -133.49 133.37 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.199 0.599 . . . . 0.0 109.557 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.51 109.24 15.79 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.481 HG22 HG12 ' A' ' 113' ' ' ILE . 39.0 t -112.43 156.65 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -175.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -128.69 101.93 6.35 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 111' ' ' PHE . 76.2 m -92.08 105.7 17.88 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.673 ' HB ' HD13 ' A' ' 77' ' ' ILE . 8.5 tt -92.2 112.19 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.044 0.938 . . . . 0.0 109.58 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -99.94 148.84 24.05 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.571 0.748 . . . . 0.0 110.127 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -118.69 111.85 19.04 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.552 HG22 HG12 ' A' ' 106' ' ' ILE . 53.6 t -98.31 112.18 29.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.012 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -117.18 130.9 56.9 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 62.7 32.1 16.34 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.581 0.752 . . . . 0.0 111.386 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.63 -5.88 82.19 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 115.657 -0.702 . . . . 0.0 114.58 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 63.5 mmt-85 -132.22 147.44 52.41 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.6 0.76 . . . . 0.0 109.281 -175.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.552 HG12 HG22 ' A' ' 101' ' ' VAL . 66.4 mt -68.94 100.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.395 0.678 . . . . 0.0 110.256 -175.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.68 -25.71 35.31 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.563 0.745 . . . . 0.0 111.312 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 33' ' ' GLN . 96.8 mttt -145.58 150.03 35.63 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.788 0.835 . . . . 0.0 108.751 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.36 135.11 14.51 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.507 0.723 . . . . 0.0 109.408 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.421 ' HD1' ' HB2' ' A' ' 35' ' ' TYR . 2.5 m-90 -133.06 130.63 39.62 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.476 ' HB2' ' SG ' ' A' ' 97' ' ' CYS . 11.8 p90 -119.66 138.95 52.94 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.252 0.933 . . . . 0.0 109.583 175.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -127.36 119.9 27.29 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.371 0.668 . . . . 0.0 109.213 -178.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.481 HG12 HG22 ' A' ' 95' ' ' VAL . 88.7 mt -88.75 130.1 38.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.04 -78.8 0.17 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.153 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -158.38 163.26 24.96 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.632 ' HA ' HG12 ' A' ' 93' ' ' VAL . 74.5 Cg_endo -71.04 114.74 4.0 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.28 1.987 . . . . 0.0 112.189 170.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -107.05 150.68 26.27 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.887 0.875 . . . . 0.0 108.973 176.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 121' ' ' GLN . 32.2 mm -138.11 121.35 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.875 0.87 . . . . 0.0 108.98 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.77 -40.96 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.024 0.53 . . . . 0.0 110.752 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.2 m -58.26 -66.38 0.49 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.85 0.86 . . . . 0.0 110.99 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.512 ' H ' HG22 ' A' ' 118' ' ' ILE . 9.7 tt0 -87.66 94.82 9.85 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.848 0.859 . . . . 0.0 109.397 175.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -147.1 120.78 9.18 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.8 t . . . . . 0 C--O 1.252 1.21 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -177.559 . . . . . . . . 0 0 . 1 stop_ save_